Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
A2M	"CPAMD5, FWP007, S863-7"	ENSG00000175899	Alpha-2-macroglobulin	P01023	12	9067664-9116229	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 231.0;lung: 227.4"	"Group enriched"	"Detected in some"	5	"AF22: 111.0;ASC diff: 33.0;Hep G2: 89.4;SK-MEL-30: 32.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 4.4"	"Group enriched"	"Detected in many"	7	"dendritic cells: 1.4;T-cells: 4.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA002265, CAB017621"	Supported				"Secreted to blood"	220000000000	220000000000			"CAB017621: AB_1118894, HPA002265: AB_1078142"	"unprognostic (1.73e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.29e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.95e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.19e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.04e-3)"	"unprognostic (2.32e-2)"	"unprognostic (8.58e-2)"	"unprognostic (9.03e-3)"	77.4	20.5	12.5	14.7	16.8	0.3	39.6	6.1	16.1	41.8	27.3	25.3	10.5	15.0	54.6	28.2	39.5	30.6	49.7	68.0	12.4	10.2	50.0	231.0	227.4	14.9	16.9	8.0	40.8	13.0	20.9	20.4	48.0	20.5	77.3	35.9	47.5	20.5	26.3	26.0	10.2	23.1	57.7	20.9	42.3	25.8	26.2	13.0	4.0	29.5	17.0	8.6	68.9	59.0	0.2	1.4	0.0	0.4	0.0	4.4	0.3	0.0	0.0	111.0	0.0	33.0	2.4	0.3	13.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	89.4	0.0	0.1	0.1	5.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	32.1	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.1	0.0	0.1	0.0	0.0	2.1	0.0	0.4	0.0	4.4	0.2	2.6	0.2	0.5	1.2	0.3	0.0	0.1	0.7	0.0	0.0	0.0	1.4	0.0	0.3	12.5	16.8	6.1	16.1	12.4	10.2	16.9	8.0	20.5	13.0
AADACL2	MGC72001	ENSG00000197953	"Arylacetamide deacetylase like 2"	Q6P093	3	151733916-151761339	"Predicted secreted proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	10	"placenta: 8.6;skin 1: 26.1;tongue: 22.2"	"Cell line enriched"	"Detected in single"	5	"hTCEpi: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"							"unprognostic (2.20e-2)"				"unprognostic (3.10e-3)"		"unprognostic (2.63e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.22e-1)"				"unprognostic (3.00e-1)"			"unprognostic (2.91e-4)"	1.3	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.4	0.8	0.0	0.7	0.0	0.0	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.4	0.0	0.0	0.4	0.0	0.2	26.1	0.3	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.0	22.2	1.0	0.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ABHD15		ENSG00000168792	"Abhydrolase domain containing 15"	Q6UXT9	17	29560547-29567137	"Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 11.1;MAIT T-cell: 5.0;NK-cell: 7.2;plasmacytoid DC: 17.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA014470	Approved		Approved	Nucleoplasm,Cytosol	"Secreted in other tissues"			"Nucleoplasm, Cytosol"		"HPA014470: AB_1852993"	"unprognostic (1.79e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.60e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.61e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.00e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.46e-1)"	"unprognostic (5.45e-2)"	22.6	3.5	4.9	6.0	3.2	5.4	21.6	2.9	4.1	3.8	8.8	4.2	4.4	8.5	4.2	3.1	4.1	4.3	7.8	6.6	2.1	1.9	8.4	21.2	5.6	12.7	2.7	3.9	2.8	10.9	8.8	8.5	3.2	4.3	4.0	5.0	3.6	4.5	4.6	2.1	3.4	12.7	5.5	3.3	9.1	6.3	1.4	4.6	1.6	5.2	2.7	6.0	5.6	9.1	2.0	17.0	11.1	0.4	7.2	5.0	0.7	3.8	14.9	1.9	5.3	20.6	9.0	7.9	5.3	5.9	5.3	4.8	3.4	2.0	5.7	3.9	5.6	10.6	6.6	2.2	2.9	17.6	5.0	2.3	7.4	4.3	6.3	5.9	10.7	6.7	6.1	5.1	0.9	3.8	3.0	5.5	2.8	5.2	5.6	6.9	0.4	4.5	13.1	7.3	13.2	9.4	5.9	1.3	2.2	7.9	3.6	2.0	9.1	13.7	4.7	3.0	3.9	7.6	4.6	9.3	6.2	3.0	6.1	3.7	6.5	11.1	0.4	1.8	1.9	0.2	5.0	1.0	1.0	1.7	1.0	2.0	0.3	1.0	0.5	7.2	0.2	17.0	0.9	0.7	4.9	3.2	2.9	4.1	2.1	1.9	2.7	3.9	4.3	4.6
AC233755.1		ENSG00000275063	"Immunoglobulin heavy variable 4-38-2 "	P0DP08	Unmapped	41444-41876	"Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"blood: 75.1;intestine: 32.1;lymphoid tissue: 37.1;urinary bladder: 45.9"	"Cell line enriched"	"Detected in some"	8	"REH: 54.7"									"Group enriched"	"Detected in some"	363	"memory B-cell: 75.1;naive B-cell: 42.7"	"Lineage enriched"	"Detected in single"	463	"B-cells: 75.1"														"Secreted to blood"																							0.8	0.0		14.4		2.6	2.8		0.0	10.9	32.1			24.1	0.0	0.0	4.3	0.0	1.0	0.0			0.0	0.0	0.7	5.5			0.0	0.0	0.0		0.0		0.0	11.1		11.1	0.0	0.0	0.0	6.4	0.6		9.4	11.7	0.0			0.0		37.1	45.9		75.1	0.1	0.1	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	7.2	0.1	0.1	0.0	54.7	0.6	1.2	0.0	0.0	0.0	3.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.1	0.0	0.0	0.0	42.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	6.0										
ACR		ENSG00000100312	Acrosin	P10323	22	50738196-50745334	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	87	"testis: 106.3"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.7;HUVEC TERT2: 1.1;NTERA-2: 1.7;TIME: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA048687	Enhanced				"Secreted in male reproductive system"					"HPA048687: "	"unprognostic (1.71e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.27e-3)"	"unprognostic (3.58e-2)"	"unprognostic (8.04e-2)"	"unprognostic (3.30e-3)"	"unprognostic (5.41e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.25e-1)"	0.9	0.0	0.2	0.2	0.3	0.0	0.6	0.2	0.3	0.2	0.2	0.2	0.2	0.1	0.3	0.7	0.2	0.4	0.2	0.2	0.2	0.0	0.2	0.3	0.6	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.2	1.2	0.0	106.3	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.6	0.2	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.4	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.0	1.4	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.3	0.2	0.0	0.2	0.2	0.2	0.2
ADAMTS12		ENSG00000151388	"ADAM metallopeptidase with thrombospondin type 1 motif 12"	P58397	5	33523535-33892192	"Plasma proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 17.3;BJ hTERT+: 15.7;hTEC/SVTERT24-B: 22.6;U-2 OS: 17.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA035973, HPA075079"	Uncertain		Approved	Nucleoli,Mitochondria	"Secreted to extracellular matrix"			Nucleoli	Mitochondria	"HPA035973: AB_10669663, HPA075079: "	"unprognostic (6.18e-3)"	"unprognostic (3.12e-4)"	"unprognostic (1.05e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.60e-2)"	"unprognostic (3.49e-3)"	"unprognostic (3.78e-3)"	"unprognostic (3.39e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.45e-1)"	"unprognostic (4.27e-7)"	"unprognostic (4.45e-3)"	"unprognostic (1.47e-1)"	"unprognostic (5.85e-2)"	"prognostic unfavourable (6.78e-4)"	13.7	5.4	0.2	2.5	0.8	0.0	17.6	0.3	1.0	6.0	3.0	2.3	2.6	0.6	13.0	4.4	1.4	3.1	5.9	1.4	0.3	0.6	2.0	2.1	9.4	4.2	1.2	0.2	4.9	8.7	1.2	0.9	5.5	2.1	6.7	1.4	2.7	4.4	4.2	4.1	2.0	1.6	9.4	6.5	0.6	1.8	5.0	0.3	0.1	2.6	4.1	1.6	4.3	7.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	12.9	0.4	11.7	0.0	17.3	8.3	0.0	6.0	15.7	8.0	9.8	0.0	0.0	0.0	0.0	4.2	0.4	0.3	7.9	11.2	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	6.5	0.0	22.6	5.9	0.0	0.0	0.0	12.9	0.0	0.0	0.0	2.4	0.0	0.0	13.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	17.5	0.1	3.6	2.0	1.5	0.0	12.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.3	1.0	0.3	0.6	1.2	0.2	2.1	0.3
ADAMTS14		ENSG00000138316	"ADAM metallopeptidase with thrombospondin type 1 motif 14"	Q8WXS8	10	70672803-70762441	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.4;gallbladder: 12.3;placenta: 13.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 10.2;K-562: 11.4;RH-30: 6.2;U-138 MG: 10.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.1"	"Lineage enriched"	"Detected in single"	11	"monocytes: 1.1"	"Region enriched"	"Detected in single"	5	"hippocampal formation: 0.4"	"Low region specificity"	"Detected in many"								"Secreted to extracellular matrix"						"unprognostic (1.30e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.98e-3)"	"unprognostic (3.54e-3)"	"unprognostic (2.17e-3)"	"unprognostic (2.40e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.98e-2)"	"unprognostic (6.81e-2)"	"unprognostic (3.84e-13)"	"unprognostic (3.90e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.16e-2)"	1.7	0.5	4.6	5.4	10.7	1.1	0.6	1.0	4.7	1.3	3.3	13.4	1.0	4.1	1.4	1.0	1.8	1.1	12.3	2.8	7.2	3.0	0.7	0.5	2.7	2.0	8.1	5.7	0.7	0.5	0.2	0.4	13.5	4.0	1.1	3.6	2.6	1.6	0.4	0.4	2.5	5.7	3.9	4.6	0.8	2.6	0.9	5.9	0.5	0.4	2.3	2.3	6.7	0.8	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	4.7	0.0	1.2	3.6	0.3	2.0	0.0	10.2	0.0	0.8	1.8	0.8	0.0	0.0	0.1	3.9	0.0	0.4	0.0	0.3	0.0	0.0	2.7	0.4	0.1	0.9	0.2	0.0	11.4	0.0	1.4	0.0	0.0	1.0	0.4	0.0	0.0	6.2	0.2	0.0	0.0	3.9	0.6	0.0	0.1	0.3	0.0	0.0	0.0	10.3	0.1	0.8	0.5	0.9	0.0	0.0	0.5	1.1	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.6	10.7	1.0	4.7	7.2	3.0	8.1	5.7	4.0	5.9
ADAMTS15		ENSG00000166106	"ADAM metallopeptidase with thrombospondin type 1 motif 15"	Q8TE58	11	130448974-130476641	"Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 47.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 36.0;ASC TERT1: 21.7;EFO-21: 18.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA042867	Uncertain		Approved	Cytosol	"Secreted to extracellular matrix"			Cytosol		"HPA042867: AB_10794535"	"unprognostic (7.64e-2)"	"unprognostic (1.49e-3)"	"unprognostic (7.15e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.07e-3)"	"unprognostic (7.07e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (9.72e-4)"	"unprognostic (6.18e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.29e-2)"	"unprognostic (5.95e-3)"	"unprognostic (6.68e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (5.63e-5)"	47.4	1.1	0.2	1.7	0.3	0.1	14.5	0.1	0.8	3.4	3.8	0.8	3.0	0.6	3.7	9.8	3.8	9.3	9.1	12.6	0.4	0.3	9.1	0.4	6.6	5.6	0.8	0.2	7.0	1.6	0.9	1.0	16.4	1.3	3.7	2.1	10.9	1.0	1.3	1.6	4.1	3.1	6.9	1.4	1.9	4.9	2.4	0.6	0.7	9.8	2.5	0.8	8.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.8	0.4	36.0	21.7	0.0	1.3	2.5	0.5	0.1	0.2	0.6	0.0	18.1	0.1	3.3	0.3	0.3	0.1	0.0	0.8	0.0	1.6	0.0	0.3	0.0	0.0	7.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.6	2.7	0.0	2.0	0.0	0.0	0.0	0.3	0.0	5.8	0.0	0.0	1.9	0.0	0.0	0.3	4.3	3.4	1.6	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.7	0.4	0.3	0.8	0.2	1.3	0.6
ADAMTS16	ADAMTS16s	ENSG00000145536	"ADAM metallopeptidase with thrombospondin type 1 motif 16"	Q8TE57	5	5140330-5320304	"Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.4;ovary: 16.3"	"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 6.2;U-2 OS: 4.9;U-2197: 9.1;U-87 MG: 4.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"cerebellum: 20.4;cerebral cortex: 5.2"	"Cell type enriched"	"Detected in single"	10	"NK-cell: 3.6"	"Lineage enriched"	"Detected in single"	10	"NK-cells: 3.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA067668			Approved	"Nucleoplasm,Nuclear membrane,Midbody ring,Mitochondria"	"Secreted to extracellular matrix"			"Nuclear membrane, Mitochondria"	"Nucleoplasm, Midbody ring"	"HPA067668: "	"unprognostic (8.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.98e-4)"	"unprognostic (1.91e-2)"	"unprognostic (5.04e-2)"	"unprognostic (7.64e-2)"	"unprognostic (7.80e-3)"	"unprognostic (2.12e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.18e-1)"	"prognostic favourable (3.29e-5)"	"unprognostic (1.20e-4)"	"unprognostic (1.46e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.86e-3)"	7.4	0.4	1.8	0.5	2.8	0.6	1.0	20.4	5.2	2.6	0.9	0.1	3.7	0.6	2.3	11.0	1.9	1.1	8.8	0.9	1.7	0.5	5.4	0.6	0.9	0.2	0.5	1.9	16.3	6.3	0.0	0.5	0.2	2.2	0.7	0.4	0.0	0.4	0.8	0.5	0.5	0.6	10.4	0.6	0.4	0.6	0.8	0.0	0.0	0.8	0.0	0.1	3.4	1.5	0.2	0.1	0.3	0.0	3.6	0.2	0.0	2.6	2.7	2.7	0.1	0.2	0.6	0.2	0.1	0.1	0.6	0.9	0.1	2.4	0.2	3.3	0.0	0.2	0.0	0.0	0.8	0.1	1.6	0.1	3.9	0.1	0.0	0.3	0.1	0.0	0.0	6.2	0.2	0.0	0.8	0.4	1.2	0.1	0.1	0.3	1.7	2.5	0.5	3.3	0.2	0.1	0.0	1.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	3.3	4.9	9.1	2.1	0.5	0.2	0.1	4.7	0.1	0.4	0.3	0.0	0.1	0.2	0.0	0.2	0.0	0.2	0.1	0.1	0.2	0.2	0.1	0.3	3.6	0.0	0.0	0.0	0.0	1.8	2.8	20.4	5.2	1.7	0.5	0.5	1.9	2.2	0.0
ADAMTS19		ENSG00000145808	"ADAM metallopeptidase with thrombospondin type 1 motif 19"	Q8TE59	5	129460265-129738683	"Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 16.6;endometrium 1: 14.6;smooth muscle: 9.0"	"Group enriched"	"Detected in some"	8	"MCF7: 11.7;SH-SY5Y: 27.0"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"olfactory region: 4.8"	"Low region specificity"	"Detected in all"			"HPA056171, HPA058438"	Uncertain		Approved	Vesicles,Midbody	"Secreted to extracellular matrix"			"Vesicles, Midbody"		"HPA056171: , HPA058438: "	"unprognostic (1.14e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.49e-2)"		"unprognostic (3.93e-2)"		"unprognostic (4.17e-2)"	"unprognostic (5.99e-3)"	"unprognostic (5.17e-1)"		"unprognostic (1.14e-1)"	"unprognostic (5.88e-2)"		"unprognostic (3.06e-2)"	0.2	1.2	0.7	0.6	3.6	0.1	0.2	0.0	4.9	16.6	0.5	1.2	0.0	0.4	14.6	0.3	1.5	2.6	0.8	0.5	1.0	0.8	0.7	0.1	0.2	0.2	0.5	4.3	2.8	0.2	0.2	0.1	5.3	1.8	0.4	0.6	0.9	1.1	0.2	0.8	0.2	0.3	9.0	1.0	0.2	0.2	0.4	0.8	0.0	0.1	1.8	0.1	0.9	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	27.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	3.6	0.0	4.9	1.0	0.8	0.5	4.3	1.8	0.8
ADAMTS3	"ADAMTS-4, KIAA0366"	ENSG00000156140	"ADAM metallopeptidase with thrombospondin type 1 motif 3"	O15072	4	72280969-72569386	"Cancer-related genes, Predicted secreted proteins"		"Heparin-binding, Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 12.3;AN3-CA: 7.1;HEL: 12.7;K-562: 10.8;SH-SY5Y: 6.5;U-2 OS: 7.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA021368, HPA021369"	Uncertain		Approved	"Intermediate filaments"	"Secreted to extracellular matrix"			"Intermediate filaments"		"HPA021368: , HPA021369: "	"unprognostic (1.93e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.05e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.26e-3)"	"unprognostic (1.60e-3)"	"unprognostic (5.92e-4)"	"unprognostic (3.11e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.60e-1)"	"unprognostic (8.63e-3)"	"unprognostic (1.65e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.50e-4)"	5.3	2.6	3.3	4.4	5.6	2.1	7.8	0.3	4.6	4.4	2.3	1.1	1.9	0.5	9.6	14.4	1.0	7.5	1.9	2.8	1.3	0.9	4.7	2.7	3.1	2.0	0.7	2.2	7.5	1.0	12.4	1.1	8.2	2.2	2.6	1.1	3.9	1.4	3.4	0.8	1.5	0.9	4.6	1.8	1.9	1.6	5.6	1.3	0.6	4.4	0.8	1.0	2.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	7.1	0.1	0.3	0.1	0.6	2.0	1.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	1.7	0.0	1.6	12.7	0.9	0.0	0.2	0.0	0.0	1.6	0.1	0.6	0.1	0.0	10.8	0.0	0.0	0.0	1.1	0.0	2.0	3.7	0.0	2.5	0.0	4.2	0.0	0.5	6.5	0.0	0.5	0.1	0.1	0.1	0.1	5.3	7.9	0.0	0.6	0.0	0.0	0.0	1.1	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	5.6	0.3	4.6	1.3	0.9	0.7	2.2	2.2	1.3
ADAMTS5	"ADAMTS11, ADMP-2"	ENSG00000154736	"ADAM metallopeptidase with thrombospondin type 1 motif 5"	Q9UNA0	21	26917912-26966513	"Cancer-related genes, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 21.2;placenta: 20.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 23.3;ASC TERT1: 9.9;fHDF/TERT166: 9.3;RH-30: 24.7;U-87 MG: 8.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	6	"classical monocyte: 1.5"	"Lineage enriched"	"Detected in single"	6	"monocytes: 1.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"HPA005661, CAB025996, HPA030906, HPA030908"	Approved		Supported	Nucleoplasm	"Secreted to extracellular matrix"	18000	18000	Nucleoplasm		"CAB025996: , HPA005661: AB_1078101, HPA030906: , HPA030908: "	"unprognostic (1.97e-1)"	"unprognostic (2.88e-3)"	"unprognostic (2.69e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.67e-1)"	"unprognostic (2.10e-2)"	"unprognostic (4.38e-8)"	"unprognostic (1.11e-3)"	"unprognostic (7.66e-2)"	"unprognostic (6.17e-2)"	"unprognostic (8.13e-2)"	"unprognostic (7.76e-2)"	"prognostic unfavourable (2.46e-4)"	"unprognostic (6.69e-3)"	"unprognostic (3.01e-1)"	"prognostic unfavourable (8.54e-4)"	"unprognostic (1.15e-1)"	14.1	0.4	1.0	1.6	0.6	0.0	21.2	2.5	0.9	5.5	2.3	0.4	7.2	0.3	10.7	8.2	1.2	3.3	1.0	6.9	1.0	0.0	1.6	0.8	1.2	0.4	1.1	0.4	14.9	0.4	0.1	0.4	20.9	1.5	2.2	0.8	2.3	1.8	9.7	11.0	3.3	2.4	6.2	1.1	6.4	1.8	2.3	0.4	0.6	5.3	1.5	0.6	2.8	3.1	0.0	0.2	0.0	1.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	23.3	9.9	0.0	1.2	0.2	1.4	0.5	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	2.0	0.0	0.9	0.0	0.3	0.0	2.4	0.0	0.0	5.4	0.0	0.9	0.1	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.1	0.0	0.0	24.7	0.0	2.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.3	1.3	0.5	0.0	0.0	0.0	8.9	0.1	1.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.6	2.5	0.9	1.0	0.0	1.1	0.4	1.5	0.4
ADAMTS6	ADAM-TS6	ENSG00000049192	"ADAM metallopeptidase with thrombospondin type 1 motif 6"	Q9UKP5	5	65148736-65481920	"Cancer-related genes, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"placenta: 32.4"	"Cell line enhanced"	"Detected in many"		"BJ: 9.8;HBF TERT88: 10.8;hTEC/SVTERT24-B: 10.0;hTERT-HME1: 11.9;TIME: 11.2;U-2197: 12.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 4.8;naive B-cell: 3.6"	"Group enriched"	"Detected in many"	13	"B-cells: 4.8;T-cells: 1.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA043441	Enhanced				"Secreted to extracellular matrix"					"HPA043441: "	"unprognostic (1.53e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.70e-3)"	"unprognostic (4.33e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.39e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.77e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.13e-6)"	"unprognostic (3.23e-5)"	"unprognostic (2.09e-1)"	"unprognostic (3.02e-4)"	"unprognostic (4.18e-3)"	2.2	0.7	0.9	2.0	0.8	0.3	1.8	0.2	1.8	2.9	1.4	0.8	1.6	0.6	5.1	3.0	1.0	2.7	6.3	2.3	0.8	0.9	1.5	0.5	2.3	1.7	0.8	1.4	1.8	0.5	0.4	2.0	32.4	2.9	2.3	0.9	1.4	0.6	0.9	0.4	0.8	2.4	5.4	3.2	3.4	1.8	1.9	0.7	3.3	0.9	1.2	1.9	3.6	1.7	4.8	0.2	0.0	0.0	0.0	1.4	0.1	2.0	0.0	0.5	0.5	0.0	1.6	0.0	9.8	5.8	6.1	7.2	0.0	0.2	0.0	0.0	3.7	0.4	0.1	1.9	10.8	1.5	0.0	0.1	3.6	0.2	0.3	0.0	0.5	0.7	0.0	10.0	11.9	5.4	0.0	0.0	3.7	0.0	0.5	0.0	0.0	0.0	0.3	2.1	0.0	0.0	0.0	0.3	0.4	0.2	0.0	0.0	0.0	0.0	11.2	2.4	3.6	12.8	7.8	0.0	0.0	0.0	2.7	0.5	0.0	0.0	0.0	0.0	1.3	0.0	1.0	4.8	0.3	0.5	0.0	3.6	1.3	1.4	0.0	0.0	0.0	0.2	0.0	0.1	0.9	0.8	0.2	1.4	0.8	0.9	0.8	1.4	2.9	0.7
ADAMTS7	"ADAM-TS7, DKFZp434H204"	ENSG00000136378	"ADAM metallopeptidase with thrombospondin type 1 motif 7"	Q9UKP4	15	78759203-78811431	"Plasma proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 31.9"	"Cell line enriched"	"Detected in some"	9	"HMC-1: 76.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA045284, HPA048453"	Uncertain		Supported	Vesicles	"Secreted to extracellular matrix"			Vesicles		"HPA045284: , HPA048453: "	"unprognostic (5.94e-3)"	"unprognostic (9.94e-3)"	"unprognostic (2.76e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.88e-4)"	"unprognostic (3.34e-3)"	"unprognostic (2.89e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.34e-2)"	"prognostic unfavourable (9.53e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.66e-2)"	"unprognostic (8.86e-2)"	6.0	4.1	0.7	4.1	2.5	0.3	2.8	1.5	1.8	4.3	2.9	1.7	1.4	2.2	8.6	1.9	2.2	1.6	9.9	31.9	1.7	0.6	1.5	0.8	5.3	3.2	1.2	0.7	8.7	1.0	0.4	0.7	4.0	2.3	1.5	0.6	4.4	0.9	1.1	1.8	1.4	2.8	4.5	1.3	4.1	1.7	3.5	2.6	0.3	1.6	1.1	1.4	3.1	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.8	2.1	2.0	2.4	6.1	1.0	0.3	0.3	0.1	0.0	0.0	0.0	1.4	0.1	0.1	0.1	0.5	0.0	0.0	0.1	0.5	0.1	0.0	2.0	0.0	76.1	0.9	0.6	0.5	0.3	6.9	0.0	0.2	1.6	0.0	0.0	1.3	1.3	0.4	4.8	2.2	0.0	0.1	0.2	0.0	7.0	1.3	0.0	0.1	0.9	0.1	8.5	2.8	0.3	0.9	0.0	0.0	0.0	0.0	0.4	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	2.5	1.5	1.8	1.7	0.6	1.2	0.7	2.3	2.6
ADAMTS8	"ADAM-TS8, FLJ41712, METH2"	ENSG00000134917	"ADAM metallopeptidase with thrombospondin type 1 motif 8"	Q9UP79	11	130404925-130428993	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		"Heparin-binding, Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 13.0;lung: 21.0"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.9;HMC-1: 5.7;NTERA-2: 2.8;U-2 OS: 12.9"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 6.4;cerebral cortex: 7.6;hippocampal formation: 7.3;olfactory region: 5.2"	HPA066349	Approved				"Secreted to extracellular matrix"	2200000	2200000			"HPA066349: "	"unprognostic (4.76e-6)"	"unprognostic (3.92e-2)"	"unprognostic (6.13e-2)"	"prognostic favourable (1.38e-4)"	"unprognostic (2.41e-1)"	"unprognostic (7.81e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.09e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.40e-1)"	"unprognostic (4.66e-3)"	"unprognostic (4.03e-3)"	"unprognostic (5.23e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.41e-1)"	2.1	0.1	1.5	10.2	2.5	0.0	0.5	0.6	4.4	1.3	5.3	0.5	0.2	1.1	2.6	1.5	3.1	1.7	13.0	3.9	1.6	0.6	2.1	0.2	21.0	0.2	0.7	0.2	1.0	0.7	0.0	0.8	2.7	0.9	2.9	0.5	0.7	0.3	5.7	0.4	0.1	1.6	7.4	0.8	0.9	5.6	0.2	0.4	0.2	0.4	0.2	0.4	3.8	3.4	0.0	0.0	0.2	0.0	0.1	0.6	0.0	0.0	0.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	1.8	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	2.5	0.6	3.2	1.6	0.6	0.7	0.2	0.9	0.4
ADAMTSL3	"KIAA1233, punctin-2"	ENSG00000156218	"ADAMTS like 3"	P82987	15	83654086-84039842	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"EFO-21: 12.0;RPTEC TERT1: 14.0;TIME: 12.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA034773, HPA034774"	Uncertain		Approved	Vesicles	"Secreted in other tissues"	110000	110000	Vesicles		"HPA034773: AB_10601965, HPA034774: "	"unprognostic (2.20e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.56e-1)"	"unprognostic (9.89e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.27e-1)"	"unprognostic (9.18e-3)"	"unprognostic (5.92e-2)"	"unprognostic (9.97e-2)"	"unprognostic (3.85e-1)"	"unprognostic (8.59e-3)"	"unprognostic (5.00e-3)"	"unprognostic (4.62e-1)"	"unprognostic (8.64e-2)"	"unprognostic (3.95e-5)"	6.9	5.0	1.5	6.2	2.9	0.0	5.3	2.8	2.8	8.7	14.3	4.4	1.8	1.5	12.0	3.7	5.4	5.6	4.7	15.9	3.1	1.3	3.8	12.1	10.6	1.5	5.1	2.9	2.0	12.9	1.1	2.6	12.0	7.2	8.1	3.7	19.9	4.7	8.7	2.6	2.2	3.1	26.8	3.6	2.0	7.5	2.9	4.2	0.2	4.6	2.2	0.5	8.0	13.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.9	0.0	14.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	12.8	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.9	2.8	2.8	3.1	1.3	5.1	2.9	7.2	4.2
ADAMTSL4	"DKFZP434K1772, TSRC1"	ENSG00000143382	"ADAMTS like 4"	Q6UY14	1	150549369-150560937	"Disease related genes, Predicted secreted proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"placenta: 157.1"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 29.5;BEWO: 62.2;HSkMC: 13.9;K-562: 19.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"classical monocyte: 1.6;intermediate monocyte: 1.8;neutrophil: 2.3;non-classical monocyte: 3.5"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.3;monocytes: 3.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA006279	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	47000000	47000000	"Plasma membrane, Cytosol"		"HPA006279: AB_1078102"	"unprognostic (2.00e-2)"	"unprognostic (1.24e-2)"	"prognostic unfavourable (1.86e-4)"	"unprognostic (8.09e-4)"	"prognostic unfavourable (2.43e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.52e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (4.35e-7)"	"unprognostic (1.90e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.40e-3)"	14.4	2.4	0.8	8.9	1.4	2.2	13.2	0.7	1.1	11.0	8.2	1.5	3.9	2.2	9.7	8.1	19.7	11.1	6.6	10.7	1.0	0.2	3.4	14.9	13.3	2.3	1.4	0.4	14.5	1.8	0.2	1.3	157.1	3.4	9.4	2.4	19.1	5.7	2.3	21.1	5.4	6.0	17.4	2.2	3.9	8.9	3.3	1.1	0.8	3.8	15.5	4.8	19.1	15.9	0.0	0.5	2.3	3.5	0.0	0.1	0.6	6.5	0.1	0.1	1.2	6.0	29.5	62.2	6.3	5.6	3.8	2.2	0.5	2.5	0.0	1.3	4.3	3.3	0.2	0.9	1.5	0.5	0.1	1.8	0.7	2.6	4.8	0.0	0.9	13.9	0.2	0.9	2.1	0.0	19.9	0.1	0.6	0.1	0.0	0.3	1.1	0.2	0.0	0.0	0.0	0.6	0.2	0.0	0.2	2.0	4.9	0.0	1.4	3.4	1.1	0.2	1.8	2.6	0.1	0.5	0.1	1.4	0.2	1.2	0.1	0.0	1.6	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.3	0.0	3.5	0.0	0.0	0.6	0.8	1.4	0.7	1.1	1.0	0.2	1.4	0.4	3.4	1.1
ADCK1	FLJ39600	ENSG00000063761	"AarF domain containing kinase 1"	Q86TW2	14	77800083-77935012	"Enzymes, Predicted secreted proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051012, HPA055014"	Uncertain		Approved	Nucleoplasm	"Secreted - unknown location"			Nucleoplasm		"HPA051012: , HPA055014: "	"unprognostic (6.36e-2)"	"unprognostic (7.09e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavourable (1.70e-4)"	"prognostic favourable (4.11e-5)"	"unprognostic (2.33e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.38e-1)"	"prognostic favourable (5.82e-6)"	"unprognostic (6.30e-3)"	"unprognostic (2.06e-1)"	"unprognostic (9.57e-2)"	"unprognostic (4.06e-1)"	7.2	11.0	11.0	7.0	15.2	7.4	6.9	6.8	20.5	5.6	10.3	19.0	7.7	11.2	7.7	10.3	7.7	7.1	9.1	11.1	12.4	10.4	8.8	10.5	6.2	6.0	13.5	9.4	6.6	9.8	11.3	11.3	7.8	15.0	8.2	10.3	13.8	10.6	8.9	13.7	8.5	8.5	10.5	10.6	9.7	7.5	5.5	11.5	10.8	9.1	7.8	7.5	6.9	5.0	4.0	8.9	1.4	7.2	3.4	5.3	3.1	3.3	5.4	3.2	10.8	8.1	4.6	4.3	3.4	5.7	3.1	3.7	2.9	8.0	7.3	5.5	6.0	6.4	17.8	5.4	2.0	4.2	5.6	1.9	3.4	4.8	8.3	2.8	4.1	5.7	10.1	1.2	3.9	4.4	6.9	4.5	4.0	16.8	3.4	5.6	6.4	6.4	5.6	0.5	5.8	4.4	8.5	7.2	4.0	6.6	9.2	4.0	13.3	6.2	3.9	2.9	2.3	5.9	3.0	4.6	5.0	4.1	4.4	4.9	3.7	1.4	4.7	1.3	5.3	7.2	3.5	1.7	2.2	3.1	8.9	4.0	2.5	4.6	0.4	3.4	2.8	7.0	3.7	3.1	11.0	15.2	6.8	20.5	12.4	10.4	13.5	9.4	15.0	11.5
ADCYAP1	PACAP	ENSG00000141433	"Adenylate cyclase activating polypeptide 1"	P18509	18	904943-912172	"Predicted secreted proteins"	Neurogenesis	Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.8;lymphoid tissue: 16.5"	"Cell line enriched"	"Detected in some"	12	"SCLC-21H: 19.8"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 3.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065887	Supported	Supported			"Secreted in other tissues"					"HPA065887: "	"unprognostic (2.68e-1)"	"unprognostic (1.83e-2)"	"unprognostic (7.09e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.87e-4)"	"unprognostic (9.58e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.86e-2)"	"unprognostic (4.16e-2)"	"unprognostic (9.94e-2)"	"prognostic favourable (2.91e-6)"	"unprognostic (2.24e-3)"	"unprognostic (9.22e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.74e-4)"	2.1	0.5	2.5	16.5	7.7	0.1	1.6	2.1	12.5	3.4	2.6	0.8	0.0	0.1	4.0	0.1	2.2	0.5	12.3	1.0	1.2	18.4	0.6	0.3	1.7	1.6	2.8	6.2	0.2	7.7	0.1	4.5	0.3	33.8	1.4	1.4	2.5	2.2	1.0	0.3	0.9	1.3	1.5	5.9	0.2	1.8	3.6	0.2	0.1	0.3	0.0	1.4	3.1	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	7.7	2.1	12.1	1.2	18.4	2.8	6.2	33.8	0.2
ADIPOQ	"ACDC, ACRP30, adiponectin, AdipoQ, apM1, GBP28"	ENSG00000181092	"Adiponectin, C1Q and collagen domain containing"	Q15848	3	186842690-186858463	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"		Hormone	"Diabetes mellitus, Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 176.7;breast: 79.4"	"Cell line enriched"	"Detected in single"	670	"ASC diff: 84.1"	"Group enriched"	"Detected in some"	8	"breast cancer: 6.5;pancreatic cancer: 1.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB046467, HPA051767"	Uncertain				"Secreted to blood"	1000000000	1000000000			"CAB046467: AB_1078104, HPA051767: "	"unprognostic (1.76e-2)"									"unprognostic (1.53e-1)"	"unprognostic (2.20e-2)"			"unprognostic (6.99e-3)"	"unprognostic (1.87e-1)"			176.7	1.9	0.0	16.7	0.0	0.1	79.4	0.0	0.1	0.1	23.2	0.0	0.4	0.1	0.1	1.3	0.3	0.1	13.2	5.8	0.0	0.0	0.5	0.1	0.1	6.1	0.0	0.0	0.2	1.3	0.1	0.0	0.1	0.0	0.4	1.4	0.0	14.7	0.6	2.0	1.5	2.1	0.4	0.0	0.1	0.6	0.1	0.0	0.0	0.7	9.5	0.3	1.0	0.9	0.8	0.6	2.4	0.4	0.7	0.5	0.1	0.0	0.0	0.0	0.0	84.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.4	0.6	0.4	0.3	0.3	0.4	0.3	0.3	0.1	0.8	0.3	0.5	1.9	0.7	0.4	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADM2	"AM2, FLJ21135"	ENSG00000128165	"Adrenomedullin 2"	Q7Z4H4	22	50481556-50486440	"Predicted secreted proteins"		Hormone		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pancreas: 30.2;salivary gland: 32.2"	"Cell line enhanced"	"Detected in many"		"HHSteC: 21.7;hTCEpi: 13.6;Karpas-707: 21.6;SK-MEL-30: 14.2;U-266/70: 15.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"												"Secreted to blood"						"unprognostic (1.30e-2)"	"unprognostic (4.96e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.15e-1)"	"unprognostic (4.62e-3)"	"unprognostic (7.26e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.20e-2)"	"unprognostic (9.41e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (2.72e-4)"	"unprognostic (1.06e-2)"	0.5	0.5	0.4	2.9	0.4	0.1	0.7	0.4	0.4	0.8	1.2	0.0	1.3	3.7	0.5	2.9	2.2	0.6	5.6	0.4	0.4	0.4	11.4	6.6	0.8	4.1	0.4	0.0	0.4	30.2	0.0	0.6	0.7	0.2	2.6	0.4	0.1	32.2	2.2	0.4	0.5	5.2	0.0	0.5	2.0	4.3	0.6	0.0	1.6	11.7	1.7	4.0	0.5	0.6	0.9	0.5	2.0	0.5	0.4	1.4	0.2	1.0	0.2	0.3	1.1	0.7	1.2	4.0	5.1	0.4	0.7	1.7	2.1	0.8	0.0	0.7	4.3	0.8	1.1	0.6	0.2	9.7	0.0	0.0	0.2	1.5	21.7	2.0	1.4	4.3	13.6	2.3	4.9	0.0	1.3	21.6	0.1	3.1	0.2	0.4	0.7	3.2	0.0	0.0	8.1	0.9	0.1	0.5	2.3	0.0	3.1	14.2	4.3	6.7	0.0	0.0	4.8	0.0	0.0	15.8	2.2	2.8	0.4	0.0	1.2	0.7	0.5	0.4	0.6	0.2	0.3	0.6	0.5	0.6	0.0	0.9	1.4	1.1	2.0	0.4	0.5	0.5	0.3	0.2	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.2	0.0
ADM5	"AM5, C19orf76"	ENSG00000224420	"Adrenomedullin 5 (putative)"	C9JUS6	19	49688664-49690575	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NB-4: 15.7"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.1"	"Low lineage specificity"	"Detected in single"																"Secreted - unknown location"						"unprognostic (2.34e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.08e-3)"	"unprognostic (5.62e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.39e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.47e-2)"	"unprognostic (8.94e-2)"	"unprognostic (4.21e-11)"	"unprognostic (2.39e-2)"	"unprognostic (9.25e-2)"	"unprognostic (9.92e-3)"	"prognostic favourable (6.74e-4)"	5.5	0.9	1.0	1.8	1.2	3.2	4.2	2.6	1.5	1.8	1.1			2.2	3.1	1.0	2.0	3.9	1.8	0.7	0.7	1.0	1.5	0.7	3.5	2.7	1.0		1.4	1.0	0.4	1.7	2.2		2.6	0.6		1.6	1.1	2.4	6.5	1.6	2.3	0.9	5.0	1.1	1.6			1.5		2.0	1.3	2.1	0.6	0.2	0.0	0.3	0.0	1.1	0.0	2.9	5.0	3.0	2.1	0.1	0.0	3.5	0.3	0.2	1.0	0.5	5.8	2.7	4.5	1.1	0.2	0.9	5.3	1.7	0.4	5.2	10.2	5.0	1.2	3.7	0.1	1.5	3.4	0.5	3.8	0.7	0.4	1.0	3.6	3.4	0.1	4.7	2.2	15.7	4.0	1.4	6.5	2.3	4.6	0.5	5.2	1.8	0.8	0.7	1.5	1.3	3.3	2.2	0.8	1.6	6.1	0.8	1.2	11.5	8.9	5.1	1.1	8.8	1.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	1.1	0.2	0.6	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0										
AFM	"ALB2, ALBA"	ENSG00000079557	Afamin	P43652	4	73481683-73504001	"Plasma proteins, Predicted secreted proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 169.0"	"Cell line enriched"	"Detected in some"	5	"CACO-2: 5.8"	"Cancer enriched"	"Detected in single"	167	"liver cancer: 62.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA017006, HPA052437"	Enhanced				"Secreted to blood"	5000000000	5000000000			"HPA017006: AB_1844635, HPA052437: AB_2732575"							"prognostic favourable (1.80e-4)"				"unprognostic (5.73e-2)"		"unprognostic (4.24e-2)"					0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	169.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.5	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
AFP	"FETA, HPAFP"	ENSG00000081051	"Alpha fetoprotein"	P02771	4	73431138-73456174	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"heart muscle: 4.3;liver: 9.6;lung: 2.9"	"Cell line enriched"	"Detected in some"	190	"Hep G2: 214.4"	"Group enriched"	"Detected in some"	14	"liver cancer: 208.8;testis cancer: 49.4"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 0.8"	"Not detected"	"Not detected"			"HPA010607, HPA023600, CAB024283, CAB025339"	Approved		Approved	"Golgi apparatus,Cytosol"	"Secreted to blood"	930000	930000	"Golgi apparatus"	Cytosol	"CAB024283: AB_2650473, CAB025339: , HPA010607: AB_1078141, HPA023600: AB_1844769"	"unprognostic (4.69e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.34e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-3)"	"unprognostic (2.95e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.54e-1)"		"unprognostic (3.81e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.63e-6)"	"unprognostic (1.98e-2)"	"unprognostic (5.80e-2)"		"unprognostic (1.14e-1)"	0.0	0.4	0.1	0.0	1.0	0.0	1.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	4.3	0.3	0.0	0.0	9.6	2.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	214.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0
AGRP	"Agrt, ART, ASIP2"	ENSG00000159723	"Agouti related neuropeptide"	O00253	16	67482571-67483813	"Disease related genes, Plasma proteins, Predicted secreted proteins"			"Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 19.4;epididymis: 49.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.6;CAPAN-2: 2.7;HeLa: 1.5;Hep G2: 2.1;HMC-1: 1.8"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in some"	13	"hypothalamus: 19.4"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	16	"hypothalamus: 18.9"	"Region enhanced"	"Detected in some"		"hypothalamus: 3.9"	HPA041017	Enhanced	Supported			"Secreted in other tissues"					"HPA041017: AB_10795498"	"unprognostic (1.32e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.16e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.34e-1)"	"unprognostic (4.68e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.74e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-2)"	0.1	9.6	0.1	0.1	1.4	0.0	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.0	0.1	49.8	0.1	0.0	0.1	0.1	0.1	19.4	0.5	0.1	2.1	0.3	0.1	0.3	0.1	0.1	0.0	0.4	0.1	0.2	0.1	0.0	0.3	0.5	0.1	0.1	0.4	0.1	0.1	0.3	0.3	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	2.2	2.1	1.4	3.8	0.3	3.2	1.0	0.1	0.0	0.4	1.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.6	2.7	0.8	0.2	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.4	1.5	2.1	0.0	0.0	1.8	0.6	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.3	0.3	0.7	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.5	0.2	0.0	0.1	1.0	0.5	0.9	0.0	0.4	0.3	0.0	3.8	1.4	3.2	2.3	1.6	2.2	0.8	1.1	1.5	1.9	2.1	2.2	0.6	0.3	1.2	2.1	1.3	1.0	0.1	1.4	0.1	0.2	0.1	19.4	0.1	0.3	0.2	0.1
AGT	SERPINA8	ENSG00000135744	Angiotensinogen	P01019	1	230702523-230714297	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"		"Vasoactive, Vasoconstrictor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"liver: 309.0"	"Group enriched"	"Detected in some"	6	"Hep G2: 108.5;THP-1: 41.4"	"Group enriched"	"Detected in all"	10	"glioma: 275.3;liver cancer: 1163.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB025798	Supported				"Secreted to blood"	110000000000	110000000000			"CAB025798: "	"unprognostic (7.77e-2)"	"unprognostic (4.46e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.61e-2)"	"unprognostic (5.75e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.46e-2)"	"unprognostic (4.32e-3)"	"unprognostic (6.70e-2)"	"unprognostic (9.28e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.17e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.38e-1)"	2.8	3.2	23.6	1.9	25.0	1.4	1.6	17.1	37.0	3.8	2.1	24.2	0.0	1.9	1.7	1.8	2.0	2.3	22.5	30.9	18.0	11.9	9.3	309.0	1.6	1.5	19.5	15.0	1.8	2.3	1.8	2.6	1.5	23.8	2.5	2.2	0.0	1.5	1.9	7.8	1.4	2.2	2.6	29.8	1.4	2.4	2.0	15.9	0.0	1.9	0.5	1.4	3.2	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	108.5	0.3	0.1	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.9	0.0	41.4	0.0	0.0	0.2	0.0	0.1	0.5	7.6	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.6	25.0	17.1	20.0	18.0	11.9	19.5	15.0	23.8	15.9
AHSG	"A2HS, FETUA, HSGA"	ENSG00000145192	"Alpha 2-HS glycoprotein"	P02765	3	186612923-186621318	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Mineral balance"		"Cancer-related genes, Disease mutation, Hypotrichosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	269	"liver: 402.0"	"Cell line enriched"	"Detected in some"	77	"Hep G2: 210.3"	"Cancer enriched"	"Detected in some"	284	"liver cancer: 1231.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.4"	"Lineage enhanced"	"Detected in single"		"NK-cells: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001524, HPA001525, CAB026209"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted to blood"	140000000000	140000000000	"Golgi apparatus"		"CAB026209: , HPA001524: AB_1078851, HPA001525: AB_1078849"		"unprognostic (6.40e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.47e-3)"	"unprognostic (3.05e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.64e-2)"		"unprognostic (3.99e-7)"	"unprognostic (5.21e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.04e-1)"		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	402.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	210.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
ALKAL1	"AUGB, FAM150A, UNQ9433"	ENSG00000196711	"ALK and LTK ligand 1"	Q6UXT8	8	52534037-52565507	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"gallbladder: 8.7;prostate: 6.8;urinary bladder: 9.9"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.1;HMC-1: 1.5;NTERA-2: 1.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"olfactory region: 0.5"	"Low region specificity"	"Detected in all"			HPA027368	Uncertain				"Secreted - unknown location"					"HPA027368: AB_10602317"			"unprognostic (1.18e-1)"	"unprognostic (1.13e-4)"				"unprognostic (9.47e-2)"		"unprognostic (9.64e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.70e-4)"	"unprognostic (4.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.58e-3)"	0.0	0.0	0.3	1.6	0.2	0.0	0.0	0.0	0.4	3.2	3.0	0.0	0.0	1.5	0.1	0.0	3.9	0.6	8.7	0.0	0.1	0.2	0.3	1.1	1.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.3	0.2	6.8	0.3	0.0	2.4	0.0	0.0	0.2	2.2	4.6	0.2	0.0	1.0	0.4	0.3	0.3	6.0	0.0	0.0	9.9	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.4	0.1	0.2	0.2	0.0	0.2	0.3
AMBN		ENSG00000178522	Ameloblastin	Q9NP70	4	70592256-70607288	"Disease related genes, Predicted secreted proteins"	Biomineralization		"Amelogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	9	"brain: 10.6"	"Cell line enriched"	"Detected in some"	8	"HEK 293: 12.1"	"Group enriched"	"Detected in some"	7	"cervical cancer: 2.6;endometrial cancer: 2.9"	"Region enriched"	"Detected in some"	5	"basal ganglia: 10.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036099			Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"			Vesicles	Nucleoplasm	"HPA036099: "															"unprognostic (3.22e-1)"			0.2	0.0	0.0	0.0	10.6	0.0	0.0	0.0	2.4	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.4	0.1	0.0	1.2	0.2	1.2	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.9	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	10.6	0.0	2.0	0.0	0.4	0.1	0.0	0.4	2.0
AMELX	"AIH1, AMG"	ENSG00000125363	"Amelogenin, X-linked"	Q99217	X	11293413-11300761	"Disease related genes, Predicted secreted proteins"	Biomineralization		"Amelogenesis imperfecta, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"ductus deferens: 3.5;epididymis: 3.0;seminal vesicle: 9.4"	"Cell line enhanced"	"Detected in single"		"K-562: 1.3"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 1.9"	"Region enhanced"	"Detected in single"		"amygdala: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"								"unprognostic (1.76e-1)"									"unprognostic (1.00e-1)"		"unprognostic (2.00e-1)"				0.0	0.0	2.3	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.1	0.3	3.5	0.0	0.0	3.0	0.0	0.1	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	9.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.3	0.0	0.6	0.5	0.5	0.0	0.7	0.0	0.0
AMELY	AMGL	ENSG00000099721	"Amelogenin, Y-linked"	Q99218	Y	6865918-6874027	"Predicted secreted proteins"	Biomineralization			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"epididymis: 1.2;prostate: 1.2;thyroid gland: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"																	"unprognostic (1.62e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0			0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0		0.0	0.9	0.0	0.0	0.2		1.2	0.0		0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.8			2.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AMH	MIS	ENSG00000104899	"Anti-Mullerian hormone"	P03971	19	2249309-2252073	"Disease related genes, Predicted secreted proteins"	"Differentiation, Gonadal differentiation"	"Growth factor"	"Disease mutation, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 35.7"	"Cell line enhanced"	"Detected in some"		"HEK 293: 17.4;NTERA-2: 6.7;REH: 6.9;SH-SY5Y: 8.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA066973			Approved	Vesicles,Aggresome	"Secreted to blood"	56000	56000	"Vesicles, Aggresome"		"HPA066973: "	"unprognostic (8.10e-5)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (9.21e-5)"	"unprognostic (8.73e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.32e-1)"	"unprognostic (8.03e-2)"	"unprognostic (8.99e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.53e-1)"	"unprognostic (5.95e-3)"	"unprognostic (1.34e-2)"	"unprognostic (8.73e-8)"	"unprognostic (4.64e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.76e-1)"	0.3	0.2	1.0	0.3	2.8	0.3	0.3	4.8	1.4	0.3	0.5	0.3	0.3	0.2	0.4	0.6	0.3	0.2	0.3	0.3	0.5	1.3	0.3	0.3	0.4	0.5	0.3	0.3	1.1	0.7	0.2	3.5	0.4	0.3	0.3	0.2	0.3	0.3	0.3	2.6	0.4	0.6	0.3	0.3	0.5	0.6	35.7	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.2	0.1	0.4	0.0	0.0	4.4	0.7	0.0	0.0	0.0	0.1	0.2	0.5	1.7	0.0	0.0	0.0	0.0	0.0	2.9	17.4	0.1	0.6	0.0	0.0	0.2	2.8	0.0	0.0	0.0	0.0	0.0	2.5	0.4	0.0	0.5	0.1	1.3	6.7	1.5	6.9	1.4	0.9	0.0	0.2	0.5	8.0	0.1	0.0	1.5	0.8	0.0	0.7	0.6	1.3	0.9	2.5	4.9	3.6	0.8	0.3	1.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.8	4.8	1.4	0.5	1.3	0.3	0.3	0.3	0.3
AMTN	"RSTI689, UNQ689"	ENSG00000187689	Amelotin	Q6UX39	4	70518540-70532742	"Disease related genes, Predicted secreted proteins"	"Biomineralization, Cell adhesion"		"Amelogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"lymphoid tissue: 24.6;salivary gland: 12.9;stomach 1: 6.7"	"Cell line enhanced"	"Detected in some"		"HeLa: 2.0;hTERT-HME1: 9.0;MCF7: 6.6"	"Group enriched"	"Detected in many"	11	"cervical cancer: 13.9;head and neck cancer: 38.3;lung cancer: 12.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036136, HPA036137"	Uncertain				"Secreted in other tissues"					"HPA036136: AB_2674963, HPA036137: AB_10673614"	"unprognostic (1.72e-1)"	"unprognostic (2.47e-1)"				"unprognostic (2.04e-1)"		"unprognostic (2.36e-1)"			"unprognostic (3.80e-1)"	"unprognostic (1.52e-1)"		"unprognostic (1.86e-2)"		"unprognostic (7.35e-2)"	"unprognostic (2.55e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.8	12.9	0.0	0.0	0.5	0.0	0.0	0.6	0.0	6.7	0.2	0.0	0.0	0.9	0.9	24.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	9.0	0.3	0.2	0.0	0.0	6.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0
AMY1A	AMY1	ENSG00000237763	"Amylase, alpha 1A (salivary)"	P04745	1	103655290-103664554	"Enzymes, Predicted secreted proteins"	"Carbohydrate metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	100	"salivary gland: 654.0"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.3;SH-SY5Y: 2.3"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"											"CAB004310, HPA045394, HPA045399, HPA046980"	Enhanced				"Secreted to digestive system"	68000000	68000000			"CAB004310: AB_626668, HPA045394: , HPA045399: , HPA046980: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0			0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0		0.0	3.7	0.0	0.0	0.0		0.0	0.0		654.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.2		0.0	0.0	0.1	0.1	0.3	0.3	0.6	0.0	1.1	0.7	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.1	0.6	0.0	0.1	1.1	0.1	0.3	0.1	0.0	0.7	0.2	0.0	0.5	0.0	0.1	0.7										
AMY1B	AMY1	ENSG00000174876	"Amylase, alpha 1B (salivary)"	P04745	1	103687415-103696680	"Enzymes, Predicted secreted proteins"	"Carbohydrate metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"salivary gland: 302.4"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.2;SH-SY5Y: 2.1;U-266/70: 1.8"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"											"HPA045394, HPA045399, HPA046980"	Supported				"Secreted to digestive system"	68000000	68000000			"HPA045394: , HPA045399: , HPA046980: "					"unprognostic (7.34e-2)"			"unprognostic (2.59e-1)"		"unprognostic (6.05e-2)"				"unprognostic (6.08e-2)"		"unprognostic (1.96e-1)"		0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	6.5	0.2	0.2	0.2	0.0	0.2	0.2	0.2	4.0	0.2	0.2	0.2	0.0	0.2	0.2	0.7	0.2	0.2	0.2	0.2	23.0	0.0	0.2	0.2	0.2	0.2	0.0	0.2	302.4	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.4	0.2	0.2	1.1	0.2	0.2	0.2	0.2	0.1	0.3	0.3	0.6	0.0	1.1	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.4	1.2	0.0	0.7	0.1	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.2	0.6	0.0	0.1	1.1	0.1	0.3	0.1	0.0	0.7	0.2	0.0	0.5	0.0	0.1	0.7	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
AMY1C	AMY1	ENSG00000187733	"Amylase, alpha 1C (salivary)"	P04745	1	103750406-103758690	"Enzymes, Predicted secreted proteins"	"Carbohydrate metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pancreas: 34.3;salivary gland: 62.5"	"Cell line enriched"	"Detected in single"	4	"THP-1: 3.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045394, HPA045399, HPA046980"	Supported				"Secreted to digestive system"	68000000	68000000			"HPA045394: , HPA045399: , HPA046980: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.2	0.0			0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0		0.0	34.3	0.0	0.0	0.0		0.0	0.0		62.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5			9.6		4.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0										
AMY2A	AMY2	ENSG00000243480	"Amylase, alpha 2A (pancreatic)"	P04746	1	103616811-103625780	"Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Carbohydrate metabolism"	"Glycosidase, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"pancreas: 1849.4"	"Cell line enhanced"	"Detected in some"		"THP-1: 1.0;U-2 OS: 1.2"	"Cancer enriched"	"Detected in single"	2010	"pancreatic cancer: 200.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045394, HPA045399, CAB045960, HPA046980"	Enhanced				"Secreted to digestive system"	77000000	77000000			"CAB045960: AB_2226891, HPA045394: , HPA045399: , HPA046980: "					"unprognostic (3.27e-1)"					"unprognostic (1.78e-3)"	"unprognostic (3.24e-2)"			"unprognostic (1.29e-1)"		"unprognostic (2.13e-2)"		0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.9	1849.4	0.0	0.2	0.2	0.2	0.2	0.0	0.2	59.9	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.3	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
AMY2B	AMY2	ENSG00000240038	"Amylase, alpha 2B (pancreatic)"	P19961	1	103553815-103579534	"Enzymes, Plasma proteins, Predicted secreted proteins"	"Carbohydrate metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"pancreas: 939.9"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 11.3;EFO-21: 11.6"	"Cancer enriched"	"Detected in many"	15	"pancreatic cancer: 25.1"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 8.5"	"Low lineage specificity"	"Detected in many"											"HPA045394, HPA045399, HPA046980"	Supported				"Secreted to digestive system"	75000000	75000000			"HPA045394: , HPA045399: , HPA046980: "	"unprognostic (8.69e-4)"	"unprognostic (3.71e-3)"	"unprognostic (6.41e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.51e-4)"	"unprognostic (1.21e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.49e-2)"	"unprognostic (7.41e-3)"	"unprognostic (1.55e-2)"	"unprognostic (5.74e-2)"	"unprognostic (4.22e-1)"	"unprognostic (3.12e-4)"	1.7	0.5	0.8	0.8	1.5	0.4	1.0	2.6	0.8	0.9	0.9	0.8	0.8	0.5	0.8	1.0	0.8	1.5	0.9	1.1	0.8	0.5	1.5	1.1	1.0	1.1	1.0	0.9	1.2	939.9	0.8	1.1	0.8	0.8	0.9	0.4	0.9	145.7	1.0	1.7	1.3	0.9	0.8	0.8	1.0	0.4	0.8	0.8	0.8	2.4	1.1	0.8	0.8	0.8	1.8	2.6	1.9	8.5	0.1	1.1	1.9	0.0	0.6	1.2	0.0	6.3	11.3	1.2	0.9	0.9	0.7	1.7	0.0	0.2	1.1	11.6	0.3	1.3	0.1	1.4	1.6	1.4	1.7	2.0	4.3	0.8	0.9	2.6	2.8	7.7	7.5	0.8	1.3	0.2	0.0	3.4	0.9	0.0	2.0	0.5	0.1	1.6	0.6	0.0	5.0	6.5	2.1	3.1	0.5	2.6	1.2	0.8	0.1	1.5	0.9	0.4	1.0	0.5	0.7	3.9	0.1	0.3	2.1	1.9	0.2	0.0	8.5	1.7	0.8	3.9	0.6	1.7	0.3	0.4	2.6	1.8	1.1	0.4	1.9	0.1	3.6	0.8	0.3	1.9	0.8	1.5	2.6	0.8	0.8	0.5	1.0	0.9	0.8	0.8
ANG	"RAA1, RNASE5"	ENSG00000214274	Angiogenin	P03950	14	20684177-20698971	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation, Stress response"	"Developmental protein, DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein synthesis inhibitor"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"liver: 371.4"	"Cell line enriched"	"Detected in many"	5	"Hep G2: 56.6"	"Cancer enriched"	"Detected in all"	17	"liver cancer: 279.2"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 18.1;myeloid DC: 10.4"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA055896			Approved	"Nucleoli,Actin filaments"	"Secreted to blood"	230000000	230000000	Nucleoli	"Actin filaments"	"HPA055896: "	"unprognostic (2.50e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.77e-2)"	"prognostic favourable (6.85e-4)"	"unprognostic (5.71e-3)"	"unprognostic (6.99e-2)"	"prognostic favourable (7.83e-5)"	"unprognostic (1.16e-1)"	"unprognostic (3.20e-3)"	"unprognostic (9.19e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.69e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.09e-1)"	17.0	0.9	0.7	2.6	0.7	0.7	16.4	0.5	0.7	14.4	9.0	0.7	6.6	3.5	10.7	10.3	8.0	3.8	13.3	3.8	0.8	0.7	10.6	371.4	6.9	2.3	1.0	0.1	17.7	9.0	1.3	1.1	1.9	0.8	17.5	6.5	5.5	20.2	7.7	3.5	4.0	7.4	9.7	1.5	1.5	7.9	7.1	0.4	0.0	4.2	5.5	3.6	14.3	15.0	4.5	10.4	0.3	18.1	0.0	0.9	4.8	1.4	3.7	0.9	0.0	9.3	11.2	0.1	1.6	3.2	0.4	1.5	2.2	1.9	0.1	0.4	4.5	1.4	1.0	1.1	0.5	6.2	1.4	0.3	2.0	56.6	2.0	1.4	0.2	9.0	0.9	0.5	1.9	2.1	0.0	10.4	1.3	0.2	0.3	0.4	0.2	4.1	0.2	1.5	4.2	0.9	1.1	0.0	0.1	1.6	0.6	2.5	1.5	0.2	1.8	0.6	1.1	0.5	0.2	2.2	1.7	0.2	1.1	0.7	1.8	0.0	18.1	0.0	0.3	2.1	0.2	4.5	0.9	0.8	10.4	2.4	0.2	0.2	0.3	0.0	0.1	1.6	0.4	4.8	0.7	0.7	0.5	0.6	0.8	0.7	1.0	0.1	0.8	0.4
ANGPT2	Ang2	ENSG00000091879	"Angiopoietin 2"	O15123	8	6499651-6563409	"Cancer-related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"HMC-1: 9.9;HSkMC: 23.6;HUVEC TERT2: 36.5;WM-115: 11.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB011437, CAB017626"	Approved				"Secreted to blood"	31000	31000			"CAB011437: , CAB017626: AB_1118956"	"unprognostic (1.28e-1)"	"prognostic unfavourable (7.99e-5)"	"unprognostic (1.93e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.85e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavourable (6.36e-5)"	"unprognostic (1.66e-3)"	"prognostic unfavourable (4.48e-4)"	"unprognostic (2.94e-3)"	"unprognostic (6.19e-3)"	"unprognostic (1.38e-1)"	"prognostic unfavourable (1.52e-7)"	"prognostic unfavourable (3.87e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.44e-2)"	15.8	0.8	5.3	5.0	20.6	0.6	17.9	10.4	19.5	9.3	3.5	0.5	2.2	1.6	6.2	2.8	3.8	5.8	7.2	10.1	6.1	5.9	3.0	4.1	4.6	8.3	13.1	1.0	3.0	1.2	1.9	1.1	20.0	20.8	4.3	2.7	0.5	2.8	4.4	17.7	3.3	2.6	9.9	9.4	2.3	2.3	1.4	12.4	2.9	10.5	2.2	3.9	14.8	8.1	1.9	1.1	5.4	0.7	0.8	1.2	0.2	0.0	0.1	0.1	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.5	0.2	0.0	0.5	0.0	9.9	23.6	0.0	0.0	0.0	36.5	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	11.9	5.4	0.7	0.6	0.9	0.4	0.9	0.7	0.8	0.8	0.1	1.9	0.9	1.2	0.8	0.8	0.4	1.1	0.2	0.2	5.3	20.6	10.4	19.5	6.1	5.9	13.1	1.0	20.8	12.4
ANGPT4		ENSG00000101280	"Angiopoietin 4"	Q9Y264	20	869899-916317	"Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 18.7;breast: 12.3;cervix, uterine: 16.8"	"Group enriched"	"Detected in some"	80	"ASC diff: 21.1;BEWO: 30.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 2.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB013260, CAB013305"	Uncertain				"Secreted to blood"					"CAB013260: , CAB013305: "	"unprognostic (1.77e-1)"	"unprognostic (3.25e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.04e-3)"	"unprognostic (6.37e-2)"	"unprognostic (3.41e-1)"	"unprognostic (5.82e-4)"	"unprognostic (1.25e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.66e-4)"	"unprognostic (9.01e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.95e-4)"	"unprognostic (9.14e-2)"	18.7	0.7	0.1	0.1	0.3	0.1	12.3	0.0	0.5	16.8	1.4	0.6	2.1	0.2	7.1	4.9	1.2	3.5	2.5	1.1	0.1	0.3	0.4	0.1	2.6	0.1	0.3	0.0	4.8	0.2	0.1	0.0	0.4	0.3	1.8	0.1	2.4	1.3	2.2	0.2	1.4	0.3	2.6	0.1	0.1	0.4	3.7	0.0	0.0	2.1	1.6	0.4	1.3	2.2	0.3	0.6	2.4	0.9	0.2	0.3	0.5	0.1	0.0	0.0	0.0	21.1	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.9	0.4	0.2	0.5	0.0	0.1	0.2	0.3	0.6	0.3	0.1	0.2	0.8	0.2	0.6	0.2	0.0	0.5	0.1	0.3	0.0	0.5	0.1	0.3	0.3	0.0	0.3	0.0
ANGPTL1	"ANG3, ANGPT3, AngY, ARP1"	ENSG00000116194	"Angiopoietin like 1"	O95841	1	178849705-178871052	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	18	"ASC diff: 47.6;ASC TERT1: 19.2;HHSteC: 20.6;HSkMC: 46.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.3;naive B-cell: 2.9"	"Lineage enhanced"	"Detected in single"		"B-cells: 2.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA009976	Approved				"Secreted to blood"	100000	100000			"HPA009976: AB_1844822"	"unprognostic (2.59e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.80e-3)"	"unprognostic (2.63e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.71e-2)"	"prognostic favourable (8.73e-4)"	"unprognostic (3.81e-2)"	"unprognostic (5.78e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.31e-2)"	"prognostic favourable (5.11e-4)"	"unprognostic (1.49e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.61e-3)"	17.7	16.3	1.2	8.5	1.1	0.0	14.4	0.7	1.4	26.3	36.2	0.9	9.6	2.6	34.6	46.5	33.6	29.7	16.6	12.9	1.0	0.6	15.9	7.1	12.4	15.8	0.6	2.5	35.7	6.4	0.0	2.2	42.0	1.6	16.7	8.7	0.9	14.2	4.2	20.0	4.5	28.2	22.7	1.8	7.0	13.1	24.7	0.4	0.9	19.3	57.5	2.8	25.5	13.7	2.9	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	47.6	19.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	20.6	0.0	0.0	46.9	0.0	0.6	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	2.9	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.2	1.1	0.7	1.4	1.0	0.6	0.6	2.5	1.6	0.4
ANGPTL3	ANGPT5	ENSG00000132855	"Angiopoietin like 3"	Q9Y5C1	1	62597487-62606159	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Lipid metabolism"	Heparin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 276.6"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.1;HL-60: 2.1"	"Cancer enriched"	"Detected in some"	39	"liver cancer: 94.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038097	Approved				"Secreted to blood"	45000000	45000000			"HPA038097: AB_10675628"	"unprognostic (2.29e-1)"	"unprognostic (8.01e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.11e-3)"	"unprognostic (6.85e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.09e-2)"	"unprognostic (5.38e-2)"	"unprognostic (7.62e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	13.7	276.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.2	0.2	1.1	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.4	0.0	0.7	0.2	0.0	0.6	0.1	0.0	0.1	0.0	0.2	0.7	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ANGPTL5		ENSG00000187151	"Angiopoietin like 5"	Q86XS5	11	101890674-101916522	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 9.4;ovary: 24.9"	"Group enriched"	"Detected in some"	6	"ASC diff: 7.7;ASC TERT1: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"			HPA038516	Uncertain				"Secreted in other tissues"					"HPA038516: AB_10672749"	"unprognostic (8.28e-3)"	"unprognostic (3.08e-2)"		"unprognostic (1.21e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.23e-2)"		"unprognostic (2.18e-1)"		"unprognostic (4.88e-2)"	"unprognostic (6.74e-4)"	"unprognostic (1.96e-1)"	"unprognostic (1.53e-8)"	"unprognostic (3.40e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.17e-3)"	9.4	0.3	0.2	0.0	0.3	0.0	6.4	0.2	0.7	1.3	0.3	0.0	0.6	0.1	0.1	5.0	1.0	0.4	0.3	3.7	0.2	0.2	0.1	0.2	1.0	0.1	2.0	0.5	24.9	0.0	0.0	0.3	0.1	0.8	1.4	0.2	0.0	0.5	0.3	1.9	3.5	0.5	1.3	1.7	0.0	0.2	6.2	0.3	0.2	2.4	2.9	0.0	1.8	1.1	0.7	1.0	0.0	0.0	0.9	0.3	0.0	0.0	0.1	0.0	0.0	7.7	2.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.7	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.9	0.0	1.0	0.0	0.0	0.2	0.3	0.2	0.7	0.2	0.2	2.0	0.5	0.8	0.3
ANGPTL6	"AGF, ARP5"	ENSG00000130812	"Angiopoietin like 6"	Q8NI99	19	10092338-10102796	"Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"liver: 31.8"	"Cell line enriched"	"Detected in some"	8	"HMC-1: 36.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"								"Secreted to blood"	550000	550000				"unprognostic (1.28e-1)"	"unprognostic (2.18e-6)"	"unprognostic (1.42e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.77e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.26e-10)"	"unprognostic (8.96e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.32e-1)"	0.3	0.3	0.7	2.1	1.6	2.6	0.3	0.7	2.7	0.2	0.5	0.7	0.5	0.7	0.1	0.2	0.7	0.7	0.9	0.7	0.6	0.7	0.9	31.8	0.5	3.3	1.6	0.2	0.4	1.2	0.0	0.4	2.3	1.4	0.2	0.4	0.1	0.5	0.0	0.1	0.3	2.9	0.2	0.9	3.0	1.6	1.3	0.5	0.3	0.3	0.0	3.4	0.6	0.9	2.9	0.6	0.0	1.4	1.3	2.6	0.9	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	4.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.1	0.1	0.0	0.3	36.1	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.7	2.7	0.1	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	2.9	0.0	0.0	0.0	0.0	0.0	3.1	0.7	1.7	0.1	0.4	0.4	0.0	1.3	0.0	2.6	1.4	1.8	2.9	1.6	1.8	0.6	2.8	1.0	1.6	0.0	1.3	0.7	0.4	2.0	0.9	0.7	1.6	0.7	2.7	0.6	0.7	1.6	0.2	1.4	0.5
ANGPTL7	"AngX, CDT6"	ENSG00000171819	"Angiopoietin like 7"	O43827	1	11189341-11195981	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 22.9"	"Cell line enriched"	"Detected in single"	263	"SCLC-21H: 30.3"	"Cancer enriched"	"Detected in some"	14	"melanoma: 18.4"	"Region enriched"	"Detected in single"	6	"cerebellum: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"								"Secreted in other tissues"	490000	490000				"unprognostic (3.23e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.67e-3)"	"unprognostic (2.87e-3)"	"unprognostic (2.80e-1)"		"unprognostic (4.89e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.49e-2)"	12.8	3.7	0.1	2.0	0.2	0.0	4.8	3.2	0.2	5.4	8.0	0.3	9.3	1.3	1.4	4.3	7.0	1.7	5.9	10.4	0.1	0.3	6.5	0.4	2.1	1.0	0.1	0.4	1.9	0.6	0.0	7.8	0.9	0.5	4.7	2.4	5.3	4.2	11.4	22.9	5.9	2.6	16.5	3.5	0.4	2.2	3.9	0.5	0.1	0.7	13.8	1.4	6.2	4.5	0.2	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	3.2	0.2	0.1	0.3	0.1	0.4	0.5	0.5
ANOS1	"ADMLX, KAL, KAL1, KALIG-1, WFDC19"	ENSG00000011201	"Anosmin 1"	P23352	X	8528874-8732186	"Disease related genes, Predicted secreted proteins"	"Cell adhesion, Chemotaxis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.5;lung: 37.1;parathyroid gland: 27.7"	"Group enriched"	"Detected in some"	5	"NTERA-2: 26.9;U-2 OS: 13.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in brain"						"unprognostic (2.93e-1)"	"unprognostic (5.33e-2)"	"unprognostic (9.54e-2)"	"unprognostic (4.16e-3)"	"unprognostic (7.77e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.17e-3)"	"unprognostic (4.53e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.09e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.71e-2)"	"unprognostic (9.38e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.56e-2)"	5.4	4.0	13.8	1.3	14.0	0.6	3.6	1.3	18.0	4.5	1.0	7.3	1.3	0.7	0.9	3.2	1.6	1.4	1.9	4.6	11.1	7.9	1.1	1.1	37.1	1.8	5.7	6.0	0.9	0.8	27.7	1.0	1.4	19.3	4.1	1.3	6.0	2.8	4.5	10.9	3.0	0.9	1.1	25.5	1.1	1.1	5.0	8.5	1.3	8.5	1.0	1.2	1.6	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.6	0.5	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.5	3.0	0.1	4.0	0.4	4.4	0.0	0.0	0.0	1.1	0.1	2.2	0.2	0.1	0.0	0.0	0.0	0.3	0.3	0.2	0.0	26.9	0.0	0.0	0.0	0.0	1.5	0.5	1.5	0.0	1.3	0.4	0.0	0.0	0.7	0.0	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	14.0	1.3	7.6	11.1	7.9	5.7	6.0	19.3	8.5
AOAH		ENSG00000136250	"Acyloxyacyl hydrolase"	P28039	7	36512949-36724549	"Enzymes, Predicted secreted proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 54.6;lymphoid tissue: 57.4"	"Group enriched"	"Detected in some"	5	"NB-4: 20.9;THP-1: 16.0;U-937: 7.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 54.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021666, HPA026716"	Approved				"Secreted to blood"					"HPA021666: , HPA026716: AB_2671960"	"unprognostic (3.55e-2)"	"unprognostic (4.03e-3)"	"unprognostic (4.45e-2)"	"unprognostic (3.58e-1)"	"unprognostic (6.06e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.14e-3)"	"unprognostic (5.42e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.92e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.35e-1)"	8.4	3.4	5.2	17.2	4.9	19.3	2.8	1.9	3.6	3.1	5.3	7.4	0.2	4.9	3.9	7.2	2.5	3.1	8.4	3.4	4.8	3.8	3.1	6.8	9.4	23.2	6.9	2.0	2.1	2.3	0.6	2.4	5.7	5.8	3.8	7.3	3.8	4.5	1.4	1.5	1.6	7.6	4.7	12.6	57.4	3.3	1.4	6.8	14.0	2.9	0.4	10.9	7.2	2.8	0.3	34.8	18.7	54.6	19.2	8.8	31.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.9	0.0	0.3	0.1	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	20.9	0.1	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	7.0	0.0	0.3	54.6	17.6	8.8	47.9	1.8	0.3	0.4	6.1	34.8	0.0	1.0	7.8	18.7	19.2	20.2	0.5	0.1	31.0	5.2	4.9	1.9	3.6	4.8	3.8	6.9	2.0	5.8	6.8
AOC1	"ABP1, DAO"	ENSG00000002726	"Amine oxidase, copper containing 1"	P19801	7	150824627-150861504	"Enzymes, Predicted secreted proteins"		"Heparin-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 108.6;placenta: 240.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 16.0;HaCaT: 4.9;NB-4: 4.8;RPMI-8226: 5.8;THP-1: 20.9"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 61.3;endometrial cancer: 39.1;pancreatic cancer: 26.9;renal cancer: 69.4;stomach cancer: 43.2"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	10	"eosinophil: 20.3"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 20.3"					"Low region specificity"	"Detected in all"			"HPA031032, HPA031033"	Approved				"Secreted in other tissues"	800000	800000			"HPA031032: AB_10670150, HPA031033: AB_10669670"	"unprognostic (1.73e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.84e-2)"	"unprognostic (6.31e-3)"	"unprognostic (8.31e-3)"	"unprognostic (9.07e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.11e-1)"	"prognostic favourable (1.71e-4)"	"unprognostic (5.32e-3)"	"unprognostic (3.62e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.64e-1)"	0.3	0.3	0.3	6.7	0.3	0.0	0.3	0.3	0.3	0.9	68.3	0.2	1.2	30.2	0.3	3.9	1.7	0.3	4.4	0.3	0.3	0.3	37.9	1.5	0.3	0.6	0.3	0.1	0.3	0.6	0.0	0.3	240.4	0.1	1.3	15.5	0.1	0.4	0.2	0.3	0.8	108.6	0.2	0.3	0.4	2.7	1.8	0.1	0.7	0.3	0.1	1.0	0.4	0.4	0.0	1.0	20.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.8	0.1	0.0	0.0	0.0	2.5	16.0	0.0	2.2	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	4.8	0.2	0.0	0.0	0.0	5.8	0.2	0.1	1.8	2.1	0.0	0.7	0.0	0.6	20.9	0.5	0.2	0.1	0.4	0.0	0.2	0.1	0.1	0.1	0.8	0.0	0.1	0.1	20.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.1	0.1
AP000790.4		ENSG00000285010			11	59964033-59970146	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	4	"blood: 5.9;kidney: 1.5"	"Group enriched"	"Detected in some"	5	"HEL: 2.8;K-562: 7.1"									"Cell type enriched"	"Detected in single"	10	"basophil: 5.9"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 5.9"														"Secreted - unknown location"																							0.0	0.1		0.4		0.2	0.0		0.7	0.2	0.2			0.0	0.1	0.0	0.0	0.0	0.0	0.0			1.5	0.0	0.0	0.0			0.5	0.0	0.0		0.0		0.0	0.3		0.0	0.0	0.0	0.0	0.0	0.0		0.1	0.0	0.8			0.0		0.0	0.0		0.5	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	2.8	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AP002347.1		ENSG00000285231			11	59878809-59896481	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	7	"blood: 7.4;testis: 2.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.4;HAP1: 1.4;K-562: 2.4;U-698: 3.0"									"Cell type enriched"	"Detected in single"	24	"basophil: 7.4"	"Lineage enriched"	"Detected in single"	44	"granulocytes: 7.4"														"Secreted - unknown location"																							0.0	0.0		0.5		0.7	0.0		0.3	0.0	0.3			0.6	0.1	0.0	0.2	0.0	0.0	0.0			0.5	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.2		0.6	0.0	0.6	0.0	0.0	0.0		0.0	0.4	2.5			0.0		0.0	0.0		0.0	0.1	7.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	1.4	0.5	0.0	0.9	1.4	0.0	0.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	2.4	0.3	0.4	0.7	0.0	0.3	0.8	0.0	0.0	0.0	0.5	0.4	0.6	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.3	3.0	0.0	0.2	0.2	7.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0										
APCS	"MGC88159, PTX2, SAP"	ENSG00000132703	"Amyloid P component, serum"	P02743	1	159587825-159588865	"Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	81	"liver: 316.6"	"Cell line enhanced"	"Detected in some"		"HL-60: 3.3;RH-30: 4.2;SiHa: 2.1"	"Cancer enriched"	"Detected in some"	25	"liver cancer: 826.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB007817, HPA053294"	Supported				"Secreted to blood"	76000000000	76000000000			"CAB007817: AB_598185, HPA053294: "							"unprognostic (3.19e-3)"				"unprognostic (2.30e-2)"							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.0	0.7	316.6	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.8	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.0	0.0	3.3	0.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.0	1.0	0.0	0.7	4.2	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.7	0.2	1.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
APELA	"ELA, Ende, tdl"	ENSG00000248329	"Apelin receptor early endogenous ligand"	P0DMC3	4	164877004-164898965	"Predicted secreted proteins"	"Angiogenesis, Differentiation, Gastrulation"	"Developmental protein, Hormone"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"placenta: 7.8;prostate: 8.2"	"Cell line enriched"	"Detected in some"	5	"NTERA-2: 29.4"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in single"		"neutrophil: 2.5"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"						"unprognostic (2.97e-2)"	"unprognostic (6.97e-2)"	"unprognostic (9.83e-4)"	"unprognostic (8.92e-3)"		"unprognostic (1.43e-3)"		"unprognostic (4.50e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.34e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.95e-4)"	0.0	0.0	0.0	0.1	0.0	0.2	2.8	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0		3.9	0.0	1.5	0.1	0.0	2.2	0.7	0.0	0.0	0.0	7.8	0.0	8.2	0.0	0.0	1.9	0.0	0.0	1.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.9	0.4	0.0	0.6	0.6	2.5	0.3	0.3	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	29.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.2	0.1	0.0	0.0	0.1	0.0	0.7	0.3	0.7	0.1	0.1	0.1	0.3	0.2	0.2	0.0	0.6	0.3	0.3	2.5	0.3	0.0	0.6	0.2	0.0										
APLN	"apelin, XNPEP2"	ENSG00000171388	Apelin	Q9ULZ1	X	129645259-129654937	"Predicted secreted proteins"	"Angiogenesis, Gastrulation, Host-virus interaction"	"Developmental protein, Hormone"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 21.8;placenta: 52.0"	"Cell line enriched"	"Detected in some"	6	"HUVEC TERT2: 104.4"	"Group enriched"	"Detected in all"	6	"glioma: 44.2;renal cancer: 21.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"						"unprognostic (1.50e-1)"	"prognostic unfavourable (2.92e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.50e-2)"	"unprognostic (5.94e-2)"	"prognostic unfavourable (9.32e-4)"	"prognostic unfavourable (6.09e-4)"	"unprognostic (4.71e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.30e-1)"	"unprognostic (9.12e-2)"	"prognostic unfavourable (9.61e-5)"	"unprognostic (1.55e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.42e-2)"	3.8	9.7	10.0	2.8	8.0	0.7	2.3	2.0	10.9	0.9	1.2	21.8	0.0	1.5	1.4	1.0	1.3	0.9	1.1	8.3	9.7	10.3	5.2	1.0	13.6	0.8	13.9	7.6	12.5	0.9	0.9	4.3	52.0	14.5	1.5	1.0	0.0	1.3	1.2	2.9	1.2	1.0	2.5	19.3	1.1	1.1	1.6	10.7	0.0	1.6	0.2	0.9	1.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.3	0.1	0.4	0.7	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	1.3	0.0	0.0	0.2	2.9	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.3	1.6	0.0	1.5	0.0	104.4	0.0	0.4	0.5	0.0	0.0	0.1	0.3	5.6	0.0	0.1	0.1	0.0	0.0	0.4	1.3	0.0	0.0	0.0	0.0	0.1	17.7	0.4	0.0	7.6	0.4	0.1	0.0	0.0	7.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	8.0	2.0	8.1	9.7	10.3	13.9	7.6	14.5	10.7
APOA4		ENSG00000110244	"Apolipoprotein A4"	P06727	11	116820700-116823306	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 593.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.9;CACO-2: 8.0;Hep G2: 7.5;NB-4: 7.3;RPMI-8226: 11.7;SH-SY5Y: 10.8"	"Cancer enriched"	"Detected in some"	29	"liver cancer: 291.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA001352, HPA002549, CAB068250, CAB068251, CAB068252"	Enhanced		Approved	Vesicles	"Secreted to blood"	140000000000	140000000000	Vesicles		"CAB068250: , CAB068251: , CAB068252: , HPA001352: AB_1078179, HPA002549: AB_1078177"							"unprognostic (8.81e-2)"				"unprognostic (2.12e-2)"			"unprognostic (1.75e-2)"	"unprognostic (7.91e-2)"			0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	293.8	0.0	0.0	175.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	93.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	593.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	11.7	0.0	0.0	3.2	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
APOA5	"APOA-V, RAP3"	ENSG00000110243	"Apolipoprotein A5"	Q6Q788	11	116789367-116792420	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Lipid transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	209	"liver: 112.2"	"Cell line enriched"	"Detected in single"	65	"Hep G2: 35.8"	"Cancer enriched"	"Detected in single"	489	"liver cancer: 112.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	15000000	15000000				"unprognostic (1.57e-4)"						"unprognostic (4.67e-3)"	"unprognostic (5.57e-2)"		"unprognostic (2.60e-3)"		"unprognostic (2.40e-1)"		"unprognostic (2.31e-4)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	112.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	35.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
APOB		ENSG00000084674	"Apolipoprotein B"	P04114	2	21001429-21044073	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	Heparin-binding	"Atherosclerosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	145	"intestine: 224.8;liver: 442.2"	"Cell line enriched"	"Detected in some"	30	"Hep G2: 151.8"	"Cancer enriched"	"Detected in some"	99	"liver cancer: 295.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016070, HPA049793"	Supported		Supported	Vesicles,Cytosol	"Secreted to blood"	89000000000	89000000000	"Vesicles, Cytosol"		"CAB016070: AB_626690, HPA049793: "	"unprognostic (1.63e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.04e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.53e-3)"	"unprognostic (4.43e-2)"	"unprognostic (8.89e-3)"	"unprognostic (3.01e-1)"	"unprognostic (4.59e-3)"	"unprognostic (3.60e-3)"	"unprognostic (2.89e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.99e-1)"	"unprognostic (6.23e-2)"	0.3	0.1	0.1	0.0	0.1	0.0	2.3	0.1	0.1	0.1	68.9	0.0	0.0	24.9	0.1	0.0	0.1	0.1	0.0	1.2	0.1	0.1	0.1	442.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	224.8	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.4	0.3	0.9	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	151.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.2	0.0	0.2	0.2	0.1	0.0	0.4	0.2	0.1	0.9	0.3	0.0	0.3	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
APOC1		ENSG00000130208	"Apolipoprotein C1"	P02654	19	44914247-44919349	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Lipid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"liver: 702.7"	"Cell line enhanced"	"Detected in many"		"Hep G2: 98.0;HSkMC: 60.7;K-562: 25.5;SK-MEL-30: 45.2"	"Cancer enriched"	"Detected in all"	21	"liver cancer: 3253.7"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"myeloid DC: 8.9"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 8.9"	"Low region specificity"	"Detected in many"							HPA051518	Supported				"Secreted to blood"	26000000000	26000000000			"HPA051518: "	"unprognostic (3.51e-2)"	"unprognostic (3.31e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.47e-1)"	"prognostic favourable (1.15e-7)"	"unprognostic (9.51e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.13e-3)"	"unprognostic (3.48e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.65e-1)"	1.5	58.9	6.6	1.6	30.0	2.4	3.6	0.6	4.4	1.5	1.8	4.9	0.3	0.9	0.6	2.5	0.4	0.8	1.8	0.4	4.1	7.8	0.6	702.7	12.6	6.1	20.2	1.0	4.1	1.1	0.4	2.6	2.3	6.6	0.6	1.1	1.3	2.0	0.4	1.2	1.4	1.0	0.5	11.7	9.6	1.3	1.0	5.2	1.0	0.7	0.5	1.9	1.2	0.3	0.2	8.9	0.0	0.6	0.2	0.0	0.6	0.4	4.6	2.1	0.8	6.7	7.0	19.8	0.2	0.3	0.8	1.3	9.7	8.7	1.4	1.7	0.1	0.3	2.7	0.3	0.4	0.0	11.2	6.2	0.6	98.0	6.0	4.6	3.2	60.7	0.5	0.8	0.3	0.2	25.5	0.1	0.3	0.6	0.2	0.3	20.0	0.9	1.0	2.8	0.1	1.2	0.3	0.9	0.5	3.3	0.0	45.2	0.4	17.0	0.7	0.0	0.3	0.0	0.2	0.8	0.8	1.5	0.1	1.3	0.5	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	8.9	0.2	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.6	6.6	30.0	0.6	3.1	4.1	7.8	20.2	1.0	6.6	5.2
APOC2		ENSG00000234906	"Apolipoprotein C2"	P02655	19	44945982-44949565	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism, Lipid transport, Transport"		"Disease mutation, Hyperlipidemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	78	"liver: 506.5"	"Group enriched"	"Detected in some"	4	"Hep G2: 82.9;THP-1: 153.3"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 49.7"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	21	"NK-cell: 6.5"	"Lineage enriched"	"Detected in single"	21	"NK-cells: 6.5"					"Not detected"	"Not detected"			HPA055877	Supported				"Secreted to blood"	110000000000	110000000000			"HPA055877: "	"unprognostic (4.28e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.66e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.14e-8)"	"unprognostic (1.32e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.80e-3)"	0.2	0.4	2.8	0.3	3.7	0.2	0.5	0.4	1.6	0.4	2.1	3.7	0.0	2.8	0.2	0.5	0.3	0.4	0.4	0.2	2.3	2.2	1.2	506.5	2.2	0.8	4.7	0.5	0.2	0.2	0.3	0.2	0.3	2.2	0.2	0.4	0.0	0.3	0.3	0.3	0.4	6.3	0.2	4.7	0.3	0.3	0.2	2.1	0.0	0.2	0.0	0.7	0.3	0.0	0.1	0.3	0.0	0.0	6.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	14.4	0.2	82.9	0.0	1.7	28.4	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.1	13.8	0.0	0.0	0.1	0.6	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.8	0.0	153.3	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	2.8	3.7	0.4	1.6	2.3	2.2	4.7	0.5	2.2	2.1
APOC3		ENSG00000110245	"Apolipoprotein C3"	P02656	11	116829706-116833072	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism, Lipid transport, Transport"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 714.1"	"Group enriched"	"Detected in some"	19	"CACO-2: 27.8;Hep G2: 75.2"	"Cancer enriched"	"Detected in many"	643	"liver cancer: 4021.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"HPA065365, HPA073918"	Supported		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"	"Secreted to blood"	97000000000	97000000000	Nucleoplasm	"Nucleoli, Cell Junctions"	"HPA065365: , HPA073918: "							"prognostic favourable (3.77e-4)"				"unprognostic (2.33e-1)"		"prognostic unfavourable (6.87e-5)"	"unprognostic (1.60e-2)"	"unprognostic (5.21e-2)"			0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	38.7	0.1	0.1	31.7	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.4	714.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	91.3	0.1	0.1	0.3	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	27.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	75.2	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.6	0.9	0.0	0.0	0.3	1.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.1
APOC4		ENSG00000267467	"Apolipoprotein C4"	P55056	19	44942238-44945496	"Plasma proteins, Predicted secreted proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"liver: 126.0"	"Cell line enhanced"	"Detected in some"		"HEL: 4.2;SK-MEL-30: 6.4"	"Cancer enriched"	"Detected in single"	15	"liver cancer: 0.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA062671	Approved				"Secreted to blood"	1500000000	1500000000			"HPA062671: "							"unprognostic (1.82e-3)"											0.0	0.2	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	126.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	3.1	4.3	1.7	0.8	1.2	0.1	0.8	0.0	0.0	0.8	0.0	0.9	1.6	0.0	0.0	1.1	0.2	0.0	0.2	1.1	0.1	0.0	0.1	0.6	0.4	0.3	0.2	0.4	4.2	0.0	2.6	0.0	0.3	1.2	2.4	0.3	0.0	0.4	0.0	1.2	1.9	0.7	1.0	0.3	0.0	0.0	0.5	0.0	0.5	0.8	0.0	1.4	0.5	0.2	0.7	0.8	6.4	1.3	0.0	3.0	0.6	0.3	0.4	0.0	0.8	0.8	2.0	0.2	1.3	0.0	2.1	0.8	1.9	0.9	1.7	0.4	0.6	0.9	1.2	0.4	1.4	0.6	0.6	4.3	0.8	0.8	3.1	0.5	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.2	0.0	0.0	0.0
APOD		ENSG00000189058	"Apolipoprotein D"	P05090	3	195568702-195584205	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"breast: 840.7"	"Group enriched"	"Detected in some"	7	"ASC diff: 233.9;ASC TERT1: 126.0"	"Cancer enhanced"	"Detected in all"		"melanoma: 925.2"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"memory B-cell: 6.7"	"Lineage enriched"	"Detected in single"	10	"B-cells: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040520	Enhanced		Approved	"Plasma membrane"	"Secreted to blood"	220000000000	220000000000	"Plasma membrane"		"HPA040520: "	"prognostic favourable (5.51e-4)"	"unprognostic (7.62e-3)"	"unprognostic (7.85e-3)"	"unprognostic (3.34e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.19e-1)"	"unprognostic (6.90e-3)"	"prognostic unfavourable (6.02e-4)"	"unprognostic (1.38e-1)"	"prognostic unfavourable (4.12e-4)"	"unprognostic (1.71e-3)"	134.4	15.2	39.7	5.7	39.9	3.4	840.7	14.7	66.1	75.0	16.4	79.7	10.9	12.9	36.6	30.0	46.1	42.9	36.4	124.7	45.5	29.2	8.5	3.5	11.8	6.5	96.9	28.2	19.4	28.3	9.0	14.3	59.6	50.9	39.7	13.1	99.1	152.5	35.1	110.4	66.0	7.2	30.4	81.6	3.6	28.7	32.0	56.5	0.0	87.7	42.2	6.6	62.1	95.7	6.7	0.1	0.4	0.6	0.0	0.1	0.1	0.0	0.1	0.0	0.0	233.9	126.0	0.3	2.0	0.5	0.0	0.0	12.9	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	6.4	1.4	0.0	1.1	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.3	2.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	25.3	0.4	0.1	0.0	0.1	0.1	0.0	6.7	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.6	0.1	0.0	0.1	39.7	39.9	14.7	39.5	45.5	29.2	96.9	28.2	50.9	56.5
APOE	AD2	ENSG00000130203	"Apolipoprotein E"	P02649	19	44905754-44909393	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	Heparin-binding	"Alzheimer disease, Amyloidosis, Cancer-related genes, Disease mutation, Hyperlipidemia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 226.8;liver: 508.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 163.3;Hep G2: 75.9;HSkMC: 119.7;SK-MEL-30: 151.8"	"Cancer enhanced"	"Detected in all"		"liver cancer: 3183.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008363, HPA065539, HPA068768, CAB069921"	Enhanced		Approved	Vesicles	"Secreted to blood"	63000000000	63000000000	Vesicles		"CAB008363: AB_590560, CAB069921: AB_920623, HPA065539: AB_2685509, HPA068768: AB_2686029"	"unprognostic (8.98e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.49e-2)"	"unprognostic (5.28e-2)"	"unprognostic (3.77e-2)"	"unprognostic (7.25e-2)"	"unprognostic (5.22e-3)"	"unprognostic (6.13e-2)"	"unprognostic (5.06e-2)"	"unprognostic (4.13e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.12e-3)"	"unprognostic (4.13e-2)"	76.8	226.8	78.4	14.6	106.8	9.7	12.8	26.6	109.8	13.6	15.1	40.3	0.8	7.7	9.4	10.9	2.6	4.3	17.1	6.9	41.4	57.9	121.8	508.1	21.5	46.0	104.0	34.5	23.5	5.2	2.7	4.9	17.2	54.1	6.6	5.2	11.2	8.5	3.4	5.7	33.0	10.2	3.6	35.1	89.2	13.4	12.6	33.9	4.9	6.0	1.3	8.6	11.8	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.8	0.2	163.3	6.7	5.9	0.1	0.3	0.7	0.1	38.7	0.2	0.1	0.8	0.0	0.5	1.0	0.1	0.0	0.1	0.3	0.2	0.1	75.9	16.8	0.5	0.1	119.7	0.2	1.2	0.1	0.0	9.9	0.2	0.1	0.2	0.1	0.2	20.4	0.1	0.2	0.6	0.1	0.2	0.0	0.4	0.2	0.3	0.1	151.8	14.0	4.3	0.2	1.1	0.2	0.1	0.1	0.4	0.6	0.3	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	78.4	106.8	26.6	53.4	41.4	57.9	104.0	34.5	54.1	33.9
APOF		ENSG00000175336	"Apolipoprotein F"	Q13790	12	56360569-56362823	"Plasma proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	53	"liver: 114.0"	"Cell line enriched"	"Detected in single"	10	"Hep G2: 9.7"	"Cancer enriched"	"Detected in some"	6	"liver cancer: 34.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"												"Secreted to blood"	4000000000	4000000000				"unprognostic (3.55e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.48e-2)"	"unprognostic (8.99e-3)"	"unprognostic (9.84e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.08e-3)"	"unprognostic (7.84e-2)"	"unprognostic (4.22e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.68e-3)"	"unprognostic (8.55e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.43e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	114.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.9	1.8	0.5	1.1	1.4	0.1	0.2	0.2	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.7	0.1	0.0	0.5	0.0	0.0	0.0	0.2	0.3	0.6	0.9	9.7	0.0	0.9	0.3	0.2	0.0	0.1	0.1	0.0	0.5	0.3	0.1	0.3	0.2	0.1	0.5	0.4	0.3	0.4	0.6	0.5	0.4	0.3	0.1	0.4	0.4	0.1	0.2	0.0	0.0	0.1	0.1	0.3	0.0	0.8	0.4	0.4	0.2	0.4	0.3	1.8	0.5	0.3	0.5	0.2	0.8	1.6	0.7	0.6	0.1	2.1	1.4	1.1	1.3	1.1	0.4	0.9	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ARSK	"DKFZp313G1735, TSULF"	ENSG00000164291	"Arylsulfatase family member K"	Q6UWY0	5	95555074-95605064	"Plasma proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042384	Approved		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"			Vesicles	Nucleoplasm	"HPA042384: AB_10795703"	"unprognostic (9.50e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.03e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (2.59e-4)"	"unprognostic (3.39e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.19e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.32e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.06e-2)"	8.5	10.2	6.9	4.8	7.6	4.7	7.6	14.2	12.3	8.9	8.6	4.3	9.6	5.1	8.5	9.6	6.7	7.4	6.9	8.5	7.9	7.1	11.5	9.7	7.4	5.6	8.4	9.9	12.8	11.7	29.3	14.5	11.2	7.2	10.7	5.9	7.3	6.7	11.2	5.5	8.4	5.4	6.7	8.8	5.5	9.7	4.5	7.5	10.6	15.8	2.8	4.5	9.2	14.0	6.7	2.7	10.0	1.6	3.9	9.2	2.3	3.3	2.1	4.6	4.6	22.8	11.9	6.6	10.7	6.2	4.2	8.7	2.7	5.3	4.6	5.6	3.6	3.2	4.0	6.8	9.3	4.9	5.8	3.7	5.5	4.4	6.6	2.0	3.0	8.7	6.1	6.4	4.1	6.8	3.7	5.0	9.3	1.6	5.5	3.9	5.9	10.4	3.4	7.3	7.2	9.7	0.8	3.2	3.3	6.6	2.2	6.4	6.1	2.1	12.2	6.7	5.4	10.3	6.5	4.3	7.3	5.5	6.6	5.4	24.8	10.0	1.6	2.5	5.3	1.5	6.1	5.3	6.0	6.7	0.8	6.7	9.2	6.9	1.5	3.9	1.0	2.7	4.5	2.3	6.9	7.6	14.2	12.3	7.9	7.1	8.4	9.9	7.2	7.5
ASIP	"AGTIL, ASP"	ENSG00000101440	"Agouti signaling protein"	P42127	20	34194569-34269344	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 43.7;epididymis: 18.4;ovary: 24.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.5;HSkMC: 5.3;U-698: 3.9"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	6	"hippocampal formation: 5.4"	"Cell type enriched"	"Detected in single"	321	"plasmacytoid DC: 43.7"	"Lineage enriched"	"Detected in single"	321	"dendritic cells: 43.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA048636	Uncertain		Supported	Vesicles	"Secreted to blood"			Vesicles		"HPA048636: "	"unprognostic (4.81e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.97e-3)"	"unprognostic (3.26e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.07e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.57e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.53e-6)"	"unprognostic (1.02e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.33e-1)"	0.5	0.1	0.3	0.3	0.3	0.2	1.9	0.3	0.8	2.0	1.0	0.3	0.3	0.0	2.0	18.4	0.3	2.1	0.3	10.3	5.4	0.0	0.3	0.5	0.3	0.4	0.3	0.3	24.8	0.3	0.0	0.3	0.3	0.7	2.5	0.0	0.3	0.3	0.3	0.3	5.4	0.3	0.3	1.3	0.3	0.1	7.1	0.3	0.3	0.3	0.3	0.8	0.5	0.4	0.1	43.7	0.0	0.0	0.0	0.0	0.2	0.1	2.3	0.8	0.8	0.5	1.6	0.2	0.2	0.0	0.0	0.0	6.5	0.1	2.4	0.5	0.6	0.3	0.0	0.0	0.0	0.1	1.6	3.4	0.7	1.1	0.0	0.0	0.9	5.3	0.0	0.0	0.0	0.0	1.2	2.0	0.0	0.7	0.5	3.4	0.0	1.3	0.7	0.6	2.9	0.0	0.2	0.6	0.6	0.0	0.4	3.8	0.6	0.4	0.7	1.2	1.2	0.2	0.6	0.8	0.7	3.9	0.5	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	43.7	0.0	0.2	0.3	0.3	0.3	0.8	5.4	0.0	0.3	0.3	0.7	0.3
ASPN	"FLJ20129, PLAP-1, SLRR1C"	ENSG00000106819	Asporin	Q9BXN1	9	92456205-92482506	"Disease related genes, Plasma proteins, Predicted secreted proteins"	Biomineralization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 62.1"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 14.4;BJ hTERT+: 4.9;HHSteC: 20.5;HSkMC: 4.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in single"		"basophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008435, HPA024230"	Approved				"Secreted to extracellular matrix"	33000	33000			"HPA008435: AB_1845112, HPA024230: AB_1845113"	"unprognostic (2.40e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.13e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.01e-2)"	"unprognostic (9.50e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.74e-3)"	"unprognostic (6.38e-2)"	"unprognostic (3.70e-2)"	"unprognostic (4.70e-2)"	"prognostic unfavourable (1.64e-7)"	"unprognostic (1.42e-3)"	"unprognostic (3.04e-2)"	"unprognostic (6.27e-3)"	"unprognostic (2.48e-2)"	13.4	2.2	0.5	5.2	1.7	0.0	4.8	0.4	0.7	40.2	14.6	0.6	8.1	2.8	62.1	26.7	15.3	9.9	26.4	31.6	0.6	0.6	3.5	21.9	10.3	0.7	0.9	1.4	7.8	4.7	0.8	1.9	3.7	1.0	12.2	3.6	1.6	2.0	3.6	10.8	3.7	19.7	37.1	0.8	0.8	8.8	6.7	0.4	1.5	7.1	27.7	2.2	24.2	3.8	0.4	0.2	1.9	0.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.3	14.4	0.0	1.9	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.5	0.0	0.0	4.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.4	0.2	0.1	0.2	0.1	0.7	0.2	0.0	0.0	0.5	1.7	0.4	0.7	0.6	0.6	0.9	1.4	1.0	0.4
ASTL	"ovastacin, SAS1B"	ENSG00000188886	"Astacin like metalloendopeptidase"	Q6HA08	2	96123850-96138436	"Enzymes, Predicted secreted proteins"	Fertilization	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.1;fHDF/TERT166: 2.1;RT4: 3.8"	"Low cancer specificity"	"Detected in single"							"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"NK-cells: 1.9;T-cells: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA015620	Uncertain				"Secreted in female reproductive system"					"HPA015620: AB_1845121"	"unprognostic (3.21e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.45e-4)"	"unprognostic (1.00e-2)"	"unprognostic (3.03e-2)"		"unprognostic (3.53e-2)"	"unprognostic (5.12e-2)"	"unprognostic (3.62e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.61e-5)"	"unprognostic (3.41e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.93e-3)"	0.2	0.1	0.2	0.6	0.4	8.5	0.1	1.3	0.8	0.0	0.5			0.1	0.3	0.4	0.5	0.0	0.4	0.0	0.8	0.0	0.1	0.0	0.5	1.1	0.0		0.2	0.0	0.0	0.8	0.0		0.9	0.2		0.6	2.7	0.0	2.3	1.1	0.0	0.0	2.3	0.2	0.7			0.0		0.7	3.2	0.0	0.3	0.0	0.0	0.0	1.9	1.8	0.3	0.0	0.0	0.0	0.1	0.0	0.4	3.1	0.0	0.0	0.0	0.1	1.2	0.1	0.1	1.2	2.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	1.1	0.9	0.7	0.0	0.0	0.0	0.4	0.0	3.8	0.8	0.0	0.0	0.3	0.3	1.4	0.5	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.5	0.0	0.2	0.2	0.0	0.0	0.0	0.5	0.0	1.2	0.3	1.8	1.8	0.0	0.0	0.3	0.6	0.0	1.9	0.0	0.0	0.0	0.3										
AVP	"ADH, ARVP"	ENSG00000101200	"Arginine vasopressin"	P01185	20	3082556-3084724	"Disease related genes, Predicted secreted proteins"		"Hormone, Vasoactive, Vasoconstrictor"	"Diabetes insipidus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	44	"brain: 270.1"	"Cell line enriched"	"Detected in single"	13	"NB-4: 6.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	18	"hypothalamus: 270.1"	"Cell type enriched"	"Detected in some"	6	"eosinophil: 6.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 6.1"	"Region enriched"	"Detected in some"	10	"hypothalamus: 273.6"	"Group enriched"	"Detected in some"	645	"basal ganglia: 1065.4;hypothalamus: 1058.2"	"CAB025318, HPA071892"	Enhanced	Supported			"Secreted to blood"					"CAB025318: , HPA071892: "										"unprognostic (1.15e-1)"					"unprognostic (2.61e-1)"			0.7	0.9	11.7	0.4	15.0	4.2	0.0	0.0	0.9	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	270.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	1.0	0.1	11.7	15.0	0.0	0.9	3.4	270.1	0.0	0.0	0.8	0.0
BCAN	"BEHAB, CSPG7, MGC13038"	ENSG00000132692	Brevican	Q96GW7	1	156641390-156659532	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"brain: 144.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 24.2;K-562: 34.1;U-266/70: 20.5;U-266/84: 39.4"	"Group enriched"	"Detected in many"	77	"glioma: 348.5;melanoma: 75.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"basophil: 8.2"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007865, CAB025862"	Enhanced	Supported			"Secreted in brain"	98000	98000			"CAB025862: , HPA007865: AB_1078299"	"unprognostic (7.14e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.03e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.80e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.30e-2)"	"unprognostic (9.47e-3)"	"unprognostic (2.76e-2)"	"unprognostic (8.54e-2)"	"unprognostic (5.40e-1)"	"unprognostic (1.90e-1)"	1.4	5.8	51.8	1.6	35.9	1.3	1.4	10.4	144.2	2.3	2.4	30.5	1.3	4.6	2.7	9.5	1.6	2.4	3.1	1.5	40.8	22.9	1.4	1.3	1.5	1.5	26.6	21.5	1.4	1.3	1.3	0.7	1.7	15.1	1.4	1.3	4.3	2.0	2.4	1.6	9.0	5.0	2.4	13.0	1.6	2.4	2.0	26.7	0.0	1.4	0.0	1.3	2.3	0.3	0.6	0.0	8.2	0.4	0.0	0.0	0.0	13.7	9.5	0.0	2.6	0.0	0.0	3.9	0.1	0.0	0.0	0.0	0.3	6.8	0.0	14.7	0.0	9.7	0.1	0.0	0.0	24.2	0.8	2.4	6.3	7.8	0.0	0.9	2.4	0.0	0.0	0.0	0.0	0.0	34.1	6.7	0.0	4.0	0.0	0.0	0.7	1.4	0.0	15.8	0.0	0.0	1.7	0.0	0.2	0.0	0.0	14.3	0.0	0.9	2.9	0.0	7.8	2.8	3.7	20.5	39.4	0.0	2.9	6.4	1.1	8.2	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.8	35.9	10.4	33.3	40.8	22.9	26.6	21.5	15.1	26.7
BGLAP	OCN	ENSG00000242252	"Bone gamma-carboxyglutamate protein"	P02818	1	156241962-156243321	"FDA approved drug targets, Predicted secreted proteins"	Biomineralization		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.0"	"Cell line enhanced"	"Detected in some"		"U-87 MG: 7.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	16	"NK-cell: 2.2;plasmacytoid DC: 4.2"	"Group enriched"	"Detected in many"	16	"dendritic cells: 4.2;NK-cells: 2.2"														"Secreted to blood"	430000	430000				"unprognostic (2.50e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.82e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.44e-5)"	"unprognostic (2.63e-2)"	"unprognostic (6.54e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.53e-3)"	"unprognostic (4.70e-2)"	"unprognostic (9.67e-6)"	"unprognostic (3.02e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.34e-2)"	"unprognostic (8.64e-3)"	1.6	0.7	6.0	6.7	6.9	2.2	1.4	5.2	11.0	1.1	9.3	6.2	0.0	3.2	4.8	1.4	0.8	2.3	1.7	0.7	4.3	2.9	1.2	1.6	1.4	2.3	6.2	6.8	3.4	0.8	1.5	1.3	3.1	9.7	2.1	3.4	0.0	3.6	2.8	2.2	6.8	6.4	3.9	8.4	2.1	2.3	0.3	4.1	0.6	1.6	0.0	1.2	0.7	1.2	0.0	4.2	0.2	0.0	2.2	0.1	0.1	0.4	0.8	1.8	0.5	0.0	0.6	1.3	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.5	0.0	0.6	0.0	0.4	0.0	2.0	1.0	0.0	2.2	1.2	0.5	0.0	0.4	0.0	0.7	0.7	0.6	0.7	0.5	2.5	0.0	2.1	0.0	1.6	1.0	0.4	1.0	0.1	1.5	0.6	0.0	0.2	2.1	0.7	0.4	0.8	1.3	0.0	0.0	0.0	0.5	0.4	0.5	3.1	2.8	1.6	7.1	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.2	0.0	4.2	0.0	0.1	6.0	6.9	5.2	11.0	4.3	2.9	6.2	6.8	9.7	4.1
BGN	"DSPG1, SLRR1A"	ENSG00000182492	Biglycan	P21810	X	153494939-153509554	"Disease related genes, Predicted secreted proteins"			"Aortic aneurysm, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ: 45.5;BJ hTERT+: 58.9;fHDF/TERT166: 82.2;HSkMC: 43.2;hTEC/SVTERT24-B: 34.9;HUVEC TERT2: 82.4;U-138 MG: 37.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003157, CAB003678"	Enhanced		Approved	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to extracellular matrix"	2500000	2500000	"Golgi apparatus"	"Endoplasmic reticulum"	"CAB003678: AB_425325, HPA003157: AB_1078282"	"unprognostic (1.74e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.11e-3)"	"unprognostic (3.60e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.30e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavourable (6.00e-8)"	"unprognostic (7.05e-3)"	"unprognostic (2.40e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.57e-3)"	41.1	39.7	8.1	23.2	14.6	0.4	20.2	5.6	14.3	76.7	12.0	18.7	16.7	6.0	63.4	31.7	21.1	23.6	86.7	133.0	8.9	5.2	67.6	78.1	77.6	29.4	8.9	16.3	39.6	16.8	5.1	26.7	131.1	15.0	33.6	7.0	48.3	20.4	38.2	17.0	31.0	8.6	56.9	5.9	101.3	10.0	28.0	15.8	3.9	45.3	29.9	14.6	34.5	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	4.7	10.8	0.1	45.5	58.9	8.4	2.8	5.7	0.0	0.0	8.4	82.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.5	4.1	0.0	0.0	43.2	0.3	34.9	1.6	82.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	17.4	37.5	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	14.6	5.6	14.3	8.9	5.2	8.9	16.3	15.0	15.8
BMP1	PCOLC	ENSG00000168487	"Bone morphogenetic protein 1"	P13497	8	22164736-22212326	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor, Hydrolase, Metalloprotease, Protease"	"Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"lung: 72.2;placenta: 106.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014572	Enhanced				"Secreted to extracellular matrix"	2100000	2100000			"HPA014572: AB_1845390"	"unprognostic (1.24e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.75e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.76e-2)"	"unprognostic (9.53e-2)"	"unprognostic (2.64e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.75e-3)"	"unprognostic (7.05e-3)"	"unprognostic (3.14e-2)"	"prognostic unfavourable (3.37e-9)"	"unprognostic (2.11e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.34e-2)"	6.9	11.7	2.7	3.6	4.6	1.1	5.9	7.8	4.2	8.1	5.8	3.1	3.7	4.4	9.4	5.2	4.8	7.7	5.4	3.4	2.6	1.3	4.9	9.2	72.2	3.2	3.4	1.5	5.2	3.7	2.8	2.2	106.2	3.5	6.5	4.7	4.6	2.4	4.6	2.4	6.8	5.7	11.0	3.6	3.2	2.9	2.2	3.6	1.0	7.1	2.4	2.9	9.9	9.5	0.0	0.9	0.1	1.4	0.8	2.2	0.4	4.6	4.8	1.3	6.2	15.3	11.3	6.8	20.3	16.9	10.4	9.6	2.5	3.0	1.1	12.7	18.6	10.2	1.6	5.4	2.0	1.0	2.1	1.7	7.3	2.9	12.5	0.7	3.5	12.9	8.5	8.1	2.6	10.0	2.2	2.1	5.6	1.7	0.5	1.0	0.8	2.6	1.1	3.3	4.9	9.0	0.7	0.8	3.3	14.6	0.8	3.3	0.9	2.0	12.7	2.7	6.0	6.5	6.0	1.0	0.6	0.2	5.3	2.7	7.5	0.0	1.4	0.0	2.2	0.7	1.4	0.0	0.4	1.0	0.0	0.0	0.3	1.7	0.1	0.8	0.5	0.9	0.0	0.4	2.7	4.6	7.8	4.2	2.6	1.3	3.4	1.5	3.5	3.6
BMP10		ENSG00000163217	"Bone morphogenetic protein 10"	O95393	2	68865481-68871517	"Predicted secreted proteins"	"Cell adhesion"	"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"heart muscle: 110.1"	"Cell line enhanced"	"Detected in single"		"MOLT-4: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"T-reg: 1.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"	120000	120000																		"unprognostic (1.74e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	110.1	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BMP15	GDF9B	ENSG00000130385	"Bone morphogenetic protein 15"	O95972	X	50910784-50916607	"Disease related genes, Predicted secreted proteins"		"Cytokine, Growth factor"	"Disease mutation, Premature ovarian failure"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"fallopian tube: 2.2;testis: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"																							0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1			0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0		0.1	0.0	0.0	0.0	0.2		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
BMP2	BMP2A	ENSG00000125845	"Bone morphogenetic protein 2"	P12643	20	6767664-6780280	"Cancer-related genes, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"	"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 20.7;HeLa: 13.5;hTERT-HME1: 12.2;RT4: 16.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"NK-cell: 2.2"	"Lineage enriched"	"Detected in single"	7	"NK-cells: 2.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA058610, CAB078457"			Enhanced	Vesicles	"Secreted to blood"			Vesicles		"CAB078457: AB_2532532, HPA058610: "	"unprognostic (2.22e-2)"	"unprognostic (9.32e-2)"	"unprognostic (6.12e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.70e-3)"	"unprognostic (3.12e-3)"	"unprognostic (8.51e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.53e-3)"	"unprognostic (5.39e-3)"	"unprognostic (7.81e-2)"	"unprognostic (3.76e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.01e-2)"	"unprognostic (7.49e-2)"	11.1	1.1	1.6	10.5	3.1	0.6	5.3	1.8	7.5	3.7	13.1	2.6	1.9	4.2	3.4	6.7	3.7	3.7	15.6	3.9	2.4	1.6	3.6	3.8	12.8	1.3	2.9	1.3	3.1	9.2	4.7	2.3	7.6	2.7	8.8	9.5	18.3	2.0	1.2	2.6	9.1	13.4	3.4	1.4	8.0	13.8	1.1	2.7	0.3	13.2	6.2	3.1	14.1	9.1	0.0	0.0	0.3	0.0	2.2	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.5	2.3	0.0	0.0	20.7	0.0	0.0	0.3	0.7	6.9	4.1	1.8	0.0	0.0	3.7	0.0	13.5	0.0	1.0	0.0	0.5	0.1	6.3	0.0	12.2	4.2	0.0	0.0	0.1	0.0	0.0	3.9	0.5	0.5	4.0	0.0	0.3	1.5	16.5	0.7	1.0	4.9	0.0	0.0	0.0	4.3	1.0	1.2	1.8	0.0	0.5	0.2	0.5	0.0	2.1	1.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.0	0.0	0.0	0.0	1.6	3.1	1.8	3.3	2.4	1.6	2.9	1.3	2.7	2.7
BMP3		ENSG00000152785	"Bone morphogenetic protein 3"	P12645	4	81030965-81057531	"Plasma proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 15.0;lung: 21.0;urinary bladder: 18.7"	"Group enriched"	"Detected in some"	4	"AF22: 10.3;Daudi: 15.7;RT4: 13.1;SK-BR-3: 5.9"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 7.5"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 3.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"						"unprognostic (5.21e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.36e-2)"		"unprognostic (2.73e-3)"		"unprognostic (9.11e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.16e-4)"	"unprognostic (2.26e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.22e-2)"	2.4	0.5	1.4	3.8	0.6	0.8	4.5	0.8	0.7	0.9	15.0	0.0	0.3	3.5	0.2	0.3	4.2	1.1	2.5	0.2	0.7	1.0	0.3	0.2	21.0	0.5	0.3	0.4	3.0	1.0	0.0	0.4	0.0	0.5	3.7	7.9	2.9	6.9	0.0	0.6	0.7	11.2	1.5	0.9	0.2	2.2	0.3	0.0	0.0	0.3	1.6	2.3	18.7	10.5	3.5	0.0	0.6	0.1	1.2	0.1	0.2	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	1.9	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	13.1	0.1	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	3.5	0.1	0.0	0.5	1.2	0.0	0.0	0.0	0.2	1.4	0.6	0.8	0.7	0.7	1.0	0.3	0.4	0.5	0.0
BMP6	"VGR, VGR1"	ENSG00000153162	"Bone morphogenetic protein 6"	P22004	6	7726797-7881422	"Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 17.4"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 57.6;Karpas-707: 29.9;SiHa: 25.1;TIME: 26.4"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in some"	8	"basophil: 4.0;neutrophil: 2.3"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002773, HPA062683"	Approved		Approved	Mitochondria	"Secreted to blood"	21000	21000	Mitochondria		"CAB002773: , HPA062683: "	"prognostic favourable (6.45e-4)"	"unprognostic (2.99e-1)"	"unprognostic (4.20e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.44e-1)"	"unprognostic (7.27e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.82e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.29e-3)"	10.5	1.5	1.7	1.3	2.8	0.0	7.7	0.2	1.1	2.5	2.7			1.9	2.1	0.0	1.5	1.1	1.6	3.8	1.7	1.4	6.6	1.4	5.8	0.7	2.2		5.8	0.1	0.0	2.8	17.4		1.5	2.2		1.1	2.2	1.4	1.7	2.0	2.0	1.9	3.4	3.4	1.5			0.5		1.8	2.9	1.7	0.3	0.4	4.0	0.0	0.0	0.2	2.1	0.3	0.9	0.1	0.0	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.4	0.1	0.4	0.0	0.0	0.0	2.0	5.5	8.5	0.5	0.3	0.3	5.8	0.0	0.0	0.2	1.0	57.6	0.0	29.9	0.0	0.1	0.0	0.0	0.3	4.1	0.2	0.0	5.2	0.1	0.0	4.3	0.0	25.1	0.0	0.0	0.0	0.0	26.4	0.0	1.6	0.1	0.8	3.8	13.1	0.0	0.9	0.0	0.5	4.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.4	0.3	0.0	0.0	2.3	0.0	0.0	0.2	0.0	2.1										
BMP8A		ENSG00000183682	"Bone morphogenetic protein 8a"	Q7Z5Y6	1	39491646-39525935	"Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	5	"thyroid gland: 45.6"	"Cell line enhanced"	"Detected in some"		"U-2197: 15.9;U-266/70: 7.7;U-266/84: 7.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to blood"						"unprognostic (9.62e-3)"	"unprognostic (2.11e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.91e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.95e-9)"	"unprognostic (2.62e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.28e-3)"	"unprognostic (2.55e-2)"	0.7	1.0	1.7	1.2	2.0	0.9	0.5	0.8	3.6	3.3	1.0	8.5	0.0	1.4	3.7	1.2	0.7	2.0	2.6	1.2	1.9	1.3	0.6	0.5	0.7	5.6	4.6	1.1	8.9	3.8	0.5	0.9	1.0	4.8	1.0	0.6	0.4	1.3	1.8	1.4	1.6	2.2	1.9	8.3	1.4	1.0	4.0	2.3	1.7	45.6	0.0	0.6	0.9	0.9	0.7	0.0	0.0	0.6	0.0	0.1	0.4	0.4	0.8	0.4	0.3	0.0	0.0	0.5	0.2	0.0	0.0	0.0	1.3	0.0	0.1	0.3	0.2	0.6	0.0	0.0	0.0	0.4	1.8	0.0	1.6	0.3	3.8	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	2.9	0.0	1.6	0.0	2.1	1.1	0.1	0.5	0.3	2.4	0.1	0.1	1.4	0.4	0.1	0.2	1.1	0.7	2.9	0.1	0.0	0.7	15.9	0.0	7.7	7.0	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.7	2.0	0.8	3.6	1.9	1.3	4.6	1.1	4.8	2.3
BMP8B	"BMP8, OP-2"	ENSG00000116985	"Bone morphogenetic protein 8b"	P34820	1	39757182-39788861	"Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"intestine: 21.9;thyroid gland: 26.8"	"Cell line enhanced"	"Detected in many"		"THP-1: 46.4;U-266/70: 14.0;U-266/84: 20.0;WM-115: 22.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"																"Secreted to blood"						"unprognostic (1.53e-3)"	"unprognostic (7.29e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.64e-3)"	"unprognostic (8.79e-2)"	"unprognostic (3.44e-2)"	"unprognostic (7.27e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.41e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.72e-4)"	"unprognostic (1.79e-2)"	"unprognostic (3.15e-1)"	"unprognostic (9.67e-2)"	"unprognostic (8.68e-3)"	"unprognostic (4.82e-1)"	2.8	8.1	5.5	2.4	6.7	1.4	1.6	2.5	4.1	3.8	13.2	6.9	8.2	7.5	2.6	14.2	3.5	2.3	2.1	1.6	5.0	3.3	1.6	1.0	3.1	3.6	6.1	5.5	1.4	9.9	6.6	5.8	2.3	2.8	5.1	4.0	3.6	3.6	4.7	1.2	3.2	21.9	2.1	3.6	2.4	3.0	3.1	6.2	0.4	26.8	3.4	3.1	2.1	3.3	1.7	0.2	0.8	0.7	2.6	1.9	0.3	1.0	1.9	0.1	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	2.1	0.0	0.7	0.0	0.2	1.6	0.0	0.0	0.4	2.3	1.9	1.5	0.1	0.4	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.2	7.4	0.1	1.5	0.0	1.0	0.3	0.7	1.1	6.3	2.4	1.6	1.0	5.3	1.3	1.7	0.1	5.1	1.3	46.4	0.0	0.0	0.1	1.6	0.1	14.0	20.0	0.8	0.0	1.4	22.4	0.8	0.7	0.1	0.5	0.3	0.6	1.7	0.2	1.9	0.1	0.7	0.3	0.4	0.6	2.6	0.3	0.2	0.1	0.3	5.5	6.7	2.5	4.1	5.0	3.3	6.1	5.5	2.8	6.2
BMPER	"CRIM3, Cv2"	ENSG00000164619	"BMP binding endothelial regulator"	Q8N8U9	7	33904911-34155872	"Disease related genes, Plasma proteins, Predicted secreted proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 11.5;BJ: 11.0;fHDF/TERT166: 14.2;HBF TERT88: 15.6;HSkMC: 11.7;hTEC/SVTERT24-B: 10.3;U-138 MG: 16.2"	"Cancer enhanced"	"Detected in some"		"glioma: 2.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to extracellular matrix"						"unprognostic (4.50e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.83e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.96e-4)"	"unprognostic (5.34e-3)"	"unprognostic (3.10e-1)"	"unprognostic (9.98e-3)"	"unprognostic (3.50e-3)"	"unprognostic (8.01e-4)"	"unprognostic (1.96e-1)"	"unprognostic (5.67e-5)"	"unprognostic (2.54e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.47e-3)"	7.0	1.1	2.2	8.5	6.3	0.3	2.2	9.5	9.7	5.0	2.4	0.6	0.0	1.3	3.4	6.7	1.6	1.6	2.0	2.7	2.4	1.9	1.1	12.9	5.7	7.8	1.6	4.7	3.3	1.0	0.4	5.3	11.3	6.0	9.5	2.0	1.8	1.9	0.9	3.7	1.0	3.8	2.0	1.7	1.0	4.2	1.4	0.0	0.0	1.1	2.0	0.3	1.6	2.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	11.5	6.2	0.0	11.0	2.7	6.9	6.1	0.0	0.0	0.1	0.0	14.2	5.2	0.0	0.0	15.6	0.0	0.5	0.0	0.5	0.0	1.2	0.0	0.0	11.7	0.0	10.3	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.9	0.0	0.0	16.2	1.4	8.0	0.0	1.3	0.0	0.0	5.8	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	6.3	9.5	9.7	2.4	1.9	1.6	4.7	6.0	0.0
BPIFA1	"bA49G10.5, LUNX, PLUNC, SPLUNC1"	ENSG00000198183	"BPI fold containing family A member 1"	Q9NP55	20	33235995-33243311	"Plasma proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix, uterine: 8.0;lung: 20.2;lymphoid tissue: 25.2;pituitary gland: 16.9;tongue: 11.9"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 1.3;NTERA-2: 2.2;REH: 1.2;U-266/70: 1.6"	"Cancer enriched"	"Detected in many"	27	"lung cancer: 262.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			CAB025669	Supported				"Secreted in other tissues"	1200000	1200000			"CAB025669: "						"unprognostic (1.06e-1)"		"unprognostic (1.53e-1)"						"unprognostic (3.65e-1)"		"unprognostic (1.80e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	11.9	25.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	2.2	0.0	1.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BPIFA2	"bA49G10.1, C20orf70, PSP, SPLUNC2"	ENSG00000131050	"BPI fold containing family A member 2"	Q96DR5	20	33161768-33181412	"Predicted secreted proteins"		"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	265	"salivary gland: 1210.9"	"Group enriched"	"Detected in some"	5	"RT4: 4.8;SK-BR-3: 1.9"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA044006	Enhanced				"Secreted to digestive system"					"HPA044006: AB_10963580"							"unprognostic (9.10e-3)"	"unprognostic (1.22e-1)"		"unprognostic (1.95e-1)"	"unprognostic (3.56e-2)"		"unprognostic (3.03e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.14e-4)"	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.4	0.1	1.2	0.1	0.7	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	1210.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	4.5	0.0	0.0	1.6	1.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0
BPIFA3	"bA49G10.4, C20orf71, SPLUNC3"	ENSG00000131059	"BPI fold containing family A member 3"	Q9BQP9	20	33217310-33227758	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	54	"testis: 86.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA062708	Enhanced				"Secreted in male reproductive system"					"HPA062708: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	86.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BPIFB1	"bA49G10.6, C20orf114, dJ1187J4.1, LPLUNC1, MGC14597, VEMSGP"	ENSG00000125999	"BPI fold containing family B member 1"	Q8TDL5	20	33273480-33309878	"Plasma proteins, Predicted secreted proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 100.1;lung: 101.0;lymphoid tissue: 115.1;stomach 1: 76.9"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.2;HMC-1: 2.0;RT4: 4.1;SK-BR-3: 8.4"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 75.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"olfactory region: 6.2"	"Low region specificity"	"Detected in all"			HPA024256	Enhanced				"Secreted in other tissues"	7500000	7500000			"HPA024256: AB_1845664"	"unprognostic (2.42e-1)"	"unprognostic (5.41e-2)"		"unprognostic (3.67e-2)"	"unprognostic (3.09e-1)"	"unprognostic (6.72e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.82e-1)"	"unprognostic (4.00e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.36e-7)"	"unprognostic (3.30e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-2)"	0.1	0.0	0.2	0.2	0.2	0.0	0.2	0.1	0.2	100.1	0.1	0.3	0.1	3.7	0.5	0.2	23.3	0.0	0.3	0.3	0.2	0.0	0.1	0.1	101.0	0.1	0.1	0.1	0.1	0.1	0.0	4.7	0.1	0.1	0.9	0.0	0.1	38.8	0.8	1.0	0.0	0.1	0.1	0.1	0.1	76.9	1.1	0.1	0.2	0.2	29.6	115.1	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.1	0.0	0.7	0.0	0.3	0.0	4.1	0.0	0.0	0.0	8.4	0.0	0.6	0.0	0.6	0.0	0.9	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.2	0.0	0.1	0.1	0.1	0.1
BPIFB4	"C20orf186, dJ726C3.5, LPLUNC4"	ENSG00000186191	"BPI fold containing family B member 4"	P59827	20	33079644-33111751	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"parathyroid gland: 4.0;pituitary gland: 12.2"	"Group enriched"	"Detected in some"	4	"HSkMC: 5.3;U-2 OS: 8.5"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted - unknown location"							"unprognostic (1.32e-1)"		"unprognostic (1.16e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.31e-3)"	"unprognostic (4.70e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.98e-4)"			"unprognostic (1.31e-1)"	"unprognostic (1.82e-1)"		"unprognostic (8.97e-2)"	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	4.0	12.2	0.0		0.0	0.0		2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8			0.0		0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.5	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
BRINP2	"DBCCR1L2, FAM5B"	ENSG00000198797	"BMP/retinoic acid inducible neural specific 2"	Q9C0B6	1	177171497-177282422	"Predicted secreted proteins, Transporters"	"Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"adrenal gland: 11.5;brain: 27.9"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 10.5;PC-3: 2.6;REH: 3.0;SCLC-21H: 9.5;SH-SY5Y: 2.1"	"Cancer enriched"	"Detected in some"	5	"glioma: 11.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050681	Uncertain				"Secreted in other tissues"					"HPA050681: "	"unprognostic (7.78e-2)"	"unprognostic (4.49e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.20e-4)"	"unprognostic (8.95e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.60e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.60e-2)"	"unprognostic (4.82e-3)"	0.4	11.5	12.2	0.3	8.2	0.3	1.9	0.4	27.9	0.3	0.4	0.6	0.0	0.3	0.5	0.9	0.3	0.6	0.4	0.4	7.0	6.0	0.3	0.4	0.3	0.3	4.5	3.6	0.3	0.3	0.3	2.0	1.0	0.8	0.4	0.3	0.0	0.3	0.4	0.3	0.3	0.3	0.4	1.5	0.5	0.3	1.8	0.3	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	2.6	3.0	0.0	0.0	0.0	0.0	9.5	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	8.2	0.4	15.9	7.0	6.0	4.5	3.6	0.8	0.3
BSPH1	"BSP1, ELSPBP2"	ENSG00000188334	"Binder of sperm protein homolog 1"	Q075Z2	19	47968046-47992170	"Predicted secreted proteins"	Fertilization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	45	"epididymis: 97.1"	"Group enriched"	"Detected in some"	5	"BEWO: 1.2;HMC-1: 1.3;NB-4: 4.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA048335	Enhanced				"Secreted in male reproductive system"					"HPA048335: "																		0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.2	0.0	0.0			0.0	0.0	97.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
BTBD17	"BTBD17A, LGALS3BPL, TANGO10A"	ENSG00000204347	"BTB domain containing 17"	A6NE02	17	74356416-74361946	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 18.2"	"Group enriched"	"Detected in some"	20	"AF22: 3.8;NTERA-2: 5.0;SCLC-21H: 15.0"	"Group enriched"	"Detected in some"	11	"glioma: 9.5;testis cancer: 1.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.4"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025022	Approved				"Secreted in brain"					"HPA025022: AB_2067352"					"unprognostic (2.63e-1)"					"unprognostic (2.77e-1)"	"unprognostic (4.82e-5)"			"unprognostic (3.89e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.89e-3)"		0.4	1.5	5.4	0.4	5.1	0.4	0.4	5.6	18.2	0.4	0.4	2.7	0.0	1.2	0.4	0.4	0.4	0.4	0.4	0.4	3.7	5.7	0.4	0.4	0.4	0.4	3.8	1.8	0.4	0.4	0.4	0.2	0.4	6.1	0.4	0.4	0.0	0.4	0.4	0.4	0.4	0.5	0.4	3.7	0.6	1.4	0.5	2.2	0.0	0.6	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.1	0.3	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	5.4	5.1	5.6	8.2	3.7	5.7	3.8	1.8	6.1	2.2
BX248415.1		ENSG00000276911			1	196819745-196959210	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in single"	938	"liver: 93.7"	"Cell line enhanced"	"Detected in single"		"RH-30: 2.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA038915, HPA040726, HPA049813"	Supported				"Secreted to blood"					"HPA038915: , HPA040726: , HPA049813: "																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	93.7	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
C10orf95	FLJ14280	ENSG00000120055	"Chromosome 10 open reading frame 95"		10	102449837-102451543	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"epididymis: 12.7"	"Cell line enhanced"	"Detected in many"		"HEK 293: 11.7"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"												"Secreted - unknown location"						"unprognostic (2.31e-1)"	"unprognostic (7.76e-3)"	"unprognostic (3.19e-1)"	"unprognostic (5.62e-3)"	"unprognostic (4.02e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.22e-2)"	"unprognostic (4.80e-3)"	0.0	1.0	0.4	1.2	0.4	1.1	0.0	1.0	1.2	1.7	1.4	0.0	0.0	2.0	0.7	12.7	0.9	9.7	1.2	0.0	0.4		1.0	0.0	9.8	2.2	0.0	0.2	8.9	4.2	0.0	2.6	7.0	0.9	1.0	0.0	10.1	3.4	3.4	0.1	3.6	1.9	0.0	0.0	1.9	3.2	0.9	0.0	0.1	5.0	2.7	4.1	0.5	0.0	9.3	5.6	1.6	1.2	8.4	11.6	4.5	5.5	1.0	0.1	2.3	0.0	0.0	4.9	0.2	0.0	0.0	0.0	4.4	9.7	4.8	2.3	0.0	9.7	0.0	0.4	0.0	4.1	11.7	3.1	4.0	3.6	0.0	4.2	3.0	0.1	1.8	0.0	0.1	0.0	5.3	4.1	0.0	4.3	2.2	4.0	2.2	3.3	6.7	0.1	5.3	1.1	2.0	8.9	1.3	2.4	1.5	3.0	4.8	0.3	0.4	0.3	1.1	0.2	0.5	3.5	2.7	3.2	0.2	6.3	0.1	1.6	1.2	1.5	7.4	0.5	7.0	9.3	8.2	7.6	3.2	7.5	11.6	9.7	1.0	8.4	0.2	5.6	8.2	4.5										
C10orf99	"AP-57, CSBF, FLJ21763, RLLV1833, UNQ1833"	ENSG00000188373	"Chromosome 10 open reading frame 99"	Q6UWK7	10	84173738-84185294	"Predicted secreted proteins"	Chemotaxis	"Antibiotic, Antimicrobial, Cytokine"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 93.5;intestine: 66.0;lymphoid tissue: 48.4;tongue: 95.1"	"Cell line enriched"	"Detected in some"	5	"RT4: 31.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA050920	Enhanced				"Secreted in other tissues"					"HPA050920: "		"unprognostic (3.13e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.04e-2)"		"unprognostic (1.78e-2)"		"unprognostic (7.46e-3)"	"unprognostic (2.05e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavourable (1.20e-5)"	"unprognostic (3.70e-1)"			"unprognostic (4.67e-2)"	0.1	0.0	0.0	48.4	0.0	0.0	0.1	0.0	0.1	22.5	63.5	0.0	0.2	0.0	2.6	0.0	93.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.7	66.0	0.0	5.9	0.7	0.0	8.8	5.4	3.5	0.0	0.0	0.0	0.1	0.0	0.3	0.0	95.1	21.6	17.0	26.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	31.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
C11orf45	"FLJ43646, MGC35558"	ENSG00000174370	"Chromosome 11 open reading frame 45"	Q8TAV5	11	128899565-128906035	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 12.3;U-937: 9.5"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.5"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3.5;monocytes: 1.8;T-cells: 1.1"									HPA039716	Approved		Approved	Cytosol	"Secreted - unknown location"			Cytosol		"HPA039716: AB_10672892"	"unprognostic (8.32e-2)"	"unprognostic (3.93e-2)"	"unprognostic (5.99e-3)"	"unprognostic (1.35e-3)"	"unprognostic (1.01e-1)"	"unprognostic (9.93e-2)"	"unprognostic (4.50e-5)"	"unprognostic (1.97e-2)"	"unprognostic (4.78e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.80e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.55e-9)"	"unprognostic (2.37e-1)"	"unprognostic (2.60e-2)"	"unprognostic (6.87e-2)"	"unprognostic (7.22e-2)"	0.7	4.9	1.1	0.3	5.3	0.4	0.7	0.0	1.0	0.9	0.4			1.2	0.3	0.4	3.3	0.9	2.1	5.0	0.7	0.9	1.6	0.2	2.8	0.3	1.1		0.7	4.1	4.7	3.7	2.1		1.2	0.6		1.7	3.6	0.0	8.0	0.6	0.1	1.5	1.6	2.0	1.0			1.8		0.6	1.7	1.8	0.4	3.5	0.0	1.8	0.0	1.1	0.6	2.4	4.7	0.0	0.0	0.1	0.4	1.8	0.8	5.1	1.9	4.8	6.8	6.1	0.0	3.4	0.4	2.5	2.5	12.3	0.9	0.0	1.2	0.3	3.0	0.0	0.2	0.0	0.0	0.3	1.7	1.3	0.8	1.1	0.0	0.3	2.1	1.3	2.7	2.5	1.9	3.4	1.2	4.9	0.5	4.3	1.2	0.0	0.2	2.0	5.6	0.4	0.7	4.1	0.6	0.0	7.0	0.0	0.8	0.1	0.0	0.0	0.9	9.5	0.2	0.0	1.8	0.0	0.3	0.8	0.7	0.4	0.5	0.5	3.5	0.4	1.1	0.7	0.0	0.0	0.0	0.7	0.0	0.6										
C11orf94		ENSG00000234776	"Chromosome 11 open reading frame 94"	C9JXX5	11	45906513-45907282	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	28	"testis: 43.4"	"Cell line enhanced"	"Detected in many"		"HEK 293: 3.8;U-266/84: 3.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.5"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"												"Secreted in male reproductive system"						"unprognostic (1.55e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.28e-2)"	"unprognostic (5.99e-2)"	"unprognostic (6.21e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.11e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.24e-2)"	"unprognostic (9.05e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.47e-1)"	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	43.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	1.5	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.7	1.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.7	0.0	0.0	1.0	0.0	1.4	0.0	2.5	3.8	1.1	2.3	0.0	1.4	0.0	0.6	0.0	1.2	0.0	0.0	0.0	0.3	0.6	1.4	0.0	0.0	1.2	1.9	1.4	0.6	1.5	0.8	0.0	0.0	0.5	0.0	0.0	0.6	1.0	1.1	1.1	0.0	1.5	1.0	2.0	0.0	2.4	3.1	0.0	1.6	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C12orf73	"DKFZp547P055, FLJ13975"	ENSG00000204954	"Chromosome 12 open reading frame 73"	Q69YU5	12	103950202-103965708	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 43.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA038883	Uncertain		Approved	"Plasma membrane,Centrosome,Mitochondria"	"Secreted - unknown location"			"Centrosome, Mitochondria"	"Plasma membrane"	"HPA038883: AB_10794735"	"unprognostic (9.24e-2)"	"unprognostic (3.26e-3)"	"unprognostic (3.66e-3)"	"unprognostic (7.20e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (6.98e-4)"	"unprognostic (8.96e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.03e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-2)"	"unprognostic (6.27e-2)"	"prognostic favourable (1.61e-4)"	6.7	11.4	14.3	8.3	14.5	4.4	9.7	15.5	17.5	7.2	7.4	11.4	7.2	7.7	9.5	13.2	7.0	8.9	5.5	11.1	13.0	14.6	9.4	8.3	5.8	10.0	13.3	13.3	11.5	9.7	9.4	21.0	7.3	13.6	10.7	9.5	8.3	8.3	11.1	43.8	9.0	7.7	7.9	14.1	7.0	9.9	10.1	13.8	11.4	11.5	12.9	10.2	6.6	6.9	11.7	11.3	8.6	5.1	12.0	14.5	3.9	5.9	11.2	16.9	10.4	4.9	6.5	11.0	6.5	3.9	7.2	5.9	11.9	5.2	7.1	8.6	3.9	9.6	10.1	8.2	5.5	10.1	20.4	10.7	16.3	14.9	7.2	15.7	9.8	5.7	9.5	3.6	6.4	6.6	13.7	4.9	6.6	6.8	17.4	23.7	8.2	19.1	10.1	6.3	7.0	9.5	8.1	27.8	9.5	6.5	11.4	15.0	19.4	8.5	3.4	8.9	5.0	6.6	6.6	13.2	20.2	14.8	10.1	8.9	7.7	7.3	5.1	8.6	10.5	4.2	10.4	11.7	9.8	10.0	7.2	10.7	14.5	13.5	1.4	12.0	3.8	11.3	13.8	3.9	14.3	14.5	15.5	17.5	13.0	14.6	13.3	13.3	13.6	13.8
C16orf89	MGC45438	ENSG00000153446	"Chromosome 16 open reading frame 89"	Q6UX73	16	5044122-5066110	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 35.8;thyroid gland: 79.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 4.8;Hep G2: 5.8;HHSteC: 3.1;NTERA-2: 3.6;U-2197: 4.9"	"Group enriched"	"Detected in many"	14	"lung cancer: 64.7;thyroid cancer: 145.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013613, HPA016934"	Enhanced				"Secreted to blood"	1200000	1200000			"HPA013613: AB_1845584, HPA016934: AB_2732417"	"unprognostic (1.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.29e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.23e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.39e-2)"	"unprognostic (3.25e-2)"	"unprognostic (6.64e-3)"	"unprognostic (3.53e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.54e-2)"	"unprognostic (8.48e-3)"	6.0	1.7	7.7	4.4	9.3	0.3	4.7	5.1	8.6	7.3	2.3	5.2	0.3	5.9	1.4	30.3	2.5	4.6	15.3	7.1	6.1	3.0	5.6	0.3	35.8	0.5	6.2	7.4	1.9	8.2	0.3	1.9	0.5	5.3	4.0	1.9	5.0	11.5	0.6	0.2	0.4	2.8	6.2	7.4	0.4	28.0	1.4	2.9	0.0	79.3	2.7	1.4	4.3	1.8	1.1	0.9	3.3	0.5	1.3	0.6	0.2	0.1	0.2	0.0	0.4	4.8	0.1	0.8	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.2	0.4	0.6	1.4	5.8	3.1	0.2	0.5	1.4	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.3	1.6	0.7	3.6	0.1	0.5	0.1	0.3	0.0	0.5	0.6	0.4	0.3	0.6	1.1	0.4	0.0	0.2	0.6	0.3	4.9	0.2	0.4	0.2	0.1	0.4	0.2	0.1	3.3	0.5	0.7	0.4	0.4	0.3	0.7	0.4	0.4	0.2	1.1	0.5	0.6	1.9	1.3	0.2	0.9	0.3	0.2	7.7	9.3	5.1	8.6	6.1	3.0	6.2	7.4	5.3	2.9
C17orf67		ENSG00000214226	"Chromosome 17 open reading frame 67"	Q0P5P2	17	56791913-56838773	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"vagina: 24.4"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 9.8;MOLT-4: 15.0;PC-3: 10.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"olfactory region: 3.8"	"Low region specificity"	"Detected in many"			HPA043479	Uncertain				"Secreted - unknown location"					"HPA043479: AB_10964083"	"unprognostic (2.78e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.59e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.82e-3)"	"unprognostic (9.64e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.68e-5)"	"unprognostic (2.49e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.43e-3)"	3.2	1.9	5.5	3.4	7.3	1.0	7.4	9.9	6.2	5.1	2.2	2.0	3.5	1.9	5.2	4.0	2.4	3.3	4.8	2.2	5.2	2.9	2.1	3.3	3.1	3.9	6.4	1.6	4.4	3.3	2.1	3.2	2.2	5.8	4.9	1.4	1.3	2.8	3.5	1.7	2.0	2.7	4.8	3.6	6.9	2.8	3.8	8.5	9.1	2.4	0.5	2.7	5.2	24.4	3.8	1.1	0.9	0.8	0.6	3.9	1.0	3.3	2.1	1.4	1.5	0.7	1.0	0.6	1.9	2.5	1.6	2.0	2.7	1.1	1.7	3.4	0.8	1.6	0.9	0.5	1.6	9.8	3.6	1.7	2.3	1.6	0.8	1.3	3.3	0.4	2.7	1.1	1.1	1.6	1.6	8.5	1.1	2.5	15.0	2.3	1.3	10.4	3.2	2.7	1.8	1.2	0.9	0.7	1.8	1.9	0.4	1.0	2.1	0.9	2.3	1.8	4.4	1.2	1.4	3.5	8.8	1.0	1.2	1.5	0.6	0.0	0.5	0.9	0.6	0.7	1.2	3.8	1.9	2.6	0.4	2.3	2.0	2.5	0.8	0.6	0.8	1.1	3.9	1.0	5.5	7.3	9.9	6.2	5.2	2.9	6.4	1.6	5.8	8.5
C1orf54	FLJ23221	ENSG00000118292	"Chromosome 1 open reading frame 54"	Q8WWF1	1	150268200-150280916	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 20.5;AN3-CA: 30.9;ASC diff: 22.0;ASC TERT1: 36.7;HSkMC: 29.7;HUVEC TERT2: 28.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"myeloid DC: 36.2"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 36.2"	"Low region specificity"	"Detected in all"							"HPA026518, HPA043874"	Approved		Approved	"Plasma membrane"	"Secreted to blood"			"Plasma membrane"		"HPA026518: AB_1845647, HPA043874: "	"unprognostic (4.64e-3)"	"unprognostic (6.81e-3)"	"unprognostic (4.01e-3)"	"unprognostic (5.69e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.21e-1)"	"prognostic unfavourable (2.43e-4)"	"unprognostic (3.16e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.48e-2)"	16.0	8.8	16.4	19.0	19.3	4.5	13.8	5.8	10.5	11.9	14.0	4.5	19.1	5.8	19.8	21.1	11.0	17.1	21.6	13.8	13.7	13.7	12.7	12.0	11.8	21.5	21.8	8.3	8.3	6.8	2.0	6.7	24.4	14.0	15.3	11.1	10.9	9.8	30.4	13.4	4.5	8.1	24.1	20.4	27.3	8.3	5.7	14.8	4.9	8.3	17.1	11.2	22.0	14.3	0.3	36.2	0.4	7.7	0.2	1.5	2.2	0.5	0.1	20.5	30.9	22.0	36.7	0.6	3.3	4.9	0.9	3.0	0.2	0.6	0.1	1.1	2.9	0.8	0.0	0.1	1.1	0.3	3.6	0.5	0.5	0.3	4.5	1.1	0.8	29.7	1.5	6.1	0.4	28.5	0.4	4.0	3.1	1.1	0.2	7.1	1.7	1.1	5.1	0.5	0.4	0.3	1.6	0.4	0.4	0.4	0.2	2.2	0.4	15.5	0.2	7.3	0.6	0.2	0.3	1.7	1.4	0.3	16.2	0.9	0.2	0.0	7.7	0.3	0.2	6.8	0.9	0.3	1.5	0.6	36.2	0.3	1.5	0.8	0.4	0.2	1.9	0.7	0.6	2.2	16.4	19.3	5.8	10.5	13.7	13.7	21.8	8.3	14.0	14.8
C1orf56	"FLJ20519, MENT"	ENSG00000143443	"Chromosome 1 open reading frame 56"	Q9BUN1	1	151047740-151051986	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"blood: 54.8;testis: 67.7"	"Cell line enhanced"	"Detected in many"		"MCF7: 15.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA037429, HPA037430"	Enhanced				"Secreted to blood"	90000000	90000000			"HPA037429: AB_10671755, HPA037430: AB_2675473"	"unprognostic (7.60e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.83e-1)"	"unprognostic (4.31e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.59e-2)"	"unprognostic (2.70e-3)"	"unprognostic (3.28e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.61e-2)"	"unprognostic (3.61e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.79e-2)"	3.3	6.4	2.9	2.0	3.6	0.9	3.1	3.8	3.5	3.7	2.7	5.2	5.1	2.9	3.4	5.6	3.1	4.3	4.6	5.6	3.1	2.1	4.0	6.4	2.6	2.8	3.3	2.0	4.8	7.0	3.9	6.3	3.0	3.4	4.7	1.2	4.3	6.5	6.4	4.0	3.3	2.0	3.8	2.3	2.7	3.1	67.7	3.8	0.7	7.1	1.2	1.7	3.3	3.0	16.3	7.8	54.8	15.4	15.5	28.4	1.0	3.9	8.0	2.8	1.2	4.7	4.6	2.5	2.2	3.3	1.5	1.1	3.5	5.7	0.9	3.7	2.4	5.4	1.5	0.3	0.8	5.1	1.7	1.0	6.3	4.2	3.2	1.1	0.8	3.3	1.7	2.2	0.8	2.2	2.1	2.0	1.3	15.5	1.5	2.7	4.6	4.5	1.3	2.7	2.8	1.2	2.2	3.7	7.3	7.2	3.7	5.2	7.4	2.9	2.2	1.9	3.5	5.1	2.0	4.9	3.8	12.5	3.7	0.6	2.4	54.8	7.3	13.7	27.8	15.4	20.8	14.2	24.2	24.2	5.5	16.3	20.6	28.4	20.2	15.5	12.7	7.8	13.7	1.0	2.9	3.6	3.8	3.5	3.1	2.1	3.3	2.0	3.4	3.8
C1QA		ENSG00000173372	"Complement C1q A chain"	P02745	1	22636506-22639608	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 204.0"	"Cell line enhanced"	"Detected in some"		"HMC-1: 3.8;NB-4: 2.2;RPMI-8226: 11.5;SCLC-21H: 5.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	34	"intermediate monocyte: 50.3;non-classical monocyte: 37.5"	"Lineage enriched"	"Detected in single"	57	"monocytes: 50.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002350, CAB009823"	Supported				"Secreted to blood"	1100000000	1100000000			"CAB009823: AB_2228238, HPA002350: AB_1078552"	"unprognostic (1.97e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.98e-3)"	"unprognostic (3.07e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavourable (1.58e-6)"	"unprognostic (1.54e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.75e-2)"	"unprognostic (7.30e-2)"	51.4	33.0	12.4	19.3	21.0	5.3	40.6	1.9	10.9	10.8	20.3	8.0	2.1	22.1	8.2	25.9	11.3	15.5	22.6	43.9	9.2	10.4	14.4	27.6	60.7	94.4	17.2	4.6	9.5	11.9	2.4	9.6	33.6	15.8	16.0	15.9	12.2	9.4	7.5	7.9	4.3	24.7	24.8	26.8	204.0	11.6	12.3	16.6	7.5	10.9	5.4	8.4	24.1	12.8	0.0	0.8	0.1	50.3	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	2.2	0.5	0.0	0.8	0.5	11.5	0.0	0.0	5.1	1.6	0.1	0.0	0.0	0.9	0.1	0.4	0.0	0.3	0.6	0.2	1.5	0.0	0.1	0.2	0.2	0.1	0.0	1.2	0.0	0.0	50.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	37.5	0.0	0.0	2.1	12.4	21.0	1.9	10.9	9.2	10.4	17.2	4.6	15.8	16.6
C1QB		ENSG00000173369	"Complement C1q B chain"	P02746	1	22652762-22661538	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 262.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.4;HaCaT: 2.7;NB-4: 2.5;SH-SY5Y: 2.9;U-266/70: 2.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	66	"intermediate monocyte: 41.9;non-classical monocyte: 26.9"	"Lineage enriched"	"Detected in single"	83	"monocytes: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052116	Approved				"Secreted to blood"	4700000000	4700000000			"HPA052116: "	"unprognostic (1.42e-1)"	"unprognostic (3.36e-2)"	"unprognostic (5.61e-3)"	"unprognostic (8.20e-2)"	"unprognostic (5.93e-2)"	"unprognostic (4.09e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.57e-1)"	"prognostic unfavourable (9.58e-6)"	"unprognostic (4.14e-2)"	"unprognostic (7.76e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.35e-2)"	76.7	42.3	30.3	22.0	54.5	7.1	17.6	3.3	27.8	12.1	28.2	27.6	1.4	30.0	9.0	25.5	10.8	21.5	33.2	19.8	19.8	17.0	21.8	51.5	87.9	84.1	45.7	6.8	9.8	11.2	4.2	14.4	41.2	35.7	15.0	24.6	17.2	13.9	9.3	9.2	4.3	30.5	41.9	52.2	262.8	14.4	11.7	38.1	7.4	9.8	3.7	9.5	36.8	6.6	0.0	0.5	0.1	41.9	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.4	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	1.2	2.5	1.6	0.0	1.6	1.1	1.9	0.0	0.0	1.9	2.9	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.8	0.3	2.9	0.1	0.5	0.5	0.3	0.6	0.0	0.5	0.0	0.0	41.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.2	26.9	0.0	0.0	1.4	30.3	54.5	3.3	27.8	19.8	17.0	45.7	6.8	35.7	38.1
C1QC	C1QG	ENSG00000159189	"Complement C1q C chain"	P02747	1	22643630-22648110	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 192.2"	"Cell line enhanced"	"Detected in some"		"NB-4: 2.6;RPMI-8226: 6.6;SH-SY5Y: 2.0;U-266/70: 2.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"intermediate monocyte: 28.4"	"Lineage enriched"	"Detected in single"	284	"monocytes: 28.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001471, CAB009828"	Supported				"Secreted to blood"	1300000000	1300000000			"CAB009828: AB_2067541, HPA001471: AB_1078553"	"unprognostic (2.97e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.40e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.66e-2)"	"unprognostic (7.44e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.32e-1)"	"prognostic unfavourable (1.17e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.73e-2)"	50.5	35.7	24.2	24.6	39.2	5.9	15.6	2.5	18.3	9.8	21.8	19.9	1.2	30.0	8.5	23.4	9.7	17.0	26.8	22.6	17.5	13.6	14.4	41.2	48.2	75.1	34.8	6.1	8.5	7.8	2.6	10.2	34.8	30.2	15.0	15.7	14.8	13.2	8.3	8.0	4.6	33.1	27.1	34.5	192.2	15.5	10.3	29.1	10.7	8.3	4.0	9.5	28.3	6.0	0.0	0.0	0.0	28.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.8	1.3	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.7	2.6	0.7	0.0	1.5	0.8	6.6	0.0	0.0	1.2	2.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.3	0.3	2.9	0.0	0.3	0.3	0.4	0.0	0.0	0.7	0.0	0.0	28.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.5	24.2	39.2	2.5	18.3	17.5	13.6	34.8	6.1	30.2	29.1
C1QL1	"C1QRF, C1QTNF14, CRF"	ENSG00000131094	"Complement C1q like 1"	O75973	17	44959693-44968071	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.5"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 17.8;SH-SY5Y: 12.7;U-2 OS: 44.5;U-251 MG: 13.4;U-87 MG: 14.4"	"Cancer enriched"	"Detected in all"	7	"glioma: 116.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted in brain"						"unprognostic (6.37e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.63e-3)"	"unprognostic (3.15e-2)"	"unprognostic (2.05e-2)"	"unprognostic (7.65e-2)"	"unprognostic (3.40e-3)"	"unprognostic (2.34e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavourable (1.31e-8)"	"unprognostic (2.67e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.04e-1)"	2.5	2.3	20.2	2.0	9.7	1.3	1.5	4.9	42.5	1.6	2.9	12.7	0.0	5.2	5.0	2.0	2.5	1.8	1.8	1.8	14.4	16.3	6.4	1.4	1.3	1.3	13.3	10.4	1.3	4.3	1.2	0.7	1.3	35.2	11.6	1.8	10.3	1.4	1.4	1.2	1.6	3.9	2.5	12.8	1.3	4.4	1.6	8.5	0.0	1.4	0.0	1.2	2.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.5	0.6	9.0	0.2	0.0	0.2	0.3	0.3	0.3	0.8	0.3	0.3	0.1	1.4	0.2	0.2	1.4	0.1	0.1	5.7	3.8	0.0	4.1	0.0	1.1	0.0	1.1	0.2	0.0	0.3	0.1	0.0	0.0	0.1	0.2	0.5	1.9	0.0	1.5	5.4	3.2	0.1	0.1	0.0	0.2	17.8	12.7	7.6	0.6	0.5	2.1	0.1	0.0	0.7	44.5	0.5	13.4	0.5	0.0	0.0	14.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	9.7	4.9	13.9	14.4	16.3	13.3	10.4	35.2	8.5
C1QL2	"C1QTNF10, CTRP10"	ENSG00000144119	"Complement C1q like 2"	Q7Z5L3	2	119156243-119158889	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 15.4"	"Group enriched"	"Detected in some"	14	"NTERA-2: 2.2;SCLC-21H: 7.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"hippocampal formation: 25.0"	"Low region specificity"	"Detected in many"			HPA057934	Uncertain				"Secreted in brain"					"HPA057934: "	"unprognostic (6.95e-2)"				"unprognostic (9.74e-2)"			"unprognostic (4.48e-3)"		"unprognostic (1.08e-1)"	"unprognostic (9.91e-4)"			"unprognostic (2.60e-5)"	"unprognostic (1.18e-1)"	"unprognostic (1.35e-1)"		0.7	0.7	15.3	0.7	6.8	0.7	1.1	0.9	15.1	0.7	0.7	3.1	0.0	0.7	0.7	0.7	0.7	0.7	0.7	0.8	15.4	9.0	0.7	0.8	0.7	1.3	4.5	5.4	0.7	0.7	0.7	0.3	0.7	1.3	0.7	0.7	2.4	1.0	0.7	0.7	0.9	0.7	0.7	1.5	0.8	0.7	1.1	3.1	0.0	0.7	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.3	6.8	0.9	15.1	15.4	9.0	4.5	5.4	1.3	3.1
C1QL3	"C1ql, C1QTNF13, CTRP13, K100"	ENSG00000165985	"Complement C1q like 3"	Q5VWW1	10	16513743-16522005	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 33.8"	"Group enriched"	"Detected in some"	7	"HDLM-2: 24.3;SCLC-21H: 15.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 99.4;cerebral cortex: 74.9;hippocampal formation: 78.6"						"Secreted in brain"						"unprognostic (7.24e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.19e-3)"	"unprognostic (6.31e-2)"	"unprognostic (5.12e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.20e-1)"	"prognostic favourable (6.29e-5)"	"unprognostic (3.27e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.59e-2)"	"unprognostic (6.12e-2)"	1.2	1.5	24.8	1.0	14.6	0.5	0.5	7.4	33.8	0.5	0.6	0.1	0.0	2.6	0.7	0.4	0.7	0.5	0.6	1.4	22.8	4.3	1.9	0.8	0.9	1.3	1.4	23.4	0.4	0.9	0.4	0.3	0.6	2.3	1.0	0.4	0.2	1.0	0.5	1.7	1.6	1.2	0.4	0.9	1.0	0.9	0.5	0.0	0.0	1.6	0.0	0.5	1.2	0.4	1.0	0.9	0.8	2.0	0.7	2.8	0.6	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	1.6	0.8	2.7	0.0	0.0	0.3	0.0	0.0	0.0	24.3	0.2	1.3	0.9	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.2	0.1	0.1	0.9	0.1	0.9	0.2	1.3	0.1	0.5	15.0	1.2	1.3	0.2	0.8	0.1	0.2	0.0	0.0	0.1	0.7	0.0	0.5	0.7	0.7	0.1	1.4	0.6	0.0	1.1	0.8	2.1	2.0	1.3	1.0	1.6	1.8	0.5	0.8	1.7	2.8	0.2	0.7	1.4	0.9	1.7	0.6	24.8	14.6	7.4	29.5	22.8	4.3	1.4	23.4	2.3	0.0
C1QL4	"C1QTNF11, CTRP11"	ENSG00000186897	"Complement C1q like 4"	Q86Z23	12	49332411-49337188	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.2;testis: 7.4"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 27.3;HAP1: 4.2;PC-3: 4.6;U-2 OS: 7.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 9.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"midbrain: 7.4"	"Group enriched"	"Detected in some"	5	"midbrain: 5.1;pons and medulla: 9.7"						"Secreted in brain"						"unprognostic (1.97e-2)"	"unprognostic (2.77e-2)"	"unprognostic (4.87e-2)"	"unprognostic (7.37e-2)"	"unprognostic (4.48e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.49e-3)"	"unprognostic (8.64e-3)"	"unprognostic (2.89e-1)"	"unprognostic (5.11e-3)"	"unprognostic (7.62e-2)"	"unprognostic (5.03e-2)"	"prognostic unfavourable (3.03e-5)"	"unprognostic (9.73e-2)"	"unprognostic (2.85e-2)"	"unprognostic (9.40e-2)"	"unprognostic (3.72e-2)"	0.4	0.3	2.0	0.1	1.0	0.1	0.4	0.4	2.3	0.7	0.1	0.3	0.0	0.2	0.2	0.2	0.1	0.2	0.1	0.2	0.6	2.4	0.8	0.2	0.1	0.1	1.4	0.0	0.6	0.1	0.1	0.4	0.1	9.2	0.2	0.1	0.8	0.1	0.1	0.4	1.7	0.1	0.2	2.1	0.4	0.1	7.4	0.9	0.0	3.6	0.0	0.1	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.3	27.3	0.0	0.0	0.1	0.0	0.1	0.3	1.5	0.7	0.1	0.3	1.5	0.0	0.0	4.2	0.0	0.5	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.5	4.6	0.1	0.1	0.0	0.1	0.0	0.0	2.3	0.0	0.2	1.2	0.5	0.1	0.0	0.4	7.2	0.1	0.3	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.0	0.4	2.1	0.6	2.4	1.4	0.0	9.2	0.9
C1QTNF12	"ADIPOLIN, C1QDC2, CTRP12, FAM132A, MGC105127"	ENSG00000184163	"C1q and TNF related 12"	Q5T7M4	1	1242446-1246722	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"intestine: 11.0;skin 1: 7.8"	"Group enriched"	"Detected in some"	5	"EFO-21: 8.1;U-2 OS: 8.1"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"neutrophil: 2.6;NK-cell: 2.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA024107	Uncertain		Approved	Vesicles	"Secreted to blood"			Vesicles		"HPA024107: AB_2101207"	"unprognostic (1.10e-2)"	"unprognostic (5.68e-3)"	"unprognostic (3.45e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.60e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.02e-3)"	"unprognostic (1.10e-2)"	"unprognostic (9.68e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.20e-1)"	1.0	0.0	0.5	0.2	0.0	0.0	0.5	0.2	0.2	0.1	3.4			11.0	0.1	0.0	1.2	0.2	0.1	0.2	0.0	1.0	3.1	0.2	0.1	0.0	0.1		0.0	0.0	0.0	0.1	0.3		0.0	1.2		0.4	0.0	0.1	7.8	10.4	0.1	0.2	0.0	0.3	2.4			0.2		0.1	0.0	0.4	0.3	0.6	2.6	0.3	2.2	0.4	0.2	0.3	0.0	0.0	0.6	0.4	0.1	1.5	1.1	0.0	0.1	0.0	0.6	0.4	0.1	8.1	0.3	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.2	0.3	0.1	0.1	0.1	0.3	0.0	0.3	0.0	0.0	0.5	0.3	0.1	0.8	0.1	0.3	0.0	1.3	0.0	0.0	1.2	0.3	0.0	0.0	0.7	0.6	0.1	0.0	0.0	8.1	0.1	0.0	1.6	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.2	0.2	0.0	0.6	0.3	0.4	0.0	2.6	2.2	0.3	0.0	0.0	0.2										
C1QTNF2	CTRP2	ENSG00000145861	"C1q and TNF related 2"	Q9BXJ5	5	160347751-160370641	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RH-30: 26.0;U-138 MG: 11.6;U-2 OS: 6.3;WM-115: 5.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061290	Uncertain		Approved	"Golgi apparatus,Centrosome"	"Secreted to blood"			"Golgi apparatus, Centrosome"		"HPA061290: "	"unprognostic (2.28e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.53e-2)"	"unprognostic (8.92e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.91e-2)"	"unprognostic (8.33e-2)"	"unprognostic (3.23e-2)"	"unprognostic (8.32e-2)"	"unprognostic (2.11e-5)"	"unprognostic (5.40e-5)"	"unprognostic (1.14e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.10e-2)"	5.5	2.1	2.1	1.9	5.2	0.6	5.6	4.4	4.9	9.5	4.9	1.1	1.3	3.4	10.9	6.9	6.8	4.9	9.3	8.5	2.0	1.8	1.3	1.0	5.0	1.1	1.4	3.0	2.9	0.9	0.6	1.2	2.4	1.0	7.7	3.4	14.3	3.4	9.6	4.8	3.0	4.6	6.4	1.3	1.7	4.3	5.8	1.5	0.0	4.3	12.1	1.3	6.0	5.8	0.6	0.4	3.7	0.1	1.0	0.2	0.1	0.2	0.0	0.4	0.1	0.0	0.0	0.0	2.9	3.9	0.7	2.5	0.1	0.6	0.0	0.1	1.0	0.1	0.1	0.3	0.2	0.0	0.1	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	26.0	0.0	0.0	0.1	0.0	0.6	0.7	0.0	0.1	0.3	0.1	0.2	11.6	6.3	1.1	3.1	0.1	0.0	0.0	0.4	0.0	5.1	3.7	0.1	0.3	0.2	0.1	0.2	0.3	0.2	0.1	0.2	0.6	0.2	0.2	1.1	1.0	0.1	0.4	0.1	0.1	2.1	5.2	4.4	4.9	2.0	1.8	1.4	3.0	1.0	1.5
C1QTNF3	"2310005P21Rik, Corcs, Cors, Cors-26, CTRP3"	ENSG00000082196	"C1q and TNF related 3"	Q9BXJ4	5	34019448-34043832	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"salivary gland: 171.5"	"Cell line enriched"	"Detected in single"	199	"U-266/84: 129.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.3"	"Low lineage specificity"	"Detected in single"											"HPA064996, HPA066011"	Uncertain		Approved	"Golgi apparatus"	"Secreted to blood"	27000000	27000000	"Golgi apparatus"		"HPA064996: , HPA066011: "	"unprognostic (7.71e-2)"	"unprognostic (2.81e-3)"	"unprognostic (5.83e-2)"	"unprognostic (6.58e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.09e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.70e-2)"	"prognostic unfavourable (6.29e-4)"	"unprognostic (4.89e-3)"	"unprognostic (1.80e-1)"	"unprognostic (9.38e-3)"	"unprognostic (2.35e-1)"	4.4	0.3	5.7	2.7	6.4	0.2	4.5	9.6	3.4	2.4	7.9	1.8	4.8	2.1	2.5	3.9	22.5	2.0	3.6	0.9	4.2	3.1	4.0	0.5	2.6	0.5	4.3	1.4	1.1	1.0	0.3	0.7	0.8	3.7	30.2	6.6	2.4	171.5	3.2	1.3	1.4	5.5	14.4	5.6	0.5	8.4	7.9	2.6	0.6	1.0	3.6	0.7	13.1	3.2	0.4	0.1	0.4	0.0	0.0	1.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.1	0.0	0.1	0.1	129.4	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.1	0.4	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.4	5.7	6.4	9.6	2.8	4.2	3.1	4.3	1.4	3.7	2.6
C1QTNF4	"CTRP4, ZACRP4"	ENSG00000172247	"C1q and TNF related 4"	Q9BXJ3	11	47589664-47594659	"Predicted secreted proteins"		Cytokine	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 37.8"	"Cell line enriched"	"Detected in some"	6	"REH: 10.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA041032	Approved				"Secreted in brain"					"HPA041032: AB_10671170"	"unprognostic (1.84e-3)"	"unprognostic (1.58e-1)"	"unprognostic (8.98e-4)"	"unprognostic (8.19e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.26e-3)"	"unprognostic (6.78e-2)"	"unprognostic (6.11e-2)"	"unprognostic (6.35e-2)"	"unprognostic (4.00e-1)"	"unprognostic (4.91e-4)"	"unprognostic (1.22e-1)"	"unprognostic (8.22e-6)"	"unprognostic (6.02e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.80e-2)"	"unprognostic (6.28e-2)"	2.5	1.5	14.2	1.4	34.2	4.1	1.6	16.8	37.8	1.6	1.5	2.0	0.0	1.7	2.1	1.4	1.3	1.5	1.6	1.4	9.7	7.1	1.4	1.4	1.4	1.5	7.9	15.5	3.3	2.2	6.3	4.7	1.4	14.5	1.8	1.4	0.0	1.3	1.7	1.8	1.5	1.6	1.8	5.2	1.6	1.5	2.0	3.7	0.0	1.5	0.0	1.4	1.3	0.3	0.0	0.5	0.0	0.0	0.0	0.4	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.0	0.7	0.0	10.9	0.0	0.2	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	14.2	34.2	16.8	37.8	9.7	7.1	7.9	15.5	14.5	3.7
C1QTNF5	"CTRP5, DKFZp586B0621, LORD"	ENSG00000223953	"C1q and TNF related 5"	Q9BXJ0	11	119338939-119340940	"Disease related genes, Predicted secreted proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 30.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 9.4;fHDF/TERT166: 7.4;HHSteC: 19.0;HUVEC TERT2: 28.0;TIME: 25.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"CAB025607, HPA038604"	Uncertain				"Secreted to blood"	1600000	1600000			"CAB025607: , HPA038604: "																		13.6	3.2	3.7	4.3	4.0	0.0	6.4	3.1	7.1	6.4	6.1	7.9	1.5	5.5	7.1	8.3	3.7	3.8	19.0	10.2	3.9	3.6	7.3	3.2	8.9	3.6	8.1	2.3	6.2	3.1	1.2	4.2	5.0	9.6	4.3	2.7	30.5	3.2	3.2	4.2	3.1	5.8	10.9	5.4	5.7	4.3	3.1	5.2	0.0	4.1	4.6	1.1	8.1	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	9.4	2.6	0.1	2.3	0.1	0.3	1.4	0.0	0.0	0.0	1.0	7.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	19.0	0.0	0.0	4.5	0.0	0.1	0.0	28.0	0.0	0.0	1.4	0.0	0.0	0.0	0.4	0.0	0.0	2.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.5	0.0	0.0	25.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.7	4.0	3.1	3.2	3.9	3.6	8.1	2.3	9.6	5.2
C1QTNF7	CTRP7	ENSG00000163145	"C1q and TNF related 7"	Q9BXJ2	4	15339818-15446166	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 39.6"	"Group enriched"	"Detected in some"	5	"ASC diff: 9.0;ASC TERT1: 6.2;HSkMC: 3.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	14	"neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 1.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB007055, HPA051797, HPA055392"	Uncertain		Approved	Vesicles	"Secreted to blood"			Vesicles		"CAB007055: , HPA051797: , HPA055392: "	"unprognostic (6.61e-2)"	"unprognostic (4.50e-2)"	"unprognostic (6.16e-2)"	"unprognostic (6.50e-4)"	"unprognostic (1.24e-1)"	"unprognostic (4.98e-3)"	"unprognostic (2.31e-2)"	"unprognostic (7.69e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.97e-4)"	"unprognostic (3.01e-3)"	"unprognostic (8.31e-2)"	"unprognostic (7.56e-3)"	"unprognostic (7.28e-3)"	16.0	0.9	0.6	24.7	0.8	0.0	7.4	0.3	0.7	39.6	12.0	0.5	3.3	0.6	24.6	10.1	17.3	6.2	20.3	5.4	0.6	0.6	4.0	1.0	7.9	0.5	0.8	0.5	15.9	1.3	0.0	1.4	5.4	0.8	22.0	3.2	5.4	2.7	2.4	2.2	3.5	4.1	22.1	0.7	10.2	10.4	4.4	0.1	0.3	4.2	13.0	2.0	16.3	15.8	0.1	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	6.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	3.3	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.3	0.7	0.6	0.6	0.8	0.5	0.8	0.1
C1QTNF8	"CTRP8, UNQ5829"	ENSG00000184471	"C1q and TNF related 8"	P60827	16	1090005-1096244	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 2.6;brain: 2.1;fallopian tube: 4.5;pituitary gland: 4.1"	"Cell line enhanced"	"Detected in single"		"A549: 1.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in some"			HPA056438	Uncertain				"Secreted - unknown location"					"HPA056438: "			"unprognostic (8.65e-2)"		"unprognostic (2.56e-2)"									"unprognostic (5.46e-2)"				0.0	2.6	0.7	0.0	1.7	0.0	0.0	0.0	0.5	0.1	0.0			0.2	0.0	0.0	0.0	4.5	0.0	0.0	0.8	2.1	0.1	0.0	0.3	0.0	0.4		0.0	0.0	0.0	4.1	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.2	0.8			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
C1QTNF9	"AQL1, C1QTNF9A, CTRP9, MGC48915"	ENSG00000240654	"C1q and TNF related 9"	P0C862	13	24307166-24322535	"Predicted secreted proteins, Transporters"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 15.2;skeletal muscle: 14.1"	"Cell line enhanced"	"Detected in some"		"MCF7: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA056632	Uncertain				"Secreted to blood"					"HPA056632: "	"unprognostic (1.18e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.44e-2)"	"unprognostic (3.14e-3)"	"unprognostic (9.22e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.29e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.22e-1)"	5.6	0.3	0.2	2.4	0.9	0.3	4.9	0.1	0.2	0.7	2.8	0.1	0.1	1.1	1.6	1.6	4.8	0.3	1.9	15.2	0.9	0.3	0.3	0.8	0.4	0.4	0.2	0.1	0.4	1.2	0.5	0.2	4.8	0.1	2.6	0.7	0.1	0.9	1.0	14.1	0.6	1.2	1.8	0.2	0.6	1.1	1.6	0.1	0.3	0.5	5.2	0.9	1.0	7.1	0.5	0.7	0.7	0.3	0.0	0.2	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.1	0.5	0.1	0.9	0.0	1.3	0.7	0.5	0.3	0.0	0.2	0.1	0.0	0.5	0.5	0.8	0.0	0.4	0.0	0.0	0.2	0.5	0.3	0.1	0.0	0.5	0.0	0.3	1.7	0.0	1.9	0.7	1.2	0.2	1.4	0.2	0.2	0.0	0.6	0.5	0.1	0.2	0.5	0.0	0.2	0.4	0.3	0.0	0.4	0.6	1.1	0.4	0.9	0.4	0.6	0.7	0.7	1.1	0.1	0.1	0.0	0.2	0.1	0.0	0.5	0.1	0.2	0.0	0.5	0.0	0.2	0.7	0.0	0.3	0.7	0.0	0.0	0.2	0.9	0.1	0.1	0.9	0.3	0.2	0.1	0.1	0.1
C1QTNF9B	CTRP9B	ENSG00000205863	"C1q and TNF related 9B"	B2RNN3	13	23890525-23902655	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skin 1: 17.7;testis: 8.5"	"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in single"		"prostate cancer: 0.8"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA056632	Uncertain				"Secreted - unknown location"					"HPA056632: "	"unprognostic (3.43e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.18e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.32e-3)"	"unprognostic (1.52e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.01e-3)"	"unprognostic (7.04e-2)"	"unprognostic (5.56e-3)"	"unprognostic (3.89e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.34e-1)"	1.5	0.5	0.6	0.3	0.5	0.0	0.8	0.0	0.5	0.1	0.6			0.3	0.5	0.0	1.4	0.1	0.5	3.2	4.4	1.3	0.1	0.1	0.1	0.0	0.1		0.2	0.5	0.0	1.1	0.4		4.8	0.0		1.5	0.0	3.5	17.7	0.2	0.4	0.0	1.4	0.6	8.5			0.5		0.0	0.8	0.2	2.3	3.0	1.7	1.6	1.3	1.2	0.5	1.5	3.6	1.4	1.6	0.0	0.0	0.4	0.5	0.0	0.0	0.0	1.5	2.2	0.3	0.1	0.1	3.7	0.0	0.0	0.0	2.2	3.0	0.8	1.9	1.9	0.4	0.4	0.9	0.1	0.0	0.0	0.0	0.0	0.8	1.9	0.0	2.4	0.5	0.1	2.4	3.5	1.4	1.8	2.8	0.0	0.2	4.3	0.1	2.2	0.2	3.6	1.1	0.5	0.3	3.5	1.0	0.2	2.1	3.1	0.5	1.5	4.3	1.3	0.8	0.0	0.8	1.7	1.2	1.1	0.4	1.0	0.2	0.1	0.6	2.3	0.4	0.6	0.0	1.3	1.6	3.0	0.0	0.5										
C22orf15	"FLJ36561, N27C7-3"	ENSG00000169314	"Chromosome 22 open reading frame 15"	Q8WYQ4	22	23763021-23765861	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"fallopian tube: 22.3"	"Cell line enhanced"	"Detected in some"		"AF22: 3.3;BJ: 2.5;BJ hTERT+: 5.4;HSkMC: 2.3;MOLT-4: 3.4"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.7"					"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 2.9"	"Low lineage specificity"	"Detected in many"																"Secreted in female reproductive system"						"unprognostic (2.37e-2)"	"unprognostic (3.28e-3)"	"unprognostic (1.28e-1)"	"prognostic favourable (8.53e-5)"	"unprognostic (1.86e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.38e-2)"	"unprognostic (6.14e-2)"	"unprognostic (3.60e-2)"	"unprognostic (7.70e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.79e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.08e-3)"	0.0	0.1	1.0	0.0	1.7	0.4	0.1	0.0	0.0	0.8	0.1			0.0	0.2	0.0	0.0	22.3	0.2	0.0	1.4	1.9	0.0	0.0	2.7	0.2	0.0		0.5	0.0	0.0	1.5	0.2		0.1	0.0		0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.0	3.6			0.0		0.0	0.0	0.0	0.6	2.9	0.0	0.0	0.0	1.8	0.2	0.0	0.0	3.3	0.0	0.0	0.0	0.0	2.5	5.4	0.0	0.5	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	3.4	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	1.0	0.6	1.0	0.8	0.4	0.5	1.8	0.5	0.0	0.0	0.0	2.9	0.0	0.2										
C22orf46	"CTA-216E10.6, FLJ23584"	ENSG00000184208	"Chromosome 22 open reading frame 46"	C9J442	22	41688939-41698136	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"brain: 19.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			HPA052741	Uncertain		Approved	Nucleoplasm,Nucleoli	"Secreted - unknown location"			Nucleoplasm	Nucleoli	"HPA052741: "	"unprognostic (3.76e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.45e-2)"	"prognostic favourable (4.70e-4)"	"unprognostic (1.56e-1)"	"unprognostic (6.02e-3)"	"unprognostic (2.61e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.38e-2)"	"unprognostic (3.32e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.62e-1)"	3.9	2.0	8.1	3.1	6.8	1.0	3.9	2.2	5.7	2.7	2.4			2.3	3.1	4.5	1.7	2.4	2.7	4.8	8.7	7.5	2.7	2.3	2.2	3.1	12.8		5.2	1.4	8.3	3.5	2.1		3.3	2.8		2.8	3.0	3.3	3.3	2.6	2.9	19.8	2.8	2.4	6.2			3.5		3.1	2.2	1.5	1.1	0.4	0.1	2.6	3.5	1.2	0.7	8.7	4.5	11.0	6.7	8.1	8.6	9.9	7.4	8.0	6.3	8.5	4.5	5.7	5.5	5.4	6.1	4.1	5.6	5.7	7.6	19.5	5.3	6.0	9.3	3.7	4.7	4.4	11.9	6.8	7.7	10.5	7.5	1.6	9.8	8.1	5.5	14.4	3.5	5.4	4.5	3.5	5.1	9.1	6.0	5.4	6.0	2.7	4.2	8.6	7.8	11.1	9.0	5.5	4.3	8.3	14.2	4.4	3.9	17.3	17.6	5.1	5.0	5.4	11.2	0.1	0.5	0.0	0.7	0.4	0.9	1.1	1.1	1.1	0.2	0.5	0.9	1.2	0.1	3.5	2.6	0.4	0.7	0.7										
C2orf66	UNQ6411	ENSG00000187944	"Chromosome 2 open reading frame 66"	Q6UXQ4	2	196805002-196810276	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 7.0;pituitary gland: 6.4"	"Group enriched"	"Detected in some"	4	"HEL: 9.2;RT4: 3.4;TIME: 3.8"	"Low cancer specificity"	"Detected in single"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA020869	Uncertain				"Secreted - unknown location"					"HPA020869: AB_1851545"	"unprognostic (1.19e-1)"	"unprognostic (4.85e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.61e-2)"	"unprognostic (6.80e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.10e-3)"	"unprognostic (4.54e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.75e-5)"	"unprognostic (1.84e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.86e-2)"	7.0	4.0	0.4	0.2	0.7	0.2	1.0	0.1	0.4	0.0	0.2			0.0	0.1	1.2	0.1	1.1	0.4	0.7	0.4	2.8	0.3	0.0	0.2	0.0	0.7		0.3	0.6	0.0	6.4	0.1		0.3	0.4		0.0	0.2	0.0	2.8	0.3	0.1	0.0	0.2	0.0	2.6			0.1		0.2	0.8	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.4	0.1	0.1	0.4	1.0	0.5	0.2	0.0	0.5	0.2	0.2	0.3	0.1	0.2	0.1	0.0	0.1	0.0	0.0	1.1	0.2	0.3	0.5	9.2	1.0	0.1	0.0	0.1	0.8	0.7	1.3	0.2	0.2	0.8	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	3.4	0.4	0.1	0.0	0.1	0.1	0.0	0.0	3.8	0.3	0.3	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.4										
C2orf69	FLJ38973	ENSG00000178074	"Chromosome 2 open reading frame 69"	Q8N8R5	2	199911256-199955935	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045225	Approved				"Secreted - unknown location"					"HPA045225: AB_10960841"	"unprognostic (6.94e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.17e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.39e-3)"	"unprognostic (1.92e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.33e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.41e-3)"	"unprognostic (8.87e-2)"	"unprognostic (1.03e-2)"	"unprognostic (5.86e-2)"	11.6	18.4	17.7	8.9	18.5	23.6	12.1	14.3	20.0	7.9	9.9	7.3	5.1	10.4	8.3	8.7	8.8	6.0	8.0	8.2	16.2	16.3	11.3	12.3	7.6	8.4	15.9	13.4	8.8	10.2	11.4	8.5	6.7	13.3	8.5	10.4	6.4	9.0	6.6	13.5	8.2	9.0	9.7	15.8	8.3	8.8	18.6	12.7	10.2	8.6	8.9	9.0	7.4	8.5	5.2	3.6	10.8	5.4	2.9	8.6	4.3	11.6	5.3	10.0	13.5	14.1	17.9	16.9	16.7	10.0	11.4	13.6	12.0	8.5	9.6	9.9	11.8	9.5	10.5	8.9	19.2	14.3	9.6	14.9	9.3	15.2	8.2	14.9	18.5	9.1	8.0	13.0	11.4	12.7	10.6	19.2	19.2	10.1	8.2	13.1	14.6	14.3	7.9	13.0	8.7	11.2	12.1	16.4	7.1	8.1	6.1	12.4	9.0	12.9	11.0	17.8	14.6	19.8	13.3	12.7	20.4	9.6	14.3	9.6	8.9	7.1	4.2	10.8	6.0	5.4	8.6	5.2	6.7	5.6	3.6	4.8	7.1	7.4	3.5	2.9	4.0	2.1	6.1	4.3	17.7	18.5	14.3	20.0	16.2	16.3	15.9	13.4	13.3	12.7
C4A	"C4, C4A2, C4A3, C4A4, C4A6, C4B, C4S, CO4, CPAMD2, RG"	ENSG00000244731	"Complement C4A (Rodgers blood group)"	P0C0L4	6	31982024-32002681	"Blood group antigen proteins, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Inflammatory response, Innate immunity"	"Blood group antigen"	"Disease mutation, FDA approved drug targets, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 49.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 24.8;HSkMC: 35.2;U-266/70: 8.2;U-266/84: 15.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 27.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB009811, CAB032603, HPA046356, HPA048287, HPA050103"	Supported				"Secreted to blood"	98000000000	98000000000			"CAB009811: AB_2066891, CAB032603: AB_2290613, HPA046356: , HPA048287: , HPA050103: "	"unprognostic (2.13e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.10e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.15e-1)"	"unprognostic (4.47e-2)"	"unprognostic (3.20e-2)"	"unprognostic (5.20e-2)"	"unprognostic (3.97e-2)"	"unprognostic (8.63e-2)"	2.7	17.5	1.3	4.3	1.1	0.0	3.3	0.0	0.1	0.4	3.0			2.9	1.6	5.8	0.7	3.5	0.8	2.7	0.7	0.9	12.8	49.5	6.7	1.4	0.9		8.0	2.6	0.0	2.2	0.0		1.5	1.7		1.3	0.0	0.0	0.1	1.2	0.0	0.7	2.9	4.1	0.3			8.1		1.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.2	0.0	24.8	0.2	0.0	0.0	0.4	0.0	0.0	0.0	35.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	8.2	15.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
C4B	"C4B1, C4B3, C4F, CH, CO4, CPAMD3"	ENSG00000224389	"Complement C4B (Chido blood group)"	P0C0L5	6	32014762-32035418	"Blood group antigen proteins, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Inflammatory response, Innate immunity"	"Blood group antigen"	"FDA approved drug targets, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 30.7;liver: 52.4"	"Cell line enriched"	"Detected in some"	5	"Karpas-707: 52.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 33.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046356, HPA048287, HPA050103"	Approved				"Secreted to blood"	97000000000	97000000000			"HPA046356: , HPA048287: , HPA050103: "	"unprognostic (1.29e-1)"	"unprognostic (2.99e-2)"	"unprognostic (5.50e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.09e-2)"	"unprognostic (6.24e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.24e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.99e-3)"	"unprognostic (1.11e-2)"	3.7	30.7	0.9	0.0	0.7	0.0	1.3	0.0	0.9	0.7	2.3			0.9	1.4	0.0	0.0	4.7	2.4	2.6	0.4	0.9	7.2	52.4	2.0	0.7	0.7		7.2	2.7	1.0	1.8	0.5		0.5	2.7		2.0	0.4	0.0	0.0	1.0	3.8	0.6	1.4	0.8	0.7			5.7		1.6	2.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	3.3	0.2	0.0	10.2	0.0	0.0	0.0	0.0	0.0	52.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
C4BPA	C4BP	ENSG00000123838	"Complement component 4 binding protein alpha"	P04003	1	207104262-207144972	"Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"liver: 377.2"	"Cell line enriched"	"Detected in some"	7	"Hep G2: 28.3"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 434.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	153	"neutrophil: 21.6"	"Lineage enriched"	"Detected in single"	153	"granulocytes: 21.6"									"HPA000926, HPA001578"	Enhanced				"Secreted to blood"	34000000000	34000000000			"HPA000926: AB_1078355, HPA001578: AB_1078354"	"unprognostic (3.85e-4)"	"unprognostic (9.07e-2)"	"unprognostic (2.06e-1)"	"prognostic favourable (6.37e-5)"	"unprognostic (3.58e-2)"	"unprognostic (2.41e-1)"	"prognostic favourable (2.24e-4)"	"unprognostic (3.64e-2)"	"unprognostic (1.94e-1)"	"unprognostic (5.90e-4)"	"unprognostic (4.47e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.51e-7)"	"unprognostic (9.74e-2)"	"unprognostic (2.52e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.66e-1)"	0.1	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.6	0.2	0.1	0.1	0.0	0.6	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.2	377.2	26.0	0.1	0.1	0.1	0.3	1.8	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	21.6	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	28.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
C4BPB	C4BP	ENSG00000123843	"Complement component 4 binding protein beta"	P20851	1	207088842-207099993	"Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"liver: 156.5"	"Group enriched"	"Detected in some"	18	"CACO-2: 38.3;HeLa: 15.9;Hep G2: 49.8"	"Cancer enriched"	"Detected in many"	19	"liver cancer: 83.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.5;plasmacytoid DC: 3.6"	"Group enriched"	"Detected in many"	16	"dendritic cells: 3.6;T-cells: 2.5"					"Low region specificity"	"Detected in all"			HPA051620	Approved				"Secreted to blood"	1300000000	1300000000			"HPA051620: "	"unprognostic (1.73e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.54e-2)"	"unprognostic (4.58e-3)"	"unprognostic (9.49e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.25e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.25e-2)"	0.5	0.0	0.1	0.5	0.1	0.0	0.3	0.1	0.1	0.5	2.0	0.1	0.1	0.6	0.1	0.9	0.2	0.1	1.0	0.6	0.1	0.0	0.2	156.5	0.6	0.1	0.1	0.1	9.9	2.2	0.0	0.1	1.3	0.1	0.3	0.3	0.1	0.2	0.1	0.2	0.0	0.9	0.2	0.1	0.1	1.5	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	3.6	0.0	0.0	0.0	2.5	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.3	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	49.8	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	2.5	0.8	0.0	0.0	0.0	3.6	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
C4orf48		ENSG00000243449	"Chromosome 4 open reading frame 48"	Q5BLP8	4	2041993-2043970	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 78.4;brain: 37.2"	"Cell line enhanced"	"Detected in many"		"HEK 293: 37.8;NB-4: 27.1;PC-3: 82.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052447	Uncertain		Supported	Cytosol	"Secreted to blood"	32000	32000	Cytosol		"HPA052447: "	"unprognostic (7.96e-2)"	"unprognostic (2.57e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.26e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.51e-3)"	"unprognostic (2.28e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.55e-2)"	"unprognostic (3.42e-2)"	"unprognostic (5.38e-3)"	"unprognostic (2.68e-1)"	"unprognostic (5.55e-2)"	"unprognostic (3.17e-3)"	11.4	7.8	25.5	9.7	22.2	5.6	4.8	7.7	37.2	3.4	19.7	18.2	3.2	6.5	4.1	3.0	1.2	3.2	3.1	3.8	26.4	26.2	5.2	2.5	4.7	8.7	24.8	15.6	2.9	16.8	5.6	19.8	5.3	14.9	3.9	3.1	4.3	5.1	4.3	3.3	3.7	16.6	2.4	30.7	9.6	9.8	13.9	15.7	1.2	2.2	0.7	2.4	2.6	2.6	29.8	49.4	67.5	78.4	4.5	31.0	28.4	7.6	6.4	1.2	5.9	0.5	0.9	8.5	7.4	1.4	1.3	1.3	4.4	4.6	1.0	7.1	0.2	2.1	0.1	0.8	0.4	4.6	37.8	2.4	3.5	2.4	1.3	4.9	16.9	0.7	1.4	0.3	0.0	1.4	8.0	0.0	0.9	4.7	5.6	27.1	3.8	82.0	13.0	2.0	2.5	1.1	2.9	10.3	14.5	3.6	0.1	9.9	2.0	2.4	6.2	3.6	7.7	2.6	8.2	5.7	4.9	0.0	3.5	3.1	4.9	11.5	78.4	67.5	21.5	50.6	22.0	29.8	27.8	23.9	44.2	22.6	16.0	16.7	59.0	4.5	44.0	49.4	31.0	28.4	25.5	22.2	7.7	37.2	26.4	26.2	24.8	15.6	14.9	15.7
C5	"C5a, C5b, CPAMD4"	ENSG00000106804	"Complement C5"	P01031	9	120952335-121050276	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Inflammatory response, Innate immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	55	"liver: 259.9"	"Cell line enhanced"	"Detected in many"		"A549: 20.1;Hep G2: 21.1"	"Cancer enriched"	"Detected in many"	17	"liver cancer: 73.0"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA029339	Supported				"Secreted to blood"	46000000000	46000000000			"HPA029339: AB_10601125"	"unprognostic (2.51e-1)"	"unprognostic (5.88e-3)"	"unprognostic (2.50e-3)"	"unprognostic (1.57e-2)"	"unprognostic (5.05e-2)"	"unprognostic (9.52e-3)"	"prognostic favourable (9.43e-4)"	"unprognostic (1.83e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.46e-5)"	"unprognostic (5.91e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.75e-1)"	0.5	0.3	0.4	0.3	0.5	0.3	0.4	0.3	0.3	0.4	1.1	0.3	0.3	0.7	0.5	0.7	0.3	0.6	0.4	0.3	0.4	0.3	1.1	259.9	2.3	0.3	0.4	0.3	0.7	4.7	0.8	0.7	0.3	0.4	0.6	0.2	0.3	0.3	0.4	0.3	0.7	3.2	0.3	0.5	0.3	1.2	0.4	0.3	0.3	0.3	0.3	0.3	0.5	0.4	1.8	2.1	1.8	1.6	0.1	1.2	0.5	1.1	20.1	4.6	8.1	6.0	6.9	0.2	2.4	2.5	0.7	1.4	0.6	1.9	2.9	0.1	1.2	7.9	0.2	0.2	1.1	0.6	0.0	1.2	1.0	21.1	1.1	0.7	0.5	3.1	0.4	1.4	2.7	0.7	0.5	2.8	1.5	3.9	0.3	0.1	1.2	7.8	1.7	2.0	0.3	1.2	0.6	1.2	4.8	1.1	0.0	2.0	1.6	2.6	0.9	2.0	0.1	5.4	2.4	1.6	1.2	1.2	1.6	2.7	4.9	0.0	1.6	1.8	0.3	0.4	1.2	1.8	0.6	0.5	2.1	1.0	0.5	0.3	0.1	0.1	0.1	0.1	0.1	0.5	0.4	0.5	0.3	0.3	0.4	0.3	0.4	0.3	0.4	0.3
C5orf46	"MGC23985, SSSP1"	ENSG00000178776	"Chromosome 5 open reading frame 46"	Q6UWT4	5	147880726-147906538	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"salivary gland: 107.9;skin 1: 42.7"	"Cell line enhanced"	"Detected in some"		"PC-3: 40.1;SiHa: 9.0;U-2 OS: 26.2;U-251 MG: 10.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 8.3"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA058999			Approved	"Nuclear speckles,Mitochondria"	"Secreted in other tissues"			"Nuclear speckles"	Mitochondria	"HPA058999: "	"unprognostic (1.72e-1)"	"prognostic unfavourable (3.98e-4)"	"unprognostic (1.26e-4)"	"unprognostic (9.75e-3)"	"unprognostic (2.95e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.99e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.22e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.86e-3)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (1.75e-9)"	"unprognostic (6.48e-3)"	"unprognostic (3.47e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.79e-2)"	0.2	0.0	0.1	0.1	0.1	0.0	5.2	2.0	0.1	0.6	0.1	0.1	0.1	0.0	0.3	0.6	0.2	0.0	0.2	3.0	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.3	0.6	0.0	0.1	4.3	0.4	0.4	0.0	0.2	107.9	0.4	0.6	42.7	0.1	1.0	0.1	0.1	0.0	6.5	0.2	0.2	0.1	1.1	0.6	0.2	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	9.0	0.1	0.1	0.0	0.0	0.0	4.7	26.2	0.3	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.0	0.1	0.1	0.0	0.1	0.1	0.4	0.2
C6		ENSG00000039537	"Complement C6"	P13671	5	41142234-41261438	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"	"Complement pathway, Cytolysis, Immunity, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"liver: 176.1"	"Group enriched"	"Detected in some"	13	"ASC diff: 5.1;ASC TERT1: 7.1;HSkMC: 18.8"	"Group enriched"	"Detected in many"	7	"liver cancer: 49.0;pancreatic cancer: 12.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA043823, CAB069427"	Enhanced				"Secreted to blood"	7600000000	7600000000			"CAB069427: AB_1614336, HPA043823: AB_10960262"	"unprognostic (9.79e-2)"	"unprognostic (1.96e-2)"	"unprognostic (5.94e-3)"	"unprognostic (3.02e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.12e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.04e-3)"	"prognostic favourable (4.31e-4)"	"unprognostic (2.69e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.51e-2)"	2.3	0.1	0.2	0.1	0.2	0.0	1.0	0.1	0.2	0.3	0.5	0.5	0.1	0.1	0.2	2.7	0.3	8.8	2.4	24.1	0.2	0.0	5.2	176.1	0.9	0.8	0.1	0.1	3.2	10.1	0.0	0.4	0.4	0.6	0.2	0.0	0.2	0.1	0.1	0.2	0.0	0.8	0.1	0.2	0.1	0.4	1.7	0.1	0.1	0.4	0.7	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	7.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.2	0.0	18.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.2	0.0	0.1	0.1	0.6	0.1
C6orf120	bA160E12.4	ENSG00000185127	"Chromosome 6 open reading frame 120"	Q7Z4R8	6	169702190-169704856	"Predicted secreted proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039626	Uncertain				"Secreted to blood"					"HPA039626: AB_10673361"	"unprognostic (2.98e-2)"	"prognostic unfavourable (2.26e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.30e-3)"	"prognostic unfavourable (9.52e-5)"	"unprognostic (1.78e-1)"	"unprognostic (2.84e-1)"	"prognostic unfavourable (8.37e-4)"	"unprognostic (1.56e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.14e-3)"	22.1	23.5	18.4	14.8	20.8	7.0	16.8	12.3	25.1	15.5	18.9	16.0	8.9	17.4	15.2	13.2	14.9	14.2	14.4	21.2	15.5	11.3	21.3	29.9	13.8	16.0	16.2	17.0	20.9	20.0	12.2	11.6	23.7	15.3	14.1	16.0	14.0	15.4	14.1	17.1	11.4	23.5	14.8	13.0	20.2	16.7	16.5	16.2	17.0	12.3	10.8	16.2	16.6	11.4	7.1	9.0	9.6	10.6	4.1	9.6	4.7	5.7	4.6	11.3	17.3	31.7	26.5	12.9	12.1	17.5	10.1	11.9	6.2	5.4	4.9	9.8	14.8	8.9	7.3	11.1	17.1	8.2	17.8	7.0	4.3	13.0	22.5	11.6	11.2	32.5	9.1	12.0	14.0	12.2	18.4	14.1	17.4	10.4	6.2	8.0	9.7	5.4	4.6	6.2	13.2	12.5	6.5	4.6	10.5	10.0	6.4	8.0	10.7	15.3	13.4	4.3	8.4	22.6	8.2	18.3	28.1	7.0	14.2	10.8	11.2	8.1	10.6	9.6	4.9	10.6	6.6	4.7	7.2	8.5	9.0	7.1	9.6	7.7	5.9	4.1	8.2	3.1	4.7	4.7	18.4	20.8	12.3	25.1	15.5	11.3	16.2	17.0	15.3	16.2
C6orf15	STG	ENSG00000204542	"Chromosome 6 open reading frame 15"	Q6UXA7	6	31111223-31112559	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"cervix, uterine: 5.6;lymphoid tissue: 7.3;skin 1: 10.8;tongue: 11.5"	"Group enriched"	"Detected in some"	11	"RH-30: 8.1;U-2 OS: 3.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA001436	Uncertain				"Secreted - unknown location"					"HPA001436: AB_2243752"	"unprognostic (2.73e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.56e-1)"		"unprognostic (1.77e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.71e-2)"			"unprognostic (1.72e-1)"		"unprognostic (1.90e-1)"	"unprognostic (1.34e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	5.6	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.8	0.0	0.0	0.0	0.6	0.0	0.3	10.8	0.0	0.0	0.4	0.0	0.0	0.1	0.0	7.3	0.0	11.5	3.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0
C6orf58	LEG1	ENSG00000184530	"Chromosome 6 open reading frame 58"	Q6P5S2	6	127519455-127591817	"Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	48	"intestine: 98.4;salivary gland: 189.6;stomach 1: 54.2;tongue: 122.6"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 6.7;WM-115: 4.8"	"Group enriched"	"Detected in some"	6	"pancreatic cancer: 17.1;stomach cancer: 14.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036263, HPA041449"	Enhanced				"Secreted to digestive system"	41000	41000			"HPA036263: AB_10673349, HPA041449: AB_2677486"	"unprognostic (1.49e-1)"	"unprognostic (8.55e-2)"	"unprognostic (2.71e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.72e-3)"	"unprognostic (1.69e-1)"	"unprognostic (6.62e-4)"	"unprognostic (2.10e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.53e-2)"	"unprognostic (8.99e-3)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.4	0.0	98.4	0.1	0.0	2.4	0.1	0.4	0.1	0.1	0.1	0.1	0.1	2.3	0.0	0.1	0.0	0.1	1.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	189.6	0.1	0.1	0.1	0.1	0.0	0.1	0.1	54.2	0.2	0.0	0.0	0.1	122.6	1.7	0.1	0.1	1.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.5	0.3	0.1	0.3	0.3	0.2	0.0	1.0	0.3	0.4	0.5	0.1	0.0	0.0	0.8	0.9	0.1	0.1	0.0	0.1	0.3	0.0	0.1	0.0	0.0	1.5	0.1	0.0	0.0	0.1	0.5	0.2	0.4	1.0	0.3	0.2	0.3	0.0	6.7	0.7	0.1	0.2	1.0	0.3	0.0	0.0	0.0	0.1	0.3	1.5	0.0	0.0	1.8	0.1	0.0	0.1	0.0	0.0	4.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
C7		ENSG00000112936	"Complement C7"	P10643	5	40909252-40982939	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 199.9"	"Group enriched"	"Detected in some"	9	"ASC diff: 37.6;HHSteC: 49.7;HSkMC: 68.4;SH-SY5Y: 46.4"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 73.8"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA001465	Approved				"Secreted to blood"	67000000000	67000000000			"HPA001465: AB_1078554"	"unprognostic (5.01e-2)"	"unprognostic (3.74e-2)"	"unprognostic (7.40e-2)"	"unprognostic (4.68e-3)"	"unprognostic (5.35e-2)"	"unprognostic (1.43e-3)"	"prognostic favourable (5.89e-4)"	"unprognostic (6.67e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.24e-2)"	"unprognostic (6.10e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.06e-3)"	54.4	99.5	0.8	7.4	1.6	0.0	10.5	1.1	1.0	30.2	34.7	3.1	14.8	2.5	36.8	48.6	55.3	47.7	48.2	79.7	0.9	0.3	81.3	41.0	29.1	69.0	3.9	1.5	199.9	32.4	3.0	5.2	55.4	3.7	52.5	4.8	1.4	5.1	17.5	1.9	1.8	17.0	43.3	3.2	33.6	17.9	44.6	0.7	3.1	32.4	1.1	7.2	39.9	29.6	0.7	0.4	1.6	0.3	1.5	0.4	0.0	0.0	0.0	0.0	0.0	37.6	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.7	0.0	0.0	68.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	46.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.4	0.2	0.3	0.1	0.2	0.2	0.2	0.0	0.7	0.3	0.4	1.1	1.5	0.3	0.4	0.0	0.0	0.8	1.6	1.1	1.0	0.9	0.3	3.9	1.5	3.7	0.7
C8A		ENSG00000157131	"Complement C8 alpha chain"	P07357	1	56854806-56918221	"Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	305	"liver: 210.3"	"Cell line enriched"	"Detected in some"	5	"Hep G2: 5.4"	"Cancer enriched"	"Detected in single"	279	"liver cancer: 85.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"								"Secreted to blood"	3400000000	3400000000										"unprognostic (3.73e-3)"	"unprognostic (2.44e-1)"			"unprognostic (1.28e-1)"			"unprognostic (6.40e-2)"		"unprognostic (9.82e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	210.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C8G		ENSG00000176919	"Complement C8 gamma chain"	P07360	9	136945246-136946974	"Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 165.8"	"Cell line enriched"	"Detected in some"	13	"HMC-1: 59.5"	"Cancer enriched"	"Detected in all"	58	"liver cancer: 260.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 3.4"	"Group enriched"	"Detected in many"	18	"dendritic cells: 1.5;T-cells: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA046269	Approved				"Secreted to blood"	1500000000	1500000000			"HPA046269: "	"unprognostic (5.00e-2)"	"unprognostic (4.05e-3)"	"prognostic unfavourable (2.99e-4)"	"unprognostic (3.94e-1)"	"unprognostic (4.53e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.16e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.05e-2)"	0.2	0.7	0.2	0.3	0.2	0.0	0.2	0.2	0.2	0.2	6.0	0.2	0.2	14.6	0.2	0.2	0.2	0.2	2.7	0.2	0.2	0.1	0.4	165.8	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.8	0.3	12.1	0.2	0.2	0.6	0.6	0.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	1.5	0.0	0.1	0.0	3.4	0.3	0.1	0.8	0.1	0.2	0.1	0.0	0.6	0.3	0.0	0.0	0.0	1.1	0.6	1.1	0.7	0.0	0.9	0.0	0.1	0.0	1.1	0.1	0.3	1.6	4.5	0.0	0.0	59.5	0.0	0.2	0.2	0.0	0.2	0.1	0.6	0.2	0.8	0.1	0.5	0.0	0.2	0.1	0.2	0.8	0.2	0.5	0.2	0.2	0.2	1.7	0.3	1.5	0.4	0.6	0.3	0.1	0.1	0.2	0.3	0.5	0.0	0.2	0.5	0.2	0.0	0.1	0.0	3.4	0.0	0.4	0.0	0.7	1.8	0.0	0.0	0.0	2.2	0.0	0.0	0.0	1.5	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
C9		ENSG00000113600	"Complement C9"	P02748	5	39284262-39424868	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"		"Age-related macular degeneration, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	577	"liver: 419.5"	"Cell line enhanced"	"Detected in some"		"HL-60: 2.5;RH-30: 1.6;SiHa: 1.0;U-698: 6.3"	"Cancer enriched"	"Detected in single"	244	"liver cancer: 90.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002151, HPA029577"	Uncertain				"Secreted to blood"	97000000000	97000000000			"CAB002151: AB_563670, HPA029577: AB_10603779"	"unprognostic (1.00e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.50e-1)"		"unprognostic (2.01e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.49e-3)"		"unprognostic (1.91e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.19e-2)"	"unprognostic (9.43e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.04e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	419.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.8	0.0	0.1	0.0	0.1	1.6	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C9orf47	"bA791O21.3, C9orf108, FLJ37523"	ENSG00000186354	"Chromosome 9 open reading frame 47"	Q6ZRZ4	9	88990863-88996140	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 6.6;ASC diff: 3.2;HeLa: 5.6"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	5	"classical monocyte: 2.2"	"Lineage enriched"	"Detected in single"	6	"monocytes: 2.2"									CAB009902	Approved				"Secreted - unknown location"					"CAB009902: AB_2184764"	"unprognostic (6.51e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.94e-4)"	"unprognostic (2.24e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.47e-2)"	"unprognostic (9.39e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.98e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.19e-6)"	"unprognostic (5.61e-2)"	"unprognostic (3.72e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.77e-2)"	1.7	5.3	0.6	1.0	0.7	0.8	2.3	0.0	0.7	1.8	1.0			0.3	1.1	0.6	2.1	2.1	0.9	1.8	0.8	0.5	3.9	0.8	1.0	1.7	0.4		0.4	1.7	0.0	3.3	1.2		1.9	0.2		0.3	0.8	0.0	0.0	0.8	1.4	0.5	1.7	1.0	0.0			0.7		0.5	0.9	1.9	0.0	0.2	0.3	2.2	0.0	0.0	0.4	0.0	0.4	6.6	0.2	3.2	1.9	0.1	1.1	0.3	0.4	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.5	0.0	0.1	0.0	5.6	0.0	0.0	0.4	0.0	0.2	0.1	0.7	0.0	0.7	0.3	0.0	0.0	0.5	1.6	1.4	0.4	0.3	0.7	0.0	0.0	0.0	0.6	0.2	0.5	0.3	0.1	0.0	0.1	1.8	1.8	0.6	1.4	1.1	0.0	0.0	0.0	0.0	0.7	0.5	0.1	0.0	2.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.4										
CA6		ENSG00000131686	"Carbonic anhydrase 6"	P23280	1	8945867-8975092	"Enzymes, Predicted secreted proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	50	"salivary gland: 1237.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 5.3;U-2197: 4.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 15.4"	"Lineage enriched"	"Detected in many"	10	"T-cells: 15.4"					"Low region specificity"	"Detected in all"			"HPA028550, HPA028692"	Enhanced				"Secreted to digestive system"	34000000	34000000			"HPA028550: AB_10600105, HPA028692: AB_10601883"	"unprognostic (2.54e-5)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.90e-1)"	"unprognostic (9.28e-2)"		"unprognostic (2.70e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.73e-1)"	"unprognostic (5.93e-2)"	"unprognostic (4.41e-2)"	"unprognostic (4.29e-5)"	"unprognostic (1.14e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.35e-1)"		0.3	0.0	0.1	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1237.9	0.0	0.1	24.9	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.8	0.2	0.0	0.1	0.6	0.4	1.5	0.3	0.4	15.4	1.6	1.1	0.5	0.9	1.8	0.3	0.3	1.4	0.9	0.1	0.2	0.6	1.0	1.5	5.3	0.6	0.5	1.5	0.4	0.1	0.8	0.6	0.6	0.8	1.9	1.0	0.4	2.0	1.9	0.0	1.0	0.9	0.1	0.6	0.7	3.3	0.1	0.8	1.0	1.5	1.1	0.7	1.4	0.6	0.3	0.2	1.0	1.0	0.9	0.2	0.9	0.3	1.4	0.8	0.3	2.7	1.4	4.6	1.2	1.4	0.5	1.7	0.6	1.8	1.3	1.1	0.3	0.2	0.4	0.2	0.4	0.3	0.8	2.8	0.0	0.6	5.6	15.4	1.5	0.4	0.2	0.4	0.3	1.6	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0
CALCA	CALC1	ENSG00000110680	"Calcitonin related polypeptide alpha"	"P01258, P06881"	11	14966668-14972354	"Cancer-related genes, Plasma proteins, Predicted secreted proteins, Transporters"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"parathyroid gland: 122.2;thyroid gland: 55.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.8;hTERT-HME1: 1.7;Karpas-707: 1.8;SCLC-21H: 3.4"	"Cancer enriched"	"Detected in many"	7	"lung cancer: 64.7"	"Region enriched"	"Detected in single"	48	"pons and medulla: 19.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"pons and medulla: 60.6"					HPA059886		Supported			"Secreted to blood"					"HPA059886: "			"unprognostic (1.97e-1)"	"prognostic unfavourable (4.49e-5)"	"unprognostic (5.99e-2)"		"unprognostic (2.42e-1)"	"unprognostic (1.17e-1)"		"unprognostic (6.45e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.33e-2)"	"unprognostic (7.49e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.02e-2)"	0.2	0.0	0.1	0.3	0.4	0.0	0.8	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	6.2	16.8	0.6	0.0	0.1	0.0	0.0	0.1	122.2	0.2	0.0	19.8	1.2	0.0	0.3	0.4	0.0	0.3	0.0	0.0	0.3	1.5	4.6	0.0	0.0	0.0	0.6	55.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	1.8	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.4	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.4	0.1	0.2	0.0	0.2	0.1	0.0	19.8	0.0
CALCB	"CALC2, CGRP-II, FLJ30166"	ENSG00000175868	"Calcitonin related polypeptide beta"	P10092	11	14904997-15082342	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 14.3;pancreas: 7.9;thyroid gland: 26.0"	"Cell line enhanced"	"Detected in some"		"HEK 293: 6.2;Karpas-707: 11.0;SH-SY5Y: 3.8;U-266/70: 16.6"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.4"	"Group enriched"	"Detected in many"	8	"hypothalamus: 13.5;pons and medulla: 14.3"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	7	"pons and medulla: 10.1"					HPA059886		Supported			"Secreted to blood"					"HPA059886: "	"unprognostic (7.84e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.92e-1)"	"prognostic unfavourable (3.42e-5)"	"unprognostic (2.02e-1)"	"unprognostic (8.40e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.21e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.33e-1)"	0.5	0.2	0.0	1.6	1.6	0.3	1.5	1.5	0.8	0.3	1.5	0.0	0.0	0.9	0.4	0.3	0.3	0.2	0.3	0.9	0.0	13.5	0.4	1.1	1.3	1.0	0.7	0.2	0.2	7.9	0.3	2.7	0.4	14.3	0.4	0.5	1.8	0.7	0.2	1.2	0.3	0.8	0.4	3.9	0.9	0.3	1.4	0.3	0.6	26.0	0.0	0.3	0.3	0.0	0.2	0.3	1.1	0.2	1.8	1.2	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.3	6.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	2.0	0.4	0.0	11.0	0.0	0.0	0.0	0.6	3.0	0.1	0.5	0.0	0.2	0.0	0.0	1.2	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	16.6	0.6	0.4	2.2	0.0	0.0	0.0	0.2	1.1	0.8	0.1	1.2	0.0	0.5	0.7	0.3	0.2	1.2	1.1	0.6	1.8	0.0	0.0	0.1	0.4	0.0	1.6	1.5	0.8	0.0	13.5	0.7	0.2	14.3	0.3
CAMP	"CAP18, FALL-39, FALL39, LL37"	ENSG00000164047	"Cathelicidin antimicrobial peptide"		3	48223347-48225491	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"blood: 63.7;bone marrow: 201.8;epididymis: 275.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 13.3;hTCEpi: 9.3;U-698: 38.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.1"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 63.7"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 63.7"	"Low region specificity"	"Detected in single"							"CAB015949, CAB016522, HPA029874"	Enhanced				"Secreted to blood"					"CAB015949: , CAB016522: , HPA029874: AB_10600859"	"unprognostic (2.14e-2)"	"prognostic favourable (5.73e-4)"	"unprognostic (4.59e-2)"	"unprognostic (2.62e-1)"	"unprognostic (9.41e-2)"	"unprognostic (4.57e-5)"	"unprognostic (3.09e-1)"	"unprognostic (5.71e-2)"	"unprognostic (4.89e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.08e-4)"	"unprognostic (1.23e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.03e-2)"	0.2	0.1	0.1	0.1	0.2	201.8	0.2	0.1	0.1	0.1	0.1	0.0	14.7	0.0	0.0	275.0	0.1	0.2	0.0	0.5	0.1	0.1	0.1	0.2	1.5	0.5	0.1	0.0	0.1	0.1	0.0	0.1	0.4	0.0	0.2	0.0	0.1	1.1	0.1	0.1	0.1	2.6	0.0	0.1	10.1	0.1	4.0	0.0	0.4	0.4	0.1	0.2	0.4	0.1	0.5	1.5	63.7	5.2	0.5	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	38.5	0.0	1.4	0.0	5.5	1.1	15.8	0.0	1.7	0.0	0.5	0.0	0.0	1.5	0.3	0.0	0.0	63.7	0.5	5.2	0.8	0.0	10.9	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
CARTPT	CART	ENSG00000164326	"CART prepropeptide"	Q16568	5	71719163-71721048	"FDA approved drug targets, Predicted secreted proteins"		"Neuropeptide, Neurotransmitter"	"FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"adrenal gland: 67.5;brain: 101.4"	"Group enriched"	"Detected in some"	7	"NB-4: 1.0;SH-SY5Y: 3.4"	"Cancer enriched"	"Detected in many"	9	"breast cancer: 117.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hippocampal formation: 179.9"	"CAB025515, HPA046278, CAB079776"	Enhanced	Supported			"Secreted to blood"					"CAB025515: , CAB079776: , HPA046278: AB_10961570"			"unprognostic (1.37e-1)"		"unprognostic (1.43e-1)"					"unprognostic (2.27e-1)"	"unprognostic (3.45e-2)"	"unprognostic (6.67e-2)"		"prognostic unfavourable (4.36e-4)"		"unprognostic (1.14e-1)"		1.6	67.5	8.0	2.8	22.3	0.5	5.8	0.1	29.0	0.5	3.4	2.1	0.0	3.5	0.6	0.9	3.5	0.7	0.6	0.5	31.1	101.4	0.5	0.5	0.5	0.5	1.0	4.5	0.5	5.3	0.5	1.7	0.5	54.1	3.3	3.1	1.6	0.5	0.5	0.5	0.5	1.4	8.1	8.6	0.5	3.4	1.9	9.7	0.0	3.4	0.0	0.5	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	22.3	0.1	29.0	31.1	101.4	1.0	4.5	54.1	9.7
CBLN1		ENSG00000102924	"Cerebellin 1 precursor"	P23435	16	49277917-49281831	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 106.6"	"Group enriched"	"Detected in some"	28	"NTERA-2: 16.3;SCLC-21H: 51.9"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 8.5"	"Region enriched"	"Detected in many"	12	"cerebellum: 106.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	9	"cerebellum: 688.3"	"Region enriched"	"Detected in many"	15	"cerebellum: 300.1"						"Secreted in brain"	2900000	2900000				"unprognostic (1.39e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.07e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.18e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.04e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.06e-2)"	"prognostic favourable (7.10e-4)"	"unprognostic (1.60e-2)"	9.9	0.8	0.9	0.1	1.0	0.0	1.2	106.6	4.9	2.0	0.4	0.4	0.4	0.6	5.9	1.4	0.8	0.9	9.0	4.2	0.7	9.2	0.2	0.7	0.1	0.9	4.5	1.0	0.5	2.4	0.0	0.9	0.4	4.6	0.3	0.4	1.1	0.7	3.0	0.5	0.3	0.5	1.5	2.3	0.1	0.5	16.0	0.4	0.2	0.6	0.6	2.4	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	1.1	1.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	0.1	0.0	0.0	0.0	0.0	0.0	51.9	1.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	106.6	1.4	0.7	9.2	4.5	1.0	4.6	0.4
CBLN4	"CBLNL1, dJ885A10.1"	ENSG00000054803	"Cerebellin 4 precursor"	Q9NTU7	20	55997440-56005472	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 23.5;brain: 16.8;epididymis: 11.8"	"Cell line enriched"	"Detected in single"	49	"SH-SY5Y: 14.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA074497		Supported			"Secreted in brain"	10000000	10000000			"HPA074497: "	"unprognostic (3.61e-1)"	"unprognostic (8.43e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.00e-1)"	"unprognostic (3.25e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.88e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.40e-3)"	"unprognostic (3.22e-4)"	"unprognostic (7.50e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.79e-3)"	1.3	23.5	11.9	0.3	8.9	0.2	1.8	0.1	16.8	2.8	0.3	0.5	0.8	0.3	1.2	11.8	0.3	5.4	0.9	0.2	5.9	14.8	1.0	1.3	1.1	0.2	1.6	5.0	2.2	1.2	0.4	0.1	0.5	2.4	0.4	0.2	0.1	0.3	0.7	0.5	0.3	0.3	0.6	0.4	0.2	0.7	2.7	0.0	0.0	1.3	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	8.9	0.1	16.8	5.9	14.8	1.6	5.0	2.4	0.0
CCDC134	FLJ22349	ENSG00000100147	"Coiled-coil domain containing 134"	Q9H6E4	22	41800679-41826299	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003936	Approved				"Secreted to blood"					"HPA003936: AB_1078419"	"unprognostic (2.09e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.82e-2)"	"prognostic favourable (4.09e-4)"	"unprognostic (1.73e-1)"	"unprognostic (3.85e-2)"	"prognostic unfavourable (7.42e-7)"	"unprognostic (4.35e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.30e-2)"	"unprognostic (7.32e-2)"	"prognostic favourable (1.36e-5)"	"unprognostic (6.24e-3)"	"unprognostic (2.52e-2)"	"unprognostic (5.47e-1)"	"unprognostic (6.63e-2)"	3.8	23.4	3.3	8.1	5.0	15.1	4.4	19.1	5.2	4.6	5.7	7.7	5.7	5.5	5.9	15.0	6.9	7.3	4.8	4.6	4.3	3.1	7.5	6.9	5.6	7.3	4.2	2.4	4.4	8.1	12.2	12.3	6.6	5.6	5.2	4.9	8.6	12.9	9.0	6.5	5.9	5.8	3.4	5.1	7.3	6.1	17.2	5.4	12.6	8.7	3.5	11.8	4.4	4.1	4.2	2.2	9.4	8.2	4.5	7.1	3.4	7.7	6.7	6.0	11.9	3.5	0.9	7.0	6.3	5.3	11.8	13.9	10.1	5.2	7.0	10.9	5.2	8.6	6.0	6.3	6.6	7.7	9.5	6.6	16.7	7.1	1.5	9.1	9.2	1.9	2.5	13.6	2.8	6.1	4.3	14.5	6.5	5.3	5.8	5.5	4.6	4.9	11.0	9.2	9.9	8.6	7.0	3.6	2.7	11.5	9.2	4.6	11.7	5.2	3.4	6.2	10.3	4.2	10.9	16.7	9.9	5.4	6.6	5.9	12.4	0.0	4.9	9.4	5.8	8.0	3.6	4.2	3.6	4.4	2.2	2.5	7.1	3.8	2.6	4.5	8.2	2.0	6.0	3.4	3.3	5.0	19.1	5.2	4.3	3.1	4.2	2.4	5.6	5.4
CCK		ENSG00000187094	Cholecystokinin	P06307	3	42257825-42266207	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 95.1;intestine: 71.6"	"Group enriched"	"Detected in some"	7	"CAPAN-2: 8.7;RPTEC TERT1: 22.7"	"Group enriched"	"Detected in many"	5	"glioma: 4.0;pancreatic cancer: 1.8;prostate cancer: 3.5;stomach cancer: 1.0"	"Group enriched"	"Detected in many"	5	"amygdala: 59.0;basal ganglia: 29.8;cerebral cortex: 95.1;hippocampal formation: 35.8;olfactory region: 26.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 565.3"	"HPA045039, HPA069515"	Enhanced	Supported			"Secreted to blood"					"HPA045039: , HPA069515: "	"unprognostic (3.36e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.70e-1)"		"unprognostic (2.39e-3)"		"unprognostic (1.97e-2)"	"unprognostic (3.91e-1)"	"unprognostic (8.77e-2)"		"unprognostic (1.35e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.10e-2)"	0.9	1.1	59.0	1.1	29.8	0.8	0.9	0.2	95.1	0.8	11.3	1.4	0.0	71.6	0.8	0.8	0.9	0.9	0.9	0.9	35.8	10.8	0.8	0.9	1.1	0.8	8.0	26.9	0.8	1.1	0.8	4.1	9.4	1.3	13.5	0.9	0.0	0.8	1.0	0.8	0.9	10.5	1.0	1.3	0.8	1.7	1.7	0.5	0.0	0.8	0.0	0.8	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	8.7	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.9	22.7	0.1	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.0	29.8	0.2	95.1	35.8	10.8	8.0	26.9	1.3	0.5
CCL1	"I-309, P500, SCYA1, SISe, TCA3"	ENSG00000108702	"C-C motif chemokine ligand 1"	P22362	17	34360328-34363231	"Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 7.7;lymphoid tissue: 6.7;tongue: 3.2"	"Cell line enriched"	"Detected in some"	41	"HMC-1: 125.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 2.5"	"Group enriched"	"Detected in some"	4	"classical monocyte: 2.0;intermediate monocyte: 1.2"	"Lineage enriched"	"Detected in single"	20	"monocytes: 2.0"					"Region enriched"	"Detected in some"	4	"hippocampal formation: 2.2"	HPA049861	Uncertain				"Secreted to blood"					"HPA049861: "		"unprognostic (6.52e-2)"				"unprognostic (4.81e-3)"		"unprognostic (5.84e-2)"	"unprognostic (5.01e-1)"	"unprognostic (6.04e-1)"				"unprognostic (2.71e-1)"	"unprognostic (1.37e-1)"			0.1	0.0	0.2	0.2	2.5	0.0	0.1	0.1	0.9	0.1	0.5	0.1	0.1	0.0	0.1	0.8	0.1	0.2	0.4	0.1	0.5	0.3	0.1	0.1	0.4	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	7.7	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.0	1.8	0.1	6.7	0.1	3.2	0.5	0.1	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	125.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	2.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.2	2.5	0.1	0.8	0.5	0.3	0.2	0.1	0.1	0.1
CCL11	"eotaxin, MGC22554, SCYA11"	ENSG00000172156	"C-C motif chemokine ligand 11"	P51671	17	34285668-34288334	"Cancer-related genes, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 31.0;intestine: 29.6;lymphoid tissue: 29.2"	"Cell line enriched"	"Detected in single"	21	"BJ hTERT+: 13.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"												"Secreted to blood"						"unprognostic (4.61e-2)"	"unprognostic (1.45e-1)"	"prognostic favourable (8.70e-4)"	"unprognostic (8.18e-2)"		"prognostic favourable (1.99e-4)"	"unprognostic (9.91e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.64e-8)"	"unprognostic (2.66e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.72e-2)"	2.6	0.4	0.2	29.2	0.2	0.0	0.2	0.2	0.2	4.5	29.6	0.4	0.6	17.3	3.5	0.0	20.7	0.8	12.0	31.0	0.2	0.2	7.0	1.2	7.3	0.3	0.2	0.0	2.6	11.6	0.2	1.1	0.0	0.2	16.1	8.0	0.0	0.2	0.3	0.5	0.2	18.7	10.2	0.2	1.2	18.2	0.6	0.0	0.7	0.4	0.0	0.8	12.1	5.8	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	13.9	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.0
CCL14	"CKb1, HCC-1, HCC-3, MCIF, NCC-2, SCYA14, SCYL2"	ENSG00000276409	"C-C motif chemokine ligand 14"	Q16627	17	35983291-35987004	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 80.7;lymphoid tissue: 98.4"	"Cell line enriched"	"Detected in single"	52	"HUVEC TERT2: 35.0"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB004423, HPA030268"	Uncertain				"Secreted to blood"	19000000	19000000			"CAB004423: AB_627716, HPA030268: AB_10603782"	"unprognostic (4.13e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.55e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.99e-2)"	"unprognostic (8.79e-5)"	"unprognostic (1.44e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.10e-2)"	"unprognostic (6.33e-3)"	"unprognostic (3.00e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.36e-2)"	"unprognostic (3.95e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.14e-1)"	56.3	5.1	0.0	5.9	0.0	0.0	80.7	0.0	0.0	37.6	8.4	0.0	16.6	0.0	37.6	11.1	20.9	9.1	17.3	27.5	0.0		8.7	34.2	26.4	39.1	0.0	0.0	12.4	0.8	2.0	6.5	0.0	0.0	23.5	0.7	4.1	6.5	11.4	21.9	7.5	3.9	19.1	0.0	98.4	0.2	15.0	0.0	1.3	17.6	16.7	6.2	25.3	45.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CCL16	"CKb12, HCC-4, LCC-1, LEC, LMC, Mtn-1, NCC-4, SCYA16, SCYL4"	ENSG00000275152	"C-C motif chemokine ligand 16"	O15467	17	35976493-35981496	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	127	"liver: 79.1"	"Cell line enriched"	"Detected in single"	23	"Hep G2: 14.6"	"Cancer enriched"	"Detected in single"	154	"liver cancer: 49.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"								"Secreted to blood"	20000000	20000000				"unprognostic (3.85e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.75e-2)"		"unprognostic (2.72e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.91e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.66e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.08e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	79.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2										
CCL17	"ABCD-2, SCYA17, TARC"	ENSG00000102970	"C-C motif chemokine ligand 17"	Q92583	16	57404767-57416062	"Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 39.0"	"Cell line enriched"	"Detected in single"	613	"HDLM-2: 226.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.8;myeloid DC: 1.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			CAB002583	Uncertain				"Secreted to blood"					"CAB002583: AB_564022"	"unprognostic (4.62e-3)"	"prognostic favourable (1.91e-5)"	"unprognostic (5.83e-2)"	"unprognostic (3.52e-4)"	"unprognostic (4.51e-2)"	"unprognostic (1.78e-3)"	"unprognostic (4.44e-1)"	"unprognostic (3.41e-2)"	"unprognostic (6.36e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.91e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.35e-1)"	"unprognostic (7.72e-3)"	"unprognostic (4.14e-3)"	"prognostic favourable (5.80e-4)"	0.9	0.2	0.3	8.7	0.3	0.0	2.0	0.3	0.4	1.3	1.2	0.3	0.3	0.0	0.5	0.8	4.8	0.4	3.0	1.5	0.3	0.2	1.7	0.6	9.7	8.6	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.5	0.6	3.2	0.5	7.4	0.3	0.3	3.3	6.7	2.5	0.3	1.4	0.7	0.9	0.3	39.0	2.0	1.3	6.2	4.5	1.5	1.8	1.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	226.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	1.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.4	0.3	0.2	0.3	0.3	0.5	0.3
CCL18	"AMAC-1, CKb7, DC-CK1, DCCK1, MIP-4, PARC, SCYA18"	ENSG00000275385	"C-C motif chemokine ligand 18"	P55774	17	36064280-36072032	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 41.4;lung: 77.9;lymphoid tissue: 61.9"	"Cell line enhanced"	"Detected in single"		"SK-MEL-30: 1.5"	"Low cancer specificity"	"Detected in all"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to blood"	940000	940000				"unprognostic (8.91e-2)"	"unprognostic (2.96e-2)"	"unprognostic (5.71e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.60e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.63e-1)"	"unprognostic (4.87e-2)"	18.2	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.2	0.0	3.1	0.0	0.0	1.6	0.0	5.8	3.2	0.0	0.4	41.4	0.0		0.0	1.3	77.9	61.9	0.0	0.0	3.7	0.3	0.0	0.0	5.9	0.0	0.2	2.5	0.0	0.2	0.0	0.0	0.3	3.4	4.1	0.0	3.7	0.3	1.6	0.0	43.8	2.2	4.3	16.7	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CCL19	"CKb11, ELC, exodus-3, MIP-3b, SCYA19"	ENSG00000172724	"C-C motif chemokine ligand 19"	Q99731	9	34689567-34691277	"Cancer-related genes, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"lymphoid tissue: 418.9"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.9;Daudi: 2.5;HDLM-2: 7.5;HL-60: 1.9;TIME: 3.7"	"Cancer enhanced"	"Detected in all"		"testis cancer: 118.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	4	"intermediate monocyte: 2.3"	"Lineage enriched"	"Detected in single"	6	"monocytes: 2.3"					"Low region specificity"	"Detected in many"			HPA067758	Enhanced				"Secreted to blood"					"HPA067758: "	"prognostic favourable (2.88e-5)"	"prognostic favourable (9.91e-6)"	"unprognostic (8.25e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.36e-3)"	"unprognostic (8.31e-2)"	"unprognostic (2.43e-1)"	"prognostic unfavourable (8.63e-7)"	"unprognostic (7.98e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.87e-1)"	22.5	0.6	1.2	82.3	1.1	0.0	10.2	0.8	1.3	5.8	4.7	1.5	1.5	1.0	1.5	5.9	16.3	3.4	10.4	16.5	0.8	0.7	11.8	12.8	13.6	418.9	2.1	1.0	3.4	1.7	0.0	2.0	0.6	1.5	7.0	11.0	7.4	23.1	1.0	0.7	8.7	40.2	4.5	2.2	8.2	9.0	2.8	0.6	73.1	14.9	9.9	90.9	13.4	2.3	0.0	0.0	0.3	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.4	0.0	0.0	0.0	7.5	0.0	0.6	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.9	0.0	1.6	0.4	0.0	0.0	0.3	0.0	0.4	0.0	0.7	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.5	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	1.2	1.1	0.8	1.3	0.8	0.7	2.1	1.0	1.5	0.6
CCL2	"GDCF-2, HC11, MCAF, MCP-1, MCP1, MGC9434, SCYA2, SMC-CF"	ENSG00000108691	"C-C motif chemokine ligand 2"	P13500	17	34255218-34257203	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"BJ hTERT+: 159.2;HMC-1: 207.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 10.3;eosinophil: 3.9"	"Group enriched"	"Detected in many"	6	"granulocytes: 3.9;monocytes: 10.3"					"Low region specificity"	"Detected in many"			"CAB013676, HPA019163"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"			"Golgi apparatus"	Vesicles	"CAB013676: , HPA019163: AB_1846179"	"unprognostic (6.43e-2)"	"unprognostic (4.14e-2)"	"unprognostic (4.78e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.37e-3)"	"unprognostic (8.64e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.19e-1)"	"unprognostic (9.33e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavourable (4.51e-4)"	"unprognostic (1.33e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.92e-2)"	78.1	31.2	10.3	52.3	50.6	19.1	19.0	1.5	23.3	9.7	41.9	28.6	3.0	9.4	7.2	7.6	14.4	25.8	62.0	76.9	45.1	6.7	32.5	38.4	105.2	16.9	16.0	2.0	28.6	32.8	15.2	17.3	22.8	63.6	42.0	25.3	22.3	13.5	13.4	17.8	10.5	16.7	34.6	85.4	16.1	30.2	4.6	8.6	4.8	20.8	21.6	19.1	27.2	9.0	0.0	1.1	3.9	10.3	0.0	0.1	2.3	0.0	1.2	3.4	0.0	9.6	8.2	0.0	9.7	159.2	20.7	44.4	0.5	0.0	0.0	7.7	2.2	5.3	0.3	0.0	10.5	0.0	0.0	0.0	1.1	0.0	0.3	0.0	207.5	9.1	0.0	4.3	0.2	9.4	0.5	1.7	0.0	0.0	0.0	1.5	0.4	0.0	0.0	0.2	1.7	29.6	0.0	0.0	0.6	0.0	0.5	0.2	0.3	0.2	0.5	11.1	0.4	0.3	0.0	0.1	0.0	0.0	6.5	3.0	7.0	0.0	10.3	3.9	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.7	0.0	0.0	0.3	0.0	2.3	10.3	50.6	1.5	23.3	45.1	6.7	16.0	2.0	63.6	8.6
CCL20	"CKb4, exodus-1, LARC, MIP-3a, SCYA20, ST38"	ENSG00000115009	"C-C motif chemokine ligand 20"	P78556	2	227805739-227817564	"Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	"Antibiotic, Antimicrobial, Cytokine"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 48.5;lung: 36.8;lymphoid tissue: 50.9"	"Cell line enhanced"	"Detected in many"		"Hep G2: 24.5;NB-4: 17.7;RT4: 10.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 6.6"	"Lineage enriched"	"Detected in single"	10	"T-cells: 6.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"						"unprognostic (2.40e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.87e-2)"	"unprognostic (7.06e-2)"	"unprognostic (7.08e-3)"	"prognostic unfavourable (9.29e-4)"	"unprognostic (1.53e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.21e-1)"	"prognostic unfavourable (2.73e-4)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (9.19e-8)"	"unprognostic (1.39e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.82e-1)"	5.6	0.1	0.4	23.3	0.9	1.5	0.4	0.3	0.4	7.1	5.5	0.3	0.3	4.4	3.9	1.5	11.8	2.0	48.5	1.5	0.4	0.2	7.1	17.2	36.8	16.3	0.4	0.3	1.5	1.9	0.0	0.3	0.9	1.3	2.0	7.8	0.4	4.0	0.3	0.5	4.3	18.2	1.0	1.3	0.5	2.8	1.6	0.4	1.8	0.5	18.3	50.9	19.6	2.5	0.3	0.6	0.0	0.3	0.0	6.6	0.3	0.3	1.0	0.5	0.6	2.3	4.7	0.6	0.3	1.4	0.1	0.5	2.7	0.4	0.8	3.2	0.0	0.5	0.1	6.1	1.0	0.6	1.0	0.1	2.0	24.5	1.8	3.4	0.3	7.3	1.3	1.4	1.7	0.0	0.2	3.8	0.4	0.2	0.2	17.7	1.2	0.6	0.5	6.3	0.7	0.1	10.8	0.4	0.3	0.2	1.0	0.6	0.9	3.5	1.8	2.3	3.1	5.2	0.5	0.7	2.0	1.4	3.6	2.4	4.8	0.0	0.3	0.0	0.1	0.1	6.6	0.2	2.7	1.4	0.3	0.3	0.4	0.3	0.0	0.0	0.2	0.6	1.0	0.3	0.4	0.9	0.3	0.4	0.4	0.2	0.4	0.3	1.3	0.4
CCL21	"6Ckine, CKb9, ECL, exodus-2, SCYA21, SLC, TCA4"	ENSG00000137077	"C-C motif chemokine ligand 21"	O00585	9	34709005-34710124	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 430.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 3.6;HL-60: 2.3;K-562: 3.8;RH-30: 2.4;U-937: 1.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"CAB005067, HPA051210"	Enhanced				"Secreted to blood"	770000	770000			"CAB005067: AB_2071925, HPA051210: "	"unprognostic (3.06e-3)"	"unprognostic (7.19e-3)"	"unprognostic (9.89e-2)"	"unprognostic (5.50e-2)"		"unprognostic (4.51e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.07e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.70e-1)"	"unprognostic (8.99e-3)"	"unprognostic (3.50e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.66e-2)"	"unprognostic (8.91e-2)"	24.4	6.5	0.3	83.5	0.4	0.0	18.0	0.3	0.4	13.6	25.5	0.4	5.9	3.7	26.8	23.7	80.1	23.0	23.2	18.8	0.3	0.0	19.6	11.0	30.5	430.9	0.3	0.3	13.8	3.3	0.0	0.4	7.4	0.5	9.4	11.9	0.7	96.9	4.1	4.7	7.6	71.2	10.6	0.3	35.9	10.7	5.5	0.3	2.3	91.0	44.8	181.2	15.7	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.3	0.0	0.4	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.0	0.7	2.3	0.3	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	1.2	0.8	0.0	0.9	2.4	0.6	0.0	0.0	0.3	0.5	1.0	0.0	0.0	0.0	0.0	1.5	0.0	0.2	0.5	0.0	0.8	0.0	0.8	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.3	0.4	0.3	0.0	0.3	0.3	0.5	0.3
CCL22	"A-152E5.1, ABCD-1, DC/B-CK, MDC, MGC34554, SCYA22, STCP-1"	ENSG00000102962	"C-C motif chemokine ligand 22"	O00626	16	57358772-57366190	"Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 89.8"	"Cell line enriched"	"Detected in some"	18	"HDLM-2: 32.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"								"Secreted to blood"						"unprognostic (2.67e-2)"	"unprognostic (7.68e-3)"	"prognostic favourable (2.98e-4)"	"prognostic favourable (2.23e-6)"	"unprognostic (8.87e-2)"	"prognostic favourable (9.17e-5)"	"unprognostic (1.20e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.15e-2)"	"unprognostic (7.71e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.88e-2)"	10.5	0.6	0.3	27.7	0.5	0.3	1.9	0.2	0.3	1.6	1.3	0.0	0.4	1.0	0.6	0.5	4.6	0.4	2.6	0.4	0.3	0.3	0.6	0.5	4.6	11.9	0.3	0.0	0.3	0.9	0.0	0.3	0.2	0.1	0.7	5.4	0.1	5.9	0.2	0.3	7.1	7.4	0.7	0.3	5.5	1.1	0.3	0.0	89.8	0.7	5.9	31.8	3.6	1.6	3.1	2.6	3.7	0.8	1.4	0.7	0.5	0.3	0.2	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.5	0.2	0.1	0.1	0.9	0.0	0.0	0.1	32.4	0.1	0.1	0.2	0.3	0.0	0.1	1.0	0.1	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.1	0.1	0.2	0.3	0.0	0.1	0.1	1.2	0.0	1.8	0.2	0.1	0.1	1.4	0.0	0.2	1.6	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	3.6	0.8	0.6	0.6	0.4	0.4	3.1	0.5	0.4	2.6	1.6	0.6	0.7	3.7	1.4	0.4	1.0	0.4	0.5	0.3	0.5	0.2	0.3	0.3	0.3	0.3	0.0	0.1	0.0
CCL23	"Ckb-8, CKb8, MIP-3, MPIF-1, SCYA23"	ENSG00000274736	"C-C motif chemokine ligand 23"	P55773	17	36013056-36017968	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	"Cytokine, Heparin-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 50.3"	"Group enriched"	"Detected in some"	4	"HEL: 12.6;THP-1: 26.9"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	173	"eosinophil: 50.3"	"Lineage enriched"	"Detected in single"	173	"granulocytes: 50.3"									HPA042015	Uncertain				"Secreted to blood"	57000	57000			"HPA042015: AB_10794039"	"unprognostic (1.65e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.50e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.20e-4)"	"unprognostic (2.17e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.05e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.35e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.95e-1)"	5.8	0.5	0.0	13.1	0.0	2.1	3.7	0.0	0.5	2.1	2.0	0.0	1.0	0.0	1.8	3.0	1.3	1.5	2.2	4.6	0.0		3.0	5.9	7.9	8.0	0.3	0.0	1.2	0.0	0.0	0.5	1.5	0.2	1.7	7.2	0.7	0.0	1.1	0.5	0.4	1.0	8.4	0.0	2.0	0.0	0.1	0.0	0.4	1.1	0.6	0.5	3.0	0.0	0.2	0.1	50.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	1.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.2	0.2	50.3	0.0	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0										
CCL24	"Ckb-6, eotaxin-2, MPIF-2, MPIF2, SCYA24"	ENSG00000106178	"C-C motif chemokine ligand 24"	O00175	7	75811665-75823356	"Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 33.1;lung: 23.3;lymphoid tissue: 63.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 8.8;EFO-21: 2.6;HMC-1: 2.7;RH-30: 3.4;U-2 OS: 9.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 67.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"intermediate monocyte: 3.3"	"Lineage enriched"	"Detected in single"	5	"monocytes: 3.3"	"Low region specificity"	"Detected in many"												"Secreted to blood"						"unprognostic (4.55e-2)"	"unprognostic (1.13e-1)"	"prognostic favourable (5.41e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.44e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.73e-2)"	8.2	0.5	0.3	5.7	0.3	0.0	0.8	0.3	0.3	0.6	12.2	0.3	0.2	9.4	0.4	0.6	1.0	0.4	1.1	0.5	0.3	0.3	0.6	3.8	23.3	21.2	0.3	0.2	0.6	0.4	0.0	0.4	0.3	0.3	0.5	33.1	0.6	0.6	0.5	0.4	0.7	26.8	0.5	0.3	63.3	1.0	1.0	0.2	1.2	0.5	0.9	2.8	13.4	0.7	0.0	0.6	0.0	3.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.1	0.0	8.8	0.2	2.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.4	0.7	0.2	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	3.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.3	0.0	0.0	9.3	0.0	0.5	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.5	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.2	0.3	0.2
CCL25	"Ckb15, SCYA25, TECK"	ENSG00000131142	"C-C motif chemokine ligand 25"	O15444	19	8052767-8062650	"Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	23	"intestine: 136.8;lymphoid tissue: 185.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.8;HEL: 4.9;NB-4: 3.8;REH: 10.1;RPMI-8226: 2.9;SH-SY5Y: 3.3"	"Group enriched"	"Detected in many"	5	"liver cancer: 25.4;stomach cancer: 33.5;testis cancer: 6.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"memory B-cell: 1.8;NK-cell: 7.0"	"Group enriched"	"Detected in many"	12	"B-cells: 1.8;NK-cells: 7.0"									HPA055883	Approved				"Secreted to blood"					"HPA055883: "	"unprognostic (9.22e-3)"	"unprognostic (3.13e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.87e-1)"	"unprognostic (9.30e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.27e-4)"	"unprognostic (6.43e-2)"	"unprognostic (3.86e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.17e-1)"	0.1	0.1	0.3	0.0	0.2	0.0	0.1	0.2	0.2	0.1	64.9	0.0	0.0	91.9	0.1	0.0	0.1	0.1	0.0	0.1	0.3	0.2	0.1	0.2	0.1	0.1	0.3	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	136.8	0.0	0.2	0.4	0.1	0.4	0.0	185.2	0.1	0.0	0.0	0.1	0.1	1.8	0.1	0.0	0.0	7.0	0.3	0.4	0.0	0.0	0.1	0.8	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.4	0.0	3.8	0.2	0.5	10.1	0.0	2.9	0.0	0.0	0.8	3.3	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	1.1	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.1	0.0	0.3	0.2	0.0	7.0	0.0	0.0	0.0	0.4	0.3	0.2	0.2	0.2	0.3	0.2	0.3	0.0	0.0	0.0
CCL26	"eotaxin-3, IMAC, MIP-4a, MIP-4alpha, SCYA26, TSC-1"	ENSG00000006606	"C-C motif chemokine ligand 26"	Q9Y258	7	75769533-75789896	"Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"ovary: 16.6;retina: 50.2"	"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 10.4;PC-3: 29.6;U-2 OS: 8.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 14.0"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	27	"intermediate monocyte: 2.7"	"Lineage enriched"	"Detected in single"	27	"monocytes: 2.7"					"Not detected"	"Not detected"								"Secreted to blood"						"unprognostic (1.14e-1)"	"unprognostic (4.17e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.18e-2)"	"unprognostic (6.17e-2)"	"unprognostic (3.02e-1)"	"unprognostic (8.71e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.05e-11)"	"unprognostic (2.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.73e-1)"	"unprognostic (6.29e-3)"	1.7	2.9	0.4	0.5	0.6	0.0	1.4	0.4	0.9	2.8	0.8	0.9	1.0	0.4	0.8	2.3	1.1	1.9	1.3	3.3	0.6	0.0	1.5	0.4	1.2	4.1	1.2	0.4	16.6	0.4	5.9	13.6	0.4	3.3	1.3	8.7	50.2	1.0	0.4	0.4	1.4	0.7	1.6	0.8	0.4	0.6	1.5	0.6	0.8	0.8	0.8	0.9	1.0	3.2	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.1	6.7	0.0	0.0	0.7	0.9	0.0	0.3	3.1	2.7	5.7	0.3	1.9	0.0	4.6	2.6	1.2	0.1	0.0	3.8	0.0	0.6	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.3	10.4	0.1	0.0	5.1	0.0	2.0	0.7	0.0	0.0	6.4	29.6	0.0	0.6	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.2	5.0	8.4	2.7	1.7	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.4	0.9	0.6	0.0	1.2	0.4	3.3	0.6
CCL27	"ALP, CTACK, CTAK, ESkine, ILC, PESKY, SCYA27, skinkine"	ENSG00000213927	"C-C motif chemokine ligand 27"	Q9Y4X3	9	34661880-34664048	"Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"skin 1: 96.5"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.5;HAP1: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.0"	"Group enriched"	"Detected in many"	15	"B-cells: 1.0;T-cells: 2.0"					"Not detected"	"Not detected"			HPA073848	Enhanced				"Secreted to blood"					"HPA073848: "																		0.1	0.0	0.1	0.1	0.1	0.1	5.9	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.6	0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	2.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	96.5	0.1	0.1	0.1	0.1	0.0	0.1	0.1	8.0	0.1	0.1	0.1	0.1	0.1	1.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.1	5.5	1.8	1.6	0.5	0.0	0.0	0.5	0.0	0.9	0.0	0.3	0.1	0.0	2.1	3.5	0.0	2.4	2.1	0.0	0.0	1.8	0.8	0.7	0.0	0.0	3.0	1.9	0.6	0.0	0.0	0.5	2.3	1.2	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.0	2.8	0.0	0.4	1.6	0.0	0.0	0.2	1.6	0.0	0.0	2.5	2.0	2.0	0.0	0.3	1.0	0.1	0.9	0.4	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CCL3	"G0S19-1, LD78ALPHA, MIP-1-alpha, SCYA3"	ENSG00000277632	"C-C motif chemokine ligand 3"	P10147	17	36088256-36090169	"Cancer-related genes, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 35.7;lymphoid tissue: 18.0"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 26.7;U-266/70: 45.9;U-266/84: 116.1"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"gdT-cell: 10.2"	"Group enriched"	"Detected in many"	5	"B-cells: 4.5;granulocytes: 4.0;T-cells: 10.2"														"Secreted to blood"						"unprognostic (2.41e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.44e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.54e-1)"	"unprognostic (8.90e-2)"	"unprognostic (7.92e-3)"	"unprognostic (2.00e-1)"	"unprognostic (7.20e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.92e-3)"	"unprognostic (1.08e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.23e-2)"	5.3	4.3	0.0	5.7	1.6	35.7	2.4	0.5	6.0	0.9	0.9	11.6	0.0	0.8	0.7	1.4	0.4	0.4	3.5	3.4	0.0		0.5	7.9	15.1	5.8	0.0	0.0	2.0	0.4	1.8	0.0	5.7	3.7	0.5	0.9	1.7	1.0	0.2	1.2	0.0	0.8	1.1	0.0	18.0	0.2	3.7	0.0	1.8	0.8	0.5	1.8	2.3	0.0	4.5	0.2	4.0	0.8	1.1	10.2	4.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	26.7	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.1	45.9	116.1	0.0	0.2	0.0	0.0	0.1	0.8	4.0	10.2	0.5	0.3	1.4	0.3	2.8	0.2	4.5	0.0	3.0	4.0	1.1	0.5	0.0	0.0	4.6										
CCL3L1	"CCL3L3, D17S1718, G0S19-2, LD78BETA, MGC12815, SCYA3L, SCYA3L1"	ENSG00000276085	"C-C motif chemokine ligand 3 like 1"	P16619	17	36194869-36196758	"Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 17.7;brain: 16.5"	"Group enriched"	"Detected in some"	38	"U-266/70: 22.3;U-266/84: 44.3"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in some"	5	"eosinophil: 7.7;neutrophil: 2.5"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 7.7"														"Secreted to blood"						"unprognostic (6.30e-2)"	"unprognostic (8.18e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.50e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.36e-2)"	"unprognostic (3.69e-1)"	"unprognostic (5.75e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.66e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.90e-2)"	"unprognostic (8.58e-2)"	0.4	0.1	0.0	3.5	2.2	17.7	0.2	0.0	9.0	0.7	0.4	16.5	0.0	0.4	0.6	0.6	0.1	0.2	1.9	0.1	0.0		0.6	2.7	4.0	0.9	0.0	0.1	1.2	0.3	0.1	0.0	3.0	4.4	0.9	0.3	1.9	2.3	0.4	0.1	0.1	0.6	0.3	0.2	2.7	0.3	2.5	0.0	1.3	0.3	0.6	0.7	0.9	0.0	0.0	0.1	7.7	0.1	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	22.3	44.3	0.5	0.0	0.0	0.0	0.3	0.1	7.7	0.9	0.0	0.6	0.0	0.0	0.6	0.1	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.1										
CCL4	"Act-2, AT744.1, LAG1, MIP-1-beta, SCYA4"	ENSG00000275302	"C-C motif chemokine ligand 4"	P13236	17	36103590-36105621	"Cancer-related genes, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"blood: 69.3;lung: 23.1;lymphoid tissue: 20.8"	"Group enriched"	"Detected in some"	23	"Karpas-707: 5.1;U-266/70: 11.2;U-266/84: 5.4"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in many"	5	"gdT-cell: 69.3;MAIT T-cell: 21.8;memory CD8 T-cell: 40.6;naive CD8 T-cell: 30.5"	"Lineage enriched"	"Detected in many"	17	"T-cells: 69.3"									CAB007805	Approved				"Secreted to blood"					"CAB007805: AB_598177"	"unprognostic (6.03e-2)"	"unprognostic (2.48e-2)"	"prognostic favourable (3.54e-4)"	"prognostic favourable (1.97e-5)"	"unprognostic (2.06e-1)"	"unprognostic (7.02e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.69e-1)"	"prognostic favourable (3.97e-4)"	"unprognostic (3.45e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavourable (1.68e-4)"	"unprognostic (3.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.18e-2)"	2.3	2.6	0.0	3.7	0.4	9.3	5.7	0.1	3.6	0.9	2.9	1.4	0.5	0.2	1.6	0.8	1.7	1.6	4.4	3.8	0.0		1.3	5.7	23.1	20.8	1.1	0.0	3.4	0.9	0.0	0.2	4.3	0.9	1.1	1.0	3.9	1.6	1.6	0.5	0.0	0.9	1.4	1.5	10.4	2.3	0.3	0.0	1.0	1.6	2.0	4.3	1.9	0.8	1.8	0.4	4.0	0.6	3.0	69.3	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	5.4	0.3	0.0	0.0	0.0	1.7	0.2	4.0	69.3	0.0	21.8	0.9	7.7	40.6	0.1	1.8	2.3	30.5	1.6	3.0	0.6	0.4	0.0	11.6										
CCL4L2		ENSG00000276070	"C-C motif chemokine ligand 4 like 2"	Q8NHW4	17	36210924-36212878	"Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 41.8;bone marrow: 18.7;lung: 15.2"	"Group enriched"	"Detected in some"	4	"Daudi: 5.6;HMC-1: 8.0;U-266/70: 12.4"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in many"	7	"eosinophil: 41.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 41.8"														"Secreted to blood"						"unprognostic (1.79e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.07e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.08e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.99e-3)"	0.8	2.4	0.0	4.5	0.6	18.7	8.0	0.3	4.6	0.9	0.4	2.3	0.0	0.6	0.3	0.3	0.1	0.0	4.5	2.1	0.0		0.7	5.0	15.2	8.1	0.6	0.3	0.1	0.1	1.0	0.0	1.0	0.5	0.7	0.8	1.0	1.6	0.0	0.0	0.0	0.5	0.5	0.0	2.6	0.0	0.4	0.4	0.3	0.0	0.9	1.8	1.9	0.0	0.0	0.0	41.8	0.1	0.3	5.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	12.4	1.9	1.0	0.0	0.1	0.0	0.2	0.1	41.8	5.6	0.0	1.3	0.0	0.2	3.2	0.0	0.0	0.0	3.3	6.3	0.3	0.0	0.0	0.0	1.5										
CCL8	"HC14, MCP-2, SCYA8"	ENSG00000108700	"C-C motif chemokine ligand 8"	P80075	17	34319036-34321402	"Cancer-related genes, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	"Cytokine, Heparin-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 19.7"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.9;BJ hTERT+ SV40 Large T+ RasG12V: 1.8;EFO-21: 4.0;HSkMC: 6.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	8	"classical monocyte: 5.8"	"Lineage enriched"	"Detected in single"	8	"monocytes: 5.8"					"Low region specificity"	"Detected in all"								"Secreted to blood"						"unprognostic (7.51e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.90e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.65e-1)"	"unprognostic (9.97e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavourable (1.05e-7)"	"unprognostic (1.39e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.41e-2)"	10.6	2.8	1.0	7.2	1.2	0.2	4.4	0.6	1.6	0.8	12.0	1.4	1.1	6.9	3.4	3.8	1.2	2.9	3.7	2.4	0.8	0.7	2.8	2.1	8.4	1.3	0.8	0.9	5.3	0.8	6.0	1.6	19.7	1.1	1.5	8.0	5.0	1.1	2.9	1.5	1.3	13.1	4.1	2.4	3.1	1.9	1.6	0.2	2.1	3.0	4.0	2.7	4.4	0.8	0.7	0.2	0.0	5.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.9	0.5	0.1	0.0	1.9	0.0	1.8	0.0	0.0	0.0	4.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	1.2	0.6	1.6	0.8	0.7	0.8	0.9	1.1	0.2
CD14		ENSG00000170458	"CD14 molecule"	P08571	5	140631728-140633701	"Cancer-related genes, CD markers, Plasma proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 189.4;liver: 165.8"	"Cell line enhanced"	"Detected in many"		"A549: 8.9;CACO-2: 13.6;SiHa: 16.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 189.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 52.3;monocytes: 189.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001887, HPA002127, CAB033631, CAB072865, CAB072866"	Enhanced		Supported	Vesicles	"Secreted to blood"	15000000000	15000000000	Vesicles		"CAB033631: AB_781932, CAB072865: , CAB072866: , HPA001887: AB_1078442, HPA002127: AB_1078440"	"unprognostic (1.92e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.42e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.71e-3)"	"unprognostic (4.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavourable (6.80e-5)"	"unprognostic (1.20e-2)"	"unprognostic (6.87e-3)"	"unprognostic (8.12e-2)"	"unprognostic (6.92e-2)"	27.9	44.1	9.0	42.7	25.2	9.8	11.7	3.5	8.9	5.6	10.0	6.0	1.8	5.4	5.6	24.0	4.5	12.0	14.6	18.9	11.7	7.4	12.7	165.8	23.8	34.7	21.6	2.9	14.2	5.3	4.3	10.1	37.3	18.9	8.5	9.2	14.6	28.5	5.8	10.2	3.5	12.1	21.4	18.2	35.5	6.6	6.5	17.3	2.2	7.9	5.8	6.6	15.9	3.8	0.5	23.6	52.3	189.4	0.2	0.4	124.2	0.1	8.9	0.1	0.5	1.2	0.3	0.4	0.8	4.1	1.3	1.6	13.6	2.1	0.4	0.6	4.9	3.8	0.0	1.6	0.2	0.1	0.9	0.3	0.5	1.8	4.8	1.0	0.4	3.9	0.2	0.2	1.3	0.0	0.2	0.2	1.2	0.3	0.0	0.5	0.2	0.3	0.3	0.4	1.1	0.2	0.0	2.4	1.0	16.3	0.4	0.5	0.3	1.7	0.6	0.2	0.3	1.5	1.2	0.7	0.9	0.5	0.4	0.4	0.1	0.4	189.4	1.0	0.3	36.6	0.4	0.5	0.2	0.2	23.6	0.1	0.3	0.2	52.3	0.2	4.8	1.3	0.1	124.2	9.0	25.2	3.5	8.9	11.7	7.4	21.6	2.9	18.9	17.3
CD5L	"API6, Spalpha"	ENSG00000073754	"CD5 molecule like"	O43866	1	157830914-157898256	"Plasma proteins, Predicted secreted proteins"	"Apoptosis, Immunity, Inflammatory response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"lymphoid tissue: 178.3"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.1;Karpas-707: 1.9;REH: 2.0;RH-30: 1.2;U-266/70: 3.5"	"Cancer enriched"	"Detected in some"	5	"liver cancer: 4.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.2"	"Lineage enriched"	"Detected in single"	13	"monocytes: 1.2"	"Not detected"	"Not detected"							"HPA065686, HPA068384"	Enhanced				"Secreted to blood"	6800000000	6800000000			"HPA065686: AB_2685532, HPA068384: AB_2685979"		"unprognostic (2.96e-1)"		"unprognostic (2.90e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.94e-1)"	"prognostic favourable (8.88e-5)"	"unprognostic (1.73e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.56e-1)"		"unprognostic (5.95e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.63e-1)"		0.2	0.0	0.1	0.1	0.1	2.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.1	21.3	0.2	2.6	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.1	178.3	0.0	0.1	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.8	0.0	0.0	0.2	0.0	0.0	0.0	1.9	0.0	0.0	0.5	0.0	0.8	0.0	2.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	3.5	0.0	0.2	0.2	0.3	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1
CDSN	D6S586E	ENSG00000204539	Corneodesmosin		6	31115090-31120446	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"placenta: 19.2;skin 1: 109.3;tongue: 29.7"	"Cell line enriched"	"Detected in single"	7	"A-431: 5.8"	"Group enriched"	"Detected in some"	8	"head and neck cancer: 2.4;melanoma: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"amygdala: 1.0;cerebral cortex: 1.5;hippocampal formation: 1.0"	"Low region specificity"	"Detected in some"			"HPA044730, HPA054184"	Enhanced				"Secreted in other tissues"					"HPA044730: AB_10964923, HPA054184: AB_2682409"	"unprognostic (1.46e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.20e-1)"		"unprognostic (1.85e-1)"	"unprognostic (3.44e-2)"		"unprognostic (8.80e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.92e-4)"	"unprognostic (3.92e-3)"		"unprognostic (1.74e-4)"	"unprognostic (6.34e-2)"		"unprognostic (2.75e-1)"	"unprognostic (2.22e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	109.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	29.7	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CEACAM16	DFNA4B	ENSG00000213892	"Carcinoembryonic antigen related cell adhesion molecule 16"	Q2WEN9	19	44699151-44710714	"Disease related genes, Predicted secreted proteins"			"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 1.9;pancreas: 7.0"	"Cell line enhanced"	"Detected in some"		"A549: 1.2;RH-30: 1.5;T-47d: 2.7;U-266/70: 5.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA045075	Uncertain				"Secreted in other tissues"					"HPA045075: AB_10959617"	"unprognostic (1.27e-1)"	"unprognostic (3.73e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.72e-1)"	"unprognostic (1.42e-2)"	"unprognostic (7.76e-2)"	"unprognostic (3.59e-2)"		"unprognostic (7.81e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.05e-1)"		"unprognostic (1.06e-1)"	"unprognostic (1.86e-1)"		"unprognostic (7.94e-2)"	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1			0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0		0.0	7.0	0.0	1.1	0.0		0.0	0.0		0.1	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.2			0.0		1.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.7	0.0	0.0	0.0	0.0	5.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0										
CEL	"BSSL, MODY8"	ENSG00000170835	"Carboxyl ester lipase"		9	133061978-133071861	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in some"	348	"pancreas: 1584.8"	"Cell line enhanced"	"Detected in many"		"HMC-1: 8.4"	"Cancer enriched"	"Detected in many"	29	"pancreatic cancer: 469.3"	"Region enriched"	"Detected in single"	9	"cerebral cortex: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA008023, HPA052701"	Enhanced				"Secreted to digestive system"					"HPA008023: AB_1846509, HPA052701: AB_2681921"	"prognostic unfavourable (4.14e-4)"	"unprognostic (2.30e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.26e-3)"	"unprognostic (2.98e-1)"	"unprognostic (4.41e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.02e-1)"	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	2.3	0.2	0.2	0.2	0.2	0.1	0.2	2.9	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	3.5	0.2	0.2	0.2	0.8	1584.8	0.0	4.5	0.2	0.2	0.2	0.0	0.2	0.2	4.5	0.2	0.0	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.2	1.6	0.2	0.2	0.2	0.0	0.0	0.4	0.0	0.3	0.0	0.4	1.1	4.4	2.7	1.5	1.0	4.5	0.9	0.5	0.6	0.8	1.3	0.8	1.3	2.2	0.8	3.0	1.0	8.2	0.3	2.6	1.6	2.2	0.6	2.9	0.6	0.9	8.4	2.2	5.4	0.8	0.5	0.8	1.3	1.1	0.8	1.8	1.3	4.4	7.3	1.4	2.4	1.3	0.9	0.5	3.8	7.6	1.9	1.0	0.9	0.4	1.4	4.0	0.6	2.1	2.8	2.5	0.6	0.6	4.5	1.0	0.0	2.1	1.1	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.2	0.2	2.3	0.2	0.0	0.2	0.2	0.2	0.2
CELA2A	ELA2A	ENSG00000142615	"Chymotrypsin like elastase family member 2A"	P08217	1	15456728-15472091	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1559	"pancreas: 2376.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.1;HEL: 1.2;HL-60: 1.0;HMC-1: 4.9;K-562: 1.1;U-2 OS: 1.6"	"Cancer enriched"	"Detected in single"	3819	"pancreatic cancer: 463.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	15	"neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.5"														"Secreted to digestive system"						"unprognostic (9.78e-2)"	"unprognostic (3.33e-2)"		"unprognostic (5.60e-2)"	"unprognostic (5.27e-2)"	"unprognostic (3.63e-3)"		"unprognostic (2.35e-1)"	"unprognostic (4.14e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.94e-9)"	"unprognostic (4.10e-2)"		"unprognostic (3.42e-1)"	"unprognostic (3.55e-2)"	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.8	2376.3	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.1	0.7	1.2	0.0	0.0	0.0	1.0	4.9	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CER1	DAND4	ENSG00000147869	"Cerberus 1, DAN family BMP antagonist"	O95813	9	14719724-14722717	"Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 2.5;epididymis: 5.5"	"Group enriched"	"Detected in some"	9	"HEL: 6.3;NTERA-2: 11.5;SCLC-21H: 4.4"	"Cancer enriched"	"Detected in single"	82	"testis cancer: 17.3"	"Group enriched"	"Detected in many"	8	"basal ganglia: 2.5;cerebellum: 2.2;cerebral cortex: 1.1;pons and medulla: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA019917	Uncertain				"Secreted - unknown location"					"HPA019917: AB_1846539"					"unprognostic (2.98e-2)"						"unprognostic (5.36e-2)"				"unprognostic (5.99e-2)"			0.1	0.0	0.1	0.1	2.5	0.1	0.2	2.2	1.1	0.1	0.2	0.1	0.1	0.7	0.7	5.5	0.1	0.0	0.4	0.2	0.1	0.2	1.2	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.2	0.1	0.1	1.5	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.9	0.5	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	2.2	1.1	0.1	0.2	0.1	0.1	1.5	0.1
CFC1	"CRYPTIC, HTX2"	ENSG00000136698	"Cripto, FRL-1, cryptic family 1"	P0CG37	2	130592168-130599575	"Disease related genes, Predicted secreted proteins"	Gastrulation	"Developmental protein"	"Disease mutation, Heterotaxy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	12	"brain: 13.0;pancreas: 21.9;pituitary gland: 22.4;prostate: 7.6;stomach 1: 9.4"	"Group enriched"	"Detected in some"	21	"RPMI-8226: 19.1;SCLC-21H: 10.9"	"Cancer enriched"	"Detected in some"	7	"pancreatic cancer: 4.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA041773	Uncertain				"Secreted - unknown location"					"HPA041773: "					"unprognostic (6.65e-2)"						"unprognostic (2.19e-3)"	"unprognostic (1.11e-3)"			"unprognostic (2.01e-1)"			0.1	0.1	0.9	0.0	2.1	0.0	0.0	2.3	1.1	0.1	0.5			0.1	0.1	0.1	0.0	1.2	0.1	0.3	0.2	13.0	0.1	0.0	0.0	0.0	2.5		0.1	21.9	0.0	22.4	0.0		7.6	0.3		0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	9.4	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1										
CFC1B		ENSG00000152093	"Cripto, FRL-1, cryptic family 1B"	P0CG36	2	130521197-130528604	"Predicted secreted proteins"	Gastrulation	"Developmental protein"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	9	"brain: 3.4;pancreas: 13.0;pituitary gland: 8.1"	"Group enriched"	"Detected in some"	9	"SCLC-21H: 2.2;U-2 OS: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA041773	Approved				"Secreted - unknown location"					"HPA041773: "																		0.3	0.1	0.4	0.1	1.6	0.1	0.1	1.5	0.5	0.1	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.3	0.1	0.3	0.1	3.4	0.2	0.1	0.2	0.1	0.6	0.1	0.1	13.0	0.1	8.1	0.1	1.0	0.8	0.7	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.4	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	1.6	1.5	0.5	0.1	3.4	0.6	0.1	1.0	0.1
CFD	"ADN, DF, PFD"	ENSG00000197766	"Complement factor D"	P00746	19	859643-863630	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement alternate pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"ASC diff: 39.8;THP-1: 56.5"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 125.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 125.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"	8000000000	8000000000				"unprognostic (3.00e-2)"	"unprognostic (6.09e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.22e-3)"	"unprognostic (6.92e-2)"	"unprognostic (5.28e-2)"	"unprognostic (8.11e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.46e-2)"	"unprognostic (8.10e-2)"	"prognostic favourable (1.77e-4)"	"unprognostic (9.53e-2)"	"prognostic unfavourable (7.09e-4)"	"unprognostic (1.23e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.92e-2)"	"unprognostic (9.75e-2)"	161.3	4.6	0.0	16.4	0.0	5.6	96.7	0.0	1.7	44.2	35.2	0.2	42.2	10.9	8.9	89.8	54.1	15.6	59.0	102.0	0.0	0.0	1.9	2.3	34.0	6.2	0.0	0.0	13.7	6.0	1.7	0.1	20.2	0.1	102.0	4.3	3.4	22.7	15.1	40.5	35.8	16.5	97.3	0.1	3.7	19.7	33.6	0.0	0.8	52.6	55.6	9.0	83.7	130.3	0.6	5.6	125.0	25.8	0.1	1.0	10.4	0.7	1.9	0.0	0.3	39.8	6.2	2.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.5	0.2	0.0	0.0	1.1	2.8	0.0	1.7	0.6	0.6	0.3	1.0	6.3	0.0	0.0	0.0	0.0	2.3	0.1	0.0	0.9	0.0	8.9	0.1	2.8	0.2	0.0	0.9	0.0	0.1	0.3	0.3	0.8	0.2	0.0	1.1	56.5	0.0	0.0	0.9	0.4	0.1	1.7	0.7	0.0	0.0	3.3	0.0	125.0	18.2	58.8	0.7	20.1	1.0	0.6	0.5	0.9	5.6	0.2	0.7	0.8	43.2	0.1	25.8	0.5	0.3	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
CFH	"ARMD4, ARMS1, FHL1, HF, HF1, HF2, HUS"	ENSG00000000971	"Complement factor H"	P08603	1	196651878-196747504	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Host-virus interaction, Immunity, Innate immunity"		"Age-related macular degeneration, Cancer-related genes, Disease mutation, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 295.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 25.2;HHSteC: 31.8;HSkMC: 31.0;RH-30: 23.2;RT4: 56.3"	"Cancer enriched"	"Detected in all"	9	"liver cancer: 151.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 16.5"	"Lineage enriched"	"Detected in single"	27	"T-cells: 16.5"									"CAB016385, CAB016769, HPA038922, HPA049176, HPA053326"	Supported		Approved	Vesicles	"Secreted to blood"	110000000000	110000000000	Vesicles		"CAB016385: AB_627572, CAB016769: , HPA038922: , HPA049176: , HPA053326: "	"unprognostic (2.40e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.39e-2)"	"unprognostic (5.40e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.75e-3)"	"unprognostic (7.40e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavourable (1.92e-6)"	"unprognostic (6.50e-3)"	"unprognostic (4.49e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.37e-1)"	28.6	5.5	1.6	3.7	3.8	0.1	8.8	2.6	2.7	10.4	9.1	1.0	3.9	3.7	2.5	8.7	15.2	3.4	17.0	47.3	2.0	1.2	7.0	295.2	11.0	10.3	5.3	1.7	40.9	1.9	1.7	4.3	5.1	5.3	10.3	10.4	6.3	19.0	3.3	10.0	11.5	8.1	12.6	4.2	3.3	5.8	6.4	2.9	0.7	22.0	22.8	5.8	17.2	16.8	0.0	0.1	0.6	0.1	0.0	16.5	1.0	0.0	16.1	0.0	0.0	25.2	14.3	0.0	6.5	15.9	0.9	3.5	0.0	3.0	0.0	2.4	0.0	0.5	0.0	5.9	0.6	0.3	0.0	4.8	19.1	0.0	31.8	0.2	0.0	31.0	0.1	4.7	2.0	19.8	18.1	0.6	22.5	0.0	0.1	0.0	0.1	0.0	0.0	23.2	5.1	0.0	56.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	19.2	0.2	0.2	0.2	0.2	0.0	0.0	3.4	0.0	1.4	0.0	0.1	0.0	1.8	0.0	16.5	0.0	6.0	3.5	0.1	0.0	0.4	1.4	0.6	0.0	0.0	0.0	0.0	1.0	1.6	3.8	2.6	2.7	2.0	1.2	5.3	1.7	5.3	2.9
CFHR1	"CFHL, CFHL1, CFHL1P, CFHR1P, FHR1, H36-1, H36-2, HFL1, HFL2"	ENSG00000244414	"Complement factor H related 1"	Q03591	1	196819757-196832189	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	174	"liver: 218.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 2.6;HeLa: 3.1;HL-60: 4.7;U-266/70: 6.2"	"Cancer enriched"	"Detected in single"	798	"liver cancer: 182.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA038915, HPA038922, HPA040726"	Supported		Approved	Vesicles	"Secreted to blood"	15000000000	15000000000	Vesicles		"HPA038915: , HPA038922: , HPA040726: "	"unprognostic (2.28e-1)"	"unprognostic (3.18e-1)"			"unprognostic (3.50e-2)"	"unprognostic (1.88e-2)"	"prognostic favourable (8.71e-6)"	"unprognostic (3.02e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.48e-2)"		"unprognostic (7.21e-4)"	"unprognostic (7.01e-4)"	"unprognostic (1.13e-1)"		"unprognostic (6.41e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	218.9	0.0	0.5	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.0	0.3	0.2	2.6	1.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.2	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	1.6	3.1	0.2	0.2	4.7	0.8	0.1	0.0	0.0	0.0	0.1	0.3	2.3	0.8	0.0	1.4	0.0	0.8	0.0	0.8	2.0	0.0	0.0	0.3	0.0	0.1	0.9	0.0	0.2	0.4	0.0	1.4	0.9	0.4	0.2	0.2	6.2	0.0	1.1	0.0	0.4	0.9	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1										
CFHR2	"CFHL2, FHR2, HFL3"	ENSG00000080910	"Complement factor H related 2"	P36980	1	196943772-196959226	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1462	"liver: 146.2"	"Cell line enhanced"	"Detected in some"		"HEL: 2.8;TIME: 1.2"	"Cancer enriched"	"Detected in single"	175	"liver cancer: 8.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA038915, HPA040726, HPA049813"	Supported				"Secreted to blood"	5700000000	5700000000			"HPA038915: , HPA040726: , HPA049813: "							"unprognostic (1.25e-2)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	146.2	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CFHR3	"CFHL3, DOWN16, FHR-3, FHR3, HLF4"	ENSG00000116785	"Complement factor H related 3"	Q02985	1	196774795-196795406	"Plasma proteins, Predicted secreted proteins"			"Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	171	"liver: 121.9"	"Group enriched"	"Detected in some"	5	"NTERA-2: 3.3;T-47d: 6.8;U-266/70: 12.4"	"Cancer enriched"	"Detected in single"	80	"liver cancer: 27.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to blood"	3800000000	3800000000				"unprognostic (1.73e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.16e-2)"	"unprognostic (6.77e-2)"	"unprognostic (4.46e-1)"	"unprognostic (4.20e-3)"	"prognostic favourable (2.86e-5)"	"unprognostic (1.78e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.19e-2)"	"unprognostic (6.11e-3)"	"unprognostic (2.06e-10)"	"unprognostic (2.67e-4)"	"unprognostic (3.00e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.32e-1)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	121.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.7	0.4	0.0	0.6	0.2	0.1	1.4	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.2	0.1	0.5	0.0	0.0	0.0	0.3	0.9	0.0	0.1	0.0	0.0	3.3	0.0	0.0	0.4	0.5	0.0	1.3	0.0	0.0	0.0	0.7	0.0	6.8	0.0	0.0	0.1	0.3	0.3	0.0	12.4	0.2	0.1	0.0	0.0	0.0	0.7	0.0	0.2	0.3	0.4	0.6	0.1	0.5	0.3	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CFHR5	"CFHL5, FHR-5, FHR5"	ENSG00000134389	"Complement factor H related 5"	Q9BXR6	1	196977556-197009674	"Disease related genes, Plasma proteins, Predicted secreted proteins"			"Disease mutation, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	241	"liver: 85.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	396	"liver cancer: 57.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA038915, HPA040726"	Supported				"Secreted to blood"	1700000000	1700000000			"HPA038915: , HPA040726: "							"unprognostic (9.12e-3)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.7	0.6	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CFI	"C3b-INA, FI, IF, KAF"	ENSG00000205403	"Complement factor I"	P05156	4	109740694-109802179	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease mutation, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"kidney: 90.7;liver: 198.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 28.9;Hep G2: 45.8;HSkMC: 19.0;RPTEC TERT1: 51.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA001143, CAB016777, HPA024061"	Supported				"Secreted to blood"	11000000000	11000000000			"CAB016777: , HPA001143: AB_1078555, HPA024061: AB_1847129"	"unprognostic (1.04e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.42e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.61e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavourable (6.06e-4)"	9.5	13.2	1.5	2.3	1.4	0.0	3.9	0.9	2.5	5.0	4.1	1.1	2.9	4.9	5.0	12.0	4.4	9.7	9.3	6.2	1.6	0.8	90.7	198.4	7.2	3.1	1.8	0.7	10.6	7.6	0.5	3.8	3.2	2.6	3.9	0.7	6.8	3.6	3.6	1.4	0.5	4.6	3.0	3.0	7.8	1.7	3.6	1.6	0.5	5.3	2.3	1.4	3.8	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.6	0.7	0.0	0.0	0.0	28.9	0.0	9.2	0.0	0.0	0.0	0.0	0.0	9.7	0.3	0.0	0.1	45.8	2.0	0.0	0.0	19.0	0.0	0.0	0.0	1.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	51.2	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	5.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.4	0.9	2.5	1.6	0.8	1.8	0.7	2.6	1.6
CGA	"FSHA, GPHa, GPHA1, HCG, LHA, TSHA"	ENSG00000135346	"Glycoprotein hormones, alpha polypeptide"	P01215	6	87085498-87095406	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	62	"pituitary gland: 398.8;placenta: 489.3"	"Cell line enriched"	"Detected in some"	19	"BEWO: 105.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 13.0"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	11	"hypothalamus: 69.2"	"CAB023350, HPA029698"	Enhanced				"Secreted to blood"					"CAB023350: AB_617281, HPA029698: "	"unprognostic (1.66e-1)"	"unprognostic (2.10e-1)"		"unprognostic (3.22e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.69e-2)"	"unprognostic (3.17e-1)"			"unprognostic (7.04e-3)"	"unprognostic (1.51e-1)"		"unprognostic (2.85e-1)"	"unprognostic (4.32e-2)"	"unprognostic (8.32e-2)"	"unprognostic (9.15e-3)"	0.1	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	3.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	398.8	489.3	0.2	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.6	0.0	0.1	7.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	2.2	1.9	3.5	1.5	1.1	2.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	105.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	2.3	1.1	1.0	1.7	0.5	0.7	1.3	0.8	1.4	0.6	2.2	1.2	2.1	3.5	1.1	1.5	1.9	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0
CGB3	CGB	ENSG00000104827	"Chorionic gonadotropin beta subunit 3"	P0DN86	19	49022869-49024333	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"pituitary gland: 6.7;placenta: 15.0"	"Cell line enriched"	"Detected in some"	20	"BEWO: 38.8"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.9;testis cancer: 4.2"					"Cell type enhanced"	"Detected in single"		"T-reg: 1.0"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.0"									"CAB000042, CAB010884, HPA038925, HPA038934"	Enhanced		Approved	Cytosol	"Secreted to blood"			Cytosol		"CAB000042: , CAB010884: AB_259037, HPA038925: , HPA038934: "									"unprognostic (1.39e-1)"		"unprognostic (7.88e-2)"				"unprognostic (6.92e-2)"		"unprognostic (1.04e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	3.2	0.0	6.7	15.0		0.0	0.0		0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.0			0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	38.8	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.0	1.9	0.7	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0										
CGB5	HCG	ENSG00000189052	"Chorionic gonadotropin beta subunit 5"	P0DN86	19	49043884-49045311	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	8	"placenta: 105.2"	"Group enriched"	"Detected in some"	24	"BEWO: 45.8;U-251 MG: 20.8"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA038925, HPA038934"	Supported		Approved	Cytosol	"Secreted to blood"			Cytosol		"HPA038925: , HPA038934: "		"unprognostic (1.38e-1)"				"unprognostic (1.68e-1)"					"unprognostic (1.51e-3)"			"prognostic unfavourable (1.18e-5)"	"unprognostic (1.07e-1)"		"prognostic unfavourable (9.47e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.1	12.7	105.2	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.4	0.2	0.0	0.0	0.0	0.0	45.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	20.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CGB7	CG-beta-a	ENSG00000196337	"Chorionic gonadotropin beta subunit 7"	P0DN87	19	49054275-49058860	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"skin 1: 8.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 6.9;HaCaT: 5.6;HBEC3-KT: 4.7;hTCEpi: 6.8;U-251 MG: 10.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA038925, HPA038934"	Supported		Approved	Cytosol	"Secreted in other tissues"			Cytosol		"HPA038925: , HPA038934: "	"unprognostic (9.53e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.53e-1)"	"unprognostic (4.60e-5)"	"unprognostic (2.64e-1)"	"unprognostic (2.46e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.88e-2)"	"unprognostic (4.80e-2)"	"unprognostic (8.83e-4)"	"unprognostic (1.54e-1)"	"unprognostic (3.89e-8)"	"unprognostic (1.63e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.28e-2)"	0.3	0.2	0.3	0.3	0.3	0.0	0.8	0.3	1.5	1.7	0.3	0.3	3.7	0.3	1.2	0.5	4.0	1.0	2.0	2.0	0.4	0.2	1.0	0.3	0.8	0.3	0.3	0.3	0.9	2.5	0.0	2.7	3.7	1.3	4.6	0.0	0.8	1.3	3.9	6.4	8.1	0.3	0.3	0.3	0.3	0.0	1.5	0.3	0.3	0.9	2.2	0.3	2.4	2.7	0.2	0.0	0.0	0.0	0.0	0.3	0.0	3.1	0.8	0.2	1.5	0.0	0.2	6.9	0.6	0.0	1.4	1.2	1.2	2.6	0.0	0.1	1.3	5.6	0.1	4.7	0.5	0.1	0.3	0.0	0.0	0.0	0.3	0.0	0.3	0.4	6.8	0.4	0.7	0.0	0.0	0.2	1.3	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	3.9	0.1	0.1	1.4	0.1	0.1	1.0	0.1	0.2	2.2	2.3	0.0	10.2	0.3	0.4	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.3	0.3	1.5	0.4	0.2	0.3	0.3	1.3	0.3
CGB8		ENSG00000213030	"Chorionic gonadotropin beta subunit 8"	P0DN86	19	49047638-49049106	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	85	"pituitary gland: 7.0;placenta: 22.2"	"Group enriched"	"Detected in some"	7	"BEWO: 60.5;U-251 MG: 21.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 5.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA038925, HPA038934"	Supported		Approved	Cytosol	"Secreted to blood"			Cytosol		"HPA038925: , HPA038934: "		"unprognostic (3.35e-2)"				"unprognostic (1.72e-1)"					"unprognostic (7.44e-3)"				"unprognostic (4.70e-1)"		"unprognostic (1.67e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.1	7.0	22.2		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.3	0.0	0.0	0.0	0.0	60.5	0.0	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	1.2	2.5	0.2	21.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CHIT1	"CHI3, CHIT"	ENSG00000133063	"Chitinase 1"	Q13231	1	203212827-203273641	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"	"Carbohydrate metabolism, Chitin degradation, Polysaccharide degradation"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 99.9;lymphoid tissue: 106.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.7;LHCN-M2: 1.7;RH-30: 1.7;U-266/70: 2.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 31.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"neutrophil: 2.9;non-classical monocyte: 1.1"	"Group enriched"	"Detected in many"	4	"granulocytes: 2.9;monocytes: 1.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA010575, HPA074844"	Supported				"Secreted to blood"	58000000	58000000			"HPA010575: AB_1078512, HPA074844: "	"unprognostic (5.80e-3)"	"prognostic favourable (2.02e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.87e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.55e-2)"	"unprognostic (6.36e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.56e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.95e-1)"	99.9	0.2	0.2	0.4	0.3	26.7	5.5	0.1	0.3	5.9	0.6	0.5	0.1	0.0	2.5	0.2	0.3	0.1	0.2	0.6	0.2	0.1	0.1	0.4	22.1	106.5	0.4	0.1	1.4	1.1	0.0	0.2	0.4	0.5	0.6	0.5	0.3	0.3	0.1	0.1	0.3	0.7	0.2	9.4	4.3	0.1	0.1	0.1	2.3	0.9	0.2	0.5	0.1	0.3	0.5	0.2	2.9	1.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	2.7	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.7	0.2	0.0	0.0	0.1	0.2	0.0	1.7	0.9	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	2.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.9	0.0	1.1	0.2	0.0	1.3	0.2	0.3	0.1	0.3	0.2	0.1	0.4	0.1	0.5	0.1
CHRD		ENSG00000090539	Chordin	Q9H2X0	3	184380073-184390736	"Plasma proteins, Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.8;liver: 48.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 3.6;Hep G2: 15.0;MCF7: 3.2;U-2 OS: 5.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA035827	Approved				"Secreted in other tissues"	120000	120000			"HPA035827: AB_10669657"	"unprognostic (2.26e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.52e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.12e-2)"	"unprognostic (6.55e-2)"	"prognostic unfavourable (6.09e-7)"	"unprognostic (5.53e-3)"	"unprognostic (1.85e-1)"	"unprognostic (9.84e-2)"	"unprognostic (7.99e-3)"	8.9	6.2	8.9	3.1	6.4	0.4	4.2	32.8	15.9	13.0	2.9	2.4	1.8	2.7	14.9	6.4	3.2	5.7	3.9	4.6	6.5	1.1	10.1	48.3	3.0	2.2	1.8	7.0	7.9	13.9	0.8	2.5	3.8	4.7	4.2	1.6	2.6	2.0	8.3	4.9	3.2	3.0	7.0	2.9	4.6	3.4	1.2	1.8	0.0	3.2	2.3	0.9	3.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.1	0.1	1.9	0.5	0.0	0.3	0.2	3.6	0.0	0.0	1.4	0.4	0.0	2.3	0.0	0.0	0.0	1.0	0.0	0.1	15.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	2.0	2.5	0.0	0.0	0.9	0.0	0.1	0.1	0.1	1.9	0.0	0.0	0.0	5.2	0.0	0.5	0.0	0.5	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	6.4	32.8	15.9	6.5	1.1	1.8	7.0	4.7	1.8
CHRDL1	"CHL, MGC1, NRLN1"	ENSG00000101938	"Chordin like 1"	Q9BU40	X	110673856-110795819	"Disease related genes, Predicted secreted proteins"	"Differentiation, Neurogenesis, Osteogenesis"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	11	"ASC diff: 93.7;ASC TERT1: 128.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	24	"plasmacytoid DC: 2.5"	"Lineage enriched"	"Detected in single"	24	"dendritic cells: 2.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000226, HPA000250"	Approved				"Secreted in other tissues"	620000	620000			"HPA000226: AB_1078522, HPA000250: AB_1078521"	"unprognostic (5.13e-2)"	"unprognostic (6.31e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.26e-3)"	"unprognostic (1.42e-2)"	"unprognostic (4.89e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.56e-1)"	"prognostic unfavourable (2.36e-4)"	"unprognostic (4.75e-3)"	"unprognostic (7.91e-2)"	"unprognostic (5.01e-2)"	"prognostic unfavourable (2.23e-4)"	53.1	2.2	7.2	11.5	12.3	0.2	40.8	3.7	8.4	22.0	25.7	1.4	40.9	3.1	57.3	29.5	18.7	18.1	14.2	22.0	5.4	1.7	4.5	0.7	27.6	7.5	1.7	6.8	7.5	3.6	51.4	2.8	15.2	2.2	46.1	11.1	15.2	8.5	73.9	3.2	6.9	7.7	31.0	3.4	6.5	8.6	5.8	2.4	0.8	14.9	23.7	3.4	16.3	11.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	93.7	128.9	0.0	1.2	0.5	3.1	2.7	0.0	0.0	0.0	0.0	0.1	0.0	3.7	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.6	9.8	1.2	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	7.2	12.3	3.7	8.4	5.4	1.7	1.7	6.8	2.2	2.4
CHSY1	"CSS1, KIAA0990"	ENSG00000131873	"Chondroitin sulfate synthase 1"	Q86X52	15	101175723-101251932	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"		Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 72.5"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 68.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048902	Uncertain				"Secreted - unknown location"					"HPA048902: "	"unprognostic (7.28e-2)"	"unprognostic (6.39e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.60e-2)"	"unprognostic (9.51e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.02e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (6.33e-5)"	"unprognostic (3.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.91e-3)"	"unprognostic (5.58e-3)"	23.2	15.6	14.4	14.6	13.7	15.7	17.7	8.5	11.1	17.7	6.5	9.6	8.6	4.9	15.6	11.6	9.1	14.1	19.0	19.0	11.4	7.5	9.0	8.1	20.6	12.4	15.3	5.5	21.9	6.0	5.9	8.7	72.5	12.9	13.6	7.0	12.1	9.8	10.1	7.3	13.7	6.8	16.4	11.9	18.4	9.3	10.8	13.5	8.3	9.7	9.2	8.7	14.3	20.0	1.9	1.5	8.7	2.4	1.2	3.2	1.0	2.7	3.4	11.7	5.9	6.1	8.2	7.8	6.8	6.0	8.2	8.4	2.9	2.2	6.7	4.0	11.2	7.7	7.7	8.6	9.1	7.4	3.9	13.3	3.9	3.5	7.6	20.1	13.7	7.5	7.3	7.1	6.5	9.7	4.8	68.3	6.2	2.4	2.7	13.8	13.4	2.5	6.2	11.7	9.9	5.7	5.5	2.0	11.0	7.1	3.5	12.3	4.0	24.9	8.1	13.5	7.7	6.3	14.2	12.1	28.0	3.9	10.4	19.1	10.0	0.0	2.4	5.1	2.9	1.5	3.1	1.7	1.8	3.1	1.5	1.9	1.0	1.9	8.7	1.2	1.6	0.9	3.2	1.0	14.4	13.7	8.5	11.1	11.4	7.5	15.3	5.5	12.9	13.5
CILP	HsT18872	ENSG00000138615	"Cartilage intermediate layer protein"	O75339	15	65194758-65211488	"Disease related genes, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 7.1;ASC TERT1: 4.3;EFO-21: 1.8;HSkMC: 10.9"	"Cancer enhanced"	"Detected in many"		"breast cancer: 30.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA003195	Uncertain				"Secreted to extracellular matrix"	11000000	11000000			"HPA003195: AB_1078524"	"unprognostic (2.21e-2)"	"unprognostic (3.43e-2)"	"unprognostic (4.22e-2)"	"unprognostic (7.18e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.31e-13)"	"unprognostic (5.10e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavourable (2.24e-5)"	"unprognostic (4.68e-3)"	32.0	0.4	0.0	8.1	0.1	0.0	17.0	0.4	0.0	39.9	11.1	0.1	12.7	1.2	9.2	44.7	21.4	10.5	19.6	16.5	0.0	0.0	0.5	1.0	1.8	1.4	0.2	0.0	9.6	2.4	0.1	0.4	3.0	0.1	13.3	3.9	0.6	5.6	5.1	19.7	8.4	12.5	41.6	0.3	0.3	5.4	18.4	0.0	1.4	2.0	23.4	3.1	41.4	17.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	7.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.1	10.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0
CILP2	MGC45771	ENSG00000160161	"Cartilage intermediate layer protein 2"	Q8IUL8	19	19538248-19546659	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 9.4;testis: 10.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 8.7;HEK 293: 5.1;NB-4: 3.8;THP-1: 4.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	4	"naive CD4 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA041847	Uncertain				"Secreted to extracellular matrix"	11000000	11000000			"HPA041847: AB_10795599"	"unprognostic (6.51e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.42e-4)"	"prognostic unfavourable (3.22e-6)"	"unprognostic (4.81e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.31e-2)"	"unprognostic (4.13e-3)"	"unprognostic (4.48e-2)"	"prognostic unfavourable (2.50e-4)"	"unprognostic (5.09e-2)"	"unprognostic (1.41e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.59e-2)"	"unprognostic (3.19e-2)"	"unprognostic (3.12e-3)"	"unprognostic (1.36e-2)"	2.8	0.1	0.9	1.1	1.0	3.1	3.6	0.3	1.1	3.1	0.7	0.0	0.8	0.1	0.7	1.1	0.8	0.9	5.6	1.0	0.8	1.4	0.2	0.7	0.9	2.5	0.3	0.0	9.4	0.2	1.4	0.9	2.4	0.4	1.2	0.2	3.0	2.8	0.9	4.0	0.7	0.3	0.5	0.1	0.7	0.2	10.1	0.0	0.0	7.8	0.4	1.8	1.1	0.6	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.2	0.3	0.2	8.7	0.3	1.2	1.1	0.0	0.5	0.1	2.3	0.9	0.1	2.2	0.4	1.0	0.2	0.0	0.1	0.6	5.1	0.0	0.2	0.3	0.3	0.0	0.6	1.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.7	0.0	3.8	3.2	1.6	0.6	0.0	0.0	0.1	0.0	0.1	2.2	0.5	2.7	0.3	0.5	4.9	0.0	0.1	1.1	0.4	0.2	0.7	1.9	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	0.3	1.1	0.8	1.4	0.3	0.0	0.4	0.0
CLCA1	"CaCC, CLCRG1"	ENSG00000016490	"Chloride channel accessory 1"	A8K7I4	1	86468368-86500289	"Predicted secreted proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 242.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.5;K-562: 1.7;NB-4: 5.2;RPMI-8226: 5.6;SH-SY5Y: 4.0;U-2197: 3.3"	"Group enriched"	"Detected in some"	9	"colorectal cancer: 86.8;pancreatic cancer: 27.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA052787, HPA059301"	Enhanced				"Secreted to digestive system"	70000	70000			"HPA052787: AB_2681947, HPA059301: AB_2683971"			"prognostic favourable (2.98e-4)"								"unprognostic (3.42e-1)"			"unprognostic (8.61e-2)"	"unprognostic (1.06e-1)"			0.2	0.2	0.2	41.7	0.2	0.0	0.2	0.2	0.2	0.2	100.0	0.1	0.1	80.7	0.2	0.1	0.2	0.3	4.4	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.1	0.2	0.2	0.0	0.2	0.1	0.1	0.2	98.0	0.2	0.2	0.1	0.2	0.2	242.9	1.1	0.2	0.2	0.2	0.3	0.1	0.1	0.2	0.2	0.1	0.2	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.6	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.1
CLCF1	"BSF-3, BSF3, CISS2, CLC, NNT-1, NNT1, NR6"	ENSG00000175505	"Cardiotrophin like cytokine factor 1"	Q9UBD9	11	67364168-67374177	"Disease related genes, Predicted secreted proteins"		Cytokine	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SiHa: 26.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042444	Uncertain		Approved	"Nuclear bodies,Vesicles"	"Secreted to blood"			"Nuclear bodies, Vesicles"		"HPA042444: AB_10794527"	"unprognostic (2.68e-1)"	"unprognostic (7.87e-3)"	"unprognostic (6.21e-3)"	"unprognostic (2.62e-2)"	"prognostic unfavourable (9.91e-4)"	"unprognostic (1.61e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.47e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.37e-1)"	10.5	2.9	1.2	11.6	1.5	10.2	7.5	0.8	1.8	11.2	7.6	2.0	3.5	1.1	18.9	5.9	3.9	12.2	16.5	5.7	1.1	0.7	17.3	2.6	6.0	4.3	0.9	1.3	12.1	5.8	0.1	4.3	11.6	3.1	4.7	1.4	3.9	5.9	1.5	4.6	1.4	5.5	7.5	1.9	7.2	7.7	3.8	1.5	1.1	6.3	9.8	11.6	5.6	5.1	11.9	1.0	11.1	8.0	0.2	8.8	2.1	6.8	14.4	1.0	4.6	1.9	2.7	0.0	9.6	5.3	6.7	3.3	2.3	19.0	4.2	8.2	12.0	4.8	0.2	4.8	2.9	0.2	0.1	0.0	9.7	1.8	6.4	0.8	1.1	3.6	1.2	6.9	3.1	1.4	1.6	0.2	6.8	5.5	0.0	3.1	3.8	13.2	0.4	2.3	0.2	10.4	0.3	0.0	0.7	26.3	1.0	0.5	0.6	1.1	5.8	13.2	5.7	16.6	14.1	0.9	0.0	0.5	16.7	0.8	5.2	0.0	0.7	11.1	8.8	2.6	5.1	8.2	4.1	6.8	1.0	11.9	0.1	3.0	0.2	0.2	8.0	0.0	0.7	2.1	1.2	1.5	0.8	1.6	1.1	0.7	0.9	1.3	3.1	1.5
CLEC11A	"CLECSF3, LSLCL, P47, SCGF"	ENSG00000105472	"C-type lectin domain containing 11A"	Q9Y240	19	50723329-50725718	"Plasma proteins, Predicted secreted proteins"	Osteogenesis	"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 77.1"	"Group enriched"	"Detected in many"	4	"HEL: 44.4;HMC-1: 82.3;NB-4: 109.3;THP-1: 88.3;U-937: 45.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 17.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 12.0;monocytes: 17.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042690	Approved		Approved	Centrosome	"Secreted in other tissues"	45000	45000	Centrosome		"HPA042690: AB_10795511"	"unprognostic (9.33e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.40e-2)"	"prognostic favourable (6.91e-4)"	"unprognostic (2.33e-1)"	"unprognostic (8.22e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.29e-2)"	"unprognostic (5.26e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.79e-2)"	"unprognostic (8.30e-2)"	"prognostic unfavourable (1.02e-5)"	"unprognostic (6.09e-2)"	"unprognostic (8.66e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.57e-2)"	5.5	5.4	3.0	5.6	3.1	77.1	4.5	4.5	3.6	33.6	6.5	1.2	6.7	3.9	26.6	27.8	6.7	13.5	10.7	5.6	2.6	3.4	7.4	5.4	7.5	3.5	2.9	1.3	16.1	2.6	2.0	7.5	6.9	4.0	18.9	2.1	8.9	2.9	10.2	3.4	5.0	5.2	8.5	3.4	4.9	3.1	4.9	0.8	4.0	3.8	4.5	2.6	8.4	10.1	0.3	12.0	1.2	17.2	3.4	3.2	6.7	0.3	0.4	0.0	0.3	4.3	5.9	10.1	17.3	4.7	2.0	1.9	0.0	0.0	0.0	0.2	8.6	0.2	0.0	0.0	1.3	0.0	2.8	44.4	0.0	0.0	2.7	0.0	82.3	4.3	0.0	0.2	0.2	2.2	0.5	0.2	3.7	0.3	0.3	109.3	0.2	0.5	3.8	0.0	0.0	0.1	0.0	0.0	0.4	0.5	0.0	6.7	0.1	88.3	12.4	0.1	5.4	0.0	0.1	0.2	0.2	0.0	6.3	45.8	5.7	1.0	17.2	0.2	0.6	7.2	0.0	0.3	0.2	0.1	12.0	0.3	1.5	3.2	1.2	3.4	3.3	3.2	0.1	6.7	3.0	3.1	4.5	3.6	2.6	3.4	2.9	1.3	4.0	0.8
CLEC18B	MRCL2	ENSG00000140839	"C-type lectin domain family 18 member B"	Q6UXF7	16	74408270-74421953	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"kidney: 28.1"	"Cell line enhanced"	"Detected in some"		"AF22: 3.0;K-562: 7.4;U-266/70: 2.8"	"Group enriched"	"Detected in some"	12	"glioma: 2.7;ovarian cancer: 1.2;renal cancer: 5.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA048976	Uncertain				"Secreted to blood"					"HPA048976: "	"unprognostic (5.69e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.30e-3)"	"unprognostic (9.37e-2)"	"prognostic unfavourable (2.07e-4)"	"unprognostic (7.15e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.91e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.31e-2)"	"unprognostic (5.87e-2)"	"unprognostic (5.43e-2)"	"unprognostic (4.27e-2)"	0.1	1.1	1.1	0.3	1.4	0.1	0.1	2.5	1.2	0.1	0.1			0.4	0.1	0.6	1.2	0.1	0.3	0.0	1.0	1.0	28.1	0.1	0.0	0.1	1.0		0.1	0.3	0.1	0.1	0.1		0.2	0.1		0.2	0.0	0.2	0.0	0.2	0.1	2.0	0.1	0.1	6.1			0.1		0.1	0.0	0.6	0.0	0.0	0.0	0.9	0.6	0.0	0.0	0.0	1.6	3.0	1.8	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.7	0.2	1.1	0.5	1.1	1.0	0.0	0.1	0.3	0.3	0.4	0.3	0.1	0.7	0.0	0.3	1.8	0.4	0.1	0.1	0.0	7.4	0.0	0.3	0.0	0.0	0.0	1.2	0.8	0.4	0.0	1.6	0.0	0.3	0.6	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.4	0.2	0.9	2.8	1.6	0.3	0.5	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0										
CLEC18C	"MGC34761, MRCL3"	ENSG00000157335	"C-type lectin domain family 18 member C"	Q8NCF0	16	70173322-70187361	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	13	"kidney: 16.5;testis: 4.6"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.0;RT4: 1.2;TIME: 2.9"	"Cancer enriched"	"Detected in single"	9	"renal cancer: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA048976	Uncertain				"Secreted to blood"					"HPA048976: "		"unprognostic (3.90e-1)"		"unprognostic (3.03e-1)"	"unprognostic (1.20e-4)"					"unprognostic (5.55e-2)"	"unprognostic (5.72e-3)"	"unprognostic (2.92e-1)"	"unprognostic (7.64e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.61e-3)"		"unprognostic (6.98e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	16.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	4.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.3	1.2	0.5	0.2	0.0	0.0	0.0	0.0	0.6	2.9	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.1	0.1	0.5	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CLEC19A		ENSG00000261210	"C-type lectin domain containing 19A"	Q6UXS0	16	19285739-19322145	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	13	"brain: 7.2;retina: 24.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.2;EFO-21: 1.3;MCF7: 1.8;NTERA-2: 1.1;RPMI-8226: 2.0;U-2 OS: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted - unknown location"									"unprognostic (3.19e-1)"				"unprognostic (3.72e-1)"		"unprognostic (1.11e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.20e-1)"		"unprognostic (1.53e-1)"				0.1	0.0	2.6	0.0	0.2	0.0	0.0	0.8	7.2	0.1	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	4.5	1.3	0.0	0.1	0.5	0.3	0.3	0.2	0.0	0.1	0.0	0.3	0.1	1.2	0.8	0.1	24.4	0.4	0.0	0.3	1.2	0.1	0.0	0.1	0.0	0.8	0.5	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	1.1	0.0	0.0	0.0	2.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	2.6	0.2	0.8	5.0	4.5	1.3	0.3	0.2	1.2	0.0
CLEC3A	CLECSF1	ENSG00000166509	"C-type lectin domain family 3 member A"		16	78022515-78066761	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"breast: 14.6;prostate: 8.6;smooth muscle: 17.1;urinary bladder: 17.2"	"Group enriched"	"Detected in some"	4	"SK-BR-3: 7.3;T-47d: 20.9"	"Cancer enriched"	"Detected in some"	102	"breast cancer: 78.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 0.5"	"Low region specificity"	"Detected in single"			HPA051511	Uncertain				"Secreted to extracellular matrix"					"HPA051511: "	"prognostic unfavourable (1.61e-4)"				"unprognostic (1.60e-1)"							"unprognostic (2.42e-1)"		"unprognostic (1.25e-1)"	"unprognostic (4.95e-2)"		"unprognostic (3.80e-2)"	0.1	0.1	0.1	1.8	0.3	0.0	14.6	0.1	0.8	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	4.6	0.3	0.1	1.1	0.1	0.1	0.5	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.4	8.6	0.0	3.3	0.1	0.0	0.1	0.1	0.1	17.1	0.1	0.1	0.8	0.1	0.0	0.0	0.1	1.9	0.0	17.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.8	0.1	1.1	0.1	0.0	0.4	0.0
CLPSL2	"C6orf126, dJ510O8.5, UNQ3045"	ENSG00000196748	"Colipase like 2"	Q6UWE3	6	35776594-35779552	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	13	"epididymis: 124.8"	"Cell line enriched"	"Detected in some"	6	"T-47d: 12.3"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.6"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	25	"plasmacytoid DC: 2.4"	"Lineage enriched"	"Detected in single"	25	"dendritic cells: 2.4"									HPA051655	Approved				"Secreted in male reproductive system"					"HPA051655: "	"unprognostic (2.38e-1)"	"unprognostic (3.65e-1)"	"unprognostic (6.39e-3)"	"unprognostic (9.38e-2)"	"unprognostic (4.03e-2)"			"unprognostic (2.47e-1)"		"unprognostic (4.85e-3)"	"unprognostic (8.69e-2)"	"unprognostic (3.17e-2)"		"unprognostic (3.95e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.37e-1)"	0.0	0.0	0.4	0.0	0.2	0.0	0.7	0.0	1.1	0.0	0.0	0.0	2.3	0.0	0.0	124.8	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	9.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.4	0.3	1.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	2.0	0.4	0.5	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	1.3	1.3	1.1	0.3	0.0	0.0	0.0	0.0	1.1	0.8	0.0	0.6	0.0	12.3	1.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.4	0.4	0.2	0.0	1.1	0.8	0.1	0.2	0.2	0.0	0.0
COL10A1		ENSG00000123500	"Collagen type X alpha 1 chain"	Q03692	6	116118923-116158747	"Disease related genes, Predicted secreted proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 12.2;retina: 32.7"	"Cell line enriched"	"Detected in some"	6	"hTEC/SVTERT24-B: 29.4"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 51.9"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.7"	"Region enhanced"	"Detected in single"		"amygdala: 1.0"	"Low region specificity"	"Detected in all"			HPA053268			Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	21000	21000	"Endoplasmic reticulum"		"HPA053268: "	"unprognostic (3.83e-2)"	"unprognostic (6.81e-2)"	"unprognostic (7.20e-2)"	"unprognostic (7.45e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.37e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.38e-11)"	"unprognostic (2.16e-3)"	"unprognostic (7.22e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.06e-3)"	0.9	0.1	0.4	0.8	0.7	0.1	0.3	0.3	1.4	1.4	0.3	0.9	0.3	0.0	0.6	0.3	0.5	0.0	12.2	0.3	0.6	0.2	0.8	0.7	3.5	0.4	0.3	0.6	5.4	4.2	0.5	0.9	0.3	3.2	2.6	0.0	32.7	6.5	0.9	0.3	0.7	0.3	0.5	0.3	2.9	0.2	0.5	0.3	0.8	1.4	0.3	2.0	0.3	0.3	0.6	0.3	2.7	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	2.1	0.3	4.5	0.0	0.0	0.1	0.0	0.7	0.5	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	29.4	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.3	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.2	0.0	0.0	4.8	0.1	0.3	0.3	0.0	0.0	0.1	0.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.3	2.7	0.0	0.0	0.0	0.0	0.3	0.4	0.7	0.3	1.4	0.6	0.2	0.3	0.6	3.2	0.3
COL11A2	"DFNA13, DFNB53, HKE5"	ENSG00000204248	"Collagen type XI alpha 2 chain"	P13942	6	33162681-33192499	"Disease related genes, Plasma proteins, Predicted secreted proteins"			"Deafness, Disease mutation, Dwarfism, Non-syndromic deafness, Stickler syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"pituitary gland: 28.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.0;HMC-1: 2.1;U-266/70: 2.3;U-698: 2.9"	"Cancer enriched"	"Detected in many"	8	"melanoma: 13.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to extracellular matrix"	720000	720000				"unprognostic (4.62e-1)"	"unprognostic (8.69e-2)"	"unprognostic (1.65e-4)"	"unprognostic (5.15e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.04e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.26e-6)"	"unprognostic (8.27e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.96e-2)"	1.6	0.7	0.8	0.6	1.5	0.2	0.4	6.6	2.8	1.2	0.4	2.5	0.1	1.2	0.6	1.2	0.4	0.3	0.5	1.6	1.1	0.9	0.4	0.8	0.7	0.3	2.7	0.1	0.5	1.7	0.2	28.8	0.5	1.7	0.8	0.2	2.6	2.2	0.6	2.5	1.6	1.5	0.9	2.2	0.8	3.5	4.5	1.8	1.1	2.1	0.9	0.6	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.9	0.3	0.2	0.0	0.0	0.5	0.0	0.0	0.5	0.1	0.1	0.2	0.1	2.0	0.3	1.6	0.9	0.2	0.2	0.0	0.0	0.5	0.3	0.2	0.4	0.0	0.0	0.0	0.3	2.1	0.3	0.0	0.1	0.1	0.1	0.5	0.8	0.1	0.3	0.0	0.6	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	1.4	1.2	0.4	0.2	0.8	1.5	0.0	0.1	2.3	1.7	2.9	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.4	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.8	1.5	6.6	1.2	1.1	0.9	2.7	0.1	1.7	1.8
COL15A1		ENSG00000204291	"Collagen type XV alpha 1 chain"	P39059	9	98943179-99070792	"Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ: 13.0;BJ hTERT+: 27.2;HDLM-2: 11.5;U-2197: 22.5;U-87 MG: 10.3;WM-115: 15.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.7;NK-cell: 1.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA017913, HPA017915"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	23000000	23000000	"Endoplasmic reticulum"		"HPA017913: AB_1847099, HPA017915: AB_1847100"	"unprognostic (4.30e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.09e-2)"	"prognostic favourable (5.47e-4)"	"unprognostic (3.08e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.84e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.20e-3)"	"unprognostic (3.66e-3)"	"unprognostic (8.98e-2)"	"unprognostic (6.98e-2)"	"prognostic unfavourable (3.08e-4)"	36.1	17.6	0.5	12.7	0.7	0.0	21.4	0.4	0.7	22.4	19.7	1.4	5.0	3.0	42.4	22.0	26.6	9.0	25.2	41.2	0.5	0.7	8.7	1.0	5.6	11.7	1.6	0.8	28.9	13.7	4.5	3.4	66.9	2.1	16.6	4.0	11.4	23.4	6.2	12.8	6.7	11.1	27.3	1.3	3.9	14.8	22.8	0.4	5.1	10.5	21.7	8.6	21.3	8.8	0.6	0.1	0.0	0.4	1.7	1.7	0.2	0.0	0.0	0.0	0.0	2.3	1.3	0.0	13.0	27.2	0.7	0.2	0.0	0.0	0.1	0.3	2.8	0.0	0.0	0.0	0.1	11.5	0.0	0.1	6.6	0.0	0.5	0.1	1.2	3.8	0.0	3.0	0.1	0.0	8.8	0.0	1.0	0.0	0.0	0.2	0.1	0.0	0.0	7.3	0.1	0.0	0.0	0.0	0.0	0.4	1.9	3.5	0.1	0.2	0.0	0.0	0.3	22.5	0.2	0.1	0.0	0.0	10.3	0.1	15.2	0.0	0.3	0.0	1.7	0.4	0.1	0.6	0.4	0.5	0.1	0.1	0.1	0.3	0.0	1.7	0.2	0.0	0.4	0.2	0.5	0.7	0.4	0.7	0.5	0.7	1.6	0.8	2.1	0.4
COL1A2	OI4	ENSG00000164692	"Collagen type I alpha 2 chain"	P08123	7	94394561-94431232	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes, Disease mutation, Dwarfism, Ehlers-Danlos syndrome, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 244.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 150.8;ASC TERT1: 181.0;BJ: 148.1;BJ hTERT+: 108.7;fHDF/TERT166: 501.0;HSkMC: 157.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"CAB032650, HPA059738"	Approved		Supported	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	21000000	21000000	"Endoplasmic reticulum"		"CAB032650: AB_2082039, HPA059738: "	"unprognostic (1.20e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.15e-2)"	"unprognostic (7.38e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (1.51e-9)"	"unprognostic (1.35e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.31e-3)"	44.7	9.8	1.2	34.9	4.3	0.0	33.4	1.7	2.4	244.6	26.5	2.1	54.1	3.8	166.9	139.1	28.2	36.6	101.4	45.1	1.3	0.8	10.2	4.1	37.1	20.4	1.8	2.8	68.3	10.9	1.8	6.0	70.6	3.8	40.3	10.1	23.0	17.5	28.0	12.1	35.6	15.2	100.7	3.2	16.4	16.1	49.7	1.1	5.6	14.7	42.7	12.6	62.4	55.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	55.8	150.8	181.0	0.0	148.1	108.7	24.4	32.5	0.0	0.1	0.0	0.1	501.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	39.5	0.0	0.0	157.1	0.0	19.2	0.0	0.0	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	62.2	0.0	38.5	4.2	0.0	0.0	0.0	15.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	4.3	1.7	2.4	1.3	0.8	1.8	2.8	3.8	1.1
COL24A1		ENSG00000171502	"Collagen type XXIV alpha 1 chain"	Q17RW2	1	85729233-86156943	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 3.4;HSkMC: 3.1;Karpas-707: 6.0;NTERA-2: 3.1;RH-30: 4.4;U-266/70: 11.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"plasmacytoid DC: 6.2"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 6.2"	"Low region specificity"	"Detected in some"												"Secreted to extracellular matrix"	12000	12000				"unprognostic (3.00e-1)"	"unprognostic (6.19e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.76e-3)"	"unprognostic (1.82e-3)"	"unprognostic (2.45e-2)"	"unprognostic (2.44e-5)"	"unprognostic (1.37e-1)"	"unprognostic (4.08e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.48e-6)"	"unprognostic (2.79e-5)"	"unprognostic (5.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (9.90e-2)"	1.1	0.4	6.2	3.4	7.1	2.3	1.1	1.7	18.0	7.0	9.5	0.3	0.0	4.1	3.6	2.4	2.2	0.6	4.4	4.1	12.1	1.2	1.5	0.3	1.7	1.0	1.1	5.2	6.9	0.3	0.2	2.0	0.3	1.7	2.3	2.4	2.4	1.2	4.3	1.4	1.6	3.7	2.8	1.0	0.8	3.4	1.9	2.9	0.0	0.8	2.6	0.8	8.3	4.9	0.0	6.2	0.0	0.1	0.6	0.0	0.0	0.0	0.0	1.5	0.0	3.4	0.6	0.0	0.6	0.1	0.2	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.9	0.0	1.4	0.0	0.8	0.0	1.0	0.1	0.1	0.0	0.0	3.1	0.0	0.2	0.0	0.0	0.0	6.0	0.9	0.0	0.0	0.2	3.1	0.0	0.0	4.4	0.5	0.5	1.1	0.1	0.0	0.0	0.2	0.5	0.0	0.9	0.0	2.0	0.2	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	6.2	0.0	0.0	6.2	7.1	1.7	18.0	12.1	1.2	1.1	5.2	1.7	2.9
COL26A1	"EMI6, EMID2, Emu2"	ENSG00000160963	"Collagen type XXVI alpha 1 chain"	Q96A83	7	101362820-101559024	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 11.4;brain: 18.3"	"Group enriched"	"Detected in some"	4	"AF22: 20.6;BEWO: 16.5;HAP1: 7.3;Hep G2: 5.2;NTERA-2: 17.4"	"Group enriched"	"Detected in many"	6	"endometrial cancer: 12.6;ovarian cancer: 5.7;prostate cancer: 4.6;testis cancer: 14.7"					"Cell type enriched"	"Detected in single"	63	"plasmacytoid DC: 11.4"	"Lineage enriched"	"Detected in single"	63	"dendritic cells: 11.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA027059	Approved		Approved	Vesicles	"Secreted to extracellular matrix"			Vesicles		"HPA027059: AB_1848142"	"unprognostic (5.94e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.35e-1)"	"prognostic favourable (2.32e-5)"	"unprognostic (1.48e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.24e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.48e-4)"	"unprognostic (2.83e-3)"	0.0	4.1	2.5	0.3	7.0	0.3	0.2	0.4	18.3	0.1	0.0	0.2	0.0	0.1	0.5	0.3	0.0	0.2	0.3	0.1	3.3		3.1	4.8	0.6	0.9	0.0	8.1	0.2	3.1	6.7	0.0	0.5	0.6	3.7	0.0	0.0	0.2	1.1	0.0	0.1	0.1	0.1	0.3	0.4	0.2	0.8	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	11.4	0.1	0.0	0.0	0.0	0.0	0.0	0.6	20.6	1.3	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.8	0.0	0.1	3.2	0.0	0.0	7.3	0.0	0.0	0.7	0.9	0.0	0.0	5.2	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	17.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0										
COL2A1	"AOM, SEDC, STL1"	ENSG00000139219	"Collagen type II alpha 1 chain"	P02458	12	47972965-48004554	"Cancer-related genes, Disease related genes, Predicted secreted proteins"			"Cancer-related genes, Cataract, Deafness, Disease mutation, Dwarfism, Stickler syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"epididymis: 22.7;pituitary gland: 11.0;retina: 8.1;stomach 1: 11.3"	"Cell line enhanced"	"Detected in some"		"AF22: 54.0;HAP1: 33.8;HEK 293: 12.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002214, HPA055753"	Supported		Approved	Nucleoplasm	"Secreted to extracellular matrix"			Nucleoplasm		"CAB002214: AB_563666, HPA055753: "	"unprognostic (7.25e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.44e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.08e-2)"	"unprognostic (8.63e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.31e-4)"	"unprognostic (2.64e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.02e-1)"	0.0	0.0	0.1	2.2	0.3	0.0	0.7	0.9	0.9	0.0	0.2	0.3	0.0	0.0	0.3	22.7	0.0	0.0	0.0	0.0	0.5	1.3	0.0	0.0	1.4	0.0	0.0	0.7	1.3	0.0	0.0	11.0	0.4	1.9	2.6	0.4	8.1	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	11.3	2.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.0	33.8	0.0	0.0	0.0	12.5	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.9	0.9	0.5	1.3	0.0	0.7	1.9	0.0
COL4A4	CA44	ENSG00000081052	"Collagen type IV alpha 4 chain"	P53420	2	227002711-227164453	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"			"Alport syndrome, Cancer-related genes, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 28.7"	"Cell line enhanced"	"Detected in some"		"HeLa: 25.0;Karpas-707: 6.9;RPTEC TERT1: 11.4;U-266/70: 5.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	7	"memory B-cell: 8.0"	"Lineage enriched"	"Detected in many"	7	"B-cells: 8.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to extracellular matrix"						"unprognostic (7.31e-2)"	"unprognostic (7.56e-2)"	"unprognostic (6.65e-2)"	"unprognostic (4.88e-5)"	"unprognostic (1.12e-1)"	"unprognostic (2.92e-2)"	"unprognostic (8.50e-3)"	"unprognostic (5.14e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.91e-2)"	"prognostic favourable (2.30e-13)"	"unprognostic (1.53e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.15e-2)"	1.6	8.8	1.2	7.2	2.4	0.2	1.3	1.0	1.8	1.0	1.1	0.7	16.1	1.2	4.8	12.7	2.4	3.0	13.7	11.5	1.4	1.5	28.7	1.9	15.8	13.0	2.4	0.0	3.2	6.6	0.5	15.3	0.7	7.4	7.2	1.2	8.3	1.4	10.9	7.5	0.9	3.3	12.0	4.6	3.7	1.9	1.9	1.5	0.9	12.1	6.6	6.2	3.9	3.7	8.0	0.0	0.1	0.0	1.1	0.5	0.0	0.0	0.6	0.0	0.0	0.1	0.2	0.0	0.2	0.1	0.1	0.5	0.0	0.5	0.0	1.3	0.0	0.1	2.3	0.8	0.2	0.0	2.6	0.0	25.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	2.1	11.4	4.2	0.6	0.0	1.6	0.1	0.0	0.3	0.0	0.0	0.0	2.1	0.0	0.2	5.2	3.8	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.5	0.0	0.0	8.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.2	2.4	1.0	1.8	1.4	1.5	2.4	0.0	7.4	1.5
COL4A6		ENSG00000197565	"Collagen type IV alpha 6 chain"	Q14031	X	108155607-108439497	"Disease related genes, Predicted secreted proteins"	"Cell adhesion"		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 60.9"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 18.1;HeLa: 15.9;HHSteC: 24.4;hTERT-HME1: 17.9;HUVEC TERT2: 16.5;TIME: 36.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"							HPA065393			Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"			"Endoplasmic reticulum"		"HPA065393: "	"unprognostic (8.47e-3)"	"unprognostic (4.50e-3)"	"unprognostic (9.75e-3)"	"unprognostic (9.80e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.54e-3)"	"unprognostic (3.51e-1)"	2.1	0.4	0.4	0.8	0.5	0.0	1.7	0.2	0.4	12.1	1.0	1.3	8.0	0.7	22.9	17.1	25.0	11.3	35.8	3.6	0.6	0.6	3.0	0.3	2.1	0.0	1.0	0.9	6.4	0.3	7.6	11.3	1.9	0.9	16.5	1.3	8.3	1.4	15.6	1.0	4.1	1.8	60.9	1.4	1.1	10.4	2.1	0.7	0.2	0.6	1.4	0.5	24.7	6.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	12.1	3.9	0.0	9.9	0.7	0.0	0.0	0.7	0.1	0.1	6.9	0.0	0.0	0.0	0.0	2.3	4.1	18.1	0.3	0.1	3.4	0.3	15.9	0.1	24.4	0.0	0.0	1.0	11.2	2.6	17.9	16.5	0.0	0.0	0.2	0.0	0.0	0.0	5.5	1.5	0.0	0.0	0.0	0.7	1.3	0.0	0.0	0.9	0.0	0.0	0.3	0.0	36.9	0.0	0.0	2.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.2	0.4	0.6	0.6	1.0	0.9	0.9	0.7
COL5A3		ENSG00000080573	"Collagen type V alpha 3 chain"	P25940	19	9959561-10010471	"Cancer-related genes, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 48.9"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 23.4;BJ: 13.5;BJ hTERT+: 15.1;BJ hTERT+ SV40 Large T+: 8.4;HSkMC: 16.8;WM-115: 15.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"MAIT T-cell: 1.7"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA048256	Approved				"Secreted to extracellular matrix"	210000	210000			"HPA048256: "	"unprognostic (1.17e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.84e-3)"	"unprognostic (3.01e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.09e-1)"	"prognostic unfavourable (7.17e-8)"	"unprognostic (3.25e-2)"	"unprognostic (7.31e-3)"	"unprognostic (6.00e-2)"	"prognostic unfavourable (6.87e-5)"	48.9	2.6	11.6	10.8	15.9	0.4	27.0	3.2	11.9	24.5	7.8	3.2	3.1	3.6	17.5	9.8	11.3	8.1	10.7	9.5	10.1	3.0	1.9	4.1	6.4	9.2	5.2	3.5	3.4	3.8	3.2	0.9	30.2	4.5	6.8	2.2	9.7	5.1	9.1	15.4	19.0	3.9	9.6	2.5	1.3	3.4	5.3	2.6	1.6	4.5	11.5	4.7	7.3	10.2	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.3	0.0	7.4	23.4	0.0	13.5	15.1	8.4	3.4	0.0	0.0	0.0	0.1	2.5	1.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	16.8	0.3	3.0	3.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.7	0.0	0.0	0.0	6.9	3.2	0.2	0.0	0.0	0.0	0.0	0.9	0.0	15.1	0.0	0.0	0.0	0.3	0.0	1.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	11.6	15.9	3.2	11.9	10.1	3.0	5.2	3.5	4.5	2.6
COL6A1		ENSG00000142156	"Collagen type VI alpha 1 chain"	P12109	21	45981737-46005050	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes, Congenital muscular dystrophy, Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 92.0;ASC TERT1: 187.3;BJ: 70.3;HHSteC: 81.7;HSkMC: 136.9;U-138 MG: 102.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.0;memory CD8 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.7"	"Low region specificity"	"Detected in all"							"HPA019142, HPA029401"	Enhanced		Approved	Cytosol	"Secreted to extracellular matrix"	250000000	250000000	Cytosol		"HPA019142: AB_1847093, HPA029401: AB_10601361"	"unprognostic (3.45e-1)"	"unprognostic (4.09e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.79e-3)"	"unprognostic (2.12e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.47e-2)"	"unprognostic (3.69e-2)"	"unprognostic (6.06e-3)"	"unprognostic (3.86e-1)"	"prognostic unfavourable (1.07e-8)"	"unprognostic (5.16e-2)"	"unprognostic (7.39e-2)"	"unprognostic (3.53e-3)"	"prognostic unfavourable (4.54e-4)"	73.4	10.8	6.8	45.5	7.1	0.1	85.4	31.9	9.1	100.7	111.6	5.1	34.7	17.1	98.8	75.0	54.5	64.7	89.7	39.7	6.0	5.6	10.2	9.9	21.6	24.7	4.8	5.4	83.0	13.5	6.2	19.8	65.7	9.2	59.6	9.9	18.6	23.1	36.4	20.0	28.2	33.8	147.8	4.7	15.9	40.9	20.2	5.5	9.4	15.9	23.4	12.8	86.9	49.5	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.2	1.5	2.4	7.7	92.0	187.3	0.3	70.3	45.4	18.1	6.3	1.2	4.8	0.0	5.8	39.5	0.3	1.0	0.1	1.5	0.0	1.0	0.0	0.2	0.3	81.7	0.0	0.1	136.9	0.0	45.0	0.6	0.4	0.0	0.0	4.6	0.1	0.0	0.2	1.7	19.7	0.0	1.4	0.3	0.1	0.8	0.0	3.0	6.5	0.0	1.3	0.3	0.3	0.0	102.6	6.8	28.1	26.8	0.0	0.0	0.0	36.6	0.5	8.9	0.0	0.0	0.0	0.7	0.0	1.0	0.0	0.3	1.7	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.8	7.1	31.9	9.1	6.0	5.6	4.8	5.4	9.2	5.5
COL8A1	"C3orf7, MGC9568"	ENSG00000144810	"Collagen type VIII alpha 1 chain"	P27658	3	99638475-99799226	"Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 56.0"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 36.4;fHDF/TERT166: 149.5;LHCN-M2: 43.9;TIME: 65.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA053107	Enhanced		Supported	Vesicles	"Secreted to extracellular matrix"			Vesicles		"HPA053107: "	"unprognostic (3.13e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.71e-1)"	"prognostic unfavourable (9.39e-8)"	"unprognostic (2.98e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.32e-3)"	20.5	4.7	1.0	6.1	3.0	0.1	7.5	2.4	0.9	5.8	16.9	1.8	11.8	0.6	5.9	16.8	15.3	6.4	6.8	26.7	1.2	1.4	9.4	1.9	36.5	0.5	1.8	2.1	7.7	0.9	32.3	9.4	5.5	2.9	13.1	4.8	38.7	5.2	8.8	5.0	2.3	2.7	18.8	3.0	0.9	4.2	6.4	0.6	0.0	56.0	6.4	0.8	21.3	12.1	0.4	0.1	0.9	0.2	0.3	0.4	0.1	0.0	0.0	0.4	0.0	22.0	36.4	0.0	8.9	5.8	9.0	18.1	0.0	0.0	0.0	0.8	149.5	0.0	0.0	11.6	23.5	0.0	0.0	0.0	1.2	0.0	4.0	0.0	0.0	20.7	0.4	7.0	11.8	17.5	0.0	0.0	43.9	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.1	4.2	3.3	0.2	4.7	0.0	0.0	0.0	8.3	0.0	32.1	0.9	0.2	0.2	0.3	0.1	0.1	0.2	0.2	0.1	0.0	0.4	0.4	0.4	0.7	0.3	0.1	0.1	0.1	0.1	1.0	3.0	2.4	0.9	1.2	1.4	1.8	2.1	2.9	0.6
COL9A1		ENSG00000112280	"Collagen type IX alpha 1 chain"	P20849	6	70215061-70303083	"Disease related genes, Predicted secreted proteins"			"Deafness, Stickler syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 29.6;retina: 52.6"	"Group enriched"	"Detected in some"	6	"AF22: 23.2;NTERA-2: 7.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA074749	Enhanced				"Secreted to extracellular matrix"					"HPA074749: "	"unprognostic (2.18e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.48e-3)"	"unprognostic (5.72e-2)"	"unprognostic (5.32e-4)"	"unprognostic (3.24e-3)"	"unprognostic (8.79e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.68e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.62e-2)"	0.7	0.6	8.5	0.7	7.5	0.5	0.6	3.6	4.7	0.6	1.1	7.2	0.0	1.8	1.1	0.8	0.8	0.7	1.1	5.6	8.4	9.4	1.1	0.5	0.6	0.6	10.3	1.7	0.6	0.5	0.9	3.3	0.6	5.6	29.6	1.4	52.6	3.0	1.1	0.6	0.6	2.0	0.9	5.3	0.6	2.6	4.1	6.9	0.0	1.0	0.2	0.7	0.7	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	7.5	3.6	4.7	8.4	9.4	10.3	1.7	5.6	6.9
COLEC10	CL-L1	ENSG00000184374	"Collectin subfamily member 10"	Q9Y6Z7	8	118995452-119106582	"Disease related genes, Plasma proteins, Predicted secreted proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 47.4"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 8.2;HHSteC: 3.4;SK-BR-3: 14.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"	5700000	5700000				"unprognostic (1.28e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.79e-4)"	"unprognostic (6.25e-3)"	"unprognostic (1.80e-3)"	"unprognostic (7.73e-2)"	"prognostic favourable (5.79e-4)"	"unprognostic (1.05e-1)"		"unprognostic (1.61e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.25e-2)"	"unprognostic (9.02e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.85e-5)"	"unprognostic (7.12e-2)"	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.1	0.1	0.3	47.4	0.7	0.6	0.1	0.0	0.0	0.0	0.0	0.1	8.5	0.1	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.7	8.2	0.0	0.0	0.1	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.4	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	1.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
CORT	MGC32686	ENSG00000241563	Cortistatin	O00230	1	10449719-10451902	"Predicted secreted proteins"		Hormone		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	9	"brain: 28.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	33	"amygdala: 13.7;basal ganglia: 5.1;cerebral cortex: 16.9;hippocampal formation: 11.6;olfactory region: 6.1"	"Low region specificity"	"Detected in many"								"Secreted in brain"						"unprognostic (1.25e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.70e-3)"	"unprognostic (8.87e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.94e-3)"	"unprognostic (7.08e-7)"	"unprognostic (2.01e-1)"	"unprognostic (9.01e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.14e-4)"	1.0	0.7	3.3	0.9	28.8	0.9	0.6	3.2	26.6	0.7	1.0	0.1	0.0	1.3	0.8	1.0	0.5	0.7	1.0	0.6	2.3	2.5	1.2	0.8	0.7	0.7	1.0	6.2	1.0	0.9	1.0	3.2	1.7	0.0	1.1	0.8	0.0	0.7	0.8	0.8	1.1	1.2	0.7	0.7	0.8	0.9	2.1	20.3	0.0	1.1	0.0	0.5	0.8	0.5	0.2	0.4	0.0	0.1	1.2	0.3	0.3	1.2	3.7	1.8	2.3	0.2	0.2	0.8	1.1	0.2	0.4	0.4	3.1	0.5	1.2	0.8	0.0	1.0	1.1	0.0	0.0	2.0	3.1	1.7	2.7	3.0	0.4	2.4	1.1	0.0	0.3	0.5	0.0	0.0	1.0	1.0	0.3	2.5	0.5	2.2	0.3	4.4	0.9	1.6	0.5	0.2	0.9	1.5	0.8	0.9	1.1	0.7	0.7	0.0	1.7	0.3	1.8	2.2	0.6	0.9	2.7	1.0	0.7	1.8	0.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.4	0.2	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.3	3.3	28.8	3.2	21.5	2.3	2.5	1.0	6.2	0.0	20.3
CPA2		ENSG00000158516	"Carboxypeptidase A2"	P48052	7	130266827-130289798	"Enzymes, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	529	"pancreas: 1357.9"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.4;CACO-2: 7.3;RH-30: 6.1;SCLC-21H: 3.3"	"Cancer enriched"	"Detected in many"	60	"pancreatic cancer: 411.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA020342, HPA021317"	Enhanced		Approved	"Golgi apparatus"	"Secreted to digestive system"	1500000	1500000	"Golgi apparatus"		"HPA020342: AB_1846007, HPA021317: AB_1846008"	"unprognostic (1.12e-1)"	"unprognostic (3.97e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.76e-2)"		"unprognostic (4.65e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.84e-5)"	"unprognostic (7.52e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.12e-2)"	"unprognostic (8.48e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.4	1357.9	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	1.0	0.1	0.2	0.1	2.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.9	4.4	0.0	0.1	0.0	0.0	0.0	0.7	0.0	7.3	0.0	0.0	1.0	0.0	0.0	1.4	0.0	0.1	1.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.4	0.0	6.1	0.1	0.1	0.6	3.3	0.0	0.2	0.0	2.0	0.0	0.2	0.0	0.0	1.1	0.8	0.6	0.0	0.7	0.2	0.8	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CPA3		ENSG00000163751	"Carboxypeptidase A3"	P15088	3	148865256-148897196	"Enzymes, Plasma proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 111.7"	"Cell line enriched"	"Detected in some"	43	"HEL: 79.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	1118	"basophil: 111.7"	"Lineage enriched"	"Detected in single"	1118	"granulocytes: 111.7"	"Low region specificity"	"Detected in single"							"HPA006479, HPA008689, CAB020712"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"			"Golgi apparatus"	Nucleoplasm	"CAB020712: , HPA006479: AB_1078396, HPA008689: AB_1846009"	"unprognostic (1.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.66e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.14e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.30e-3)"	"unprognostic (3.50e-3)"	"unprognostic (5.18e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.69e-3)"	12.4	0.6	0.4	12.0	0.4	5.6	6.2	0.4	0.5	25.4	14.1	0.8	4.4	7.1	14.1	21.2	16.5	3.7	50.9	4.5	0.4	0.2	5.8	2.8	37.3	15.2	0.4	0.4	2.0	7.2	0.7	0.8	1.3	0.5	37.3	16.4	8.5	8.8	5.8	1.4	12.7	20.2	24.3	0.4	1.0	13.7	7.1	0.4	3.6	1.4	9.9	7.1	14.0	8.9	0.0	0.0	111.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	79.6	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	111.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.4	0.4	0.5	0.4	0.2	0.4	0.4	0.5	0.4
CPA6	CPAH	ENSG00000165078	"Carboxypeptidase A6"	Q8N4T0	8	67422038-67746385	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 16.2;prostate: 10.6;retina: 13.0"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.0;CACO-2: 6.2;EFO-21: 3.5;Hep G2: 9.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	10	"olfactory region: 15.5"	"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"						"unprognostic (2.85e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.23e-2)"	"unprognostic (6.99e-2)"	"unprognostic (3.57e-4)"	"unprognostic (9.61e-5)"	"unprognostic (1.75e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.41e-2)"	0.2	0.1	0.1	9.8	0.1	0.2	0.2	0.1	0.1	9.4	16.2	0.7	0.8	0.2	8.3	1.7	3.7	0.2	0.3	0.1	0.2	0.1	0.3	0.1	0.7	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.3	0.3	10.6	7.2	13.0	0.1	0.7	0.1	0.2	1.3	3.4	0.7	0.3	0.5	1.3	0.0	0.0	0.2	1.5	0.6	4.1	5.5	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.0	0.0	6.2	0.0	0.0	3.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.0	0.3	0.0
CPB1		ENSG00000153002	"Carboxypeptidase B1"	P15086	3	148791102-148860187	"Enzymes, Plasma proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	590	"pancreas: 3628.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 2.7;EFO-21: 2.9;HDLM-2: 3.0;U-2 OS: 5.1;U-251 MG: 1.5;U-266/84: 2.4"	"Group enriched"	"Detected in some"	312	"breast cancer: 293.8;pancreatic cancer: 641.4"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"CAB026158, HPA038069, HPA046340"	Enhanced				"Secreted to digestive system"	6600000	6600000			"CAB026158: , HPA038069: , HPA046340: "	"unprognostic (6.90e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (6.26e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.59e-2)"	"unprognostic (4.51e-2)"	"unprognostic (5.50e-8)"	"unprognostic (3.08e-1)"	"unprognostic (1.60e-1)"		"unprognostic (4.93e-2)"	0.2	1.7	0.1	0.1	0.2	0.0	0.7	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	1.2	3628.4	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.7	0.2	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	1.8	1.1	6.1	1.0	3.1	3.5	0.9	0.0	0.0	0.0	0.0	2.7	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	2.9	0.0	0.0	0.0	0.0	0.1	3.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	5.1	0.0	1.5	0.0	2.4	0.6	0.0	0.0	0.0	6.1	0.7	1.1	3.0	0.9	2.2	0.9	1.3	2.6	0.3	1.8	0.9	3.5	4.5	3.1	1.0	1.1	0.6	0.9	0.1	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.2
CPB2	"CPU, PCPB, TAFI"	ENSG00000080618	"Carboxypeptidase B2"	Q96IY4	13	46053195-46105033	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis"	"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	82	"liver: 246.8"	"Cell line enriched"	"Detected in single"	76	"Hep G2: 61.1"	"Cancer enriched"	"Detected in some"	112	"liver cancer: 268.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA004146	Approved				"Secreted to blood"	14000000000	14000000000			"HPA004146: AB_1078397"	"unprognostic (3.44e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.69e-2)"	"unprognostic (1.17e-2)"	"prognostic favourable (2.06e-4)"	"unprognostic (1.89e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.17e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.34e-2)"	"unprognostic (9.61e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	246.8	3.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.5	0.5	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	61.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.4	0.2	0.5	0.4	0.5	0.2	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
CPN2	ACBP	ENSG00000178772	"Carboxypeptidase N subunit 2"	P22792	3	194339765-194351328	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	26	"liver: 225.5"	"Cell line enriched"	"Detected in some"	25	"Hep G2: 36.3"	"Cancer enriched"	"Detected in some"	32	"liver cancer: 72.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.5"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA004732	Uncertain				"Secreted to blood"	42000000000	42000000000			"HPA004732: AB_1078561"	"unprognostic (4.27e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.42e-1)"			"unprognostic (4.12e-2)"	"prognostic favourable (2.05e-4)"	"unprognostic (1.27e-1)"	"unprognostic (8.65e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.64e-1)"		"prognostic unfavourable (4.59e-4)"	"unprognostic (2.91e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.90e-5)"	"unprognostic (8.42e-2)"	0.2	1.1	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	8.5	225.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	2.5	0.3	0.2	0.6	0.0	0.1	0.0	0.1	0.2	0.0	0.5	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.5	0.3	0.0	0.0	0.1	0.0	0.1	0.2	0.3	36.3	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.1	0.1	0.2	0.2	0.0	0.1	0.3	0.0	0.1	0.2	0.2	0.1	0.2	0.1	0.2	0.1	0.8	1.1	0.1	1.4	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.3	0.5	0.5	0.2	0.4	0.2	0.5	0.4	0.0	0.6	0.3	0.6	2.5	0.2	0.1	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
CPXM1	"CPX-1, CPX1, CPXM"	ENSG00000088882	"Carboxypeptidase X, M14 family member 1"	Q96SM3	20	2794069-2800637	"Enzymes, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 60.3"	"Cell line enhanced"	"Detected in some"		"AF22: 45.0;HSkMC: 24.4;NB-4: 39.4;REH: 40.2;SH-SY5Y: 30.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	22	"memory B-cell: 2.3;myeloid DC: 1.4;NK-cell: 3.9;plasmacytoid DC: 1.1"	"Group enriched"	"Detected in many"	26	"B-cells: 2.3;dendritic cells: 1.4;NK-cells: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"								"Secreted in other tissues"						"unprognostic (7.48e-2)"	"unprognostic (3.61e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.41e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.98e-2)"	"unprognostic (9.32e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.23e-2)"	"prognostic unfavourable (4.62e-10)"	"unprognostic (1.30e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.55e-3)"	"unprognostic (1.27e-2)"	24.0	2.4	0.5	4.6	1.1	5.6	14.9	0.9	3.7	32.2	7.4	1.3	7.6	0.2	43.6	41.4	1.4	13.6	31.1	14.4	0.5	0.2	4.3	0.6	2.7	1.9	2.1	0.6	20.7	1.7	0.6	2.7	60.3	2.4	8.5	0.2	16.2	2.7	5.3	2.2	5.8	1.4	14.5	1.4	0.5	1.0	10.1	0.3	15.2	8.8	0.7	1.5	23.0	15.2	2.3	1.4	0.0	0.0	3.9	0.0	0.7	0.0	0.0	45.0	0.0	0.0	1.4	0.0	0.1	0.2	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	3.3	0.0	0.1	0.2	2.3	5.9	0.0	0.0	0.6	0.0	0.9	24.4	0.0	2.1	0.0	0.0	2.4	0.0	0.0	0.0	0.1	39.4	9.5	0.0	40.2	0.0	1.1	0.0	0.0	0.0	30.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	3.9	0.0	1.1	0.0	0.7	0.5	1.1	0.9	1.1	0.5	0.2	2.1	0.6	2.4	0.3
CREG1	CREG	ENSG00000143162	"Cellular repressor of E1A stimulated genes 1"	O75629	1	167529677-167553767	"Predicted secreted proteins"	"Growth regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 155.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 15.1;classical monocyte: 36.8;eosinophil: 21.7;intermediate monocyte: 21.5;myeloid DC: 26.9;neutrophil: 13.0;non-classical monocyte: 19.9"	"Group enriched"	"Detected in all"	5	"dendritic cells: 26.9;granulocytes: 21.7;monocytes: 36.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056390			Approved	Vesicles,Microtubules	"Secreted to blood"	550000	550000	Microtubules	Vesicles	"HPA056390: "	"unprognostic (3.25e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.91e-1)"	"unprognostic (9.65e-3)"	"unprognostic (4.64e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.07e-3)"	"unprognostic (8.54e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.24e-3)"	"unprognostic (2.99e-1)"	"unprognostic (4.63e-2)"	"unprognostic (3.78e-3)"	"unprognostic (3.16e-1)"	50.9	52.6	15.7	21.0	17.9	29.6	56.7	11.8	15.0	23.0	32.8	21.7	21.3	16.5	22.0	46.8	41.9	25.0	40.8	48.9	15.5	13.6	39.8	81.3	68.5	83.8	16.4	9.6	43.3	41.6	19.1	36.2	46.8	14.7	41.4	23.7	28.7	39.0	22.6	33.0	37.1	30.4	40.9	21.0	98.2	22.7	27.6	15.1	12.6	53.1	32.7	23.7	50.8	40.9	1.3	26.9	21.7	36.8	3.3	5.3	13.9	11.8	5.3	2.7	5.7	43.9	12.2	7.0	5.1	2.3	4.0	5.3	8.7	13.6	13.0	14.9	5.6	18.7	3.1	10.9	2.8	17.6	10.7	5.3	4.4	4.8	15.1	11.7	39.3	12.8	33.1	4.7	5.1	1.3	27.3	53.4	5.5	4.9	2.4	12.1	3.0	8.4	4.1	7.8	155.2	7.2	8.3	1.8	3.4	12.7	17.5	14.1	23.1	32.2	2.5	1.0	5.3	16.7	3.3	10.5	20.8	8.6	17.6	12.2	2.1	15.1	36.8	21.7	1.6	21.5	2.5	1.3	2.4	2.0	26.9	0.6	5.3	2.6	13.0	3.3	19.9	1.8	1.1	13.9	15.7	17.9	11.8	15.0	15.5	13.6	16.4	9.6	14.7	15.1
CREG2		ENSG00000175874	"Cellular repressor of E1A stimulated genes 2"	Q8IUH2	2	101345551-101387595	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"brain: 56.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 4.1;CAPAN-2: 2.4;HaCaT: 10.7;HeLa: 4.1;PC-3: 4.3;RT4: 2.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"T-reg: 2.6"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA038224	Enhanced				"Secreted in brain"					"HPA038224: AB_10673167"	"unprognostic (5.09e-2)"	"unprognostic (3.78e-3)"	"unprognostic (4.10e-3)"	"unprognostic (8.15e-3)"	"unprognostic (5.63e-3)"	"unprognostic (9.68e-3)"	"unprognostic (4.52e-8)"	"unprognostic (3.86e-4)"	"unprognostic (1.39e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.90e-2)"	"unprognostic (7.69e-2)"	"unprognostic (5.41e-3)"	"unprognostic (4.44e-2)"	"unprognostic (2.91e-1)"	"unprognostic (8.26e-3)"	"unprognostic (7.77e-2)"	0.8	0.9	12.6	0.8	13.8	0.9	0.8	0.2	56.0	0.9	0.8	1.0	0.0	0.9	0.8	0.8	0.8	1.1	0.9	0.9	17.2	4.4	0.9	0.8	0.8	0.8	3.3	16.6	0.9	0.8	0.8	0.2	0.9	7.2	0.8	0.9	0.0	0.8	0.8	0.8	0.8	0.9	0.8	1.2	0.8	0.8	0.9	0.5	0.0	0.8	0.0	0.8	0.8	0.6	0.2	0.3	0.5	0.0	0.0	2.6	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	2.4	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.1	0.0	0.0	4.1	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.6	0.2	0.0	0.4	0.1	0.0	0.0	0.1	0.1	4.3	0.0	0.0	0.0	0.0	2.9	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.2	0.1	0.0	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.3	2.6	0.0	12.6	13.8	0.2	29.7	17.2	4.4	3.3	16.6	7.2	0.5
CRELD2	MGC11256	ENSG00000184164	"Cysteine rich with EGF like domains 2"	Q6UXH1	22	49918167-49927540	"Predicted secreted proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 98.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000603, CAB025604"	Approved				"Secreted to blood"	270000	270000			"CAB025604: , HPA000603: AB_1078565"	"unprognostic (1.12e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.10e-1)"	"prognostic favourable (2.42e-7)"	"unprognostic (5.04e-2)"	"unprognostic (5.43e-2)"	"unprognostic (3.21e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.57e-2)"	"unprognostic (7.97e-2)"	"prognostic unfavourable (1.34e-9)"	"unprognostic (6.13e-2)"	"unprognostic (3.01e-1)"	"unprognostic (7.30e-2)"	"unprognostic (4.02e-1)"	10.2	10.1	8.1	14.1	11.5	8.6	17.2	7.2	7.9	11.1	12.5	7.7	18.0	15.0	10.8	26.1	8.5	10.0	13.2	11.3	7.5	9.6	10.5	39.3	15.7	24.3	9.5	6.6	9.5	98.1	4.8	23.1	8.1	10.9	10.8	9.5	6.9	24.9	17.6	7.3	5.4	10.9	10.0	8.1	13.8	17.6	12.8	7.5	7.4	31.1	7.8	10.5	11.6	7.1	15.8	29.4	13.0	8.2	18.8	13.7	6.8	12.8	9.0	10.4	34.7	11.3	12.9	14.4	26.5	16.4	15.2	12.9	15.3	15.9	6.9	21.5	23.0	12.9	13.1	13.4	6.6	3.7	20.5	3.8	13.5	19.1	46.8	14.9	15.0	11.7	12.1	13.0	11.0	15.3	5.5	29.3	11.3	40.7	5.8	15.8	7.5	18.4	13.8	18.6	16.5	7.2	11.7	7.0	19.8	22.8	27.2	10.6	11.2	18.3	11.2	13.2	21.7	12.0	8.3	23.5	5.5	6.0	19.3	11.2	20.5	13.0	6.8	8.9	10.4	8.2	10.6	15.8	8.9	13.7	7.6	11.5	7.3	6.1	3.5	18.8	4.6	29.4	5.9	6.8	8.1	11.5	7.2	7.9	7.5	9.6	9.5	6.6	10.9	7.5
CRH	"CRF, CRH1"	ENSG00000147571	"Corticotropin releasing hormone"	P06850	8	66176382-66178725	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"placenta: 209.9"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.2;SCLC-21H: 2.5"	"Cancer enriched"	"Detected in some"	28	"urothelial cancer: 34.5"	"Region enhanced"	"Detected in many"		"hypothalamus: 28.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA062111	Uncertain				"Secreted to blood"					"HPA062111: "					"unprognostic (1.62e-1)"						"unprognostic (9.68e-2)"				"unprognostic (1.00e-1)"	"unprognostic (9.55e-2)"	"unprognostic (7.22e-3)"	2.7	0.2	4.1	0.2	2.1	0.3	0.2	0.0	6.7	0.2	0.2	0.4	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	2.7	28.4	0.2	0.2	0.3	0.2	0.4	1.1	0.2	1.3	0.2	0.1	209.9	13.8	0.2	0.2	0.0	0.2	0.2	0.3	0.2	0.2	0.5	0.1	0.2	0.4	0.9	0.0	0.0	0.5	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	2.1	0.0	6.7	2.7	28.4	0.4	1.1	13.8	0.0
CRHBP	"CRF-BP, CRFBP"	ENSG00000145708	"Corticotropin releasing hormone binding protein"	P24387	5	76952713-76981158	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.9;liver: 99.9"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 4.9;BJ hTERT+ SV40 Large T+ RasG12V: 4.8;HBF TERT88: 8.7;U-698: 9.5;U-87 MG: 5.2;WM-115: 4.5"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Region enhanced"	"Detected in many"		"hypothalamus: 24.9"	"Cell type enriched"	"Detected in single"	4	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036234, HPA046120"	Approved	Supported			"Secreted to blood"	43000000	43000000			"HPA036234: , HPA046120: AB_10959760"	"unprognostic (1.41e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.36e-3)"	"unprognostic (4.44e-5)"	"unprognostic (2.16e-1)"	"unprognostic (7.08e-2)"	"unprognostic (4.98e-4)"	"unprognostic (1.09e-1)"	"unprognostic (6.63e-5)"	"unprognostic (2.76e-2)"	"unprognostic (4.64e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.95e-2)"	8.4	5.6	3.5	0.4	5.4	1.2	2.6	0.0	7.8	1.6	0.3	3.2	1.8	0.4	1.2	0.7	0.2	0.9	0.5	3.2	4.0	24.9	16.1	99.9	0.3	0.4	2.7	5.4	0.8	0.2	0.4	0.0	18.1	1.8	0.6	0.3	1.5	0.6	1.9	0.5	0.2	0.3	0.8	2.2	13.9	0.3	0.5	1.2	0.0	1.9	0.9	0.4	0.5	0.2	0.0	0.0	1.2	0.1	0.0	0.2	0.8	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.0	0.1	4.9	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.7	0.0	0.0	2.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.5	0.0	0.0	0.0	9.5	5.2	0.0	4.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.8	3.5	5.4	0.0	7.8	4.0	24.9	2.7	5.4	1.8	1.2
CRISP1	"AEGL1, ARP, CRISP-1, HSCRISP1D, HSCRISP1G, HUMARP"	ENSG00000124812	"Cysteine rich secretory protein 1"	P54107	6	49834257-49877096	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"epididymis: 203.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;NB-4: 7.1;RPMI-8226: 2.0;SH-SY5Y: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA028445, HPA030534"	Enhanced				"Secreted in male reproductive system"					"HPA028445: AB_10670428, HPA030534: "																		0.2	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.0	48.8	0.0	0.2	203.0	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.4	8.8	0.2	0.2	0.6	0.0	0.2	0.2	0.2	7.4	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0
CRISP2	"CRISP-2, CT36, GAPDL5, TPX1"	ENSG00000124490	"Cysteine rich secretory protein 2"	P16562	6	49692358-49713590	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"testis: 135.5"	"Cell line enhanced"	"Detected in some"		"HEL: 2.9;U-2 OS: 1.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA031248	Enhanced				"Secreted in male reproductive system"					"HPA031248: AB_10602211"	"unprognostic (1.10e-1)"							"unprognostic (1.51e-1)"		"unprognostic (1.72e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.35e-2)"		"unprognostic (9.23e-3)"	"unprognostic (4.05e-2)"			0.0	0.0	0.0	0.0	0.3	3.5	0.0	0.0	0.1	0.3	0.0	0.1	3.2	0.0	0.0	7.0	0.7	4.4	1.7	0.0	0.2	0.1	0.2	0.0	0.4	0.0	0.0	0.1	0.1	0.7	0.0	0.3	0.0	0.1	0.1	0.0	0.1	3.4	0.5	0.0	0.0	0.1	0.1	0.1	0.0	0.0	135.5	0.0	0.0	0.1	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.0
CRTAP	"CASP, LEPREL3, P3H5"	ENSG00000170275	"Cartilage associated protein"	O75718	3	33113979-33147773	"Disease related genes, Predicted secreted proteins"			"Disease mutation, Dwarfism, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 121.2;ASC TERT1: 79.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"classical monocyte: 67.8"	"Group enriched"	"Detected in all"	5	"dendritic cells: 55.8;monocytes: 67.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043598, HPA044150"	Approved		Approved	"Intermediate filaments,Actin filaments,Cytosol"	"Secreted to blood"			"Intermediate filaments, Actin filaments, Cytosol"		"HPA043598: AB_10960991, HPA044150: AB_10959594"	"unprognostic (5.29e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.85e-3)"	"unprognostic (7.36e-2)"	"unprognostic (4.73e-3)"	"unprognostic (4.28e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.97e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.79e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.28e-3)"	59.2	33.4	16.3	13.4	22.2	13.6	63.2	5.4	14.1	57.5	39.4	23.3	32.7	12.8	54.2	41.1	42.8	35.1	43.5	37.0	16.8	13.1	25.7	16.8	35.9	37.8	24.2	13.0	48.5	13.3	14.6	7.6	25.4	13.8	54.5	19.7	35.4	16.4	42.2	23.9	24.6	18.8	66.1	22.8	17.6	25.2	26.1	19.0	5.1	34.1	25.8	18.3	62.4	59.7	7.6	55.8	5.5	67.8	6.9	12.9	30.8	9.0	17.9	5.6	17.6	121.2	79.4	32.6	19.8	43.2	24.0	22.9	6.0	5.1	6.3	22.1	37.5	11.7	9.9	15.1	17.4	15.6	15.6	9.9	14.0	6.2	36.3	6.4	8.1	63.3	31.0	21.6	27.6	25.2	8.4	12.1	24.2	7.7	2.3	6.5	6.7	24.4	8.4	16.5	12.1	18.8	6.1	1.1	9.1	13.4	11.8	28.5	12.6	15.7	16.4	31.5	13.5	17.1	20.9	8.8	29.7	0.9	24.7	12.9	17.2	2.1	67.8	4.9	6.9	26.3	10.0	7.6	10.1	7.7	55.8	6.8	5.8	5.4	5.5	6.9	7.8	15.0	12.9	30.8	16.3	22.2	5.4	14.1	16.8	13.1	24.2	13.0	13.8	19.0
CSF2	"GM-CSF, GMCSF"	ENSG00000164400	"Colony stimulating factor 2"	P04141	5	132073790-132076170	"Cancer-related genes, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 9.5;lung: 6.8;pancreas: 4.5"	"Cell line enriched"	"Detected in some"	4	"BJ hTERT+: 44.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"NK-cell: 9.5"	"Lineage enriched"	"Detected in single"	11	"NK-cells: 9.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA057404, HPA062006"			Enhanced	Vesicles	"Secreted to blood"			Vesicles		"HPA057404: , HPA062006: "	"unprognostic (7.29e-2)"	"unprognostic (2.49e-3)"	"unprognostic (8.77e-2)"	"unprognostic (2.09e-2)"		"unprognostic (1.05e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.68e-3)"		"unprognostic (1.87e-8)"	"unprognostic (4.81e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.06e-2)"	0.2	0.1	0.1	3.9	0.1	1.1	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.7	0.0	1.5	0.1	1.1	0.2	0.1	0.1	0.3	0.9	6.8	0.3	0.1	0.0	0.1	4.5	0.0	0.1	0.5	0.0	0.2	0.7	0.0	1.9	0.0	0.1	0.4	1.0	0.6	0.1	1.0	0.2	0.2	0.0	0.4	0.2	0.0	1.8	2.3	0.1	0.0	0.0	0.0	0.0	9.5	0.8	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.0	0.0	2.5	0.0	3.5	0.0	0.7	0.0	0.1	0.0	3.2	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	10.2	6.8	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.1	1.8	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
CSF3	"C17orf33, G-CSF, GCSF, MGC45931"	ENSG00000108342	"Colony stimulating factor 3"	P09919	17	40015361-40017813	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 27.9;lung: 60.9"	"Group enriched"	"Detected in some"	5	"BJ hTERT+: 19.5;U-87 MG: 76.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"pons and medulla: 7.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"						"unprognostic (3.59e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.73e-1)"	"prognostic favourable (8.45e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.40e-2)"		"unprognostic (1.10e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.82e-2)"	"unprognostic (7.40e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.10e-2)"	"unprognostic (4.80e-3)"	12.4	1.5	1.0	13.8	1.3	3.0	2.8	0.8	1.6	27.9	3.0	1.4	0.0	0.2	2.3	2.2	5.9	2.9	2.1	6.9	1.1	1.0	0.2	0.5	60.9	0.5	1.2	0.1	3.3	4.1	0.2	3.8	2.6	7.4	4.3	0.7	1.6	0.6	0.3	20.6	0.4	1.4	1.6	2.6	1.0	2.0	1.1	1.2	0.1	0.7	8.8	7.0	7.2	1.8	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.6	3.1	2.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	1.3	0.8	1.6	1.1	1.0	1.2	0.1	7.4	1.2
CSN2	CASB	ENSG00000135222	"Casein beta"	P05814	4	69955256-69961007	"Predicted secreted proteins"		"Milk protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	43	"breast: 82.6"	"Cell line enriched"	"Detected in single"	5	"U-266/70: 1.4"	"Cancer enriched"	"Detected in single"	156	"breast cancer: 75.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA041036	Supported				"Secreted in female reproductive system"					"HPA041036: AB_10793865"																		0.0	0.0	0.0	0.0	0.0	0.0	82.6	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CSN3	CSN10	ENSG00000171209	"Casein kappa"	P07498	4	70242588-70251428	"Predicted secreted proteins"		"Milk protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	96	"breast: 91.1;salivary gland: 31.2"	"Cell line enhanced"	"Detected in single"		"U-266/70: 2.0"	"Group enriched"	"Detected in some"	15	"breast cancer: 35.3;lung cancer: 7.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"HPA035953, HPA035954"	Enhanced				"Secreted in female reproductive system"					"HPA035953: AB_10673226, HPA035954: AB_2674884"																		0.1	0.0	0.1	0.1	0.1	0.0	91.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	31.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CST1		ENSG00000170373	"Cystatin SN"	P01037	20	23747553-23751268	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	46	"salivary gland: 704.2"	"Cell line enriched"	"Detected in some"	5	"RT4: 153.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB026769, HPA043706, HPA044763"	Enhanced				"Secreted to digestive system"	6600000	6600000			"CAB026769: , HPA043706: , HPA044763: "	"prognostic favourable (4.00e-4)"	"unprognostic (2.47e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.26e-2)"	"unprognostic (9.58e-2)"	"unprognostic (2.58e-1)"	"unprognostic (9.00e-2)"	"unprognostic (9.91e-3)"	0.1	0.2	0.1	0.2	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	4.8	0.1	0.1	0.3	7.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.0	0.0	0.1	0.1	0.1	15.2	0.0	0.1	704.2	0.1	0.1	4.0	0.1	0.1	0.2	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.3	1.6	0.1	0.0	0.2	0.0	0.7	0.0	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	153.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
CST11	"CST8L, CTES2, dJ322G13.6"	ENSG00000125831	"Cystatin 11"	Q9H112	20	23450403-23452857	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	25	"epididymis: 76.3"	"Cell line enhanced"	"Detected in single"		"RT4: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053399	Enhanced				"Secreted in male reproductive system"					"HPA053399: "						"unprognostic (9.42e-2)"				"unprognostic (2.21e-2)"								0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	76.3	0.5	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.0	0.9	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CST2		ENSG00000170369	"Cystatin SA"	P09228	20	23823769-23826731	"Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	230	"salivary gland: 1538.3"	"Cell line enriched"	"Detected in some"	12	"RT4: 38.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB024963, HPA043706, HPA044763"	Enhanced				"Secreted to digestive system"	110000	110000			"CAB024963: , HPA043706: , HPA044763: "	"unprognostic (1.57e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.64e-2)"	"unprognostic (5.17e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.75e-3)"	"unprognostic (2.73e-1)"	"unprognostic (4.82e-3)"	"unprognostic (6.43e-3)"	"unprognostic (2.51e-1)"	"unprognostic (4.58e-11)"	"unprognostic (1.29e-3)"	"unprognostic (3.22e-1)"	"unprognostic (4.30e-1)"	"unprognostic (1.71e-1)"	1.6	6.6	0.1	0.1	0.1	0.0	0.1	0.3	0.1	3.8	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.1	1.3	0.1	0.1	0.1	0.1	0.7	0.0	5.9	0.7	0.1	2.6	0.0	0.1	1538.3	0.1	0.1	0.2	0.1	0.3	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.8	0.1	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	38.1	0.0	0.0	0.0	0.0	3.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CST3		ENSG00000101439	"Cystatin C"	P01034	20	23626706-23638473	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"	"Age-related macular degeneration, Amyloidosis, Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 160.1;ASC TERT1: 109.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 163.9;intermediate monocyte: 211.0;myeloid DC: 269.6;non-classical monocyte: 135.1;plasmacytoid DC: 153.5"	"Group enriched"	"Detected in many"	9	"dendritic cells: 269.6;monocytes: 211.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000118, HPA013143"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"	4100000000	4100000000	"Golgi apparatus, Vesicles"		"CAB000118: , HPA013143: AB_1847417"	"unprognostic (3.89e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.45e-1)"	"prognostic favourable (1.83e-4)"	"unprognostic (8.53e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.29e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.97e-1)"	"unprognostic (5.01e-2)"	"prognostic favourable (8.77e-4)"	95.8	72.6	229.0	37.9	254.7	22.2	68.6	61.4	196.7	76.6	78.2	75.4	39.5	59.4	47.6	143.6	73.8	64.9	89.4	79.7	157.4	96.2	35.9	67.3	58.0	91.2	148.3	90.6	51.4	142.1	34.5	45.6	25.8	69.9	55.2	66.1	195.0	338.2	74.2	44.2	44.9	77.9	57.3	73.3	85.5	105.5	57.4	68.4	40.7	43.2	40.1	31.9	49.4	50.2	0.6	269.6	27.4	211.0	6.4	2.4	106.7	12.6	28.8	6.7	15.5	160.1	109.6	12.6	22.1	30.8	15.2	12.3	54.7	19.6	0.0	20.8	30.1	43.0	6.2	44.1	4.7	0.0	21.3	13.0	5.7	93.0	57.3	0.6	21.9	84.8	37.2	20.4	21.9	23.7	11.8	0.3	21.1	20.2	0.1	13.8	9.0	63.2	0.4	8.2	17.5	62.4	28.7	7.4	8.5	16.1	4.8	27.4	13.6	47.7	59.8	14.4	10.4	20.1	8.2	13.6	0.4	0.1	12.3	28.6	16.2	1.4	163.9	1.0	2.4	211.0	0.9	0.6	0.6	1.6	269.6	0.5	0.6	1.2	27.4	6.4	135.1	153.5	0.4	106.7	229.0	254.7	61.4	196.7	157.4	96.2	148.3	90.6	69.9	68.4
CST4		ENSG00000101441	"Cystatin S"	P01036	20	23685640-23689040	"Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	94	"salivary gland: 705.3"	"Group enriched"	"Detected in some"	4	"CACO-2: 6.6;RT4: 16.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA043706, HPA044763"	Supported				"Secreted to digestive system"	2700000	2700000			"HPA043706: , HPA044763: "	"unprognostic (2.80e-1)"		"unprognostic (7.88e-2)"	"unprognostic (2.48e-1)"		"unprognostic (1.09e-1)"		"unprognostic (2.59e-1)"		"prognostic unfavourable (4.98e-5)"	"unprognostic (1.00e-2)"	"unprognostic (9.52e-2)"		"unprognostic (2.11e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.95e-2)"	"prognostic favourable (2.88e-4)"	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	2.5	0.1	0.1	0.0	1.6	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.8	0.0	0.1	0.1	0.1	7.5	0.0	0.1	705.3	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	4.7	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	6.6	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	16.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CST5		ENSG00000170367	"Cystatin D"	P28325	20	23875935-23879750	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	268	"salivary gland: 1065.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.2;RPTEC TERT1: 3.7;RT4: 1.9;U-2 OS: 1.6"	"Cancer enriched"	"Detected in many"	5	"breast cancer: 17.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB024944, HPA061449"	Enhanced				"Secreted to digestive system"					"CAB024944: , HPA061449: "	"unprognostic (2.43e-1)"		"unprognostic (8.83e-2)"	"unprognostic (3.20e-1)"	"unprognostic (3.19e-1)"			"unprognostic (1.51e-2)"	"unprognostic (4.73e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.83e-3)"		"unprognostic (5.14e-2)"	"unprognostic (2.31e-1)"	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	3.8	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.6	0.0	0.0	1065.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.8	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.9	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	3.7	1.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.3	0.8	0.0	0.6	0.9	0.3	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CST6		ENSG00000175315	"Cystatin E/M"	Q15828	11	66011841-66013505	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skin 1: 124.5"	"Group enriched"	"Detected in some"	6	"A-431: 26.2;CAPAN-2: 73.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 171.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB019316, HPA044963"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted in other tissues"	110000000	110000000	"Plasma membrane"	Cytosol	"CAB019316: , HPA044963: "	"unprognostic (3.01e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.59e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.38e-2)"	"unprognostic (5.02e-1)"	"unprognostic (8.89e-3)"	"unprognostic (1.29e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.74e-3)"	"unprognostic (5.89e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.59e-2)"	0.6	0.2	0.1	1.5	0.1	0.2	8.7	0.4	0.2	5.5	0.2	0.0	1.4	0.1	0.3	0.8	11.3	4.3	0.7	2.4	0.1	0.2	1.0	0.1	27.2	1.2	0.1	0.0	1.3	0.2	0.5	0.4	26.5	0.2	0.9	0.1	1.1	1.3	26.5	0.7	124.5	0.2	0.2	0.2	0.2	0.2	1.0	0.0	2.8	14.6	13.6	4.4	0.5	3.7	0.4	0.9	0.0	1.6	0.0	0.2	0.7	26.2	0.0	0.0	0.1	0.0	0.0	7.8	0.2	0.0	0.0	0.0	0.1	73.1	0.0	0.4	0.9	0.9	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	7.3	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.7	0.1	0.1	0.4	0.1	0.1	0.2	0.1	0.0	0.2	0.0
CST7		ENSG00000077984	"Cystatin F"	O76096	20	24949230-24959928	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 120.9;bone marrow: 160.2;lymphoid tissue: 51.3"	"Cell line enhanced"	"Detected in some"		"HL-60: 15.7;HMC-1: 44.0;NB-4: 43.2;U-937: 77.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 120.9"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"olfactory region: 2.3"	"Low region specificity"	"Detected in all"			HPA040442	Enhanced				"Secreted to blood"	12000	12000			"HPA040442: "	"prognostic favourable (6.55e-4)"	"prognostic favourable (7.90e-4)"	"unprognostic (9.37e-2)"	"prognostic favourable (9.17e-6)"	"unprognostic (2.38e-2)"	"prognostic favourable (5.85e-5)"	"unprognostic (1.00e-2)"	"unprognostic (8.66e-2)"	"unprognostic (2.84e-3)"	"unprognostic (7.93e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.42e-2)"	"prognostic unfavourable (4.37e-6)"	"unprognostic (7.64e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.45e-1)"	"unprognostic (7.62e-2)"	4.9	0.9	0.8	9.7	0.9	160.2	1.4	0.9	1.0	2.5	1.9	0.1	0.5	1.1	2.2	1.8	2.4	4.6	10.7	6.2	0.9	0.8	1.6	3.5	23.0	30.4	4.0	0.0	2.2	1.1	0.2	0.9	1.6	0.7	3.5	1.0	3.2	1.3	0.7	1.9	1.2	3.7	1.0	1.2	51.3	1.6	1.7	0.2	6.6	1.6	2.5	15.4	6.0	11.8	0.3	2.5	29.8	0.2	53.9	120.9	42.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	15.7	44.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	43.2	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	77.6	0.0	5.0	0.2	0.8	120.9	0.2	67.5	0.3	18.3	84.3	2.5	0.3	4.0	52.3	29.8	53.9	0.2	0.6	10.5	42.2	0.8	0.9	0.9	1.0	0.9	0.8	4.0	0.0	0.7	0.2
CST8	"CRES, CTES5"	ENSG00000125815	"Cystatin 8"	O60676	20	23491101-23496018	"Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	66	"testis: 31.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in male reproductive system"																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CST9	"CLM, CTES7A"	ENSG00000173335	"Cystatin 9"	Q5W186	20	23602410-23605876	"Predicted secreted proteins"		"Antimicrobial, Protease inhibitor, Thiol protease inhibitor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	11	"breast: 6.6"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	37	"breast cancer: 9.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA029190	Uncertain				"Secreted - unknown location"					"HPA029190: AB_10602804"	"unprognostic (2.06e-2)"									"unprognostic (2.21e-4)"								0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0			0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CST9L	"bA218C14.1, CTES7B"	ENSG00000101435	"Cystatin 9 like"	Q9H4G1	20	23564732-23568749	"Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 49.8"	"Cell line enriched"	"Detected in single"	20	"HEL: 5.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in male reproductive system"						"unprognostic (2.10e-2)"																	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT55	"CXorf48, FLJ20527"	ENSG00000169551	"Cancer/testis antigen 55"	Q8WUE5	X	135156536-135171398	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	11	"testis: 9.2"	"Cell line enriched"	"Detected in single"	14	"K-562: 12.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA059575			Approved	Vesicles	"Secreted in male reproductive system"			Vesicles		"HPA059575: "	"unprognostic (6.20e-2)"				"unprognostic (1.39e-1)"			"unprognostic (8.36e-2)"		"unprognostic (5.86e-3)"			"unprognostic (3.47e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.49e-1)"		0.1	0.2	0.5	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.0			0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.1	0.2		0.1	0.1	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	9.2			0.2		0.0	0.0	0.0	0.8	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	12.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.2	0.6	0.8	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0										
CTGF	"CCN2, IGFBP8"	ENSG00000118523	"Connective tissue growth factor"	P29279	6	131948176-131951373	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion, DNA synthesis"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 128.3;HUVEC TERT2: 107.9;TIME: 222.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"naive B-cell: 11.6"	"Lineage enriched"	"Detected in single"	117	"B-cells: 11.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB005123, HPA031074, HPA031075"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted in other tissues"	5200000	5200000	"Golgi apparatus, Vesicles"		"CAB005123: AB_638805, HPA031074: AB_10599618, HPA031075: AB_10611248"	"unprognostic (2.87e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.41e-2)"	"unprognostic (5.68e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.27e-3)"	"prognostic unfavourable (5.04e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.84e-3)"	51.9	15.5	3.5	48.2	7.6	0.0	39.2	1.6	7.1	84.0	26.9	7.2	27.5	5.8	84.9	50.1	38.9	56.3	82.5	73.6	8.8	3.6	83.5	18.8	45.8	53.3	4.7	9.4	30.7	26.3	4.7	9.7	44.0	13.8	54.5	19.7	55.0	28.2	45.3	29.4	30.1	28.7	123.4	12.0	169.8	41.6	24.4	2.3	5.9	66.9	46.9	9.8	48.5	23.3	11.6	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.5	10.0	0.2	22.7	12.9	0.1	29.0	13.9	18.0	9.6	0.0	0.9	0.0	128.3	37.2	0.4	0.3	2.0	17.0	0.1	0.2	0.0	4.1	10.4	8.9	0.0	0.0	18.8	0.4	13.0	3.2	107.9	0.0	0.0	51.0	0.1	0.0	0.0	4.8	1.7	2.4	0.4	0.0	6.5	0.0	0.0	0.0	2.9	4.9	1.3	0.4	0.2	222.6	25.0	19.5	31.4	53.4	0.9	0.1	0.2	3.4	0.0	31.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.5	7.6	1.6	7.1	8.8	3.6	4.7	9.4	13.8	2.3
CTRC	"CLCR, ELA4"	ENSG00000162438	"Chymotrypsin C"	Q99895	1	15438439-15449242	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	417	"pancreas: 1443.7"	"Cell line enhanced"	"Detected in some"		"A-431: 3.6"	"Cancer enriched"	"Detected in some"	168	"pancreatic cancer: 236.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 3.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA046920	Enhanced				"Secreted to digestive system"					"HPA046920: "	"unprognostic (2.62e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.81e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.94e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.00e-1)"	"unprognostic (9.55e-11)"	"unprognostic (4.98e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.99e-3)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.6	1443.7	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.1	0.4	3.4	0.7	1.5	0.6	0.1	3.6	0.6	0.5	0.7	0.2	0.0	0.2	0.3	0.4	0.0	0.0	0.0	1.7	0.5	1.1	0.0	0.5	0.0	0.1	0.2	1.1	0.5	0.4	0.3	0.1	0.9	0.2	1.7	0.2	0.0	0.0	0.0	0.0	0.1	1.7	0.2	0.5	1.0	1.6	0.4	0.0	0.5	0.1	0.3	0.0	0.1	0.4	1.0	0.4	0.2	0.2	0.3	0.1	0.9	0.4	1.4	0.9	0.2	0.8	1.6	0.3	0.8	0.8	0.3	3.4	0.4	0.4	0.4	0.2	0.2	0.3	0.3	0.6	0.1	1.1	0.3	0.4	1.7	1.5	0.7	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CTRL		ENSG00000141086	"Chymotrypsin like"	P40313	16	67927640-67932414	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	281	"pancreas: 639.8"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA034504, HPA034505"	Enhanced				"Secreted to digestive system"					"HPA034504: AB_2674196, HPA034505: AB_10602212"	"unprognostic (3.03e-5)"	"unprognostic (3.53e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.66e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.83e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.20e-4)"	"unprognostic (6.69e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.29e-3)"	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.3	639.8	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	1.1	1.1	0.7	0.0	2.2	0.5	0.5	3.7	1.1	0.3	0.2	0.1	1.8	0.3	0.7	1.1	1.3	2.3	1.4	0.7	0.4	0.7	1.0	5.6	0.7	3.1	1.4	6.3	0.7	1.1	1.4	0.3	0.9	2.5	1.2	0.2	3.9	1.0	0.0	1.5	1.0	0.6	1.0	0.7	2.7	6.2	2.2	2.8	0.5	4.5	0.0	0.9	2.6	1.4	1.3	0.7	0.6	1.2	4.3	1.6	0.1	2.0	0.5	1.6	6.5	2.7	3.6	0.2	0.8	0.8	0.6	0.7	0.3	1.5	0.7	0.2	0.3	1.1	0.5	0.9	0.6	0.5	2.2	1.1	0.0	0.7	1.1	0.0	0.5	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CTSB		ENSG00000164733	"Cathepsin B"	P07858	8	11842524-11869448	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 297.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 237.0;fHDF/TERT166: 137.7"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 1446.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 53.1;classical monocyte: 127.4;intermediate monocyte: 97.0;myeloid DC: 68.0;non-classical monocyte: 54.7;plasmacytoid DC: 95.4"	"Group enriched"	"Detected in all"	5	"dendritic cells: 95.4;granulocytes: 53.1;monocytes: 127.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000457, HPA018156, HPA048998"	Enhanced		Supported	Nucleoli,Vesicles	"Secreted to blood"	130000000	130000000	Vesicles	Nucleoli	"CAB000457: , HPA018156: AB_1846069, HPA048998: "	"unprognostic (5.74e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.98e-3)"	"unprognostic (5.96e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.61e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.12e-2)"	"prognostic favourable (5.76e-4)"	"prognostic unfavourable (9.02e-4)"	227.9	42.1	19.6	67.2	24.4	14.7	67.6	14.9	31.4	76.7	49.1	30.1	22.7	29.9	53.2	44.8	54.2	52.4	43.6	120.7	18.3	23.7	95.6	167.8	94.3	175.1	29.1	16.5	44.2	31.6	13.8	21.6	68.7	24.8	42.6	27.9	33.8	63.7	33.6	41.3	22.8	51.2	51.1	35.9	116.4	26.7	21.5	20.4	18.1	297.0	25.9	38.4	56.8	62.2	7.9	95.4	53.1	127.4	5.3	17.1	108.5	6.4	29.1	3.7	16.0	65.8	74.1	11.6	121.4	237.0	42.5	50.4	13.9	37.9	0.1	17.6	137.7	35.4	5.1	33.5	26.9	3.1	5.0	9.4	3.4	34.1	67.0	2.1	7.0	81.1	45.7	38.4	34.4	83.1	7.8	21.5	35.3	5.1	0.8	3.4	3.1	9.8	3.3	3.8	16.4	12.9	10.1	1.6	9.5	14.0	7.6	63.3	12.3	6.3	115.1	72.3	24.5	23.1	22.6	21.4	15.5	0.5	82.9	8.1	33.8	53.1	127.4	16.3	5.2	97.0	7.2	7.9	17.1	5.8	68.0	6.1	9.6	4.1	18.5	5.3	54.7	95.4	13.4	108.5	19.6	24.4	14.9	28.0	18.3	23.7	29.1	16.5	24.8	20.4
CTSW		ENSG00000172543	"Cathepsin W"	P56202	11	65879809-65883741	"Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 157.2;bone marrow: 41.4"	"Group enriched"	"Detected in some"	23	"HEL: 37.9;NB-4: 86.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"gdT-cell: 106.6;MAIT T-cell: 67.7;memory CD8 T-cell: 68.3;naive CD8 T-cell: 51.4;NK-cell: 157.2"	"Group enriched"	"Detected in many"	48	"NK-cells: 157.2;T-cells: 106.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			CAB016345	Enhanced				"Secreted to blood"	340000	340000			"CAB016345: AB_626813"	"prognostic favourable (3.06e-4)"	"unprognostic (2.06e-2)"	"unprognostic (2.71e-2)"	"prognostic favourable (8.36e-6)"	"unprognostic (1.21e-1)"	"prognostic favourable (9.89e-4)"	"unprognostic (5.69e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.25e-3)"	"unprognostic (5.14e-3)"	"unprognostic (2.83e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavourable (8.84e-6)"	"unprognostic (3.86e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.01e-3)"	5.2	1.2	0.9	4.9	1.0	41.4	2.3	0.6	0.7	3.9	4.9	0.8	0.5	2.4	8.4	4.0	2.1	2.1	2.5	9.0	0.9	1.0	2.5	6.8	12.7	36.0	1.1	0.6	3.0	1.1	0.0	1.4	10.7	1.4	7.4	2.5	6.3	10.9	1.5	1.9	1.5	5.9	1.7	2.1	33.1	3.3	3.4	0.4	11.1	3.1	1.3	18.2	4.5	2.6	0.4	2.7	2.3	0.3	157.2	106.6	45.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	37.9	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.4	86.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	2.3	0.0	2.3	0.2	0.3	106.6	0.2	67.7	0.4	11.7	68.3	2.7	0.3	7.0	51.4	2.0	157.2	0.3	1.7	1.6	45.7	0.9	1.0	0.6	0.7	0.9	1.0	1.1	0.6	1.4	0.4
CXCL1	"FSP, GRO1, GROa, MGSA, MGSA-a, NAP-3, SCYB1"	ENSG00000163739	"C-X-C motif chemokine ligand 1"	P09341	4	73869393-73871242	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Inflammatory response"	"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 124.8"	"Group enriched"	"Detected in some"	6	"BJ hTERT+: 78.9;EFO-21: 201.6;RPTEC TERT1: 72.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	253	"neutrophil: 25.3"	"Lineage enriched"	"Detected in single"	253	"granulocytes: 25.3"														"Secreted to blood"						"prognostic favourable (7.83e-4)"	"prognostic unfavourable (7.23e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.23e-3)"	"prognostic unfavourable (2.91e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavourable (1.60e-4)"	"unprognostic (1.17e-1)"	"unprognostic (5.30e-2)"	"unprognostic (7.41e-2)"	"unprognostic (9.41e-2)"	12.0	0.8	1.3	22.5	2.2	14.8	4.1	0.8	1.4	49.2	7.7	1.0	0.7	4.3	0.9	2.1	27.8	6.1	11.2	12.1	1.7	1.3	8.9	4.2	23.0	10.9	3.1	1.0	3.8	13.0	0.0	0.7	26.1	3.9	8.7	7.1	2.1	8.1	4.1	3.2	0.8	10.8	1.2	3.8	124.8	3.1	2.1	1.7	1.7	0.7	7.9	22.6	29.9	6.6	0.0	0.0	25.3	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.4	1.3	0.0	2.1	78.9	1.9	2.0	0.0	1.4	0.0	201.6	0.1	4.0	0.0	0.3	10.2	0.2	0.0	0.0	0.1	0.0	0.4	0.0	0.0	1.0	0.1	14.2	1.1	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	72.8	1.7	0.0	0.0	0.1	0.0	3.9	0.0	0.1	18.2	0.0	0.6	3.9	0.1	0.0	0.1	0.3	0.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.3	0.0	0.0	0.0	0.0	0.0	1.3	2.2	0.8	1.4	1.7	1.3	3.1	1.0	3.9	1.7
CXCL10	"C7, crg-2, gIP-10, IFI10, INP10, IP-10, mob-1, SCYB10"	ENSG00000169245	"C-X-C motif chemokine ligand 10"	P02778	4	76021117-76023497	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 36.2;lymphoid tissue: 34.8;prostate: 34.6"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 9.6;BJ hTERT+ SV40 Large T+: 3.6;BJ hTERT+ SV40 Large T+ RasG12V: 3.5;Daudi: 3.1;RPMI-8226: 6.6;RT4: 3.7;THP-1: 4.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"classical monocyte: 10.6;intermediate monocyte: 25.5;non-classical monocyte: 15.9"	"Lineage enriched"	"Detected in many"	15	"monocytes: 25.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"								"Secreted to blood"						"unprognostic (1.94e-1)"	"unprognostic (5.32e-2)"	"unprognostic (9.98e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.59e-2)"	"prognostic favourable (1.12e-5)"	"prognostic unfavourable (4.61e-4)"	"unprognostic (2.75e-1)"	"prognostic unfavourable (1.16e-6)"	"unprognostic (1.03e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.66e-2)"	4.3	2.1	2.7	34.8	2.5	0.0	7.3	1.8	4.8	8.1	3.5	0.9	0.2	3.8	2.3	6.7	4.7	1.2	3.8	7.6	1.2	1.2	7.5	10.6	36.2	21.7	3.2	1.6	3.9	1.2	0.0	2.3	5.6	3.0	34.6	6.0	2.6	9.1	2.1	7.3	2.1	4.1	5.5	11.3	15.8	6.4	1.3	0.9	15.0	25.7	5.4	9.2	9.2	2.2	0.5	1.6	0.6	25.5	0.0	0.1	3.7	0.7	0.0	0.0	0.3	0.0	0.2	0.0	0.0	9.6	3.6	3.5	0.3	0.1	3.1	0.4	0.0	0.0	0.0	0.2	0.2	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	6.6	0.1	3.7	0.0	0.0	0.0	0.7	2.1	0.2	4.6	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.9	0.0	0.0	10.6	0.0	0.0	25.5	0.0	0.5	0.1	0.0	1.6	0.0	0.0	0.0	0.6	0.0	15.9	0.0	0.0	3.7	2.7	2.5	1.8	4.8	1.2	1.2	3.2	1.6	3.0	0.9
CXCL11	"b-R1, H174, I-TAC, IP-9, SCYB11, SCYB9B"	ENSG00000169248	"C-X-C motif chemokine ligand 11"	O14625	4	76033682-76041415	"Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 20.1"	"Group enriched"	"Detected in some"	6	"BJ hTERT+: 5.2;BJ hTERT+ SV40 Large T+: 8.2;BJ hTERT+ SV40 Large T+ RasG12V: 8.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 2.1"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in some"			CAB009921	Uncertain				"Secreted to blood"					"CAB009921: AB_2088137"	"unprognostic (2.00e-1)"	"unprognostic (3.62e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.87e-2)"	"unprognostic (9.95e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.73e-1)"	"prognostic favourable (4.31e-7)"	"prognostic unfavourable (8.18e-5)"	"unprognostic (2.90e-1)"	"prognostic unfavourable (3.29e-6)"	"unprognostic (1.53e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.48e-2)"	"unprognostic (5.32e-2)"	3.6	0.3	3.8	10.5	3.1	0.0	3.4	1.3	2.0	3.3	1.4	0.6	0.1	0.6	1.3	2.0	2.3	1.4	2.0	3.3	2.2	2.8	2.5	2.1	13.7	10.0	3.1	1.5	1.3	8.9	0.0	0.7	3.5	2.8	8.5	4.5	0.3	2.9	1.1	6.4	0.6	1.0	1.4	9.8	7.0	5.6	0.6	1.5	4.3	20.1	3.6	1.4	3.2	0.7	0.0	0.9	0.0	2.1	0.0	0.1	0.6	1.3	0.4	0.0	0.0	0.0	0.1	0.0	0.0	5.2	8.2	8.6	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	1.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.7	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.2	0.0	2.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.6	3.8	3.1	1.3	2.0	2.2	2.8	3.1	1.5	2.8	1.5
CXCL12	"PBSF, SCYB12, SDF-1a, SDF-1b, SDF1, SDF1A, SDF1B, TLSF-a, TLSF-b, TPAR1"	ENSG00000107562	"C-X-C motif chemokine ligand 12"	P48061	10	44370165-44386493	"Predicted secreted proteins"	"Chemotaxis, Host-virus interaction"	"Cytokine, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC diff: 61.2;BJ hTERT+ SV40 Large T+ RasG12V: 52.5;fHDF/TERT166: 57.3;HSkMC: 155.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"intermediate monocyte: 2.4"	"Lineage enriched"	"Detected in single"	9	"monocytes: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB017564	Approved				"Secreted to blood"					"CAB017564: AB_2088170"	"unprognostic (2.41e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.28e-3)"	"unprognostic (2.55e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.95e-3)"	83.4	14.6	4.1	38.2	5.6	3.8	65.7	1.8	6.0	94.2	39.4	6.9	21.1	7.6	84.2	45.5	50.0	35.8	74.7	59.5	4.7	3.6	35.9	61.9	15.4	55.6	4.6	7.0	45.6	76.3	20.7	6.8	2.1	5.8	47.1	17.8	35.2	44.6	25.8	31.4	29.1	25.8	54.5	5.9	95.6	14.5	17.6	3.0	34.8	32.5	63.7	57.7	55.1	63.6	0.0	0.0	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	61.2	9.5	0.0	21.6	35.3	34.7	52.5	0.0	0.0	0.0	0.2	57.3	0.0	0.0	0.0	11.5	21.0	0.2	0.0	0.0	0.0	20.8	0.0	0.1	155.7	0.0	7.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.7	0.0	0.0	0.0	25.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.7	0.0	0.0	0.0	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.2	2.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4.1	5.6	1.8	6.0	4.7	3.6	4.6	7.0	5.8	3.0
CXCL13	"ANGIE, ANGIE2, BCA-1, BLC, BLR1L, SCYB13"	ENSG00000156234	"C-X-C motif chemokine ligand 13"	O43927	4	77511753-77611834	"Cancer-related genes, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 82.5"	"Cell line enhanced"	"Detected in some"		"HL-60: 1.4;RH-30: 1.2;U-266/70: 5.3"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.0"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.0"									HPA052613	Uncertain				"Secreted to blood"					"HPA052613: "	"unprognostic (5.25e-3)"	"unprognostic (1.19e-2)"	"prognostic favourable (9.12e-4)"	"prognostic favourable (5.52e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.49e-1)"	"unprognostic (6.41e-3)"	"unprognostic (9.82e-3)"	"prognostic favourable (5.41e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.07e-1)"	"prognostic unfavourable (1.16e-10)"	"unprognostic (2.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.68e-3)"	0.2	0.1	0.0	15.3	0.2	0.0	1.5	0.3	0.0	0.1	1.1			0.0	0.8	0.0	0.6	0.2	0.2	0.0	0.0	0.0	0.3	4.3	0.2	65.1	0.0		0.2	0.0	0.0	0.8	0.0		3.8	1.8		0.8	0.0	0.0	0.1	15.5	0.0	0.0	82.5	3.7	0.3			0.5		57.5	6.2	0.2	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	1.4	0.1	0.3	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	5.3	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0										
CXCL14	"BMAC, bolekine, BRAK, Kec, KS1, MIP-2g, NJAC, SCYB14"	ENSG00000145824	"C-X-C motif chemokine ligand 14"	O95715	5	135570679-135579279	"Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skin 1: 140.1"	"Group enriched"	"Detected in some"	12	"HAP1: 17.6;hTCEpi: 23.3;RPTEC TERT1: 63.3;U-2 OS: 26.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 3.2;granulocytes: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB029996	Uncertain				"Secreted to blood"					"CAB029996: AB_2086070"	"unprognostic (1.82e-3)"	"prognostic favourable (1.71e-4)"	"prognostic favourable (4.52e-4)"	"unprognostic (2.75e-2)"	"unprognostic (2.71e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.33e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.22e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.89e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.54e-1)"	59.5	0.9	19.4	25.8	14.9	0.2	44.1	0.6	20.7	40.7	30.0	1.5	4.5	38.8	6.8	26.1	16.7	5.2	3.8	11.2	10.8	4.6	79.2	10.3	1.7	13.9	6.3	9.3	2.1	2.8	0.3	25.4	30.5	7.6	7.0	34.3	14.3	44.2	3.7	17.2	140.1	59.2	8.6	1.0	15.1	18.7	5.1	2.4	1.5	10.0	30.2	22.9	12.7	17.0	0.2	3.2	1.1	0.3	0.3	0.3	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.8	0.2	0.0	0.0	0.0	2.6	0.0	0.8	0.0	0.0	17.6	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.3	63.3	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	26.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.9	0.3	0.2	0.2	0.1	0.3	0.1	0.2	0.1	3.2	0.2	0.3	0.2	1.1	0.3	0.2	0.2	0.2	0.1	19.4	14.9	0.6	20.7	10.8	4.6	6.3	9.3	7.6	2.4
CXCL17	"Dcip1, DMC, UNQ473, VCC1"	ENSG00000189377	"C-X-C motif chemokine ligand 17"	Q6UXB2	19	42428288-42443048	"Predicted secreted proteins"	"Angiogenesis, Chemotaxis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 68.0;lung: 83.0;stomach 1: 79.9"	"Group enriched"	"Detected in some"	4	"Karpas-707: 2.1;RT4: 6.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.4"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.4"	"Not detected"	"Not detected"												"Secreted to blood"						"unprognostic (2.74e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.03e-2)"		"unprognostic (4.46e-3)"	"unprognostic (3.77e-1)"	"prognostic favourable (4.92e-5)"	"unprognostic (6.68e-2)"	"unprognostic (3.07e-1)"	"prognostic unfavourable (4.63e-4)"	"unprognostic (1.70e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.88e-1)"	"unprognostic (8.13e-3)"	"unprognostic (2.29e-1)"	0.1	0.0	0.1	0.2	0.2	0.0	0.7	0.1	0.1	17.4	0.1	0.4	0.1	0.0	1.0	5.1	68.0	6.3	1.3	0.1	0.1	0.0	0.7	0.4	83.0	0.1	0.1	0.1	2.8	11.4	0.0	2.3	0.1	0.3	6.8	0.0	0.3	39.2	0.5	0.1	0.0	0.1	0.3	0.1	0.1	79.9	0.3	0.1	0.5	1.2	8.8	40.1	5.5	10.0	0.0	0.0	1.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	6.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1
CXCL2	"CINC-2a, GRO2, GROb, MGSA-b, MIP-2a, SCYB2"	ENSG00000081041	"C-X-C motif chemokine ligand 2"	P19875	4	74097035-74099293	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"liver: 113.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 24.4;HHSteC: 17.2;hTCEpi: 18.1;hTEC/SVTERT24-B: 12.9;hTERT-HME1: 17.6;RPTEC TERT1: 12.3;U-87 MG: 14.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.0;non-classical monocyte: 3.5"	"Group enriched"	"Detected in many"	25	"granulocytes: 1.4;monocytes: 3.5"														"Secreted to blood"						"prognostic favourable (5.93e-5)"	"prognostic unfavourable (1.41e-4)"	"unprognostic (5.28e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.27e-1)"	"unprognostic (7.14e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (2.07e-6)"	"unprognostic (1.05e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.59e-1)"	22.8	3.8	2.4	19.9	4.3	20.7	10.9	0.8	1.7	20.4	5.7	2.3	0.9	0.9	4.4	3.8	6.2	5.8	15.2	14.2	1.7	2.0	3.2	113.1	22.4	35.0	2.8	0.5	5.8	24.9	0.6	2.3	1.4	4.3	5.1	6.4	5.1	4.8	3.6	30.9	1.3	3.8	4.1	4.6	3.7	7.5	3.1	1.6	0.0	2.1	18.5	1.8	11.7	4.1	0.0	0.0	1.4	3.5	0.0	0.0	0.1	0.6	1.7	0.1	0.0	0.6	2.1	0.0	1.9	24.4	1.0	2.9	0.1	3.8	0.0	3.4	0.1	0.0	0.1	5.3	4.0	0.0	0.0	1.5	2.0	0.0	17.2	0.6	0.0	1.9	18.1	12.9	17.6	2.1	0.1	0.0	0.5	0.0	0.2	0.3	0.0	0.6	0.0	0.0	0.0	12.3	0.0	0.0	0.0	1.1	0.1	0.5	0.0	0.1	3.2	0.9	0.3	3.8	1.8	0.0	0.0	0.0	14.9	4.0	0.1	1.4	0.6	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	3.5	0.0	0.0	0.1	2.4	4.3	0.8	1.7	1.7	2.0	2.8	0.5	4.3	1.6
CXCL3	"CINC-2b, GRO3, GROg, MIP-2b, SCYB3"	ENSG00000163734	"C-X-C motif chemokine ligand 3"	P19876	4	74036589-74038807	"Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 28.5"	"Group enriched"	"Detected in some"	4	"BJ hTERT+: 22.8;hTEC/SVTERT24-B: 35.8;RPTEC TERT1: 20.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.4"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.0"	"Low lineage specificity"	"Detected in single"																"Secreted to blood"						"unprognostic (2.12e-3)"	"prognostic unfavourable (2.33e-4)"	"unprognostic (1.08e-3)"	"unprognostic (6.97e-3)"	"unprognostic (2.41e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.80e-4)"	"unprognostic (2.45e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.68e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.89e-6)"	"unprognostic (2.61e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.20e-1)"	18.8	0.6	1.7	16.5	1.2	10.3	4.3	0.2	1.2	19.6	3.3	1.0	0.4	0.5	0.7	2.2	1.3	1.7	9.2	7.2	1.3	0.8	1.7	3.2	28.5	1.8	2.0	1.0	4.9	3.1	0.0	0.6	1.5	3.0	2.3	7.9	0.8	4.4	0.9	2.3	0.6	2.8	1.2	2.2	5.3	10.3	1.6	0.6	2.7	0.8	2.7	1.9	11.7	0.5	0.0	0.5	0.4	1.0	0.0	0.4	2.4	0.2	1.7	0.7	0.0	0.4	0.6	0.0	2.5	22.8	0.6	1.4	0.0	2.7	0.0	2.5	0.0	0.1	0.1	0.8	5.0	0.0	0.0	1.8	0.2	0.0	2.8	0.2	0.0	0.5	0.6	35.8	3.5	0.5	0.4	0.0	1.0	0.0	0.5	0.1	0.3	0.7	0.0	0.8	0.0	20.6	0.6	0.0	0.0	0.2	0.0	0.5	0.1	0.0	0.9	5.1	0.2	2.5	6.3	0.0	0.0	0.0	5.7	0.1	0.3	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	1.0	0.5	0.0	2.4	1.7	1.2	0.2	1.2	1.3	0.8	2.0	1.0	3.0	0.6
CXCL5	"ENA-78, SCYB5"	ENSG00000163735	"C-X-C motif chemokine ligand 5"	P42830	4	73995642-73998779	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 20.0;lymphoid tissue: 28.0;salivary gland: 31.2"	"Cell line enhanced"	"Detected in some"		"A549: 33.7;EFO-21: 28.4;HSkMC: 20.5;hTEC/SVTERT24-B: 14.7;RPTEC TERT1: 108.7"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 74.0"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.1"									HPA065474	Approved				"Secreted to blood"					"HPA065474: "	"unprognostic (5.56e-3)"	"prognostic unfavourable (3.43e-4)"	"unprognostic (1.80e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavourable (1.39e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavourable (2.23e-4)"	"unprognostic (7.99e-2)"	"prognostic unfavourable (2.45e-5)"	"unprognostic (3.72e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.30e-2)"	1.7	0.3	1.6	28.0	6.0	0.7	2.4	0.4	1.4	10.5	0.7	1.5	0.2	0.6	0.3	0.0	0.6	0.4	3.9	1.4	4.3	2.8	0.4	2.1	20.0	13.6	1.2	0.1	0.3	0.8	0.0	0.3	1.5	7.4	1.5	0.2	0.0	31.2	0.5	0.3	0.3	1.8	0.1	2.6	5.2	6.4	5.4	0.2	1.0	0.3	10.8	0.8	10.9	0.3	0.0	0.0	1.1	0.1	0.0	0.2	5.5	0.0	33.7	0.1	0.0	0.0	1.2	0.0	0.6	0.5	0.2	0.5	0.1	0.3	0.0	28.4	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	20.5	0.0	14.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	108.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	5.5	1.6	6.0	0.4	1.0	4.3	2.8	1.2	0.1	7.4	0.2
CXCL6	"CKA-3, GCP-2, SCYB6"	ENSG00000124875	"C-X-C motif chemokine ligand 6"	P80162	4	73836497-73849064	"Predicted secreted proteins"	Chemotaxis	"Antibiotic, Antimicrobial, Cytokine, Heparin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 59.6"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 16.8;EFO-21: 40.5;HUVEC TERT2: 26.4;RPTEC TERT1: 31.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	107	"neutrophil: 10.7"	"Lineage enriched"	"Detected in single"	107	"granulocytes: 10.7"														"Secreted to blood"						"unprognostic (4.35e-4)"	"unprognostic (4.47e-2)"	"unprognostic (6.09e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.49e-3)"	"unprognostic (2.62e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.02e-2)"	"unprognostic (3.75e-2)"	"unprognostic (9.02e-2)"	"prognostic unfavourable (4.82e-4)"	"unprognostic (2.47e-1)"	"unprognostic (4.88e-1)"	"unprognostic (2.72e-1)"	"unprognostic (4.48e-2)"	3.5	0.1	0.1	5.7	0.2	0.5	0.3	0.1	0.2	7.4	3.7	0.0	1.7	3.1	0.1	0.9	1.6	1.7	16.3	2.7	0.5	0.1	4.4	4.6	8.9	0.9	0.3	0.3	0.7	9.4	0.0	0.2	0.0	1.3	3.5	0.1	0.3	2.4	4.7	0.1	0.1	5.2	0.0	0.5	59.6	0.3	1.4	0.0	1.4	0.1	0.6	2.2	13.7	3.1	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	5.4	0.0	0.9	16.8	0.1	0.2	0.0	0.0	0.0	40.5	0.0	3.4	0.0	0.0	2.6	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.3	0.1	8.5	0.0	26.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	0.0	0.0	0.0	31.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.3	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.5	0.1	0.3	0.3	1.3	0.0
CXCL8	"3-10C, AMCF-I, b-ENAP, GCP-1, GCP1, IL-8, IL8, K60, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1, SCYB8, TSG-1"	ENSG00000169429	"C-X-C motif chemokine ligand 8"	P10145	4	73740506-73743716	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 79.4;bone marrow: 300.7;lung: 106.1"	"Cell line enriched"	"Detected in many"	7	"BJ hTERT+: 288.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	428	"neutrophil: 79.4"	"Lineage enriched"	"Detected in single"	794	"granulocytes: 79.4"					"Not detected"	"Not detected"			HPA057179	Supported				"Secreted to blood"					"HPA057179: "	"unprognostic (3.42e-1)"	"prognostic unfavourable (1.18e-5)"	"unprognostic (3.91e-3)"	"unprognostic (8.49e-2)"	"unprognostic (3.29e-2)"	"unprognostic (3.03e-3)"	"prognostic unfavourable (1.19e-5)"	"unprognostic (1.37e-3)"	"unprognostic (3.19e-1)"	"unprognostic (4.46e-1)"	"unprognostic (7.19e-3)"	"unprognostic (7.16e-2)"	"prognostic unfavourable (3.13e-6)"	"unprognostic (4.73e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.15e-2)"	13.4	1.6	1.8	21.9	1.9	300.7	1.7	0.4	1.5	6.5	1.4	0.8	0.0	0.5	4.5	0.9	6.7	3.9	18.9	17.7	1.3	1.1	2.4	8.4	106.1	2.3	2.4	0.9	4.4	4.3	0.3	1.1	9.6	7.8	4.3	1.0	1.9	7.4	0.3	2.9	0.5	1.6	1.4	5.5	1.6	2.8	13.5	1.1	1.0	1.1	9.3	7.7	27.9	1.5	0.0	0.0	79.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	1.4	0.0	1.8	288.7	2.6	8.5	0.0	0.9	0.0	39.6	0.0	3.4	0.0	0.0	41.2	0.1	0.0	0.0	0.0	0.4	0.5	2.6	0.1	0.9	0.1	8.6	0.2	8.9	0.0	0.0	0.0	0.0	0.0	3.8	0.0	1.4	0.0	0.0	0.0	22.9	1.2	0.0	0.0	0.1	0.0	3.9	0.0	0.3	22.2	4.1	0.3	1.1	3.7	0.0	0.0	0.1	18.6	2.1	6.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	79.4	0.0	0.0	0.0	0.0	0.0	1.8	1.9	0.4	1.5	1.3	1.1	2.4	0.9	7.8	1.1
CXCL9	"CMK, crg-10, Humig, MIG, SCYB9"	ENSG00000138755	"C-X-C motif chemokine ligand 9"	Q07325	4	76001275-76007488	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 70.6;thyroid gland: 28.6"	"Cell line enriched"	"Detected in single"	8	"RPMI-8226: 4.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.2;non-classical monocyte: 2.6"	"Lineage enriched"	"Detected in single"	27	"monocytes: 2.6"	"Region enhanced"	"Detected in single"		"olfactory region: 0.6"	"Low region specificity"	"Detected in many"								"Secreted to blood"						"prognostic favourable (6.36e-4)"	"unprognostic (6.86e-3)"	"unprognostic (1.25e-2)"	"prognostic favourable (2.07e-4)"	"unprognostic (2.97e-1)"	"unprognostic (3.78e-3)"	"unprognostic (8.79e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.46e-2)"	"prognostic favourable (8.06e-4)"	"unprognostic (2.18e-3)"	"unprognostic (1.88e-1)"	"prognostic unfavourable (5.15e-6)"	"unprognostic (4.76e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.54e-2)"	6.3	0.4	0.5	30.8	0.8	0.0	4.4	0.4	0.4	6.0	2.4	0.4	1.0	0.5	1.1	3.6	2.5	0.5	2.1	5.3	0.5	0.4	9.9	5.9	16.4	70.6	0.3	0.5	4.5	1.0	0.0	1.5	2.1	1.3	5.0	7.3	2.9	4.9	0.6	7.0	2.2	6.6	3.4	2.6	18.6	4.1	1.9	0.4	17.3	28.6	3.5	15.7	4.3	1.6	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.2	4.8	0.0	0.0	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.5	0.8	0.4	0.4	0.5	0.4	0.3	0.5	1.3	0.4
CXorf36	"DIA1R, FLJ14103"	ENSG00000147113	"Chromosome X open reading frame 36"	Q9H7Y0	X	45148374-45200901	"Disease related genes, Predicted secreted proteins"			"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enriched"	"Detected in single"	143	"HUVEC TERT2: 42.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 2.4"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA002806	Uncertain				"Secreted - unknown location"	370000	370000			"HPA002806: AB_1078595"	"unprognostic (2.12e-1)"	"unprognostic (1.32e-2)"	"unprognostic (8.51e-3)"	"unprognostic (2.05e-1)"	"unprognostic (4.65e-2)"	"unprognostic (4.07e-3)"	"unprognostic (7.30e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.39e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.75e-3)"	"unprognostic (3.79e-3)"	"unprognostic (1.98e-1)"	"unprognostic (8.47e-2)"	"unprognostic (3.11e-2)"	42.1	3.2	3.8	6.2	4.4	0.8	47.7	1.4	3.2	17.9	7.3	2.9	6.7	2.4	28.5	10.2	8.0	9.9	7.5	23.6	4.7	3.7	4.5	2.1	9.3	12.1	6.8	1.2	7.9	4.2	4.3	3.7	39.6	4.2	12.0	3.5	4.3	4.4	7.7	14.4	4.9	4.7	17.7	6.4	5.0	4.2	5.6	2.0	0.3	12.3	12.0	3.7	10.6	26.5	0.5	0.2	2.4	0.2	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	42.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.3	0.1	0.3	0.4	0.4	0.4	0.0	0.5	0.4	0.3	2.4	0.1	0.0	0.2	0.1	0.1	3.8	4.4	1.4	3.2	4.7	3.7	6.8	1.2	4.2	2.0
CYR61	"CCN1, GIG1, IGFBP10"	ENSG00000142871	"Cysteine rich angiogenic inducer 61"	O00622	1	85580761-85583962	"Predicted secreted proteins"	"Cell adhesion, Chemotaxis"	"Growth factor binding, Heparin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 98.6;U-138 MG: 98.8;U-251 MG: 95.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029853	Uncertain				"Secreted to extracellular matrix"					"HPA029853: AB_10611822"	"unprognostic (6.09e-2)"	"unprognostic (3.25e-2)"	"unprognostic (9.97e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.80e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.59e-1)"	"unprognostic (9.95e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (1.39e-4)"	"unprognostic (1.04e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.74e-3)"	79.6	23.6	3.5	106.4	6.4	0.0	47.8	0.8	4.8	110.6	27.4	13.1	20.3	3.0	73.4	64.4	26.3	76.5	108.4	60.1	4.7	4.0	30.8	41.7	98.8	59.9	2.9	4.4	66.8	17.2	5.1	8.8	64.7	7.2	60.8	16.5	23.6	14.6	49.3	55.3	28.2	15.6	102.4	6.1	58.9	35.0	26.6	3.7	1.9	56.4	23.6	16.3	101.6	42.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.6	2.2	6.3	1.3	41.4	38.4	9.5	67.8	50.9	98.6	75.6	16.3	2.4	0.0	43.4	66.8	4.5	6.4	16.2	82.0	0.1	0.8	0.0	10.3	2.3	63.8	0.4	0.0	20.8	10.6	44.5	30.1	73.4	0.1	0.0	51.2	2.0	0.0	0.1	4.1	4.3	0.0	18.8	0.0	75.2	2.7	0.0	0.4	76.0	15.4	10.3	5.0	0.3	79.0	98.8	30.8	14.1	95.5	0.0	0.1	0.1	1.2	0.0	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	6.4	0.8	4.8	4.7	4.0	2.9	4.4	7.2	3.7
CYTL1	"C17, C4orf4"	ENSG00000170891	"Cytokine like 1"	Q9NRR1	4	5014586-5019472	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 42.2"	"Cell line enhanced"	"Detected in some"		"HEL: 41.7;HUVEC TERT2: 33.5;NB-4: 81.5;WM-115: 19.7"	"Cancer enhanced"	"Detected in many"		"glioma: 21.0;melanoma: 20.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	10	"NK-cell: 18.8"	"Lineage enriched"	"Detected in many"	10	"NK-cells: 18.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067201			Supported	"Nuclear membrane,Endoplasmic reticulum"	"Secreted in other tissues"			"Nuclear membrane, Endoplasmic reticulum"		"HPA067201: "	"unprognostic (2.35e-2)"	"unprognostic (9.01e-3)"	"unprognostic (3.56e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.78e-2)"	"prognostic unfavourable (7.43e-4)"	"prognostic unfavourable (3.00e-5)"	"unprognostic (2.18e-1)"	"unprognostic (3.07e-2)"	"prognostic unfavourable (1.25e-4)"	5.2	2.3	6.5	2.0	6.0	10.8	6.4	0.7	4.2	11.0	4.9	9.2	4.9	1.0	10.1	2.8	5.3	7.3	4.6	4.4	5.4	4.4	1.2	0.8	17.1	9.4	6.2	2.1	2.5	1.1	1.7	1.6	42.2	4.7	10.5	1.8	4.5	4.0	14.2	0.8	3.3	2.1	4.2	11.0	1.1	4.9	2.2	8.4	0.5	5.7	3.6	4.8	13.2	7.4	0.0	0.3	1.9	1.0	18.8	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.7	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.6	0.0	33.5	0.0	1.7	0.0	0.0	0.0	81.5	0.1	0.0	1.2	1.7	0.0	0.0	0.0	0.0	1.9	0.0	0.0	5.1	0.0	0.0	11.4	0.0	7.9	0.0	0.0	0.2	0.0	0.0	0.0	1.0	19.7	1.9	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.6	0.1	18.8	0.0	0.3	0.0	0.6	6.5	6.0	0.7	4.2	5.4	4.4	6.2	2.1	4.7	8.4
DAND5	"CER2, CKTSF1B3, Coco, DANTE, DTE, FLJ38607, GREM3"	ENSG00000179284	"DAN domain BMP antagonist family member 5"	Q8N907	19	12965159-12974762	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 5.3;heart muscle: 13.7"	"Cell line enriched"	"Detected in some"	15	"SH-SY5Y: 20.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"neutrophil: 5.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA043493, HPA049472"	Uncertain		Approved	Mitochondria	"Secreted in other tissues"			Mitochondria		"HPA043493: , HPA049472: "	"unprognostic (1.18e-2)"	"unprognostic (4.63e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.82e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.95e-3)"	"unprognostic (7.27e-3)"	"unprognostic (8.17e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.48e-10)"	"unprognostic (4.43e-1)"	"unprognostic (2.48e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.37e-1)"	0.2	2.0	0.9	0.9	2.5	3.0	0.4	1.4	1.4	0.2	3.6	2.1	0.0	0.4	0.4	0.4	0.3	0.1	0.7	13.7	0.4	0.3	0.1	0.1	0.2	0.3	0.5	0.0	0.4	0.4	0.4	0.2	0.0	3.8	0.2	0.5	3.6	2.6	0.0	0.2	0.7	2.5	0.4	1.6	0.1	0.7	0.8	0.3	0.0	0.5	0.0	0.0	0.3	0.2	1.6	1.4	5.3	0.6	1.4	1.2	0.3	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.2	0.2	0.0	0.1	0.2	0.0	0.0	0.2	0.1	0.4	0.0	0.7	0.3	0.0	0.0	0.2	0.2	0.0	0.3	0.0	0.1	0.4	1.3	0.0	0.5	0.3	0.1	0.2	0.2	0.2	0.0	0.3	0.2	0.1	1.1	20.5	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.3	0.1	0.2	0.5	0.1	0.1	0.0	0.3	0.1	2.7	0.6	1.3	0.7	0.4	0.6	0.9	0.4	0.4	0.2	1.6	0.7	1.2	5.3	1.4	0.3	1.4	0.2	0.3	0.9	2.5	1.4	0.8	0.4	0.3	0.5	0.0	3.8	0.3
DCD	"AIDD, DCD-1, DSEP, HCAP, PIF"	ENSG00000161634	Dermcidin	P81605	12	54644591-54648493	"Plasma proteins, Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Fungicide, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"breast: 84.3;skin 1: 197.7"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 3.9"	"Cancer enriched"	"Detected in some"	9	"breast cancer: 91.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA063967	Enhanced				"Secreted in other tissues"	370000000	370000000			"HPA063967: "	"unprognostic (3.55e-2)"													"unprognostic (1.61e-1)"				7.3	0.0	0.1	0.1	0.1	0.2	84.3	0.1	0.1	0.1	0.1	0.1	4.4	0.0	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.0	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	4.6	0.1	2.7	197.7	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	1.3	0.1	0.1	0.1	1.8	1.8	5.2	2.2	3.2	2.5	0.8	0.7	0.9	1.5	1.4	0.8	1.2	1.7	1.9	0.3	0.0	1.1	0.0	1.7	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.6	2.4	2.1	0.8	0.5	0.0	0.4	1.3	0.7	0.4	0.0	0.0	0.4	1.1	3.9	0.0	0.0	0.0	1.5	0.6	0.7	1.0	0.7	0.3	0.0	0.8	1.6	1.1	0.0	1.4	0.4	0.5	0.6	0.0	1.1	0.9	0.9	0.1	0.0	0.6	0.3	0.3	1.0	0.2	5.2	1.6	2.0	1.4	1.2	2.5	1.8	1.7	1.4	1.0	1.7	2.1	2.3	3.6	3.2	2.2	1.8	1.9	0.8	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
DEFA4	"DEF4, HP-4"	ENSG00000164821	"Defensin alpha 4"	P12838	8	6935822-6938338	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin, Fungicide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"bone marrow: 245.5"	"Cell line enriched"	"Detected in some"	8	"THP-1: 11.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"neutrophil: 9.8"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 9.8"									HPA051266	Enhanced				"Secreted to blood"					"HPA051266: "																		0.3	0.0	0.1	0.1	0.2	245.5	0.2	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	35.0	0.1	0.1	0.1	1.5	8.9	0.5	0.1	0.0	0.4	0.0	0.0	0.4	3.5	0.4	0.0	0.0	0.1	0.3	0.0	0.2	0.2	0.0	0.2	0.0	26.5	0.0	0.0	0.0	8.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.3	0.0	0.7	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	16.8	0.1	0.2	0.0	0.3	0.1	0.1	0.1	0.0	0.4	0.0
DEFA5	"DEF5, HD-5"	ENSG00000164816	"Defensin alpha 5"	Q01523	8	7055304-7056734	"Plasma proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin, Fungicide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	231	"intestine: 574.2"	"Group enriched"	"Detected in some"	8	"BEWO: 19.5;NB-4: 16.0;RPMI-8226: 16.8;SH-SY5Y: 13.7;U-2197: 5.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 181.1;colorectal cancer: 147.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA015309, HPA015775, CAB069919"	Enhanced		Approved	Vesicles,Midbody	"Secreted to digestive system"			Vesicles	Midbody	"CAB069919: AB_905358, HPA015309: , HPA015775: AB_1847594"			"prognostic favourable (9.44e-5)"											"unprognostic (3.91e-2)"				0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	408.9	0.0	0.0	249.9	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.1	574.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	16.8	0.0	0.0	1.7	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
DEFA6	"DEF6, HD-6"	ENSG00000164822	"Defensin alpha 6"	Q01524	8	6924693-6926076	"Plasma proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin, Fungicide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	189	"intestine: 316.3"	"Group enriched"	"Detected in some"	12	"BEWO: 12.5;NB-4: 13.1;RPMI-8226: 15.4;SH-SY5Y: 10.6;U-2197: 4.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 75.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.6"	"Lineage enriched"	"Detected in single"	17	"B-cells: 1.6"									HPA019462	Enhanced				"Secreted to digestive system"					"HPA019462: AB_1847595"			"unprognostic (7.48e-3)"											"unprognostic (1.63e-1)"	"unprognostic (1.34e-1)"			0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	262.3	0.0	0.0	181.7	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	316.3	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.9	10.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
DEFB1	"BD1, DEFB-1, DEFB101, HBD-1, HBD1, MGC51822"	ENSG00000164825	"Defensin beta 1"	P60022	8	6870575-6878022	"Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 121.1;pancreas: 219.9;salivary gland: 173.0"	"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 27.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 522.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"classical monocyte: 1.4;intermediate monocyte: 1.6"	"Lineage enriched"	"Detected in single"	9	"monocytes: 1.6"					"Not detected"	"Not detected"								"Secreted in other tissues"						"unprognostic (2.31e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.16e-3)"	"unprognostic (4.41e-2)"	"prognostic unfavourable (5.62e-4)"	"unprognostic (2.77e-1)"	"unprognostic (2.38e-2)"	"prognostic unfavourable (5.94e-4)"	"unprognostic (3.24e-1)"	"prognostic favourable (1.90e-5)"	"unprognostic (9.62e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.16e-1)"	1.1	0.0	0.2	0.5	0.3	0.5	10.5	0.6	0.3	38.7	2.3	0.3	1.6	0.6	2.6	3.1	14.9	2.7	6.5	0.7	0.3	0.0	121.1	22.3	0.7	0.2	0.4	0.3	0.8	219.9	0.0	1.6	4.3	0.8	3.8	1.5	0.5	173.0	3.2	0.8	14.6	0.7	0.5	0.7	0.3	4.0	0.7	0.3	0.3	0.8	10.4	8.8	1.8	10.6	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.1	0.0	0.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.0	1.2	0.5	27.2	0.1	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.6	0.3	0.3	0.0	0.4	0.3	0.8	0.3
DEFB103A	"DEFB-3, DEFB103, DEFB3, HBD-3, HBD3, HBP-3, HBP3"	ENSG00000176797	"Defensin beta 103A"	P81534	8	7881204-7882664	"Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 6.6;tongue: 16.7;vagina: 6.9"	"Cell line enhanced"	"Detected in some"		"LHCN-M2: 1.7;U-2 OS: 1.2;U-2197: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"																							0.3	0.0	0.1	0.1	0.1	0.0	1.0	0.1	0.1	2.2	0.1	0.1	0.1	0.0	0.1	0.5	3.3	0.0	0.1	0.1	0.1	0.0	2.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	3.5	0.1	0.1	1.9	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	16.7	6.6	0.1	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	3.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
DEFB103B		ENSG00000177243	"Defensin beta 103B"	P81534	8	7428888-7430348	"Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 4.1;lymphoid tissue: 6.3"	"Cell line enhanced"	"Detected in some"		"LHCN-M2: 1.7;U-2 OS: 1.2;U-2197: 3.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"																							0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	4.1	0.0			0.0	0.0	0.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		1.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0			0.0		6.3	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	3.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
DEFB104A	"DEFB-4, DEFB104, DEFB4"	ENSG00000176782	"Defensin beta 104A"	Q8WTQ1	8	7836471-7841242	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	45	"epididymis: 110.0"	"Cell line enriched"	"Detected in single"	15	"SH-SY5Y: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045292	Supported				"Secreted in male reproductive system"					"HPA045292: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	110.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
DEFB104B		ENSG00000177023	"Defensin beta 104B"	Q8WTQ1	8	7470308-7475082	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	46	"epididymis: 108.2"	"Cell line enriched"	"Detected in single"	15	"SH-SY5Y: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045292	Supported				"Secreted in male reproductive system"					"HPA045292: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.1	108.2	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
DEFB105A	"DEFB-5, DEFB105"	ENSG00000186562	"Defensin beta 105A"	Q8NG35	8	7821966-7823889	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	438	"epididymis: 227.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.3;NB-4: 12.5;SH-SY5Y: 2.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in male reproductive system"																							0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0			0.0	0.0	227.6	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2		0.4	0.0	0.0	0.0	0.0		0.1	0.0		0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.4			0.0		0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
DEFB105B		ENSG00000186599	"Defensin beta 105B"	Q8NG35	8	7487669-7489593	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	396	"epididymis: 150.1"	"Cell line enriched"	"Detected in single"	12	"NB-4: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in male reproductive system"																							0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.0	0.1	150.1	0.2	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.0	0.0
DEFB106A	"DEFB-6, DEFB106"	ENSG00000186579	"Defensin beta 106A"	Q8N104	8	7825172-7829053	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	17	"epididymis: 22.0"	"Group enriched"	"Detected in some"	32	"BEWO: 2.9;RPMI-8226: 1.9;SH-SY5Y: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045592	Supported				"Secreted in male reproductive system"					"HPA045592: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	22.0	0.1	1.3	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0
DEFB106B		ENSG00000187082	"Defensin beta 106B"	Q8N104	8	7482504-7486400	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	362	"epididymis: 164.2"	"Cell line enriched"	"Detected in single"	55	"NB-4: 5.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045592	Supported				"Secreted in male reproductive system"					"HPA045592: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	164.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
DEFB107A	"DEFB-7, DEFB107"	ENSG00000186572	"Defensin beta 107A"	Q8IZN7	8	7811720-7815716	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	100	"epididymis: 77.2"	"Cell line enhanced"	"Detected in single"		"NB-4: 1.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045626	Approved				"Secreted in male reproductive system"					"HPA045626: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.1			0.0	0.3	77.2	0.1	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
DEFB107B	HsT21816	ENSG00000198129	"Defensin beta 107B"	Q8IZN7	8	7495846-7509311	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	95	"epididymis: 78.7"	"Cell line enhanced"	"Detected in single"		"NB-4: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045626	Approved				"Secreted in male reproductive system"					"HPA045626: "																		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.4	0.1	0.0	0.0	0.0	0.3	78.7	0.1	0.8	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0
DEFB108B		ENSG00000184276	"Defensin beta 108B"	Q8NET1	11	71833200-71837710	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	28	"HaCaT: 2.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042588	Uncertain				"Secreted - unknown location"					"HPA042588: AB_10959523"																		0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0		0.0	0.3	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0			0.2		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
DEFB110	"DEFB-10, DEFB-11, DEFB111"	ENSG00000203970	"Defensin beta 110"	Q30KQ9	6	50009138-50021981	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	158	"epididymis: 149.7"	"Cell line enriched"	"Detected in single"	6	"NB-4: 5.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in male reproductive system"																							0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.5	0.1	0.1	0.0	0.9	0.0	0.1	149.7	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.6	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.0	0.0	0.0
DEFB113	DEFB-13	ENSG00000214642	"Defensin beta 113"	Q30KQ7	6	49968677-49969625	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	139	"epididymis: 34.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"												"Secreted in male reproductive system"																							0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1			0.0	0.0	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
DEFB114	DEFB-14	ENSG00000177684	"Defensin beta 114"	Q30KQ6	6	49960249-49964105	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	67	"epididymis: 39.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"								"Secreted in male reproductive system"																							0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	39.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
DEFB115	DEFB-15	ENSG00000215547	"Defensin beta 115"	Q30KQ5	20	31257664-31259632	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	22	"epididymis: 5.4"	"Cell line enriched"	"Detected in single"	60	"U-2 OS: 5.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA053160	Uncertain				"Secreted in male reproductive system"					"HPA053160: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0			0.0	0.0	5.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
DEFB116	DEFB-16	ENSG00000215545	"Defensin beta 116"	Q30KQ4	20	31303212-31308585	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"epididymis: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA047430	Uncertain				"Secreted in male reproductive system"					"HPA047430: AB_10964749"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0			0.0	0.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
DEFB118	"C20orf63, DEFB-18, dJ1018D12.3, ESC42"	ENSG00000131068	"Defensin beta 118"	Q96PH6	20	31368618-31373923	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	147	"epididymis: 167.4"	"Group enriched"	"Detected in some"	5	"BEWO: 2.8;NB-4: 4.4;RPMI-8226: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042634	Enhanced				"Secreted in male reproductive system"					"HPA042634: AB_10797505"														"unprognostic (3.24e-1)"				0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	167.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
DEFB119	"DEFB-19, DEFB-20, DEFB120"	ENSG00000180483	"Defensin beta 119"	Q8N690	20	31377164-31390603	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	61	"epididymis: 218.6;testis: 126.7"	"Cell line enhanced"	"Detected in some"		"NB-4: 5.0;RPMI-8226: 3.1;SCLC-21H: 1.2;SH-SY5Y: 2.4"	"Cancer enriched"	"Detected in single"	67	"testis cancer: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043059	Supported				"Secreted in male reproductive system"					"HPA043059: AB_10797025"															"unprognostic (2.03e-1)"			0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	218.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	126.7	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	1.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB121	DEFB-21	ENSG00000204548	"Defensin beta 121"	Q5J5C9	20	31404845-31412838	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	133	"epididymis: 201.9"	"Cell line enriched"	"Detected in single"	79	"NB-4: 7.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in male reproductive system"																							0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	201.9	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.5	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
DEFB123	DEFB-23	ENSG00000180424	"Defensin beta 123"	Q8N688	20	31440519-31450257	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	403	"epididymis: 39.9;testis: 75.3"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.2;U-2197: 1.4"	"Cancer enriched"	"Detected in single"	17	"testis cancer: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"																				"unprognostic (9.16e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	75.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB124	DEFB-24	ENSG00000180383	"Defensin beta 124"	Q8NES8	20	31465506-31476757	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 9.1;testis: 7.7"	"Cell line enhanced"	"Detected in some"		"HEL: 4.8;HMC-1: 2.8;U-2 OS: 2.1;WM-115: 10.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"midbrain: 2.6;pons and medulla: 1.6;thalamus: 3.4"						"Secreted in other tissues"						"unprognostic (1.24e-2)"	"unprognostic (9.76e-3)"		"unprognostic (1.27e-1)"	"unprognostic (3.23e-3)"	"unprognostic (6.92e-3)"		"unprognostic (3.69e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.78e-1)"	"unprognostic (9.07e-2)"	"unprognostic (4.43e-1)"	"unprognostic (3.32e-7)"	"unprognostic (1.56e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.42e-2)"	"unprognostic (4.28e-1)"	3.5	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	3.7	1.9			0.0	5.3	4.6	0.4	9.1	0.0	0.4	0.0	0.0	0.2	0.0	0.4	0.6	0.0		0.4	0.0	1.3	0.9	0.0		1.0	0.9		0.5	5.0	0.9	0.2	0.9	0.6	0.0	0.6	0.9	7.7			0.8		0.5	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
DEFB125	DEFB-25	ENSG00000178591	"Defensin beta 125"	Q8N687	20	87250-97094	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"epididymis: 74.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in male reproductive system"																							0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	13.6	0.0	0.0	74.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.1	0.1	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0
DEFB126	"bA530N10.1, C20orf8, DEFB-26"	ENSG00000125788	"Defensin beta 126"	Q9BYW3	20	142369-145751	"Disease related genes, Predicted secreted proteins"	Fertilization	"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"epididymis: 255.5"	"Cell line enhanced"	"Detected in some"		"NB-4: 2.9;RPMI-8226: 1.6;SH-SY5Y: 1.5;SK-BR-3: 1.8;SK-MEL-30: 1.1"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in male reproductive system"											"unprognostic (1.16e-1)"		"unprognostic (1.21e-1)"		"unprognostic (3.16e-2)"		"unprognostic (2.41e-2)"			"unprognostic (2.32e-1)"		"unprognostic (1.47e-1)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.4	0.1	0.0	18.2	0.0	0.1	255.5	0.3	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.4	0.1	0.1	0.1	0.0	0.3	0.1	0.1	1.4	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.5	0.0	1.8	1.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
DEFB127	"bA530N10.2, C20orf73, DEF-27"	ENSG00000088782	"Defensin beta 127"	Q9H1M4	20	157470-159163	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	56	"epididymis: 170.3"	"Group enriched"	"Detected in some"	27	"BEWO: 3.0;NB-4: 2.9;SH-SY5Y: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"								"Secreted in male reproductive system"																							0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.4	0.1	0.0	3.0	0.0	0.1	170.3	0.1	0.1	0.0	0.1	0.1	0.1	1.2	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.9	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
DEFB128	DEFB-28	ENSG00000185982	"Defensin beta 128"	Q7Z7B8	20	187853-189681	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	239	"epididymis: 186.7"	"Group enriched"	"Detected in some"	26	"BEWO: 2.8;NB-4: 3.1;RPMI-8226: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"								"Secreted in male reproductive system"																							0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	186.7	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0
DEFB129	"bA530N10.3, C20orf87, DEFB-29"	ENSG00000125903	"Defensin beta 129"	Q9H1M3	20	227258-229886	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"epididymis: 223.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.3;NB-4: 7.0;RPMI-8226: 1.6;SH-SY5Y: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA014581	Supported				"Secreted in male reproductive system"					"HPA014581: "																		0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	14.0	0.0	0.2	223.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.3	0.1	0.6	0.1	0.0	0.1	0.1	0.1	1.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	3.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
DEFB130A	"DEFB-30, DEFB130, DEFB30"	ENSG00000232948	"Defensin beta 130A"	P0DP74	8	12310962-12318316	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	19	"epididymis: 8.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in male reproductive system"																							0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1		0.0	0.1	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
DEFB130B		ENSG00000233050	"Defensin beta 130B"	P0DP73	8	12064389-12071747	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	19	"epididymis: 8.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in male reproductive system"																							0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1		0.0	0.1	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
DEFB131A	"DEFB-31, DEFB131"	ENSG00000186146	"Defensin beta 131A"	P59861	4	9444534-9450514	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"ductus deferens: 31.3;epididymis: 65.5"	"Cell line enriched"	"Detected in some"	6	"TIME: 6.7"	"Cancer enriched"	"Detected in single"	18	"thyroid cancer: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"																					"unprognostic (2.11e-1)"		0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	9.0	0.0	31.3	5.5	0.1	65.5	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.1	10.9	0.1	0.1	10.3	0.0	0.1	0.1	0.2	0.3	0.0	0.0	8.5	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
DEFB131B		ENSG00000225805	"Defensin beta 131B"	A0A096LNP1	11	71878453-71884561	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	12	"epididymis: 36.6"	"Cell line enhanced"	"Detected in many"		"RH-30: 17.4"	"Low cancer specificity"	"Detected in single"							"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.0"	"Low lineage specificity"	"Detected in many"																"Secreted in male reproductive system"						"unprognostic (5.87e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.78e-2)"		"unprognostic (7.44e-2)"	"unprognostic (3.57e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.09e-3)"	"unprognostic (7.45e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.62e-1)"	0.0	0.0		0.2		0.0	0.0		0.1	0.0	0.0			0.5	0.0	36.6	0.0	0.0	1.2	0.0			0.0	0.0	0.0	0.7			0.4	0.0	0.0		0.0		0.0	0.0		0.1	0.0	0.0	0.8	0.1	0.0		0.0	0.0	0.1			1.5		0.0	0.9		0.3	3.0	0.8	0.7	1.4	1.2	0.0	0.6	0.0	3.6	1.4	0.0	0.0	0.4	3.7	0.0	0.0	0.0	4.4	4.1	3.5	1.3	0.0	3.8	0.0	0.0	0.0	2.8	2.9	3.7	2.1	2.5	0.0	4.6	1.7	0.0	0.0	0.0	0.0	0.0	8.4	6.0	0.0	3.3	2.0	1.2	1.1	5.7	3.9	17.4	1.1	0.0	1.1	4.0	1.6	3.4	2.0	3.4	3.5	0.4	2.1	1.3	3.6	2.5	0.3	3.0	1.0	4.7	2.1	4.1	0.8	0.8	0.7	0.0	1.2	0.0	0.0	0.0	0.7	0.0	0.4	0.3	0.4	0.6	0.0	1.4	0.5	3.0	0.9	0.0										
DEFB132	"DEFB32, RP5-1103G7.6"	ENSG00000186458	"Defensin beta 132"	Q7Z7B7	20	257736-261096	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"ductus deferens: 37.1;epididymis: 119.7"	"Group enriched"	"Detected in some"	7	"BEWO: 1.1;NB-4: 3.2;RPMI-8226: 1.8;SH-SY5Y: 1.6"	"Cancer enhanced"	"Detected in some"		"liver cancer: 0.8;prostate cancer: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046399	Approved				"Secreted in male reproductive system"					"HPA046399: AB_10960992"	"unprognostic (9.27e-3)"						"unprognostic (1.61e-2)"					"unprognostic (2.54e-2)"						17.2	0.1	0.1	0.0	0.1	0.0	4.4	0.1	0.1	0.1	0.1	0.0	37.1	0.0	0.1	119.7	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.9	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.1	6.4	0.1	0.1	0.2	0.0	0.1	0.1	0.1	1.3	0.0	0.0	0.1	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
DEFB133		ENSG00000214643	"Defensin beta 133"	Q30KQ1	6	49946021-49950265	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	30	"epididymis: 18.2"	"Cell line enriched"	"Detected in single"	42	"K-562: 4.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in male reproductive system"																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
DEFB134		ENSG00000205882	"Defensin beta 134"	Q4QY38	8	11993174-11996312	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	4	"epididymis: 24.4"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.5;NTERA-2: 1.2;U-87 MG: 1.1;WM-115: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in male reproductive system"																				"unprognostic (3.80e-2)"	"unprognostic (2.20e-1)"		0.0	0.0	0.3	0.0	0.4	0.0	0.0	1.0	0.2	0.0	0.0	0.0	1.6	0.3	0.0	24.4	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	1.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0
DEFB135		ENSG00000205883	"Defensin beta 135"	Q30KP9	8	11982321-11984590	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	23	"epididymis: 30.8"	"Group enriched"	"Detected in some"	4	"HEK 293: 1.8;MCF7: 6.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"								"Secreted in male reproductive system"																							0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	30.8	0.0	0.0	0.0	0.6	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.5	0.3	0.3	0.1	0.0	0.0	0.0
DEFB136	DEFB137	ENSG00000205884	"Defensin beta 136"	Q30KP8	8	11973937-11974599	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	5	"epididymis: 5.8;prostate: 1.5"	"Group enriched"	"Detected in some"	16	"HAP1: 2.7;WM-115: 1.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA068255	Enhanced				"Secreted in male reproductive system"					"HPA068255: "																		0.2	0.0	0.2	0.0	0.5	0.0	0.0	0.3	0.4	0.0	0.0			0.0	0.3	5.8	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1		0.0	0.0	0.0	0.3	0.0		1.5	0.0		0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.3			0.0		0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
DEFB4A	"DEFB-2, DEFB102, DEFB2, DEFB4, HBD-2, SAP1"	ENSG00000171711	"Defensin beta 4A"	O15263	8	7894629-7896711	"Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 44.1;lymphoid tissue: 15.7;tongue: 50.4"	"Group enriched"	"Detected in some"	13	"EFO-21: 6.7;NTERA-2: 2.5"	"Group enriched"	"Detected in many"	6	"head and neck cancer: 32.2;melanoma: 9.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"							"unprognostic (6.96e-2)"		"unprognostic (1.17e-2)"		"unprognostic (2.72e-2)"		"unprognostic (4.37e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.50e-1)"				"unprognostic (2.75e-1)"				0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	1.0	0.2	0.2	0.2	0.0	0.3	0.2	44.1	0.0	8.6	0.2	0.2	0.0	0.2	0.2	2.9	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	7.3	0.2	0.2	1.3	0.2	0.2	0.2	0.2	2.9	0.2	0.2	0.2	0.2	50.4	15.7	0.2	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
DEFB4B	DEFB4P	ENSG00000177257	"Defensin beta 4B"	O15263	8	7414860-7416863	"Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 14.3;lymphoid tissue: 8.8"	"Cell line enriched"	"Detected in single"	16	"CAPAN-2: 1.5"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"											"unprognostic (1.35e-1)"												0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		2.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0			0.0		8.8	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
DHH	"HHG-3, MGC35145"	ENSG00000139549	"Desert hedgehog"	O43323	12	49089421-49094819	"Disease related genes, Predicted secreted proteins"		"Developmental protein, Hydrolase, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 35.7"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.3;EFO-21: 7.1;HUVEC TERT2: 2.8;K-562: 11.9;TIME: 6.4"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in some"	4	"midbrain: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"midbrain: 2.1"						"Secreted in male reproductive system"						"unprognostic (7.56e-2)"	"unprognostic (2.05e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.93e-3)"	"unprognostic (2.36e-4)"	"unprognostic (1.29e-1)"	"unprognostic (7.22e-3)"	"unprognostic (8.21e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.97e-2)"	0.9	0.4	0.2	1.2	0.6	0.1	1.4	0.3	0.6	0.6	0.5	0.2	0.3	0.3	1.0	0.9	0.5	0.6	1.7	0.9	0.2	0.2	0.6	0.2	0.9	0.2	5.2	0.0	0.4	0.2	0.2	0.8	1.5	1.2	0.7	0.2	1.3	0.7	0.8	0.6	0.3	0.5	1.0	1.2	0.3	0.3	35.7	0.0	0.0	0.4	1.3	0.2	0.6	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.8	11.9	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.3	0.6	0.2	0.2	5.2	0.0	1.2	0.0
DKK1	"DKK-1, SK"	ENSG00000107984	"Dickkopf WNT signaling pathway inhibitor 1"	O94907	10	52314296-52318042	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"placenta: 153.6"	"Cell line enhanced"	"Detected in many"		"BJ: 111.1;BJ hTERT+: 61.0;CACO-2: 97.0;fHDF/TERT166: 153.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	9	"pons and medulla: 15.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in female reproductive system"						"unprognostic (5.65e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.09e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (4.35e-8)"	"unprognostic (7.93e-2)"	"prognostic unfavourable (7.80e-6)"	"unprognostic (1.54e-1)"	"unprognostic (6.87e-2)"	"prognostic unfavourable (1.27e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.68e-1)"	"unprognostic (7.47e-3)"	"unprognostic (4.05e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.06e-2)"	15.6	0.1	0.5	0.3	0.4	0.0	4.0	0.4	0.6	26.2	0.3	0.6	1.8	0.1	2.1	0.5	5.3	0.1	2.8	0.6	0.8	1.7	0.5	0.2	0.6	0.3	0.7	0.3	0.9	0.1	0.1	0.2	153.6	15.2	4.2	0.1	0.7	1.6	1.3	0.6	11.7	0.2	1.2	0.2	0.4	0.8	1.6	0.4	0.1	0.2	0.1	0.5	10.6	7.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	29.7	20.8	0.0	3.1	15.2	3.1	0.0	111.1	61.0	38.2	20.3	97.0	6.2	0.0	0.1	153.6	23.8	0.0	12.7	36.3	0.0	0.0	0.0	0.4	2.4	3.2	0.0	0.0	3.0	1.5	8.2	49.0	3.5	0.0	0.0	25.1	12.8	0.0	0.0	0.0	53.4	0.0	3.4	0.0	14.6	2.4	0.0	34.1	9.9	0.1	1.6	0.1	0.0	7.6	0.0	0.0	33.5	20.2	0.0	0.0	0.0	0.4	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.4	0.6	0.8	1.7	0.7	0.3	15.2	0.4
DKK3	"REIC, RIG"	ENSG00000050165	"Dickkopf WNT signaling pathway inhibitor 3"	Q9UBP4	11	11963106-12009769	"Plasma proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"brain: 94.7;heart muscle: 297.4"	"Cell line enhanced"	"Detected in many"		"BJ: 60.0;BJ hTERT+: 92.8;fHDF/TERT166: 86.9;TIME: 49.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"MAIT T-cell: 8.9;memory CD8 T-cell: 5.5;naive CD8 T-cell: 2.2"	"Lineage enriched"	"Detected in single"	90	"T-cells: 8.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA011868, CAB024949"	Approved		Supported	"Nuclear bodies,Vesicles,Cytosol"	"Secreted in other tissues"	15000000	15000000	Vesicles	"Nuclear bodies, Cytosol"	"CAB024949: , HPA011868: AB_1847716"	"unprognostic (4.24e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.84e-2)"	"unprognostic (3.06e-3)"	"unprognostic (6.58e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.31e-3)"	"unprognostic (5.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.87e-2)"	"prognostic unfavourable (6.31e-5)"	"unprognostic (7.41e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.02e-3)"	4.8	21.7	44.9	3.5	94.7	1.3	6.8	32.5	60.3	25.8	7.3	12.1	4.1	4.9	7.8	5.6	8.8	4.9	17.9	297.4	49.6	23.5	5.1	2.7	17.8	3.1	19.1	45.8	10.8	5.7	10.9	6.6	7.5	24.7	16.8	4.6	10.7	9.1	22.3	2.7	8.3	7.3	12.0	32.9	9.0	7.0	8.9	25.5	0.0	4.7	2.5	2.6	10.5	7.8	0.0	0.0	0.0	0.0	0.0	8.9	0.6	0.2	1.8	2.6	0.0	2.2	4.4	0.0	60.0	92.8	26.6	30.2	1.3	0.4	0.0	6.6	86.9	9.2	0.2	25.9	10.2	0.0	0.0	0.0	0.2	0.0	16.9	0.0	0.0	6.7	8.7	9.0	22.2	28.1	0.0	0.0	36.7	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	9.1	0.0	0.0	7.8	0.2	0.0	0.0	0.0	0.0	49.8	15.8	12.4	1.6	15.5	0.0	0.0	0.0	2.6	0.0	14.8	0.0	0.0	0.0	0.8	0.0	8.9	0.0	0.8	5.5	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.6	44.9	94.7	32.5	46.5	49.6	23.5	19.1	45.8	24.7	25.5
DKK4		ENSG00000104371	"Dickkopf WNT signaling pathway inhibitor 4"	Q9UBT3	8	42374068-42377232	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 10.6;gallbladder: 9.9"	"Cell line enriched"	"Detected in single"	11	"Hep G2: 6.7"	"Cancer enriched"	"Detected in many"	20	"endometrial cancer: 174.4"	"Region enhanced"	"Detected in some"		"cerebellum: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA052916	Uncertain				"Secreted in other tissues"					"HPA052916: AB_2681987"	"unprognostic (1.64e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.37e-3)"	"unprognostic (3.23e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.99e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.63e-2)"	"unprognostic (6.73e-2)"		"unprognostic (1.48e-2)"	"unprognostic (3.53e-1)"		"unprognostic (8.11e-2)"	0.2	0.0	0.1	0.1	0.1	0.2	1.6	2.8	0.1	2.3	0.1	0.1	0.1	5.1	1.6	2.3	10.6	0.7	9.9	0.1	0.1	1.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	2.0	0.1	0.5	1.4	0.0	0.1	1.7	1.9	0.2	0.2	0.9	0.5	0.1	0.1	2.2	2.9	0.1	1.8	0.1	5.9	1.6	2.5	4.3	0.7	0.7	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.1	0.1	2.8	0.1	0.1	1.0	0.1	0.1	0.5	0.1
DMBT1	"Gp-340, GP340, hensin, muclin, SALSA, vomeroglandin"	ENSG00000187908	"Deleted in malignant brain tumors 1"	Q9UGM3	10	122560665-122643736	"Disease related genes, Predicted secreted proteins"	"Antiviral defense, Differentiation, Host-virus interaction, Protein transport, Transport"	"Developmental protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 122.3;salivary gland: 130.0"	"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 4.5;LHCN-M2: 9.0;RH-30: 20.9"	"Group enriched"	"Detected in many"	10	"colorectal cancer: 47.6;lung cancer: 18.0;pancreatic cancer: 33.3;stomach cancer: 76.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA040778	Enhanced		Approved	"Centriolar satellite"	"Secreted in other tissues"	7500000	7500000	"Centriolar satellite"		"HPA040778: "	"unprognostic (3.32e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.47e-2)"	"prognostic favourable (1.43e-4)"	"unprognostic (8.77e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.70e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.51e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.08e-9)"	"unprognostic (2.26e-1)"	"unprognostic (2.92e-4)"	"unprognostic (2.00e-3)"	"unprognostic (2.22e-1)"	0.1	0.1	0.2	2.4	0.2	0.0	0.1	0.1	0.2	1.1	34.8	0.1	0.1	122.3	0.2	0.1	0.3	0.3	2.7	0.1	0.3	0.2	0.1	0.1	13.1	0.1	0.6	0.1	0.2	1.2	0.0	0.1	0.1	0.1	0.5	1.5	0.1	130.0	0.1	0.2	0.2	68.3	0.9	1.1	0.1	0.2	0.3	0.1	0.1	0.1	19.7	14.7	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.3	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.3	0.3	0.2	4.5	0.0	0.0	0.0	9.0	0.0	0.0	0.7	0.0	0.0	0.0	20.9	2.4	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.1	0.5	2.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.3	0.2	0.6	0.1	0.1	0.1
DMP1		ENSG00000152592	"Dentin matrix acidic phosphoprotein 1"	Q13316	4	87650307-87664361	"Disease related genes, Predicted secreted proteins"	Biomineralization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 2.9;testis: 3.6"	"Group enriched"	"Detected in some"	5	"RH-30: 1.4;U-266/70: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA037465	Approved				"Secreted to extracellular matrix"					"HPA037465: AB_10672492"	"unprognostic (6.77e-2)"	"unprognostic (1.55e-1)"		"unprognostic (1.42e-3)"	"unprognostic (1.80e-1)"	"unprognostic (4.96e-3)"		"unprognostic (7.73e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.35e-2)"		"unprognostic (8.50e-9)"	"unprognostic (5.82e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.74e-3)"	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	3.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.9	0.0
DNASE1L2	DNAS1L2	ENSG00000167968	"Deoxyribonuclease 1 like 2"	Q92874	16	2235816-2238711	"Predicted secreted proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 11.7;skin 1: 20.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"eosinophil: 1.4;neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA044714			Approved	Mitochondria	"Secreted in other tissues"			Mitochondria		"HPA044714: AB_10962870"	"unprognostic (9.88e-2)"	"unprognostic (1.11e-3)"	"unprognostic (6.80e-4)"	"unprognostic (4.29e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.72e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.96e-3)"	"unprognostic (2.17e-2)"	"unprognostic (4.67e-4)"	"unprognostic (1.40e-4)"	"unprognostic (3.51e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.94e-4)"	0.6	1.3	1.3	0.6	2.1	0.8	2.1	8.8	2.8	0.6	0.6	0.6	0.6	0.8	1.2	3.5	0.6	0.4	0.6	0.6	1.6	2.1	0.9	1.6	0.6	0.6	1.5	0.6	0.7	1.9	0.2	2.1	1.3	1.3	0.8	0.2	0.6	11.7	0.6	0.7	20.6	0.8	0.6	1.3	1.0	0.9	1.9	0.6	2.4	2.7	7.1	3.4	0.6	0.6	0.0	0.0	1.6	0.0	0.0	0.2	0.0	1.9	3.9	1.7	1.7	1.4	0.7	6.8	0.6	0.5	1.6	0.8	4.3	4.1	2.6	2.1	0.2	0.6	0.6	0.2	0.1	5.0	3.7	1.1	6.2	1.0	0.2	1.2	4.1	0.9	1.4	1.2	0.3	0.3	3.5	3.8	0.6	4.5	3.5	7.4	1.6	2.6	6.6	2.0	3.5	0.9	0.8	3.5	1.8	0.9	1.5	2.7	6.1	2.7	0.1	3.3	4.4	1.9	1.3	9.3	4.5	2.3	1.1	2.4	1.7	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	1.3	2.1	8.8	2.8	1.6	2.1	1.5	0.6	1.3	0.6
DPT		ENSG00000143196	Dermatopontin	Q07507	1	168695459-168729264	"Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 128.1"	"Group enriched"	"Detected in some"	13	"ASC diff: 54.0;fHDF/TERT166: 21.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065548			Approved	Vesicles	"Secreted to extracellular matrix"	25000	25000	Vesicles		"HPA065548: "	"unprognostic (1.49e-1)"	"unprognostic (7.62e-2)"	"unprognostic (5.66e-2)"	"unprognostic (4.39e-2)"	"unprognostic (4.64e-2)"	"unprognostic (3.78e-3)"	"unprognostic (4.09e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.16e-2)"	"prognostic unfavourable (4.74e-5)"	"unprognostic (2.12e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.98e-3)"	128.1	6.1	0.8	22.6	0.8	0.0	99.3	0.8	2.4	51.0	81.7	0.9	19.8	2.4	20.4	38.8	33.1	23.0	52.3	48.8	0.8	0.3	2.4	6.0	9.6	7.7	0.8	0.8	12.8	13.4	0.0	0.9	7.8	0.9	24.0	9.4	1.8	14.4	10.2	13.0	8.6	23.1	76.1	0.8	1.0	23.6	8.7	0.8	2.3	16.3	55.7	22.8	48.7	39.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.0	0.2	0.0	0.0	2.4	2.6	2.7	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.8	2.4	0.8	0.3	0.8	0.8	0.9	0.8
DRAXIN	"C1orf187, Draxin, FLJ34999, Neucrin"	ENSG00000162490	"Dorsal inhibitory axon guidance protein"	Q8NBI3	1	11691729-11725857	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 5.6;brain: 9.5"	"Cell line enriched"	"Detected in some"	5	"NTERA-2: 24.7"	"Group enriched"	"Detected in some"	6	"glioma: 5.1;testis cancer: 2.8"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 5.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA014302	Uncertain				"Secreted in brain"					"HPA014302: AB_1853084"	"unprognostic (5.28e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.58e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.51e-2)"	"unprognostic (7.47e-2)"	"unprognostic (5.16e-6)"	"unprognostic (4.65e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.52e-2)"	"unprognostic (5.08e-1)"	0.7	0.4	9.5	1.0	4.4	2.8	1.4	4.1	4.7	0.3	0.4	4.9	0.0	0.6	1.0	0.8	0.6	0.7	0.6	0.4	8.9	0.9	0.5	0.2	1.2	1.0	2.7	3.0	0.5	0.7	0.4	0.2	0.4	2.4	0.4	0.5	0.0	3.6	0.7	0.6	1.3	0.7	0.3	1.9	0.9	0.4	1.5	2.5	0.0	0.7	0.8	0.5	0.4	0.2	1.2	0.6	5.6	1.1	0.9	1.9	0.5	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.3	0.0	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.1	1.8	0.3	24.7	0.0	5.4	0.2	0.0	0.0	0.0	1.6	0.7	0.0	0.0	0.1	0.0	0.1	0.2	0.1	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.3	5.6	1.1	0.7	1.9	0.6	0.7	0.6	0.5	1.1	0.3	1.2	0.8	1.0	2.9	0.9	0.7	0.6	0.8	0.5	9.5	4.4	4.1	4.2	8.9	0.9	2.7	3.0	2.4	2.5
DSPP	"DFNA39, DGI1, DMP3"	ENSG00000152591	"Dentin sialophosphoprotein"	Q9NZW4	4	87608529-87616910	"Disease related genes, Predicted secreted proteins"	Biomineralization		"Deafness, Disease mutation"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA036230	Uncertain				"Secreted in other tissues"					"HPA036230: AB_10672239"				"unprognostic (2.34e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.01e-1)"		"unprognostic (1.27e-1)"		"unprognostic (2.21e-2)"				"unprognostic (1.26e-1)"			"unprognostic (1.76e-1)"	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0			0.0	0.2	0.0	0.1	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0		0.2	0.0	0.0	0.0	0.0		0.0	0.1		0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4			0.0		0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0										
EBI3	"IL27B, IL35B"	ENSG00000105246	"Epstein-Barr virus induced 3"	Q14213	19	4229498-4237531	"Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"placenta: 411.9"	"Cell line enriched"	"Detected in some"	13	"HDLM-2: 67.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 15.5;naive B-cell: 8.5"	"Group enriched"	"Detected in many"	15	"B-cells: 15.5;monocytes: 4.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA046635	Enhanced				"Secreted to blood"	1200000	1200000			"HPA046635: "	"unprognostic (7.26e-2)"	"unprognostic (1.49e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.78e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.25e-3)"	"unprognostic (8.27e-2)"	"prognostic unfavourable (1.04e-8)"	"unprognostic (1.97e-1)"	"unprognostic (2.78e-2)"	"unprognostic (9.29e-2)"	"unprognostic (4.67e-2)"	2.1	2.5	1.9	5.7	1.5	0.4	1.4	0.3	1.0	0.8	1.3	1.1	0.3	1.7	0.6	0.8	0.5	1.7	2.3	0.7	1.7	1.4	2.1	1.9	1.8	18.5	2.5	0.7	0.6	1.0	0.1	1.1	411.9	1.1	1.0	0.7	0.7	1.1	0.6	0.4	0.2	5.1	0.8	3.8	24.6	1.5	0.9	1.3	4.9	0.5	0.3	2.9	2.0	0.5	15.5	0.6	0.1	4.5	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	2.3	0.2	1.3	0.1	0.0	0.4	0.3	1.3	5.3	0.0	0.0	0.0	0.0	0.0	67.2	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.1	0.0	0.6	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.1	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	3.7	0.0	15.5	0.0	0.0	0.6	8.5	0.0	0.0	0.1	0.0	4.5	0.0	0.0	0.4	1.9	1.5	0.3	1.0	1.7	1.4	2.5	0.7	1.1	1.3
ECM1		ENSG00000143369	"Extracellular matrix protein 1"	Q16610	1	150508062-150513789	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Biomineralization, Mineral balance, Osteogenesis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 133.2;esophagus: 257.1;lymphoid tissue: 107.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 76.4;BJ hTERT+: 53.2;fHDF/TERT166: 50.1;hTEC/SVTERT24-B: 36.0;LHCN-M2: 39.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.2;myeloid DC: 1.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA027241	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	12000000000	12000000000	Cytosol	Nucleoplasm	"HPA027241: AB_1847976"	"unprognostic (2.89e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.79e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.90e-2)"	"unprognostic (7.50e-2)"	"prognostic unfavourable (3.55e-4)"	"unprognostic (5.33e-2)"	"prognostic unfavourable (1.51e-9)"	"unprognostic (1.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavourable (1.20e-5)"	16.1	2.5	0.9	1.8	1.3	0.1	11.0	0.9	4.2	37.9	2.8	0.1	7.4	1.5	10.5	133.2	257.1	3.3	30.7	11.6	0.9	1.0	2.5	16.7	3.8	0.2	1.0	1.7	3.0	0.8	0.3	2.0	20.2	4.2	2.6	3.1	1.6	28.7	2.9	3.5	11.5	2.0	5.3	0.8	3.6	2.1	5.9	0.0	0.0	1.8	45.5	107.2	6.0	46.6	0.0	1.8	0.0	1.2	0.0	0.4	1.3	6.1	0.6	2.3	0.0	13.8	76.4	2.1	22.4	53.2	14.0	18.3	0.3	3.4	0.1	0.2	50.1	12.9	0.0	2.6	14.7	0.1	0.1	0.9	0.7	0.1	3.8	0.0	23.2	6.7	0.1	36.0	1.3	3.9	4.8	0.1	39.0	0.0	0.0	0.7	0.2	0.7	0.3	16.8	0.1	0.5	0.0	0.1	0.0	5.2	0.1	19.1	0.0	5.9	1.0	29.7	4.4	3.3	4.8	0.1	0.1	0.2	15.6	2.0	4.0	0.0	1.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.9	1.3	0.9	4.2	0.9	1.0	1.0	1.7	4.2	0.0
ECM2		ENSG00000106823	"Extracellular matrix protein 2"	O94769	9	92493554-92536655	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"ASC diff: 11.1;ASC TERT1: 20.3;HSkMC: 21.4;hTCEpi: 24.4;hTERT-HME1: 6.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035347	Approved				"Secreted to extracellular matrix"	5500000	5500000			"HPA035347: AB_10669856"	"unprognostic (2.48e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.20e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.30e-1)"	"prognostic favourable (4.50e-5)"	"unprognostic (6.14e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (4.09e-6)"	"unprognostic (1.12e-3)"	"unprognostic (2.39e-2)"	"unprognostic (3.80e-2)"	"unprognostic (6.63e-3)"	43.3	5.0	5.4	7.2	4.3	0.0	18.6	9.5	1.9	20.9	6.5	5.4	11.6	2.9	14.7	27.5	8.4	11.6	11.2	13.8	9.3	3.6	10.1	28.2	8.8	2.3	11.0	4.2	34.6	1.9	4.9	4.7	1.4	17.8	16.4	2.4	5.8	3.4	8.1	6.0	5.8	5.4	10.1	15.8	0.5	2.8	15.4	7.4	1.1	8.3	15.5	2.4	13.7	8.8	0.3	0.6	0.0	0.5	0.1	0.5	0.0	0.4	0.0	0.2	0.0	11.1	20.3	0.7	0.4	0.6	0.0	0.3	0.3	0.0	0.0	0.0	1.0	0.3	0.5	0.4	0.0	2.4	0.0	0.0	0.0	0.0	1.9	0.1	0.0	21.4	24.4	0.5	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.4	0.4	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.5	0.0	0.1	0.4	0.0	0.3	0.0	0.0	0.5	0.2	0.5	0.0	0.0	0.1	0.1	0.6	0.0	0.0	5.4	4.3	9.5	1.9	9.3	3.6	11.0	4.2	17.8	7.4
EDDM3A	"FAM12A, HE3-ALPHA"	ENSG00000181562	"Epididymal protein 3A"	Q14507	14	20745892-20748380	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"ductus deferens: 61.8;epididymis: 129.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;NB-4: 3.3;SH-SY5Y: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"naive B-cell: 1.2"	"Lineage enriched"	"Detected in single"	13	"B-cells: 1.2"									HPA049952	Approved				"Secreted in male reproductive system"					"HPA049952: "	"unprognostic (1.42e-1)"				"unprognostic (9.88e-2)"								"unprognostic (8.56e-3)"		"unprognostic (2.10e-1)"			0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.0	61.8	0.0	0.1	129.9	0.1	0.2	0.0	0.1	0.1	0.1	1.5	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.2	14.7	0.1	0.1	0.1	0.0	0.1	0.4	0.4	4.7	0.0	0.0	0.1	0.0	0.0	0.2	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
EDDM3B	"FAM12B, HE3-BETA"	ENSG00000181552	"Epididymal protein 3B"	P56851	14	20768427-20770948	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"epididymis: 261.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.7;NB-4: 7.1;RPMI-8226: 1.6;SH-SY5Y: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA001323	Enhanced				"Secreted in male reproductive system"					"HPA001323: AB_1848377"	"unprognostic (2.40e-2)"																	0.1	0.1	0.1	0.0	0.1	0.0	0.8	0.1	0.1	0.2	0.1	0.0	12.9	0.0	0.2	261.1	0.1	0.1	0.0	0.2	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.8	0.9	0.2	0.4	0.1	0.0	0.2	0.1	0.1	3.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
EDIL3	DEL1	ENSG00000164176	"EGF like repeats and discoidin domains 3"	O43854	5	83940554-84384793	"Predicted secreted proteins"	"Cell adhesion"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 85.3"	"Cell line enhanced"	"Detected in many"		"HHSteC: 26.1;LHCN-M2: 42.9;TIME: 50.7;U-2 OS: 43.0;U-87 MG: 29.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020415	Approved				"Secreted to blood"					"HPA020415: "	"unprognostic (9.93e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.71e-2)"	"unprognostic (8.63e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.16e-2)"	"unprognostic (9.19e-2)"	"unprognostic (6.64e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.28e-3)"	7.9	12.6	29.3	7.2	45.3	0.2	3.6	5.5	46.2	10.9	20.1	77.0	0.3	9.3	15.6	26.2	9.9	4.9	19.2	10.8	42.6	24.7	6.5	1.1	11.7	0.5	67.3	22.5	6.1	2.0	0.9	2.1	2.6	37.1	8.1	21.8	5.0	2.5	13.5	1.2	5.5	14.3	14.4	85.3	1.8	10.6	1.4	61.6	0.0	2.4	0.1	2.1	7.7	5.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.9	0.0	0.0	1.2	0.0	3.2	4.3	0.0	5.3	0.0	0.0	0.0	4.9	0.0	0.2	2.4	0.0	2.3	0.0	15.3	0.0	26.1	0.2	0.0	6.7	0.6	15.6	2.2	5.4	0.0	0.0	42.9	0.0	0.0	0.0	2.2	10.0	0.0	10.5	0.0	7.2	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	50.7	15.7	43.0	0.5	13.9	0.4	0.0	0.0	29.0	0.0	4.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	29.3	45.3	5.5	30.1	42.6	24.7	67.3	22.5	37.1	61.6
EDN1	ET1	ENSG00000078401	"Endothelin 1"	P05305	6	12290363-12297194	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"		"Vasoactive, Vasoconstrictor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 107.5;HUVEC TERT2: 71.2;T-47d: 22.0;TIME: 52.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"non-classical monocyte: 7.9"	"Lineage enriched"	"Detected in many"	6	"monocytes: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031976, CAB032500, CAB037291"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"	"Secreted to blood"			"Nucleoli, Golgi apparatus"	Nucleoplasm	"CAB032500: AB_2096241, CAB037291: AB_259277, HPA031976: AB_10602489"	"unprognostic (1.51e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.72e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.42e-1)"	"unprognostic (8.92e-2)"	"unprognostic (4.19e-2)"	"unprognostic (3.17e-1)"	"unprognostic (8.02e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.47e-1)"	35.7	1.5	8.4	6.2	30.8	3.6	19.2	3.2	22.0	8.2	9.2	4.2	1.1	9.0	7.2	15.3	10.8	8.6	11.9	5.2	19.0	6.2	5.7	2.8	25.1	6.7	10.9	5.5	4.3	8.2	1.6	1.0	16.0	25.1	5.4	12.9	6.9	9.7	8.5	25.6	8.2	6.7	9.7	13.5	10.2	6.8	4.8	5.6	0.2	2.9	3.8	2.1	5.3	4.1	0.2	0.2	1.2	7.9	0.0	0.2	0.0	1.5	9.0	0.1	0.0	0.0	0.0	0.0	2.8	2.5	2.4	2.0	11.6	1.3	0.0	107.5	1.1	0.8	0.0	1.6	1.7	0.1	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	1.0	0.4	0.3	71.2	0.0	0.0	9.0	0.2	0.0	0.0	0.1	0.1	0.0	0.8	0.0	5.6	1.4	0.1	0.0	0.2	8.5	0.0	22.0	0.1	52.7	6.0	4.8	0.1	3.6	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	7.9	0.1	0.0	0.0	8.4	30.8	3.2	22.0	19.0	6.2	10.9	5.5	25.1	5.6
EDN2	ET2	ENSG00000127129	"Endothelin 2"	P20800	1	41478775-41484673	"Predicted secreted proteins"		"Vasoactive, Vasoconstrictor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"intestine: 27.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 8.4;EFO-21: 21.2;HeLa: 7.2;SCLC-21H: 10.2;SK-BR-3: 25.2;U-2 OS: 9.8"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 24.0"	"Region enriched"	"Detected in single"	12	"pons and medulla: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"hippocampal formation: 1.0"	HPA028459	Uncertain		Approved	Cytosol	"Secreted to blood"			Cytosol		"HPA028459: AB_10602490"	"unprognostic (2.71e-2)"	"unprognostic (5.64e-2)"	"unprognostic (8.39e-2)"	"prognostic unfavourable (2.85e-4)"	"unprognostic (1.47e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.44e-2)"	"unprognostic (5.61e-2)"	"prognostic unfavourable (5.81e-4)"	"unprognostic (5.59e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.14e-2)"	"unprognostic (3.85e-1)"	0.5	0.2	0.0	0.9	0.2	0.3	2.2	0.0	0.1	15.1	13.6	0.4	1.4	4.5	1.8	6.3	17.4	2.3	0.4	1.9	0.0	0.0	4.0	0.8	18.4	0.1	0.0	0.0	0.8	3.2	0.1	1.1	0.4	2.6	9.7	1.3	1.4	4.3	1.0	0.9	8.9	27.8	0.2	0.0	0.1	0.9	0.7	0.1	0.0	1.3	4.0	13.7	1.2	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.5	8.4	0.0	21.2	0.0	1.0	0.0	0.0	0.0	2.4	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.4	0.0	0.0	0.8	4.9	5.7	0.4	10.2	0.0	0.2	25.2	0.0	0.5	0.0	0.0	0.0	9.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.1
EDN3	ET3	ENSG00000124205	"Endothelin 3"	P14138	20	59300427-59325992	"Disease related genes, Predicted secreted proteins"		"Vasoactive, Vasoconstrictor"	"Deafness, Disease mutation, Hirschsprung disease, Waardenburg syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 35.8;retina: 86.8;salivary gland: 37.0;vagina: 37.8"	"Cell line enriched"	"Detected in single"	5	"SH-SY5Y: 3.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	17	"memory CD4 T-cell: 2.1;T-reg: 1.2"	"Lineage enriched"	"Detected in single"	22	"T-cells: 2.1"	"Low region specificity"	"Detected in all"												"Secreted to blood"						"unprognostic (4.64e-3)"	"unprognostic (7.87e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.88e-3)"	"prognostic favourable (1.73e-4)"	"unprognostic (1.58e-1)"		"unprognostic (1.78e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.69e-1)"	"unprognostic (4.01e-2)"	"unprognostic (4.08e-2)"	"unprognostic (4.48e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.40e-2)"		0.0	1.2	1.1	0.7	2.5	0.0	3.7	0.8	3.3	22.7	21.7	2.1	0.2	20.7	2.6	3.2	9.2	0.0	1.3	0.0	2.3	1.6	0.2	0.0	0.2	0.0	1.8	1.7	0.6	5.1	0.0	20.8	0.2	3.2	3.2	8.9	86.8	37.0	0.4	0.6	0.8	35.8	1.3	1.7	3.6	0.8	1.1	0.4	0.1	33.2	1.3	0.6	0.2	37.8	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	1.1	2.5	0.8	3.3	2.3	1.6	1.8	1.7	3.2	0.4
EFNA1	"ECKLG, EPLG1, LERK1, TNFAIP4"	ENSG00000169242	"Ephrin A1"	P20827	1	155127460-155134857	"Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis		"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 123.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 57.1;HaCaT: 19.9;SiHa: 32.9;SK-BR-3: 50.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"naive CD4 T-cell: 12.1;naive CD8 T-cell: 6.0"	"Lineage enriched"	"Detected in single"	26	"T-cells: 12.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB032498	Uncertain				"Secreted to blood"	2100000	2100000			"CAB032498: AB_2262137"	"unprognostic (5.14e-2)"	"unprognostic (3.04e-3)"	"unprognostic (5.03e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.78e-2)"	"unprognostic (5.80e-3)"	"unprognostic (1.53e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.44e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.32e-1)"	16.2	6.1	6.8	2.9	14.5	0.4	29.5	4.4	10.9	7.1	27.6	11.8	10.7	21.7	7.2	11.7	12.6	8.0	8.7	13.3	6.4	4.6	16.1	123.2	27.0	2.7	15.7	4.3	5.7	14.0	4.9	5.3	38.2	13.8	18.6	20.2	5.0	17.7	17.2	10.4	27.5	27.5	5.1	9.6	2.3	13.1	3.3	14.8	3.7	30.2	7.8	4.1	10.7	12.7	0.3	0.0	0.4	0.0	0.3	12.1	2.0	3.1	1.3	0.1	2.4	0.4	0.0	57.1	0.0	0.0	0.0	0.0	3.2	7.0	0.0	5.7	0.0	19.9	1.3	6.9	0.0	1.9	0.4	0.0	4.4	17.2	0.1	0.0	0.3	0.9	17.0	0.0	5.9	10.7	0.5	0.1	0.0	11.4	0.0	0.2	0.4	4.2	1.2	0.3	1.9	13.5	4.9	2.0	3.0	32.9	50.5	1.2	10.6	0.0	1.3	0.0	2.0	0.1	0.3	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	1.0	0.7	0.0	0.3	12.1	6.0	0.4	0.3	0.0	0.0	0.0	2.0	6.8	14.5	4.4	10.9	6.4	4.6	15.7	4.3	13.8	14.8
EGFL6	MAEG	ENSG00000198759	"EGF like domain multiple 6"	Q8IUX8	X	13569605-13633575	"Predicted secreted proteins"	"Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"placenta: 137.5"	"Group enriched"	"Detected in some"	5	"BJ hTERT+: 9.4;NTERA-2: 3.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA001838	Enhanced				"Secreted to extracellular matrix"					"HPA001838: "	"unprognostic (1.66e-1)"	"unprognostic (1.32e-2)"	"unprognostic (9.15e-3)"	"unprognostic (3.76e-3)"	"unprognostic (1.77e-2)"	"prognostic favourable (9.73e-4)"	"unprognostic (4.13e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.19e-3)"	"prognostic favourable (4.95e-4)"	"unprognostic (2.39e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.14e-9)"	"unprognostic (7.10e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.82e-3)"	16.1	0.1	0.3	0.2	0.2	0.1	2.3	0.0	0.2	0.4	4.1	0.0	0.1	0.2	0.5	0.4	3.3	0.6	1.5	0.6	0.1	0.7	0.2	0.1	18.6	0.2	0.1	0.1	0.2	0.3	0.1	1.7	137.5	0.9	0.6	0.2	27.1	0.2	0.1	0.1	0.4	0.2	2.0	0.6	0.2	0.4	0.2	0.0	0.0	0.2	0.2	0.4	4.1	1.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	9.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.1	0.7	0.1	0.1	0.9	0.0
EGFL7	ZNEU1	ENSG00000172889	"EGF like domain multiple 7"	Q9UHF1	9	136658856-136672678	"Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 112.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 39.1;HUVEC TERT2: 69.2;RPMI-8226: 27.2;TIME: 64.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 2.6;eosinophil: 4.2;intermediate monocyte: 7.7;non-classical monocyte: 6.2;plasmacytoid DC: 7.1"	"Group enriched"	"Detected in many"	20	"dendritic cells: 7.1;granulocytes: 4.2;monocytes: 7.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050716	Approved				"Secreted to extracellular matrix"					"HPA050716: "	"unprognostic (1.72e-2)"	"unprognostic (1.26e-1)"	"prognostic unfavourable (4.22e-6)"	"unprognostic (1.55e-2)"	"unprognostic (2.70e-2)"	"unprognostic (9.76e-3)"	"unprognostic (5.03e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.31e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.14e-3)"	"unprognostic (6.35e-2)"	"prognostic unfavourable (5.28e-4)"	"unprognostic (5.69e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.49e-2)"	54.8	11.2	17.7	9.0	23.7	8.7	34.2	8.5	23.6	19.7	10.3	7.2	17.4	9.3	28.9	19.7	9.5	14.6	17.5	31.0	18.0	12.7	24.3	10.6	46.9	12.0	21.5	8.1	7.5	9.7	5.7	10.5	112.4	27.5	13.7	3.5	19.9	21.3	16.1	29.3	14.1	9.9	10.9	10.4	41.1	7.4	11.4	17.6	0.2	20.7	16.2	4.9	10.7	55.3	0.1	7.1	4.2	7.7	0.2	0.3	3.4	0.0	9.4	3.0	11.0	0.2	0.2	7.1	2.6	0.5	1.5	0.5	3.3	8.8	0.0	39.1	0.9	1.3	0.7	1.7	0.0	15.6	2.9	5.8	0.7	0.2	2.4	0.0	8.5	0.3	0.6	0.7	0.0	69.2	20.9	0.0	0.5	16.9	0.1	0.1	4.4	0.5	18.5	1.2	27.2	0.9	0.2	1.9	6.5	1.3	1.2	2.4	3.2	8.9	64.6	0.3	8.0	0.9	0.5	0.0	0.0	0.1	0.0	0.0	8.0	0.0	2.6	4.2	0.1	7.7	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.3	1.1	0.2	6.2	7.1	0.0	3.4	17.7	23.7	8.5	23.6	18.0	12.7	21.5	8.1	27.5	17.6
EGFL8	"C6orf8, NG3"	ENSG00000241404	"EGF like domain multiple 8"	Q99944	6	32164583-32168281	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.7"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.2;Hep G2: 3.6;NB-4: 3.0;SK-MEL-30: 3.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA061173	Uncertain		Approved	"Nuclear speckles,Vesicles"	"Secreted - unknown location"			Vesicles	"Nuclear speckles"	"HPA061173: "	"unprognostic (7.13e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.79e-3)"	"unprognostic (3.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.60e-4)"	"unprognostic (3.42e-2)"	"unprognostic (2.49e-1)"	"unprognostic (6.42e-3)"	"unprognostic (1.97e-1)"	"unprognostic (7.60e-3)"	"unprognostic (8.11e-3)"	"unprognostic (1.07e-4)"	"unprognostic (1.11e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.29e-2)"	4.5	6.3	7.3	2.6	7.6	4.5	5.0	6.3	9.4	7.1	6.7	8.4	8.7	4.7	6.4	5.5	4.3	4.8	8.4	4.8	8.2	4.4	4.3	1.8	4.3	2.0	25.7	3.9	14.4	2.9	1.3	2.9	9.2	14.1	6.0	2.7	14.7	3.9	5.3	3.8	12.9	5.8	3.0	11.9	3.5	3.9	2.3	7.0	0.2	3.1	8.3	2.0	5.2	6.8	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.6	0.3	1.3	3.2	0.4	0.0	0.3	0.0	0.0	0.0	0.0	1.8	0.0	0.1	1.2	0.0	2.0	1.3	0.4	0.0	0.0	1.9	0.0	0.9	3.6	1.1	0.0	0.7	0.0	0.3	0.3	0.0	0.7	0.3	0.0	0.0	1.7	0.9	3.0	0.0	0.0	1.1	0.1	0.0	0.2	0.6	0.5	1.2	0.0	0.1	3.7	1.4	2.2	0.0	0.8	1.7	0.0	0.1	0.0	0.1	0.1	0.1	1.1	1.2	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.3	7.6	6.3	9.4	8.2	4.4	25.7	3.9	14.1	7.0
ELANE	"ELA2, HLE, HNE, NE"	ENSG00000197561	"Elastase, neutrophil expressed"	P08246	19	851014-856247	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"bone marrow: 244.3"	"Cell line enriched"	"Detected in some"	65	"THP-1: 193.2"	"Group enriched"	"Detected in some"	7	"pancreatic cancer: 3.5;stomach cancer: 3.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"classical monocyte: 3.2;neutrophil: 6.9"	"Group enriched"	"Detected in many"	9	"granulocytes: 6.9;monocytes: 3.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB015409, HPA066836"	Enhanced				"Secreted to blood"	59000	59000			"CAB015409: AB_831596, HPA066836: "	"unprognostic (3.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.42e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.80e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.92e-1)"	"unprognostic (6.38e-3)"	"unprognostic (5.80e-1)"	"unprognostic (2.54e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.19e-10)"	"unprognostic (6.27e-3)"	"unprognostic (4.00e-2)"	"unprognostic (2.76e-2)"	"unprognostic (4.75e-3)"	1.5	0.3	0.1	0.3	0.1	244.3	1.6	0.2	0.6	0.3	0.6	0.7	0.0	0.3	0.3	0.7	0.5	0.6	0.8	31.2	0.0	0.0	0.3	1.5	17.8	1.6	0.0	0.0	0.3	1.8	0.3	0.4	4.7	0.5	1.4	0.3	1.0	0.7	0.3	1.1	2.1	0.5	0.5	0.0	22.5	0.5	0.3	0.0	23.0	2.3	0.9	0.3	1.0	0.2	0.0	0.0	6.9	3.2	0.0	0.5	11.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	193.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	3.2	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	11.2	0.1	0.1	0.2	0.6	0.0	0.0	0.0	0.0	0.5	0.0
ELN	"SVAS, WBS, WS"	ENSG00000049540	Elastin	P15502	7	74027789-74069907	"Disease related genes, Plasma proteins, Predicted secreted proteins"			"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 16.5;BJ: 22.9;fHDF/TERT166: 32.8;U-2197: 130.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB010750, HPA018111, HPA056941"	Supported		Approved	"Plasma membrane"	"Secreted to extracellular matrix"	2900000	2900000	"Plasma membrane"		"CAB010750: AB_476930, HPA018111: AB_1848109, HPA056941: "	"unprognostic (1.51e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.70e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.18e-3)"	"unprognostic (1.79e-2)"	"unprognostic (3.90e-2)"	"prognostic unfavourable (6.29e-4)"	"unprognostic (1.62e-3)"	35.0	8.8	4.3	14.9	3.6	0.0	24.8	27.8	5.8	23.3	12.1	12.9	9.1	3.2	22.3	26.0	30.1	17.1	30.8	41.5	5.4	3.0	8.3	3.7	49.7	7.5	4.4	9.2	10.6	35.3	0.7	6.1	22.5	13.7	25.1	4.6	34.3	16.8	14.5	6.0	23.6	9.2	34.7	9.9	10.7	16.0	8.1	6.4	0.9	11.9	10.3	4.4	34.0	21.7	0.4	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.3	0.1	0.0	16.5	0.1	0.1	22.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	32.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	1.3	0.1	0.0	8.8	0.1	0.0	0.0	4.5	10.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	130.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	4.3	3.6	27.8	5.8	5.4	3.0	4.4	9.2	13.7	6.4
EMILIN2	"FLJ33200, FOAP-10"	ENSG00000132205	"Elastin microfibril interfacer 2"	Q9BXX0	18	2847030-2915993	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 83.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 22.4;BEWO: 17.2;HL-60: 16.2;HMC-1: 27.6;HSkMC: 12.1;THP-1: 16.1;U-2197: 21.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 8.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"midbrain: 9.1;pons and medulla: 16.9;thalamus: 6.3"	HPA064576	Supported				"Secreted to extracellular matrix"	600000	600000			"HPA064576: "	"unprognostic (1.31e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.91e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.98e-3)"	"unprognostic (9.91e-3)"	"prognostic unfavourable (6.30e-4)"	"unprognostic (2.01e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavourable (1.62e-4)"	"unprognostic (1.49e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.96e-1)"	32.3	1.4	0.9	8.4	0.7	4.9	14.5	0.3	0.8	5.8	3.9	1.1	2.2	1.1	6.8	6.7	3.9	5.2	4.3	9.6	1.0	1.1	2.0	1.3	10.9	24.4	3.1	0.0	11.0	1.8	83.7	0.6	34.9	3.7	4.6	2.0	2.4	2.9	1.0	3.9	3.0	2.4	5.7	16.4	6.9	1.9	2.8	0.3	2.8	3.0	4.1	1.8	7.9	6.6	0.5	2.1	8.0	2.3	3.1	0.9	0.6	0.1	0.1	1.3	0.0	22.4	9.3	17.2	3.5	0.0	0.6	1.1	2.4	0.0	0.0	0.2	8.5	0.0	0.4	0.0	1.2	0.0	1.2	0.2	0.0	0.1	0.7	16.2	27.6	12.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.5	2.2	0.0	0.0	1.1	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.6	0.0	16.1	0.2	0.0	2.4	21.1	0.2	0.0	0.0	0.0	1.4	4.0	0.4	8.0	2.3	0.6	0.9	1.6	0.7	0.4	0.9	0.6	2.1	0.5	0.5	0.9	2.3	3.1	1.4	1.4	0.6	0.6	0.9	0.7	0.3	0.8	1.0	1.1	3.1	0.0	3.7	0.3
EMILIN3	"C20orf130, dJ620E11.4, EMILIN5"	ENSG00000183798	"Elastin microfibril interfacer 3"	Q9NT22	20	41359966-41366827	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"epididymis: 49.9"	"Group enriched"	"Detected in some"	7	"AF22: 6.8;HAP1: 11.8;NTERA-2: 7.5;SCLC-21H: 14.1"	"Cancer enhanced"	"Detected in many"		"glioma: 10.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	29	"cerebellum: 3.7"	"Low region specificity"	"Detected in single"			"HPA059912, HPA078559"	Enhanced				"Secreted to extracellular matrix"	650000	650000			"HPA059912: , HPA078559: "	"unprognostic (1.66e-4)"	"unprognostic (1.85e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.18e-3)"	"unprognostic (2.57e-1)"	"unprognostic (6.54e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.13e-7)"	"unprognostic (2.64e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.62e-2)"	0.9	1.9	2.9	1.6	2.0	0.5	3.5	0.7	8.2	7.1	4.1	1.9	8.5	1.1	2.7	49.9	1.1	3.2	0.9	6.0	3.0	2.9	0.8	0.6	0.7	0.6	3.8	0.7	9.2	0.6	0.5	1.6	0.6	2.7	8.1	0.8	5.8	1.5	10.0	1.3	3.4	1.4	1.6	2.2	0.6	1.9	4.3	2.3	0.3	0.7	2.9	0.8	2.4	5.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	6.8	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.4	0.0	0.0	0.1	0.0	0.0	11.8	0.0	0.2	0.0	1.3	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.1	0.0	0.0	14.1	1.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.9	2.0	0.7	8.2	3.0	2.9	3.8	0.7	2.7	2.3
ENAM	AIH2	ENSG00000132464	Enamelin	Q9NRM1	4	70628744-70686816	"Disease related genes, Predicted secreted proteins"	Biomineralization		"Amelogenesis imperfecta, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 10.1;heart muscle: 5.0;kidney: 7.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.3;RPTEC TERT1: 1.5;U-266/70: 2.4;U-266/84: 3.3"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.7"					"Group enriched"	"Detected in some"	18	"memory B-cell: 1.2;naive B-cell: 1.7;plasmacytoid DC: 2.2"	"Group enriched"	"Detected in many"	20	"B-cells: 1.7;dendritic cells: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted to extracellular matrix"						"unprognostic (1.52e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.94e-3)"	"unprognostic (4.73e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.06e-4)"	"unprognostic (1.01e-2)"	"unprognostic (1.14e-1)"	"prognostic favourable (1.81e-14)"	"unprognostic (1.26e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.45e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.2	10.1	0.0	0.1	1.5	5.0	0.0	0.0	7.9	0.5	0.0	0.0	0.0		0.0	2.5	0.8	0.5	0.0		0.0	0.0		0.0	0.0	3.6	0.0	0.2	0.0	0.0	0.0	1.3	1.2			0.0		0.0	0.0	0.0	1.7	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.4	3.3	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0										
ENDOU	"P11, PP11, PRSS26"	ENSG00000111405	"Endonuclease, poly(U) specific"	P21128	12	47709734-47725567	"Predicted secreted proteins"		"Endonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 42.1;placenta: 86.0;tongue: 28.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.3;SK-BR-3: 9.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA012388, HPA067448"	Enhanced				"Secreted in other tissues"					"HPA012388: AB_1854860, HPA067448: AB_2685843"	"unprognostic (2.61e-2)"	"unprognostic (4.92e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.09e-1)"	"prognostic favourable (6.29e-4)"	"unprognostic (6.50e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.04e-1)"	0.6	0.1	1.3	0.2	1.4	0.2	1.2	0.2	1.1	7.5	0.2	0.2	0.2	0.1	0.3	0.8	42.1	0.6	0.4	0.4	0.7	0.1	0.2	0.2	0.2	0.2	0.4	0.3	0.9	0.2	0.1	0.2	86.0	0.5	0.2	0.1	0.2	9.3	0.2	0.2	13.5	0.2	0.4	0.3	0.2	0.1	0.2	0.2	0.5	0.4	28.8	21.6	0.2	10.9	0.2	0.2	0.8	0.2	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.6	2.4	1.5	0.3	1.9	1.6	1.4	0.2	0.1	4.3	1.0	0.2	0.2	0.0	0.0	2.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.2	1.1	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	9.6	0.1	0.2	0.0	0.3	0.4	0.1	1.2	0.2	2.4	2.3	0.8	0.2	0.4	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.2	1.3	1.4	0.2	0.7	0.7	0.1	0.4	0.3	0.5	0.2
ENHO	"C9orf165, UNQ470"	ENSG00000168913	"Energy homeostasis associated"	Q6UWT2	9	34521040-34523041	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	4	"brain: 79.6"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 13.2;NTERA-2: 18.2;SCLC-21H: 9.3;SH-SY5Y: 8.8"	"Cancer enhanced"	"Detected in many"		"glioma: 44.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"myeloid DC: 19.4"	"Lineage enriched"	"Detected in many"	7	"dendritic cells: 19.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042575	Approved				"Secreted to blood"					"HPA042575: AB_10794914"	"unprognostic (2.63e-2)"	"unprognostic (9.53e-3)"	"unprognostic (2.46e-1)"	"prognostic unfavourable (3.71e-4)"	"unprognostic (1.30e-1)"	"unprognostic (7.51e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.78e-4)"	"unprognostic (1.75e-1)"	"unprognostic (2.57e-3)"	"unprognostic (6.47e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.50e-2)"	"unprognostic (8.76e-2)"	1.5	1.9	58.0	1.9	59.3	1.7	3.7	15.5	79.6	2.9	3.9	13.9	0.0	3.0	1.4	1.4	1.5	3.6	1.8	1.8	36.3	37.5	1.5	12.0	2.0	1.4	52.0	27.1	1.5	2.6	1.2	1.0	1.3	13.7	5.2	3.2	0.1	1.8	1.7	1.6	3.8	3.6	1.3	17.1	1.6	5.3	6.4	13.4	0.0	1.4	0.0	1.4	1.5	0.0	0.0	19.4	0.0	2.5	2.7	0.0	0.4	0.1	0.9	5.2	13.2	0.1	0.0	0.3	0.0	0.0	2.1	2.1	0.5	0.2	2.2	3.6	0.0	0.2	6.0	0.4	0.4	0.3	5.8	0.0	0.1	1.2	0.1	0.0	2.9	0.0	0.1	0.0	0.2	0.0	0.0	1.9	0.4	0.3	0.0	0.0	18.2	3.7	0.1	0.0	0.3	0.5	0.0	9.3	8.8	0.7	4.1	0.4	0.3	1.7	0.0	0.4	2.0	0.1	0.1	1.1	1.2	0.1	0.4	0.0	3.0	0.0	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.0	0.0	2.7	0.7	1.0	0.0	0.4	58.0	59.3	15.5	37.0	36.3	37.5	52.0	27.1	13.7	13.4
EPO	EP	ENSG00000130427	Erythropoietin	P01588	7	100720800-100723700	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Predicted secreted proteins"	"Erythrocyte maturation"	Hormone	"Cancer-related genes, Congenital erythrocytosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 10.9;endometrium 1: 8.7;liver: 29.3"	"Group enriched"	"Detected in some"	7	"BEWO: 3.5;Hep G2: 13.0"	"Group enriched"	"Detected in many"	5	"liver cancer: 2.7;renal cancer: 5.4"	"Region enriched"	"Detected in single"	9	"cerebral cortex: 4.4"	"Cell type enriched"	"Detected in single"	13	"non-classical monocyte: 1.2"	"Lineage enriched"	"Detected in single"	13	"monocytes: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			CAB010336	Supported				"Secreted to blood"					"CAB010336: AB_2098408"	"unprognostic (2.93e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.08e-3)"	"unprognostic (7.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.78e-3)"	"prognostic unfavourable (5.67e-5)"	"unprognostic (3.52e-2)"	"unprognostic (5.16e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.44e-3)"	"unprognostic (3.31e-1)"	"prognostic unfavourable (2.18e-6)"	"unprognostic (4.80e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.34e-1)"	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	4.4	10.9	0.0	0.0	0.0	0.0	8.7	0.6	0.4	0.0	0.0	0.1	0.0	0.0	2.8	29.3	0.0	0.0	0.0	0.0	0.1	7.8	0.0	0.0	0.7	0.0	1.6	0.0	0.7	0.9	1.6	0.0	0.7	0.0	0.6	0.0	0.0	0.0	2.4	0.4	0.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	3.5	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	1.1	0.1	0.0	0.0	13.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.2	0.2	0.2	0.0	0.0	0.6	0.4	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.6	0.2	0.0	0.1	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.5	0.1	4.4	0.0	0.0	0.0	0.0	0.0	0.4
EPPIN-WFDC6	SPINLW1-WFDC6	ENSG00000249139	"EPPIN-WFDC6 readthrough"	O95925	20	45536986-45547426	"Predicted secreted proteins"		"Antimicrobial, Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	48	"epididymis: 25.8;testis: 68.0"	"Cell line enhanced"	"Detected in single"		"U-87 MG: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA067335	Supported				"Secreted in male reproductive system"					"HPA067335: "										"unprognostic (1.46e-3)"					"unprognostic (6.38e-2)"			0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.9	25.8	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	68.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
EPYC	"DSPG3, Pg-Lb, SLRR3B"	ENSG00000083782	Epiphycan	Q99645	12	90963679-91005026	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"placenta: 67.1"	"Group enriched"	"Detected in some"	5	"HaCaT: 1.4;U-266/70: 3.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 7.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 1.6"	"Group enriched"	"Detected in many"	5	"amygdala: 3.8;basal ganglia: 3.8;cerebral cortex: 6.2;hippocampal formation: 4.4"	"HPA038212, HPA045455"	Approved				"Secreted to extracellular matrix"					"HPA038212: AB_10672739, HPA045455: "	"unprognostic (2.25e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.79e-1)"	"unprognostic (4.28e-2)"		"unprognostic (1.81e-2)"		"unprognostic (4.07e-2)"	"unprognostic (9.20e-2)"	"unprognostic (3.23e-1)"	"prognostic unfavourable (1.85e-4)"	"unprognostic (2.77e-2)"	"unprognostic (6.44e-9)"	"unprognostic (2.83e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.20e-1)"	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.8	0.4	0.1	0.2	0.4	0.5	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	2.5	0.0	0.0	0.0	67.1	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.0	3.9	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ESM1		ENSG00000164283	"Endothelial cell specific molecule 1"	Q9NQ30	5	54977864-55022671	"Predicted secreted proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 31.4;thyroid gland: 14.8"	"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 54.2;TIME: 101.3"	"Cancer enriched"	"Detected in all"	8	"renal cancer: 65.8"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	4	"MAIT T-cell: 1.6;memory CD4 T-cell: 2.7;memory CD8 T-cell: 1.7;naive CD8 T-cell: 1.6;NK-cell: 3.7"	"Group enriched"	"Detected in many"	32	"NK-cells: 3.7;T-cells: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	400000	400000				"unprognostic (4.70e-2)"	"prognostic unfavourable (2.11e-7)"	"unprognostic (2.63e-3)"	"unprognostic (2.31e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.46e-2)"	"prognostic unfavourable (4.00e-4)"	"unprognostic (7.77e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.84e-2)"	"unprognostic (2.94e-1)"	1.5	3.5	0.3	0.4	0.6	0.2	0.6	0.2	0.7	1.5	1.1	0.8	4.2	0.3	3.0	1.1	0.3	0.2	0.9	2.4	0.9	3.7	31.4	2.2	12.9	0.9	0.5	0.3	2.3	1.8	1.7	9.0	0.5	1.3	4.8	0.0	1.5	5.6	3.2	0.7	0.3	2.4	0.4	1.1	4.0	0.5	0.6	0.5	0.6	14.8	0.8	0.4	1.4	1.0	0.0	0.0	0.0	0.0	3.7	2.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	1.7	0.7	0.1	0.0	0.0	0.0	1.3	1.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	54.2	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	101.3	0.8	2.4	7.0	3.7	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.5	0.0	1.6	0.0	2.7	1.7	0.0	0.0	0.0	1.6	0.0	3.7	0.0	0.0	0.0	0.5	0.3	0.6	0.2	0.7	0.9	3.7	0.5	0.3	1.3	0.5
F10		ENSG00000126218	"Coagulation factor X"	P00742	13	113122814-113149529	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 116.7"	"Cell line enhanced"	"Detected in some"		"BJ: 8.3;CACO-2: 7.1;fHDF/TERT166: 7.4;Hep G2: 32.8;HHSteC: 6.8;SH-SY5Y: 16.2"	"Cancer enriched"	"Detected in many"	11	"liver cancer: 95.4"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"	16000000000	16000000000				"unprognostic (4.18e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.62e-2)"	"unprognostic (9.88e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.24e-1)"	"prognostic favourable (1.82e-5)"	"unprognostic (6.39e-2)"	"prognostic unfavourable (5.14e-5)"	"unprognostic (6.60e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.23e-3)"	8.1	3.7	0.3	2.9	0.7	0.0	5.4	0.4	0.8	20.3	5.9	0.6	7.6	4.5	12.6	21.4	4.5	9.9	10.0	18.4	0.5	0.5	2.3	116.7	4.9	1.6	0.5	0.7	18.2	3.0	0.0	1.7	3.6	1.0	18.1	0.7	6.9	2.0	6.1	2.6	7.8	7.6	11.7	0.6	1.3	3.2	9.5	0.6	0.6	3.1	5.6	1.8	7.8	10.3	0.0	0.0	0.0	0.0	0.9	1.0	0.3	0.0	0.0	1.4	0.2	4.8	4.9	0.0	8.3	6.6	0.5	0.2	7.1	0.0	0.0	0.3	7.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	32.8	6.8	0.0	0.2	4.8	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.6	16.2	0.0	0.3	0.0	0.3	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.9	0.0	0.0	0.0	0.3	0.3	0.7	0.4	0.8	0.5	0.5	0.5	0.7	1.0	0.6
F12		ENSG00000131187	"Coagulation factor XII"	P00748	5	177402140-177409576	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	26	"liver: 180.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 8.6;MCF7: 10.9;PC-3: 8.1;SH-SY5Y: 5.5;U-937: 5.6"	"Cancer enriched"	"Detected in many"	21	"liver cancer: 171.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.5;eosinophil: 6.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 6.9;monocytes: 2.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA003825	Approved				"Secreted to blood"	6600000000	6600000000			"HPA003825: AB_1078790"	"unprognostic (9.75e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.93e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.32e-1)"	"prognostic favourable (4.63e-5)"	"unprognostic (6.97e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.96e-2)"	"unprognostic (4.41e-1)"	"unprognostic (6.54e-2)"	"prognostic unfavourable (7.09e-4)"	"unprognostic (4.11e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.40e-6)"	"unprognostic (6.48e-2)"	0.1	0.0	0.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.2	180.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	1.0	6.9	2.5	0.7	0.3	1.0	0.8	2.0	0.0	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.0	2.3	1.3	0.0	0.4	0.0	1.4	0.7	0.4	0.0	8.6	1.8	1.3	0.3	0.9	0.2	0.7	3.0	0.2	1.3	0.1	0.4	0.2	0.4	3.2	0.0	10.9	0.1	2.6	0.0	8.1	0.6	0.2	1.8	1.1	0.0	2.5	5.5	0.3	1.0	0.7	0.4	0.0	0.0	0.2	1.1	0.0	0.3	0.5	0.0	0.1	0.1	5.6	0.6	0.0	2.5	6.9	0.3	0.1	0.2	0.5	0.3	0.2	0.1	0.2	0.0	0.1	0.9	0.7	0.9	1.0	0.0	1.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
F13B	FXIIIB	ENSG00000143278	"Coagulation factor XIII B chain"	P05160	1	197039191-197067267	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	95	"liver: 76.3"	"Cell line enhanced"	"Detected in some"		"A549: 1.8;Hep G2: 2.2"	"Cancer enriched"	"Detected in single"	816	"liver cancer: 46.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA003827, HPA052139"	Supported				"Secreted to blood"	3400000000	3400000000			"HPA003827: AB_1078794, HPA052139: "					"unprognostic (1.46e-1)"		"prognostic favourable (6.78e-5)"							"unprognostic (1.21e-2)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	76.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
F5		ENSG00000198734	"Coagulation factor V"	P12259	1	169514166-169586588	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Disease mutation, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.9;liver: 88.8;placenta: 32.2"	"Cell line enriched"	"Detected in some"	10	"Hep G2: 26.7"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 69.6"	"Region enriched"	"Detected in many"	11	"pons and medulla: 27.9"	"Cell type enhanced"	"Detected in some"		"eosinophil: 8.7;neutrophil: 8.0"	"Group enriched"	"Detected in many"	13	"granulocytes: 8.7;monocytes: 4.2;T-cells: 7.0"	"Group enriched"	"Detected in many"	5	"basal ganglia: 2.8;hippocampal formation: 7.4;pons and medulla: 4.6;thalamus: 5.8"	"Group enriched"	"Detected in many"	7	"amygdala: 59.9;basal ganglia: 33.8;cerebral cortex: 88.3;hippocampal formation: 79.2;olfactory region: 58.9"	HPA002036			Approved	"Golgi apparatus"	"Secreted to blood"	13000000000	13000000000	"Golgi apparatus"		"HPA002036: AB_1078787"	"unprognostic (3.67e-2)"	"unprognostic (2.77e-4)"	"unprognostic (5.42e-2)"	"unprognostic (2.56e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.39e-4)"	"unprognostic (3.46e-3)"	"unprognostic (9.25e-3)"	"unprognostic (2.02e-1)"	"unprognostic (8.99e-3)"	"unprognostic (6.55e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.01e-2)"	"prognostic unfavourable (3.39e-4)"	"unprognostic (7.15e-2)"	"unprognostic (3.41e-1)"	"unprognostic (4.31e-1)"	1.1	0.4	0.4	1.4	0.5	1.5	0.8	1.0	0.4	0.4	0.4	6.7	0.0	0.5	0.4	2.2	0.4	1.6	14.1	13.9	2.5	0.5	1.2	88.8	1.1	1.1	1.4	0.1	0.4	1.3	0.1	2.0	32.2	27.9	1.0	0.4	17.8	4.4	0.1	0.4	1.3	0.5	0.5	2.6	1.9	2.2	0.7	1.1	0.0	0.7	0.2	2.6	1.5	0.4	0.0	0.5	8.7	4.2	0.0	7.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.7	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.2	8.7	0.0	0.2	0.0	0.0	1.7	0.2	0.5	0.0	0.3	0.0	8.0	0.0	0.0	0.0	7.0	1.1	0.4	0.5	1.0	0.4	2.5	0.5	1.4	0.1	27.9	1.1
F7		ENSG00000057593	"Coagulation factor VII"	P08709	13	113105788-113120681	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	39	"liver: 68.0"	"Group enriched"	"Detected in some"	9	"CACO-2: 16.2;Hep G2: 10.1"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 41.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"gdT-cell: 1.7;MAIT T-cell: 1.2;memory CD8 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004826			Approved	Mitochondria	"Secreted to blood"	1500000000	1500000000	Mitochondria		"HPA004826: AB_10602805"	"unprognostic (2.06e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.50e-3)"	"unprognostic (3.81e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.36e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.47e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.4	0.2	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	68.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	1.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0.1
F9	FIX	ENSG00000101981	"Coagulation factor IX"	P00740	X	139530758-139563458	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease mutation, FDA approved drug targets, Hemophilia, Thrombophilia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	2334	"liver: 233.6"	"Cell line enhanced"	"Detected in some"		"HL-60: 1.7;RH-30: 1.9;SiHa: 1.5;U-698: 1.1"	"Cancer enriched"	"Detected in single"	1354	"liver cancer: 67.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"								"Secreted to blood"	11000000000	11000000000										"prognostic favourable (6.69e-4)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	233.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.7	0.2	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM180A	"HWKM1940, UNQ1940"	ENSG00000189320	"Family with sequence similarity 180 member A"	Q6UWF9	7	135728348-135748846	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 23.0"	"Cell line enriched"	"Detected in some"	4	"U-2197: 73.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"basophil: 2.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA021224	Uncertain		Approved	Nucleoplasm	"Secreted - unknown location"			Nucleoplasm		"HPA021224: AB_1851352"	"unprognostic (3.85e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.33e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.97e-3)"	"unprognostic (5.62e-2)"	"unprognostic (7.55e-2)"	"unprognostic (8.88e-4)"	"unprognostic (3.14e-3)"	"unprognostic (1.82e-1)"	"unprognostic (4.35e-4)"	"unprognostic (6.62e-4)"	9.3	2.6	0.1	1.7	0.5	0.0	5.6	0.1	1.0	7.8	5.7	0.3	0.5	0.7	9.4	2.0	5.1	3.0	21.2	14.7	0.1	0.1	8.7	23.0	4.6	0.0	0.1	0.0	8.1	1.1	0.0	0.3	1.4	0.5	6.1	1.8	1.9	2.2	0.1	3.5	5.5	3.2	8.1	0.4	0.9	1.6	3.9	0.1	0.0	4.6	4.8	0.9	6.6	8.3	0.6	0.2	2.0	0.3	0.4	0.5	0.1	0.0	0.0	0.0	0.0	7.9	8.2	0.0	4.1	15.7	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.0	10.0	1.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	16.3	0.0	73.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.0	0.1	0.1	0.3	0.1	0.2	0.2	0.3	0.2	0.0	0.6	0.4	0.5	0.8	0.4	0.3	0.2	0.2	0.1	0.1	0.5	0.1	1.0	0.1	0.1	0.1	0.0	0.5	0.1
FAM19A3	"TAFA-3, TAFA3"	ENSG00000184599	"Family with sequence similarity 19 member A3, C-C motif chemokine like"	Q7Z5A8	1	112720419-112727235	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	12	"adrenal gland: 19.6;brain: 5.2;testis: 8.8"	"Cell line enhanced"	"Detected in some"		"A-431: 2.7;BJ hTERT+: 9.3;HEL: 3.6;U-87 MG: 3.7"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA055927	Approved				"Secreted in other tissues"					"HPA055927: AB_2682972"	"unprognostic (9.96e-2)"	"unprognostic (4.30e-1)"	"unprognostic (3.36e-2)"	"unprognostic (5.63e-4)"	"prognostic unfavourable (9.60e-4)"	"unprognostic (1.66e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.32e-1)"	"unprognostic (9.82e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.14e-6)"	"unprognostic (2.10e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.27e-1)"	0.1	19.6	0.4	0.1	0.0	0.0	0.3	5.2	0.4	0.1	0.0			0.0	0.1	0.9	0.2	0.4	0.1	0.0	0.3	0.5	0.0	0.0	0.0	0.4	3.9		0.6	0.0	0.0	0.2	0.1		0.3	0.0		0.1	0.2	0.0	0.2	0.0	0.0	1.2	0.0	0.0	8.8			0.2		0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.4	0.2	0.0	0.0	0.6	0.7	0.2	9.3	0.7	0.6	0.0	0.3	0.0	0.1	0.1	0.0	0.1	0.5	0.4	1.5	0.3	3.6	0.0	0.1	0.1	0.2	0.2	0.1	0.3	0.2	0.2	0.0	0.0	0.4	0.4	0.4	0.1	0.0	0.2	2.3	0.0	0.0	0.0	0.1	0.0	0.7	0.2	0.0	0.3	0.6	0.0	1.1	0.0	1.3	1.3	0.2	0.5	0.1	0.0	0.0	3.7	0.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FAM20C	"DKFZp547D065, DMP4, G-CK, IMAGE:4942737"	ENSG00000177706	"FAM20C, golgi associated secretory pathway kinase"	Q8IXL6	7	192969-260745	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	Biomineralization	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 80.6"	"Cell line enhanced"	"Detected in many"		"HSkMC: 52.0;U-87 MG: 32.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019823			Approved	"Nucleoplasm,Golgi apparatus"	"Secreted in other tissues"	160000000	160000000	"Golgi apparatus"	Nucleoplasm	"HPA019823: AB_1848389"	"unprognostic (1.94e-1)"	"prognostic unfavourable (8.89e-4)"	"unprognostic (3.15e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.47e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.35e-2)"	"prognostic unfavourable (9.40e-6)"	"unprognostic (1.97e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.83e-3)"	27.5	10.2	10.8	19.3	16.6	3.3	25.6	7.4	14.9	8.3	20.1	13.5	15.1	12.9	9.5	6.9	11.1	9.7	15.0	15.0	8.8	7.2	31.8	31.6	12.7	5.1	16.9	5.6	11.8	14.8	2.6	9.2	7.2	15.8	15.0	4.6	8.8	80.6	11.8	20.4	6.8	16.5	17.0	17.0	6.9	20.0	5.9	14.8	0.4	9.6	8.4	4.4	20.5	17.5	0.0	0.6	0.0	1.6	0.2	0.0	0.0	13.8	6.7	0.2	9.6	12.3	20.4	0.0	12.3	20.9	6.7	5.4	0.8	8.5	0.0	6.8	18.4	12.0	1.0	0.6	1.7	2.9	0.6	0.0	3.2	3.7	9.3	0.0	0.9	52.0	1.5	0.2	0.7	4.6	0.0	0.1	1.7	1.8	0.0	0.7	6.5	0.4	1.5	0.4	0.0	5.0	0.0	3.2	0.1	12.8	0.0	1.9	9.1	6.3	12.9	8.4	4.2	7.1	3.7	0.0	0.0	0.0	32.0	0.8	23.8	0.0	1.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.8	16.6	7.4	14.9	8.8	7.2	16.9	5.6	15.8	14.8
FAM46B	MGC16491	ENSG00000158246	"Family with sequence similarity 46 member B"	Q96A09	1	27005020-27012836	"Predicted secreted proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 55.8;tongue: 42.0"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 31.9;hTERT-HME1: 16.4;NTERA-2: 16.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 87.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"eosinophil: 1.3;intermediate monocyte: 2.5"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted - unknown location"						"unprognostic (1.67e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.61e-1)"	"unprognostic (5.28e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.44e-4)"	"unprognostic (4.05e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.02e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.82e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.46e-2)"	3.3	0.6	0.6	3.9	0.3	0.1	10.4	0.3	0.4	20.6	13.4	0.4	3.6	0.8	8.0	2.8	55.8	5.5	4.0	9.1	0.2	0.0	3.8	0.5	11.6	0.7	0.4	0.9	3.8	1.2	1.0	0.7	7.4	0.9	6.8	1.2	1.5	23.5	11.1	0.9	36.3	3.5	21.5	0.3	0.4	6.8	4.6	0.1	0.6	3.1	42.0	18.7	23.0	13.6	0.0	0.4	1.3	2.5	0.0	0.0	0.0	1.9	0.3	3.9	1.2	0.5	0.6	0.9	2.7	0.9	11.1	4.4	7.6	2.5	0.0	4.7	1.5	6.2	0.6	10.1	3.0	0.0	0.6	0.1	1.5	1.3	5.6	0.0	0.1	2.5	31.9	3.4	16.4	0.1	0.2	0.0	1.4	1.4	0.0	0.6	16.7	0.7	0.2	0.0	0.1	10.8	0.0	0.4	0.3	5.3	11.9	6.9	9.4	0.1	0.2	2.7	9.2	0.3	0.5	0.1	0.4	0.0	0.5	0.0	1.6	0.0	0.0	1.3	0.0	2.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.3	0.4	0.2	0.0	0.4	0.9	0.9	0.1
FBLN5	"ARMD3, DANCE, EVEC, UP50"	ENSG00000140092	"Fibulin 5"	Q9UBX5	14	91869412-91947987	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"		"Age-related macular degeneration, Charcot-Marie-Tooth disease, Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC diff: 85.9;ASC TERT1: 44.9;BJ: 40.2;BJ hTERT+: 37.7;fHDF/TERT166: 71.8;HSkMC: 41.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 8.5"	"Group enriched"	"Detected in many"	19	"granulocytes: 8.5;T-cells: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000848, HPA000868, CAB025843"	Supported		Supported	"Plasma membrane"	"Secreted to extracellular matrix"	4500000	4500000	"Plasma membrane"		"CAB025843: , HPA000848: AB_1078620, HPA000868: AB_1078619"	"unprognostic (5.53e-3)"	"unprognostic (1.14e-1)"	"unprognostic (7.78e-2)"	"unprognostic (9.29e-2)"	"unprognostic (5.55e-3)"	"unprognostic (4.73e-2)"	"prognostic favourable (6.75e-4)"	"unprognostic (5.21e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.90e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.18e-2)"	"unprognostic (3.17e-3)"	48.3	23.5	3.4	11.5	9.5	1.8	49.5	2.2	5.6	52.4	26.6	5.3	20.3	6.0	51.7	36.0	22.6	32.2	97.4	54.5	2.5	2.6	38.9	12.1	50.5	8.6	7.0	4.1	36.5	14.6	7.6	3.9	21.0	9.4	41.2	6.4	40.6	18.3	23.8	24.7	17.5	12.8	51.8	6.8	48.2	18.8	43.9	2.1	1.2	30.3	15.1	9.4	56.4	51.1	0.2	0.1	8.5	0.3	0.0	2.8	0.6	0.0	0.2	0.0	0.0	85.9	44.9	4.5	40.2	37.7	1.1	0.8	0.7	0.0	0.0	0.8	71.8	0.0	1.8	0.1	0.2	0.0	0.4	0.0	0.8	0.0	14.3	0.0	0.0	41.2	0.0	0.7	2.6	1.8	0.0	0.0	4.6	0.1	0.0	0.0	0.0	0.1	0.0	5.7	0.0	0.2	0.0	0.0	0.0	2.2	0.1	0.5	0.5	0.0	0.3	0.5	1.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.2	3.5	1.2	0.2	0.7	0.1	0.5	0.1	0.0	0.2	1.7	2.8	4.1	0.0	0.3	0.1	0.1	0.6	3.4	9.5	2.2	5.6	2.5	2.6	7.0	4.1	9.4	2.1
FBN1	"FBN, MASS, MFS1, OCTD, SGS, WMS"	ENSG00000166147	"Fibrillin 1"	P35555	15	48408306-48645849	"Disease related genes, Plasma proteins, Predicted secreted proteins"		"Heparin-binding, Hormone"	"Aortic aneurysm, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 69.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 36.6;ASC TERT1: 79.0;fHDF/TERT166: 67.8;HSkMC: 42.7;U-138 MG: 34.8;U-2197: 50.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB002670, HPA017759, HPA021057, CAB058696, CAB068188"	Enhanced		Approved	Cytosol	"Secreted to blood"	540000000	540000000	Cytosol		"CAB002670: , CAB058696: , CAB068188: , HPA017759: AB_1848584, HPA021057: AB_1848586"	"unprognostic (3.97e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.40e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.00e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavourable (7.44e-5)"	"prognostic unfavourable (6.57e-4)"	"unprognostic (1.25e-2)"	"unprognostic (8.69e-3)"	"prognostic unfavourable (5.11e-4)"	34.2	5.4	2.1	7.8	2.7	1.8	10.9	1.0	2.8	24.6	11.1	3.5	10.7	2.2	18.4	25.6	22.1	12.1	15.5	24.3	2.5	2.3	2.9	1.9	10.7	5.8	2.8	2.6	20.4	2.5	2.6	3.3	69.8	3.1	11.8	6.9	13.4	5.7	7.8	15.4	6.6	6.9	21.5	3.8	11.3	7.2	13.6	1.6	1.9	17.9	16.3	4.9	22.8	11.2	0.8	0.8	1.8	0.6	1.1	0.6	0.2	0.0	0.8	3.3	3.7	36.6	79.0	0.0	28.5	10.3	8.5	5.4	0.0	0.0	0.0	1.3	67.8	0.1	0.6	0.1	7.7	3.2	0.2	0.3	14.5	0.0	20.6	0.1	0.0	42.7	0.0	22.5	2.6	9.1	0.0	0.0	9.1	0.0	0.2	0.0	0.6	1.1	0.0	2.8	0.0	1.0	0.0	0.0	2.1	0.0	0.3	0.0	0.0	0.2	17.2	34.8	1.0	50.5	6.0	0.2	0.1	0.0	23.3	0.0	2.2	1.1	0.5	0.7	0.5	0.3	0.4	0.5	0.4	0.4	0.2	0.8	0.5	0.6	1.8	1.1	0.6	0.8	0.3	0.2	2.1	2.7	1.0	2.8	2.5	2.3	2.8	2.6	3.1	1.6
FCN2	"EBP-37, FCNL, ficolin-2, P35"	ENSG00000160339	"Ficolin 2"	Q15485	9	134880812-134887520	"Plasma proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"liver: 77.4"	"Cell line enhanced"	"Detected in some"		"RH-30: 1.3;SCLC-21H: 1.1;T-47d: 1.3;U-698: 1.2"	"Group enriched"	"Detected in some"	8	"breast cancer: 1.0;liver cancer: 2.0;prostate cancer: 1.1;renal cancer: 0.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 6.0;intermediate monocyte: 5.6"	"Low lineage specificity"	"Detected in many"																"Secreted to blood"	1800000000	1800000000				"unprognostic (1.91e-1)"	"unprognostic (1.07e-1)"			"unprognostic (6.96e-4)"		"unprognostic (3.73e-2)"	"unprognostic (2.09e-2)"		"unprognostic (3.81e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.06e-2)"		"unprognostic (1.05e-1)"	"unprognostic (3.07e-1)"		2.0	11.4	0.2	0.2	0.2	0.0	4.0	0.2	0.3	0.2	0.3	0.3	0.5	0.0	0.3	0.6	0.2	0.0	0.2	0.5	0.2	0.0	2.2	77.4	0.2	0.2	0.2	0.2	0.2	0.2	0.2	1.5	0.2	0.3	1.5	0.0	0.2	1.4	0.2	0.2	0.0	0.2	0.2	0.2	1.4	0.0	0.3	0.2	0.2	0.9	0.2	0.2	0.3	0.2	0.0	3.3	1.3	6.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.9	0.0	0.0	6.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	1.3	0.0	2.5	0.0	0.0	7.2	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.2	0.3	0.2
FCN3	"FCNH, HAKA1"	ENSG00000142748	"Ficolin 3"	O75636	1	27369112-27374824	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"liver: 83.2;lung: 153.7"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 2.7;MCF7: 2.2;U-2197: 2.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											CAB025945	Approved				"Secreted to blood"	33000000000	33000000000			"CAB025945: "	"unprognostic (1.59e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.27e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.21e-1)"	"unprognostic (6.28e-4)"	"unprognostic (7.07e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.87e-3)"	"unprognostic (4.14e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.61e-2)"	7.2	5.0	0.1	1.7	0.2	0.0	21.2	0.1	0.3	0.3	0.6	0.4	0.1	0.2	0.3	0.1	1.0	0.5	0.5	25.0	0.4	0.0	13.0	83.2	153.7	1.0	0.1	0.1	0.3	2.3	0.7	2.1	6.7	1.1	0.5	0.2	0.8	0.4	0.2	1.0	0.3	0.7	0.6	0.2	2.7	0.8	0.5	0.2	0.1	9.1	0.3	0.3	1.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	1.1	0.8	0.0	0.0	0.0	1.2	1.2	0.0	0.0	0.0	0.0	0.8	0.4	0.6	0.0	1.0	0.0	0.4	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.3	0.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.6	0.0	0.0	0.4	0.3	2.2	0.2	0.3	0.1	0.5	0.4	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.3	0.4	0.0	0.1	0.1	1.1	0.2
FDCSP	"C4orf7, FDC-SP"	ENSG00000181617	"Follicular dendritic cell secreted protein"	Q8NFU4	4	70226071-70235252	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"lymphoid tissue: 176.5;salivary gland: 452.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.6;HL-60: 2.4;K-562: 2.2;RH-30: 3.6;U-87 MG: 9.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 336.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA014326, CAB014890"	Enhanced				"Secreted in other tissues"					"CAB014890: , HPA014326: AB_1845719"	"unprognostic (1.26e-3)"	"unprognostic (2.32e-1)"	"unprognostic (8.73e-3)"	"unprognostic (9.62e-2)"		"prognostic favourable (2.38e-4)"	"unprognostic (5.99e-3)"	"prognostic favourable (1.32e-4)"	"unprognostic (2.04e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.79e-1)"		"unprognostic (1.96e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.80e-1)"	"unprognostic (7.83e-2)"	0.4	0.4	0.4	95.4	0.4	0.0	9.7	0.4	0.4	0.4	1.0	0.0	0.0	0.0	0.4	0.0	1.9	0.4	0.0	0.4	0.4	0.4	0.4	0.4	0.5	124.7	0.4	0.0	0.4	0.4	0.0	0.4	0.0	0.0	0.4	0.7	0.0	452.5	0.0	0.5	0.4	3.7	0.0	0.4	12.1	0.4	0.4	0.0	0.4	0.5	35.9	176.5	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.8	0.9	0.0	0.2	0.0	0.0	0.0	0.2	9.6	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.0	0.0
FGA		ENSG00000171560	"Fibrinogen alpha chain"	P02671	4	154583126-154590766	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity"		"Amyloidosis, Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	740	"liver: 2009.3"	"Cell line enriched"	"Detected in some"	15	"Hep G2: 94.6"	"Cancer enriched"	"Detected in many"	43	"liver cancer: 2431.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"CAB016776, HPA051370, HPA064755"	Supported		Approved	"Endoplasmic reticulum"	"Secreted to blood"	170000000000	170000000000	"Endoplasmic reticulum"		"CAB016776: , HPA051370: , HPA064755: "		"unprognostic (5.95e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.02e-1)"		"unprognostic (5.68e-2)"	"prognostic favourable (7.33e-4)"	"unprognostic (1.29e-3)"			"unprognostic (1.84e-1)"		"prognostic unfavourable (4.23e-6)"	"unprognostic (4.20e-1)"	"unprognostic (1.41e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	2.7	2009.3	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	94.6	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.4	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
FGF10		ENSG00000070193	"Fibroblast growth factor 10"	O15520	5	44303544-44389706	"Disease related genes, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"	"Disease mutation, Ectodermal dysplasia, Lacrimo-auriculo-dento-digital syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 26.4"	"Cell line enriched"	"Detected in some"	9	"AF22: 33.9"	"Cancer enriched"	"Detected in some"	6	"breast cancer: 5.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			CAB010315	Uncertain				"Secreted in other tissues"					"CAB010315: AB_2262731"	"unprognostic (1.40e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.20e-1)"		"unprognostic (3.54e-2)"	"unprognostic (4.06e-3)"	"unprognostic (2.72e-2)"	"unprognostic (6.73e-2)"	"unprognostic (5.59e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.23e-4)"	10.5	1.8	0.2	3.4	1.2	0.0	13.1	0.6	1.9	15.5	6.1	0.4	2.1	0.2	3.1	17.2	3.8	5.4	5.0	4.2	0.2	0.5	0.9	0.1	2.5	1.8	1.0	0.3	26.4	5.4	0.0	5.4	7.7	1.4	11.7	2.0	3.2	6.8	4.2	0.7	0.9	2.5	11.0	1.7	0.1	4.4	6.2	0.4	0.2	5.0	8.6	0.8	9.3	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.9	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.6	1.9	0.2	0.5	1.0	0.3	1.4	0.4
FGF17	FGF-13	ENSG00000158815	"Fibroblast growth factor 17"	O60258	8	22042398-22048809	"Cancer-related genes, Disease related genes, Predicted secreted proteins, RAS pathway related proteins"		"Developmental protein, Growth factor"	"Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 31.3"	"Cell line enhanced"	"Detected in some"		"HaCaT: 3.2;Hep G2: 2.3;MOLT-4: 2.2;RPMI-8226: 4.4"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.9"	"Region enriched"	"Detected in many"	4	"cerebellum: 31.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"basal ganglia: 2.2"	"Low region specificity"	"Detected in some"			HPA052600	Uncertain				"Secreted in brain"					"HPA052600: "	"unprognostic (3.45e-2)"	"unprognostic (1.64e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.78e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.92e-5)"	"unprognostic (6.85e-2)"	"unprognostic (2.58e-4)"	"unprognostic (6.55e-3)"	"unprognostic (7.18e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.95e-3)"	0.4	4.9	2.5	0.4	3.2	0.2	0.4	31.3	7.7	0.5	0.4	0.4	0.4	0.2	2.2	0.6	0.4	0.7	0.6	0.4	2.2	4.7	0.4	0.4	0.5	0.4	1.3	2.9	0.5	2.6	3.6	2.1	0.4	3.3	1.2	0.2	0.4	2.4	0.5	0.4	0.9	0.4	1.0	0.9	3.0	0.8	0.6	0.4	1.6	2.3	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.2	0.6	0.6	1.0	0.3	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.6	0.0	3.2	0.0	0.0	0.0	0.0	0.9	0.7	0.0	2.3	0.1	0.0	1.5	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.7	2.2	0.8	0.0	0.0	0.0	0.0	4.4	0.0	0.0	1.0	1.5	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.2	31.3	7.7	2.2	4.7	1.3	2.9	3.3	0.4
FGF18	"FGF-18, ZFGF5"	ENSG00000156427	"Fibroblast growth factor 18"	O76093	5	171419656-171457623	"Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"heart muscle: 23.0"	"Cell line enriched"	"Detected in some"	57	"EFO-21: 65.1"	"Group enriched"	"Detected in many"	6	"endometrial cancer: 19.0;ovarian cancer: 21.9"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA018795	Uncertain				"Secreted in other tissues"					"HPA018795: AB_1848523"	"unprognostic (3.01e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.66e-3)"	"unprognostic (6.62e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.65e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.37e-8)"	"unprognostic (7.33e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.76e-2)"	4.4	0.6	0.6	2.8	0.6	0.1	2.0	0.4	1.2	1.3	0.8	0.5	0.0	1.1	1.6	1.5	0.9	2.0	1.4	23.0	0.5	0.4	1.3	0.4	2.9	0.5	0.4	0.0	1.6	0.9	0.1	1.8	0.9	1.6	2.2	0.3	0.3	1.0	0.7	5.4	1.8	2.2	1.2	0.9	1.1	0.7	1.0	0.3	0.2	2.2	2.5	0.8	2.2	0.5	0.9	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.1	0.0	65.1	0.0	0.1	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.6	0.4	1.2	0.5	0.4	0.4	0.0	1.6	0.3
FGF19		ENSG00000162344	"Fibroblast growth factor 19"	O95750	11	69698232-69704642	"Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"gallbladder: 62.4"	"Cell line enriched"	"Detected in some"	16	"CAPAN-2: 46.7"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 0.8"	"Region enriched"	"Detected in single"	18	"basal ganglia: 0.9"	HPA036082	Approved				"Secreted to blood"					"HPA036082: AB_10669665"	"unprognostic (7.46e-3)"	"unprognostic (2.43e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.22e-1)"		"unprognostic (4.68e-3)"	"unprognostic (6.45e-2)"	"unprognostic (5.72e-3)"		"unprognostic (2.26e-1)"	"unprognostic (6.39e-3)"			"unprognostic (1.66e-2)"	"unprognostic (8.82e-3)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	62.4	0.0	0.0	0.4	0.0	2.8	0.0	0.0	0.0		0.0	0.1	0.4	0.4	0.0		0.0	0.0		0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FGF21		ENSG00000105550	"Fibroblast growth factor 21"	Q9NSA1	19	48755559-48758333	"Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	113	"liver: 37.8"	"Group enriched"	"Detected in some"	9	"HHSteC: 3.0;U-2 OS: 10.3"	"Cancer enriched"	"Detected in single"	315	"liver cancer: 33.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA061286	Supported				"Secreted to blood"					"HPA061286: "				"unprognostic (1.64e-2)"		"unprognostic (3.62e-1)"	"unprognostic (3.21e-2)"			"unprognostic (3.42e-1)"				"unprognostic (1.54e-1)"	"unprognostic (1.85e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	3.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	10.3	0.0	0.0	0.1	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FGF22		ENSG00000070388	"Fibroblast growth factor 22"	Q9HCT0	19	639879-644371	"Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 14.1"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"						"unprognostic (1.58e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.84e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.25e-4)"	"unprognostic (1.16e-1)"	"unprognostic (3.66e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.10e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.55e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.36e-2)"	0.5	0.7	2.2	0.0	2.6	0.1	0.4	0.9	3.5	0.1	0.1			0.4	0.4	0.0	0.1	0.2	0.0	0.1	1.8	2.3	0.2	0.1	0.2	0.1	2.0		2.7	0.0	0.0	0.0	0.2		0.6	0.1		1.2	0.4	1.3	14.1	0.2	0.1	0.8	0.2	0.1	0.6			0.1		0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.7	1.0	0.3	5.8	0.4	0.0	1.4	0.4	0.0	0.2	0.0	1.4	0.2	0.0	0.1	0.2	0.5	0.0	0.0	0.0	0.9	2.5	0.3	1.7	0.7	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.0	2.1	0.0	0.0	1.1	0.6	1.2	2.1	1.4	0.0	0.3	0.2	1.0	0.5	0.7	0.5	0.6	0.0	0.4	0.1	1.7	0.3	0.5	0.6	0.4	0.2	0.4	2.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FGF23		ENSG00000118972	"Fibroblast growth factor 23"	Q9GZV9	12	4368227-4379728	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins, Transporters"	Differentiation	"Growth factor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 11.1;heart muscle: 9.1;liver: 10.1;urinary bladder: 6.7"	"Cell line enhanced"	"Detected in many"		"AF22: 5.4;HBEC3-KT: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"								"Secreted to blood"									"unprognostic (1.31e-1)"						"unprognostic (2.18e-2)"				"unprognostic (1.44e-1)"	"unprognostic (1.67e-1)"			0.3	0.4	0.2	0.2	0.2	0.8	0.2	0.2	0.8	0.2	0.2	0.2	0.2	0.4	0.5	3.5	1.2	0.5	0.2	9.1	0.2	0.2	0.3	10.1	0.3	2.6	0.2	0.2	0.3	0.2	0.1	0.4	0.3	0.2	0.2	1.4	0.2	1.0	0.2	2.5	0.4	0.3	0.7	0.2	1.1	0.2	0.9	0.2	0.6	0.3	0.2	1.3	6.7	0.2	3.1	2.9	11.1	3.6	3.4	3.1	1.7	0.2	0.0	5.4	1.8	2.8	0.6	0.8	0.1	0.1	0.0	0.2	1.0	1.9	0.3	0.2	0.9	1.2	0.8	3.9	0.2	0.2	0.6	0.2	0.7	0.6	1.6	1.1	0.5	1.6	0.1	2.5	3.2	0.4	0.5	2.3	0.1	0.0	0.7	1.3	1.4	0.2	0.9	0.1	0.8	0.6	1.1	1.2	1.1	0.0	1.8	0.2	1.3	0.8	0.0	2.0	0.5	1.4	0.3	0.1	0.2	0.3	1.2	0.4	1.3	11.1	2.3	2.9	2.6	2.4	3.1	2.9	2.5	2.0	1.8	3.1	2.8	2.9	7.2	3.4	3.6	2.9	2.3	1.7	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2
FGF3	"HBGF-3, INT2"	ENSG00000186895	"Fibroblast growth factor 3"	P11487	11	69809969-69819024	"Cancer-related genes, Disease related genes, Predicted secreted proteins, RAS pathway related proteins"	Differentiation	"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	43	"brain: 16.6"	"Cell line enriched"	"Detected in single"	48	"CAPAN-2: 4.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	38	"cerebellum: 16.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"basal ganglia: 2.7"	"Not detected"	"Not detected"			HPA012692	Enhanced				"Secreted in brain"					"HPA012692: AB_1848526"				"unprognostic (6.42e-3)"						"unprognostic (7.82e-2)"	"unprognostic (1.89e-1)"			"unprognostic (3.61e-1)"	"unprognostic (7.75e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0
FGF4	"HBGF-4, HST, HST-1, HSTF1, K-FGF, KFGF"	ENSG00000075388	"Fibroblast growth factor 4"	P08620	11	69771016-69775403	"Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins"	Differentiation	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.6;intestine: 1.6;testis: 2.4;tongue: 2.0"	"Cell line enriched"	"Detected in single"	93	"NTERA-2: 18.6"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 13.9"	"Group enriched"	"Detected in some"	19	"midbrain: 2.6;pons and medulla: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011209	Uncertain				"Secreted in other tissues"					"HPA011209: AB_1848527"			"unprognostic (1.47e-2)"	"unprognostic (6.22e-2)"										"unprognostic (7.77e-2)"	"unprognostic (8.56e-2)"			0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	2.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.4	0.0	1.2	0.8	0.1	2.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	1.2	0.0
FGF5		ENSG00000138675	"Fibroblast growth factor 5"	P12034	4	80266599-80336680	"Disease related genes, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Mitogen"	"Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"brain: 38.2"	"Cell line enhanced"	"Detected in some"		"BJ: 19.7;BJ hTERT+: 37.4;fHDF/TERT166: 26.9;HBF TERT88: 28.1;LHCN-M2: 25.2;U-138 MG: 34.9;U-251 MG: 16.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	9	"cerebellum: 38.2"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB010313, HPA042442"			Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"	"Secreted in brain"			"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"CAB010313: AB_2102677, HPA042442: "	"unprognostic (6.44e-2)"	"unprognostic (6.24e-3)"	"unprognostic (8.49e-4)"	"unprognostic (1.10e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.80e-3)"		"unprognostic (6.87e-4)"	"unprognostic (2.53e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.33e-16)"	"unprognostic (3.02e-3)"	"unprognostic (3.14e-1)"		"unprognostic (2.83e-2)"	0.1	0.1	0.1	1.7	0.1	0.5	0.1	38.2	1.3	0.1	3.1	0.0	0.0	0.4	0.4	0.1	1.3	0.1	9.2	0.3	1.6	0.2	2.3	0.1	0.1	0.2	0.2	0.2	0.2	0.1	0.0	1.3	0.1	4.1	0.2	0.1	0.0	0.1	0.0	0.5	0.4	2.8	2.4	0.3	0.1	0.8	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.7	0.7	1.7	0.3	0.2	0.5	0.0	0.0	0.0	0.0	0.0	1.9	7.1	0.0	19.7	37.4	5.2	3.8	0.0	0.0	0.0	0.0	26.9	0.0	0.0	6.9	28.1	0.0	0.3	0.0	0.0	0.0	0.5	0.1	0.0	2.0	0.0	15.3	7.3	1.7	0.0	0.1	25.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	6.4	34.9	1.4	1.7	16.7	0.0	0.0	0.0	2.0	0.0	0.7	1.7	0.3	0.3	0.4	0.2	0.5	0.2	0.3	0.4	0.2	0.7	0.5	0.5	0.9	0.2	0.2	0.7	0.2	0.0	0.1	0.1	38.2	1.3	1.6	0.2	0.2	0.2	4.1	0.1
FGFBP1	"FGFBP, HBP17"	ENSG00000137440	"Fibroblast growth factor binding protein 1"	Q14512	4	15935569-15938740	"Cancer-related genes, Predicted secreted proteins"		"Growth factor binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 106.6;lymphoid tissue: 56.8;tongue: 133.1"	"Group enriched"	"Detected in some"	4	"HaCaT: 77.2;HBEC3-KT: 133.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 246.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA004332	Enhanced				"Secreted in other tissues"					"HPA004332: AB_1078856"	"unprognostic (2.87e-3)"	"unprognostic (3.55e-1)"	"unprognostic (5.03e-2)"	"unprognostic (6.99e-2)"		"unprognostic (1.86e-2)"		"unprognostic (1.97e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (5.03e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.31e-3)"	0.2	0.0	0.2	0.6	0.2	0.0	4.1	0.2	0.2	27.1	5.1	0.2	0.2	0.4	1.1	0.2	106.6	0.1	0.3	0.2	0.2	0.0	0.3	0.2	1.9	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.7	0.2	0.3	4.6	0.4	14.1	0.2	0.2	14.6	1.3	0.3	0.2	0.2	0.5	0.2	0.2	0.2	0.3	133.1	56.8	1.8	31.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	20.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.2	0.0	1.5	0.0	77.2	0.0	133.6	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	19.8	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	13.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
FGFBP2	KSP37	ENSG00000137441	"Fibroblast growth factor binding protein 2"	Q9BYJ0	4	15960243-15969309	"Plasma proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 79.8"	"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 10.9;T-47d: 5.4;WM-115: 2.2"	"Group enriched"	"Detected in many"	9	"glioma: 4.8;head and neck cancer: 13.1;lung cancer: 16.7;melanoma: 16.9"	"Region enriched"	"Detected in many"	6	"midbrain: 16.0"	"Cell type enhanced"	"Detected in many"		"gdT-cell: 79.8"	"Lineage enriched"	"Detected in many"	10	"T-cells: 79.8"														"Secreted to blood"	6900000	6900000				"unprognostic (3.51e-3)"	"unprognostic (8.81e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.35e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.59e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.49e-2)"	21.0	1.4	0.3	0.4	1.0	33.4	19.4	0.0	0.9	1.1	7.1	0.2	0.9	0.2	0.6	6.0	3.4	0.7	0.8	16.1	0.4	0.2	0.5	0.8	6.7	1.9	16.0	1.0	0.9	0.2	0.1	0.2	0.8	2.8	3.1	0.8	30.7	5.7	0.9	6.7	14.4	1.8	5.3	5.0	10.4	1.2	11.3	0.0	5.8	0.7	3.8	1.9	1.5	3.7	0.1	0.2	1.2	0.2	8.3	79.8	39.3	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	10.9	5.4	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.8	0.0	2.2	0.4	0.1	0.3	79.8	0.1	0.7	0.1	19.7	47.0	0.1	0.0	7.6	47.5	1.2	8.3	0.2	0.2	0.1	39.3	0.3	1.0	0.0	0.9	0.4	0.2	16.0	1.0	2.8	0.0
FGFBP3	"C10orf13, MGC39320"	ENSG00000174721	"Fibroblast growth factor binding protein 3"	Q8TAT2	10	91906589-91909483	"Predicted secreted proteins"		"Growth factor binding, Heparin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 20.6"	"Cell line enriched"	"Detected in some"	9	"AF22: 83.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA053943	Uncertain				"Secreted in brain"					"HPA053943: "	"unprognostic (8.66e-2)"	"unprognostic (6.00e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.88e-1)"	"unprognostic (9.98e-3)"	"unprognostic (7.76e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.39e-3)"	"unprognostic (2.61e-1)"	"unprognostic (3.90e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.63e-1)"	"unprognostic (6.76e-3)"	1.4	2.1	6.4	1.4	4.6	1.0	2.0	3.4	20.6	1.3	1.6	4.1	0.3	1.1	1.8	2.8	1.0	1.1	0.6	2.1	6.9	5.9	1.4	0.8	1.1	2.2	4.0	5.6	2.5	1.9	2.0	2.3	0.9	6.7	2.3	1.9	0.5	1.9	1.4	3.3	1.8	1.1	1.0	3.9	1.7	2.2	1.1	4.4	0.9	2.7	0.3	1.2	1.0	0.8	3.7	0.6	2.0	0.5	0.9	1.9	0.2	0.0	0.6	83.8	1.2	0.3	0.1	0.3	0.0	0.0	0.1	0.2	0.2	0.3	0.1	0.1	0.1	0.3	0.5	0.0	0.2	0.3	0.9	1.6	0.6	0.9	0.2	8.9	0.2	0.2	0.1	0.4	0.4	0.0	0.8	0.3	0.0	0.7	1.0	3.6	6.2	0.3	2.6	0.5	0.1	0.1	0.2	0.8	1.1	0.2	0.0	1.4	0.3	0.1	0.1	0.1	0.6	0.1	0.2	0.2	0.5	0.3	0.0	1.0	0.1	2.0	0.5	0.0	1.7	0.1	0.6	2.1	1.1	0.9	0.6	3.7	1.9	1.4	0.0	0.9	0.0	0.3	0.1	0.2	6.4	4.6	3.4	6.4	6.9	5.9	4.0	5.6	6.7	4.4
FGL1	HFREP-1	ENSG00000104760	"Fibrinogen like 1"	Q08830	8	17864380-17910365	"Plasma proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 450.7"	"Group enriched"	"Detected in some"	15	"A549: 21.7;Hep G2: 51.0"	"Cancer enriched"	"Detected in some"	40	"liver cancer: 399.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"								"Secreted to blood"	1800000	1800000				"unprognostic (3.62e-2)"	"unprognostic (1.14e-2)"		"unprognostic (1.75e-5)"	"unprognostic (3.00e-1)"	"unprognostic (3.54e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.62e-1)"		"unprognostic (2.71e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.86e-7)"	"prognostic unfavourable (5.38e-4)"	"unprognostic (3.62e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.35e-1)"	0.1	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	450.7	0.2	0.1	0.1	0.1	0.1	71.3	0.0	0.1	0.6	0.2	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.3	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	21.7	0.0	2.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	51.0	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.1
FGL2	"pT49, T49"	ENSG00000127951	"Fibrinogen like 2"	Q14314	7	77193371-77199848	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 82.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 4.0;Karpas-707: 3.7;LHCN-M2: 4.1;NB-4: 4.5;RPTEC TERT1: 7.8;U-937: 8.2;WM-115: 8.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	50	"classical monocyte: 59.3;eosinophil: 52.6;intermediate monocyte: 82.0;myeloid DC: 38.1;neutrophil: 68.4;non-classical monocyte: 73.5"	"Group enriched"	"Detected in many"	56	"dendritic cells: 38.1;granulocytes: 68.4;monocytes: 82.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021011, HPA026682"	Enhanced				"Secreted to blood"	6400000	6400000			"HPA021011: AB_1848532, HPA026682: AB_1848533"	"unprognostic (9.80e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.51e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.01e-2)"	30.0	8.7	6.0	28.7	10.7	1.5	18.0	5.7	4.7	8.0	29.5	5.0	7.7	14.2	7.6	18.4	41.4	13.8	16.2	17.8	5.1	5.5	23.3	14.3	17.0	28.1	10.3	4.1	6.4	3.0	1.8	8.0	7.0	11.4	17.9	20.3	6.8	11.7	4.4	6.2	8.6	40.9	73.7	18.4	63.4	16.9	3.4	8.6	12.0	19.2	18.3	9.1	55.8	7.7	1.0	38.1	68.4	82.0	0.7	1.1	34.6	0.0	0.0	0.0	0.0	4.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.3	0.1	0.0	0.0	0.1	0.1	0.1	0.0	3.7	4.1	0.1	0.0	4.5	0.3	0.2	0.2	0.5	0.4	7.8	1.0	0.1	0.3	0.1	0.0	0.0	0.0	3.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.3	8.2	8.8	0.6	59.3	52.6	1.1	82.0	0.5	1.0	0.7	1.0	38.1	0.5	0.4	0.8	68.4	0.7	73.5	1.2	1.1	34.6	6.0	10.7	5.7	4.7	5.1	5.5	10.3	4.1	11.4	8.6
FMOD	SLRR2E	ENSG00000122176	Fibromodulin	Q06828	1	203340628-203351489	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 7.0;CACO-2: 24.1;HHSteC: 7.8;HSkMC: 14.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"								"Secreted to extracellular matrix"	2400000	2400000				"unprognostic (1.48e-1)"	"unprognostic (8.88e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.17e-3)"	"unprognostic (1.86e-1)"	"unprognostic (3.30e-1)"	"unprognostic (5.25e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavourable (1.40e-5)"	"unprognostic (9.40e-3)"	"unprognostic (3.58e-2)"	"unprognostic (1.27e-3)"	"prognostic unfavourable (2.67e-4)"	35.9	6.0	1.0	12.6	2.0	0.0	32.2	1.2	2.0	62.5	14.2	2.0	12.0	12.1	69.6	43.6	16.9	31.2	87.1	58.3	1.1	1.2	10.8	6.1	22.8	27.4	3.0	2.5	86.7	39.4	5.0	12.1	21.0	5.0	37.5	16.0	44.3	25.0	16.2	20.1	10.5	8.4	27.4	7.5	18.3	36.5	14.2	0.6	2.7	57.6	20.4	37.6	32.0	42.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.4	0.1	4.5	5.1	0.0	0.7	24.1	0.0	0.0	0.5	4.8	0.1	0.0	0.4	0.3	0.0	0.0	0.0	0.6	0.0	7.8	0.0	0.0	14.5	0.0	0.0	0.2	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.2	1.3	0.0	0.2	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.0	1.2	2.0	1.1	1.2	3.0	2.5	5.0	0.6
FOLR3	FR-G	ENSG00000110203	"Folate receptor 3"	P41439	11	72114869-72139892	"Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 73.4;bone marrow: 43.4;lymphoid tissue: 22.6"	"Group enriched"	"Detected in some"	5	"hTERT-HME1: 34.8;U-2197: 30.7"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 5.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	12	"classical monocyte: 52.9;neutrophil: 73.4"	"Group enriched"	"Detected in many"	12	"granulocytes: 73.4;monocytes: 52.9"														"Secreted to blood"	9600000	9600000				"unprognostic (1.47e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.94e-2)"	"unprognostic (8.72e-3)"	"unprognostic (6.87e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.54e-1)"	"unprognostic (7.35e-2)"	"unprognostic (7.90e-2)"	"unprognostic (8.39e-2)"	"unprognostic (9.99e-4)"	"unprognostic (1.96e-1)"	"unprognostic (2.03e-6)"	"unprognostic (4.17e-1)"	2.9	0.3	0.1	4.8	0.2	43.4	4.2	0.1	0.8	0.1	0.1	0.2	0.0	0.2	0.2	0.3	0.4	1.0	0.1	1.7	0.2	0.1	2.7	0.6	14.4	8.2	0.2	0.0	0.1	1.7	0.0	0.1	4.5	0.2	0.1	0.0	0.2	0.2	0.0	0.1	0.3	0.2	0.2	0.1	22.6	0.4	0.7	0.2	0.3	0.9	0.4	0.4	0.2	7.5	0.0	5.1	73.4	52.9	0.0	0.2	29.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	4.8	6.1	1.8	4.4	0.0	0.0	0.0	0.6	0.9	0.4	0.0	3.3	4.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.1	2.5	34.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.1	30.7	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1.2	52.9	4.3	0.0	3.5	0.2	0.0	0.0	0.0	5.1	0.0	0.0	0.0	73.4	0.0	0.1	0.9	0.0	29.5	0.1	0.2	0.1	0.8	0.2	0.1	0.2	0.0	0.2	0.2
FREM3		ENSG00000183090	"FRAS1 related extracellular matrix 3"	P0C091	4	143577302-143700675	"Predicted secreted proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	8	"brain: 5.0;lung: 1.8"	"Cell line enriched"	"Detected in single"	5	"TIME: 3.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basal ganglia: 3.3;hypothalamus: 3.2;thalamus: 4.8"	"Low region specificity"	"Detected in some"			HPA041641	Uncertain				"Secreted to extracellular matrix"					"HPA041641: "	"unprognostic (1.19e-2)"			"unprognostic (4.09e-9)"	"unprognostic (3.09e-3)"	"unprognostic (2.74e-1)"		"unprognostic (1.66e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.11e-3)"	"unprognostic (3.24e-1)"	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0			0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.7	0.2	0.0	1.8	0.0	0.2		0.0	0.0	0.1	0.1	0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FRZB	"FRE, FRITZ, FRP-3, FRZB-1, FRZB-PEN, FRZB1, FZRB, hFIZ, SFRP3, SRFP3"	ENSG00000162998	"Frizzled related protein"	Q92765	2	182833275-182867162	"Disease related genes, Predicted secreted proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"retina: 265.8"	"Cell line enhanced"	"Detected in some"		"AF22: 17.3;ASC diff: 8.4;NTERA-2: 7.0;SH-SY5Y: 6.0"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"pons and medulla: 21.7"	"Group enriched"	"Detected in some"	9	"memory B-cell: 3.0;naive B-cell: 1.5"	"Lineage enriched"	"Detected in single"	12	"B-cells: 3.0"	"Region enhanced"	"Detected in many"		"olfactory region: 69.9"	"Low region specificity"	"Detected in all"								"Secreted in other tissues"	27000	27000				"unprognostic (5.39e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.64e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.67e-2)"	"unprognostic (8.58e-2)"	"unprognostic (5.41e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavourable (8.97e-6)"	"unprognostic (3.53e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.04e-2)"	"unprognostic (3.21e-1)"	4.4	1.4	2.8	4.8	5.4	0.0	5.1	2.9	3.5	7.1	5.1	3.3	2.6	4.5	5.5	3.5	3.6	2.8	12.9	8.4	2.8	2.8	5.5	2.2	3.7	4.8	3.6	3.4	4.4	2.4	0.6	11.3	44.3	21.7	4.0	6.6	265.8	5.1	5.4	8.4	4.3	4.7	10.5	2.9	28.2	12.0	4.2	2.3	3.1	5.0	3.1	3.4	3.5	6.2	3.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	17.3	0.2	8.4	0.2	0.1	0.0	0.8	3.0	2.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.2	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.7	0.6	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	7.0	0.0	0.6	0.7	0.0	0.0	0.0	1.1	6.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	5.4	2.9	3.5	2.8	2.8	3.6	3.4	21.7	2.3
FSHB		ENSG00000131808	"Follicle stimulating hormone beta subunit"	P01225	11	30231016-30235261	"Cancer-related genes, Disease related genes, Predicted secreted proteins"		Hormone	"Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	90	"pituitary gland: 70.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"CAB023410, HPA069703"	Enhanced				"Secreted to blood"	47000	47000			"CAB023410: AB_324983, HPA069703: "												"unprognostic (1.04e-1)"						0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	70.7	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.5	0.0	0.0	0.3	0.3	0.0
FSTL5	"DKFZp566D234, KIAA1263"	ENSG00000168843	"Follistatin like 5"	Q8N475	4	161383897-162164035	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 106.9"	"Cell line enriched"	"Detected in some"	5	"Karpas-707: 39.8"	"Cancer enriched"	"Detected in single"	6	"melanoma: 1.7"	"Region enriched"	"Detected in all"	6	"cerebellum: 106.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in brain"							"unprognostic (4.90e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.08e-10)"	"unprognostic (8.45e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.60e-3)"	0.5	12.1	3.5	0.6	6.9	0.5	0.5	106.9	19.9	0.5	0.6	0.6	0.0	0.5	0.5	1.7	0.5	0.6	0.5	0.5	3.2	5.9	0.6	0.5	0.5	0.5	3.0	3.0	0.5	1.0	0.5	1.1	0.7	18.2	0.5	0.8	7.1	0.5	0.6	0.5	0.8	0.6	0.6	3.1	0.5	0.5	1.5	2.9	0.0	0.6	0.0	0.5	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	5.7	0.0	39.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1	5.7	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	8.6	0.0	3.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	6.9	106.9	6.9	3.2	5.9	3.0	3.0	18.2	2.9
GAL	"GAL-GMAP, GALN, GLNN, GMAP"	ENSG00000069482	"Galanin and GMAP prepropeptide"	P22466	11	68683779-68691175	"Disease related genes, Plasma proteins, Predicted secreted proteins"		"Hormone, Neuropeptide"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"pituitary gland: 149.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 46.9;HEK 293: 21.9;K-562: 24.3;NB-4: 86.7;SH-SY5Y: 35.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	8	"hypothalamus: 18.8"	"Cell type enriched"	"Detected in single"	15	"intermediate monocyte: 1.5"	"Lineage enriched"	"Detected in single"	15	"monocytes: 1.5"	"Region enhanced"	"Detected in many"		"hypothalamus: 111.6"	"Low region specificity"	"Detected in all"			"HPA049864, CAB079779"	Enhanced	Supported	Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"			"Golgi apparatus"	Vesicles	"CAB079779: , HPA049864: "	"unprognostic (8.56e-2)"	"unprognostic (1.45e-2)"	"unprognostic (7.50e-2)"	"prognostic unfavourable (1.22e-4)"	"unprognostic (2.70e-1)"	"unprognostic (2.27e-2)"	"unprognostic (8.07e-3)"	"prognostic unfavourable (8.17e-4)"	"unprognostic (5.98e-2)"	"unprognostic (1.07e-2)"	"unprognostic (8.84e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.85e-2)"	"unprognostic (7.88e-2)"	"unprognostic (5.38e-2)"	"unprognostic (3.24e-2)"	2.8	0.2	0.1	14.8	0.5	0.4	4.5	0.6	2.0	0.2	6.0	0.1	0.4	1.7	0.2	0.7	0.7	0.2	0.3	0.6	1.3	18.8	0.3	0.2	0.2	0.1	0.2	0.6	0.2	2.9	0.0	149.9	0.9	2.2	0.7	4.1	0.6	0.5	1.8	0.3	4.5	2.2	9.7	0.3	0.2	1.5	0.5	0.4	0.7	0.2	0.4	0.3	1.5	0.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.9	0.2	0.0	0.0	0.0	4.4	6.6	0.0	0.1	0.0	46.9	1.7	0.0	2.4	0.2	0.0	0.0	0.0	0.0	0.0	21.9	1.1	14.1	0.0	0.2	0.6	0.0	0.3	0.7	0.0	0.0	1.1	24.3	0.0	0.0	13.3	0.0	86.7	11.2	4.2	0.0	0.0	8.9	0.1	0.0	9.1	35.0	4.6	0.2	0.0	0.2	10.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	0.7	1.3	18.8	0.2	0.6	2.2	0.4
GALP		ENSG00000197487	"Galanin like peptide"	Q9UBC7	19	56176020-56185775	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Hormone, Neuropeptide"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"brain: 4.4;liver: 4.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.1;EFO-21: 1.3"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.6"	"Region enhanced"	"Detected in many"		"pons and medulla: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"hippocampal formation: 29.0"	HPA053938	Uncertain				"Secreted in brain"					"HPA053938: "				"unprognostic (8.51e-3)"			"unprognostic (1.22e-2)"			"unprognostic (2.65e-1)"					"unprognostic (7.02e-2)"			0.0	0.2	1.2	0.0	1.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.7	0.0	4.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.0	0.0	0.1	1.1	0.7	0.4	0.0	4.4	0.0
GAS6	"AXLLG, AXSF, DKFZp666G247, FLJ34709"	ENSG00000183087	"Growth arrest specific 6"	Q14393	13	113820549-113864067	"Predicted secreted proteins"	"Growth regulation, Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 55.7;BJ hTERT+: 80.6;HSkMC: 47.2;RPMI-8226: 76.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"plasmacytoid DC: 31.7"	"Lineage enriched"	"Detected in single"	51	"dendritic cells: 31.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008275, HPA056080"	Approved		Approved	"Centriolar satellite,Cytosol"	"Secreted to blood"	920000	920000	Cytosol	"Centriolar satellite"	"HPA008275: AB_1849497, HPA056080: "	"unprognostic (1.57e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.37e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.16e-2)"	"unprognostic (9.00e-2)"	"prognostic unfavourable (8.93e-6)"	25.6	12.6	10.6	6.8	10.7	1.0	35.3	8.0	13.2	52.9	17.1	7.9	35.7	17.9	48.6	20.1	27.0	45.8	24.3	45.9	10.6	8.3	14.7	13.9	27.9	14.4	9.2	9.5	33.0	18.4	7.3	15.8	19.1	13.9	34.2	9.5	20.3	26.8	35.9	27.1	27.9	17.0	53.4	8.8	7.7	16.5	25.2	9.5	10.0	29.2	13.1	6.5	31.8	44.7	0.0	31.7	0.0	0.6	0.0	0.1	0.5	23.6	1.0	0.7	0.6	28.4	15.9	3.0	55.7	80.6	23.3	27.9	1.5	11.4	0.2	1.8	25.1	22.3	0.3	12.4	5.9	0.0	3.2	0.1	1.7	0.1	20.3	0.1	0.2	47.2	7.3	6.4	6.4	0.8	0.4	13.0	37.5	1.1	0.1	0.2	1.5	1.6	0.7	0.0	76.5	8.4	0.3	3.8	3.5	6.1	0.2	0.0	7.4	18.9	13.1	6.1	7.6	0.7	15.7	0.0	1.2	0.2	6.9	0.5	0.9	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.1	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.1	31.7	0.0	0.5	10.6	10.7	8.0	13.2	10.6	8.3	9.2	9.5	13.9	9.5
GAST	GAS	ENSG00000184502	Gastrin	P01350	17	41712326-41715969	"Cancer-related genes, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	61	"stomach 1: 529.2"	"Group enriched"	"Detected in some"	6	"BEWO: 5.0;HaCaT: 9.5;hTCEpi: 5.9"	"Group enriched"	"Detected in many"	6	"pancreatic cancer: 38.8;stomach cancer: 23.5"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			CAB000038	Enhanced				"Secreted to digestive system"	43000	43000			"CAB000038: "		"unprognostic (1.27e-1)"	"unprognostic (4.27e-3)"		"unprognostic (1.12e-1)"	"unprognostic (1.07e-2)"		"unprognostic (2.75e-2)"		"unprognostic (5.68e-2)"	"unprognostic (2.11e-1)"			"unprognostic (2.85e-1)"	"unprognostic (3.17e-1)"		"unprognostic (9.07e-2)"	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.2	0.1	1.7	6.9	0.0	2.4	7.3	0.0	0.0	0.0	2.6	0.0	0.1	0.3	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	529.2	0.1	0.0	8.6	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.0	0.3	0.0	0.0	0.0	0.6	0.0	0.2	0.7	0.0	9.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	1.2	0.1	0.3	0.1	0.0	0.0	0.0
GC	"DBP, hDBP, VDBP"	ENSG00000145321	"GC, vitamin D binding protein"	P02774	4	71741693-71804041	"Plasma proteins, Predicted secreted proteins"	Transport	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 552.1"	"Cell line enhanced"	"Detected in some"		"HL-60: 4.1;RH-30: 6.4;SiHa: 3.1;U-698: 2.3"	"Cancer enriched"	"Detected in many"	18	"liver cancer: 1016.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001526, CAB008596, HPA019855"	Supported				"Secreted to blood"	69000000000	69000000000			"CAB008596: AB_1622398, HPA001526: AB_1078959, HPA019855: AB_1849545"							"prognostic favourable (8.08e-4)"				"unprognostic (1.06e-3)"		"prognostic unfavourable (5.81e-5)"	"unprognostic (1.55e-1)"	"unprognostic (2.15e-1)"			0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.9	0.0	0.0	2.6	0.1	0.2	0.1	0.1	43.7	0.1	0.1	0.1	2.0	552.1	0.1	0.0	0.1	0.0	0.1	6.5	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	1.0	0.0	0.1	0.4	2.6	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	4.1	0.2	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	1.0	0.0	0.0	0.0	0.3	3.1	0.0	0.0	0.0	0.0	1.7	0.0	1.7	0.0	0.0	0.8	0.0	2.3	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
GCG	"GLP-1, GLP1, GLP2, GRPP"	ENSG00000115263	Glucagon	P01275	2	162142873-162152404	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"pancreas: 202.8"	"Group enriched"	"Detected in some"	5	"EFO-21: 37.1;U-2 OS: 52.8"	"Cancer enriched"	"Detected in some"	209	"pancreatic cancer: 428.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	10	"pons and medulla: 3.7"	"Region enhanced"	"Detected in single"		"midbrain: 2.0"	"CAB000040, HPA036760, HPA036761"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to blood"			"Endoplasmic reticulum"	Vesicles	"CAB000040: AB_10013726, HPA036760: AB_2675296, HPA036761: AB_2675297"			"unprognostic (3.13e-3)"								"unprognostic (9.99e-2)"	"unprognostic (1.16e-2)"		"unprognostic (1.26e-2)"				1.0	0.1	0.2	0.6	0.2	1.1	0.2	0.2	1.8	0.2	6.6	0.2	0.2	0.0	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.1	3.4	0.2	0.2	0.2	0.2	0.2	0.2	202.8	0.0	0.2	0.2	0.5	0.2	12.6	0.2	0.2	0.2	0.2	2.5	11.0	0.2	0.2	0.2	2.4	0.3	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.8	0.0	2.9	0.0	1.4	8.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.2	0.1	0.2	0.2	0.5	0.2
GDF1		ENSG00000130283	"Growth differentiation factor 1"	P27539	19	18868545-18896096	"Disease related genes, Predicted secreted proteins"		"Cytokine, Growth factor"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"brain: 36.4;skeletal muscle: 15.5"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.4;EFO-21: 5.2;HEK 293: 6.3;NB-4: 8.2;NTERA-2: 4.2;SCLC-21H: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to blood"																							2.2	2.1	25.6	2.2	28.6	1.9	1.9	11.7	32.1	2.0	2.0	36.4	0.0	1.9	2.0	1.9	2.0	2.0	2.0	2.1	24.6	18.0	2.0	1.9	1.9	1.9	26.2	18.3	2.4	2.0	2.0	1.1	1.9	30.4	2.2	1.9	1.4	2.1	2.0	15.5	1.9	2.0	2.0	33.7	1.9	2.0	4.9	19.8	0.0	2.0	0.0	1.9	1.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.0	3.4	0.0	0.0	0.3	0.2	0.0	0.3	0.3	0.8	0.0	0.0	5.2	0.0	0.1	0.1	0.0	0.0	0.0	6.3	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.7	0.0	8.2	4.2	0.1	0.0	0.0	0.1	0.0	0.0	3.5	2.2	0.0	0.0	1.5	0.6	2.5	0.0	0.0	1.0	0.8	0.5	0.3	0.0	0.0	0.1	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.6	28.6	11.7	32.1	24.6	18.0	26.2	18.3	30.4	19.8
GDF10	BMP-3b	ENSG00000266524	"Growth differentiation factor 10"	P55107	10	47300386-47313547	"Plasma proteins, Predicted secreted proteins"	Osteogenesis	"Cytokine, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 15.8;tongue: 14.8"	"Cell line enhanced"	"Detected in some"		"AF22: 17.3;MOLT-4: 3.7;SH-SY5Y: 7.1"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.3;naive CD4 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	16	"T-cells: 1.5"	"Region enriched"	"Detected in many"	8	"cerebellum: 47.7"	"Low region specificity"	"Detected in all"			HPA015498	Uncertain		Approved	Vesicles	"Secreted in other tissues"			Vesicles		"HPA015498: AB_1849584"	"unprognostic (4.34e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.09e-1)"	"unprognostic (3.17e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.72e-7)"	"unprognostic (3.49e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.59e-3)"	"unprognostic (2.63e-1)"	6.8	4.4	1.4	0.3	2.8	0.0	10.8	7.6	5.2	1.9	0.4	1.7	0.0	0.0	2.3	2.4	5.4	0.5	2.9	2.1	3.0		0.0	0.0	15.8	0.9	0.0	5.0	0.1	11.6	0.2	0.0	0.0	0.9	2.8	0.3	6.8	3.0	0.3	2.5	0.3	0.1	0.6	0.8	0.1	0.1	10.5	0.8	0.0	3.7	14.8	2.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.1										
GDF11	BMP-11	ENSG00000135414	"Growth differentiation factor 11"	O95390	12	55743280-55757278	"Predicted secreted proteins"		"Cytokine, Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 35.4"	"Cell line enhanced"	"Detected in many"		"HMC-1: 53.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060985, HPA069609"	Enhanced		Approved	Vesicles	"Secreted to blood"	270000	270000	Vesicles		"HPA060985: , HPA069609: "	"unprognostic (5.21e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.62e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.23e-2)"	"prognostic favourable (1.08e-4)"	"unprognostic (2.69e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.01e-3)"	"unprognostic (9.48e-2)"	4.6	4.9	15.9	5.6	13.9	2.6	1.9	10.7	13.3	10.3	4.5	9.2	6.6	2.7	10.0	3.5	4.0	6.9	7.4	11.4	13.3	12.9	3.2	1.6	3.1	4.1	13.9	7.3	7.5	4.7	4.6	4.6	3.3	9.3	7.7	2.8	35.4	7.0	16.0	1.9	2.1	3.6	7.3	13.1	5.7	3.5	1.7	9.5	5.7	4.6	1.6	2.9	7.5	2.9	2.4	2.3	1.4	1.2	0.8	3.9	0.5	1.9	3.1	13.5	7.6	10.3	7.6	3.4	4.0	3.9	5.1	4.5	10.4	0.8	3.8	5.4	4.2	1.9	10.2	7.2	1.8	7.2	9.2	4.6	5.1	1.5	2.0	3.8	53.0	7.2	0.4	7.5	2.1	6.7	5.1	12.3	6.6	3.6	6.2	3.3	10.8	7.7	9.9	3.7	2.3	3.2	2.6	9.2	5.6	2.5	1.1	1.0	4.3	4.2	4.1	6.3	9.7	4.9	2.9	3.3	1.0	1.9	3.3	3.8	4.4	0.7	0.7	1.4	3.9	0.5	3.6	2.3	2.4	2.5	0.6	2.4	2.2	3.0	1.2	0.8	1.2	2.3	1.7	0.5	15.9	13.9	10.7	10.0	13.3	12.9	13.9	7.3	9.3	9.5
GDF2	"BMP-9, BMP9"	ENSG00000263761	"Growth differentiation factor 2"	Q9UK05	10	47322490-47326270	"Disease related genes, Plasma proteins, Predicted secreted proteins"	Angiogenesis	"Cytokine, Growth factor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	273	"liver: 27.3"	"Cell line enhanced"	"Detected in single"		"K-562: 2.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB023357	Uncertain				"Secreted to blood"	300000	300000			"CAB023357: AB_2111086"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	27.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GDF3		ENSG00000184344	"Growth differentiation factor 3"	Q9NR23	12	7689782-7695776	"Disease related genes, Predicted secreted proteins"		"Cytokine, Developmental protein, Growth factor"	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 6.4;lymphoid tissue: 6.6"	"Cell line enriched"	"Detected in some"	13	"NTERA-2: 99.7"	"Cancer enriched"	"Detected in some"	422	"testis cancer: 383.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA018468	Uncertain				"Secreted to blood"					"HPA018468: AB_1849586"	"unprognostic (9.48e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.51e-1)"	"unprognostic (5.40e-2)"		"unprognostic (3.09e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.25e-3)"	"unprognostic (8.00e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.03e-1)"	1.3	1.1	0.0	1.1	0.7	0.0	6.4	0.0	0.0	0.5	0.2	0.0	0.0	0.4	0.5	1.5	0.4	1.4	0.9	2.2	0.0	0.0	4.7	0.5	0.5	0.9	0.0	0.0	1.7	0.0	0.1	2.0	0.0	0.0	0.7	0.1	0.6	0.2	1.9	0.2	0.3	1.4	0.7	0.0	6.6	0.2	1.8	0.0	0.0	1.2	1.0	0.3	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	99.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GDF5	"BMP14, CDMP1"	ENSG00000125965	"Growth differentiation factor 5"	P43026	20	35433347-35454746	"Disease related genes, Plasma proteins, Predicted secreted proteins"	Chondrogenesis	"Cytokine, Growth factor"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"salivary gland: 16.4"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 16.9;BJ hTERT+: 5.0;fHDF/TERT166: 4.0;HHSteC: 5.5;HSkMC: 13.7;U-87 MG: 6.4"	"Cancer enriched"	"Detected in single"	7	"endometrial cancer: 3.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA015648	Uncertain				"Secreted to blood"					"HPA015648: AB_1849589"	"unprognostic (4.59e-3)"	"unprognostic (3.48e-2)"	"unprognostic (5.53e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.53e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.17e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.57e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.96e-3)"	1.3	0.2	0.6	0.2	1.9	0.2	0.9	0.2	1.3	0.7	2.3	0.1	1.0	0.1	0.9	0.2	0.2	0.2	0.5	0.9	0.3	0.1	0.8	0.1	3.3	0.1	0.7	0.0	0.4	0.1	0.1	4.1	0.2	0.6	1.6	0.2	0.5	16.4	2.4	0.2	0.2	0.1	1.1	1.0	0.1	0.3	0.7	0.0	1.0	0.5	1.1	0.1	0.5	0.2	0.0	0.2	0.8	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.3	16.9	0.1	2.6	5.0	0.4	0.9	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.5	0.0	0.0	13.7	0.1	0.1	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.2	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.8	0.0	0.0	0.2	0.0	0.1	0.6	1.9	0.2	1.3	0.3	0.1	0.7	0.0	0.6	0.0
GDF6	"BMP13, KFS, KFS1, SGM1"	ENSG00000156466	"Growth differentiation factor 6"	Q6KF10	8	96142330-96160792	"Disease related genes, Predicted secreted proteins"	Apoptosis	"Cytokine, Developmental protein, Growth factor"	"Disease mutation, Dwarfism, Leber congenital amaurosis, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 11.8;placenta: 16.9"	"Cell line enriched"	"Detected in some"	8	"LHCN-M2: 26.8"	"Cancer enhanced"	"Detected in some"		"renal cancer: 2.8"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 1.6"	HPA045206	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Vesicles"	"Secreted to blood"			Vesicles	"Nucleoplasm, Nuclear membrane"	"HPA045206: AB_10962508"	"unprognostic (1.13e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.66e-9)"	"unprognostic (6.49e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.18e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.09e-3)"	"unprognostic (5.37e-2)"	"unprognostic (8.13e-3)"	"prognostic unfavourable (2.17e-4)"	"unprognostic (5.88e-4)"	"unprognostic (1.88e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.71e-1)"	2.5	0.2	1.4	1.5	0.9	0.0	0.8	0.1	1.7	0.3	1.4	0.3	1.5	0.6	3.0	0.7	0.8	1.0	6.6	11.8	0.9	1.0	0.4	0.7	0.4	1.9	0.9	0.1	2.2	1.3	0.1	0.3	16.9	1.1	0.6	0.5	2.9	0.1	2.7	0.8	0.0	1.6	1.8	0.2	0.1	1.4	1.1	1.1	0.1	1.4	0.1	0.1	3.2	2.1	0.1	1.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.9	0.5	3.2	2.1	0.0	1.9	1.7	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	2.7	0.0	0.5	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	2.4	0.0	0.1	0.0	0.0	26.8	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.4	0.9	0.1	1.7	0.9	1.0	0.9	0.1	1.1	1.1
GDF7	BMP12	ENSG00000143869	"Growth differentiation factor 7"	Q7Z4P5	2	20666664-20679245	"Predicted secreted proteins"		"Cytokine, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 13.3;seminal vesicle: 22.0"	"Cell line enhanced"	"Detected in some"		"HAP1: 2.5;Hep G2: 6.2;RT4: 11.9;SH-SY5Y: 4.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	7	"memory B-cell: 2.6;naive B-cell: 2.2"	"Lineage enriched"	"Detected in single"	8	"B-cells: 2.6"	"Region enhanced"	"Detected in single"		"amygdala: 0.3"	"Not detected"	"Not detected"								"Secreted in other tissues"						"unprognostic (1.35e-1)"	"unprognostic (9.93e-3)"	"unprognostic (5.10e-1)"	"unprognostic (2.44e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.06e-3)"	"unprognostic (8.63e-3)"	"unprognostic (6.31e-3)"	"unprognostic (8.00e-3)"	"unprognostic (3.85e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.28e-3)"	"unprognostic (8.02e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.89e-3)"	0.3	0.3	0.4	1.5	0.5	0.0	0.2	0.5	1.3	13.3	0.4	0.2	4.7	0.0	6.8	3.1	0.9	0.6	1.8	2.4	0.2	0.2	3.3	7.2	0.5	3.1	2.9	0.9	0.4	0.8	0.0	0.6	2.3	0.4	3.6	0.0	2.4	1.1	22.0	0.6	1.5	1.5	1.0	0.2	3.2	0.7	0.7	1.2	0.2	0.2	0.0	1.5	1.6	6.0	2.6	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	1.0	0.0	0.1	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.2	1.8	11.9	0.0	4.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.1	2.2	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.4	0.5	0.5	1.3	0.2	0.2	2.9	0.9	0.4	1.2
GH2	"GH-V, GHL, GHV, hGH-V"	ENSG00000136487	"Growth hormone 2"	P01242	17	63880215-63881935	"Cancer-related genes, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	309	"pituitary gland: 47.3;placenta: 138.4"	"Cell line enriched"	"Detected in single"	20	"BEWO: 13.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043715	Supported				"Secreted to blood"					"HPA043715: "															"unprognostic (1.02e-1)"			0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.3	138.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GHRH	GHRF	ENSG00000118702	"Growth hormone releasing hormone"	P01286	20	37251082-37261835	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"brain: 37.3"	"Group enriched"	"Detected in some"	7	"NTERA-2: 3.5;U-266/84: 12.4"	"Cancer enriched"	"Detected in some"	7	"urothelial cancer: 8.5"	"Region enriched"	"Detected in some"	15	"hypothalamus: 37.3"	"Cell type enhanced"	"Detected in single"		"eosinophil: 2.7"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in some"	9	"hypothalamus: 38.7"	"Low region specificity"	"Detected in many"								"Secreted in other tissues"						"unprognostic (4.78e-2)"				"unprognostic (2.57e-2)"									"unprognostic (1.58e-1)"	"unprognostic (3.10e-1)"			0.1	2.7	0.3	0.1	2.4	0.0	0.6	0.1	1.0	0.1	4.0	0.1	0.1	8.1	0.1	0.1	0.7	0.0	0.1	6.5	0.1	37.3	0.1	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	7.7	0.1	0.1	0.1	1.9	0.1	0.1	7.5	0.4	0.1	0.1	0.1	0.1	0.0	0.7	2.7	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.5	0.0	0.1	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.4	0.1	1.0	0.1	37.3	0.1	0.8	0.1	0.1
GIF	"IF, IFMH, INF, TCN3"	ENSG00000134812	"Gastric intrinsic factor"	P27352	11	59829268-59845501	"Disease related genes, Predicted secreted proteins"	"Cobalt transport, Ion transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	25	"stomach 1: 185.6"	"Cell line enriched"	"Detected in single"	4	"THP-1: 3.8"	"Cancer enriched"	"Detected in some"	11	"stomach cancer: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA039908, HPA040774"	Enhanced				"Secreted to digestive system"					"HPA039908: AB_10796335, HPA040774: AB_10795626"			"unprognostic (2.78e-4)"								"unprognostic (1.04e-1)"		"unprognostic (2.45e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.66e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	7.1	0.0	0.0	0.0	0.0	3.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	185.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0
GIP		ENSG00000159224	"Gastric inhibitory polypeptide"	P09681	17	48958554-48968596	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	64	"intestine: 87.5"	"Group enriched"	"Detected in some"	4	"A549: 8.6;BEWO: 7.8;Hep G2: 12.3"	"Cancer enriched"	"Detected in some"	63	"testis cancer: 74.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016729, HPA021612"	Enhanced				"Secreted to blood"					"CAB016729: , HPA021612: AB_1849506"										"unprognostic (2.95e-1)"	"unprognostic (2.70e-3)"			"unprognostic (4.42e-2)"	"unprognostic (1.82e-1)"			0.2	0.3	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	87.5	0.0	0.0	75.4	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	61.7	0.0	0.1	0.1	0.2	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.1	0.0	0.4	0.7	7.8	0.3	0.0	0.1	0.0	2.2	0.9	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	1.5	12.3	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	2.1	0.0	0.0	0.8	0.1	0.0	0.0	0.1	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
GKN1	"AMP18, BRICD1, CA11"	ENSG00000169605	"Gastrokine 1"	Q9NS71	2	68974573-68980974	"Plasma proteins, Predicted secreted proteins"		Mitogen		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	41	"stomach 1: 918.9"	"Cell line enhanced"	"Detected in some"		"HaCaT: 5.1;HMC-1: 13.9;MOLT-4: 9.7;NTERA-2: 13.2;REH: 5.6;U-2 OS: 8.6;U-266/70: 8.6"	"Cancer enriched"	"Detected in some"	116	"stomach cancer: 255.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA047684	Enhanced				"Secreted to digestive system"	26000000	26000000			"HPA047684: "						"unprognostic (5.40e-2)"					"prognostic unfavourable (1.54e-4)"			"unprognostic (4.54e-1)"			"prognostic favourable (4.53e-4)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.8	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	22.4	0.0	2.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	918.9	0.0	0.0	1.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.2	0.0	5.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	9.7	0.0	13.2	0.0	5.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	8.6	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0
GKN2	"blottin, BRICD1B, GDDR, PRO813, TFIZ1, VLTI465"	ENSG00000183607	"Gastrokine 2"	Q86XP6	2	68945232-68952970	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"stomach 1: 311.1"	"Cell line enhanced"	"Detected in some"		"A549: 3.6;HMC-1: 3.6;MOLT-4: 2.8;NTERA-2: 4.2;PC-3: 7.7;U-2 OS: 3.0;U-266/70: 3.4"	"Cancer enriched"	"Detected in some"	8	"stomach cancer: 43.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	19	"neutrophil: 1.8"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA057765	Enhanced				"Secreted to digestive system"					"HPA057765: "								"unprognostic (1.81e-1)"			"unprognostic (1.44e-4)"			"unprognostic (2.22e-1)"				0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.2	0.1	0.1	2.1	0.1	0.0	0.1	0.1	0.2	0.0	1.4	0.1	0.1	0.0	0.1	0.1	38.8	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.3	0.1	0.0	0.1	0.6	0.1	0.1	0.0	0.1	0.1	0.1	0.1	311.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	4.2	7.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.1	3.0	0.3	0.0	3.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.3	0.1
GLB1L2		ENSG00000149328	"Galactosidase beta 1 like 2"	Q8IW92	11	134331874-134378341	"Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 36.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 24.1;HaCaT: 25.3;HMC-1: 14.0;SCLC-21H: 17.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 11.2"	"Cell type enhanced"	"Detected in many"		"gdT-cell: 5.8;NK-cell: 5.8"	"Group enriched"	"Detected in many"	23	"NK-cells: 5.8;T-cells: 5.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA054808, HPA059955"	Uncertain		Supported	Nucleoplasm	"Secreted - unknown location"			Nucleoplasm		"HPA054808: , HPA059955: "	"unprognostic (2.63e-2)"	"unprognostic (9.77e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.01e-1)"	0.8	1.2	1.6	4.4	4.2	0.1	4.5	0.3	2.5	6.0	13.5	4.5	8.7	3.6	20.5	6.6	3.0	17.1	15.7	0.8	2.2	2.7	13.8	0.3	4.1	1.3	0.9	1.4	9.5	6.5	22.7	8.6	5.4	11.2	23.5	7.8	36.2	5.2	17.4	0.8	5.9	2.7	5.6	0.7	0.2	5.7	7.0	0.3	1.4	15.0	5.2	2.6	5.1	2.9	0.2	0.0	0.0	0.0	5.8	5.8	0.8	7.4	0.7	4.0	2.2	0.0	0.0	2.7	0.0	0.0	0.0	0.0	6.3	24.1	0.0	8.0	0.0	25.3	12.2	0.2	0.0	0.0	11.5	0.0	3.2	0.3	1.1	0.0	14.0	0.1	0.3	0.0	0.0	0.0	12.1	0.0	0.0	7.2	2.0	1.4	2.3	8.8	0.0	0.0	0.7	6.8	5.2	17.2	6.4	5.5	6.9	0.0	8.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	1.5	0.0	0.0	0.0	5.8	0.0	2.3	0.0	1.3	2.3	0.0	0.2	1.6	2.6	0.0	5.8	0.0	0.0	0.0	0.8	1.6	4.2	0.3	2.5	2.2	2.7	0.9	1.4	11.2	0.3
GLTPD2		ENSG00000182327	"Glycolipid transfer protein domain containing 2"	A6NH11	17	4788959-4790390	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"intestine: 13.0;kidney: 9.8;liver: 44.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 11.5;Hep G2: 15.1;MCF7: 5.3"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 25.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 3.2"	"Lineage enriched"	"Detected in single"	6	"monocytes: 3.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA058295, HPA065267"	Uncertain		Approved	Vesicles	"Secreted - unknown location"			Vesicles		"HPA058295: , HPA065267: "	"unprognostic (4.00e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.79e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.45e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.33e-2)"	"unprognostic (5.62e-4)"	"unprognostic (7.80e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.25e-1)"	"unprognostic (4.79e-1)"	"unprognostic (1.71e-4)"	"unprognostic (7.59e-3)"	0.2	0.3	0.5	0.2	0.7	0.8	0.2	0.8	1.8	0.2	8.0	0.3	0.2	8.6	0.3	0.2	0.4	0.3	0.2	0.2	0.5	0.7	9.8	44.4	0.6	0.2	0.5	0.4	0.2	0.5	0.2	0.5	0.2	0.4	0.2	0.0	0.5	0.8	0.2	0.8	1.4	13.0	0.2	0.4	0.8	0.9	0.2	0.2	0.4	0.2	1.6	0.3	0.4	0.3	0.0	0.5	0.0	3.2	0.0	0.2	0.2	0.6	2.5	0.2	2.0	0.0	0.0	4.6	0.4	0.0	0.0	0.0	11.5	0.9	1.2	1.3	0.0	2.2	0.0	0.1	0.0	2.2	1.7	0.1	1.0	15.1	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	5.3	0.2	0.2	0.2	1.0	0.9	0.6	0.3	0.0	0.9	1.5	1.0	2.2	0.4	0.6	1.3	0.1	2.4	0.8	0.9	0.5	0.4	0.2	0.6	0.1	0.3	0.6	0.9	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.2	0.0	0.0	3.2	0.0	0.0	0.2	0.5	0.7	0.8	0.7	0.5	0.7	0.5	0.4	0.4	0.2
GNRH1	"GNRH, GRH, LHRH"	ENSG00000147437	"Gonadotropin releasing hormone 1"	P01148	8	25419260-25424654	"Disease related genes, Predicted secreted proteins"		Hormone	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.5"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 21.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"basal ganglia: 23.5;cerebellum: 6.9"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 20.8;hypothalamus: 14.2;olfactory region: 8.3"	"Group enriched"	"Detected in some"	30	"basal ganglia: 21.7;hypothalamus: 66.0"	HPA027532	Supported				"Secreted to blood"					"HPA027532: AB_10612111"	"unprognostic (6.49e-3)"	"unprognostic (7.62e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.53e-4)"	"unprognostic (7.80e-3)"	"unprognostic (2.97e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.99e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavourable (8.08e-9)"	"unprognostic (7.98e-3)"	"unprognostic (5.11e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.68e-2)"	2.0	1.3	1.7	1.7	23.5	3.6	5.0	6.9	2.3	2.4	2.6	2.1	1.7	2.6	2.5	6.7	2.3	1.9	2.8	2.3	1.7	3.7	2.3	1.7	2.7	2.8	1.7	1.7	4.3	2.8	0.8	2.0	1.9	1.7	3.6	2.5	1.7	3.3	2.4	4.0	12.6	2.9	1.7	1.7	3.1	1.5	1.7	3.2	1.7	1.8	1.7	2.3	1.7	3.9	0.9	1.1	1.7	0.3	0.2	1.9	0.1	1.0	1.7	4.5	2.4	1.6	5.3	2.0	4.0	1.6	1.2	1.9	1.7	1.2	1.3	0.9	2.3	4.0	1.3	0.3	2.9	1.8	2.3	1.4	5.9	1.7	1.3	0.2	1.5	3.1	2.4	0.9	0.8	1.0	1.6	1.3	2.0	0.7	1.4	3.1	1.6	0.5	0.9	0.6	0.6	1.2	0.7	21.0	0.8	1.1	0.8	1.4	0.8	1.9	3.7	3.5	1.7	4.0	1.5	0.2	0.2	1.9	1.7	1.1	1.5	0.0	0.0	0.0	1.9	0.1	0.8	0.3	0.2	0.6	0.1	0.9	0.4	0.3	1.7	0.2	0.3	1.1	1.6	0.1	1.7	23.5	6.9	2.3	1.7	3.7	1.7	1.7	1.7	3.2
GNRH2		ENSG00000125787	"Gonadotropin releasing hormone 2"	O43555	20	3043622-3045747	"Predicted secreted proteins"		Hormone		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 10.2"	"Cell line enhanced"	"Detected in many"		"U-266/84: 7.4"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA004338	Uncertain				"Secreted to blood"					"HPA004338: AB_1079012"	"unprognostic (1.29e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.36e-2)"	"unprognostic (4.04e-3)"	"unprognostic (7.00e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.47e-4)"	"unprognostic (2.69e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.21e-2)"	0.8	0.9	0.6	1.2	0.9	0.4	0.5	5.1	1.7	1.6	0.5	0.5	0.5	0.3	1.3	10.2	0.5	2.4	2.0	1.1	0.7	1.2	1.7	3.3	0.5	0.6	1.5	0.5	5.6	0.5	0.5	1.8	0.5	1.2	4.2	0.1	1.0	1.6	2.0	0.5	0.1	0.5	0.5	0.5	0.5	2.2	3.9	0.5	0.5	2.8	0.5	0.5	0.5	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.2	3.2	3.9	1.9	0.5	0.6	0.8	0.0	0.5	0.8	1.9	0.8	1.5	0.1	0.2	3.2	1.2	1.0	0.9	1.2	3.6	1.3	1.1	2.5	0.0	0.2	2.1	2.5	2.5	2.4	0.0	0.8	1.4	0.5	1.3	1.0	0.7	2.5	1.4	0.0	0.9	0.4	0.8	0.5	2.7	4.5	2.1	0.2	2.7	1.5	2.9	1.4	0.0	1.9	0.8	1.6	1.8	1.1	7.4	1.0	1.7	1.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	5.1	1.7	0.7	1.2	1.5	0.5	1.2	0.5
GPHA2	"A2, GPA2, MGC126572, ZSIG51"	ENSG00000149735	"Glycoprotein hormone alpha 2"	Q96T91	11	64934471-64935888	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"pancreas: 98.0"	"Cell line enriched"	"Detected in some"	10	"Hep G2: 21.2"	"Cancer enriched"	"Detected in some"	7	"testis cancer: 15.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA067068			Approved	Vesicles	"Secreted to blood"			Vesicles		"HPA067068: "	"unprognostic (1.13e-1)"	"unprognostic (8.31e-3)"		"unprognostic (1.51e-2)"		"unprognostic (9.22e-4)"		"unprognostic (7.88e-3)"		"unprognostic (2.62e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.03e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.70e-1)"	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.3	0.2	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	6.7	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.7	98.0	0.0	15.1	0.1	0.2	0.7	0.0	0.7	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	4.2	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	21.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.3	0.2	0.1	0.0	0.1	0.1	0.2	0.1
GPHB5	"GPB5, ZLUT1"	ENSG00000179600	"Glycoprotein hormone beta 5"	Q86YW7	14	63312835-63318879	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	4	"testis: 1.7"	"Cell line enhanced"	"Detected in single"		"AF22: 1.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GPLD1		ENSG00000112293	"Glycosylphosphatidylinositol specific phospholipase D1"	P80108	6	24424565-24495205	"Enzymes, Plasma proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 61.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 10.2;U-698: 10.4"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 6.8"	"Region enriched"	"Detected in many"	4	"cerebellum: 8.5"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008625, HPA012500"	Uncertain				"Secreted to blood"	3700000000	3700000000			"CAB008625: AB_1621070, HPA012500: AB_1849931"	"unprognostic (6.80e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.81e-5)"	"unprognostic (3.65e-1)"	"unprognostic (1.02e-1)"	"prognostic favourable (1.12e-4)"	"unprognostic (6.37e-4)"	"unprognostic (7.93e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.07e-4)"	"unprognostic (2.68e-1)"	"unprognostic (5.28e-4)"	"unprognostic (2.20e-1)"	"unprognostic (9.98e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.22e-1)"	2.2	0.4	0.8	0.6	1.2	0.3	0.6	8.5	1.8	0.6	0.6	0.6	0.6	0.1	0.8	0.6	0.6	0.4	0.6	0.6	0.6	1.9	0.6	61.6	0.6	0.6	0.7	0.6	0.7	0.6	1.5	1.3	0.6	0.6	1.0	0.1	0.6	0.6	3.3	0.7	4.8	0.6	0.8	0.6	0.6	0.3	0.8	0.6	6.6	1.6	0.6	0.7	1.0	1.0	1.1	1.6	0.4	0.2	0.1	1.8	0.0	0.7	1.3	1.2	1.8	0.0	0.1	3.0	0.1	0.3	0.4	0.3	5.2	0.1	10.2	1.2	0.2	0.0	1.7	0.3	0.2	1.3	3.4	1.4	1.3	4.3	0.0	1.8	0.2	0.1	0.2	0.1	0.0	0.0	0.6	0.5	0.3	0.7	1.0	0.6	3.9	0.5	2.0	0.3	0.1	0.4	5.1	3.3	3.4	1.1	0.1	0.5	0.5	0.5	0.1	1.2	1.3	0.1	1.4	3.0	4.7	10.4	0.1	0.5	0.5	0.4	0.2	0.1	0.4	0.1	1.4	0.6	0.3	0.2	0.0	1.1	0.3	1.8	0.4	0.1	0.1	1.6	0.2	0.0	0.8	1.2	8.5	1.8	0.6	1.9	0.7	0.6	0.6	0.6
GPX5		ENSG00000224586	"Glutathione peroxidase 5"	O75715	6	28525925-28534952	"Enzymes, Predicted secreted proteins"		"Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"epididymis: 27.7"	"Group enriched"	"Detected in some"	7	"BEWO: 1.0;NB-4: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted in male reproductive system"																	"unprognostic (3.34e-2)"			"unprognostic (3.74e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPX6	GPXP3	ENSG00000198704	"Glutathione peroxidase 6"	P59796	6	28503296-28528215	"Enzymes, Predicted secreted proteins"		"Oxidoreductase, Peroxidase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"epididymis: 9.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.0;HEL: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	16	"basal ganglia: 21.3"	"Low region specificity"	"Detected in single"								"Secreted in male reproductive system"																				"unprognostic (2.99e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.1	0.0	0.0	0.4	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9			0.0		0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0										
GPX7	"FLJ14777, GPX6, NPGPx"	ENSG00000116157	"Glutathione peroxidase 7"	Q96SL4	1	52602372-52609051	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"		"Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 22.4;HEL: 20.6;REH: 24.6;RPMI-8226: 41.5;THP-1: 32.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"								"Secreted to blood"						"unprognostic (5.87e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.78e-1)"	"unprognostic (7.43e-3)"	"unprognostic (3.18e-1)"	"unprognostic (5.64e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.73e-1)"	"unprognostic (4.42e-2)"	"unprognostic (8.18e-2)"	"unprognostic (4.17e-1)"	"unprognostic (2.48e-3)"	"prognostic unfavourable (2.26e-5)"	"unprognostic (1.14e-2)"	"unprognostic (9.24e-2)"	"unprognostic (3.08e-2)"	"unprognostic (5.44e-2)"	8.6	9.4	6.9	10.1	7.5	13.8	10.4	5.8	5.8	13.7	9.6	6.6	6.2	2.8	14.8	6.8	5.5	11.1	12.0	11.0	5.2	4.9	9.9	5.5	7.3	12.8	5.5	4.2	14.1	18.3	9.9	15.4	32.9	6.8	11.1	5.1	10.0	7.7	9.2	9.3	5.7	6.5	9.7	5.2	9.3	6.0	7.8	5.2	22.6	20.5	7.9	14.1	14.0	8.2	13.6	29.8	2.0	0.6	12.0	19.8	9.3	0.0	0.0	6.1	11.3	2.3	6.6	0.0	4.1	0.2	5.0	5.2	3.9	0.0	0.0	3.3	22.4	0.0	9.6	0.0	2.7	0.0	0.0	20.6	1.2	3.6	8.2	0.0	0.0	15.2	0.0	0.8	0.0	7.6	0.0	0.0	9.3	0.0	1.0	10.7	10.5	0.0	24.6	0.0	41.5	0.4	0.0	4.6	9.1	10.9	0.0	7.1	0.0	32.8	0.4	0.0	1.2	1.2	0.0	0.0	0.0	15.4	0.0	0.0	3.7	0.0	0.6	2.0	9.9	0.1	13.6	13.6	15.1	11.6	2.2	13.3	19.8	12.8	0.3	12.0	0.0	29.8	10.8	9.3	6.9	7.5	5.8	5.8	5.2	4.9	5.5	4.2	6.8	5.2
GREM1	"CKTSF1B1, CRAC1, DAND2, DRM, gremlin, HMPS"	ENSG00000166923	"Gremlin 1, DAN family BMP antagonist"	O60565	15	32717974-32745107	"Disease related genes, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 66.8;smooth muscle: 42.5"	"Cell line enhanced"	"Detected in some"		"BJ: 32.0;BJ hTERT+: 49.1;BJ hTERT+ SV40 Large T+ RasG12V: 30.8;fHDF/TERT166: 98.6;hTEC/SVTERT24-B: 30.9"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 24.6"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"hippocampal formation: 3.6;olfactory region: 13.4"	"Low region specificity"	"Detected in many"			HPA007526	Uncertain				"Secreted to blood"					"HPA007526: AB_1849971"	"unprognostic (4.74e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.80e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.19e-1)"	"prognostic unfavourable (4.46e-4)"	"unprognostic (5.33e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.20e-3)"	"unprognostic (2.79e-1)"	"unprognostic (2.13e-11)"	"unprognostic (1.77e-2)"	"unprognostic (6.60e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.16e-3)"	14.9	1.2	3.1	23.1	10.2	1.1	11.7	0.8	5.6	31.3	15.2	6.6	1.1	2.6	5.1	1.0	15.4	1.0	66.8	1.1	4.4	2.0	1.2	1.5	1.2	8.0	6.6	6.4	1.0	1.5	1.0	0.2	1.1	5.5	6.4	15.2	0.0	1.0	5.1	2.4	4.1	24.4	42.5	4.8	1.3	23.7	1.1	9.3	0.0	1.4	2.2	2.3	27.3	32.2	0.4	0.5	1.4	0.4	0.7	0.3	0.0	0.0	0.5	0.0	0.0	1.2	1.7	0.0	32.0	49.1	12.1	30.8	0.0	0.0	0.0	0.0	98.6	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	30.9	0.0	0.0	0.0	0.0	17.1	0.0	0.0	0.0	0.1	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.2	0.4	0.5	0.3	0.2	0.3	0.3	0.3	0.2	0.1	0.4	0.3	0.3	1.4	0.7	0.4	0.5	0.2	0.0	3.1	10.2	0.8	5.6	4.4	2.0	6.6	6.4	5.5	9.3
GREM2	"CKTSF1B2, DAND3, FLJ21195, Prdc"	ENSG00000180875	"Gremlin 2, DAN family BMP antagonist"	Q9H772	1	240489573-240612149	"Disease related genes, Predicted secreted proteins"		"Cytokine, Developmental protein, Heparin-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 90.3;parathyroid gland: 31.4"	"Cell line enriched"	"Detected in some"	5	"fHDF/TERT166: 26.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.2;memory CD4 T-cell: 2.5"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB009920	Approved				"Secreted to blood"					"CAB009920: AB_2279266"	"unprognostic (2.01e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.41e-2)"	"unprognostic (7.58e-3)"	"unprognostic (2.82e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.18e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.31e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.07e-8)"	"unprognostic (1.22e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.38e-2)"	0.6	0.9	3.0	9.5	4.5	0.0	2.2	0.7	5.1	0.8	14.2	0.5	0.9	6.5	8.2	1.9	10.7	1.3	90.3	0.2	2.1	3.6	1.1	21.9	1.3	0.6	1.4	4.8	4.2	0.3	31.4	5.2	5.2	3.0	2.8	12.8	1.7	7.5	1.1	6.5	2.3	11.7	3.8	1.8	1.7	6.4	0.5	0.9	0.0	0.7	3.0	4.1	2.2	0.7	0.0	0.0	0.5	0.0	0.1	2.5	0.2	0.0	0.0	0.1	0.0	1.6	2.0	0.0	4.9	5.3	0.0	0.0	0.0	0.0	0.0	0.0	26.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.8	0.0	1.0	0.0	0.0	3.2	0.4	0.7	0.3	0.8	0.0	0.0	2.8	0.0	1.5	0.0	0.0	0.0	0.0	0.0	2.2	0.0	2.5	1.3	0.0	0.0	0.6	0.0	0.5	0.1	0.0	0.0	0.0	0.2	3.0	4.5	0.7	5.1	2.1	3.6	1.4	4.8	3.0	0.9
GUCA2A	"GUCA2, STARA"	ENSG00000197273	"Guanylate cyclase activator 2A"	Q02747	1	42162691-42164718	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	33	"intestine: 265.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 14.5;CACO-2: 11.3;NB-4: 3.7;U-2197: 3.2"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 31.6;urothelial cancer: 8.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"amygdala: 0.2"	HPA018215	Enhanced				"Secreted to blood"	26000000	26000000			"HPA018215: AB_1850443"			"unprognostic (7.98e-3)"		"unprognostic (1.60e-1)"		"unprognostic (1.16e-1)"	"unprognostic (9.07e-2)"			"unprognostic (1.14e-1)"			"unprognostic (8.06e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.10e-1)"	"unprognostic (9.15e-2)"	0.2	0.1	0.2	8.0	0.2	0.0	0.2	0.2	0.2	0.2	87.3	0.2	0.2	6.6	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.1	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.7	0.0	0.2	3.5	0.2	0.2	91.9	0.2	0.2	0.2	0.2	0.1	265.7	2.1	0.2	0.2	0.1	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	11.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
GUCA2B		ENSG00000044012	"Guanylate cyclase activator 2B"	Q16661	1	42153421-42155824	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"intestine: 92.4"	"Group enriched"	"Detected in some"	6	"A549: 3.3;CACO-2: 8.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 5.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	19	"intermediate monocyte: 1.9"	"Lineage enriched"	"Detected in single"	19	"monocytes: 1.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"cerebral cortex: 0.8;hippocampal formation: 0.5"						"Secreted to blood"	740000	740000						"unprognostic (2.59e-2)"				"unprognostic (1.44e-2)"				"unprognostic (1.34e-1)"		"unprognostic (6.22e-2)"	"unprognostic (1.86e-1)"				0.1	0.0	0.1	1.2	0.1	0.0	0.1	0.1	0.1	0.1	55.2	0.1	0.1	13.5	0.1	0.1	0.1	0.0	0.7	0.1	0.1	0.0	0.1	2.1	0.1	0.1	0.1	0.1	0.1	0.6	0.0	0.1	0.1	0.1	0.1	8.7	0.1	0.1	0.1	0.1	0.0	92.4	0.1	0.1	0.2	5.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	8.9	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
GZMA	"CTLA3, HFSP"	ENSG00000145649	"Granzyme A"	P12544	5	55102648-55110252	"Enzymes, Predicted secreted proteins"	"Apoptosis, Cytolysis"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 92.3;intestine: 31.0;lymphoid tissue: 40.9"	"Cell line enriched"	"Detected in some"	4	"HL-60: 9.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	13	"gdT-cell: 92.3;MAIT T-cell: 90.8;memory CD4 T-cell: 25.4;memory CD8 T-cell: 89.3;naive CD8 T-cell: 50.5;NK-cell: 61.9"	"Group enriched"	"Detected in many"	38	"NK-cells: 61.9;T-cells: 92.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054134	Approved				"Secreted to blood"					"HPA054134: "	"prognostic favourable (7.27e-4)"	"unprognostic (7.29e-3)"	"unprognostic (1.50e-2)"	"prognostic favourable (6.44e-6)"	"unprognostic (2.96e-3)"	"unprognostic (1.85e-3)"	"unprognostic (8.30e-3)"	"unprognostic (1.15e-2)"	"unprognostic (5.15e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.09e-1)"	"prognostic unfavourable (1.26e-6)"	"unprognostic (5.91e-2)"	"unprognostic (5.57e-1)"	"unprognostic (5.73e-3)"	"unprognostic (3.33e-3)"	4.3	1.8	1.1	16.3	1.2	10.0	2.5	0.7	0.8	3.9	12.5	0.9	1.3	10.3	5.2	2.9	2.9	2.9	9.6	4.5	1.1	1.1	4.6	5.2	11.8	20.3	1.7	0.9	3.0	5.8	0.0	1.9	5.8	1.5	3.4	6.3	4.5	5.1	1.3	2.6	1.2	31.0	2.5	2.6	40.9	3.9	1.1	0.6	1.9	3.1	4.2	11.1	6.6	2.9	0.2	0.2	2.0	0.3	61.9	92.3	52.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	2.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	92.3	0.2	90.8	0.2	25.4	89.3	0.2	0.1	5.2	50.5	2.0	61.9	0.3	0.2	2.9	52.0	1.1	1.2	0.7	0.8	1.1	1.1	1.7	0.9	1.5	0.6
GZMH	"CCP-X, CGL-2, CSP-C, CTLA1, CTSGL2"	ENSG00000100450	"Granzyme H"	P20718	14	24606480-24609699	"Enzymes, Predicted secreted proteins"	Cytolysis	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"blood: 134.9"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.5;RPMI-8226: 2.0;THP-1: 1.4;U-266/70: 4.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"gdT-cell: 134.9;memory CD4 T-cell: 41.8;memory CD8 T-cell: 109.7;naive CD8 T-cell: 102.7"	"Lineage enriched"	"Detected in many"	8	"T-cells: 134.9"					"Low region specificity"	"Detected in all"			HPA029200	Enhanced				"Secreted to blood"					"HPA029200: AB_10602908"	"unprognostic (3.72e-3)"	"unprognostic (1.47e-3)"	"unprognostic (5.35e-2)"	"prognostic favourable (2.00e-6)"	"unprognostic (8.80e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.62e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.68e-1)"	"prognostic unfavourable (1.74e-6)"	"unprognostic (1.23e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.77e-3)"	3.6	3.1	1.1	5.0	1.2	16.5	3.6	0.5	1.0	1.9	3.1	0.4	0.2	0.9	1.0	2.7	2.6	1.8	8.1	4.8	1.0	1.1	1.7	3.6	16.4	11.5	2.6	1.3	3.0	1.1	0.0	3.7	1.6	1.2	4.5	1.1	5.1	5.4	4.2	4.5	0.8	2.2	2.0	3.1	22.6	2.5	2.5	0.7	0.2	2.5	3.4	6.4	5.1	1.9	0.4	3.2	1.8	0.3	17.6	134.9	82.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.1	0.0	0.4	0.9	1.8	0.2	0.1	134.9	0.2	2.4	0.4	41.8	109.7	0.2	0.2	13.9	102.7	1.5	17.6	0.3	3.2	0.3	82.9	1.1	1.2	0.5	1.0	1.0	1.1	2.6	1.3	1.2	0.7
GZMK	"PRSS, TRYP2"	ENSG00000113088	"Granzyme K"	P49863	5	55024253-55034570	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 95.8;lymphoid tissue: 37.3"	"Cell line enhanced"	"Detected in single"		"U-2197: 1.2"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 95.8;memory CD8 T-cell: 59.0"	"Group enriched"	"Detected in many"	191	"NK-cells: 56.9;T-cells: 95.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA063181	Enhanced				"Secreted to blood"					"HPA063181: "	"prognostic favourable (8.68e-4)"	"unprognostic (3.26e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.03e-3)"	"unprognostic (8.13e-3)"	"unprognostic (3.50e-2)"	"unprognostic (4.53e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavourable (1.06e-4)"	"unprognostic (2.04e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.00e-1)"	3.5	1.6	0.6	10.5	0.6	3.6	3.1	0.5	0.5	4.1	3.7	0.2	1.7	0.4	3.2	2.6	2.8	1.8	7.4	1.6	0.6	0.7	4.3	4.1	10.2	37.3	0.7	0.2	2.1	1.5	0.0	1.0	0.9	0.5	6.6	1.9	2.9	5.7	2.1	0.8	0.8	7.4	0.8	1.6	36.4	2.4	2.1	0.3	3.3	3.1	2.7	28.2	4.9	2.6	0.0	0.1	0.4	0.1	56.9	95.8	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.8	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.1	21.1	0.1	95.8	0.0	13.2	59.0	0.0	0.0	0.6	10.5	0.4	56.9	0.1	0.1	0.8	9.9	0.6	0.6	0.5	0.5	0.6	0.7	0.7	0.2	0.5	0.3
HAMP	"HEPC, HFE2B, LEAP-1, LEAP1"	ENSG00000105697	"Hepcidin antimicrobial peptide"	P81172	19	35280716-35285143	"Disease related genes, Potential drug targets, Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Fungicide, Hormone"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"liver: 716.5"	"Cell line enriched"	"Detected in single"	229	"Hep G2: 68.3"	"Group enriched"	"Detected in many"	12	"glioma: 6.5;liver cancer: 16.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"myeloid DC: 2.5;plasmacytoid DC: 7.6"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 7.6"					"Not detected"	"Not detected"								"Secreted to blood"	3900000	3900000				"unprognostic (5.53e-2)"	"unprognostic (5.02e-4)"	"unprognostic (2.10e-3)"	"unprognostic (4.69e-3)"	"unprognostic (5.35e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.92e-2)"	"unprognostic (9.36e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.61e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.68e-7)"	"unprognostic (4.11e-2)"	"unprognostic (3.93e-2)"	"unprognostic (4.08e-2)"	"unprognostic (7.77e-2)"	0.4	0.5	1.8	0.6	10.8	1.2	0.7	0.2	4.4	0.6	0.3	0.2	0.0	0.5	0.4	0.4	0.4	0.9	0.4	45.1	10.0	1.8	0.3	716.5	0.4	1.0	4.2	0.0	1.1	8.7	0.4	0.5	0.7	6.7	0.6	0.3	0.0	0.4	0.6	0.5	0.4	0.3	0.4	13.9	0.3	0.4	0.5	4.0	0.0	0.3	0.0	1.0	0.4	0.0	0.5	7.6	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	68.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	2.5	0.5	0.0	0.0	0.0	0.5	0.0	7.6	0.0	0.0	1.8	10.8	0.2	4.4	10.0	1.8	4.2	0.0	6.7	4.0
HAPLN1	CRTL1	ENSG00000145681	"Hyaluronan and proteoglycan link protein 1"	P10915	5	83637805-83721613	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"placenta: 41.8"	"Group enriched"	"Detected in some"	37	"PC-3: 44.7;TIME: 28.2;U-2 OS: 46.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019105, HPA019482, HPA025238"	Enhanced	Approved	Supported	Vesicles	"Secreted to extracellular matrix"			Vesicles		"HPA019105: AB_1850496, HPA019482: AB_1850498, HPA025238: "	"unprognostic (5.74e-4)"	"unprognostic (2.94e-2)"	"unprognostic (6.58e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.76e-3)"	"unprognostic (6.01e-4)"	"unprognostic (2.52e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.04e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.28e-2)"	"prognostic unfavourable (4.81e-9)"	"unprognostic (6.87e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.62e-2)"	"unprognostic (3.91e-2)"	0.1	0.0	5.4	1.5	3.9	0.0	0.1	0.6	4.7	0.1	4.7	0.1	0.1	3.8	0.5	0.1	1.2	0.0	0.5	1.8	3.4	1.3	0.4	0.1	0.9	0.1	1.7	0.7	0.2	0.2	0.0	0.1	41.8	1.5	4.9	5.8	1.5	0.9	0.1	0.1	0.5	9.3	0.3	0.6	0.1	2.4	0.1	0.1	0.1	0.3	0.5	0.3	0.9	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	44.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	28.2	0.0	46.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	5.4	3.9	0.6	4.4	3.4	1.3	1.7	0.7	1.5	0.1
HAPLN2	BRAL1	ENSG00000132702	"Hyaluronan and proteoglycan link protein 2"	Q9GZV7	1	156619294-156625725	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	39	"brain: 108.1"	"Cell line enhanced"	"Detected in some"		"SH-SY5Y: 1.1;U-266/70: 4.5;U-87 MG: 1.3"	"Cancer enriched"	"Detected in some"	10	"glioma: 7.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045765	Enhanced				"Secreted in brain"					"HPA045765: AB_10964781"	"unprognostic (3.19e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.04e-3)"	"unprognostic (1.31e-1)"	"unprognostic (8.25e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.72e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.17e-3)"	1.5	1.5	11.0	1.3	21.1	1.3	1.3	4.4	45.3	1.3	1.3	43.6	0.0	2.7	1.6	1.3	1.3	1.4	1.3	1.3	21.2	13.9	1.4	1.3	1.4	1.3	49.3	9.3	1.3	1.3	1.6	0.0	1.3	43.1	1.9	1.3	0.0	1.4	1.5	1.9	1.6	1.7	1.3	108.1	1.3	1.3	1.7	31.5	0.0	1.3	0.0	1.3	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.6	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.2	0.0	4.5	0.1	0.2	1.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	21.1	4.4	15.1	21.2	13.9	49.3	9.3	43.1	31.5
HAPLN4	"BRAL2, KIAA1926"	ENSG00000187664	"Hyaluronan and proteoglycan link protein 4"	Q86UW8	19	19255641-19262796	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 38.5;intestine: 24.3"	"Cell line enhanced"	"Detected in some"		"NB-4: 5.6;NTERA-2: 14.6;SCLC-21H: 3.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055856	Enhanced				"Secreted in brain"					"HPA055856: "					"unprognostic (3.36e-4)"													0.5	1.9	3.0	0.4	7.5	0.4	0.7	8.9	38.5	2.4	0.6	1.6	0.0	19.6	1.6	0.5	0.4	0.7	0.6	0.5	8.9	9.4	0.5	7.5	0.6	0.4	7.8	2.7	1.4	1.3	0.4	0.2	0.7	26.4	1.1	0.6	0.4	0.5	0.8	0.4	0.4	24.3	0.6	3.8	0.4	0.8	0.5	0.0	0.0	0.4	0.0	0.4	0.5	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	5.6	14.6	0.0	0.0	0.0	0.0	0.0	0.0	3.1	1.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	7.5	8.9	38.5	8.9	9.4	7.8	2.7	26.4	0.0
HCRT	"OX, PPOX"	ENSG00000161610	"Hypocretin neuropeptide precursor"	O43612	17	42184060-42185452	"Disease related genes, Predicted secreted proteins"		Neuropeptide	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	31	"brain: 84.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.9;Karpas-707: 1.0;RPMI-8226: 3.6"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"					"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 2.7;granulocytes: 2.3;T-cells: 2.2"	"Region enriched"	"Detected in some"	5	"hypothalamus: 110.5"	"Region enriched"	"Detected in single"	56	"hypothalamus: 152.0"	"HPA064801, CAB079778"	Enhanced	Supported			"Secreted to blood"					"CAB079778: , HPA064801: "			"unprognostic (3.34e-2)"		"unprognostic (7.76e-5)"					"unprognostic (3.21e-2)"	"unprognostic (3.01e-2)"		"unprognostic (2.20e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.23e-1)"			0.9	0.0	0.0	1.1	0.2	0.9	0.0	0.0	0.7	0.0	0.5			1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	84.3	0.4	0.0	0.0	0.4	0.1		0.3	0.0	0.0	0.0	0.3		0.0	0.1		0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.3			0.0		0.0	0.0	0.0	2.7	0.4	2.3	0.5	0.4	2.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.9	0.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.0	0.0	0.8	0.8	0.4	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.2	0.7	0.8	0.2	0.0	0.1	0.0	2.3	0.5	0.0	1.2	0.4	2.2	1.5	0.9	1.6	0.4	2.7	1.4	1.3	0.1	0.4	0.2	0.3	0.5	0.1										
HGF	"DFNB39, F-TCF, HGFB, HPTA, SF"	ENSG00000019991	"Hepatocyte growth factor"	P14210	7	81699008-81770438	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Serine protease homolog"	"Cancer-related genes, Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 116.9"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 44.8;HHSteC: 35.1;HL-60: 19.6;hTEC/SVTERT24-B: 22.0;Karpas-707: 60.7;U-87 MG: 16.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"basophil: 33.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 33.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010333, HPA040360, HPA044088"	Approved		Approved	Centrosome,Cytosol	"Secreted to blood"			Cytosol	Centrosome	"CAB010333: AB_647965, HPA040360: , HPA044088: "	"unprognostic (5.24e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.85e-2)"	"unprognostic (7.45e-5)"	"unprognostic (1.66e-1)"	"unprognostic (9.28e-3)"	"unprognostic (3.28e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.29e-2)"	"prognostic unfavourable (5.59e-4)"	"unprognostic (7.90e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.06e-2)"	6.2	10.6	1.4	2.9	1.2	4.6	4.8	0.5	4.5	5.1	4.0	0.4	2.9	1.5	5.2	3.1	2.9	4.0	7.1	9.3	3.6	1.3	7.3	27.5	15.8	2.0	1.3	1.4	3.2	1.4	1.6	4.3	116.9	1.9	10.8	1.9	2.0	2.2	3.2	1.4	0.9	1.8	15.1	6.0	6.6	2.3	2.0	0.9	0.5	5.3	1.4	1.4	10.5	21.5	0.0	2.0	33.5	7.6	0.0	0.0	1.5	0.0	0.0	0.0	0.0	5.5	44.8	0.0	0.1	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	35.1	19.6	0.1	10.6	0.0	22.0	0.0	0.5	0.0	60.7	0.1	0.0	0.0	13.6	0.0	0.0	0.2	0.0	1.8	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.8	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	16.1	4.1	0.0	33.5	6.6	1.6	0.0	7.6	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.3	0.0	6.7	0.4	0.0	1.5	1.4	1.2	0.5	4.5	3.6	1.3	1.3	1.4	1.9	0.9
HGFAC	"HGFA, HGFAP"	ENSG00000109758	"HGF activator"	Q04756	4	3441887-3449495	"Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	141	"liver: 128.0"	"Cell line enriched"	"Detected in some"	8	"Hep G2: 10.7"	"Cancer enriched"	"Detected in some"	22	"liver cancer: 26.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA058279, HPA059076"	Enhanced				"Secreted to blood"	11000000000	11000000000			"HPA058279: AB_2683665, HPA059076: AB_2683898"	"unprognostic (2.70e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.85e-3)"	"unprognostic (5.37e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.54e-3)"	"unprognostic (5.52e-2)"	"prognostic unfavourable (9.31e-4)"	"unprognostic (2.87e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.74e-4)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.1	128.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	10.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.2	1.2	0.7	0.4	0.1	0.0	0.0	0.6	1.1	0.0	0.0	0.3	0.1	0.0	0.0	0.5	0.7	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.1	0.0
HHIPL1	KIAA1822	ENSG00000182218	"HHIP like 1"	Q96JK4	14	99645110-99680569	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 14.1"	"Cell line enhanced"	"Detected in some"		"EFO-21: 5.2;fHDF/TERT166: 8.9;SiHa: 6.0;THP-1: 6.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"	59000	59000				"unprognostic (6.16e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.75e-2)"	"unprognostic (4.70e-3)"	"unprognostic (6.68e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.35e-3)"	"unprognostic (8.49e-6)"	"unprognostic (2.52e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.70e-2)"	"unprognostic (7.12e-6)"	3.8	1.6	9.8	4.0	12.7	1.1	2.1	5.1	14.1	3.2	2.7	2.5	2.9	2.2	4.8	2.6	3.3	2.7	6.2	3.6	7.3	4.9	1.3	1.6	2.0	4.5	4.8	6.8	2.4	1.2	1.1	1.6	2.5	5.4	4.4	1.7	4.4	2.4	3.8	2.5	1.9	2.2	6.3	3.2	3.3	2.1	1.7	2.7	0.0	1.1	1.6	2.4	2.5	1.8	0.1	0.0	1.2	0.1	0.0	0.1	0.0	0.1	0.4	0.7	0.2	0.2	0.0	2.8	2.6	0.6	0.5	0.2	0.2	0.8	0.2	5.2	8.9	0.2	0.0	0.2	0.1	0.1	0.0	0.1	0.3	0.0	2.8	0.0	0.1	1.6	0.3	2.1	0.3	2.4	0.1	0.2	1.5	0.4	0.0	0.4	2.1	0.1	0.8	0.0	0.3	0.1	0.1	0.3	1.1	6.0	0.1	0.0	0.1	6.3	1.6	0.1	0.1	0.4	0.0	0.1	0.1	0.1	0.1	0.1	0.6	0.5	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	1.2	0.0	0.1	0.0	0.0	0.0	9.8	12.7	5.1	10.8	7.3	4.9	4.8	6.8	5.4	2.7
HHIPL2	"FLJ13840, KIAA1822L"	ENSG00000143512	"HHIP like 2"	Q6UWX4	1	222522258-222548103	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"prostate: 9.4;testis: 10.4;thyroid gland: 4.6"	"Cell line enhanced"	"Detected in some"		"A549: 3.9;Hep G2: 5.4;RH-30: 20.3;U-87 MG: 10.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059673	Enhanced		Uncertain	Mitochondria,Cytosol	"Secreted in other tissues"			Mitochondria	Cytosol	"HPA059673: "	"unprognostic (1.35e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.91e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.58e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.74e-3)"	"prognostic unfavourable (4.64e-4)"	"unprognostic (8.07e-2)"	"unprognostic (3.64e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.14e-2)"	"unprognostic (0.00e+0)"	"unprognostic (6.52e-2)"	"unprognostic (4.21e-4)"	"unprognostic (2.30e-3)"	"unprognostic (8.38e-2)"	0.3	0.7	0.0	0.1	0.6	0.1	0.2	0.1	1.4	0.7	0.0	0.6	0.0	0.0	0.1	0.5	0.5	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.1	0.1	0.3	0.0	0.9	9.4	0.2	0.3	1.9	3.9	0.0	0.1	0.1	0.0	0.0	0.1	0.1	10.4	0.0	0.0	4.6	0.0	0.3	0.2	0.7	0.1	0.7	0.0	0.0	0.0	0.2	0.0	0.0	3.9	0.1	0.1	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.7	5.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.8	0.3	0.0	20.3	0.0	0.2	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.2	0.0	0.1	0.0	10.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.1	1.4	0.0	0.1	0.0	0.0	0.9	0.0
HHLA1	PLA2L	ENSG00000132297	"HERV-H LTR-associating 1"	C9JL84	8	132061486-132111159	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"placenta: 1.3"	"Cell line enriched"	"Detected in single"	51	"NTERA-2: 5.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"								"Secreted - unknown location"											"unprognostic (5.15e-2)"								"unprognostic (1.19e-1)"	"unprognostic (2.15e-1)"			0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0			0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6		0.0	0.0	0.0	0.1	1.3		0.0	0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
HPSE	"HPA, HPSE1, HSE1"	ENSG00000173083	Heparanase	Q9Y251	4	83292461-83335153	"Enzymes, Predicted secreted proteins"	"Cell adhesion"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 24.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 17.8;neutrophil: 12.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 12.8;monocytes: 17.8"	"Region enhanced"	"Detected in some"		"olfactory region: 4.5"	"Low region specificity"	"Detected in all"			"CAB009813, HPA055344"			Supported	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"	9700000	9700000	Nucleoplasm	Vesicles	"CAB009813: AB_2120854, HPA055344: "	"unprognostic (6.57e-2)"	"unprognostic (1.22e-2)"	"unprognostic (9.13e-2)"	"unprognostic (5.92e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.65e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.62e-3)"	"unprognostic (3.27e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.04e-3)"	"unprognostic (4.15e-2)"	"unprognostic (3.70e-3)"	4.9	5.1	3.0	6.8	3.5	2.2	1.2	0.8	2.4	3.6	6.2	7.1	0.0	2.3	2.9	2.8	14.5	5.7	3.0	5.8	3.2	1.5	3.0	5.6	8.2	16.1	7.1	1.4	7.5	1.1	15.5	2.3	11.3	3.4	1.1	7.0	0.7	12.5	2.1	0.7	6.9	3.6	2.1	7.0	19.0	2.4	6.0	2.8	1.6	1.4	16.9	9.7	2.4	4.9	0.3	1.9	12.8	17.8	1.4	3.4	4.8	8.1	0.4	0.0	1.1	1.9	0.6	0.0	1.0	4.5	2.0	8.7	0.2	6.1	0.2	1.4	2.2	7.9	10.3	1.4	3.6	0.8	0.9	2.2	5.8	0.1	1.1	1.4	4.9	0.8	3.1	1.4	9.8	10.8	0.0	24.7	0.9	1.7	0.1	0.1	0.4	1.5	0.0	0.3	0.3	5.7	0.2	5.8	0.0	11.3	6.2	0.9	0.8	1.9	12.6	0.9	2.8	0.8	1.0	0.3	3.8	0.1	6.5	6.6	1.5	0.2	17.8	0.0	1.0	6.7	0.7	0.2	1.9	0.7	1.9	0.3	1.4	1.2	12.8	1.4	0.9	0.1	3.4	4.8	3.0	3.5	0.8	2.4	3.2	1.5	7.1	1.4	3.4	2.8
HPX		ENSG00000110169	Hemopexin	P02790	11	6431049-6442617	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Host-virus interaction, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	949	"liver: 528.6"	"Cell line enriched"	"Detected in some"	7	"Hep G2: 20.8"	"Cancer enriched"	"Detected in many"	79	"liver cancer: 571.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			CAB016725	Supported				"Secreted to blood"	230000000000	230000000000			"CAB016725: "	"unprognostic (3.39e-2)"	"unprognostic (9.26e-2)"	"unprognostic (3.88e-1)"	"unprognostic (6.19e-4)"	"unprognostic (2.05e-2)"	"unprognostic (2.41e-1)"	"prognostic favourable (2.26e-4)"	"unprognostic (6.33e-2)"	"unprognostic (5.67e-3)"	"unprognostic (3.88e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.78e-2)"	"unprognostic (5.82e-12)"	"unprognostic (2.01e-1)"	"unprognostic (4.48e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.14e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	528.6	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.2	0.0	0.6	0.0	0.0	0.1	0.1	0.3	1.4	0.0	0.8	0.1	0.0	0.2	0.0	0.1	0.1	0.2	0.2	0.6	0.1	20.8	0.0	2.9	0.0	0.8	0.6	0.1	0.0	0.1	0.4	0.1	0.1	0.4	0.0	0.0	0.3	0.0	0.1	1.3	0.2	0.0	0.1	0.2	0.0	1.0	3.0	0.2	1.1	0.0	0.4	0.3	0.2	1.0	0.1	0.3	0.2	0.9	0.2	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0
HRG	"HPRG, HRGP"	ENSG00000113905	"Histidine rich glycoprotein"	P04196	3	186660216-186678240	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Blood coagulation, Chemotaxis, Fibrinolysis, Hemostasis"	Heparin-binding	"Disease mutation, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	205	"liver: 425.4"	"Cell line enhanced"	"Detected in some"		"HEL: 1.7;HL-60: 5.7;RH-30: 6.8;SiHa: 2.4"	"Cancer enriched"	"Detected in some"	262	"liver cancer: 406.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA050269, HPA054598"	Supported				"Secreted to blood"	30000000000	30000000000			"HPA050269: , HPA054598: "		"unprognostic (2.67e-1)"		"unprognostic (1.74e-2)"		"unprognostic (7.58e-5)"	"prognostic favourable (9.64e-5)"	"unprognostic (1.44e-1)"		"unprognostic (2.98e-3)"	"unprognostic (2.22e-1)"		"unprognostic (1.55e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	425.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.2	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	5.7	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.8	0.0	1.6	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.7	0.0	1.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HTN1	HIS1	ENSG00000126550	"Histatin 1"	P15515	4	70050402-70058845	"Predicted secreted proteins"	Biomineralization	"Antibiotic, Antimicrobial, Fungicide"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	1306	"salivary gland: 1826.6"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 1.0;SK-MEL-30: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA077315	Approved				"Secreted to digestive system"					"HPA077315: "									"unprognostic (2.22e-1)"									0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.1	1.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	1826.6	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	1.3	1.1	0.1	0.1	0.2	0.4	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.6	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.0	0.0	0.0
HTN3	HIS2	ENSG00000205649	"Histatin 3"	P15516	4	70028413-70036538	"Predicted secreted proteins, Transporters"	Biomineralization	"Antibiotic, Antimicrobial, Fungicide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	535	"salivary gland: 3346.6"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 4.4;HL-60: 4.8"	"Cancer enhanced"	"Detected in single"		"melanoma: 0.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											CAB073541	Enhanced				"Secreted to digestive system"					"CAB073541: "																		0.1	0.4	0.1	0.0	0.2	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.0	0.2	1.4	0.0	6.2	0.0	0.0	0.2	0.0	0.0	3346.6	0.0	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.1	3.3	0.3	0.1	0.1	1.2	0.6	2.2	1.2	0.5	1.0	0.4	1.1	1.3	0.5	0.5	0.0	0.3	0.4	0.2	0.0	0.6	0.6	0.1	1.6	1.7	0.8	0.2	0.8	0.0	0.3	0.1	4.4	0.7	0.3	0.9	0.6	0.0	4.8	3.5	0.3	0.8	0.1	0.0	0.6	0.6	3.0	0.5	0.6	1.2	2.3	1.2	1.4	2.9	0.8	0.6	0.3	0.6	2.0	1.1	1.1	0.8	0.9	2.1	1.2	0.0	1.2	1.8	1.1	0.9	1.9	2.3	0.7	1.1	1.5	2.5	2.2	0.7	0.5	0.5	1.1	0.3	1.0	0.8	0.4	0.4	1.2	1.0	0.6	2.0	0.5	1.2	0.6	0.5	0.4	0.1	0.2	0.2	0.1	0.1	0.4	0.1	0.0	0.0	0.0
HTRA3	"Prsp, Tasp"	ENSG00000170801	"HtrA serine peptidase 3"	P83110	4	8269765-8307111	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 57.9"	"Cell line enriched"	"Detected in some"	5	"U-2197: 62.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in single"	9	"basal ganglia: 8.2"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA021187, HPA063810"	Approved		Approved	Vesicles	"Secreted in female reproductive system"			Vesicles		"HPA021187: AB_1851311, HPA063810: "	"unprognostic (5.87e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.89e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.12e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavourable (1.61e-9)"	"unprognostic (1.65e-3)"	"unprognostic (2.56e-2)"	"prognostic unfavourable (1.29e-4)"	"unprognostic (1.34e-2)"	23.7	1.8	0.6	7.3	8.2	5.3	35.6	0.7	0.9	12.3	9.4	0.8	5.4	3.7	19.6	26.6	14.4	7.9	19.8	57.9	0.7	0.3	1.7	1.6	15.4	4.3	0.8	0.9	30.7	2.8	0.0	5.1	9.6	0.9	15.4	2.0	8.6	6.6	3.0	12.9	9.0	6.7	50.1	0.8	1.8	6.8	7.2	0.6	1.3	9.3	11.6	3.0	28.7	12.7	0.0	0.4	1.3	0.3	0.0	0.0	0.1	0.0	0.3	0.4	0.0	2.0	3.8	0.1	0.8	0.0	0.9	0.2	0.0	0.0	0.0	4.7	2.1	0.0	0.4	0.0	0.3	0.0	0.7	0.4	4.9	0.0	2.1	0.0	0.2	0.4	0.0	1.4	0.0	3.3	0.1	0.0	3.5	0.0	0.0	12.0	2.1	0.1	0.1	0.0	0.0	0.0	0.0	5.5	0.1	8.9	0.1	0.0	0.0	0.3	2.7	0.5	1.6	62.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.1	0.6	8.2	0.7	0.9	0.7	0.3	0.8	0.9	0.9	0.6
HTRA4	FLJ90724	ENSG00000169495	"HtrA serine peptidase 4"	P83105	8	38974164-38988662	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"placenta: 55.2"	"Cell line enriched"	"Detected in single"	134	"BEWO: 71.1"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Region enhanced"	"Detected in some"		"hippocampal formation: 2.3"	"Low region specificity"	"Detected in all"			HPA045402	Enhanced				"Secreted in female reproductive system"					"HPA045402: "	"unprognostic (1.20e-1)"	"unprognostic (5.83e-4)"	"unprognostic (8.02e-2)"	"unprognostic (2.13e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.40e-1)"	"unprognostic (5.14e-4)"	"unprognostic (1.01e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.58e-1)"	"unprognostic (5.19e-3)"	"unprognostic (2.39e-3)"	"unprognostic (1.19e-3)"	2.6	1.1	0.2	0.3	0.2	3.4	0.9	0.2	0.4	1.2	0.5	0.2	1.9	0.0	2.3	0.5	0.5	0.1	0.2	0.2	0.2	0.0	0.2	0.2	4.3	1.0	0.2	0.2	0.4	0.3	0.4	0.5	55.2	0.4	0.5	0.3	1.8	0.8	0.5	0.6	0.4	0.6	0.3	1.8	2.5	0.1	0.4	0.2	0.2	0.6	0.2	0.8	0.5	0.9	3.1	2.2	2.5	1.0	1.0	1.7	0.0	0.1	0.1	0.1	0.1	0.3	0.2	71.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.2	0.3	0.1	0.1	0.5	0.1	0.1	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.0	0.1	0.2	0.0	0.2	0.2	0.1	0.1	0.2	0.0	0.1	0.1	0.3	0.1	1.5	0.8	2.3	1.4	0.7	1.7	1.5	1.3	1.2	0.6	3.1	1.3	1.4	2.5	1.0	1.0	2.2	1.4	0.0	0.2	0.2	0.2	0.4	0.2	0.0	0.2	0.2	0.4	0.2
IBSP	"BSP, BSP-II, SP-II"	ENSG00000029559	"Integrin binding sialoprotein"	P21815	4	87799581-87812435	"Cancer-related genes, Predicted secreted proteins"	"Biomineralization, Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 4.5;cervix, uterine: 4.0;pituitary gland: 6.2"	"Cell line enriched"	"Detected in some"	6	"U-138 MG: 12.6"	"Cancer enhanced"	"Detected in many"		"glioma: 12.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 0.9"	"Not detected"	"Not detected"								"Secreted in other tissues"						"unprognostic (2.53e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.93e-1)"	"unprognostic (3.75e-2)"	"unprognostic (9.48e-3)"	"unprognostic (1.03e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.02e-3)"		"unprognostic (5.81e-11)"	"unprognostic (6.20e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.30e-3)"	"unprognostic (2.11e-1)"	0.2	0.0	1.9	0.6	0.4	1.0	0.1	2.0	4.5	4.0	0.1	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.8	1.3	1.0	0.1	0.0	0.0	0.2	0.1	0.9	0.0	0.0	0.2	0.8	6.2	1.1	2.6	0.4	0.0	0.0	0.3	0.0	0.6	0.1	0.0	0.3	0.2	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	1.8	0.3	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.4	2.0	1.5	1.0	0.1	0.9	0.0	2.6	0.0
IFNA1	"IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA@, IFNA13"	ENSG00000197919	"Interferon alpha 1"	P01562	9	21440454-21441316	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Antiviral defense"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 2.3;urinary bladder: 2.1"	"Cell line enhanced"	"Detected in some"		"A549: 1.7;BJ: 1.0;HeLa: 6.6;NB-4: 1.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	13	"cerebellum: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"					"HPA047557: "		"unprognostic (3.14e-1)"				"unprognostic (1.55e-1)"							"unprognostic (9.75e-2)"			"unprognostic (5.88e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0
IFNA10	IFN-alphaC	ENSG00000186803	"Interferon alpha 10"	P01566	9	21206181-21207143	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"					"HPA047557: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0			0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
IFNA13		ENSG00000233816	"Interferon alpha 13"	P01562	9	21367424-21368962	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Antiviral defense"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 2.1;epididymis: 3.7"	"Cell line enhanced"	"Detected in some"		"A549: 2.7;HeLa: 1.6;NB-4: 3.5;TIME: 1.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"					"HPA047557: "																		0.0	0.0	1.1	0.0	2.1	0.0	0.0	0.4	0.6	0.0	0.0			0.0	0.1	3.7	0.0	0.1	0.0	0.0	1.5	0.6	0.4	0.0	0.2	0.2	0.8		0.1	0.0	0.0	0.0	0.0		0.0	0.0		0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.3			0.0		0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4										
IFNA14	"IFN-alphaH, LEIF2H"	ENSG00000228083	"Interferon alpha 14"	P01570	9	21239002-21239991	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 1.1;kidney: 1.2"	"Cell line enriched"	"Detected in single"	10	"HMC-1: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"					"HPA047557: "																		0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNA16	IFN-alphaO	ENSG00000147885	"Interferon alpha 16"	P05015	9	21216373-21217311	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"					"HPA047557: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
IFNA17	"IFN-alphaI, LEIF2C1"	ENSG00000234829	"Interferon alpha 17"	P01571	9	21227243-21228222	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"					"HPA047557: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1		0.0	0.1	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0			0.0		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
IFNA2	"IFN-alphaA, IFNA"	ENSG00000188379	"Interferon alpha 2"	P01563	9	21384254-21385388	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 1.6;brain: 1.3;lymphoid tissue: 1.1"	"Cell line enriched"	"Detected in single"	11	"HeLa: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	17	"eosinophil: 1.6"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 1.6"									HPA047557	Uncertain				"Secreted to blood"					"HPA047557: "																		0.1	0.0	0.8	0.1	1.3	0.8	0.1	0.3	0.4	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	1.0	0.4	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.4	1.1	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.3	0.3	0.4	1.0	0.4	0.6	0.1	0.1	0.1
IFNA21	IFN-alphaI	ENSG00000137080	"Interferon alpha 21"	P01568	9	21165637-21166660	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 1.2;brain: 2.1;lymphoid tissue: 1.4"	"Cell line enhanced"	"Detected in single"		"NB-4: 1.0"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	12	"memory CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.2"									HPA047557	Uncertain				"Secreted to blood"					"HPA047557: "																		0.0	0.4	0.3	0.3	0.9	0.0	0.0	2.1	0.9	0.0	0.0			0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.3	1.3	0.0	0.0	0.1	1.4	0.7		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.5	0.0	0.3	0.0	0.2	0.2	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
IFNA4	"IFN-alpha4a, MGC142200"	ENSG00000236637	"Interferon alpha 4"	P05014	9	21186694-21187671	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in single"		"salivary gland: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"					"HPA047557: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0		0.0	0.2	0.0	0.0	0.0		0.0	0.0		1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
IFNA5	IFN-alphaG	ENSG00000147873	"Interferon alpha 5"	P01569	9	21304326-21305312	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 2.3"	"Cell line enhanced"	"Detected in single"		"BJ: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"					"HPA047557: "																		0.3	0.3	0.0	0.0	0.2	0.2	0.2	1.0	0.2	0.2	0.5			0.6	0.4	2.3	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.4	0.3	0.0		0.0	0.1	0.0	0.3	0.2		0.2	0.1		0.0	0.0	0.2	0.3	0.3	0.0	0.0	0.3	0.1	0.0			0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
IFNA6	IFN-alphaK	ENSG00000120235	"Interferon alpha 6"	P05013	9	21349835-21351378	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in single"		"brain: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"					"HPA047557: "																		0.0	0.0	1.2	0.0	2.0	0.0	0.0	0.0	1.2	0.0	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.0	0.0	0.0	0.0	0.9		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
IFNA7	"IFN-alphaJ, IFNA-J"	ENSG00000214042	"Interferon alpha 7"	P01567	9	21201469-21202205	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"		"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	13	"THP-1: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"					"HPA047557: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.0			0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.1		0.0	0.1	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
IFNA8	IFN-alphaB	ENSG00000120242	"Interferon alpha 8"	P32881	9	21409147-21410185	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 2.0"	"Cell line enriched"	"Detected in single"	9	"HeLa: 3.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebellum: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"					"HPA047557: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0
IFNB1	"IFB, IFF, IFNB"	ENSG00000171855	"Interferon beta 1"	P01574	9	21077105-21077963	"Cancer-related genes, Predicted secreted proteins"	"Antiviral defense"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 1.8;bone marrow: 3.7;breast: 5.9"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 2.2;BJ hTERT+ SV40 Large T+ RasG12V: 4.8;NB-4: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.8"	"Lineage enriched"	"Detected in single"	8	"T-cells: 1.8"					"Low region specificity"	"Detected in some"			CAB009386	Uncertain				"Secreted to blood"					"CAB009386: AB_2248817"	"unprognostic (2.38e-1)"									"unprognostic (2.60e-4)"								0.1	0.3	0.0	0.0	0.0	3.7	5.9	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.6	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	4.8	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0
IFNE	IFNE1	ENSG00000184995	"Interferon epsilon"	Q86WN2	9	21480839-21482313	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 3.9;urinary bladder: 4.1"	"Cell line enhanced"	"Detected in some"		"BJ: 4.7;HeLa: 12.3"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	10	"intermediate monocyte: 1.0"	"Lineage enriched"	"Detected in single"	10	"monocytes: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"						"unprognostic (1.52e-3)"	"unprognostic (8.36e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.56e-5)"	"unprognostic (2.70e-1)"	"unprognostic (2.25e-1)"		"unprognostic (5.14e-3)"	"unprognostic (6.32e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.43e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.27e-2)"	"unprognostic (6.58e-3)"	"unprognostic (3.34e-2)"	0.1	0.0	0.0	0.1	0.0	0.0	0.6	2.6	0.2	1.3	0.0			1.4	0.3	3.9	3.3	1.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0		0.0	0.0	0.0	1.2	0.0		1.4	0.0		0.1	0.8	0.0	0.0	2.4	0.0	0.0	0.1	1.5	0.0			0.6		0.7	4.1	1.7	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.6	2.8	0.0	0.0	1.4	1.4	0.2	4.7	0.3	0.2	0.3	0.1	3.1	0.0	1.0	0.9	1.7	0.0	3.0	0.5	0.0	0.0	0.0	12.3	0.0	0.8	0.0	0.0	1.3	0.6	1.9	2.7	0.9	0.0	0.0	1.9	0.0	0.0	0.0	0.1	2.4	0.0	0.0	0.0	3.5	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
IFNG		ENSG00000111537	"Interferon gamma"	P01579	12	68154768-68159747	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Antiviral defense, Growth regulation"	Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.4;lung: 14.5"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.2;U-266/70: 2.2;U-698: 1.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"gdT-cell: 7.3;memory CD4 T-cell: 3.3;memory CD8 T-cell: 8.6;naive CD8 T-cell: 5.2"	"Lineage enriched"	"Detected in many"	7	"T-cells: 8.6"					"Low region specificity"	"Detected in single"			CAB010344	Approved				"Secreted to blood"					"CAB010344: AB_2123447"	"unprognostic (2.16e-4)"	"unprognostic (1.93e-3)"	"unprognostic (9.21e-2)"	"unprognostic (1.04e-4)"	"unprognostic (5.14e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.17e-4)"	"unprognostic (7.79e-2)"	"unprognostic (7.97e-3)"	"unprognostic (1.63e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.62e-9)"	"unprognostic (3.54e-2)"	"unprognostic (5.36e-1)"	"unprognostic (6.32e-2)"	"unprognostic (7.38e-3)"	2.4	0.9	0.3	4.5	0.3	14.4	0.5	0.1	1.0	1.4	0.9	0.5	0.0	0.2	0.6	1.4	1.3	0.2	0.6	1.0	0.3	0.3	0.7	4.1	14.5	8.5	1.5	0.4	0.4	0.2	0.0	0.5	0.8	0.6	1.2	0.4	1.1	1.4	0.2	1.7	0.3	0.7	0.7	1.3	4.1	0.8	0.2	0.0	0.8	1.3	3.1	4.7	2.2	0.6	0.5	0.0	0.2	0.0	1.2	8.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	3.3	8.6	0.0	0.5	0.8	5.2	0.2	1.2	0.0	0.0	0.2	1.1	0.3	0.3	0.1	1.0	0.3	0.3	1.5	0.4	0.6	0.0
IFNL1	"IL-29, IL29"	ENSG00000182393	"Interferon lambda 1"	Q8IU54	19	39296325-39298673	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 6.1"	"Cell line enhanced"	"Detected in some"		"A549: 1.0;AN3-CA: 1.3;CAPAN-2: 1.0;SK-MEL-30: 1.1;U-266/84: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	11	"gdT-cell: 4.4;MAIT T-cell: 4.4;memory CD4 T-cell: 2.1;memory CD8 T-cell: 4.1;myeloid DC: 3.3;naive CD8 T-cell: 2.3;NK-cell: 6.1"	"Group enriched"	"Detected in many"	46	"dendritic cells: 3.3;NK-cells: 6.1;T-cells: 4.4"					"Low region specificity"	"Detected in all"								"Secreted to blood"						"unprognostic (3.08e-2)"	"unprognostic (8.74e-2)"		"unprognostic (2.46e-4)"		"unprognostic (5.76e-2)"		"unprognostic (6.91e-3)"	"unprognostic (5.73e-3)"	"unprognostic (3.94e-2)"	"unprognostic (4.80e-2)"		"unprognostic (2.96e-5)"	"unprognostic (7.95e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.58e-1)"	0.1	0.0	0.1	0.9	0.1	0.6	0.1	0.1	0.1	0.3	0.3	0.1	0.1	1.1	0.1	0.1	0.1	0.2	0.3	0.1	0.1	0.0	0.2	0.3	0.9	0.4	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.7	0.1	0.1	0.5	0.3	0.1	0.1	1.6	0.1	0.6	0.1	1.8	1.6	0.1	0.1	0.1	0.1	0.0	3.3	0.0	0.0	6.1	4.4	0.9	0.0	1.0	0.0	1.3	0.0	0.0	0.8	0.0	0.0	0.0	0.7	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	4.4	0.0	2.1	4.1	3.3	0.0	0.2	2.3	0.0	6.1	0.0	0.0	0.3	0.9	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
IFNL2	"IL-28A, IL28A"	ENSG00000183709	"Interferon lambda 2"	Q8IZJ0	19	39268514-39270092	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"pancreas: 4.1;testis: 1.7"	"Cell line enriched"	"Detected in single"	24	"HDLM-2: 16.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											CAB025489	Uncertain				"Secreted to blood"					"CAB025489: "	"unprognostic (1.37e-1)"	"unprognostic (2.84e-1)"				"unprognostic (1.05e-1)"				"unprognostic (2.11e-2)"	"unprognostic (1.08e-1)"			"unprognostic (6.96e-2)"				0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNL3	"IL-28B, IL28B, IL28C"	ENSG00000197110	"Interferon lambda 3"	Q8IZI9	19	39243553-39245129	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 1.1;salivary gland: 1.0;skin 1: 1.4;testis: 1.5"	"Group enriched"	"Detected in some"	5	"AN3-CA: 1.1;CACO-2: 3.5;HDLM-2: 1.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to blood"						"unprognostic (2.67e-1)"	"unprognostic (9.19e-2)"				"unprognostic (4.17e-1)"				"unprognostic (6.86e-2)"				"unprognostic (1.89e-2)"	"unprognostic (1.66e-1)"			0.1	0.0	0.5	0.0	0.3	0.2	0.0	1.1	0.7	0.1	0.0			0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	0.0	0.0	0.1		0.0	0.2	0.0	0.0	0.2		0.0	0.0		1.0	0.0	0.0	1.4	0.0	0.0	0.0	0.3	0.0	1.5			0.0		0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0										
IFNW1		ENSG00000177047	"Interferon omega 1"	P05000	9	21140214-21142145	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.0;U-266/70: 1.1;U-937: 1.1"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	5	"eosinophil: 1.2;NK-cell: 1.1"	"Group enriched"	"Detected in many"	12	"granulocytes: 1.2;NK-cells: 1.1"														"Secreted to blood"																							0.1	0.4	0.5	0.1	0.6	1.3	0.1	0.6	1.0	0.1	0.0			0.3	0.0	0.1	0.3	0.2	0.2	0.1	0.5	0.9	0.0	0.2	0.1	0.8	0.6		0.0	0.0	0.0	0.1	0.0		0.1	0.0		0.0	0.0	0.7	1.4	0.5	0.1	0.3	0.4	0.2	0.8			0.4		0.0	0.1	0.0	0.0	0.0	1.2	0.0	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.9	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.3	0.5	0.2	0.0	0.2	0.0	0.0	0.2	0.2	0.4	0.0	0.0	0.4	0.0	0.5	0.2	0.0	0.3	0.5	0.9	0.0	1.1	0.3	0.0	0.1	1.1	0.1	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0										
IGF1	"IGF-I, IGF1A, IGFI"	ENSG00000017427	"Insulin like growth factor 1"	P05019	12	102395874-102481744	"Disease related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"	Deafness	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 21.3;HDLM-2: 27.7;K-562: 12.4;Karpas-707: 6.6;U-266/70: 7.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"memory B-cell: 2.4;naive B-cell: 4.5"	"Lineage enriched"	"Detected in single"	9	"B-cells: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA048946	Approved				"Secreted to blood"	410000000	410000000			"HPA048946: "	"unprognostic (1.25e-1)"	"unprognostic (2.86e-3)"	"unprognostic (1.46e-1)"	"prognostic favourable (1.04e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.26e-1)"	"unprognostic (9.98e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.11e-3)"	33.4	3.6	0.8	10.7	1.4	0.3	23.0	0.6	2.1	46.6	6.7	0.6	20.6	2.2	35.0	58.3	16.1	8.1	8.8	17.4	1.5	1.0	3.9	32.8	7.6	13.3	0.9	0.4	17.6	3.2	1.2	1.2	13.5	1.9	57.2	2.8	3.7	5.4	32.0	11.9	3.2	3.5	29.4	1.0	4.9	5.9	19.0	0.2	1.5	29.3	11.6	2.2	21.2	15.3	4.5	0.2	0.5	0.1	0.2	0.1	0.8	0.2	0.0	0.0	0.0	21.3	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.7	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	12.4	6.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.0	0.1	2.4	0.1	0.1	0.0	4.5	0.1	0.1	0.5	0.2	0.1	0.2	0.0	0.8	0.8	1.4	0.6	2.1	1.5	1.0	0.9	0.4	1.9	0.2
IGFBP1	"AFBP, hIGFBP-1, IBP1, IGF-BP25, PP12"	ENSG00000146678	"Insulin like growth factor binding protein 1"	P08833	7	45888357-45893668	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"liver: 157.6;placenta: 292.3"	"Group enriched"	"Detected in some"	8	"Hep G2: 17.6;U-2197: 28.8;U-87 MG: 49.8"	"Cancer enriched"	"Detected in many"	29	"liver cancer: 385.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB004445, HPA046972, HPA050640"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	22000000	22000000	"Golgi apparatus"		"CAB004445: AB_627782, HPA046972: AB_2679884, HPA050640: AB_2681197"	"unprognostic (8.66e-3)"	"unprognostic (1.45e-1)"	"unprognostic (9.41e-2)"	"unprognostic (7.80e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (1.03e-4)"	"unprognostic (1.89e-2)"	"unprognostic (2.09e-3)"	"unprognostic (8.95e-2)"		"prognostic unfavourable (6.90e-11)"	"prognostic unfavourable (6.64e-4)"	"unprognostic (7.20e-2)"	"unprognostic (7.98e-2)"	"unprognostic (3.43e-1)"	0.4	0.0	0.1	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	10.7	0.0	0.0	0.4	0.1	0.1	0.1	0.1	0.2	157.6	0.1	0.0	0.1	0.0	9.3	0.0	0.0	0.2	292.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.5	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	17.6	0.1	0.3	0.0	0.0	0.2	3.8	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	28.8	0.0	0.0	0.0	0.0	49.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1
IGFBP4	"BP-4, HT29-IGFBP, IBP4, IGFBP-4"	ENSG00000141753	"Insulin like growth factor binding protein 4"	P22692	17	40443461-40457731	"Plasma proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 370.8"	"Cell line enhanced"	"Detected in many"		"A549: 109.4;ASC diff: 82.6;ASC TERT1: 81.0;BJ: 87.8;BJ hTERT+: 90.4;HSkMC: 172.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 12.6;NK-cell: 20.5"	"Group enriched"	"Detected in many"	5	"NK-cells: 20.5;T-cells: 12.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066240	Supported				"Secreted to blood"	500000000	500000000			"HPA066240: "	"unprognostic (1.03e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.85e-1)"	"prognostic favourable (3.54e-4)"	"unprognostic (7.44e-3)"	"unprognostic (1.00e-1)"	"prognostic favourable (5.49e-4)"	"unprognostic (4.55e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.27e-2)"	"prognostic unfavourable (2.72e-5)"	"unprognostic (6.23e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.81e-2)"	79.7	23.3	2.5	36.8	5.2	0.0	198.7	1.8	3.1	115.0	57.1	3.2	41.1	9.9	88.8	126.5	67.7	67.4	117.5	119.1	2.2	1.8	72.3	255.6	88.2	101.4	3.7	2.3	370.8	21.5	6.5	19.4	99.8	5.1	66.7	17.0	46.2	24.4	38.6	36.3	22.3	36.8	80.4	6.4	68.1	38.7	53.2	2.3	4.2	81.0	50.4	22.5	89.9	123.9	3.6	0.1	0.0	0.0	20.5	12.6	0.9	0.0	109.4	5.6	0.0	82.6	81.0	0.1	87.8	90.4	16.8	13.1	4.8	1.4	0.0	47.6	41.7	0.9	1.8	0.5	7.6	0.3	0.1	0.3	8.0	7.2	51.8	0.2	0.0	172.1	0.3	22.5	3.2	29.1	1.7	0.0	24.1	3.3	0.0	20.2	3.1	14.8	5.4	0.1	0.1	0.7	3.4	1.5	4.4	39.7	0.1	1.3	40.5	2.0	43.8	23.4	1.2	73.9	0.0	0.0	0.0	0.1	13.9	0.8	6.0	0.0	0.0	0.0	1.8	0.0	12.6	0.4	3.3	4.4	0.0	3.6	0.2	0.4	0.0	20.5	0.0	0.1	0.0	0.9	2.5	5.2	1.8	3.1	2.2	1.8	3.7	2.3	5.1	2.3
IGFBP5		ENSG00000115461	"Insulin like growth factor binding protein 5"	P24593	2	216672105-216695525	"Plasma proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 245.3"	"Cell line enhanced"	"Detected in many"		"BJ: 77.9;BJ hTERT+: 207.2;T-47d: 50.4;U-138 MG: 68.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059827, HPA070407"		Supported	Approved	"Nuclear bodies,Golgi apparatus,Vesicles"	"Secreted to blood"	330000000	330000000	"Golgi apparatus, Vesicles"	"Nuclear bodies"	"HPA059827: , HPA070407: "	"unprognostic (7.69e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.02e-1)"	"prognostic unfavourable (1.78e-4)"	"unprognostic (4.58e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.41e-2)"	"unprognostic (4.04e-2)"	"unprognostic (9.62e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.91e-3)"	47.3	23.4	6.2	19.2	6.3	0.1	41.3	3.6	6.5	191.7	23.1	19.7	15.8	3.9	94.6	91.0	30.0	96.9	21.4	16.9	8.2	2.4	34.8	7.8	9.3	14.5	12.1	7.4	245.3	3.5	6.5	37.7	32.7	7.0	31.4	7.9	188.5	12.0	15.1	47.0	13.5	14.2	71.8	7.4	7.6	36.9	51.7	12.0	1.5	130.1	34.5	17.6	28.8	45.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	20.1	0.0	23.2	0.7	0.0	77.9	207.2	10.4	1.0	0.0	0.0	0.0	0.3	0.2	0.0	2.4	0.0	0.5	0.0	0.7	20.0	0.4	0.0	10.1	0.0	0.1	3.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.1	0.2	0.3	0.0	0.0	0.1	6.7	23.1	1.3	0.8	1.3	9.6	0.0	50.4	0.0	7.5	68.7	4.2	10.4	3.7	0.0	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	6.2	6.3	3.6	6.5	8.2	2.4	12.1	7.4	7.0	12.0
IGFBP6		ENSG00000167779	"Insulin like growth factor binding protein 6"	P24592	12	53097436-53102345	"Plasma proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 27.8;BJ: 74.4;fHDF/TERT166: 26.5;HaCaT: 44.2;U-87 MG: 31.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"eosinophil: 12.5;non-classical monocyte: 7.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 12.5;monocytes: 7.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA008005	Uncertain				"Secreted to blood"	320000000	320000000			"HPA008005: AB_1851499"	"unprognostic (4.93e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.55e-1)"	"unprognostic (8.62e-2)"	"prognostic unfavourable (4.80e-4)"	"unprognostic (2.55e-1)"	"unprognostic (9.79e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.52e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.23e-3)"	"unprognostic (6.97e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.35e-1)"	60.2	15.9	0.9	6.7	1.4	1.2	61.0	0.3	4.7	70.2	15.2	0.8	34.9	5.2	20.7	78.5	47.0	37.6	14.7	27.5	0.7	0.8	6.4	2.6	12.5	3.3	5.9	2.9	37.5	3.9	1.7	19.6	12.5	6.1	29.4	3.6	41.5	6.1	23.5	18.3	6.5	8.9	52.6	26.1	8.0	12.6	36.0	0.0	0.2	15.1	55.8	7.6	58.0	90.5	0.0	0.7	12.5	7.1	0.0	1.7	0.4	15.5	9.8	0.0	6.2	8.4	27.8	0.0	74.4	17.3	2.9	2.0	0.9	12.9	0.0	7.7	26.5	44.2	0.0	1.7	0.4	0.0	0.2	0.1	1.7	1.5	4.2	0.0	0.0	11.2	0.0	1.9	0.2	0.8	0.0	0.1	0.8	0.0	0.5	0.1	0.4	21.2	0.1	0.5	0.2	0.1	0.0	0.0	0.7	22.9	0.0	0.6	0.3	0.0	17.6	3.6	4.6	6.5	1.3	0.4	0.3	0.0	31.0	0.2	1.9	0.0	0.0	12.5	0.1	2.1	0.8	0.0	0.3	1.0	0.7	0.0	0.1	1.7	0.0	0.0	7.1	0.0	0.0	0.4	0.9	1.4	0.3	1.7	0.7	0.8	5.9	2.9	6.1	0.0
IGFBP7	"FSTL2, IGFBP-7, MAC25, PSF"	ENSG00000163453	"Insulin like growth factor binding protein 7"	Q16270	4	57030773-57110385	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 82.3;BJ hTERT+: 77.0;EFO-21: 52.8;RPTEC TERT1: 82.7;TIME: 119.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 15.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002196, CAB020668"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	240000000	240000000	"Golgi apparatus"		"CAB020668: , HPA002196: AB_1079107"	"unprognostic (2.76e-1)"	"unprognostic (1.39e-2)"	"unprognostic (6.82e-2)"	"unprognostic (5.97e-3)"	"unprognostic (3.86e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.62e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.58e-1)"	"unprognostic (7.55e-2)"	95.8	46.5	15.1	38.7	23.7	8.5	65.3	5.6	19.2	73.0	47.8	33.1	79.6	22.7	95.2	164.5	50.5	66.3	241.7	121.0	20.4	14.2	187.5	35.5	55.4	109.0	23.9	24.1	53.0	45.6	12.3	29.5	30.4	91.2	78.1	19.0	126.9	22.2	151.6	30.5	21.1	27.0	119.9	21.9	91.7	32.6	68.0	15.7	3.9	128.9	41.2	18.1	96.8	85.3	0.0	8.4	15.5	3.2	8.7	0.1	1.1	0.1	0.5	0.1	0.0	16.7	6.3	0.5	82.3	77.0	7.2	2.3	0.3	0.0	0.0	52.8	3.9	8.2	0.0	13.2	1.9	0.1	0.6	0.2	9.7	0.0	25.8	1.9	2.1	29.0	6.7	11.7	3.2	16.5	0.0	0.1	17.0	0.0	0.0	8.6	0.7	0.1	1.5	0.0	0.3	82.7	0.0	0.1	0.2	15.4	1.1	0.0	0.2	7.5	119.3	7.4	5.6	0.9	13.3	5.0	0.0	0.1	19.4	6.8	0.2	1.6	3.0	15.5	0.1	3.1	0.1	0.0	0.0	0.0	8.4	0.0	0.0	0.1	0.2	8.7	3.2	0.3	0.1	1.1	15.1	23.7	5.6	19.0	20.4	14.2	23.9	24.1	91.2	15.7
IGFBPL1	bA113O24.1	ENSG00000137142	"Insulin like growth factor binding protein like 1"	Q8WX77	9	38408994-38424447	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 11.0;pituitary gland: 7.4;thyroid gland: 27.2"	"Group enriched"	"Detected in some"	6	"AF22: 68.0;NTERA-2: 18.7;RH-30: 19.5;SCLC-21H: 70.0;SH-SY5Y: 67.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basal ganglia: 12.5;olfactory region: 16.2"	"Low region specificity"	"Detected in many"			HPA051354	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted to blood"			"Nucleoplasm, Vesicles"		"HPA051354: "	"unprognostic (5.63e-2)"	"unprognostic (3.33e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.66e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.94e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.59e-2)"	"unprognostic (6.67e-2)"	1.6	2.6	3.8	1.1	11.0	0.3	0.4	4.7	4.7	0.7	1.0	1.0	0.0	1.9	2.1	0.5	0.7	1.0	1.9	3.7	3.3	2.3	0.7	0.6	1.2	0.4	1.4	1.5	0.5	1.6	0.4	7.4	1.1	1.8	1.6	0.7	0.2	0.5	2.9	0.3	0.3	1.2	2.1	0.6	0.4	2.5	3.3	1.5	2.6	27.2	0.0	0.4	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	68.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	8.1	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	18.7	0.1	0.0	19.5	0.1	0.0	0.0	70.0	67.9	1.1	0.0	0.0	0.3	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	11.0	4.7	4.7	3.3	2.3	1.4	1.5	1.8	1.5
IGFL1	UNQ644	ENSG00000188293	"IGF like family member 1"	Q6UW32	19	46229752-46231243	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"esophagus: 51.5;tongue: 29.7"	"Group enriched"	"Detected in some"	7	"HaCaT: 6.2;RT4: 22.8;SK-BR-3: 7.8"	"Group enriched"	"Detected in many"	7	"cervical cancer: 47.6;head and neck cancer: 60.7;melanoma: 23.3;urothelial cancer: 84.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA014001	Uncertain				"Secreted in other tissues"					"HPA014001: "	"unprognostic (1.35e-1)"	"unprognostic (9.70e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.01e-1)"		"unprognostic (1.64e-2)"		"unprognostic (2.67e-2)"	"unprognostic (3.06e-1)"	"unprognostic (4.50e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.67e-1)"		"unprognostic (1.80e-1)"		"unprognostic (1.64e-1)"	"unprognostic (3.23e-1)"	0.1	0.1	0.0	0.1	0.0	0.1	0.3	0.0	0.1	14.7	0.1	0.0	0.0	0.1	0.3	0.1	51.5	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.7	0.1	0.0	11.0	0.1	0.1	1.8	0.1	0.1	0.0	0.2	0.1	0.3	0.0	1.9	0.1	29.7	14.4	0.4	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.2	0.0	1.7	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.1	7.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
IGFL3	UNQ483	ENSG00000188624	"IGF like family member 3"	Q6UXB1	19	46120071-46124674	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	8	"skin 1: 22.4"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 8.1;CACO-2: 2.1;hTEC/SVTERT24-B: 2.8;U-2 OS: 3.0;U-87 MG: 5.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 5.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.5"	"Low lineage specificity"	"Detected in single"											HPA062776	Uncertain				"Secreted in other tissues"					"HPA062776: "	"unprognostic (8.61e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.69e-1)"		"unprognostic (4.78e-2)"	"unprognostic (7.45e-3)"		"unprognostic (2.03e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.86e-4)"			"unprognostic (2.86e-2)"	"unprognostic (1.90e-1)"		"unprognostic (3.69e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	2.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.9	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	22.4	0.1	0.1	0.1	0.1	0.0	2.9	0.1	1.9	0.1	2.7	0.1	0.1	0.1	1.5	0.2	0.0	0.2	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	8.1	0.6	0.5	2.1	0.3	0.0	0.4	0.0	0.1	0.0	0.0	1.4	0.3	0.0	0.0	0.6	0.3	0.0	0.0	0.1	1.1	0.5	2.8	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.1	0.6	0.0	0.2	5.4	0.0	0.0	0.0	0.2	0.0	0.6	0.1	0.6	0.6	0.1	0.2	0.2	1.5	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
IGIP	"C5orf53, LOC492311"	ENSG00000182700	"IgA inducing protein"	A6NJ69	5	140125935-140129392	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 14.4;ASC TERT1: 13.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA041877, HPA048615"	Uncertain		Approved	Vesicles	"Secreted to blood"			Vesicles		"HPA041877: , HPA048615: "	"unprognostic (1.15e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.38e-1)"	"unprognostic (5.05e-2)"	"prognostic favourable (3.94e-4)"	"unprognostic (1.94e-1)"	"prognostic favourable (6.25e-6)"	"unprognostic (2.93e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.98e-2)"	"unprognostic (7.77e-2)"	5.1	7.6	13.9	2.0	13.1	0.0	5.3	16.0	13.7	7.3	3.8	3.4	1.6	2.8	3.8	8.0	2.5	3.5	3.8	4.6	13.4	13.7	7.6	6.2	3.8	3.1	17.8	3.3	5.3	3.6	16.2	6.1	3.7	9.8	5.8	3.1	3.7	4.3	7.3	7.7	7.5	3.7	8.2	14.4	3.8	3.4	1.9	9.4	2.0	7.1	2.8	3.0	3.7	3.4	0.6	0.1	1.0	0.5	0.5	2.2	0.1	2.0	0.6	1.0	2.9	14.4	13.9	1.3	5.1	5.1	1.2	1.5	2.0	1.6	3.8	5.5	6.9	2.1	1.1	3.1	2.3	3.3	1.9	0.8	2.8	1.5	3.4	1.0	1.4	4.7	7.9	2.3	4.3	1.5	0.6	1.5	4.4	1.7	1.1	2.5	0.2	1.6	1.2	2.4	1.7	6.8	1.8	1.0	1.5	2.8	1.8	2.9	1.4	3.0	8.9	3.6	0.3	1.2	2.8	3.7	2.4	1.3	3.8	2.6	2.6	0.0	0.2	1.0	0.7	0.1	1.9	0.6	1.0	0.8	0.1	0.5	2.2	1.8	0.0	0.5	0.5	0.1	1.1	0.1	13.9	13.1	16.0	12.9	13.4	13.7	17.8	3.3	9.8	9.4
IGLON5	LOC402665	ENSG00000142549	"IgLON family member 5"	A6NGN9	19	51311848-51330354	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 33.6;testis: 11.5"	"Cell line enhanced"	"Detected in some"		"HMC-1: 24.9;NTERA-2: 11.2;SH-SY5Y: 16.2;U-2 OS: 4.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 12.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"							HPA041994	Approved				"Secreted in brain"					"HPA041994: AB_10794641"	"unprognostic (2.09e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.80e-2)"	"unprognostic (8.87e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.47e-4)"	"unprognostic (6.38e-5)"	"unprognostic (4.54e-2)"	"unprognostic (7.89e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavourable (5.62e-7)"	"unprognostic (1.77e-2)"	"unprognostic (9.28e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.86e-3)"	2.0	4.6	9.6	1.1	6.0	1.9	0.7	33.6	16.5	0.6	0.8	0.8	0.0	0.9	0.8	2.2	2.8	0.7	1.0	1.2	9.5	13.7	0.6	2.3	0.6	0.6	11.1	8.4	1.5	1.1	0.5	0.5	1.3	29.3	1.1	0.7	3.0	1.1	2.4	0.6	1.5	1.1	0.8	10.9	0.7	0.7	11.5	2.6	0.0	0.6	0.0	0.6	1.1	0.4	0.0	0.9	1.4	0.3	0.2	0.3	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	24.9	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	11.2	0.0	0.0	0.0	2.4	0.0	0.1	0.1	16.2	0.0	0.0	0.0	0.1	1.5	0.0	0.0	4.7	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	1.4	0.1	0.0	0.2	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.4	0.2	0.3	0.9	0.0	0.0	9.6	6.0	33.6	10.7	9.5	13.7	11.1	8.4	29.3	2.6
IHH	"BDA1, HHG2"	ENSG00000163501	"Indian hedgehog"	Q14623	2	219054420-219060467	"Disease related genes, Plasma proteins, Predicted secreted proteins"		"Developmental protein, Hydrolase, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 19.1;intestine: 42.8;lymphoid tissue: 20.2"	"Cell line enriched"	"Detected in some"	10	"CACO-2: 20.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 45.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"	13000000	13000000				"unprognostic (1.05e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.63e-2)"	"prognostic favourable (3.67e-6)"	"unprognostic (4.01e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.74e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.33e-3)"	"unprognostic (1.81e-3)"	"unprognostic (2.05e-1)"	"unprognostic (5.31e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.91e-2)"	0.1	0.1	0.1	20.2	0.1	0.0	0.1	0.3	0.2	4.5	33.1	0.1	0.7	10.7	14.3	10.3	0.7	0.7	19.1	0.1	0.1	0.2	3.7	3.4	3.3	0.1	0.1	0.1	0.7	0.1	0.0	0.6	0.2	0.1	2.3	11.4	8.2	0.1	1.1	0.1	0.1	42.8	0.5	0.1	0.1	11.6	0.3	0.1	0.1	1.1	0.1	0.1	0.9	1.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.1	0.2	0.1	0.1	0.1	0.1
IL12B	"CLMF, CLMF2, IL-12B, NKSF, NKSF2"	ENSG00000113302	"Interleukin 12B"	P29460	5	159314783-159330887	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"		Cytokine	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 10.8"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.9;NB-4: 2.7;SCLC-21H: 3.6"	"Cancer enriched"	"Detected in single"	20	"testis cancer: 3.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.9"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA040970	Supported				"Secreted to blood"					"HPA040970: AB_10796234"	"unprognostic (5.96e-5)"	"unprognostic (4.59e-5)"	"unprognostic (1.05e-1)"	"unprognostic (3.40e-1)"		"unprognostic (9.13e-4)"	"unprognostic (6.89e-2)"	"unprognostic (2.58e-4)"	"unprognostic (6.69e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.53e-1)"	"unprognostic (7.15e-3)"	"unprognostic (9.25e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.02e-2)"	0.2	0.2	0.2	0.7	0.2	1.4	0.2	0.4	0.2	0.3	0.2	0.2	0.2	0.2	0.2	1.2	0.4	0.2	0.7	0.2	0.2	0.2	0.6	0.3	0.9	1.8	0.2	0.2	0.2	0.2	0.0	2.4	0.2	0.2	0.2	0.6	0.2	0.7	0.2	0.2	1.3	0.5	0.2	0.2	1.8	0.9	0.5	0.2	10.8	0.4	0.2	0.9	0.3	0.2	1.1	0.3	2.9	0.5	1.0	0.2	0.0	0.3	0.4	0.6	0.7	0.1	0.0	0.2	0.5	0.0	0.0	0.5	0.5	0.9	0.5	0.1	0.1	0.3	0.1	0.1	0.0	0.5	0.8	0.1	1.4	0.2	0.1	0.4	1.1	0.3	0.3	0.1	0.0	0.1	0.2	2.9	0.0	0.2	0.5	2.7	0.6	0.4	0.5	0.7	1.8	0.0	0.2	3.6	0.2	0.3	0.3	0.0	0.3	0.3	0.4	0.5	0.2	0.2	0.1	0.2	0.1	0.2	0.7	0.5	0.2	1.7	0.5	0.2	0.2	0.1	0.1	1.1	0.2	0.1	0.1	0.3	0.2	0.2	2.9	1.0	0.1	0.3	0.1	0.0	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.2	0.2
IL13	"ALRH, BHR1, IL-13, MGC116786, MGC116788, MGC116789, P600"	ENSG00000169194	"Interleukin 13"	P35225	5	132656263-132661110	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 20.7"	"Cell line enriched"	"Detected in single"	177	"HDLM-2: 29.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042421			Approved	"Plasma membrane,Cytosol"	"Secreted to blood"			"Plasma membrane, Cytosol"		"HPA042421: AB_10795504"	"unprognostic (2.17e-1)"	"unprognostic (2.29e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.69e-1)"	"unprognostic (5.20e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.61e-3)"	"unprognostic (3.34e-1)"	"unprognostic (5.97e-4)"	"unprognostic (4.70e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.38e-1)"	0.3	0.0	0.1	0.8	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.1	3.0	0.0	0.0	0.1	0.0	0.0	1.8	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.1	0.2	0.2	0.6	0.0	0.0	0.0	0.0	20.7	0.0	2.9	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0
IL17A	"CTLA8, IL-17, IL-17A, IL17"	ENSG00000112115	"Interleukin 17A"	Q16552	6	52186387-52190638	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"lymphoid tissue: 7.6;tongue: 12.2;urinary bladder: 4.4"	"Group enriched"	"Detected in some"	37	"Karpas-707: 7.2;U-266/84: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052258	Uncertain				"Secreted to blood"					"HPA052258: "		"unprognostic (5.55e-1)"	"unprognostic (2.18e-4)"			"unprognostic (3.05e-4)"		"unprognostic (1.41e-2)"						"unprognostic (2.22e-2)"				0.2	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.4	0.0	0.0	1.3	0.5	0.6	0.0	0.1	0.0	0.1	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.1	0.1	1.0	0.1	0.0	0.1	0.3	0.1	0.0	0.0	0.0	12.2	7.6	4.4	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0
IL17B	"IL-17B, IL-20, MGC138900, MGC138901, NIRF, ZCYTO7"	ENSG00000127743	"Interleukin 17B"	Q9UHF5	5	149371324-149404202	"Cancer-related genes, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 4.4;Hep G2: 2.0;K-562: 1.6;Karpas-707: 3.6;NB-4: 2.5"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in some"	6	"midbrain: 8.9"	"Cell type enriched"	"Detected in single"	14	"basophil: 4.3"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 4.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA042441	Uncertain				"Secreted to blood"					"HPA042441: AB_10797014"	"unprognostic (2.83e-4)"	"unprognostic (2.71e-2)"	"unprognostic (4.90e-3)"	"unprognostic (9.22e-2)"	"unprognostic (7.43e-2)"	"unprognostic (5.03e-2)"	"unprognostic (9.62e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.54e-2)"	"unprognostic (9.30e-3)"	"unprognostic (3.22e-1)"	"unprognostic (6.98e-8)"	"unprognostic (2.66e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.10e-1)"	2.1	3.3	0.1	2.2	0.1	0.6	7.5	0.1	0.8	4.7	4.2	0.1	2.8	0.7	6.8	3.6	4.1	1.6	1.1	5.1	0.1	0.0	0.8	0.1	0.9	0.1	8.9	1.2	0.7	0.1	0.0	0.1	0.4	1.4	3.6	0.4	2.4	7.1	5.6	1.5	1.3	1.7	5.3	5.4	1.1	1.3	5.9	0.4	0.4	0.6	1.6	0.3	1.8	1.3	0.0	0.2	4.3	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.9	0.3	0.8	0.0	0.0	0.0	0.0	0.5	0.0	4.4	0.0	2.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.6	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.1	0.4	0.0	0.5	0.2	0.1	0.0	0.0	0.9	4.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.8	0.1	0.0	8.9	1.2	1.4	0.4
IL17C	"CX2, IL-17C, IL-21, MGC126884, MGC138401"	ENSG00000124391	"Interleukin 17C"	Q9P0M4	16	88638591-88640473	"Predicted secreted proteins"	"Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"endometrium 1: 7.6"	"Cell line enhanced"	"Detected in some"		"MCF7: 3.6;RPMI-8226: 1.6;SCLC-21H: 2.6"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"cerebellum: 1.2"	"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.1"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA065051	Supported				"Secreted to blood"					"HPA065051: "	"unprognostic (1.60e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.31e-2)"	"unprognostic (4.45e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.93e-2)"		"unprognostic (3.50e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.31e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.89e-2)"	"unprognostic (3.04e-3)"	"unprognostic (2.73e-2)"	"unprognostic (7.91e-2)"	"unprognostic (3.56e-3)"	"unprognostic (8.37e-3)"	0.1	0.0	0.1	0.1	0.6	0.8	0.1	1.2	0.1	1.0	0.1	0.1	0.1	0.0	7.6	0.1	0.8	0.2	1.4	2.3	0.1	0.0	0.1	0.1	3.6	0.2	0.1	0.1	0.1	0.1	0.2	0.3	1.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	1.9	0.5	0.1	0.1	1.3	0.9	2.0	0.1	0.1	0.1	2.5	0.1	1.2	0.1	1.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	3.6	0.0	0.2	0.0	0.0	0.2	0.0	1.6	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	1.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1
IL17D	"FLJ30846, IL-17D, IL-22, IL-27, IL27"	ENSG00000172458	"Interleukin 17D"	Q8TAD2	13	20702127-20723098	"Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"brain: 36.1;skeletal muscle: 65.7"	"Cell line enhanced"	"Detected in many"		"TIME: 18.2"	"Group enriched"	"Detected in many"	9	"glioma: 10.8;melanoma: 3.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory CD8 T-cell: 1.0;NK-cell: 1.9"	"Group enriched"	"Detected in many"	5	"NK-cells: 1.9;T-cells: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"						"unprognostic (1.76e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.26e-2)"	"unprognostic (3.86e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.93e-2)"	"unprognostic (5.97e-2)"	2.5	3.2	22.4	1.3	24.6	0.6	2.1	9.5	36.1	3.6	1.9	16.1	0.2	5.6	2.9	1.1	5.5	1.4	3.2	3.9	16.5	13.9	0.8	0.5	3.5	1.0	16.7	9.4	5.3	3.7	0.7	0.6	1.4	11.0	3.1	0.7	2.2	1.8	1.4	65.7	2.0	3.5	1.2	14.6	0.7	1.4	1.9	10.9	0.0	2.5	1.1	0.6	2.6	1.6	0.3	0.0	0.1	0.1	1.9	1.0	0.1	10.7	1.5	2.4	5.2	5.7	3.2	12.5	3.0	0.8	0.3	0.6	5.0	5.9	7.3	0.6	0.3	5.7	1.0	0.1	0.1	2.6	8.3	0.5	0.5	6.0	0.7	7.9	1.6	4.4	0.1	0.4	0.0	3.4	2.9	0.0	2.0	10.4	8.8	6.5	7.3	1.8	11.6	5.9	0.8	0.1	9.4	14.2	4.6	1.7	2.6	11.8	6.5	6.8	18.2	1.2	2.1	0.9	3.7	1.3	1.1	1.9	2.8	3.8	5.3	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.2	1.0	0.0	0.2	0.1	0.0	0.1	1.9	0.0	0.0	0.0	0.1	22.4	24.6	9.5	15.2	16.5	13.9	16.7	9.4	11.0	10.9
IL17F	"IL-17F, ML-1, ML1"	ENSG00000112116	"Interleukin 17F"	Q96PD4	6	52236681-52244537	"Disease related genes, Predicted secreted proteins"		Cytokine	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"esophagus: 2.2;lymphoid tissue: 6.4;urinary bladder: 2.4"	"Cell line enhanced"	"Detected in single"		"Karpas-707: 2.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"							"unprognostic (1.40e-1)"	"unprognostic (1.20e-1)"											"unprognostic (3.02e-1)"	"unprognostic (2.52e-1)"			0.0	0.0	0.1	1.7	0.3	0.0	0.0	0.6	0.2	0.1	0.0			0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.1		0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2			0.0		6.4	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3										
IL18BP	IL18BPa	ENSG00000137496	"Interleukin 18 binding protein"	O95998	11	71998541-72005715	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 54.3;lymphoid tissue: 71.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"							"CAB025980, HPA041061"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to blood"	14000000	14000000	"Endoplasmic reticulum"		"CAB025980: , HPA041061: "	"unprognostic (2.66e-3)"	"unprognostic (2.04e-3)"	"unprognostic (9.14e-3)"	"unprognostic (1.70e-2)"	"unprognostic (5.58e-3)"	"unprognostic (7.75e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (2.93e-6)"	"unprognostic (1.19e-1)"	"unprognostic (4.14e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.93e-2)"	23.7	10.6	6.5	19.7	7.7	6.0	7.2	6.2	5.7	6.3	6.7	6.7	1.0	7.1	6.1	4.1	4.1	5.8	7.2	4.7	3.8	4.1	37.0	54.3	20.8	20.2	7.0	1.9	10.1	4.9	2.8	6.4	28.4	9.0	8.9	9.8	5.3	6.4	4.0	6.2	5.1	9.2	11.4	6.1	71.5	6.1	3.0	6.3	6.1	17.3	3.6	15.6	8.6	6.2	13.6	22.3	22.2	30.5	1.9	23.4	13.9	2.0	2.6	6.2	3.5	1.3	1.9	7.0	3.3	1.9	3.2	4.5	13.0	2.5	1.2	2.6	1.6	5.0	3.7	2.7	2.6	2.9	4.3	5.2	7.0	3.7	1.4	3.0	12.4	2.9	3.1	3.0	1.6	6.3	8.8	2.2	1.8	3.4	3.8	6.4	4.4	2.5	5.8	6.4	2.1	2.2	5.5	3.3	6.4	3.7	4.2	4.9	4.2	2.7	13.7	5.3	4.1	6.1	2.1	3.6	2.1	2.5	2.3	10.9	2.6	2.3	8.5	22.2	23.4	30.5	10.5	13.6	12.4	13.8	15.5	7.0	10.4	15.0	3.6	1.9	23.7	22.3	6.1	13.9	6.5	7.7	6.2	5.7	3.8	4.1	7.0	1.9	9.0	6.3
IL2	"IL-2, TCGF"	ENSG00000109471	"Interleukin 2"	P60568	4	122451470-122456725	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	"Cytokine, Growth factor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 1.9;intestine: 2.4;lymphoid tissue: 1.9"	"Cell line enriched"	"Detected in single"	23	"MOLT-4: 2.3"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.9"	"Lineage enriched"	"Detected in single"	19	"T-cells: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB010310	Uncertain				"Secreted to blood"					"CAB010310: AB_649346"	"unprognostic (8.87e-5)"	"unprognostic (6.13e-3)"		"unprognostic (1.38e-3)"				"unprognostic (9.79e-3)"			"unprognostic (2.56e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.06e-5)"	"unprognostic (5.21e-3)"	"unprognostic (8.01e-2)"			0.6	0.0	0.0	0.6	0.0	0.4	0.5	0.0	0.0	0.9	0.3			0.5	0.1	0.0	0.8	0.6	0.5	0.0	0.0	0.0	0.2	0.3	0.7	1.1	0.0		0.1	0.0	0.0	0.0	0.0		0.4	1.9		0.1	0.0	0.0	0.4	2.4	0.0	0.2	0.8	0.3	0.0			0.4		1.9	0.8	0.4	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
IL20	"IL-20, IL10D, ZCYTO10"	ENSG00000162891	"Interleukin 20"	Q9NYY1	1	206865354-206869223	"Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"seminal vesicle: 19.5"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.8;hTCEpi: 1.0;SiHa: 5.8;SK-MEL-30: 2.6"	"Cancer enhanced"	"Detected in some"		"breast cancer: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB025802	Uncertain				"Secreted to blood"					"CAB025802: "	"unprognostic (3.08e-2)"	"unprognostic (1.91e-1)"		"unprognostic (1.82e-1)"		"unprognostic (1.16e-2)"		"unprognostic (6.45e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.60e-1)"		"unprognostic (3.38e-2)"	"unprognostic (1.67e-1)"		"unprognostic (1.71e-1)"	4.6	2.2	0.2	0.2	0.2	0.0	1.3	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.8	0.2	0.4	0.7	1.3	0.2	0.2	0.0	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.4	0.2	0.2	0.3	0.0	0.2	0.6	19.5	0.2	3.8	0.2	3.2	0.2	0.2	0.0	1.0	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.8	0.0	2.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
IL21	"IL-21, Za11"	ENSG00000138684	"Interleukin 21"	Q9HBE4	4	122612628-122621069	"Disease related genes, Plasma proteins, Predicted secreted proteins"		Cytokine	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 16.1"	"Group enriched"	"Detected in some"	4	"HeLa: 4.2;Karpas-707: 1.1;SiHa: 3.4"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	16	"memory CD4 T-cell: 2.2;T-reg: 1.0"	"Lineage enriched"	"Detected in single"	22	"T-cells: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"								"Secreted to blood"													"unprognostic (2.42e-1)"						"unprognostic (2.12e-1)"	"unprognostic (6.80e-2)"			0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	16.1	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	3.5			0.1		7.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1										
IL22	"IL-21, IL-22, IL-D110, IL-TIF, ILTIF, MGC79382, MGC79384, TIFa, TIFIL-23, zcyto18"	ENSG00000127318	"Interleukin 22"	Q9GZX6	12	68248242-68253607	"Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 2.8;urinary bladder: 3.6"	"Cell line enhanced"	"Detected in single"		"hTERT-HME1: 1.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"								"Secreted to blood"								"unprognostic (2.57e-1)"											"unprognostic (4.24e-2)"				0.2	0.0	0.0	2.8	0.0	0.1	0.0	1.0	0.0	0.0	0.2			0.5	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.5	0.0	0.0	0.0	1.5	0.8	0.0	0.1	0.0	0.7			0.0		0.6	3.6	0.2	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0										
IL22RA2	"CRF2-S1, IL-22BP"	ENSG00000164485	"Interleukin 22 receptor subunit alpha 2"	Q969J5	6	137143820-137173648	"Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"breast: 6.9;lymphoid tissue: 6.2;placenta: 11.5"	"Group enriched"	"Detected in some"	15	"HL-60: 2.8;U-937: 4.9"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030582, CAB034906"	Uncertain				"Secreted to blood"					"CAB034906: AB_2124501, HPA030582: AB_10600716"	"unprognostic (1.09e-1)"	"unprognostic (7.97e-4)"	"unprognostic (1.32e-3)"	"unprognostic (1.24e-2)"		"unprognostic (4.03e-3)"		"unprognostic (1.11e-1)"	"unprognostic (4.51e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.10e-1)"		"unprognostic (7.58e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.61e-2)"	0.1	0.0	0.1	2.5	0.1	0.0	6.9	0.1	0.1	0.3	0.2	0.1	0.1	0.2	0.1	0.1	0.5	0.0	0.2	0.3	0.1	0.0	0.1	0.1	0.1	2.0	0.1	0.1	0.1	0.1	0.0	0.1	11.5	0.1	0.2	0.5	0.1	0.1	0.1	0.1	1.4	1.5	0.1	0.1	1.9	0.3	0.1	0.1	0.1	0.1	0.1	6.2	0.8	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
IL23A	"IL-23, IL-23A, IL23P19, P19, SGRF"	ENSG00000110944	"Interleukin 23 subunit alpha"	Q9NPF7	12	56334174-56340410	"FDA approved drug targets, Predicted secreted proteins"	"Antiviral defense, Immunity, Inflammatory response, Innate immunity, Tissue remodeling"	Cytokine	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 17.0;lymphoid tissue: 15.2;testis: 12.1"	"Cell line enhanced"	"Detected in some"		"A-431: 9.2;CAPAN-2: 16.1;U-266/70: 27.0;U-266/84: 12.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"MAIT T-cell: 8.4;memory B-cell: 10.6;memory CD4 T-cell: 15.5;memory CD8 T-cell: 7.4;naive B-cell: 10.6;naive CD4 T-cell: 17.0;naive CD8 T-cell: 10.6;T-reg: 8.4"	"Group enriched"	"Detected in many"	14	"B-cells: 10.6;T-cells: 17.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA001554	Approved		Approved	Cytosol	"Secreted to blood"			Cytosol		"HPA001554: AB_1079135"	"unprognostic (2.34e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.24e-2)"	"unprognostic (4.01e-3)"	"unprognostic (4.40e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.30e-1)"	"unprognostic (6.79e-2)"	"unprognostic (3.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.03e-10)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.50e-3)"	0.7	0.5	0.4	3.9	0.5	3.6	0.4	0.3	0.3	0.5	0.6	0.3	0.3	0.0	1.3	0.8	6.0	0.5	2.0	0.3	0.4	0.5	1.3	1.4	1.2	7.5	0.4	0.3	0.3	1.1	0.0	1.1	0.6	0.3	1.0	0.2	0.3	1.8	0.3	0.3	0.8	2.5	1.0	0.4	2.8	0.7	12.1	0.3	12.9	0.6	10.4	15.2	7.4	0.6	10.6	0.5	0.1	0.2	1.0	17.0	5.9	9.2	0.2	0.3	0.3	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.4	16.1	0.5	4.8	0.0	0.8	0.0	1.6	0.0	0.6	0.3	0.2	0.1	0.7	0.0	0.2	0.5	0.1	0.0	0.0	0.4	0.0	0.4	4.0	0.0	0.4	0.3	0.5	1.4	0.2	0.2	0.1	0.4	5.5	4.6	0.3	0.4	0.2	0.2	0.8	0.1	4.3	0.3	0.3	0.3	0.3	1.1	27.0	12.1	1.2	0.3	2.3	0.2	0.0	0.2	0.0	1.7	0.0	8.4	10.6	15.5	7.4	0.5	10.6	17.0	10.6	0.1	1.0	0.0	0.0	8.4	5.9	0.4	0.5	0.3	0.3	0.4	0.5	0.4	0.3	0.3	0.3
IL26	"AK155, IL-26"	ENSG00000111536	"Interleukin 26"	Q9NPH9	12	68201351-68225821	"Plasma proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 6.0;tongue: 5.4;urinary bladder: 4.4"	"Cell line enriched"	"Detected in some"	14	"HDLM-2: 16.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"MAIT T-cell: 2.2;memory CD4 T-cell: 1.5;memory CD8 T-cell: 1.1;T-reg: 1.1"	"Lineage enriched"	"Detected in single"	10	"T-cells: 2.2"					"Low region specificity"	"Detected in all"								"Secreted to blood"							"unprognostic (2.71e-1)"	"unprognostic (8.87e-2)"			"unprognostic (3.26e-5)"		"unprognostic (7.10e-2)"	"unprognostic (5.90e-2)"		"unprognostic (2.96e-1)"		"unprognostic (3.69e-5)"	"unprognostic (3.80e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.79e-2)"	0.1	0.0	0.5	6.0	0.2	0.0	0.0	0.7	0.1	0.1	1.0	0.0	0.0	0.2	0.0	0.0	1.4	0.1	0.5	0.3	1.0	0.2	0.1	0.1	0.5	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	2.3	0.0	0.0	0.5	1.4	0.0	0.1	1.1	0.3	0.3	0.0	0.5	0.1	5.4	3.5	4.4	0.3	0.2	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.2	1.5	1.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.1	0.5	0.2	0.7	0.1	1.0	0.2	0.1	0.0	0.0	0.0
IL3	"IL-3, MCGF, MGC79398, MGC79399, MULTI-CSF"	ENSG00000164399	"Interleukin 3"	P08700	5	132060529-132063204	"Predicted secreted proteins"		"Cytokine, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 1.8;lymphoid tissue: 2.8"	"Cell line enriched"	"Detected in single"	16	"HMC-1: 7.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to blood"																				"unprognostic (9.74e-2)"			0.1	0.1	0.0	0.3	0.0	1.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.5	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.9	0.0	2.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0
IL31	IL-31	ENSG00000204671	"Interleukin 31"	Q6EBC2	12	122172030-122174199	"Predicted secreted proteins"	Immunity	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"testis: 1.9"	"Group enriched"	"Detected in some"	11	"HDLM-2: 1.3;Karpas-707: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											CAB025657	Uncertain				"Secreted to blood"					"CAB025657: "														"unprognostic (1.70e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IL4	"BCGF-1, BCGF1, BSF1, IL-4, MGC79402"	ENSG00000113520	"Interleukin 4"	P05112	5	132673986-132682676	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"B-cell activation"	"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	16	"blood: 73.8"	"Cell line enriched"	"Detected in some"	5	"MOLT-4: 20.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	679	"basophil: 73.8"	"Lineage enriched"	"Detected in single"	679	"granulocytes: 73.8"					"Low region specificity"	"Detected in many"			HPA072995	Approved				"Secreted to blood"					"HPA072995: "	"unprognostic (3.40e-2)"	"unprognostic (9.19e-2)"		"unprognostic (1.41e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.02e-1)"		"unprognostic (1.96e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.47e-10)"	"unprognostic (9.21e-3)"	"unprognostic (2.88e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.24e-2)"	0.4	1.2	0.3	1.1	0.3	0.9	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.0	1.1	0.3	0.7	0.8	0.8	0.3	0.3	0.1	0.5	0.3	4.6	1.1	0.3	0.3	0.3	0.3	3.7	1.4	0.3	0.3	0.4	0.0	0.3	0.4	0.3	0.3	1.6	1.0	0.3	0.3	0.7	0.2	1.0	0.3	1.3	0.8	0.3	0.3	0.3	0.3	0.0	0.0	73.8	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	73.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.4	0.3	0.3	0.1	0.3	0.3	0.3	0.3
IL4I1	FIG1	ENSG00000104951	"Interleukin 4 induced 1"	Q96RQ9	19	49889654-49929539	"Enzymes, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 38.6;testis: 48.8"	"Cell line enhanced"	"Detected in some"		"EFO-21: 17.6;HDLM-2: 30.5;Karpas-707: 24.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 38.6"	"Group enriched"	"Detected in many"	6	"monocytes: 13.0;T-cells: 38.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA045598	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to blood"			"Nucleoplasm, Cytosol"		"HPA045598: AB_10969138"	"unprognostic (6.23e-2)"	"unprognostic (1.32e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (1.33e-4)"	"unprognostic (5.61e-2)"	"unprognostic (3.74e-3)"	"unprognostic (7.03e-2)"	"unprognostic (2.52e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (1.23e-10)"	"unprognostic (2.10e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.11e-3)"	5.4	3.3	4.0	30.9	4.6	7.1	4.1	5.8	5.6	4.6	4.1	5.5	2.9	8.2	5.9	3.4	4.5	8.2	5.4	4.2	3.9	3.5	11.0	3.5	6.7	15.5	4.0	3.2	6.2	3.7	1.5	5.1	6.8	4.3	5.3	3.8	3.9	4.1	5.0	6.2	3.4	7.4	3.8	7.2	7.6	6.2	48.8	4.4	14.6	4.1	4.4	12.3	6.5	4.9	0.2	4.1	0.1	13.0	0.4	38.6	3.0	0.5	0.6	0.4	0.4	0.0	0.4	0.1	0.3	1.0	0.7	1.0	0.3	1.0	1.7	17.6	0.2	0.3	0.2	0.0	0.1	30.5	0.1	0.8	0.0	0.2	0.1	0.6	6.3	0.5	0.2	0.3	0.0	1.3	0.1	24.7	0.0	0.2	0.3	1.0	0.2	0.1	0.5	0.5	1.7	1.2	1.5	0.3	0.4	0.2	0.4	0.3	0.2	1.4	1.5	3.7	0.5	0.0	0.5	2.1	4.6	1.0	0.5	0.2	0.4	0.1	8.0	0.1	2.3	13.0	38.6	0.2	5.0	4.3	4.1	0.1	0.1	0.0	0.1	0.4	1.6	0.4	0.2	3.0	4.0	4.6	5.8	5.6	3.9	3.5	4.0	3.2	4.3	4.4
IL7	IL-7	ENSG00000104432	"Interleukin 7"	P13232	8	78675743-78805523	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"intestine: 20.5;lymphoid tissue: 26.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.8;HDLM-2: 12.9;HEL: 13.7;HMC-1: 20.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 10.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA019590	Approved				"Secreted to blood"					"HPA019590: AB_10794621"	"unprognostic (3.19e-3)"	"unprognostic (1.44e-1)"	"unprognostic (9.57e-3)"	"unprognostic (5.45e-2)"	"unprognostic (9.37e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.28e-1)"	"prognostic unfavourable (2.69e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.11e-4)"	6.8	1.9	1.3	13.4	1.8	1.8	2.2	1.7	1.7	2.6	9.5	0.4	1.3	7.0	1.9	5.0	5.0	5.2	8.2	1.5	1.0	0.9	5.6	8.9	6.5	26.3	0.8	0.1	2.4	2.6	0.0	1.3	1.0	1.0	5.0	4.8	1.1	7.9	2.0	0.9	9.6	20.5	2.4	1.2	8.6	4.4	3.0	0.9	2.0	4.1	4.4	10.4	3.9	3.3	10.9	2.4	5.4	0.8	0.5	7.5	0.6	0.2	0.0	0.1	0.0	0.3	0.3	0.0	1.1	1.1	1.0	1.5	0.0	5.8	0.1	0.0	3.3	3.3	0.1	0.0	0.0	12.9	0.0	13.7	0.3	1.7	0.0	0.1	20.3	1.0	0.0	0.1	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.9	0.0	4.2	2.3	0.0	1.9	2.0	0.2	0.1	0.1	0.0	0.2	0.7	0.8	0.0	1.5	0.2	0.0	0.0	2.7	0.0	1.5	5.4	0.3	0.0	0.4	0.2	0.0	10.9	1.1	1.1	2.4	8.2	0.3	0.3	0.0	0.5	0.8	0.3	7.5	0.6	1.3	1.8	1.7	1.7	1.0	0.9	0.8	0.1	1.0	0.9
IL9	"HP40, IL-9, P40"	ENSG00000145839	"Interleukin 9"	P15248	5	135892246-135895827	"Cancer-related genes, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 5.0;skin 1: 2.1"	"Cell line enriched"	"Detected in single"	267	"HDLM-2: 30.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"								"Secreted to blood"																							0.1	0.2	0.3	0.0	2.2	0.0	0.0	0.3	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.7	0.2	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	2.1	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	2.2	0.3	1.1	0.7	0.2	2.1	0.0	0.0	0.0
INHA		ENSG00000123999	"Inhibin alpha subunit"	P05111	2	219569162-219575713	"Predicted secreted proteins"		"Growth factor, Hormone"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 24.2;ovary: 31.5;placenta: 39.3;testis: 77.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.6;CAPAN-2: 4.3;HEL: 5.6;SK-BR-3: 13.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	5	"basal ganglia: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000047, HPA019141"	Enhanced		Approved	Vesicles	"Secreted to blood"			Vesicles		"CAB000047: AB_322161, HPA019141: AB_1851789"	"unprognostic (8.90e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.57e-1)"	"unprognostic (9.61e-3)"	"unprognostic (4.15e-3)"	"unprognostic (6.71e-2)"	"unprognostic (3.73e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavourable (4.03e-5)"	"unprognostic (4.85e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.43e-2)"	0.5	24.2	0.8	0.5	8.4	0.0	0.5	1.7	0.9	0.5	0.5	1.4	0.5	0.0	0.5	1.2	0.5	0.6	0.6	4.8	0.8	0.9	0.5	0.5	0.5	0.5	0.5	0.6	31.5	6.5	0.2	1.5	39.3	0.6	0.5	0.0	0.5	0.9	0.7	0.5	1.1	0.5	0.5	0.5	0.5	0.1	77.6	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.1	2.5	0.8	0.2	4.6	0.5	0.4	0.7	0.2	0.3	4.3	0.0	0.3	1.0	2.7	0.3	0.7	0.0	0.0	0.8	5.6	2.0	3.0	0.4	0.0	0.0	1.0	1.3	0.0	0.7	0.0	3.4	0.0	0.1	3.1	0.0	0.2	1.7	1.1	0.1	0.2	0.0	0.7	0.3	0.5	1.1	1.6	13.0	0.4	0.8	0.0	0.1	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	8.4	1.7	0.9	0.8	0.9	0.5	0.6	0.6	0.5
INHBA		ENSG00000122641	"Inhibin beta A subunit"	P08476	7	41667168-41705834	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		"Growth factor, Hormone"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"placenta: 148.2"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 19.5;hTEC/SVTERT24-B: 59.6;hTERT-HME1: 24.7;TIME: 30.7;U-138 MG: 46.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.8;non-classical monocyte: 1.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to blood"	290000	290000				"unprognostic (4.11e-3)"	"prognostic unfavourable (1.46e-5)"	"unprognostic (4.22e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.18e-2)"	"prognostic unfavourable (4.34e-4)"	"unprognostic (2.05e-2)"	"prognostic unfavourable (7.72e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (7.91e-8)"	"unprognostic (6.22e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.18e-3)"	1.7	1.0	1.2	3.6	3.7	6.6	1.3	0.7	3.5	1.7	1.5	0.8	1.3	0.3	13.6	4.2	3.8	1.6	17.3	9.3	1.9	1.6	2.0	7.9	26.4	0.6	1.2	0.7	5.2	1.2	0.0	0.8	148.2	4.8	2.4	0.2	1.4	4.3	3.8	1.2	2.9	0.8	3.8	8.7	0.4	1.5	3.9	1.3	0.4	1.5	2.6	0.7	4.8	1.8	0.2	0.7	1.8	1.3	0.0	0.0	0.3	1.0	0.0	0.1	0.0	0.8	1.9	0.0	4.7	0.5	2.6	0.8	0.0	0.1	0.0	0.3	1.7	3.9	0.0	19.5	2.5	1.2	0.0	0.0	0.0	0.0	3.7	0.0	0.0	1.8	1.1	59.6	24.7	2.1	0.1	0.0	5.9	0.0	0.0	0.1	0.4	2.7	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.8	0.1	0.0	0.0	0.0	30.7	46.4	13.4	4.9	4.8	0.0	0.0	0.0	1.8	0.0	0.1	0.1	0.3	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	1.8	0.0	1.3	0.0	0.0	0.3	1.2	3.7	0.7	1.3	1.9	1.6	1.2	0.7	4.8	1.3
INHBB		ENSG00000163083	"Inhibin beta B subunit"	P09529	2	120346143-120351808	"Cancer-related genes, Predicted secreted proteins"		"Growth factor, Hormone"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 23.3"	"Cell line enhanced"	"Detected in some"		"A549: 15.1;ASC diff: 21.0;MCF7: 18.2;PC-3: 29.6;SK-BR-3: 52.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	14	"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"						"unprognostic (7.80e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavourable (1.44e-4)"	"unprognostic (1.26e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.61e-3)"	"unprognostic (2.13e-2)"	"unprognostic (5.52e-2)"	"unprognostic (6.99e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavourable (3.02e-4)"	"unprognostic (1.57e-3)"	"unprognostic (4.14e-1)"	"prognostic favourable (1.02e-4)"	"unprognostic (1.76e-2)"	23.3	3.6	6.0	1.2	3.5	0.2	19.2	0.9	3.8	7.0	0.8	3.1	2.6	1.3	3.9	2.6	1.5	3.3	2.4	3.5	4.7	1.4	1.2	19.2	2.7	1.0	2.2	3.1	1.6	3.5	4.5	3.8	1.2	4.7	7.7	0.3	0.5	7.8	0.9	4.9	7.6	0.9	2.1	1.9	0.4	1.8	14.4	2.2	0.4	19.1	1.6	1.3	4.4	7.8	0.0	0.0	1.3	0.0	0.0	0.0	0.0	7.6	15.1	0.0	0.0	21.0	1.6	0.0	1.0	1.2	6.8	12.7	0.3	0.0	0.0	2.7	0.3	0.0	1.2	0.0	9.5	0.0	0.2	0.0	0.0	0.3	0.3	0.0	0.0	0.8	1.1	0.2	0.0	0.1	0.0	0.0	0.0	18.2	0.0	0.0	0.0	29.6	0.0	0.0	0.3	1.8	0.0	1.7	0.0	0.0	52.9	0.0	12.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	6.0	3.5	0.9	3.7	4.7	1.4	2.2	3.1	4.7	2.2
INHBC		ENSG00000175189	"Inhibin beta C subunit"	P55103	12	57434760-57450828	"Plasma proteins, Predicted secreted proteins"		"Growth factor, Hormone"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	256	"liver: 121.3"	"Cell line enhanced"	"Detected in some"		"Hep G2: 9.6;Karpas-707: 9.8;RH-30: 4.9;U-266/70: 5.0"	"Cancer enriched"	"Detected in single"	85	"liver cancer: 22.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	11000000	11000000				"unprognostic (5.26e-2)"	"unprognostic (4.58e-1)"	"unprognostic (3.43e-3)"	"unprognostic (4.08e-3)"	"unprognostic (3.76e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.68e-4)"	"unprognostic (2.90e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.55e-3)"	"unprognostic (5.05e-2)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	121.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	2.2	0.1	0.0	0.2	0.2	0.1	0.1	1.5	0.1	0.5	0.0	9.6	0.0	0.4	0.1	0.3	0.0	0.0	0.6	0.0	0.1	9.8	0.0	0.2	0.1	0.0	0.0	0.1	0.3	4.9	0.7	0.0	0.0	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	5.0	0.5	0.9	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
INS	"IDDM1, IDDM2"	ENSG00000254647	Insulin	P01308	11	2159779-2161341	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Carbohydrate metabolism, Glucose metabolism"	Hormone	"Cancer-related genes, Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	193	"pancreas: 514.0"	"Group enriched"	"Detected in some"	9	"EFO-21: 52.5;U-2 OS: 68.8;U-698: 21.7"	"Cancer enriched"	"Detected in single"	7166	"pancreatic cancer: 1751.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Region enriched"	"Detected in single"	13	"midbrain: 1.7"	"CAB000048, HPA004932, CAB012098, CAB053843"	Enhanced				"Secreted to blood"					"CAB000048: , CAB012098: AB_300968, CAB053843: AB_620123, HPA004932: AB_1851816"											"unprognostic (7.61e-2)"							0.4	0.1	0.1	0.1	0.1	1.1	0.1	0.1	0.7	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	1.4	0.1	0.1	0.1	0.1	0.1	0.1	514.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	2.6	0.1	0.1	0.1	0.1	1.1	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.5	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.8	0.0	5.2	0.0	2.4	21.7	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
INS-IGF2		ENSG00000129965	"INS-IGF2 readthrough"	F8WCM5	11	2132538-2161209	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	148	"pancreas: 467.6"	"Group enriched"	"Detected in some"	5	"SCLC-21H: 2.1;SH-SY5Y: 5.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											CAB019430	Enhanced				"Secreted to digestive system"					"CAB019430: AB_10691857"					"unprognostic (1.33e-1)"						"unprognostic (2.34e-1)"							0.1	0.4	0.1	0.0	0.2	0.0	0.1	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.3	0.1	0.0	0.3	0.0	0.4	467.6	0.0	0.1	3.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.1	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.3	0.3	0.1	0.3	0.0	0.0	0.0
INSL3	"MGC119818, MGC119819, RLF, RLNL"	ENSG00000248099	"Insulin like 3"	P51460	19	17816512-17821574	"Disease related genes, Predicted secreted proteins"		Hormone	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"testis: 234.1"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 8.8;PC-3: 4.0;SCLC-21H: 8.0;SH-SY5Y: 7.2"	"Cancer enriched"	"Detected in many"	21	"testis cancer: 39.4"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA028615	Enhanced				"Secreted to blood"					"HPA028615: AB_10600717"	"unprognostic (3.25e-1)"	"unprognostic (2.25e-4)"	"unprognostic (3.50e-5)"	"unprognostic (7.04e-2)"	"unprognostic (1.74e-4)"	"unprognostic (4.60e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.46e-1)"	"unprognostic (4.93e-2)"	"unprognostic (9.51e-10)"	"unprognostic (6.80e-3)"	"unprognostic (1.41e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.09e-5)"	0.1	0.4	0.1	1.1	0.2	0.3	0.1	0.2	0.6	0.1	0.1	0.1	0.1	0.3	0.1	1.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.6	0.1	0.1	9.6	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	1.1	0.1	234.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	2.4	0.3	5.7	1.2	1.3	2.9	1.1	0.3	1.0	0.2	0.7	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.1	1.7	0.2	2.2	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.7	0.0	0.3	0.0	0.1	1.9	1.3	0.9	0.0	0.0	0.0	0.1	8.8	0.0	1.5	0.3	1.5	0.0	4.0	1.3	0.0	0.2	0.2	0.5	8.0	7.2	0.1	2.4	0.0	0.6	0.0	0.0	0.0	0.0	2.1	0.0	0.7	3.1	0.2	0.1	2.0	0.0	0.8	0.5	0.0	1.8	1.2	1.8	0.3	2.4	2.3	0.3	2.4	2.1	2.9	5.7	1.3	0.3	0.3	2.0	1.1	0.1	0.2	0.2	0.6	0.1	0.0	0.1	0.1	0.1	0.1
INSL4	EPIL	ENSG00000120211	"Insulin like 4"	Q14641	9	5231419-5235304	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	47	"placenta: 88.0"	"Cell line enriched"	"Detected in some"	11	"A549: 23.1"	"Cancer enhanced"	"Detected in some"		"lung cancer: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to blood"							"unprognostic (9.77e-2)"						"unprognostic (2.02e-1)"		"unprognostic (4.66e-1)"				"unprognostic (7.74e-2)"				0.1	0.1	0.0	0.0	0.1	0.3	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.2	1.8	0.1	0.0	0.0	0.2	0.0	0.1	0.8	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	88.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.2	0.1	0.0	0.1	0.2	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.3	0.0	0.1	0.0	0.0	23.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0
INSL5		ENSG00000172410	"Insulin like 5"	Q9Y5Q6	1	66797741-66801256	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"intestine: 52.9"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.4;hTCEpi: 1.1"	"Group enriched"	"Detected in some"	5	"colorectal cancer: 1.2;prostate cancer: 0.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030100, CAB033849"	Enhanced				"Secreted to blood"					"CAB033849: AB_2264904, HPA030100: AB_10601915"	"unprognostic (2.48e-1)"		"unprognostic (4.41e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.18e-1)"					"unprognostic (2.76e-2)"		"unprognostic (1.30e-1)"	"unprognostic (2.62e-2)"			"unprognostic (7.53e-2)"		0.0	0.0	0.8	0.0	1.3	0.0	0.0	0.1	1.0	0.0	30.8			0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.1	1.8	0.4	0.0	0.0	0.0	0.5		0.0	0.0	0.0	0.5	0.0		0.2	52.9		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9			0.2		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
INSL6	RIF1	ENSG00000120210	"Insulin like 6"	Q9Y581	9	5131979-5185668	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 22.3"	"Cell line enhanced"	"Detected in some"		"HEL: 1.1;HL-60: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA021364	Enhanced				"Secreted to blood"					"HPA021364: AB_1851807"	"unprognostic (3.85e-4)"	"unprognostic (7.41e-4)"						"unprognostic (1.28e-1)"		"unprognostic (1.94e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.30e-1)"		"unprognostic (2.52e-3)"	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.2	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	22.3	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0
ISLR	HsT17563	ENSG00000129009	"Immunoglobulin superfamily containing leucine rich repeat"	O14498	15	74173671-74176872	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 33.1;ASC TERT1: 17.8;fHDF/TERT166: 74.3;HSkMC: 13.5;RPMI-8226: 22.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	5	"olfactory region: 145.0"	"Low region specificity"	"Detected in many"			"HPA040326, HPA050811"	Approved		Approved	"Golgi apparatus,Plasma membrane"	"Secreted - unknown location"	110000000	110000000	"Plasma membrane"	"Golgi apparatus"	"HPA040326: , HPA050811: "	"unprognostic (2.58e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.76e-3)"	"unprognostic (1.16e-2)"	"unprognostic (6.81e-2)"	"unprognostic (8.93e-3)"	"prognostic unfavourable (4.89e-8)"	"unprognostic (1.64e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.86e-3)"	24.6	6.8	3.3	10.4	4.6	0.1	21.4	2.0	12.1	72.8	19.7	2.9	13.2	4.1	67.3	36.3	23.0	22.1	29.6	17.7	1.7	1.7	8.0	2.5	10.2	5.8	3.3	7.2	80.2	3.4	1.2	13.8	31.5	3.9	32.2	4.0	36.4	10.0	17.9	12.5	13.6	8.8	27.5	9.0	9.8	10.3	16.3	0.6	1.3	18.9	17.0	9.9	27.9	35.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	33.1	17.8	0.1	5.1	0.0	0.0	0.0	0.0	2.0	0.0	0.3	74.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	22.8	0.0	0.0	0.2	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	3.9	0.0	0.1	0.5	0.0	0.2	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	4.6	2.0	12.1	1.7	1.7	3.3	7.2	3.9	0.6
ISM1	"bA149I18.1, C20orf82"	ENSG00000101230	"Isthmin 1"	B1AKI9	20	13221771-13300651	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 33.8"	"Group enriched"	"Detected in some"	5	"ASC diff: 35.4;Hep G2: 13.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 4.0;naive CD4 T-cell: 3.3"	"Lineage enriched"	"Detected in single"	40	"T-cells: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"						"unprognostic (7.13e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.43e-3)"	"unprognostic (5.27e-3)"	"unprognostic (1.84e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavourable (9.32e-6)"	"unprognostic (2.58e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.81e-2)"	7.8	2.4	0.8	0.5	1.1	0.0	17.0	0.7	1.5	2.4	2.1	0.8	2.0	0.3	1.8	2.3	4.5	2.3	4.4	2.2	1.0	1.7	2.4	4.5	3.2	1.0	0.7	0.9	1.1	5.7	0.1	1.0	12.7	1.3	1.9	0.2	0.8	8.9	0.7	2.3	9.2	1.1	1.7	0.6	4.8	1.9	1.2	0.8	1.4	33.8	5.5	1.1	3.8	6.1	0.0	0.0	0.0	0.0	0.0	4.0	1.5	0.0	0.3	0.1	0.5	35.4	5.0	0.2	0.3	2.9	0.0	0.0	1.9	0.3	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	2.8	0.0	0.0	13.5	0.0	0.0	0.0	0.1	0.3	0.0	0.3	0.0	0.3	0.0	0.2	1.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	1.0	0.1	0.6	0.0	0.0	0.0	2.0	0.1	0.2	0.0	3.3	0.6	0.0	1.5	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.4	0.0	0.0	3.3	0.5	0.0	0.0	0.0	0.0	0.0	1.5	0.8	1.1	0.7	1.5	1.0	1.7	0.7	0.9	1.3	0.8
ISM2	"FLJ32147, TAIL1, THSD3"	ENSG00000100593	"Isthmin 2"	Q6H9L7	14	77474394-77498850	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	45	"placenta: 193.8"	"Cell line enriched"	"Detected in some"	15	"BEWO: 89.3"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"basal ganglia: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA039314, HPA039742"	Supported		Supported	Nucleoplasm	"Secreted in female reproductive system"			Nucleoplasm		"HPA039314: AB_10673239, HPA039742: AB_10673427"	"unprognostic (5.69e-2)"	"unprognostic (9.17e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.73e-2)"	"unprognostic (2.34e-1)"		"unprognostic (2.16e-2)"	"unprognostic (3.09e-3)"	"unprognostic (2.11e-1)"	"unprognostic (4.13e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.36e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.67e-2)"	"unprognostic (3.95e-1)"	0.7	0.0	0.2	0.2	4.2	0.0	0.1	0.1	0.3	1.1	0.2	0.1	0.3	0.1	2.7	0.9	0.2	0.5	0.1	0.1	0.1	0.8	0.6	0.1	0.1	0.1	0.1	0.1	0.2	0.3	0.1	0.5	193.8	0.2	3.2	0.0	0.2	0.1	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	2.4	0.2	0.1	0.2	0.1	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	89.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.2	0.1	0.3	0.1	0.8	0.1	0.1	0.2	0.2
ITIH2	H2P	ENSG00000151655	"Inter-alpha-trypsin inhibitor heavy chain 2"	P19823	10	7703269-7749520	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	202	"liver: 249.0"	"Cell line enriched"	"Detected in single"	1079	"Hep G2: 151.9"	"Cancer enriched"	"Detected in many"	279	"liver cancer: 626.9"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA059150	Supported		Approved	"Golgi apparatus"	"Secreted to blood"	22000000000	22000000000	"Golgi apparatus"		"HPA059150: "	"unprognostic (4.82e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.55e-3)"	"prognostic favourable (1.48e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.10e-8)"	"unprognostic (9.91e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.35e-1)"	"unprognostic (4.46e-4)"	0.0	0.0	0.1	0.0	0.6	0.0	0.3	0.1	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.2	249.0	0.1	0.0	0.5	0.5	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	0.4	0.3	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	151.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.6	0.1	0.4	0.4	0.6	0.4	0.1	0.5	0.3	0.6	0.2	0.8	0.2	1.2	0.1	0.0	0.1	0.6	0.1	0.4	0.4	0.3	0.5	0.5	1.1	0.1
ITIH3	H3P	ENSG00000162267	"Inter-alpha-trypsin inhibitor heavy chain 3"	Q06033	3	52794768-52809009	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	233	"liver: 326.9"	"Cell line enriched"	"Detected in single"	24	"Hep G2: 19.2"	"Cancer enriched"	"Detected in some"	247	"liver cancer: 273.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA017373	Approved				"Secreted to blood"	4500000000	4500000000			"HPA017373: AB_1851954"	"unprognostic (2.07e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.30e-4)"	"unprognostic (4.28e-2)"	"unprognostic (3.26e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.19e-1)"	"prognostic unfavourable (4.49e-8)"	"unprognostic (2.09e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.31e-2)"	0.9	0.0	0.1	0.2	0.1	0.0	0.2	0.1	0.1	0.8	0.3	0.1	0.3	0.0	0.5	0.5	0.3	0.3	0.5	0.2	0.1	0.0	0.2	326.9	0.4	0.3	0.2	0.1	0.6	0.0	0.0	0.1	0.3	0.2	0.2	0.1	0.2	0.2	0.4	0.3	0.1	0.1	0.1	0.1	1.4	0.1	0.4	0.1	0.1	0.3	0.2	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.1
ITIH6	"ITIH5L, UNQ6369"	ENSG00000102313	"Inter-alpha-trypsin inhibitor heavy chain family member 6"	Q6UXX5	X	54748899-54798240	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 3.8;salivary gland: 3.5;skeletal muscle: 5.0"	"Cell line enriched"	"Detected in some"	19	"WM-115: 33.3"	"Cancer enriched"	"Detected in some"	7	"melanoma: 10.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA000506	Uncertain				"Secreted to blood"					"HPA000506: "	"unprognostic (3.40e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.73e-3)"	"unprognostic (7.24e-2)"		"unprognostic (2.83e-1)"		"unprognostic (5.38e-3)"	"unprognostic (9.81e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.33e-2)"	"unprognostic (4.14e-4)"	"unprognostic (1.68e-1)"	"unprognostic (2.12e-1)"		"unprognostic (2.35e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	3.5	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ITLN1	"FLJ20022, hIntL, HL-1, ITLN, LFR"	ENSG00000179914	"Intelectin 1"	Q8WWA0	1	160876539-160885170	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 119.2;heart muscle: 48.6;intestine: 157.9;lymphoid tissue: 40.1"	"Cell line enhanced"	"Detected in some"		"HEL: 4.3;HHSteC: 1.9;HL-60: 3.1;RPMI-8226: 1.7;U-937: 11.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 61.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"intermediate monocyte: 6.9;non-classical monocyte: 17.3"	"Lineage enriched"	"Detected in many"	15	"monocytes: 17.3"	"Not detected"	"Not detected"							"CAB012652, HPA063275, HPA067326"	Enhanced				"Secreted to blood"	160000000	160000000			"CAB012652: , HPA063275: , HPA067326: "	"unprognostic (9.69e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.28e-1)"		"unprognostic (1.79e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.66e-2)"	"unprognostic (4.38e-1)"	"unprognostic (9.96e-2)"	"unprognostic (3.67e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.34e-2)"	119.2	0.0	0.2	40.1	0.2	0.0	0.2	0.2	0.2	0.4	52.5	0.2	1.0	31.9	0.5	8.8	0.7	1.2	8.7	48.6	0.2	0.0	0.5	2.6	13.9	0.2	0.2	0.3	4.3	0.2	0.0	0.4	0.4	0.3	3.0	157.9	0.2	2.6	0.6	1.5	0.1	48.6	0.8	0.2	0.6	1.9	2.7	0.2	0.4	0.2	1.4	1.5	1.6	0.8	0.0	1.1	0.1	17.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.3	0.0	0.0	1.9	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.7	0.0	0.3	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	11.9	0.0	0.0	0.3	0.0	0.0	6.9	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.1	0.0	17.3	0.0	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.3	0.3	0.2
ITLN2	HL-2	ENSG00000158764	"Intelectin 2"	Q8WWU7	1	160945025-160954799	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"intestine: 88.4"	"Cell line enhanced"	"Detected in some"		"HEL: 15.3;HHSteC: 2.6;HMC-1: 4.6;SK-MEL-30: 4.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA006683, HPA067326"	Enhanced				"Secreted to digestive system"					"HPA006683: AB_2129681, HPA067326: "		"unprognostic (1.42e-1)"	"unprognostic (9.62e-3)"	"unprognostic (4.61e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.25e-1)"	"unprognostic (6.84e-4)"	"unprognostic (2.47e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.01e-1)"		"unprognostic (1.84e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.91e-2)"	3.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	27.4	0.1	0.1	53.3	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	2.5	0.1	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.1	88.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	2.6	0.0	4.6	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	1.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
JCHAIN	"IGCJ, IGJ, JCH"	ENSG00000132465	"Joining chain of multimeric IgA and IgM"	P01591	4	70655541-70681817	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 213.0;intestine: 403.3;lymphoid tissue: 209.3;salivary gland: 220.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 158.7;Karpas-707: 84.7;RPMI-8226: 168.2;U-266/70: 358.1;U-266/84: 139.0;U-698: 206.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	118	"memory B-cell: 213.0;naive B-cell: 91.6;plasmacytoid DC: 160.7"	"Group enriched"	"Detected in many"	142	"B-cells: 213.0;dendritic cells: 160.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB034436, HPA044132"	Enhanced				"Secreted to blood"	4200000000	4200000000			"CAB034436: AB_2233368, HPA044132: "	"prognostic favourable (1.81e-6)"	"unprognostic (1.45e-3)"	"unprognostic (7.44e-3)"	"unprognostic (1.82e-2)"	"unprognostic (4.23e-2)"	"prognostic favourable (7.56e-7)"	"unprognostic (2.37e-2)"	"unprognostic (2.70e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.64e-3)"	"unprognostic (3.36e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavourable (1.40e-4)"	"unprognostic (3.43e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.96e-1)"	4.4	1.6	0.9	209.3	0.9	0.4	69.6	0.9	0.9	27.2	403.3	2.1	0.7	132.7	1.7	1.5	29.2	9.8	79.4	2.4	0.9	1.0	19.9	12.7	62.8	111.7	0.9	0.6	14.0	8.6	0.0	1.4	0.7	0.8	5.7	142.5	8.2	220.1	30.1	1.1	1.7	361.5	4.0	1.0	161.3	124.6	7.0	0.7	8.0	7.1	36.8	96.7	42.1	5.9	213.0	160.7	1.3	0.3	0.2	0.9	52.6	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	158.7	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.2	84.7	0.0	0.0	0.2	0.5	0.1	0.0	0.2	0.1	168.2	0.0	0.0	0.1	0.6	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.4	0.2	0.2	358.1	139.0	206.4	0.0	0.2	0.0	0.7	0.3	0.1	0.2	0.0	0.9	213.0	0.1	0.2	0.3	91.6	0.1	0.1	1.3	0.2	0.1	160.7	0.1	52.6	0.9	0.9	0.9	0.9	0.9	1.0	0.9	0.6	0.8	0.7
KAZALD1	"FKSG28, FKSG40"	ENSG00000107821	"Kazal type serine peptidase inhibitor domain 1"	Q96I82	10	101061841-101068131	"Predicted secreted proteins"	"Differentiation, Osteogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.6;prostate: 24.0;retina: 22.5"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 22.3;T-47d: 28.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	13	"memory B-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"B-cells: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA011800	Uncertain				"Secreted to extracellular matrix"					"HPA011800: AB_1852082"	"unprognostic (3.34e-1)"	"unprognostic (8.86e-3)"	"unprognostic (1.16e-2)"	"unprognostic (4.43e-3)"	"unprognostic (4.88e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.68e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.44e-3)"	"unprognostic (6.35e-2)"	"prognostic unfavourable (5.10e-4)"	"unprognostic (2.11e-1)"	2.6	0.6	0.8	3.2	0.5	0.1	2.6	0.3	1.0	10.3	2.3	0.4	2.9	3.3	5.2	10.6	1.6	2.0	3.0	7.7	1.0	0.4	1.9	0.4	2.4	2.8	0.6	0.3	1.9	1.1	1.6	3.6	1.1	1.5	24.0	2.0	22.5	8.3	3.0	4.8	1.7	3.7	5.6	0.5	20.6	8.7	1.8	0.3	0.6	2.5	5.7	2.3	3.0	3.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.2	1.7	22.3	1.9	6.7	1.7	4.1	4.7	1.1	1.0	4.9	1.8	0.2	2.4	4.1	0.4	1.5	0.0	0.2	2.6	0.8	0.3	4.9	4.7	0.4	0.3	2.0	0.9	0.3	0.1	0.8	0.1	0.6	2.4	0.7	3.7	0.1	1.4	0.5	9.1	9.5	8.3	0.3	0.4	1.1	0.3	1.0	0.5	0.7	1.3	28.5	0.6	0.1	0.6	1.9	0.3	1.1	0.7	2.1	2.0	1.0	2.9	1.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.3	1.0	1.0	0.4	0.6	0.3	1.5	0.3
KCP	"CRIM2, FLJ33365, NET67"	ENSG00000135253	"Kielin/chordin-like protein"		7	128862451-128910719	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	9	"ductus deferens: 30.0;kidney: 11.2;seminal vesicle: 28.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 13.4;HMC-1: 7.6;U-87 MG: 3.3"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"						"unprognostic (6.12e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.45e-3)"	"unprognostic (6.33e-3)"	"unprognostic (2.14e-1)"	"unprognostic (5.24e-3)"	"unprognostic (2.01e-3)"	"unprognostic (3.25e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.20e-3)"	"unprognostic (6.46e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.84e-2)"	"unprognostic (7.64e-3)"	2.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	30.0	0.9	0.1	1.7	0.4	0.6	2.1	0.3	0.0		11.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	1.3	0.0	0.1	0.1	28.3	0.0	0.0	2.1	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	13.4	0.2	2.0	0.0	1.0	0.0	0.0	0.0	1.8	0.1	0.9	0.0	1.1	0.2	0.0	7.6	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.6	0.1	0.0	1.8	0.5	0.0	0.0	0.0	0.0	0.4	0.1	0.9	0.4	0.0	0.0	0.1	0.1	0.0	0.3	0.3	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KERA	"CNA2, SLRR2B"	ENSG00000139330	Keratocan	O60938	12	91050491-91057983	"Disease related genes, Predicted secreted proteins"	"Sensory transduction, Vision"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 10.9"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039321	Uncertain				"Secreted to extracellular matrix"					"HPA039321: AB_10795248"	"unprognostic (2.77e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.47e-1)"	"unprognostic (3.70e-1)"	"unprognostic (4.76e-3)"	"unprognostic (3.65e-1)"		"unprognostic (6.08e-2)"		"unprognostic (1.19e-1)"	"unprognostic (3.68e-2)"	"unprognostic (5.96e-2)"		"unprognostic (4.93e-3)"	"unprognostic (2.06e-2)"		"unprognostic (2.53e-1)"	0.8	0.0	0.2	1.9	0.2	0.0	2.9	0.0	0.2	1.9	2.5	0.0	0.0	0.0	1.0	2.5	1.5	2.2	4.3	0.4	0.1	0.0	0.0	0.0	0.6	0.2	0.5	0.0	0.6	0.0	0.0	0.0	1.5	0.2	0.5	0.3	0.0	2.8	0.2	4.7	0.2	0.9	0.4	0.0	0.0	1.3	0.2	0.0	0.3	0.1	10.9	0.5	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.1	0.0	0.5	0.0	0.2	0.0
KIR3DX1	"FLJ00060, LENG12"	ENSG00000104970	"Killer cell immunoglobulin like receptor, three Ig domains X1"		19	54532692-54545771	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"brain: 3.9;heart muscle: 3.6;lymphoid tissue: 4.6"	"Cell line enriched"	"Detected in some"	6	"U-266/84: 9.7"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA052110	Uncertain				"Secreted - unknown location"					"HPA052110: "	"unprognostic (5.85e-3)"	"unprognostic (4.13e-3)"	"unprognostic (8.47e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.46e-4)"	"unprognostic (1.09e-1)"	"unprognostic (7.51e-2)"	"unprognostic (4.99e-4)"	"unprognostic (1.22e-4)"	"unprognostic (1.36e-1)"	"unprognostic (6.40e-2)"	"unprognostic (8.73e-9)"	"unprognostic (1.09e-2)"	"unprognostic (7.75e-2)"	"unprognostic (3.62e-1)"	"unprognostic (6.20e-3)"	1.9	0.0	0.0	1.3	0.6	2.2	0.3	0.0	1.2	0.6	0.2	3.9	0.0	0.0	1.0	0.0	0.5	0.1	0.4	3.6	0.1		0.1	0.2	2.2	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.2	2.3	0.0	0.2	0.0	0.0	0.0	0.9	0.1	0.1	0.5	0.6	4.6	0.0	0.5	0.1	0.0	0.2	0.0	2.7	0.0	0.0	0.4	0.3	1.7	0.2	1.2	1.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	9.7	0.0	0.0	0.8	0.0	1.7	0.2	0.0	1.1	0.2	0.2	0.2	0.2	0.2	0.0	0.4	0.1	0.2	0.6	1.2	0.0	0.3	0.3	0.0										
KISS1		ENSG00000170498	"KiSS-1 metastasis suppressor"	Q15726	1	204190341-204196486	"Cancer-related genes, Disease related genes, Predicted secreted proteins"			"Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"placenta: 267.2"	"Group enriched"	"Detected in some"	22	"BJ: 54.6;U-2 OS: 22.2"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 9.2"	"Group enriched"	"Detected in some"	8	"basal ganglia: 11.3;hypothalamus: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"CAB017775, HPA035542"	Enhanced		Approved	Vesicles	"Secreted in female reproductive system"			Vesicles		"CAB017775: , HPA035542: "	"unprognostic (9.64e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.89e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.28e-2)"		"unprognostic (1.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.98e-12)"	"unprognostic (2.25e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.76e-1)"	"prognostic favourable (6.29e-6)"	0.2	0.0	0.2	0.2	11.3	0.0	0.2	1.0	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.2	0.0	0.2	0.2	0.2	4.2	1.1	2.7	0.5	0.2	0.2	0.2	0.2	0.4	0.1	2.5	267.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.5	0.2	0.2	0.7	1.4	3.6	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	54.6	0.7	0.9	0.2	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	22.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	11.3	1.0	0.2	0.2	4.2	0.2	0.2	0.2	0.2
KLK1	Klk6	ENSG00000167748	"Kallikrein 1"	P06870	19	50819148-50823787	"Enzymes, FDA approved drug targets, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	56	"pancreas: 742.6;salivary gland: 473.0"	"Cell line enriched"	"Detected in some"	23	"RPMI-8226: 28.8"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 20.0;pancreatic cancer: 50.9;renal cancer: 84.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"memory B-cell: 10.9;naive B-cell: 3.8"	"Lineage enriched"	"Detected in single"	14	"B-cells: 10.9"														"Secreted to digestive system"	4300000	4300000				"unprognostic (1.51e-3)"	"unprognostic (1.23e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.47e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.49e-2)"	"unprognostic (8.06e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.23e-2)"	0.1	0.2	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.2	2.5	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	3.8	0.1	0.1	0.1	0.1	0.1	0.1	742.6	0.0	0.1	0.1	0.1	0.2	1.9	0.1	473.0	0.1	0.1	1.8	0.6	0.1	0.1	0.3	0.1	0.1	0.1	0.1	1.2	0.2	0.2	0.1	0.1	10.9	0.7	0.1	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.3	0.2	0.2	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	10.9	0.0	0.0	0.2	3.8	0.0	0.0	0.1	0.0	0.2	0.7	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
KLK10	"NES1, PRSSL1"	ENSG00000129451	"Kallikrein related peptidase 10"	O43240	19	51012739-51020175	"Cancer-related genes, Enzymes, Predicted secreted proteins"	"Cell cycle"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 78.6;lymphoid tissue: 58.6;tongue: 136.3"	"Group enriched"	"Detected in some"	6	"CAPAN-2: 52.5;HaCaT: 79.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in single"	4	"hippocampal formation: 1.7"	"Not detected"	"Not detected"								"Secreted in other tissues"	670000	670000				"prognostic favourable (8.32e-4)"	"unprognostic (6.06e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.26e-3)"	"unprognostic (3.81e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.38e-2)"	"prognostic unfavourable (6.46e-5)"	"unprognostic (2.71e-2)"	"unprognostic (2.46e-6)"	"unprognostic (9.34e-2)"	"unprognostic (7.81e-2)"	"unprognostic (2.66e-3)"	"unprognostic (1.52e-2)"	1.5	0.5	0.2	1.7	0.3	0.3	2.4	0.7	0.4	20.8	0.9	0.3	0.5	0.2	2.9	0.8	78.6	7.8	36.0	0.7	0.2	0.5	0.2	0.3	4.3	0.2	0.2	0.3	7.2	0.2	0.0	0.2	0.8	0.6	1.6	0.4	0.3	11.0	0.6	0.4	17.7	0.4	0.4	0.4	0.2	0.5	1.6	0.2	1.0	0.3	136.3	58.6	0.5	33.4	0.4	0.5	2.1	0.4	0.4	0.3	0.1	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	52.5	0.0	2.9	0.0	79.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.2	0.3	0.2	0.3	0.2	0.3	0.2	0.1	0.4	0.3	0.3	2.1	0.4	0.4	0.5	0.3	0.1	0.2	0.3	0.7	0.4	0.2	0.5	0.2	0.3	0.6	0.2
KLK12	KLK-L5	ENSG00000186474	"Kallikrein related peptidase 12"	Q9UKR0	19	51029092-51035230	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 27.6;esophagus: 53.9;lymphoid tissue: 24.7;tongue: 33.3;vagina: 24.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.2;HaCaT: 2.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 17.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB025473	Uncertain				"Secreted in other tissues"					"CAB025473: "	"unprognostic (2.84e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.15e-1)"		"unprognostic (5.80e-3)"		"unprognostic (4.99e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.51e-1)"		"unprognostic (1.56e-1)"		"prognostic favourable (8.01e-4)"	"unprognostic (8.50e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	27.6	2.0	0.0	0.0	3.6	1.2	0.2	53.9	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.7	0.0	16.6	0.0	0.0	0.4	4.3	0.1	0.2	0.0	0.4	0.5	0.0	0.2	0.0	33.3	24.7	0.0	24.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KLK13	KLK-L4	ENSG00000167759	"Kallikrein related peptidase 13"	Q9UKR3	19	51056206-51065114	"Cancer-related genes, Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"esophagus: 100.5"	"Cell line enriched"	"Detected in some"	11	"HaCaT: 20.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 42.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA062136	Enhanced				"Secreted in other tissues"					"HPA062136: "	"unprognostic (1.99e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.66e-2)"		"unprognostic (3.43e-1)"		"unprognostic (2.99e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.18e-2)"	"unprognostic (8.30e-2)"	"unprognostic (7.07e-6)"	"unprognostic (7.33e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.38e-2)"	"unprognostic (7.06e-2)"	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.2	15.7	0.4	0.2	0.1	0.2	0.3	0.1	100.5	0.2	0.9	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.4	1.7	0.0	0.5	0.1	0.2	0.1	0.0	0.3	12.4	0.1	1.2	2.1	0.4	0.1	0.1	0.1	0.2	6.1	0.1	0.1	0.1	17.9	12.8	0.1	19.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	20.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.1
KLK14	KLK-L6	ENSG00000129437	"Kallikrein related peptidase 14"	Q9P0G3	19	51077495-51084245	"Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 14.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 13.7;HEK 293: 3.9;U-266/84: 7.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 26.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB026228	Uncertain				"Secreted in other tissues"					"CAB026228: "	"unprognostic (2.08e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.12e-2)"	"unprognostic (4.91e-2)"	"unprognostic (5.79e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.60e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.04e-8)"	"unprognostic (1.93e-1)"	"unprognostic (3.74e-3)"	"unprognostic (1.94e-2)"	"unprognostic (8.08e-2)"	0.2	0.0	0.4	0.2	1.2	0.1	2.7	2.1	0.9	3.8	0.6			1.8	0.4	0.9	1.2	0.8	0.3	1.1	0.6	0.5	0.1	0.1	0.5	0.4	0.3		0.9	0.4	0.0	0.3	0.0		0.7	0.4		1.1	0.7	0.3	14.2	1.0	0.0	0.3	0.4	0.8	0.7			0.1		0.6	0.2	3.9	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.7	0.7	0.1	0.9	0.6	0.6	0.7	0.2	0.0	0.0	0.2	1.7	2.1	0.8	0.6	0.3	13.7	0.2	0.3	0.0	0.5	3.9	0.3	1.0	0.0	0.2	0.3	0.3	0.4	0.4	0.5	0.6	0.2	0.3	0.5	0.0	1.2	0.2	0.8	0.8	1.5	0.2	0.1	0.8	0.0	0.7	0.1	0.0	0.3	1.2	0.4	0.6	0.0	0.0	0.2	0.6	0.9	0.2	3.6	7.1	0.5	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0										
KLK3	"APS, PSA"	ENSG00000142515	"Kallikrein related peptidase 3"	P07288	19	50854915-50860764	"Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	115	"prostate: 447.4"	"Group enriched"	"Detected in some"	135	"BEWO: 21.9;NB-4: 18.5;RPMI-8226: 12.2;SH-SY5Y: 7.3;U-2197: 7.5"	"Cancer enriched"	"Detected in some"	3905	"prostate cancer: 4241.6"	"Region enriched"	"Detected in single"	8	"cerebral cortex: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB000070, HPA000764"	Enhanced				"Secreted in male reproductive system"					"CAB000070: , HPA000764: AB_1079700"	"unprognostic (5.06e-3)"	"unprognostic (5.60e-2)"	"unprognostic (9.93e-2)"	"unprognostic (3.90e-2)"		"unprognostic (1.09e-2)"				"unprognostic (1.26e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.13e-3)"	"unprognostic (1.94e-1)"	"unprognostic (4.64e-1)"	"unprognostic (3.15e-1)"		0.1	0.3	0.0	0.1	0.0	0.0	0.7	0.0	1.0	0.1	0.1	0.0	0.2	0.1	0.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	447.4	0.0	0.1	3.8	1.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.5	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0
KLK5	"KLK-L2, SCTE"	ENSG00000167754	"Kallikrein related peptidase 5"	Q9Y337	19	50943303-50953093	"Cancer-related genes, Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"skin 1: 69.2;tongue: 67.3"	"Group enriched"	"Detected in some"	40	"A-431: 85.3;HaCaT: 83.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 112.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA014343, CAB025503, CAB026341"	Enhanced				"Secreted in other tissues"					"CAB025503: , CAB026341: , HPA014343: AB_1852603"	"unprognostic (3.19e-2)"	"unprognostic (1.06e-1)"		"prognostic unfavourable (2.33e-4)"	"unprognostic (4.30e-4)"	"unprognostic (3.01e-1)"		"prognostic unfavourable (9.79e-4)"	"unprognostic (3.04e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.70e-3)"	"unprognostic (2.21e-1)"		"unprognostic (2.76e-1)"	"unprognostic (2.53e-1)"	"unprognostic (9.16e-3)"	"prognostic unfavourable (3.85e-6)"	1.1	0.0	0.7	0.4	0.2	0.0	12.1	0.2	0.5	3.8	0.3	0.2	0.2	0.1	1.4	0.9	6.5	0.2	0.3	0.2	0.2	0.1	0.6	0.2	2.5	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.4	0.2	0.0	0.3	7.0	0.2	0.4	69.2	0.2	0.2	0.2	0.2	0.0	3.3	0.2	0.4	0.3	67.3	4.4	0.2	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	83.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.2	0.5	0.2	0.1	0.2	0.2	0.4	0.2
KLK9	KLK-L3	ENSG00000213022	"Kallikrein related peptidase 9"	Q9UKQ9	19	51003111-51009634	"Cancer-related genes, Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"tongue: 37.6"	"Group enriched"	"Detected in some"	27	"HaCaT: 1.2;HBEC3-KT: 4.1"	"Cancer enriched"	"Detected in single"	6	"head and neck cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											CAB025049	Enhanced				"Secreted to digestive system"					"CAB025049: "						"unprognostic (3.22e-2)"												0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	37.6	3.8	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KNG1	"BDK, BK, KNG"	ENSG00000113889	"Kininogen 1"	P01042	3	186717276-186744410	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis, Inflammatory response"	"Protease inhibitor, Thiol protease inhibitor, Vasoactive, Vasodilator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 323.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 5.1;Hep G2: 4.4;HL-60: 2.4;RH-30: 3.9;SiHa: 2.6"	"Cancer enriched"	"Detected in some"	126	"liver cancer: 608.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 2.3"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"			"HPA001616, HPA001645, CAB009809"	Enhanced				"Secreted to blood"	64000000000	64000000000			"CAB009809: AB_2134781, HPA001616: AB_1079216, HPA001645: AB_1079215"	"unprognostic (3.88e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.30e-3)"	"unprognostic (2.04e-1)"	"prognostic favourable (1.28e-6)"	"unprognostic (1.29e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.97e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.45e-3)"	"unprognostic (5.20e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.52e-2)"		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	41.9	323.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.4	2.3	0.2	0.7	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	1.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.4	0.1	4.4	0.0	2.4	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.1	0.7	0.0	0.1	3.9	0.0	0.2	0.0	0.5	0.1	2.6	0.4	0.0	0.1	0.0	0.8	0.0	0.2	0.0	0.0	0.9	0.0	1.9	0.0	2.0	0.0	2.3	0.2	0.3	0.3	0.1	0.0	0.2	0.1	0.1	0.0	0.5	0.1	0.2	1.6	0.7	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0
KRTDAP	"KDAP, UNQ467"	ENSG00000188508	"Keratinocyte differentiation associated protein"	P60985	19	35487324-35495558	"Plasma proteins, Predicted secreted proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 110.5;skin 1: 326.3;tongue: 234.9"	"Cell line enriched"	"Detected in single"	55	"hTCEpi: 41.5"	"Group enriched"	"Detected in many"	7	"head and neck cancer: 486.4;melanoma: 207.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA063474	Enhanced				"Secreted in other tissues"	62000000	62000000			"HPA063474: "	"unprognostic (4.55e-2)"	"unprognostic (2.46e-1)"		"unprognostic (1.64e-1)"		"unprognostic (6.11e-2)"		"unprognostic (1.59e-1)"	"unprognostic (8.80e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.16e-2)"	0.2	0.0	0.2	0.2	0.2	0.1	29.4	0.2	0.2	110.5	0.2	0.2	0.2	0.0	8.2	0.2	5.7	0.1	0.3	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.6	0.2	0.2	0.0	0.2	11.3	0.2	1.4	326.3	0.2	0.2	0.2	0.2	0.0	0.2	0.2	3.5	0.2	234.9	5.5	0.2	77.8	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	41.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
LALBA	LYZL7	ENSG00000167531	"Lactalbumin alpha"	P00709	12	48567684-48570066	"Cancer-related genes, Predicted secreted proteins"	"Lactose biosynthesis"	"Milk protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	194	"breast: 217.7"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.5;MCF7: 1.3"	"Cancer enriched"	"Detected in single"	599	"breast cancer: 29.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB026343, HPA029855, HPA029856"	Enhanced				"Secreted in female reproductive system"					"CAB026343: , HPA029855: AB_2673222, HPA029856: AB_10671362"															"unprognostic (7.85e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	217.7	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
LAMC2	"BM600-100kDa, EBR2, EBR2A, kalinin-105kDa, LAMB2T, LAMNB2, nicein-100kDa"	ENSG00000058085	"Laminin subunit gamma 2"	Q13753	1	183186238-183244900	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 48.3;CAPAN-2: 43.7;HBEC3-KT: 216.9;hTERT-HME1: 133.9;RPTEC TERT1: 52.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 231.3"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004257, HPA024638, CAB078165"	Enhanced		Approved	Cytosol	"Secreted to extracellular matrix"			Cytosol		"CAB004257: AB_627873, CAB078165: , HPA024638: AB_1852689"	"unprognostic (7.27e-3)"	"unprognostic (7.21e-3)"	"unprognostic (3.24e-1)"	"unprognostic (6.20e-3)"	"unprognostic (9.43e-2)"	"unprognostic (4.94e-3)"	"unprognostic (4.12e-2)"	"prognostic unfavourable (4.20e-6)"	"unprognostic (1.25e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavourable (7.11e-5)"	"unprognostic (2.77e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.26e-1)"	2.6	0.0	1.0	20.6	4.1	0.0	11.4	3.6	1.2	8.7	8.4	0.9	2.4	0.9	6.6	2.9	6.5	19.0	12.8	1.8	0.7	0.1	10.5	0.8	18.3	3.3	1.6	1.1	1.9	2.9	0.0	7.0	21.2	1.5	3.7	6.8	0.9	11.2	3.2	1.3	12.8	14.3	1.8	0.7	0.7	7.6	1.9	0.9	3.5	9.8	10.0	15.6	3.4	4.8	0.9	0.8	1.7	0.5	0.4	0.6	0.1	48.3	2.2	0.0	0.0	0.4	1.0	3.5	0.3	0.4	0.1	0.0	3.5	43.7	0.0	18.6	0.1	21.8	0.0	216.9	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	16.8	0.5	133.9	2.8	0.0	0.0	0.2	0.1	0.0	0.0	0.3	3.1	0.0	0.1	0.0	52.0	12.6	2.7	0.0	1.2	0.0	0.0	0.1	0.2	0.3	0.2	2.6	1.3	0.6	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.4	0.6	0.4	0.3	0.4	0.5	0.4	0.4	0.1	0.9	0.5	0.6	1.7	0.4	0.5	0.8	0.3	0.1	1.0	4.1	3.6	1.2	0.7	0.1	1.6	1.1	1.5	0.9
LBP	BPIFD2	ENSG00000129988	"Lipopolysaccharide binding protein"	P18428	20	38346356-38377023	"Plasma proteins, Predicted secreted proteins, Transporters"	"Immunity, Innate immunity, Lipid transport, Transport"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	33	"liver: 429.7"	"Group enriched"	"Detected in some"	10	"ASC diff: 12.1;HSkMC: 14.3"	"Cancer enriched"	"Detected in many"	20	"liver cancer: 356.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001508, CAB025905"	Approved				"Secreted to blood"	910000000	910000000			"CAB025905: , HPA001508: AB_1079241"	"unprognostic (4.20e-2)"	"prognostic unfavourable (5.56e-4)"	"unprognostic (4.54e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.53e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.48e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.93e-2)"	"unprognostic (2.62e-1)"	"prognostic unfavourable (3.62e-12)"	"prognostic unfavourable (5.76e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.67e-1)"	12.8	0.0	0.1	4.7	0.1	0.0	0.7	0.1	0.1	0.6	0.4	0.1	0.1	0.0	0.4	0.2	0.1	0.0	0.1	0.4	0.1	0.0	3.1	429.7	0.1	0.5	0.1	0.1	0.2	0.2	0.0	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.1	4.0	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	1.4	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.1	0.1	0.0	12.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.1	14.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.1	0.2	0.2	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
LCN1	"MGC71975, PMFA, TLC, TP, VEGP"	ENSG00000160349	"Lipocalin 1"	P31025	9	135521438-135526532	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Sensory transduction, Taste, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"tongue: 204.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.3;U-87 MG: 2.0"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 3.1"	"Region enhanced"	"Detected in single"		"hippocampal formation: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"								"Secreted in other tissues"	20000000	20000000				"unprognostic (5.50e-3)"		"unprognostic (1.10e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.08e-2)"		"unprognostic (1.11e-4)"	"unprognostic (1.22e-1)"	"unprognostic (7.84e-2)"	"unprognostic (9.47e-2)"		"unprognostic (3.94e-8)"	"unprognostic (2.07e-3)"	"unprognostic (3.03e-2)"		"unprognostic (5.83e-2)"	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.1	0.0	16.8	3.3	0.0	0.7	2.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.3	0.0	2.2	0.4	0.0	0.1	0.0	0.0	0.4	15.8	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	204.2	33.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	2.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.6	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.3	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	2.0	0.0	0.1	0.0	0.0	0.0
LCN10		ENSG00000187922	"Lipocalin 10"	Q6JVE6	9	136738167-136743356	"Predicted secreted proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"epididymis: 21.8"	"Cell line enhanced"	"Detected in some"		"HeLa: 3.7;Hep G2: 1.3;REH: 2.0;RPMI-8226: 2.5"	"Cancer enriched"	"Detected in single"	8	"thyroid cancer: 1.2"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	21	"memory B-cell: 5.5;naive B-cell: 6.2"	"Lineage enriched"	"Detected in single"	22	"B-cells: 6.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA055919	Approved				"Secreted in male reproductive system"					"HPA055919: "	"unprognostic (2.02e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.85e-2)"	"unprognostic (6.54e-3)"	"unprognostic (2.22e-4)"	"unprognostic (4.54e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.14e-3)"	"unprognostic (2.96e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.52e-1)"	"unprognostic (8.32e-2)"	"unprognostic (3.86e-1)"	2.8	0.0	0.5	1.4	0.5	0.2	2.2	0.5	1.0	6.2	0.9	0.7	3.2	0.2	7.2	21.8	0.8	7.8	1.2	4.5	0.5	0.0	0.5	0.5	0.5	0.8	0.5	0.5	1.8	1.5	0.0	0.5	0.5	0.5	2.1	0.6	0.5	1.2	0.8	0.6	0.2	2.0	2.5	0.5	1.4	1.5	2.1	0.5	0.5	4.3	0.5	0.9	2.1	2.6	6.2	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.7	0.5	0.0	2.0	0.0	2.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	6.2	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.5	0.5	0.5	1.0	0.5	0.0	0.5	0.5	0.5	0.5
LCN15	"PRO6093, UNQ2541"	ENSG00000177984	"Lipocalin 15"	Q6UWW0	9	136759634-136766255	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 4.9;ductus deferens: 12.0;intestine: 16.5;seminal vesicle: 5.3"	"Cell line enriched"	"Detected in some"	7	"Hep G2: 19.2"	"Cancer enriched"	"Detected in some"	19	"colorectal cancer: 23.0"	"Group enriched"	"Detected in some"	6	"amygdala: 2.4;cerebral cortex: 4.9;hippocampal formation: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in single"			HPA060584	Enhanced				"Secreted in other tissues"					"HPA060584: "			"unprognostic (5.24e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.14e-1)"					"unprognostic (3.67e-1)"		"unprognostic (3.45e-2)"		"unprognostic (3.28e-2)"	"unprognostic (2.39e-1)"		"unprognostic (1.83e-1)"	0.1	0.0	2.4	0.1	0.4	0.0	0.1	0.1	4.9	0.1	12.8	0.1	12.0	16.5	0.1	2.0	0.1	0.0	0.1	1.9	1.7	0.1	0.1	0.1	2.0	0.1	0.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.6	2.6	0.1	0.1	5.3	1.3	0.0	5.2	0.1	0.7	0.3	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.4	0.1	4.9	1.7	0.1	0.5	0.1	0.1	0.1
LCN2	"24p3, NGAL"	ENSG00000148346	"Lipocalin 2"	P80188	9	128149071-128153455	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Apoptosis, Immunity, Innate immunity, Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 199.7;gallbladder: 173.3;lymphoid tissue: 178.1;salivary gland: 168.7"	"Group enriched"	"Detected in some"	11	"CAPAN-2: 271.0;EFO-21: 111.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	65	"basophil: 5.4;neutrophil: 11.4;non-classical monocyte: 4.5"	"Group enriched"	"Detected in many"	72	"granulocytes: 11.4;monocytes: 4.5"									"HPA002695, CAB016549, CAB016550"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted in other tissues"	870000000	870000000	"Endoplasmic reticulum"		"CAB016549: , CAB016550: , HPA002695: AB_1852758"	"prognostic favourable (9.61e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.38e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.33e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.10e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.11e-2)"	0.3	0.5	0.2	24.6	0.3	199.7	2.7	0.2	0.5	78.7	19.4	1.0	0.5	2.4	7.9	9.1	77.0	4.0	173.3	20.4	0.2	0.2	12.7	12.8	32.6	0.2	0.2	0.1	6.7	17.4	0.0	5.4	7.1	0.8	17.0	10.5	1.0	168.7	0.9	1.0	3.1	17.0	0.7	0.2	8.1	35.1	5.8	0.1	5.0	3.8	142.0	178.1	68.9	48.5	0.0	0.0	11.4	4.5	0.0	0.1	9.6	8.5	2.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	271.0	0.0	111.0	0.0	17.7	0.0	0.5	0.0	0.3	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	4.9	0.0	0.6	0.1	0.0	0.2	1.2	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.1	5.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	4.5	0.0	0.0	9.6	0.2	0.3	0.2	0.5	0.2	0.2	0.2	0.1	0.8	0.1
LCN9		ENSG00000148386	"Lipocalin 9"	Q8WX39	9	135663322-135666422	"Predicted secreted proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"ductus deferens: 17.2;epididymis: 5.0;seminal vesicle: 7.7"	"Cell line enriched"	"Detected in some"	15	"BEWO: 19.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA060941	Enhanced				"Secreted in male reproductive system"					"HPA060941: "					"unprognostic (7.64e-4)"													0.3	0.0	0.5	0.0	0.5	0.0	0.0	0.2	2.1	0.2	0.0	0.1	17.2	0.0	0.0	5.0	0.0	0.5	0.0	0.1	0.5	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	7.7	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.2	0.4	0.5	0.3	0.9	0.0	0.1	0.0
LDLRAD2		ENSG00000187942	"Low density lipoprotein receptor class A domain containing 2"	Q5SZI1	1	21812265-21825221	"Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.4;NTERA-2: 2.5;REH: 3.4;THP-1: 2.8;TIME: 6.1"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in some"		"basophil: 1.9;plasmacytoid DC: 2.5"	"Low lineage specificity"	"Detected in many"											HPA030478	Approved				"Secreted - unknown location"					"HPA030478: AB_10601541"	"unprognostic (4.16e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.13e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.22e-3)"	"unprognostic (1.35e-2)"	"unprognostic (4.85e-2)"	"unprognostic (7.52e-2)"	"unprognostic (3.80e-2)"	"unprognostic (5.34e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.04e-3)"	"unprognostic (7.39e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.94e-2)"	5.4	1.9	0.2	2.2	0.2	2.7	2.2	0.0	0.1	1.7	3.2			4.7	3.1	0.0	1.3	2.2	1.6	3.6	0.5	1.1	1.5	0.1	1.0	1.8	0.0		0.5	1.1	0.0	0.9	0.2		3.1	0.3		5.7	0.1	2.7	1.3	1.7	0.2	0.0	2.3	3.2	0.8			1.6		0.9	2.2	1.8	0.6	2.5	1.9	0.0	0.7	0.0	0.0	0.5	0.7	0.4	0.6	0.2	0.0	1.2	0.9	0.0	0.0	0.0	0.4	1.5	0.0	2.4	0.2	0.8	0.1	0.0	0.0	0.0	0.1	0.4	1.2	0.7	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.2	0.0	1.4	2.5	0.4	3.4	0.5	0.0	0.0	0.3	0.0	0.3	0.5	0.1	0.1	0.2	2.8	6.1	0.6	0.6	0.8	0.0	0.0	0.1	0.4	0.1	0.0	0.5	1.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	2.5	0.0	0.0										
LEAP2	LEAP-2	ENSG00000164406	"Liver enriched antimicrobial peptide 2"	Q969E1	5	132872322-132875046	"Plasma proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"liver: 52.4"	"Low cell line specificity"	"Detected in many"			"Cancer enriched"	"Detected in many"	17	"liver cancer: 40.0"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"	1300000	1300000				"unprognostic (2.14e-2)"	"unprognostic (8.78e-2)"	"unprognostic (4.75e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.78e-3)"	"unprognostic (6.53e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.62e-1)"	"unprognostic (7.08e-3)"	"unprognostic (2.91e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.11e-1)"	"prognostic favourable (2.68e-4)"	0.1	0.1	0.0	0.2	0.1	0.0	0.2	1.5	0.0	0.2	0.3			1.5	0.1	0.1	0.3	0.2	0.4	0.2	0.1	0.0	1.4	52.4	0.2	0.3	0.1		0.2	0.5	0.5	0.2	0.0		0.7	0.5		0.3	0.1	0.9	0.4	2.6	0.0	0.1	0.7	0.5	0.1			0.6		0.5	1.8	0.4	1.6	0.9	4.2	1.3	0.9	2.0	0.3	0.4	2.3	2.3	4.8	2.6	1.3	1.7	1.0	0.2	0.7	1.6	2.3	2.8	2.0	0.4	0.2	4.1	3.8	1.1	0.5	3.5	1.6	1.6	5.7	1.6	0.7	0.9	1.2	1.1	1.9	0.6	1.3	0.7	1.4	4.8	0.7	1.2	1.6	3.8	1.4	1.1	1.4	1.5	1.5	1.0	2.0	1.6	1.1	1.0	1.0	0.8	1.5	1.2	0.4	2.7	1.5	1.2	0.6	5.7	4.3	1.6	0.7	2.7	1.1	4.2	1.3	0.2	1.3	0.9	1.4	1.5	0.9	0.6	0.9	1.6	1.1	1.2	3.2	0.9	0.5	0.8	2.0	0.3										
LEFTY2	"EBAF, LEFTA, LEFTYA, TGFB4"	ENSG00000143768	"Left-right determination factor 2"	O00292	1	225936598-225941489	"Disease related genes, Predicted secreted proteins"		"Cytokine, Developmental protein, Growth factor"	"Disease mutation, Heterotaxy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"endometrium 1: 61.1;ovary: 80.0"	"Group enriched"	"Detected in some"	5	"NTERA-2: 24.7;RPMI-8226: 26.6"	"Cancer enriched"	"Detected in many"	8	"testis cancer: 41.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"											"CAB025801, HPA047883, HPA056210"	Approved				"Secreted in other tissues"					"CAB025801: , HPA047883: , HPA056210: "	"unprognostic (3.78e-2)"	"unprognostic (4.10e-3)"	"unprognostic (5.79e-3)"	"unprognostic (5.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.87e-2)"	"unprognostic (9.75e-4)"	"unprognostic (2.91e-1)"	"unprognostic (3.84e-1)"	"unprognostic (7.98e-2)"	"unprognostic (9.14e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.90e-4)"	"unprognostic (1.64e-3)"	0.5	0.4	0.1	0.3	0.2	0.0	0.5	0.1	0.2	15.2	0.5	0.7	0.1	0.0	61.1	4.5	0.2	1.1	0.1	0.8	0.4	0.0	0.4	0.1	0.7	0.1	0.2	0.1	80.0	0.1	0.0	8.5	16.3	0.6	0.9	0.0	0.9	0.1	4.4	0.2	0.0	0.2	14.7	0.1	0.1	0.0	1.8	0.1	0.3	0.1	0.1	0.1	0.3	0.5	0.5	0.0	0.9	0.0	0.1	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	24.7	0.0	0.0	0.0	26.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	1.4	0.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.7	0.8	0.1	0.0	0.0	0.0	0.6	0.1	0.2	0.1	0.2	0.4	0.0	0.2	0.1	0.6	0.1
LEP	"OB, OBS"	ENSG00000174697	Leptin	P41159	7	128241284-128257628	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes, Diabetes mellitus, Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"adipose tissue: 85.2;breast: 63.7;placenta: 24.3"	"Group enriched"	"Detected in some"	9	"BEWO: 6.8;HSkMC: 2.8"	"Cancer enhanced"	"Detected in some"		"breast cancer: 1.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 3.8"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB010490	Approved				"Secreted to blood"	26000000	26000000			"CAB010490: AB_2296951"	"unprognostic (8.19e-3)"	"unprognostic (5.33e-1)"	"unprognostic (1.60e-4)"	"unprognostic (1.19e-1)"	"unprognostic (7.99e-3)"	"unprognostic (1.83e-1)"		"unprognostic (6.56e-3)"	"unprognostic (1.98e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.84e-2)"	85.2	0.3	0.0	1.5	0.0	0.0	63.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.7	0.0	0.0	0.1	0.0	0.4	2.0	0.0	0.0	0.1	0.7	0.0	0.0	24.3	0.0	0.0	0.1	0.0	0.4	0.0	0.6	1.1	0.4	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	1.5	2.1	0.4	0.4	3.8	0.5	0.5	0.3	0.2	0.0	0.2	0.2	0.4	0.3	0.0	6.8	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.1	0.3	2.8	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.3	0.2	0.3	0.2	0.4	0.1	0.3	0.1	0.0	0.2	0.3	0.5	0.2	0.2	0.1	0.3	0.4	0.2	0.4	0.9	0.5	0.3	0.3	0.3	0.2	0.2	0.2	0.2	0.1	0.4	0.2	0.3	3.8	0.5	0.4	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LGALS3BP	"90K, BTBD17B, CyCAP, gp90, M2BP, MAC-2-BP, TANGO10B"	ENSG00000108679	"Galectin 3 binding protein"	Q08380	17	78971238-78980109	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 75.9;SK-BR-3: 172.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 30.2"	"Group enriched"	"Detected in all"	6	"monocytes: 10.6;T-cells: 30.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000410, HPA000554"	Uncertain				"Secreted to blood"	11000000000	11000000000			"HPA000410: , HPA000554: AB_1079246"	"unprognostic (1.23e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.22e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.55e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavourable (1.07e-6)"	"unprognostic (1.58e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.43e-2)"	34.8	60.8	10.0	18.7	16.2	9.0	28.4	3.7	21.4	36.4	40.9	49.8	32.9	61.9	31.9	43.8	34.2	32.2	85.0	73.4	12.9	16.5	27.9	23.6	33.7	11.2	28.7	10.1	45.9	17.2	18.6	36.7	43.1	31.6	39.9	16.2	35.0	100.6	39.8	5.0	9.3	56.5	20.0	43.6	17.3	62.1	29.7	20.8	25.3	37.1	21.3	21.3	30.4	30.8	2.0	3.1	2.0	10.6	3.3	30.2	10.0	41.7	26.2	0.6	0.9	13.1	15.5	12.8	5.7	3.8	30.5	60.4	10.6	75.9	0.2	36.4	2.7	17.7	4.4	16.4	0.8	0.1	31.4	3.2	22.7	42.6	31.5	0.0	2.7	26.0	9.3	16.1	1.1	0.8	0.3	0.1	6.7	6.0	11.8	0.5	1.2	16.7	8.4	18.3	0.4	11.4	36.3	21.2	24.2	5.1	172.9	67.9	5.0	1.4	1.5	23.5	16.1	0.5	19.2	0.0	0.2	0.2	29.9	8.3	22.4	0.3	7.5	2.0	5.2	10.6	10.8	2.0	18.6	7.6	3.1	1.1	30.2	14.0	0.6	3.3	4.9	0.2	10.0	10.0	10.0	16.2	3.7	21.4	12.9	16.5	28.7	10.1	31.6	20.8
LGI2	"FLJ10675, KIAA1916"	ENSG00000153012	"Leucine rich repeat LGI family member 2"	Q8N0V4	4	24998847-25030879	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"parathyroid gland: 113.9"	"Cell line enhanced"	"Detected in some"		"AF22: 22.2;HAP1: 4.0;RPMI-8226: 10.2;SCLC-21H: 14.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	10	"classical monocyte: 1.3"	"Lineage enriched"	"Detected in single"	10	"monocytes: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017140	Approved		Approved	Centrosome	"Secreted to blood"			Centrosome		"HPA017140: AB_1852833"	"unprognostic (1.62e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.20e-5)"	"unprognostic (3.99e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.72e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.38e-5)"	"unprognostic (5.78e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.06e-4)"	"unprognostic (5.03e-3)"	2.5	1.6	2.8	6.7	3.3	0.8	2.3	7.9	7.8	3.7	4.0	0.0	1.0	1.1	8.9	4.9	4.1	11.4	4.2	3.7	2.4	3.9	3.0	0.9	1.4	2.0	7.2	0.4	9.1	2.6	113.9	0.5	2.6	18.7	1.0	1.6	6.0	0.9	1.4	0.9	0.9	2.6	7.1	2.9	1.2	2.4	2.0	0.9	0.6	1.8	0.6	4.6	1.8	1.1	0.0	0.1	0.0	1.3	0.0	0.0	0.2	0.0	0.0	22.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.6	0.0	0.0	4.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.6	0.7	0.0	0.9	10.2	0.4	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	1.6	0.0	0.6	0.0	0.0	0.0	0.4	0.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.8	3.3	7.9	7.8	2.4	3.9	7.2	0.4	18.7	0.9
LHB	"CGB4, hLHB, LSH-B"	ENSG00000104826	"Luteinizing hormone beta polypeptide"	P01229	19	49015980-49017081	"Cancer-related genes, Disease related genes, Predicted secreted proteins"		Hormone	"Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"pituitary gland: 301.4"	"Cell line enhanced"	"Detected in many"		"A549: 6.5;U-266/84: 7.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.8;T-reg: 1.3"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.8"									"CAB022241, CAB022707, HPA038925"	Enhanced		Approved	Cytosol	"Secreted to blood"			Cytosol		"CAB022241: , CAB022707: , HPA038925: "	"unprognostic (8.12e-2)"	"unprognostic (3.59e-1)"	"unprognostic (2.34e-3)"	"unprognostic (1.41e-2)"	"unprognostic (8.89e-2)"	"unprognostic (6.25e-2)"	"unprognostic (3.90e-3)"	"unprognostic (5.69e-2)"	"unprognostic (7.04e-2)"	"unprognostic (6.06e-2)"	"prognostic unfavourable (6.78e-4)"	"unprognostic (2.47e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.46e-1)"	"unprognostic (9.52e-2)"	"unprognostic (4.86e-2)"	0.1	0.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	3.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.4	0.1	23.1	0.0	301.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.5	0.5	0.1	0.1	0.1	0.5	1.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	1.8	0.1	1.3	6.5	0.2	1.3	0.0	0.0	1.8	0.5	0.0	1.0	0.5	5.3	1.9	1.7	0.1	0.0	0.5	0.0	0.4	0.0	1.7	5.1	0.3	1.7	2.5	0.3	0.4	1.7	0.0	0.0	0.3	0.0	0.3	4.7	2.8	0.3	0.3	0.1	0.6	0.7	0.5	2.8	1.1	1.3	0.0	1.3	3.0	1.2	1.9	0.4	2.2	2.0	0.0	0.0	2.6	2.7	0.3	3.3	2.4	7.0	1.8	1.3	3.0	1.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.1
LIPC	"HL, HTGL"	ENSG00000166035	"Lipase C, hepatic type"	P11150	15	58410569-58569843	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 91.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.8;EFO-21: 5.2;Hep G2: 19.5;HMC-1: 5.7;MOLT-4: 4.4;U-2197: 15.4"	"Group enriched"	"Detected in some"	14	"liver cancer: 20.4;renal cancer: 10.4"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"granulocytes: 3.7;NK-cells: 3.0;T-cells: 4.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"	3200000	3200000				"unprognostic (1.76e-2)"	"unprognostic (9.15e-3)"	"unprognostic (7.89e-2)"	"unprognostic (7.15e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.93e-3)"	"unprognostic (6.25e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.27e-2)"	0.2	0.1	0.4	1.1	0.7	0.0	0.7	0.1	0.4	0.3	0.2	0.6	0.0	0.7	0.1	0.4	0.2	0.4	0.3	0.3	0.4	0.2	3.0	91.7	0.3	0.2	1.2	0.2	0.3	1.0	0.0	1.0	0.1	1.5	0.3	0.3	0.5	0.1	1.5	0.1	0.3	0.3	0.1	1.2	0.4	0.2	0.1	0.5	2.7	0.5	0.0	0.1	1.1	0.2	0.1	0.2	3.7	0.4	3.0	4.5	2.5	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.7	0.0	0.0	6.8	0.0	0.0	5.2	0.2	0.0	0.0	0.0	0.0	0.4	0.0	2.4	0.0	19.5	0.4	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	4.4	0.6	0.0	0.0	0.9	0.3	0.0	2.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	15.4	0.0	0.0	0.0	0.1	0.1	0.4	0.0	3.7	0.3	0.0	3.0	0.2	4.5	0.0	0.8	2.2	0.2	0.1	1.0	3.2	0.4	3.0	0.4	0.1	2.1	2.5	0.4	0.7	0.1	0.4	0.4	0.2	1.2	0.2	1.5	0.5
LIPF	"HGL, HLAL"	ENSG00000182333	"Lipase F, gastric type"	P07098	10	88664441-88678814	"Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"stomach 1: 762.9"	"Cell line enhanced"	"Detected in some"		"HMC-1: 6.2;MOLT-4: 4.9;NTERA-2: 5.2;REH: 3.0;THP-1: 9.8;U-2 OS: 3.5;U-266/70: 4.8"	"Cancer enriched"	"Detected in some"	75	"stomach cancer: 278.5"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.9"	"Cell type enriched"	"Detected in single"	16	"eosinophil: 1.5"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 1.5"	"Region enriched"	"Detected in single"	51	"olfactory region: 9.9"					HPA045930	Enhanced				"Secreted to digestive system"					"HPA045930: AB_10959518"										"unprognostic (1.53e-1)"				"unprognostic (1.83e-1)"				0.1	0.0	0.1	0.1	0.5	0.0	0.1	0.1	1.9	0.1	0.2	28.2	0.1	8.2	0.1	0.1	31.6	0.1	0.6	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.1	9.9	0.1	0.1	0.0	0.1	0.1	0.1	0.1	762.9	0.1	0.1	0.2	0.1	1.1	0.1	0.1	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.1	5.2	0.0	3.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	3.5	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	1.9	0.1	0.0	0.1	0.1	0.1	0.1
LIPK	"bA186O14.2, LIPL2"	ENSG00000204021	"Lipase family member K"	Q5VXJ0	10	88724544-88752786	"Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	12	"skin 1: 27.1"	"Cell line enriched"	"Detected in some"	5	"SK-BR-3: 7.4"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted in other tissues"						"unprognostic (7.65e-2)"	"unprognostic (8.64e-2)"				"unprognostic (3.57e-2)"		"unprognostic (3.19e-7)"	"unprognostic (1.25e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.13e-1)"						"unprognostic (1.67e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	1.2	0.0			0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	1.1		0.0	0.0		0.1	0.0	0.0	27.1	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.1	0.0	1.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
LIPN	"bA186O14.3, LIPL4"	ENSG00000204020	"Lipase family member N"	Q5VXI9	10	88761406-88778242	"Disease related genes, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	Ichthyosis	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"blood: 12.5;skin 1: 25.5"	"Group enriched"	"Detected in some"	7	"Daudi: 3.2;HL-60: 9.4"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.6"					"Group enriched"	"Detected in many"	5	"classical monocyte: 4.8;eosinophil: 12.5;intermediate monocyte: 10.7;neutrophil: 7.7;non-classical monocyte: 11.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 12.5;monocytes: 11.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"						"unprognostic (2.01e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.13e-1)"		"unprognostic (2.99e-1)"	"unprognostic (1.08e-1)"		"unprognostic (3.27e-1)"	"unprognostic (1.07e-1)"		"unprognostic (2.03e-2)"		"unprognostic (9.75e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.40e-2)"	"unprognostic (5.77e-3)"	"unprognostic (1.65e-1)"	1.5	0.1	0.0	2.8	0.0	3.7	1.3	0.0	0.0	0.5	0.0			0.0	0.0	0.0	0.3	0.1	0.5	0.1	0.0	0.0	0.0	0.2	1.0	0.0	0.0		0.0	0.0	0.0	0.0	0.1		0.0	0.0		0.1	0.0	0.0	25.5	0.0	0.3	0.1	1.2	0.0	0.0			0.0		0.0	0.4	1.1	0.0	1.8	12.5	11.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	9.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	1.1	4.8	12.5	0.0	10.7	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	7.7	0.0	11.3	0.0	0.0	1.3										
LOX		ENSG00000113083	"Lysyl oxidase"	P28300	5	122063195-122078360	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		Oxidoreductase	"Aortic aneurysm, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ: 103.5;fHDF/TERT166: 157.7;HSkMC: 38.5;U-138 MG: 52.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043930			Supported	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	290000	290000	"Endoplasmic reticulum"		"HPA043930: "	"unprognostic (5.10e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.99e-3)"	"unprognostic (3.64e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.91e-1)"	"prognostic unfavourable (7.38e-4)"	"unprognostic (2.42e-3)"	"unprognostic (3.06e-3)"	"unprognostic (8.92e-2)"	"unprognostic (3.21e-3)"	"unprognostic (1.91e-1)"	"prognostic unfavourable (3.93e-8)"	"unprognostic (1.11e-3)"	"unprognostic (9.92e-2)"	"unprognostic (4.31e-2)"	"prognostic unfavourable (3.32e-4)"	33.8	1.8	1.0	7.2	1.2	0.0	37.4	0.9	0.9	16.1	11.7	0.1	4.1	3.8	6.3	20.1	11.1	7.6	12.8	21.4	1.2	1.3	6.5	2.4	20.6	4.3	0.9	1.1	15.7	6.0	0.8	1.5	14.8	1.6	11.2	3.0	3.2	3.4	3.5	12.7	11.3	4.5	9.5	1.5	7.7	4.0	10.6	0.1	0.7	10.8	4.2	2.7	36.9	10.4	0.0	0.1	0.0	0.0	0.0	0.7	0.9	0.1	0.0	0.2	0.1	18.0	21.3	0.0	103.5	21.8	8.0	28.2	0.1	0.0	0.0	2.4	157.7	0.0	0.4	0.2	17.2	0.0	0.3	0.0	2.0	0.8	22.8	0.0	0.0	38.5	0.4	13.3	0.5	10.0	0.0	0.0	9.3	0.0	0.0	0.0	0.7	0.3	0.0	0.8	0.0	0.4	0.0	0.0	0.5	7.3	0.0	0.6	0.0	0.0	0.8	52.4	3.5	31.0	1.4	0.0	0.0	0.0	22.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	1.0	1.2	0.9	0.9	1.2	1.3	0.9	1.1	1.6	0.1
LOXL1	"LOL, LOXL"	ENSG00000129038	"Lysyl oxidase like 1"	Q08397	15	73925989-73952137	"Disease related genes, Plasma proteins, Predicted secreted proteins"		Oxidoreductase	Glaucoma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 20.4;BJ: 23.6;BJ hTERT+: 27.0;U-87 MG: 22.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 6.5"	"Lineage enriched"	"Detected in single"	45	"T-cells: 6.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA042111, HPA063583"	Approved		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	120000	120000	"Endoplasmic reticulum"		"HPA042111: AB_10794412, HPA063583: "	"unprognostic (6.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.61e-2)"	"prognostic unfavourable (9.52e-5)"	"unprognostic (7.95e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.83e-2)"	"unprognostic (1.14e-3)"	"unprognostic (4.51e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.41e-2)"	"unprognostic (9.76e-2)"	9.4	2.5	2.4	6.7	1.2	0.9	5.0	0.4	1.8	19.3	7.0	1.6	7.0	2.3	12.3	8.4	9.9	6.9	12.4	19.1	2.4	1.6	7.9	1.3	7.0	13.6	1.3	1.6	9.6	3.0	3.8	7.4	16.1	4.4	14.8	1.7	26.7	5.7	15.5	4.2	4.7	5.3	26.6	2.1	2.8	6.5	3.7	1.3	1.2	3.9	10.5	10.4	16.9	11.7	0.1	0.0	0.0	0.0	0.0	6.5	0.6	1.1	0.0	0.3	0.0	16.9	20.4	0.8	23.6	27.0	10.0	17.8	0.4	0.6	0.0	4.4	17.3	7.0	0.1	0.0	2.4	0.0	1.5	0.1	0.7	0.1	2.3	0.0	0.0	16.7	0.0	7.5	0.0	0.3	0.0	0.1	11.9	0.8	0.1	0.4	2.2	16.1	0.0	14.0	0.2	0.9	4.2	2.0	0.0	0.7	0.1	0.0	0.1	0.0	1.7	19.7	17.5	15.4	8.9	0.0	0.0	0.0	22.6	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.9	0.1	2.9	1.5	0.0	0.1	0.7	0.8	0.0	0.0	0.0	0.0	6.5	0.6	2.4	1.2	0.4	1.8	2.4	1.6	1.3	1.6	4.4	1.3
LOXL4	"FLJ21889, LOXC"	ENSG00000138131	"Lysyl oxidase like 4"	Q96JB6	10	98247690-98268250	"Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 29.1"	"Group enriched"	"Detected in some"	5	"BJ hTERT+: 58.7;CAPAN-2: 70.5"	"Cancer enhanced"	"Detected in all"		"melanoma: 44.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.3;plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB033876, HPA037609"	Approved		Approved	Vesicles	"Secreted to extracellular matrix"			Vesicles		"CAB033876: AB_2135101, HPA037609: "	"unprognostic (9.91e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.43e-2)"	"prognostic unfavourable (6.49e-4)"	"unprognostic (7.71e-2)"	"unprognostic (1.75e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavourable (9.57e-4)"	"unprognostic (2.51e-1)"	"unprognostic (4.97e-2)"	"unprognostic (5.25e-2)"	"unprognostic (5.77e-3)"	"unprognostic (1.28e-1)"	"unprognostic (6.10e-2)"	"unprognostic (7.40e-3)"	6.3	1.8	1.1	1.1	4.2	0.1	10.7	1.0	1.7	20.7	7.3	4.6	1.4	1.4	8.0	4.6	2.3	7.4	4.6	1.8	1.6	0.3	4.4	29.1	3.1	0.6	1.1	1.2	6.1	14.5	1.7	1.4	5.1	8.2	5.1	1.5	3.2	15.7	10.7	14.7	3.1	2.5	7.1	3.0	1.8	2.3	10.8	1.0	1.4	5.7	1.9	1.7	3.1	6.0	0.8	1.2	0.1	0.2	2.3	0.0	0.0	0.0	0.3	0.0	0.0	1.6	7.2	0.2	7.4	58.7	0.6	6.4	1.2	70.5	0.0	6.8	5.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.0	3.0	1.6	0.0	0.0	0.8	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	13.3	0.7	0.2	0.0	0.0	0.0	0.1	0.0	8.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	2.3	0.0	1.2	0.0	0.0	1.1	4.2	1.0	1.7	1.6	0.3	1.1	1.2	8.2	1.0
LRCOL1		ENSG00000204583	"Leucine rich colipase like 1"	A6NCL2	12	132603150-132610543	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"epididymis: 54.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.7;BJ hTERT+ SV40 Large T+: 1.2;RPMI-8226: 1.0"	"Cancer enhanced"	"Detected in some"		"liver cancer: 3.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in male reproductive system"						"unprognostic (5.09e-3)"	"unprognostic (7.83e-3)"	"unprognostic (3.26e-1)"	"unprognostic (6.94e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.38e-2)"	"prognostic favourable (7.04e-4)"	"unprognostic (4.54e-2)"	"unprognostic (6.08e-2)"	"unprognostic (5.29e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.52e-1)"	"unprognostic (6.50e-6)"	"unprognostic (1.46e-3)"	"unprognostic (9.63e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.00e-3)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	4.4	0.1	0.0	54.8	0.0	0.2	0.4	0.0	0.2		0.1	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	1.9	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.7	0.5	1.2	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0										
LRG1	LRG	ENSG00000171236	"Leucine rich alpha-2-glycoprotein 1"	P02750	19	4536409-4540474	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"liver: 636.5"	"Cell line enhanced"	"Detected in some"		"Hep G2: 8.0;HMC-1: 8.2;SK-BR-3: 8.7;THP-1: 14.5;U-937: 26.8"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 160.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	19	"neutrophil: 58.9"	"Lineage enriched"	"Detected in many"	42	"granulocytes: 58.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA001888, HPA001889"	Enhanced		Approved	Vesicles	"Secreted to blood"	74000000000	74000000000	Vesicles		"HPA001888: AB_1079276, HPA001889: AB_1079275"	"unprognostic (5.54e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.46e-3)"	"unprognostic (9.83e-2)"	"prognostic unfavourable (3.66e-6)"	"unprognostic (4.06e-2)"	"unprognostic (1.45e-1)"	"prognostic favourable (3.49e-4)"	"unprognostic (2.60e-2)"	1.7	0.9	0.2	3.3	0.4	5.4	0.9	0.2	0.3	1.7	1.3	0.2	2.2	1.1	0.3	1.1	4.5	1.9	3.0	0.9	0.4	0.2	3.5	636.5	2.2	5.7	0.7	0.1	1.5	8.1	0.0	0.7	0.4	0.4	1.1	0.8	0.3	4.1	3.0	0.5	0.8	0.6	0.2	0.3	4.3	2.3	0.5	0.3	0.3	0.9	1.7	3.4	1.4	1.3	0.1	0.3	58.9	1.4	0.0	0.2	0.4	5.8	0.1	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.6	4.3	2.1	7.5	0.0	0.8	0.0	0.9	0.0	7.6	0.2	0.1	0.1	8.0	0.0	0.2	8.2	2.3	0.0	0.0	0.0	0.0	5.3	0.1	0.0	0.3	0.0	5.8	0.1	0.0	0.0	0.1	6.1	0.5	1.1	0.0	0.0	0.0	8.7	0.1	2.5	14.5	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	26.8	0.0	0.5	1.4	3.0	0.0	0.4	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	58.9	0.0	0.2	0.0	0.2	0.4	0.2	0.4	0.2	0.3	0.4	0.2	0.7	0.1	0.4	0.3
LRRC17	"H_RG318M05.3, P37NB"	ENSG00000128606	"Leucine rich repeat containing 17"	Q8N6Y2	7	102912991-102944949	"Predicted secreted proteins"	Osteogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 39.0"	"Cell line enriched"	"Detected in some"	5	"LHCN-M2: 168.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	17	"eosinophil: 12.0"	"Lineage enriched"	"Detected in single"	75	"granulocytes: 12.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA073458			Approved	"Vesicles,Cytokinetic bridge"	"Secreted in other tissues"			Vesicles	"Cytokinetic bridge"	"HPA073458: "	"unprognostic (1.77e-1)"	"unprognostic (7.73e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.76e-4)"	"unprognostic (6.09e-3)"	"unprognostic (2.26e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavourable (4.12e-6)"	"unprognostic (8.57e-3)"	"unprognostic (4.48e-2)"	"unprognostic (6.17e-2)"	"prognostic unfavourable (6.30e-4)"	5.1	1.3	1.1	0.5	1.2	0.0	6.2	1.4	2.0	15.0	1.4	1.5	5.6	0.5	8.3	17.1	5.2	8.9	13.5	6.4	1.2	1.3	1.5	1.4	1.6	1.6	1.1	2.1	39.0	2.6	1.2	1.7	1.8	2.5	7.8	1.4	2.7	2.8	2.5	5.3	2.0	2.6	5.1	1.2	1.2	3.5	5.1	0.2	2.2	2.6	6.7	1.3	6.7	4.2	0.1	0.1	12.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.8	4.2	0.0	0.2	2.4	0.0	0.4	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	3.9	0.1	2.9	0.0	19.1	0.0	0.0	168.8	0.0	0.0	0.0	0.4	0.0	0.0	33.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.2	2.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.1	1.2	1.4	2.0	1.2	1.3	1.1	2.1	2.5	0.2
LTA	"LT, TNFB, TNFSF1"	ENSG00000226979	"Lymphotoxin alpha"	P01374	6	31572054-31574324	"Cancer-related genes, Disease related genes, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"lymphoid tissue: 25.3"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 3.9;U-266/84: 1.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA007729	Uncertain				"Secreted to blood"					"HPA007729: AB_1852906"	"unprognostic (3.76e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.36e-3)"	"unprognostic (8.99e-5)"	"unprognostic (3.22e-1)"	"unprognostic (5.13e-3)"	"unprognostic (2.07e-1)"	"unprognostic (4.71e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.39e-4)"	"unprognostic (2.68e-2)"	"unprognostic (6.77e-2)"	"unprognostic (8.72e-12)"	"unprognostic (2.59e-1)"	"unprognostic (5.49e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.03e-1)"	0.4	0.1	0.2	25.3	0.6	1.1	0.1	1.3	0.2	0.2	0.5	0.1	0.0	0.1	0.1	0.1	0.9	0.2	0.1	0.1	0.2	0.1	0.3	0.4	2.0	7.2	0.1	0.0	0.3	0.1	0.1	0.1	0.3	0.0	0.6	0.4	0.2	2.4	0.5	0.3	0.2	2.8	0.2	0.3	10.0	0.4	6.0	0.0	11.2	0.2	0.5	17.5	0.7	0.1	0.2	0.0	0.5	0.6	0.1	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.8	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.6	0.5	0.1	0.6	0.0	0.1	0.0	0.2	0.6	1.3	0.2	0.2	0.1	0.1	0.0	0.0	0.0
LUM	"LDC, SLRR2D"	ENSG00000139329	Lumican	P51884	12	91102629-91111831	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"placenta: 344.8"	"Cell line enriched"	"Detected in some"	5	"BJ hTERT+: 182.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	103	"basophil: 10.2"	"Lineage enriched"	"Detected in single"	103	"granulocytes: 10.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001522, CAB025783"	Supported				"Secreted to extracellular matrix"	59000000000	59000000000			"CAB025783: , HPA001522: AB_1079285"	"unprognostic (5.54e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.87e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.20e-2)"	"prognostic unfavourable (1.75e-6)"	"unprognostic (5.25e-3)"	"unprognostic (2.27e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.06e-2)"	44.8	25.3	0.8	15.1	0.7	0.0	19.7	0.7	0.7	56.7	26.9	0.7	28.1	5.1	64.8	77.8	28.1	12.2	76.6	48.8	0.8	0.7	26.9	6.4	77.1	32.0	0.9	0.6	73.0	9.1	0.7	2.7	344.8	2.8	77.4	13.3	1.4	5.6	9.9	9.1	8.3	24.0	48.7	4.0	1.3	8.2	30.9	0.3	1.7	18.1	32.3	11.5	65.3	20.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	22.5	11.1	0.0	36.9	182.3	1.5	2.3	0.0	0.0	0.0	0.0	30.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.3	0.0	17.6	0.0	0.0	15.2	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.9	0.0	0.0	0.0	1.5	0.4	1.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.7	0.7	0.8	0.7	0.9	0.6	2.8	0.3
LY86	"dJ80N2.1, MD-1"	ENSG00000112799	"Lymphocyte antigen 86"	O95711	6	6588108-6654983	"Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 58.7;lymphoid tissue: 44.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 20.4;NB-4: 11.0;RPMI-8226: 66.3;THP-1: 26.6;U-937: 12.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 58.2;myeloid DC: 58.7"	"Group enriched"	"Detected in many"	43	"B-cells: 47.7;dendritic cells: 58.7;monocytes: 58.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025000, HPA044895"	Approved				"Secreted to blood"	83000	83000			"CAB025000: , HPA044895: "	"unprognostic (1.82e-1)"	"unprognostic (2.49e-3)"	"unprognostic (2.01e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.46e-3)"	"unprognostic (3.52e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (5.61e-4)"	"unprognostic (1.11e-1)"	"unprognostic (4.20e-2)"	10.2	5.0	9.9	18.2	12.9	11.5	2.9	1.6	5.3	3.9	3.2	15.4	0.0	1.5	1.8	1.5	2.0	2.8	7.4	2.5	8.9	7.0	2.8	5.2	13.3	31.2	16.5	4.1	2.1	2.0	0.8	2.8	6.3	9.3	2.5	4.3	2.3	4.5	3.0	0.9	1.5	13.0	4.6	19.9	44.6	2.5	1.1	12.7	2.9	1.7	0.3	32.7	8.4	1.7	47.7	58.7	1.2	58.2	0.7	0.7	25.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.0	0.0	0.0	2.3	0.0	66.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	12.5	0.0	0.5	58.2	0.4	0.1	32.1	0.1	47.7	0.1	0.1	58.7	35.6	0.7	0.4	1.2	0.7	11.6	2.3	0.2	25.7	9.9	12.9	1.6	5.3	8.9	7.0	16.5	4.1	9.3	12.7
LY96	MD-2	ENSG00000154589	"Lymphocyte antigen 96"	Q9Y6Y9	8	73991352-74029087	"Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 92.6"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 20.9;Karpas-707: 52.0;RPMI-8226: 25.1;U-87 MG: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 92.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 92.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053060			Approved	Vesicles	"Secreted to blood"	95000	95000	Vesicles		"HPA053060: "	"unprognostic (2.96e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.12e-3)"	"unprognostic (1.42e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavourable (6.38e-11)"	"unprognostic (2.87e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.90e-2)"	23.4	9.6	5.7	20.9	9.6	7.3	12.6	1.6	7.8	7.5	10.3	2.5	2.7	6.0	6.2	12.3	9.6	7.6	17.1	18.8	11.2	5.8	7.4	10.9	17.3	36.3	11.6	1.9	12.7	3.2	0.7	7.2	21.8	9.2	9.6	7.4	3.9	9.0	3.4	6.0	3.5	7.0	10.0	19.6	47.3	4.9	7.2	6.6	5.3	6.5	5.2	18.4	15.3	16.1	4.0	6.8	92.6	14.2	0.0	3.1	4.6	0.4	0.0	0.1	0.0	10.0	20.9	0.0	13.9	16.9	3.7	8.7	0.0	0.1	4.3	4.8	8.9	0.1	0.0	0.2	9.7	4.6	0.1	0.1	0.0	0.4	5.0	0.7	0.2	6.1	0.1	6.1	1.2	18.5	0.0	52.0	13.4	0.0	1.7	0.5	0.0	0.3	1.7	0.0	25.1	0.7	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.9	14.3	9.7	0.7	5.1	3.3	13.7	6.3	2.6	26.8	0.2	4.1	1.6	14.2	0.0	0.0	12.3	0.2	4.0	2.0	0.3	6.8	1.8	1.3	0.4	92.6	0.0	9.8	5.6	3.1	4.6	5.7	9.6	1.6	7.8	11.2	5.8	11.6	1.9	9.2	6.6
LYG1	SALW1939	ENSG00000144214	"Lysozyme g1"	Q8N1E2	2	99284238-99304742	"Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	7	"kidney: 22.5"	"Low cell line specificity"	"Detected in many"			"Cancer enriched"	"Detected in many"	15	"renal cancer: 31.5"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted - unknown location"						"unprognostic (1.53e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.53e-2)"	"unprognostic (3.73e-1)"	"unprognostic (9.74e-2)"	"unprognostic (3.76e-4)"	"unprognostic (6.94e-4)"	"unprognostic (2.58e-2)"	"unprognostic (4.72e-2)"	"unprognostic (9.74e-3)"	"unprognostic (5.01e-2)"	"unprognostic (1.06e-2)"	"prognostic favourable (8.44e-4)"	"unprognostic (1.31e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.31e-3)"	1.0	0.4	1.0	1.1	1.0	0.7	2.1	2.3	1.0	1.1	1.0	1.0	1.0	1.2	1.4	1.9	1.0	0.7	1.0	1.0	1.0	0.4	22.5	3.1	1.0	1.5	1.0	1.0	1.1	1.0	0.0	1.0	1.0	1.0	1.6	1.1	1.0	1.0	1.0	2.0	1.5	1.2	1.0	1.0	2.6	0.6	2.9	1.0	1.0	1.2	1.0	1.2	1.0	1.0	1.0	0.4	1.2	0.9	0.0	2.4	0.5	0.5	3.9	3.0	4.9	6.9	4.1	3.4	1.5	1.7	1.6	2.7	0.8	3.5	0.8	2.7	0.7	1.7	4.0	0.6	1.9	2.7	2.4	2.2	2.9	1.3	1.4	0.8	5.4	3.2	4.3	2.6	1.0	0.8	1.2	2.6	1.8	0.8	2.0	6.7	0.7	3.8	4.9	1.7	1.3	6.9	1.5	1.7	1.0	0.6	1.2	1.1	0.5	0.7	2.2	2.0	2.5	3.6	1.7	3.0	1.8	0.6	0.6	4.0	1.0	0.0	0.9	1.2	1.5	0.1	1.4	0.2	0.2	0.6	0.4	1.0	1.2	0.7	0.0	0.0	0.0	0.0	2.4	0.5	1.0	1.0	2.3	1.0	1.0	0.4	1.0	1.0	1.0	1.0
LYG2	LYGH	ENSG00000185674	"Lysozyme g2"	Q86SG7	2	99242246-99255282	"Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 4.0;skin 1: 13.0;testis: 4.8"	"Cell line enhanced"	"Detected in many"		"THP-1: 4.3;U-937: 6.1"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 4.0;dendritic cells: 2.9;T-cells: 2.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA039179	Uncertain				"Secreted in other tissues"					"HPA039179: AB_10794633"	"unprognostic (5.12e-2)"	"unprognostic (8.70e-3)"	"unprognostic (6.29e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.30e-5)"	"unprognostic (1.40e-3)"	"unprognostic (1.08e-13)"	"unprognostic (9.98e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.19e-2)"	"unprognostic (9.24e-3)"	0.5	0.5	0.1	0.4	0.7	1.7	0.0	0.7	0.7	0.0	0.1			1.1	0.0	0.0	0.0	0.1	0.6	0.1	0.1	0.1	0.0	0.0	0.0	0.8	0.1		0.0	0.0	0.0	0.4	0.0		0.1	0.0		1.1	0.0	0.9	13.0	0.2	0.0	0.0	0.5	0.5	4.8			0.3		0.0	0.0	0.0	4.0	2.9	0.3	0.7	0.5	2.5	0.0	0.8	1.1	1.0	1.2	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.9	0.7	2.2	0.5	0.0	0.5	0.0	0.0	0.3	1.1	0.2	0.5	1.2	0.3	0.0	1.1	0.8	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	2.5	0.5	1.5	0.8	3.1	0.6	1.5	1.2	2.9	0.8	1.2	0.3	0.2	0.2	0.0	0.9	4.3	1.6	1.7	1.2	0.2	1.0	0.6	2.0	0.3	0.8	6.1	1.2	0.0	0.7	0.3	1.2	0.2	0.6	1.9	2.5	1.4	0.2	4.0	1.0	0.9	0.3	0.5	0.0	2.9	0.4	0.0										
LYPD6	MGC52057	ENSG00000187123	"LY6/PLAUR domain containing 6"	Q86Y78	2	149329985-149474148	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 17.7;placenta: 22.7"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 18.3;fHDF/TERT166: 23.4;HBF TERT88: 12.9;LHCN-M2: 23.2;RT4: 19.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA042805	Enhanced		Approved	Cytosol	"Secreted in other tissues"			Cytosol		"HPA042805: AB_10794159"	"unprognostic (1.77e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.23e-3)"	"unprognostic (1.64e-2)"	"unprognostic (3.25e-1)"	"unprognostic (6.49e-3)"	"unprognostic (6.97e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.73e-2)"	"prognostic favourable (3.59e-4)"	"unprognostic (4.14e-3)"	"unprognostic (6.75e-2)"	"unprognostic (7.33e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.09e-1)"	"prognostic favourable (2.72e-4)"	2.6	1.0	8.7	1.8	7.9	0.4	14.6	3.3	8.2	2.0	4.4	4.3	1.1	2.8	4.0	1.0	1.2	2.9	17.7	1.4	6.2	11.5	3.4	0.8	1.3	0.8	6.2	5.3	1.4	3.2	2.6	0.9	22.7	7.2	2.5	4.1	2.8	0.8	2.6	0.7	1.4	5.6	4.7	5.1	1.3	6.2	4.5	2.6	0.0	0.6	0.0	2.3	4.4	1.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	3.4	18.3	0.0	0.0	0.2	7.4	3.2	9.5	6.0	0.1	1.5	0.0	0.4	23.4	1.9	2.6	0.0	12.9	0.0	0.8	0.0	4.8	0.0	0.1	0.0	0.0	0.0	0.2	0.0	5.7	0.1	0.0	0.0	23.2	2.9	0.0	1.7	2.6	2.1	0.0	10.1	0.0	1.1	19.1	0.7	3.3	5.0	5.7	0.6	0.7	0.3	0.0	0.2	2.9	0.2	4.0	0.0	0.0	0.0	1.8	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	8.7	7.9	3.3	8.2	6.2	11.5	6.2	5.3	7.2	2.6
LYPD8		ENSG00000259823	"LY6/PLAUR domain containing 8"	Q6UX82	1	248718649-248755739	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"intestine: 60.0;lymphoid tissue: 40.9"	"Cell line enhanced"	"Detected in some"		"NB-4: 1.1;THP-1: 2.5"	"Cancer enriched"	"Detected in some"	7	"colorectal cancer: 15.2"					"Group enriched"	"Detected in some"	6	"classical monocyte: 1.0;intermediate monocyte: 1.1;MAIT T-cell: 1.7;neutrophil: 2.3;plasmacytoid DC: 3.1"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in many"								"Secreted to digestive system"						"unprognostic (6.69e-3)"		"unprognostic (3.53e-2)"	"unprognostic (1.08e-5)"	"unprognostic (1.42e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.16e-4)"	"unprognostic (8.62e-2)"	"unprognostic (7.28e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.19e-4)"	"unprognostic (2.57e-1)"	"unprognostic (2.89e-1)"		"unprognostic (1.07e-1)"	0.0	0.0	0.0	40.9	0.0	0.0	0.0	0.0	0.1	0.0	60.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	36.8	0.0	0.0	0.0	0.0	0.0	8.1	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	3.1	2.3	1.1	0.0	1.7	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.5	0.0	0.0	0.3	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.1	1.1	1.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.3	0.0	0.0	3.1	0.0	0.2										
LYZ		ENSG00000090382	Lysozyme	P61626	12	69348341-69354234	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase"	"Amyloidosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 490.0;salivary gland: 1017.8"	"Group enriched"	"Detected in some"	6	"Hep G2: 126.5;THP-1: 65.3;U-937: 70.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 490.0;myeloid DC: 308.1"	"Group enriched"	"Detected in all"	18	"dendritic cells: 308.1;monocytes: 490.0"					"Not detected"	"Not detected"			"CAB000055, HPA048284, HPA066182"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Actin filaments"	"Secreted to blood"	2600000000	2600000000	"Golgi apparatus, Actin filaments"	Nucleoplasm	"CAB000055: AB_2341230, HPA048284: , HPA066182: "	"unprognostic (8.52e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.83e-1)"	"unprognostic (7.29e-2)"	"unprognostic (7.91e-2)"	"prognostic favourable (7.45e-4)"	"unprognostic (1.21e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.13e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.65e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.62e-2)"	19.1	2.4	1.7	42.1	1.8	187.0	2.9	1.6	1.6	2.9	52.5	2.0	0.1	72.4	2.3	6.9	3.9	3.4	105.0	15.4	1.8	1.8	4.8	4.8	81.0	57.2	2.1	0.0	4.5	5.0	0.0	1.8	8.3	0.9	2.4	5.0	2.7	1017.8	2.8	1.8	2.1	95.0	1.8	2.5	34.2	212.1	1.6	0.5	24.5	2.4	207.7	75.7	6.6	2.4	1.6	308.1	21.9	490.0	2.3	1.1	407.9	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.2	0.8	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	7.7	0.1	126.5	0.0	14.8	7.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.3	14.4	0.3	0.0	0.2	0.2	2.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	65.3	0.0	0.0	0.3	0.3	0.1	0.3	0.1	0.1	0.0	70.7	0.0	7.5	490.0	5.9	0.7	102.3	1.1	1.6	0.4	0.5	308.1	0.4	0.4	0.4	21.9	2.3	17.6	6.5	0.6	407.9	1.7	1.8	1.6	1.6	1.8	1.8	2.1	0.0	0.9	0.5
LYZL4	"LYC4, MGC26768"	ENSG00000157093	"Lysozyme like 4"	Q96KX0	3	42397078-42410600	"Predicted secreted proteins"	Fertilization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	59	"testis: 29.0"	"Cell line enhanced"	"Detected in some"		"HEL: 1.0;SK-BR-3: 1.2;WM-115: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA038806	Approved				"Secreted in male reproductive system"					"HPA038806: AB_10674841"					"unprognostic (4.03e-1)"							"unprognostic (5.68e-1)"		"unprognostic (1.06e-1)"				0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	29.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0
MAMDC2	MGC21981	ENSG00000165072	"MAM domain containing 2"	Q7Z304	9	70043581-70226970	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 22.6;HHSteC: 23.6;LHCN-M2: 29.4;TIME: 28.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	4	"NK-cell: 2.6"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 2.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA021814, HPA022249"	Uncertain		Approved	"Nuclear speckles,Plasma membrane"	"Secreted in other tissues"			"Nuclear speckles, Plasma membrane"		"HPA021814: AB_1853508, HPA022249: AB_2139157"	"unprognostic (1.88e-1)"	"unprognostic (3.16e-3)"	"unprognostic (2.21e-3)"	"unprognostic (2.71e-2)"	"unprognostic (4.30e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.27e-2)"	"unprognostic (8.25e-2)"	"unprognostic (5.91e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.67e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.23e-3)"	"unprognostic (2.35e-1)"	"prognostic unfavourable (7.78e-4)"	"unprognostic (2.79e-3)"	9.0	4.3	0.6	11.1	0.5	0.0	14.7	0.6	0.8	32.3	27.7	0.3	9.1	4.3	40.7	33.7	31.6	28.7	44.9	13.5	0.6	0.6	2.0	1.0	42.4	2.3	0.7	0.8	35.5	2.4	1.0	0.8	2.6	1.3	13.9	6.6	16.1	5.4	10.8	15.5	5.0	14.2	46.3	2.6	12.0	10.7	20.0	0.0	0.3	6.8	24.6	6.1	36.4	27.5	0.0	0.3	0.0	0.0	2.6	0.6	0.0	0.1	0.0	0.2	0.0	22.6	7.7	0.7	4.4	1.9	1.0	1.8	0.0	0.5	0.0	0.3	0.8	3.6	0.0	0.3	0.9	0.0	0.0	0.0	7.3	0.0	23.6	0.0	0.0	1.4	0.2	0.6	0.4	1.9	0.0	0.2	29.4	0.0	0.0	0.0	3.1	0.0	0.0	3.5	2.7	9.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	28.3	0.0	0.8	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.3	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.6	0.5	0.6	0.8	0.6	0.6	0.7	0.8	1.3	0.0
MAN2B2	KIAA0935	ENSG00000013288	"Mannosidase alpha class 2B member 2"	Q9Y2E5	4	6575175-6623362	"Enzymes, Plasma proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"								"Secreted to blood"	11000000	11000000				"unprognostic (1.30e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.28e-1)"	"prognostic favourable (7.59e-4)"	"unprognostic (1.09e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.66e-3)"	"unprognostic (2.18e-1)"	21.3	15.4	12.4	15.6	23.2	15.7	16.7	5.1	26.8	17.3	14.3	16.2	12.1	15.9	20.0	21.5	13.9	18.1	24.7	23.2	11.6	14.2	15.8	32.4	20.1	19.4	13.7	11.4	30.4	26.0	10.8	19.2	17.0	14.3	20.6	9.8	22.2	18.6	15.2	7.8	13.5	15.9	14.5	11.6	19.7	20.9	8.7	13.4	16.6	27.3	10.4	18.4	20.7	20.7	5.0	8.4	13.4	15.7	6.0	12.0	9.1	8.1	7.4	1.5	10.1	22.2	15.5	9.5	16.7	19.5	8.2	11.2	4.3	15.5	4.1	8.0	18.0	8.3	0.5	5.2	4.5	4.8	4.2	5.4	5.4	4.8	9.7	10.1	25.3	20.3	5.3	6.5	1.7	9.5	2.3	10.6	10.6	5.0	4.9	6.5	1.8	5.7	5.0	7.0	4.8	4.3	8.2	2.5	2.7	11.1	6.7	4.2	13.3	13.7	17.2	14.9	4.6	18.5	10.5	4.4	3.8	2.2	17.4	12.0	12.8	13.1	8.5	13.4	12.0	13.0	9.3	4.4	7.4	10.9	8.4	5.0	6.9	8.7	10.7	6.0	15.7	3.2	10.1	9.1	12.4	23.2	5.1	26.8	11.6	14.2	13.7	11.4	14.3	13.4
MANF	"ARMET, ARP"	ENSG00000145050	"Mesencephalic astrocyte derived neurotrophic factor"		3	51385047-51389397	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 32.7"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011175	Approved		Supported	"Endoplasmic reticulum"	"Secreted to blood"			"Endoplasmic reticulum"		"HPA011175: AB_1845039"	"unprognostic (2.90e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.84e-2)"	"prognostic unfavourable (9.58e-6)"	"prognostic unfavourable (7.48e-4)"	"unprognostic (7.37e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.10e-2)"	13.2	14.6	11.6	18.9	16.8	8.3	19.8	6.7	12.4	20.7	16.1	5.2	47.4	11.6	15.1	52.8	19.9	14.0	16.1	23.4	9.7	9.8	22.2	65.6	16.9	15.9	12.9	5.7	11.5	64.2	6.5	23.4	23.3	20.9	16.1	16.8	5.1	64.7	37.9	7.8	13.1	11.9	14.3	8.8	21.7	16.4	14.3	12.5	12.7	64.4	20.7	21.4	14.0	37.2	5.4	32.7	19.2	4.8	7.4	11.2	4.9	19.5	9.8	26.3	32.4	18.1	23.7	28.0	31.6	26.1	32.1	30.9	15.1	45.8	42.9	26.4	19.5	11.7	32.6	32.5	31.4	19.7	16.4	34.5	14.7	34.9	59.3	16.4	22.1	10.1	27.4	33.3	44.9	41.5	7.4	47.1	29.7	11.9	27.3	32.8	22.8	42.6	11.8	16.8	44.1	27.0	13.1	9.9	32.0	26.5	16.0	19.1	12.8	22.1	19.4	18.3	17.9	22.1	34.6	38.2	15.5	27.7	32.0	32.9	35.3	19.2	4.8	2.7	8.9	3.8	11.2	5.4	6.5	8.5	4.7	3.5	4.9	5.1	2.4	7.4	2.4	32.7	3.9	4.9	11.6	16.8	6.7	12.4	9.7	9.8	12.9	5.7	20.9	12.5
MASP2	MASP1P1	ENSG00000009724	"Mannan binding lectin serine peptidase 2"	O00187	1	11026523-11047233	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	98	"liver: 185.1"	"Cell line enriched"	"Detected in many"	7	"Hep G2: 20.1"	"Cancer enriched"	"Detected in some"	71	"liver cancer: 41.9"	"Region enriched"	"Detected in single"	4	"cerebellum: 1.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA029313, HPA029314"	Uncertain		Supported	"Golgi apparatus"	"Secreted to blood"	880000000	880000000	"Golgi apparatus"		"HPA029313: AB_10669654, HPA029314: AB_10670029"	"unprognostic (7.00e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.26e-3)"	"prognostic favourable (1.60e-4)"	"unprognostic (2.92e-3)"	"unprognostic (3.13e-2)"	"unprognostic (4.04e-2)"	"unprognostic (6.90e-3)"	"unprognostic (8.30e-4)"	"unprognostic (7.14e-2)"	"unprognostic (3.91e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-4)"	0.3	0.2	0.3	0.4	0.3	1.8	0.3	1.7	0.5	0.3	0.3	0.3	0.3	0.3	0.4	0.3	0.3	0.4	0.3	0.3	0.3	0.1	0.3	185.1	0.3	0.6	0.3	0.3	0.5	0.4	0.0	0.3	0.3	0.3	0.3	0.0	0.3	0.7	0.3	1.4	1.4	0.5	0.3	0.3	0.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	1.4	1.2	1.2	0.2	0.8	1.3	0.0	0.5	0.3	2.9	1.6	0.0	0.1	0.4	0.8	0.0	0.0	0.0	1.3	1.1	2.3	0.6	0.0	0.7	0.0	0.0	0.0	0.6	2.3	1.4	2.5	20.1	0.0	2.1	1.6	0.0	0.0	0.1	0.0	0.0	0.8	0.5	0.0	0.6	0.6	1.1	0.4	0.6	1.8	1.0	0.5	0.0	1.4	1.8	0.7	0.9	0.5	0.5	0.6	1.3	1.1	0.9	0.6	1.0	0.6	0.7	1.1	1.7	0.6	1.9	0.4	1.2	0.2	1.1	0.7	0.1	1.0	0.7	0.9	0.8	0.5	1.4	1.3	1.3	0.2	0.8	0.2	1.2	0.1	0.0	0.3	0.3	1.7	0.3	0.3	0.1	0.3	0.3	0.3	0.3
MATN1	"CMP, CRTM"	ENSG00000162510	"Matrilin 1, cartilage matrix protein"	P21941	1	30711277-30723587	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 6.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 3.4;Karpas-707: 3.4"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 1.3"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 3.0"	"Group enriched"	"Detected in many"	10	"B-cells: 3.0;T-cells: 2.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA028580	Supported				"Secreted to extracellular matrix"					"HPA028580: AB_10601913"	"unprognostic (4.71e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.75e-6)"	"unprognostic (9.93e-2)"	"unprognostic (4.10e-1)"	"unprognostic (1.31e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.80e-1)"	"unprognostic (7.31e-2)"	"unprognostic (5.22e-2)"	"unprognostic (4.01e-13)"	"unprognostic (8.23e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.04e-2)"	"unprognostic (3.42e-2)"	0.4	0.4	1.1	1.0	0.7	2.6	0.4	0.4	1.7	2.0	0.4	0.4	0.4	0.3	1.7	0.6	0.4	0.9	0.7	0.4	1.2	1.1	0.4	0.4	6.6	2.0	1.1	0.4	2.9	0.6	0.0	1.1	1.1	0.4	0.5	0.0	0.4	1.4	0.4	0.4	0.9	0.5	0.4	1.4	1.4	0.5	1.0	0.4	0.4	1.4	0.4	0.4	0.5	1.2	3.0	0.1	0.2	0.1	0.0	2.3	0.6	0.9	0.5	0.2	0.9	0.2	0.0	0.3	0.5	0.2	0.1	0.0	0.1	1.4	0.7	3.4	0.1	1.3	0.2	0.1	0.2	1.5	0.4	1.3	1.0	0.1	0.0	0.4	0.9	0.0	0.0	0.0	0.9	0.0	1.9	3.4	0.0	1.4	0.1	0.2	0.2	1.0	0.5	1.4	0.5	0.0	0.4	0.4	0.6	0.5	0.4	0.7	0.4	1.2	0.6	0.3	0.8	0.2	0.8	0.8	0.1	0.3	0.0	0.6	2.0	0.0	0.1	0.0	0.5	0.0	0.9	0.9	0.6	0.5	0.0	3.0	2.3	1.2	0.2	0.0	0.0	0.1	0.8	0.6	1.1	0.7	0.4	1.7	1.2	1.1	1.1	0.4	0.4	0.4
MATN3	"EDM5, HOA"	ENSG00000132031	"Matrilin 3"	O15232	2	19992111-20012694	"Disease related genes, Predicted secreted proteins"			"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 19.5;placenta: 16.6"	"Cell line enriched"	"Detected in many"	6	"Hep G2: 55.1"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 13.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"cerebellum: 1.9;hypothalamus: 3.2"	HPA051250			Approved	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to extracellular matrix"			"Endoplasmic reticulum, Golgi apparatus"		"HPA051250: "	"unprognostic (3.47e-1)"	"prognostic unfavourable (1.41e-4)"	"unprognostic (7.57e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.33e-2)"	"prognostic unfavourable (8.62e-5)"	"unprognostic (1.27e-1)"	"unprognostic (4.84e-2)"	"unprognostic (7.40e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.11e-2)"	"prognostic unfavourable (4.74e-5)"	"unprognostic (2.51e-1)"	"unprognostic (7.04e-2)"	"unprognostic (3.15e-2)"	2.4	1.3	6.6	1.0	5.1	0.3	3.4	1.8	7.9	4.1	1.0	2.4	2.6	0.9	2.7	1.8	1.4	2.6	3.4	0.9	6.2	4.9	4.1	0.4	19.5	0.7	8.6	3.7	1.1	1.3	0.4	0.3	16.6	7.4	2.7	1.0	1.9	0.8	7.2	0.5	0.9	0.8	2.8	7.9	0.7	2.8	1.6	6.0	0.0	1.7	0.0	0.7	1.8	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.4	1.9	6.4	0.0	1.8	4.0	0.4	0.7	0.4	2.6	3.3	1.8	1.0	0.0	0.3	0.6	0.4	0.1	4.9	3.7	0.0	0.1	0.0	0.4	55.1	0.4	0.0	0.0	8.7	0.3	2.8	0.6	3.4	0.0	0.0	5.4	0.9	0.0	0.0	1.9	0.9	0.0	0.0	0.0	7.8	1.7	0.0	0.8	4.1	0.7	2.4	7.6	0.0	1.9	3.8	4.7	0.1	0.4	0.0	0.0	0.0	0.6	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.6	5.1	1.8	7.9	6.2	4.9	8.6	3.7	7.4	6.0
MATN4		ENSG00000124159	"Matrilin 4"	O95460	20	45293445-45308529	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"ductus deferens: 21.5;pancreas: 27.1;seminal vesicle: 17.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 3.1;NB-4: 6.9;SK-MEL-30: 2.2;U-937: 3.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to extracellular matrix"						"unprognostic (1.54e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.60e-2)"	"unprognostic (8.38e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.79e-2)"	"unprognostic (6.27e-2)"	"unprognostic (6.74e-3)"	"unprognostic (5.53e-1)"	"unprognostic (6.19e-3)"	"unprognostic (3.63e-6)"	"unprognostic (2.38e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.27e-1)"	"unprognostic (5.38e-2)"	0.6	0.0	0.1	0.0	0.2	0.1	2.4	0.0	0.2	1.4	0.0	0.0	21.5	0.0	0.6	0.6	0.2	0.1	0.1	1.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	27.1	0.0	0.3	0.0	0.1	0.2	0.0	1.9	1.5	17.7	0.0	4.1	0.0	0.0	0.3	0.0	0.4	1.6	0.0	0.2	0.1	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.1	0.4	0.4	3.1	0.3	0.1	0.3	0.0	0.0	0.0	1.0	0.2	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	6.9	0.3	1.0	0.0	0.1	0.0	0.3	0.2	0.5	0.0	0.1	0.3	2.2	0.1	0.6	0.0	0.2	0.9	0.0	0.1	0.1	0.6	0.2	0.2	3.5	0.7	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0
MBL2	"COLEC1, MBL"	ENSG00000165471	"Mannose binding lectin 2"	P11226	10	52765380-52771700	"Plasma proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Complement pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	825	"liver: 82.5"	"Cell line enriched"	"Detected in single"	10	"Hep G2: 6.9"	"Cancer enriched"	"Detected in single"	275	"liver cancer: 22.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"pons and medulla: 0.5"	"Region enriched"	"Detected in single"	35	"basal ganglia: 1.1"	"HPA002027, CAB016782"	Enhanced				"Secreted to blood"	1700000000	1700000000			"CAB016782: , HPA002027: AB_1079324"							"unprognostic (1.72e-2)"		"unprognostic (3.03e-1)"									0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	82.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MDK	"FLJ27379, MK, NEGF2"	ENSG00000110492	Midkine	P21741	11	46380756-46383837	"Cancer-related genes, Predicted secreted proteins"	Differentiation	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 115.9"	"Cell line enhanced"	"Detected in many"		"AF22: 75.8;NTERA-2: 88.8;REH: 129.2;SH-SY5Y: 110.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.6;neutrophil: 4.9"	"Group enriched"	"Detected in many"	5	"B-cells: 3.6;granulocytes: 4.9;T-cells: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010055, HPA057126"	Uncertain		Approved	Vesicles	"Secreted to blood"	1200000	1200000	Vesicles		"CAB010055: AB_627949, HPA057126: "	"unprognostic (8.87e-3)"	"unprognostic (6.65e-2)"	"unprognostic (4.02e-2)"	"unprognostic (7.24e-2)"	"prognostic unfavourable (5.48e-4)"	"unprognostic (1.90e-1)"	"unprognostic (5.67e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.15e-1)"	"prognostic unfavourable (3.06e-6)"	"unprognostic (8.78e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.12e-2)"	8.0	16.2	4.7	11.9	5.6	1.7	13.5	5.3	5.9	62.5	36.3	5.3	13.9	50.6	41.0	33.9	6.5	34.6	35.0	6.4	4.0	5.9	6.1	2.0	8.0	3.6	4.9	4.4	115.9	13.1	8.9	64.8	11.5	5.5	47.7	7.4	59.0	22.2	24.5	4.7	4.1	58.4	16.6	4.0	13.9	21.0	9.3	2.1	22.5	5.2	5.5	12.4	15.3	23.0	3.6	0.2	4.9	0.6	0.2	2.0	1.5	4.8	6.5	75.8	0.2	0.5	6.4	1.8	3.8	7.6	14.6	13.0	49.2	21.6	0.3	53.4	5.6	42.2	42.7	0.0	1.3	15.0	9.0	2.1	0.6	67.3	34.6	0.1	0.3	10.2	1.3	8.9	0.0	21.3	36.4	0.3	8.2	33.5	1.8	0.9	88.8	38.5	129.2	2.8	0.4	0.1	0.1	42.1	110.3	12.6	1.1	1.0	34.6	34.0	5.8	22.5	53.9	0.3	2.6	0.2	1.0	0.4	0.6	1.3	19.5	0.0	0.1	0.0	0.3	0.5	0.0	3.6	0.2	0.5	0.1	1.1	0.2	0.0	4.9	0.2	0.6	0.2	2.0	1.5	4.7	5.6	5.3	5.9	4.0	5.9	4.9	4.4	5.5	2.1
METTL24	"C6orf186, dJ71D21.2"	ENSG00000053328	"Methyltransferase like 24"	Q5JXM2	6	110245928-110358272	"Predicted secreted proteins"		"Methyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 2.8;fHDF/TERT166: 2.7;HHSteC: 3.2;SCLC-21H: 4.8;SH-SY5Y: 2.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"MAIT T-cell: 7.3"	"Lineage enriched"	"Detected in single"	34	"T-cells: 7.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA037441, HPA037442"	Uncertain				"Secreted - unknown location"					"HPA037441: AB_10670933, HPA037442: AB_10696931"	"unprognostic (6.62e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.31e-3)"	"unprognostic (5.02e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.46e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.54e-4)"	"unprognostic (4.08e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.78e-3)"	2.1	1.9	2.4	3.7	2.8	0.0	1.8	2.8	2.1	11.9	10.8	2.9	4.8	1.5	16.2	5.0	5.6	7.0	9.6	3.2	2.1	1.9	5.2	1.1	2.4	0.6	2.1	2.7	9.2	2.3	5.8	4.6	0.3	2.2	8.6	5.0	10.2	1.1	8.6	0.4	1.1	4.0	16.1	2.8	0.6	6.0	2.8	1.5	0.6	2.1	3.0	1.5	13.3	5.1	0.0	0.1	0.0	0.0	0.2	7.3	0.1	0.0	0.0	2.8	0.1	0.0	0.0	0.0	1.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	4.8	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	7.3	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	2.4	2.8	2.8	2.1	2.1	1.9	2.1	2.7	2.2	1.5
MFAP2	"MAGP, MAGP-1"	ENSG00000117122	"Microfibril associated protein 2"	P55001	1	16974502-16980835	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 51.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 48.1;ASC TERT1: 49.6;HUVEC TERT2: 50.7;SH-SY5Y: 42.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	7	"gdT-cell: 2.1"	"Lineage enriched"	"Detected in single"	7	"T-cells: 2.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA007354	Enhanced				"Secreted to extracellular matrix"					"HPA007354: AB_1079365"	"unprognostic (5.10e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.92e-2)"	"unprognostic (4.86e-1)"	"unprognostic (1.53e-3)"	"unprognostic (3.72e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.45e-3)"	"unprognostic (9.12e-2)"	"prognostic unfavourable (2.52e-8)"	"unprognostic (2.18e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.66e-3)"	13.1	1.6	0.2	6.0	0.4	0.0	20.8	0.4	0.8	24.8	5.0	0.5	6.7	1.6	28.7	14.0	5.7	6.6	29.7	29.6	0.6	0.3	3.4	0.8	12.5	1.2	0.3	1.0	23.6	33.9	0.0	4.7	51.7	1.8	16.9	1.7	15.4	6.9	5.0	4.6	10.9	4.3	18.3	2.9	1.3	3.5	10.4	0.3	0.7	3.8	7.4	3.3	10.3	13.2	0.3	0.0	0.0	0.1	0.0	2.1	0.2	0.0	0.0	18.7	0.0	48.1	49.6	1.2	4.7	19.7	7.4	14.5	4.3	0.2	0.0	16.4	16.5	0.0	1.3	1.5	3.0	0.0	14.6	0.0	6.9	0.4	4.5	0.0	0.0	20.3	3.7	20.9	8.3	50.7	0.0	3.1	3.6	2.2	0.0	0.0	21.9	0.1	0.2	0.0	0.6	0.2	0.0	1.0	42.6	1.6	7.1	1.8	2.4	2.5	14.1	13.0	27.1	10.4	0.5	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.4	0.8	0.6	0.3	0.3	1.0	1.8	0.3
MFAP4		ENSG00000166482	"Microfibril associated protein 4"	P55083	17	19383442-19387240	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 58.9;ASC TERT1: 90.0;fHDF/TERT166: 40.2;HHSteC: 41.2;HSkMC: 62.3;MOLT-4: 51.5;SH-SY5Y: 51.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"eosinophil: 2.3;intermediate monocyte: 4.0;non-classical monocyte: 4.2"	"Group enriched"	"Detected in many"	15	"granulocytes: 2.3;monocytes: 4.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA054097	Supported		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	140000000	140000000	"Endoplasmic reticulum"		"HPA054097: "	"unprognostic (3.02e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.39e-1)"	"unprognostic (8.56e-3)"	"unprognostic (9.80e-2)"	"prognostic favourable (3.51e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavourable (4.64e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (6.83e-7)"	"unprognostic (1.07e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.50e-2)"	"prognostic unfavourable (7.12e-4)"	41.5	10.0	1.3	37.3	4.1	0.0	34.9	1.3	3.7	62.5	44.8	5.1	18.1	12.1	64.3	58.7	64.2	32.2	150.2	46.9	1.8	1.3	15.9	12.0	106.1	10.7	2.4	5.8	57.6	8.5	0.0	15.8	43.3	6.8	102.4	17.2	102.5	16.3	16.6	18.7	25.9	43.8	88.9	3.2	7.6	31.4	26.2	1.3	8.4	20.3	55.3	39.0	79.2	73.7	0.0	0.2	2.3	4.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	58.9	90.0	0.1	6.4	23.0	0.6	0.4	0.0	0.0	0.0	0.0	40.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	41.2	1.9	0.0	62.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	51.5	4.7	1.0	0.0	3.6	3.6	0.0	0.0	0.0	5.2	51.3	0.0	0.0	0.0	0.0	11.6	0.0	7.5	0.5	0.3	0.0	0.0	0.0	0.0	7.2	2.1	0.0	0.0	0.3	2.3	0.0	4.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	1.3	4.1	1.3	3.7	1.8	1.3	2.4	5.8	6.8	1.3
MFGE8	"BA46, EDIL1, hP47, HsT19888, MFG-E8, OAcGD3S, SED1, SPAG10"	ENSG00000140545	"Milk fat globule-EGF factor 8 protein"	Q08431	15	88898683-88913411	"Cancer-related genes, Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Fertilization"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 177.8;ASC TERT1: 92.3;fHDF/TERT166: 62.5;HSkMC: 93.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 13.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 3.6;NK-cells: 6.3;T-cells: 13.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002753, HPA002807"	Supported		Approved	Cytosol	"Secreted to blood"	1100000	1100000	Cytosol		"CAB002753: , HPA002807: AB_1078072"	"unprognostic (1.28e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.63e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.11e-3)"	"unprognostic (6.27e-2)"	"unprognostic (8.49e-2)"	"unprognostic (3.99e-1)"	"prognostic unfavourable (6.06e-9)"	"prognostic unfavourable (3.08e-4)"	"unprognostic (4.85e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.41e-3)"	34.2	23.2	5.4	14.5	11.2	0.9	73.4	5.7	14.8	43.4	15.8	9.6	11.3	5.2	73.2	38.6	32.8	56.2	30.2	115.4	5.6	4.1	12.4	3.9	20.8	14.9	6.0	8.3	49.8	6.6	2.9	8.1	23.1	10.8	29.5	7.3	59.5	15.6	50.7	57.8	18.3	15.4	39.6	8.8	6.5	22.2	23.6	4.4	8.5	21.7	21.1	12.6	32.8	68.3	1.2	0.0	3.6	0.2	6.3	13.3	2.0	1.8	7.0	7.6	9.3	177.8	92.3	0.6	45.8	13.7	9.1	10.9	6.1	2.2	0.0	14.1	62.5	0.9	2.6	9.1	3.1	7.3	4.6	13.3	0.4	0.6	46.9	0.0	4.7	93.6	24.5	7.2	12.1	3.5	2.1	4.0	17.8	0.1	2.0	0.3	39.0	2.4	2.0	7.3	2.4	3.2	0.6	0.8	4.0	2.5	0.2	20.8	0.2	0.9	3.8	22.9	12.3	5.8	3.3	14.0	2.7	1.4	3.0	1.1	8.8	3.6	0.2	0.4	1.2	0.0	4.2	1.2	4.2	3.0	0.0	0.8	4.4	3.1	0.0	6.3	0.1	0.0	13.3	2.0	5.4	11.2	5.7	14.8	5.6	4.1	6.0	8.3	10.8	4.4
MIA	CD-RAP	ENSG00000261857	"Melanoma inhibitory activity"	Q16674	19	40771648-40777490	"Cancer-related genes, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 16.1;breast: 28.7;pituitary gland: 33.5;salivary gland: 22.7;stomach 1: 28.9"	"Group enriched"	"Detected in some"	35	"AN3-CA: 21.3;CAPAN-2: 17.8;SK-MEL-30: 62.1;WM-115: 58.8"	"Cancer enriched"	"Detected in many"	5	"melanoma: 58.6"	"Region enriched"	"Detected in some"	8	"midbrain: 16.1"	"Cell type enhanced"	"Detected in some"		"basophil: 1.6;neutrophil: 3.0"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.0"									HPA042369	Approved				"Secreted to blood"					"HPA042369: AB_10794420"	"prognostic favourable (2.08e-4)"	"unprognostic (1.30e-1)"	"unprognostic (3.15e-1)"	"unprognostic (9.02e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.37e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.19e-1)"	"unprognostic (3.29e-8)"	"unprognostic (5.88e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.56e-1)"	0.7	1.5	0.6	3.5	0.6	1.4	28.7	0.9	0.4	3.7	6.1	0.5	2.2	0.8	2.8	3.2	4.0	1.0	3.2	4.1	0.4	0.4	0.9	0.8	1.4	0.7	16.1	0.4	2.6	0.4	0.0	33.5	0.9	2.1	2.2	1.9	6.0	22.7	1.7	0.8	4.5	2.2	3.4	3.1	2.4	28.9	1.0	0.4	0.5	1.1	5.9	4.4	2.0	1.5	0.7	0.0	3.0	0.1	0.0	0.3	0.1	0.0	0.1	0.2	21.3	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.1	17.8	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	62.1	0.1	0.2	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.2	0.0	0.1	58.8	1.6	0.0	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	3.0	0.0	0.1	0.0	0.0	0.1	0.6	0.6	0.9	0.4	0.4	0.4	16.1	0.4	2.1	0.4
MLN		ENSG00000096395	Motilin	P12872	6	33794673-33804011	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	175	"intestine: 76.0"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.6;BEWO: 1.8;CACO-2: 7.4;RPMI-8226: 1.7;TIME: 3.4"	"Cancer enriched"	"Detected in some"	6	"testis cancer: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA069392	Enhanced				"Secreted to blood"					"HPA069392: "					"unprognostic (7.70e-2)"					"unprognostic (6.70e-2)"				"unprognostic (4.44e-2)"	"unprognostic (3.14e-1)"			0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	58.4	0.0	0.0	76.0	0.1	0.0	0.3	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	30.6	0.0	0.2	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	1.0	1.2	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	3.4	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0
MMP1	CLG	ENSG00000196611	"Matrix metallopeptidase 1"	P03956	11	102789920-102798160	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Collagen degradation, Host-virus interaction"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 62.4;stomach 1: 27.2"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 88.1;HBF TERT88: 87.3;HUVEC TERT2: 229.4;WM-115: 113.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 344.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA004920			Approved	Vesicles	"Secreted to extracellular matrix"	430000	430000	Vesicles		"HPA004920: "	"unprognostic (4.11e-3)"	"prognostic unfavourable (4.66e-4)"	"unprognostic (4.20e-3)"	"unprognostic (1.19e-3)"	"unprognostic (6.46e-2)"	"unprognostic (6.50e-2)"	"prognostic unfavourable (4.22e-6)"	"unprognostic (7.83e-3)"	"unprognostic (2.94e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.11e-3)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (9.86e-10)"	"unprognostic (1.67e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.26e-2)"	"unprognostic (5.11e-2)"	0.2	0.1	0.3	12.3	0.3	0.0	0.9	0.3	0.3	0.3	2.7	0.3	0.2	3.2	4.8	0.2	3.3	0.1	62.4	0.4	0.2	0.1	0.7	1.3	4.7	0.2	0.2	0.2	0.2	1.6	0.0	0.2	8.6	0.5	0.7	3.0	0.3	2.0	0.2	0.2	0.3	8.8	0.2	0.4	1.8	27.2	2.2	0.2	0.4	0.3	1.3	0.9	11.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.9	88.1	36.0	9.4	0.7	0.0	0.0	0.4	21.1	0.3	0.0	12.3	87.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	37.0	3.1	229.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	11.9	29.9	0.0	1.3	0.1	0.0	0.0	0.0	0.7	0.0	113.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.9	0.3	0.3	0.3	0.3	0.2	0.1	0.2	0.2	0.5	0.2
MMP10	STMY2	ENSG00000166670	"Matrix metallopeptidase 10"	P09238	11	102770503-102780628	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"endometrium 1: 89.4"	"Cell line enhanced"	"Detected in some"		"BJ: 12.3;HUVEC TERT2: 15.8;SCLC-21H: 5.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 102.2"	"Region enriched"	"Detected in single"	9	"pons and medulla: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							CAB002159	Uncertain		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"			Cytosol	"Plasma membrane"	"CAB002159: AB_564103"	"unprognostic (8.76e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.98e-3)"	"unprognostic (2.72e-3)"	"unprognostic (7.17e-3)"	"unprognostic (1.52e-2)"	"unprognostic (5.67e-8)"	"unprognostic (2.08e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.99e-5)"	"unprognostic (2.66e-2)"	"unprognostic (7.98e-2)"	"unprognostic (5.46e-2)"	"prognostic favourable (7.12e-4)"	0.1	0.1	0.0	2.6	0.2	0.1	0.1	0.0	0.3	1.7	0.5	0.0	0.0	0.4	89.4	0.1	0.2	0.1	0.5	0.1	0.0	0.1	0.1	3.6	11.0	0.1	0.0	0.0	0.5	0.3	0.1	0.9	19.8	2.8	3.2	0.2	0.0	2.9	0.1	0.1	0.1	0.7	0.1	0.0	0.2	3.3	0.5	0.0	1.2	0.1	0.0	1.9	0.6	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.2	0.0	0.0	0.2	12.3	0.7	0.1	0.1	0.3	0.0	0.0	3.6	1.9	2.8	0.0	1.4	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.6	15.8	0.7	0.0	0.0	0.0	0.0	0.3	2.9	1.7	0.0	0.0	0.0	0.0	0.7	5.0	0.0	2.5	0.0	0.0	0.0	0.0	2.0	3.8	1.2	0.4	0.5	0.0	0.0	0.0	0.6	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	2.8	0.0
MMP11	STMY3	ENSG00000099953	"Matrix metallopeptidase 11"	P24347	22	23768226-23784316	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"endometrium 1: 44.1;placenta: 119.6"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 18.9;BJ hTERT+: 5.1;REH: 7.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 7.8"	"Group enriched"	"Detected in many"	5	"B-cells: 2.4;dendritic cells: 7.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002593, HPA068864"	Approved				"Secreted to extracellular matrix"					"CAB002593: , HPA068864: "	"unprognostic (1.06e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.84e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.73e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.15e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.89e-3)"	"unprognostic (7.04e-2)"	"prognostic unfavourable (2.62e-4)"	"unprognostic (8.05e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.68e-2)"	1.7	0.6	0.2	1.0	0.6	0.1	1.6	1.0	0.5	13.4	1.8	0.4	0.4	1.9	44.1	1.1	0.8	2.2	2.0	3.1	0.5	0.0	1.7	0.5	0.7	1.8	0.4	0.2	7.7	1.1	0.2	0.3	119.6	0.5	1.4	1.0	0.8	2.5	0.4	0.5	2.0	4.0	2.7	0.3	0.9	0.7	3.4	0.2	2.6	0.5	0.6	0.9	1.6	2.1	2.4	7.8	0.0	0.0	0.0	1.0	0.1	0.1	0.0	2.3	18.9	2.9	4.2	0.0	0.2	5.1	0.6	0.4	0.0	0.6	0.6	3.5	1.3	0.1	1.0	0.0	0.2	0.0	0.3	0.0	0.0	1.0	2.1	0.0	0.0	2.7	0.4	0.5	0.0	3.0	0.3	0.0	0.7	0.1	0.0	0.0	0.7	0.1	7.9	0.0	0.2	0.3	0.0	3.0	5.1	1.9	0.3	0.0	1.8	0.0	1.3	0.3	0.0	0.8	0.0	0.1	0.1	2.5	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	2.4	1.0	0.3	0.0	0.0	0.0	7.8	0.0	0.1	0.2	0.6	1.0	0.5	0.5	0.0	0.4	0.2	0.5	0.2
MMP12	HME	ENSG00000262406	"Matrix metallopeptidase 12"	P39900	11	102862736-102875034	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 42.4;urinary bladder: 13.2"	"Group enriched"	"Detected in some"	12	"BJ: 4.1;fHDF/TERT166: 14.3;hTEC/SVTERT24-B: 8.2"	"Low cancer specificity"	"Detected in all"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted to extracellular matrix"						"unprognostic (7.33e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavourable (1.42e-4)"	"unprognostic (1.69e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.52e-3)"	"unprognostic (5.45e-2)"	"unprognostic (3.05e-6)"	"unprognostic (1.08e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.92e-2)"	2.7	0.0	0.0	21.2	0.0	0.0	0.0	0.0	0.0	0.3	6.9	0.0	0.0	3.3	0.0	5.9	0.0	0.0	1.0	0.0	0.0		0.0	0.4	0.6	18.9	0.0	0.0	0.1	0.0	0.0	0.0	9.7	0.0	0.3	8.4	0.0	0.9	0.0	0.0	0.0	3.8	4.6	0.0	42.4	1.3	0.1	0.0	5.5	0.0	1.5	9.9	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.4	0.2	0.0	0.1	0.0	0.0	0.0	14.3	0.5	0.0	0.0	0.4	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.6	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MMP13	CLG3	ENSG00000137745	"Matrix metallopeptidase 13"	P45452	11	102942995-102955734	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease mutation, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lung: 12.6;vagina: 10.8"	"Group enriched"	"Detected in some"	5	"HaCaT: 19.1;PC-3: 7.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 70.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB002742	Supported				"Secreted to extracellular matrix"					"CAB002742: "	"unprognostic (8.98e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.75e-2)"	"unprognostic (4.57e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.59e-3)"		"unprognostic (1.32e-1)"	"unprognostic (6.35e-3)"	"unprognostic (1.69e-1)"	"unprognostic (7.55e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.73e-8)"	"unprognostic (2.12e-2)"	"unprognostic (3.14e-1)"	"unprognostic (4.14e-2)"	"unprognostic (4.33e-2)"	0.5	0.1	0.0	0.8	0.0	1.3	0.4	0.0	0.2	1.3	0.1	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	12.6	0.1	0.0	0.0	0.1	0.0	0.0	3.1	0.1	0.1	1.2	0.0	0.0	0.6	0.0	0.0	1.0	0.5	0.0	0.0	0.1	0.1	1.9	0.0	1.4	0.0	0.0	0.1	4.6	10.8	1.0	0.7	2.7	0.5	1.9	1.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	7.2	0.0	0.0	0.1	0.0	1.9	0.0	0.1	0.1	2.2	0.0	0.0	0.0	0.0	2.7	1.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.7	0.5	0.6	1.3	0.4	1.0	0.5	0.7	0.8	0.3	1.0	0.6	1.1	1.9	1.9	0.3	0.7	0.4	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0
MMP19	"MMP18, RASI-1"	ENSG00000123342	"Matrix metallopeptidase 19"	Q99542	12	55835433-55842966	"Disease related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Angiogenesis, Collagen degradation, Differentiation"	"Developmental protein, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 60.7"	"Cell line enriched"	"Detected in many"	6	"BEWO: 55.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	16	"classical monocyte: 3.2;myeloid DC: 1.0"	"Group enriched"	"Detected in many"	16	"dendritic cells: 1.0;monocytes: 3.2"	"Region enriched"	"Detected in single"	6	"olfactory region: 8.8"	"Low region specificity"	"Detected in all"			HPA070804			Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	800000	800000	"Endoplasmic reticulum, Vesicles"		"HPA070804: "	"unprognostic (2.61e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.77e-3)"	"unprognostic (2.01e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.09e-1)"	"prognostic unfavourable (8.56e-9)"	"unprognostic (5.06e-3)"	"unprognostic (1.28e-3)"	"unprognostic (2.73e-2)"	"unprognostic (4.00e-2)"	60.7	1.9	0.2	10.9	0.7	0.0	9.9	0.2	0.5	7.6	3.9	0.4	1.4	0.8	12.7	6.0	3.6	11.8	30.3	4.7	0.6	0.1	4.1	3.0	14.0	15.5	0.5	0.2	7.4	8.1	0.0	0.5	24.5	1.0	2.9	2.8	3.1	2.0	3.5	2.1	2.7	4.1	7.7	0.8	27.4	5.0	2.9	0.2	2.7	3.3	1.8	7.1	5.9	3.5	0.0	1.0	0.1	3.2	0.0	0.0	0.6	0.8	0.0	0.0	0.0	6.2	7.9	55.9	5.9	6.9	2.4	2.8	0.3	0.2	0.0	0.0	8.2	0.0	0.0	1.8	3.3	0.3	0.0	0.0	0.0	0.1	5.1	0.0	0.2	8.2	0.2	1.5	1.5	0.4	0.1	0.0	8.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	1.0	2.8	0.0	0.0	0.1	0.0	0.0	0.0	0.1	9.5	1.5	3.3	0.0	0.2	0.0	0.0	0.0	4.3	0.0	0.0	0.0	3.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.2	0.7	0.2	0.5	0.6	0.1	0.5	0.2	1.0	0.2
MMP20		ENSG00000137674	"Matrix metallopeptidase 20"	O60882	11	102576835-102625332	"Disease related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Amelogenesis imperfecta, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 1.0;testis: 3.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.6;Hep G2: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to extracellular matrix"						"unprognostic (4.62e-3)"		"unprognostic (2.61e-2)"	"unprognostic (1.68e-3)"		"unprognostic (1.75e-1)"		"unprognostic (2.13e-1)"		"unprognostic (3.06e-1)"	"unprognostic (2.97e-2)"	"unprognostic (6.75e-2)"	"unprognostic (9.58e-5)"	"unprognostic (6.10e-2)"		"unprognostic (2.35e-1)"		0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0			0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5			0.0		1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.6	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MMP21		ENSG00000154485	"Matrix metallopeptidase 21"	Q8N119	10	125766453-125775821	"Disease related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets, Heterotaxy"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	13	"epididymis: 37.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.0;NB-4: 1.2;U-266/70: 2.1;U-266/84: 1.7"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"												"Secreted to extracellular matrix"						"unprognostic (1.32e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.51e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.89e-2)"	"unprognostic (3.62e-2)"	"unprognostic (9.70e-8)"	"unprognostic (1.30e-2)"	"unprognostic (7.69e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.18e-1)"	0.2	0.1	0.1	0.1	0.4	0.1	0.3	0.7	0.0	0.1	0.2			0.1	0.1	37.6	0.1	0.4	0.2	0.9	0.0	0.4	0.1	1.0	0.1	0.1	0.0		2.8	0.8	0.0	0.3	0.0		0.6	0.1		0.5	0.1	0.0	0.1	0.5	0.1	0.0	0.7	0.2	0.1			0.6		0.1	0.2	0.0	1.1	0.0	0.0	0.1	0.5	0.6	0.0	0.1	0.0	0.0	0.8	0.3	0.0	1.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.7	0.5	0.0	0.0	0.2	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.1	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.7	0.0	2.1	1.7	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.6	0.0	0.0	1.1	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0										
MMP26	"endometase, MGC126590, MGC126592"	ENSG00000167346	"Matrix metallopeptidase 26"	Q9NRE1	11	4704927-4992429	"Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	13	"endometrium 1: 19.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"endometrial cancer: 8.8;prostate cancer: 2.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to extracellular matrix"									"unprognostic (4.21e-3)"								"unprognostic (2.63e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		1.4	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MMP7	"MPSL1, PUMP-1"	ENSG00000137673	"Matrix metallopeptidase 7"	P09237	11	102520508-102530753	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 93.0;kidney: 129.5;salivary gland: 79.3"	"Cell line enhanced"	"Detected in some"		"A549: 22.6;CAPAN-2: 126.5;EFO-21: 30.0;RPTEC TERT1: 54.7"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 352.1"	"Region enriched"	"Detected in single"	5	"pons and medulla: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB025869, HPA051358"	Supported		Approved	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"			"Nucleoplasm, Vesicles"		"CAB025869: , HPA051358: "	"unprognostic (1.06e-3)"	"unprognostic (9.51e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.70e-3)"	"unprognostic (7.28e-2)"	"prognostic unfavourable (2.53e-4)"	"prognostic unfavourable (3.38e-4)"	"unprognostic (3.96e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.59e-3)"	"unprognostic (1.51e-1)"	"unprognostic (6.36e-3)"	"unprognostic (1.42e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.46e-1)"	6.8	0.2	0.2	1.2	0.2	0.0	28.8	0.2	0.2	5.2	0.2	0.2	2.1	0.0	17.2	12.3	3.3	16.4	93.0	0.2	0.2	0.2	129.5	1.4	5.0	0.9	0.2	0.2	3.9	23.5	0.0	0.7	2.7	1.3	42.0	0.0	0.2	79.3	6.7	0.2	7.8	0.3	0.5	0.2	0.2	0.9	9.4	0.2	1.2	0.3	1.4	4.5	19.9	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	22.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	126.5	0.0	30.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	1.3	0.2
MMP9	CLG4B	ENSG00000100985	"Matrix metallopeptidase 9"	P14780	20	46008908-46016561	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 64.0;blood: 63.2;bone marrow: 89.4;lymphoid tissue: 80.1"	"Cell line enriched"	"Detected in some"	12	"NB-4: 87.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	141	"neutrophil: 63.2"	"Lineage enriched"	"Detected in single"	339	"granulocytes: 63.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000348, HPA001238, HPA063909, CAB068199, CAB068200, CAB068201"	Enhanced		Approved	Cytosol	"Secreted to blood"	57000000	57000000	Cytosol		"CAB000348: , CAB068199: , CAB068200: , CAB068201: , HPA001238: AB_1079398, HPA063909: AB_2685150"	"unprognostic (4.62e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.85e-2)"	"prognostic favourable (2.55e-4)"	"unprognostic (6.65e-3)"	"unprognostic (2.82e-1)"	"prognostic unfavourable (7.19e-4)"	"unprognostic (1.54e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.21e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavourable (4.05e-5)"	"unprognostic (4.65e-1)"	"unprognostic (9.85e-3)"	"unprognostic (2.48e-2)"	"unprognostic (2.17e-3)"	64.0	0.5	0.6	38.6	0.7	89.4	4.3	0.4	0.6	0.8	1.2	0.1	0.0	2.8	0.6	0.2	0.9	1.5	0.6	4.0	0.5	0.6	1.4	2.0	13.3	80.1	0.6	0.0	2.7	1.4	0.0	0.8	2.6	0.5	0.6	0.8	0.5	12.5	0.0	1.3	1.3	4.2	0.3	0.5	53.7	2.5	2.7	0.0	23.6	1.3	2.3	44.5	4.5	2.9	0.0	0.0	63.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	7.3	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	87.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	2.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.2	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.4	0.6	0.5	0.6	0.6	0.0	0.5	0.0
MSMB	"IGBF, MSP, MSPB, PN44, PRPS, PSP, PSP-94, PSP57, PSP94"	ENSG00000263639	"Microseminoprotein beta"	P08118	10	46033307-46046269	"Cancer-related genes, Disease related genes, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"prostate: 437.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 20.0;NB-4: 16.1;RPMI-8226: 8.4;SH-SY5Y: 4.6;SK-BR-3: 4.7;U-2197: 9.5"	"Cancer enriched"	"Detected in many"	42	"prostate cancer: 3435.3"					"Cell type enriched"	"Detected in single"	5	"eosinophil: 1.9"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.9"									"CAB026357, HPA051257"	Enhanced				"Secreted in male reproductive system"	3700000	3700000			"CAB026357: , HPA051257: "	"unprognostic (6.47e-2)"	"unprognostic (7.21e-3)"		"unprognostic (1.37e-2)"		"unprognostic (8.18e-3)"	"unprognostic (4.28e-3)"	"unprognostic (9.24e-3)"	"unprognostic (1.66e-1)"	"unprognostic (8.66e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.55e-2)"		"unprognostic (2.01e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.39e-1)"	"prognostic favourable (7.19e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	1.0	0.8	0.0	0.1	0.1	0.0	1.8	0.1	0.0	7.2	0.0	0.0		0.0	0.0	29.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	437.8	0.0	0.0	14.8	0.1	0.0	0.0	0.0	0.2	0.0	0.0	26.8	0.6	0.0	0.0	0.0	0.1	0.7	0.7	0.0	0.0	0.0	1.9	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	20.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.2	16.1	0.2	0.0	0.0	0.0	8.4	0.0	1.2	0.9	4.6	0.0	4.7	0.0	0.3	0.0	0.0	0.0	0.0	9.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MSTN	GDF8	ENSG00000138379	Myostatin	O14793	2	190055697-190062729	"Disease related genes, Predicted secreted proteins"		"Cytokine, Growth factor, Heparin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 17.2;tongue: 15.8"	"Group enriched"	"Detected in some"	12	"LHCN-M2: 15.9;RH-30: 32.3"	"Cancer enriched"	"Detected in some"	9	"glioma: 6.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			CAB009963	Approved				"Secreted in other tissues"	4800000	4800000			"CAB009963: AB_2148798"	"unprognostic (8.45e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.54e-1)"	"prognostic favourable (2.86e-4)"	"unprognostic (7.59e-3)"	"unprognostic (2.95e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.24e-3)"	"unprognostic (7.72e-3)"	"unprognostic (1.12e-4)"	"unprognostic (1.06e-1)"	"unprognostic (3.94e-1)"	"unprognostic (6.53e-2)"	"unprognostic (5.67e-4)"	3.3	1.9	1.7	0.7	1.4	0.2	0.8	4.1	1.8	4.8	1.1	2.2	0.0	0.7	1.8	1.2	2.3	0.5	0.6	0.7	3.5	1.6	1.1	0.3	0.3	0.3	1.3	0.0	0.7	0.4	0.4	1.4	0.2	3.4	1.0	1.1	0.9	1.0	0.5	17.2	1.2	2.1	0.9	1.1	0.3	0.6	0.7	4.0	0.0	0.7	15.8	0.4	0.3	0.9	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	32.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.4	4.1	1.0	3.5	1.6	1.3	0.0	3.4	4.0
MTRNR2L11		ENSG00000270188	"MT-RNR2-like 11"	S4R3Y5	1	237943724-237945275	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"blood: 64.8;skeletal muscle: 46.5"	"Cell line enhanced"	"Detected in many"		"HeLa: 65.5;Hep G2: 41.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"neutrophil: 64.8"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 64.8"														"Secreted to blood"										"unprognostic (1.07e-1)"					"unprognostic (9.70e-2)"			"unprognostic (4.49e-2)"	"unprognostic (5.26e-2)"				9.9	11.8	3.7	0.9	3.8	1.4	5.5	2.1	8.5	2.0	7.0	1.4	3.7	2.9	2.0	3.1	2.0	2.0	0.2	12.4	4.2	2.3	11.1	7.2	3.0	2.8	2.2	2.6	2.0	3.3	0.0	2.0	1.3	4.6	2.1	3.1	0.9	4.4	6.5	46.5	2.0	3.5	0.7	3.3	2.0	4.3	4.0	3.0	0.8	2.0	7.4	0.3	2.0	2.0	5.9	3.4	64.8	7.0	2.9	3.1	8.2	7.0	16.5	7.7	21.7	6.6	1.7	6.2	11.7	0.9	0.6	0.9	6.9	10.2	12.0	7.5	2.3	21.4	0.2	1.5	0.6	5.2	11.6	12.1	65.5	41.9	2.2	3.3	9.7	6.7	2.3	0.8	2.9	0.9	8.4	7.2	2.0	6.0	3.3	11.5	2.0	3.0	6.4	6.2	4.9	4.5	9.7	2.9	5.2	4.6	5.4	8.6	6.6	10.6	19.0	8.8	6.2	7.0	3.3	5.5	1.8	4.9	4.8	11.8	2.1	14.8	7.0	16.1	1.4	3.2	1.7	5.5	2.2	1.9	2.7	5.9	3.1	3.1	64.8	2.9	3.1	3.4	2.0	8.2	3.7	3.8	2.1	5.1	4.2	2.3	2.2	2.6	4.6	3.0
MUC5AC	MUC5	ENSG00000215182	"Mucin 5AC, oligomeric mucus/gel-forming"	P98088	11	1157953-1201138	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"gallbladder: 70.3;lung: 87.0;stomach 1: 68.3"	"Cell line enriched"	"Detected in some"	18	"A549: 20.8"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 61.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB002774, CAB009395, HPA040615"	Enhanced				"Secreted to digestive system"					"CAB002774: , CAB009395: AB_2146854, HPA040615: "	"unprognostic (2.10e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.51e-2)"		"unprognostic (4.56e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.30e-3)"	"unprognostic (8.46e-2)"	"unprognostic (5.83e-4)"	"unprognostic (1.84e-1)"	"unprognostic (9.21e-3)"	"unprognostic (4.07e-1)"	"unprognostic (1.37e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	70.3	0.0	0.0		0.0	0.0	87.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	68.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MUC7	"FLJ27047, MG2"	ENSG00000171195	"Mucin 7, secreted"	Q8TAX7	4	70430492-70482997	"Disease related genes, Predicted secreted proteins"			Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"salivary gland: 1562.5"	"Cell line enriched"	"Detected in single"	6	"BJ hTERT+: 4.2"	"Group enriched"	"Detected in some"	12	"head and neck cancer: 8.1;melanoma: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA006411	Enhanced				"Secreted to digestive system"					"HPA006411: AB_1854204"	"unprognostic (5.49e-2)"					"unprognostic (3.20e-1)"			"unprognostic (1.06e-1)"									0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1562.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	265.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MXRA5	DKFZp564I1922	ENSG00000101825	"Matrix remodeling associated 5"	Q9NR99	X	3308565-3346641	"Cancer-related genes, Disease related genes, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 49.4;pancreas: 46.6"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 12.5;BJ hTERT+: 47.9;fHDF/TERT166: 22.4;HaCaT: 19.9;HSkMC: 9.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA000508	Uncertain				"Secreted - unknown location"	1700000	1700000			"HPA000508: AB_2147995"	"unprognostic (7.51e-2)"	"unprognostic (6.45e-2)"	"unprognostic (8.00e-2)"	"unprognostic (2.51e-2)"	"prognostic unfavourable (1.81e-4)"	"unprognostic (7.05e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.32e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (8.94e-4)"	6.5	12.1	0.5	10.4	1.2	0.0	7.5	0.4	0.8	49.4	4.4	0.6	18.8	2.1	11.4	6.0	8.7	4.2	5.8	9.2	0.6	0.5	8.0	4.5	5.9	0.9	0.6	0.7	7.9	46.6	0.5	1.4	7.9	0.8	11.0	5.9	10.2	11.5	29.5	1.1	16.6	7.8	8.8	0.5	7.7	5.1	4.0	0.3	5.7	15.0	11.7	6.2	12.7	9.6	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.1	12.5	0.0	7.4	47.9	0.0	0.0	0.0	0.2	0.0	0.6	22.4	19.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	2.3	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	0.4	0.8	0.6	0.5	0.6	0.7	0.8	0.3
MYOC	"GLC1A, JOAG1, TIGR"	ENSG00000034971	Myocilin	Q99972	1	171635417-171652683	"Disease related genes, Plasma proteins, Predicted secreted proteins"			"Disease mutation, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 100.8"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	6	"melanoma: 13.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA027364	Uncertain				"Secreted to extracellular matrix"	12000000	12000000			"HPA027364: AB_10602036"	"unprognostic (2.02e-2)"	"unprognostic (4.65e-2)"		"unprognostic (4.44e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.43e-1)"		"unprognostic (2.33e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.94e-4)"	"unprognostic (5.35e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.24e-1)"	26.9	0.8	0.0	0.5	0.0	0.0	8.4	0.0	0.0	5.4	6.0	0.0	5.3	2.4	8.1	7.6	40.7	7.4	8.3	12.6	0.1	0.0	0.2	0.1	3.7	0.0	0.0	0.0	3.9	2.1	0.2	0.1	0.1	0.2	9.0	2.5	100.8	10.5	4.8	21.7	2.4	2.6	39.4	0.3	0.1	29.9	2.8	0.0	0.6	14.9	28.2	5.0	26.1	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0
MZB1	"HSPC190, MEDA-7, MGC29506, PACAP, pERp1"	ENSG00000170476	"Marginal zone B and B1 cell specific protein"	Q8WU39	5	139387480-139390081	"Predicted secreted proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 97.7;lymphoid tissue: 152.6"	"Group enriched"	"Detected in some"	5	"Karpas-707: 64.6;RPMI-8226: 228.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"memory B-cell: 29.5;plasmacytoid DC: 97.7"	"Group enriched"	"Detected in many"	115	"B-cells: 29.5;dendritic cells: 97.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA043745, HPA052694"	Enhanced				"Secreted to blood"	670000	670000			"HPA043745: AB_10960359, HPA052694: AB_2681919"	"unprognostic (4.97e-3)"	"unprognostic (1.75e-2)"	"unprognostic (4.23e-2)"	"prognostic favourable (7.27e-4)"	"unprognostic (2.21e-2)"	"prognostic favourable (4.60e-5)"	"unprognostic (6.57e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.45e-3)"	"unprognostic (7.10e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavourable (1.15e-8)"	"unprognostic (7.22e-2)"	"unprognostic (3.14e-1)"	"unprognostic (9.46e-2)"	"unprognostic (7.36e-2)"	2.2	1.9	0.6	37.8	0.6	6.2	4.4	0.5	0.6	5.7	25.5	0.4	0.3	21.6	1.2	0.6	13.6	2.9	5.6	0.8	0.6	0.6	4.2	2.6	6.7	54.7	0.6	0.3	1.7	2.1	0.0	0.8	0.4	0.4	2.4	9.8	2.0	30.2	7.1	0.7	0.7	13.3	0.5	0.6	92.6	15.0	3.7	0.3	152.6	3.3	3.1	54.3	26.6	2.0	29.5	97.7	0.5	0.0	0.3	0.5	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.9	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	64.6	0.0	0.0	25.0	0.2	0.0	0.0	10.3	0.0	228.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	31.0	1.7	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	29.5	0.1	0.1	0.0	11.0	0.0	0.0	0.5	0.3	0.0	97.7	0.0	4.5	0.6	0.6	0.5	0.6	0.6	0.6	0.6	0.3	0.4	0.3
NAPSA	"KAP, Kdap, NAP1, NAPA"	ENSG00000131400	"Napsin A aspartic peptidase"	O96009	19	50358477-50365830	"Enzymes, Plasma proteins, Predicted secreted proteins"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"kidney: 47.5;lung: 153.3"	"Cell line enriched"	"Detected in some"	24	"U-698: 29.1"	"Cancer enriched"	"Detected in many"	18	"lung cancer: 249.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 10.5"	"Group enriched"	"Detected in many"	9	"B-cells: 5.1;dendritic cells: 10.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB009591, HPA045280, HPA047236, HPA047744"	Enhanced				"Secreted in other tissues"	380000	380000			"CAB009591: , HPA045280: AB_2679283, HPA047236: AB_2679993, HPA047744: AB_2680143"	"unprognostic (5.36e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.30e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.76e-3)"	"unprognostic (7.67e-3)"	"prognostic favourable (1.21e-4)"	"unprognostic (4.08e-4)"	"unprognostic (3.29e-1)"	"unprognostic (9.83e-3)"	"unprognostic (7.26e-5)"	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	5.0	0.1	0.1	0.1	0.1	0.1	0.0	47.5	0.1	153.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.5	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.1	5.1	10.5	0.5	0.9	0.5	0.6	1.1	0.1	0.4	0.0	0.2	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.4	0.2	0.2	0.1	0.5	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.2	0.0	0.2	0.3	1.2	0.1	0.0	0.0	0.3	0.1	0.0	0.6	0.1	0.3	0.2	0.3	0.6	0.0	0.1	0.9	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.3	0.1	0.0	0.1	0.8	0.0	0.2	0.4	29.1	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.9	0.0	5.1	0.2	0.4	3.0	1.9	0.6	0.5	0.5	0.5	0.9	10.5	0.0	1.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1
NAXE	"AIBP, APOA1BP, MGC119143, MGC119144, MGC119145, YJEFN1"	ENSG00000163382	"NAD(P)HX epimerase"	Q8NCW5	1	156591762-156594299	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"		Isomerase	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043766, HPA048164"	Enhanced		Enhanced	Nucleoplasm,Cytosol	"Secreted to blood"	3300000	3300000	Nucleoplasm	Cytosol	"HPA043766: AB_2678660, HPA048164: AB_2680294"	"unprognostic (1.27e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.49e-1)"	"prognostic unfavourable (4.94e-4)"	"unprognostic (7.38e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.46e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.08e-3)"	"unprognostic (3.23e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.15e-2)"	"unprognostic (8.05e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.81e-1)"	19.1	29.9	31.6	14.4	28.5	12.1	22.6	17.6	42.5	23.0	30.0	31.0	17.4	28.4	28.5	57.9	23.4	29.4	25.8	46.3	28.5	25.0	41.6	41.0	17.2	16.9	33.2	29.3	29.3	37.3	36.3	29.0	21.8	28.8	27.9	26.6	23.0	29.5	36.3	30.9	20.2	25.9	25.0	29.1	17.4	25.0	29.5	22.2	17.7	32.4	19.5	20.4	20.8	18.3	52.4	53.8	12.4	26.5	31.6	32.5	40.6	31.4	41.8	13.4	23.9	17.8	12.2	16.0	10.9	16.6	18.6	19.7	34.8	21.2	21.4	33.0	13.8	30.7	13.3	26.0	13.2	22.5	29.1	17.7	23.8	22.9	20.4	22.2	18.2	12.3	33.6	23.7	22.1	25.3	18.0	19.5	19.0	56.0	24.4	27.0	16.6	32.7	24.6	12.5	56.5	25.2	26.2	32.3	30.8	26.1	49.8	38.3	48.3	32.7	14.7	13.4	20.9	19.0	23.6	50.6	30.5	20.4	18.5	13.2	20.6	4.9	24.1	12.4	31.6	26.5	31.3	52.4	29.2	32.2	21.7	41.7	32.5	30.9	2.9	31.6	20.6	53.8	25.5	40.6	31.6	28.5	17.6	42.5	28.5	25.0	33.2	29.3	28.8	22.2
NDNF	"C4orf31, FLJ23191"	ENSG00000173376	"Neuron derived neurotrophic factor"	Q8TB73	4	121035613-121073021	"Predicted secreted proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 91.6;retina: 41.0"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 22.7;U-266/70: 10.1;U-266/84: 38.7"	"Cancer enhanced"	"Detected in many"		"lung cancer: 12.6"	"Region enriched"	"Detected in many"	4	"pons and medulla: 7.6"	"Cell type enriched"	"Detected in single"	11	"naive CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.0"	"Group enriched"	"Detected in many"	4	"basal ganglia: 11.4;olfactory region: 41.7"	"Low region specificity"	"Detected in all"			HPA048881			Supported	Vesicles	"Secreted in other tissues"			Vesicles		"HPA048881: "	"unprognostic (2.84e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.94e-1)"	"unprognostic (6.26e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.65e-4)"	"unprognostic (2.18e-3)"	"unprognostic (6.27e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavourable (3.26e-4)"	"unprognostic (2.38e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.18e-4)"	"unprognostic (1.74e-1)"	3.8	1.3	1.2	0.4	1.0	0.0	14.2	0.6	1.5	7.2	3.5	1.2	1.7	1.3	3.1	2.2	5.7	10.0	6.9	4.9	1.2	1.5	12.5	0.5	91.6	0.1	1.8	1.2	21.3	0.6	0.4	8.2	28.0	7.6	26.1	4.0	41.0	2.1	2.2	7.5	1.8	3.9	2.6	5.5	0.4	2.2	8.0	0.8	7.0	1.6	9.0	1.4	8.9	11.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	5.1	0.0	6.8	5.6	0.1	0.1	0.2	0.1	0.2	0.7	0.0	0.0	0.0	22.7	0.0	0.0	0.0	0.5	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	6.8	0.4	0.0	0.0	0.0	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	5.6	0.0	0.1	0.2	10.1	38.7	0.0	1.9	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.0	0.6	1.5	1.2	1.5	1.8	1.2	7.6	0.8
NDP	"EVR2, norrin"	ENSG00000124479	"NDP, norrin cystine knot growth factor"	Q00604	X	43948776-43973504	"Disease related genes, Predicted secreted proteins"	"Sensory transduction, Vision, Wnt signaling pathway"		"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 40.4"	"Cell line enriched"	"Detected in some"	17	"U-87 MG: 40.3"	"Cancer enhanced"	"Detected in many"		"glioma: 25.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	14	"memory CD4 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003095			Supported	Nucleoplasm,Nucleoli,Vesicles	"Secreted to extracellular matrix"			Vesicles	"Nucleoplasm, Nucleoli"	"HPA003095: AB_1079457"	"unprognostic (1.12e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.55e-3)"	"unprognostic (6.84e-3)"	"unprognostic (1.51e-1)"		"unprognostic (9.09e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.87e-3)"	0.9	0.6	17.3	0.6	18.6	0.5	3.6	14.6	15.0	19.1	0.7	12.6	0.2	0.6	13.6	19.9	0.6	18.0	0.9	1.4	14.0	7.8	0.7	0.5	0.6	0.7	11.0	10.9	40.4	0.6	0.8	0.2	5.3	13.1	6.8	0.7	1.4	0.6	12.4	1.5	1.1	0.6	10.7	7.5	0.6	0.7	1.4	12.2	0.0	1.2	0.0	0.7	1.0	1.7	0.1	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.9	0.0	0.1	1.0	0.7	0.0	0.0	1.1	2.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.1	0.0	0.0	0.0	40.3	0.4	2.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	17.3	18.6	14.6	15.0	14.0	7.8	11.0	10.9	13.1	12.2
NELL1	"FLJ45906, IDH3GL"	ENSG00000165973	"Neural EGFL like 1"	Q92832	11	20669551-21575681	"Predicted secreted proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.6;kidney: 24.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 8.9;RH-30: 1.5;SH-SY5Y: 4.1;U-2 OS: 2.3;WM-115: 2.6"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051535	Approved				"Secreted in other tissues"	120000	120000			"HPA051535: "	"unprognostic (1.73e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.29e-2)"	"unprognostic (5.35e-4)"	"unprognostic (3.78e-4)"	"unprognostic (1.67e-2)"		"unprognostic (3.91e-1)"	"unprognostic (4.38e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.27e-3)"	"unprognostic (4.23e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.29e-1)"	0.6	0.6	5.5	0.6	10.3	0.4	0.5	1.8	19.6	0.9	0.8	0.5	0.1	0.5	0.9	2.8	1.3	0.6	1.0	0.4	8.8	6.9	24.2	0.4	1.1	0.4	2.0	13.3	0.6	0.4	0.5	4.5	0.4	4.1	7.9	1.0	0.0	1.1	4.2	0.4	0.9	0.6	0.7	0.9	0.6	1.3	1.8	0.5	0.0	0.4	0.0	1.3	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.5	0.0	0.0	0.3	1.2	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	10.3	1.8	18.7	8.8	6.9	2.0	13.3	4.1	0.5
NENF	"CIR2, SCIRP10, SPUF"	ENSG00000117691	"Neudesin neurotrophic factor"	Q9UMX5	1	212432887-212446379	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026763, HPA028488"	Uncertain		Enhanced	Nucleoplasm	"Secreted - unknown location"	2400000	2400000	Nucleoplasm		"HPA026763: AB_1854379, HPA028488: "	"unprognostic (2.38e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.49e-2)"	"unprognostic (7.24e-2)"	"unprognostic (7.41e-3)"	"unprognostic (3.80e-3)"	"unprognostic (5.35e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.46e-3)"	"unprognostic (4.99e-3)"	"prognostic unfavourable (1.54e-6)"	"unprognostic (2.01e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.28e-1)"	"unprognostic (2.28e-2)"	21.9	19.9	33.5	10.1	47.7	12.8	44.4	16.2	30.6	41.9	23.9	45.2	24.0	12.7	24.1	42.2	19.4	27.6	19.6	50.6	31.3	31.4	32.0	25.8	18.0	20.4	38.3	21.3	38.3	43.4	21.0	47.1	17.9	23.6	26.7	23.9	19.8	22.1	36.1	53.6	16.5	12.2	29.7	49.5	13.2	16.8	9.6	24.5	6.5	23.6	26.0	16.2	19.3	19.9	7.2	13.3	1.9	6.7	0.8	9.2	2.5	22.6	11.9	6.5	29.3	47.9	36.2	11.6	11.4	28.2	20.5	20.2	14.0	14.5	8.7	8.9	27.3	14.7	16.1	16.7	16.8	13.3	32.2	5.6	7.7	4.0	18.1	5.6	20.3	25.9	24.6	14.2	11.9	13.2	17.3	11.8	17.9	9.3	12.9	26.4	11.3	37.6	11.5	11.7	14.6	20.9	4.0	13.0	22.7	11.8	27.0	20.5	20.6	21.8	2.5	16.1	14.9	22.3	21.1	11.0	17.7	6.7	17.6	7.9	12.2	1.0	4.8	1.9	4.1	6.7	7.3	7.2	4.9	9.2	7.7	5.1	6.5	6.5	0.5	0.8	4.5	13.3	5.7	2.5	33.5	47.7	16.2	30.6	31.3	31.4	38.3	21.3	23.6	24.5
NGF	NGFB	ENSG00000134259	"Nerve growth factor"	P01138	1	115285918-115338236	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"	"Cancer-related genes, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ: 37.6;BJ hTERT+ SV40 Large T+: 13.4;BJ hTERT+ SV40 Large T+ RasG12V: 9.9;hTEC/SVTERT24-B: 13.0;U-2197: 26.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"						"unprognostic (7.55e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.53e-3)"	"unprognostic (8.85e-2)"	"unprognostic (4.12e-1)"	"prognostic unfavourable (1.80e-4)"	"unprognostic (1.03e-1)"	"unprognostic (5.30e-2)"	"unprognostic (8.73e-3)"	"unprognostic (4.28e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.05e-1)"	"prognostic unfavourable (8.08e-7)"	"unprognostic (1.15e-3)"	"unprognostic (2.13e-1)"	"unprognostic (7.99e-3)"	"unprognostic (1.62e-4)"	9.1	2.3	1.3	2.8	1.6	0.2	6.5	0.6	2.8	7.5	3.4	0.6	2.3	0.3	11.4	5.9	1.5	10.6	6.6	16.5	3.2	0.6	3.4	2.7	1.4	1.5	2.3	1.6	17.8	0.7	0.3	2.1	2.0	1.7	3.7	1.2	7.0	3.8	2.0	1.8	0.6	1.4	7.0	2.1	3.8	1.6	3.2	1.1	0.0	2.9	3.0	0.3	6.5	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	37.6	4.3	13.4	9.9	0.0	0.0	0.0	0.8	8.9	1.5	0.0	0.2	6.0	0.0	0.1	0.0	0.2	0.0	5.6	0.0	0.0	0.0	0.2	13.0	9.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.5	0.0	0.5	0.0	0.0	0.0	0.5	0.1	0.7	0.2	0.0	0.0	0.0	0.3	0.8	1.6	26.2	1.5	0.0	0.0	0.0	1.6	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.6	0.6	2.8	3.2	0.6	2.3	1.6	1.7	1.1
NID1	"entactin, NID"	ENSG00000116962	"Nidogen 1"	P14543	1	235975830-236065162	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 174.4;ASC TERT1: 81.5;HSkMC: 68.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	18	"classical monocyte: 5.4;intermediate monocyte: 11.3;myeloid DC: 4.5;non-classical monocyte: 7.1"	"Group enriched"	"Detected in many"	20	"dendritic cells: 4.5;monocytes: 11.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB010044	Approved				"Secreted to extracellular matrix"	90000000	90000000			"CAB010044: AB_2153287"	"unprognostic (1.17e-1)"	"unprognostic (2.23e-3)"	"unprognostic (3.24e-1)"	"unprognostic (2.35e-1)"	"unprognostic (4.03e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.42e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavourable (5.38e-8)"	"unprognostic (3.64e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.36e-2)"	"unprognostic (3.72e-3)"	49.4	12.7	1.6	14.7	4.0	0.7	80.5	1.7	2.2	38.8	29.3	1.9	10.4	6.9	29.4	25.5	23.8	27.4	24.3	40.5	1.6	1.1	18.3	36.7	18.8	24.5	3.3	1.4	29.4	6.3	4.6	3.6	74.6	3.8	19.2	7.3	19.9	6.3	15.3	18.3	7.9	18.5	36.1	3.9	31.0	23.0	19.6	1.7	1.4	12.2	6.2	3.8	41.9	30.0	0.0	4.5	0.3	11.3	0.1	0.0	1.8	0.1	0.5	5.9	0.0	174.4	81.5	11.4	13.5	11.2	8.4	5.5	3.2	4.2	0.0	2.6	20.2	0.4	3.9	0.0	5.0	0.0	6.4	0.8	0.6	4.8	32.9	0.0	0.0	68.8	0.5	4.1	0.1	17.7	0.0	0.0	2.8	0.0	0.0	0.0	6.1	0.7	0.0	0.0	0.0	0.0	1.7	0.0	5.0	0.1	0.0	1.0	0.0	5.4	15.2	7.4	4.9	0.0	5.9	0.0	0.0	0.0	0.0	0.0	11.3	0.2	5.4	0.0	0.0	11.3	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.3	0.1	7.1	0.0	0.0	1.8	1.6	4.0	1.7	2.0	1.6	1.1	3.3	1.4	3.8	1.7
NMB	"MGC17211, MGC2277, MGC3936"	ENSG00000197696	"Neuromedin B"	P08949	15	84655129-84658563	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"adipose tissue: 37.2;brain: 28.5;breast: 59.9"	"Cell line enhanced"	"Detected in many"		"A-431: 27.5"	"Cancer enhanced"	"Detected in all"		"glioma: 93.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in many"	16	"olfactory region: 206.6"	"Group enriched"	"Detected in many"	6	"olfactory region: 80.6;pons and medulla: 17.5"	CAB019302	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"	"Secreted to blood"			"Nucleoplasm, Vesicles"	"Plasma membrane"	"CAB019302: "	"unprognostic (2.44e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.34e-3)"	"unprognostic (3.79e-1)"	"prognostic favourable (3.43e-4)"	"unprognostic (3.81e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.36e-1)"	"unprognostic (7.24e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavourable (2.25e-4)"	"unprognostic (7.92e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.00e-1)"	37.2	8.0	4.6	2.8	7.5	3.3	59.9	2.4	28.5	4.0	6.5	13.7	1.0	2.3	3.1	3.2	2.5	5.0	4.5	7.0	7.0	12.2	4.4	1.9	3.8	3.6	6.6	3.5	3.4	3.3	2.7	4.2	1.4	5.6	1.9	2.1	2.6	4.6	1.8	2.0	1.8	1.4	2.9	9.9	2.0	2.5	6.4	4.8	2.2	8.9	4.9	1.9	4.7	8.5	7.0	10.4	5.9	0.8	1.3	6.4	2.6	27.5	10.5	1.9	0.4	5.5	2.4	0.2	1.7	3.3	3.7	5.1	3.7	7.6	1.2	4.4	4.4	4.9	10.6	2.1	2.1	10.3	13.3	4.2	4.1	17.1	1.4	2.8	4.6	2.5	0.8	5.8	2.2	5.4	0.0	0.4	2.0	16.1	2.6	9.3	7.8	3.0	8.3	0.0	12.2	3.5	2.2	1.0	12.0	2.7	1.6	12.5	1.8	11.0	1.3	0.7	3.7	3.5	2.6	0.2	3.0	2.6	8.5	15.9	4.4	0.0	0.8	5.9	6.3	0.6	2.3	4.9	5.0	6.4	3.5	7.0	4.8	3.6	1.2	1.3	0.3	10.4	5.6	2.6	4.6	7.5	2.4	8.5	7.0	12.2	6.6	3.5	5.6	4.8
NMS		ENSG00000204640	"Neuromedin S"	Q5H8A3	2	100470482-100483280	"Predicted secreted proteins"		Neuropeptide		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"brain: 3.2;testis: 2.9"	"Group enriched"	"Detected in some"	10	"HL-60: 12.3;HMC-1: 7.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basal ganglia: 2.6;hypothalamus: 6.3;pons and medulla: 1.4"										"Secreted in brain"																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.5	0.0		0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	0.0	2.9			0.0		0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
NMU		ENSG00000109255	"Neuromedin U"	P48645	4	55595229-55636698	"Predicted secreted proteins"		Neuropeptide		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 42.9;skin 1: 28.3;tongue: 28.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 79.5;K-562: 62.4;Karpas-707: 28.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebral cortex: 3.4"	"Group enriched"	"Detected in some"	10	"MAIT T-cell: 7.2;memory CD4 T-cell: 2.3"	"Lineage enriched"	"Detected in single"	51	"T-cells: 7.2"	"Region enhanced"	"Detected in single"		"pons and medulla: 4.7"	"Low region specificity"	"Detected in single"			HPA025926	Uncertain				"Secreted in other tissues"					"HPA025926: AB_1854539"	"unprognostic (4.42e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.83e-2)"	"prognostic unfavourable (2.60e-5)"	"unprognostic (1.08e-1)"	"unprognostic (5.19e-2)"	"unprognostic (7.12e-2)"	"unprognostic (7.29e-3)"	"unprognostic (9.36e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.00e-1)"	"prognostic unfavourable (4.07e-10)"	"unprognostic (1.61e-1)"	"unprognostic (5.66e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.55e-2)"	0.1	0.3	0.2	2.0	1.1	5.9	1.3	0.1	3.4	5.4	1.1	0.2	2.5	0.6	0.5	0.0	42.9	0.2	0.3	0.3	0.2	0.9	0.1	0.0	1.0	0.4	0.4	0.5	0.0	0.0	0.0	2.8	2.1	0.3	0.1	0.6	0.0	6.6	1.5	0.1	28.3	1.7	0.2	1.2	0.1	3.1	1.3	0.0	0.7	17.2	28.4	8.5	0.1	12.2	0.1	0.0	0.0	0.0	0.0	7.2	0.1	8.3	0.0	4.6	1.1	0.0	0.0	0.0	0.0	0.0	0.6	1.6	0.0	12.8	18.4	1.8	0.0	79.5	9.6	0.7	0.5	1.1	5.2	0.1	7.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.6	0.0	62.4	28.7	0.0	2.0	0.2	0.0	2.4	2.4	0.0	0.0	0.1	0.4	0.0	4.1	10.4	6.4	0.1	0.0	4.4	0.0	0.5	0.0	6.0	0.0	11.1	8.3	0.0	0.0	3.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.2	0.0	2.3	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.1	0.1	3.4	0.2	0.9	0.4	0.5	0.3	0.0
NOG	"SYM1, SYNS1"	ENSG00000183691	Noggin	Q13253	17	56593699-56595590	"Disease related genes, Predicted secreted proteins"	"Chondrogenesis, Differentiation"	"Developmental protein"	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 32.8;placenta: 37.1;retina: 18.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 49.8;LHCN-M2: 15.1;NB-4: 11.0;PC-3: 15.1;U-2 OS: 15.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"naive CD4 T-cell: 32.8;naive CD8 T-cell: 15.1"	"Lineage enriched"	"Detected in single"	81	"T-cells: 32.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA061318	Approved				"Secreted to blood"					"HPA061318: "	"unprognostic (1.49e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.49e-5)"	"prognostic favourable (6.66e-4)"	"unprognostic (4.69e-2)"	"unprognostic (5.23e-3)"		"unprognostic (1.26e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavourable (6.86e-5)"	"unprognostic (2.88e-1)"	"unprognostic (1.14e-6)"	"unprognostic (8.39e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.00e-1)"	"unprognostic (1.65e-1)"	0.9	0.3	4.9	2.0	7.2	0.7	0.5	0.9	8.3	5.5	0.6	1.8	0.4	0.5	0.8	6.3	0.4	0.4	0.3	0.4	3.8	3.1	0.8	0.4	1.0	3.3	1.9	2.7	0.3	0.5	0.3	0.8	37.1	1.1	1.4	0.4	18.6	0.4	2.9	3.6	0.4	0.7	0.5	0.8	1.5	0.8	1.6	1.8	1.7	0.3	0.0	1.1	0.9	3.1	0.0	0.1	0.4	0.1	0.2	32.8	1.7	2.4	0.0	0.1	0.0	0.1	0.0	0.0	1.2	1.4	0.5	0.5	0.1	0.4	0.0	49.8	0.6	0.2	0.8	0.1	1.3	0.0	0.9	0.0	1.9	0.0	0.0	0.3	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	15.1	0.0	0.4	11.0	1.0	15.1	6.5	4.6	0.0	1.1	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.2	0.3	0.9	15.5	0.1	1.0	0.0	0.0	0.1	0.0	1.2	0.0	0.3	0.0	0.1	0.2	0.1	0.1	0.0	1.9	0.2	0.0	0.0	32.8	15.1	0.4	0.2	0.1	0.1	1.3	1.7	4.9	7.2	0.9	2.5	3.8	3.1	1.9	2.7	1.1	1.8
NOV	"CCN3, IGFBP9"	ENSG00000136999	"Nephroblastoma overexpressed"	P48745	8	119416306-119424353	"Plasma proteins, Predicted secreted proteins, Transporters"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"adrenal gland: 236.7"	"Group enriched"	"Detected in many"	5	"BJ hTERT+: 43.0;U-2197: 44.5"	"Cancer enhanced"	"Detected in all"		"melanoma: 62.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	113	"eosinophil: 28.1;neutrophil: 14.0"	"Lineage enriched"	"Detected in single"	151	"granulocytes: 28.1"	"Group enriched"	"Detected in many"	7	"amygdala: 134.6;basal ganglia: 51.6;cerebral cortex: 101.0;hippocampal formation: 166.1"	"Low region specificity"	"Detected in many"			"HPA018449, HPA019684, CAB034423"	Enhanced		Enhanced	Vesicles	"Secreted to blood"	2900000	2900000	Vesicles		"CAB034423: AB_2151387, HPA018449: AB_1846189, HPA019684: AB_1846190"	"unprognostic (5.04e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.36e-3)"	"unprognostic (1.30e-3)"	"unprognostic (9.35e-3)"	"unprognostic (4.92e-1)"	"unprognostic (8.10e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.79e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.72e-2)"	6.3	236.7	2.2	1.4	7.9	1.0	5.6	3.1	12.3	5.0	2.0	3.6	3.6	1.5	5.8	2.9	1.9	3.0	2.0	5.7	3.5	1.9	4.9	0.9	2.9	1.1	2.1	15.1	1.8	2.7	2.1	13.4	0.8	7.4	5.6	2.2	1.2	1.2	5.0	1.6	3.6	1.5	2.5	2.5	1.0	1.6	2.6	0.0	0.0	6.9	4.8	1.1	3.3	2.5	0.0	0.1	28.1	0.1	0.0	0.0	0.0	0.0	1.0	0.6	0.0	3.9	1.0	0.0	5.7	43.0	5.2	3.0	0.0	0.1	0.0	4.5	7.2	3.6	0.2	0.0	1.7	0.0	0.1	0.0	3.3	0.0	0.1	0.0	0.0	0.2	0.0	2.0	0.2	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	8.6	0.0	0.0	0.0	5.5	0.0	1.3	0.0	2.1	0.0	8.0	0.0	0.0	0.0	3.7	5.7	44.5	1.1	0.0	0.0	0.0	5.9	1.8	4.3	0.0	0.1	28.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	2.2	7.9	3.1	12.3	3.5	1.9	2.1	15.1	7.4	0.0
NPB	"PPL7, PPNPB"	ENSG00000183979	"Neuropeptide B"	Q8NG41	17	81900745-81902905	"Predicted secreted proteins"		Neuropeptide		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.2;PC-3: 5.6;RH-30: 4.3;SH-SY5Y: 4.6;U-2 OS: 5.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"eosinophil: 2.1;MAIT T-cell: 2.2"	"Group enriched"	"Detected in many"	14	"granulocytes: 2.1;T-cells: 2.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 9.3;basal ganglia: 16.6;cerebral cortex: 7.3;hippocampal formation: 12.3;hypothalamus: 5.9"						"Secreted in other tissues"						"unprognostic (2.44e-2)"	"unprognostic (6.21e-2)"			"unprognostic (2.90e-1)"	"unprognostic (3.47e-3)"	"unprognostic (9.42e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.40e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.06e-2)"	"unprognostic (3.71e-1)"	"unprognostic (4.32e-1)"	1.5	0.6	4.7	5.2	5.1	1.1	2.2	3.4	6.9	2.3	1.3	3.8	0.1	0.4	2.8	2.4	0.6	2.1	0.8	1.0	2.7	10.3	1.3	1.2	1.1	4.4	6.1	2.7	2.4	0.9	1.1	0.7	8.0	4.5	1.4	1.2	1.9	0.8	1.8	1.6	2.5	1.3	1.9	13.2	2.8	1.0	2.0	1.4	1.9	0.7	0.0	3.7	0.8	2.5	0.1	0.0	2.1	0.0	0.0	2.2	0.0	0.7	2.1	1.5	0.4	0.3	0.4	1.3	0.6	0.4	0.4	0.0	1.0	0.2	0.4	0.2	0.3	0.0	0.9	0.3	0.6	4.2	0.2	0.8	0.1	0.0	0.2	0.1	0.6	0.0	1.7	0.6	0.5	0.1	1.3	0.2	0.2	0.4	0.1	1.1	0.5	5.6	0.4	4.3	0.0	0.3	1.1	0.9	4.6	0.4	0.6	0.9	0.1	0.1	0.5	0.8	5.3	0.2	0.6	0.5	0.5	0.0	0.1	1.3	0.4	0.2	0.0	2.1	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	4.7	5.1	3.4	6.9	2.7	10.3	6.1	2.7	4.5	1.4
NPFF	FMRFAL	ENSG00000139574	"Neuropeptide FF-amide peptide precursor"	O15130	12	53506690-53507638	"Predicted secreted proteins"		Neuropeptide		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	28	"epididymis: 154.7"	"Cell line enriched"	"Detected in some"	7	"HHSteC: 17.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"cerebellum: 2.0;hypothalamus: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"pons and medulla: 11.9"	"Region enriched"	"Detected in all"	8	"cerebellum: 143.2"						"Secreted in male reproductive system"																							0.3	0.1	0.1	0.1	0.3	0.0	0.1	2.0	0.1	0.5	0.2	0.1	1.1	0.2	0.1	154.7	0.1	0.2	0.1	0.1	0.1	1.4	0.1	0.1	0.5	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	5.5	0.2	0.1	1.1	0.1	0.2	0.1	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.7	0.2	0.8	0.2	0.0	0.0	0.2	0.1	0.2	0.0	0.3	0.1	1.9	0.4	0.8	0.2	0.0	0.3	0.2	0.5	1.9	0.1	0.0	0.2	0.0	0.2	2.4	0.0	0.0	0.3	0.0	0.3	0.1	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	2.0	0.1	0.1	1.4	0.1	0.1	0.3	0.1
NPPB		ENSG00000120937	"Natriuretic peptide B"	P16860	1	11857464-11858931	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		"Hormone, Vasoactive"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	296	"heart muscle: 348.6"	"Group enriched"	"Detected in some"	8	"BEWO: 33.4;CACO-2: 86.9"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in many"								"Secreted to blood"									"unprognostic (3.87e-1)"	"unprognostic (1.29e-2)"					"unprognostic (2.49e-1)"	"unprognostic (4.23e-1)"				"unprognostic (3.28e-2)"			0.1	0.0	0.1	0.1	0.6	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	348.6	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.0	0.9	0.5	0.4	0.7	1.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	33.4	0.0	0.0	0.5	0.2	86.9	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.3	0.3	0.8	0.4	1.0	1.0	0.6	1.0	0.5	0.5	1.1	1.1	0.0	0.7	0.3	0.9	0.7	0.9	0.1	0.6	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
NPPC	CNP	ENSG00000163273	"Natriuretic peptide C"	P23582	2	231921820-231926403	"Predicted secreted proteins, Transporters"	Osteogenesis	"Hormone, Vasoactive"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 34.2;retina: 24.7"	"Cell line enhanced"	"Detected in some"		"HEK 293: 7.7;NTERA-2: 3.6;SCLC-21H: 5.1;SK-MEL-30: 22.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.7"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.7"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"pons and medulla: 33.4"	HPA035362	Uncertain				"Secreted to blood"					"HPA035362: AB_10671103"	"unprognostic (9.70e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.06e-2)"	"unprognostic (5.67e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.22e-3)"	"unprognostic (9.81e-3)"	"unprognostic (9.16e-2)"	"unprognostic (2.10e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.91e-1)"	1.4	0.9	4.1	6.3	4.4	4.5	1.4	5.4	12.0	3.0	5.0	2.9	0.7	0.9	1.6	34.2	7.3	1.8	0.6	3.9	6.9	6.3	0.9	0.5	0.8	4.5	2.8	2.2	1.8	0.5	0.5	3.8	1.1	12.4	13.1	1.3	24.7	4.4	2.0	2.4	0.8	1.6	2.2	13.3	1.7	4.3	1.0	0.9	13.7	2.1	9.3	6.0	0.5	0.6	0.0	1.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	3.6	0.0	0.9	0.0	0.0	0.0	0.0	5.1	0.3	0.2	0.2	22.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	4.1	4.4	5.4	12.0	6.9	6.3	2.8	2.2	12.4	0.9
NPS		ENSG00000214285	"Neuropeptide S"	P0C0P6	10	127549369-127552639	"Predicted secreted proteins"		Neuropeptide		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"brain: 1.9"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	8	"head and neck cancer: 4.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"midbrain: 6.5;pons and medulla: 5.3"	"Region enriched"	"Detected in single"	8	"cerebral cortex: 5.8"	CAB020139	Uncertain				"Secreted - unknown location"					"CAB020139: AB_776718"					"unprognostic (2.83e-1)"													0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.9		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
NPTX1		ENSG00000171246	"Neuronal pentraxin 1"	Q15818	17	80467148-80477843	"Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 68.9"	"Cell line enhanced"	"Detected in some"		"HAP1: 12.1;HeLa: 9.5;SiHa: 15.4;U-138 MG: 33.0;WM-115: 45.3"	"Cancer enhanced"	"Detected in many"		"glioma: 4.8"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	4	"NK-cell: 1.5"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 1.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"amygdala: 74.8;cerebellum: 228.3;cerebral cortex: 119.6;hippocampal formation: 173.6"	HPA077062	Enhanced				"Secreted in brain"	1000000	1000000			"HPA077062: "	"unprognostic (2.37e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.81e-2)"	"unprognostic (6.95e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.81e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.05e-6)"	"unprognostic (1.41e-4)"	"unprognostic (1.35e-1)"	"unprognostic (8.86e-6)"	"unprognostic (2.71e-3)"	1.0	3.4	28.8	1.4	14.7	0.8	1.1	68.9	62.5	0.8	9.1	0.2	0.0	1.3	1.3	2.5	1.4	1.4	1.7	0.7	15.5	3.0	0.8	0.7	1.0	1.4	1.0	18.2	0.7	0.7	0.7	0.8	1.6	4.6	1.3	2.5	0.6	0.7	2.9	1.0	3.2	1.5	1.4	1.9	2.3	1.5	1.3	0.0	0.9	0.7	0.0	0.7	0.9	0.2	0.0	0.0	0.0	0.0	1.5	0.3	0.1	0.0	0.7	0.2	0.0	0.1	0.2	0.0	0.7	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.0	12.1	0.0	0.0	0.0	7.5	0.0	9.5	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.5	0.0	0.0	3.1	0.0	0.0	8.2	0.0	15.4	0.0	0.0	0.0	0.2	0.1	33.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	45.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	28.8	14.7	68.9	29.9	15.5	3.0	1.0	18.2	4.6	0.0
NPTX2		ENSG00000106236	"Neuronal pentraxin 2"	P47972	7	98617297-98629868	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 24.0;brain: 45.6;pancreas: 19.5;pituitary gland: 71.6;testis: 20.7"	"Cell line enriched"	"Detected in some"	12	"LHCN-M2: 125.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	16	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	16	"dendritic cells: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB020801, HPA049799, HPA058320"	Enhanced		Approved	"Golgi apparatus,Actin filaments,Centrosome"	"Secreted to blood"	320000	320000	"Golgi apparatus, Actin filaments"	Centrosome	"CAB020801: , HPA049799: , HPA058320: "	"unprognostic (1.18e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.56e-2)"	"prognostic unfavourable (5.46e-5)"	"unprognostic (1.91e-3)"	"unprognostic (9.20e-2)"	"unprognostic (2.42e-2)"	"unprognostic (6.04e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.64e-2)"	"unprognostic (2.35e-1)"	"prognostic unfavourable (5.46e-9)"	"unprognostic (1.06e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.33e-2)"	"unprognostic (3.69e-2)"	4.3	24.0	7.1	2.3	8.4	1.0	1.4	0.2	45.6	8.2	3.8	3.2	0.1	1.1	1.8	3.9	2.2	1.5	1.6	3.2	9.2	11.0	0.9	0.9	0.8	0.7	9.4	2.2	1.5	19.5	0.8	71.6	0.8	7.0	2.1	1.4	1.3	1.5	2.2	2.9	4.0	1.3	2.9	2.9	6.1	1.9	20.7	5.0	0.0	1.6	0.1	0.9	1.4	2.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.4	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	125.7	0.0	0.9	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	10.8	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	7.1	8.4	0.2	24.6	9.2	11.0	9.4	2.2	7.0	5.0
NPVF	"C7orf9, RFRP"	ENSG00000105954	"Neuropeptide VF precursor"	Q9HCQ7	7	25224570-25228486	"Predicted secreted proteins"		Neuropeptide		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	30	"brain: 9.5;lymphoid tissue: 2.9;retina: 7.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	95	"hypothalamus: 9.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	17	"hypothalamus: 7.2"	"Region enriched"	"Detected in some"	4	"hypothalamus: 3.8"	HPA041733	Enhanced				"Secreted in other tissues"					"HPA041733: AB_10794524"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0
NPY	PYY4	ENSG00000122585	"Neuropeptide Y"	P01303	7	24284163-24291865	"Plasma proteins, Predicted secreted proteins"		Neuropeptide		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 50.5;brain: 63.6;prostate: 131.2"	"Cell line enriched"	"Detected in some"	36	"SH-SY5Y: 121.1"	"Cancer enriched"	"Detected in many"	187	"prostate cancer: 1214.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB016733, CAB034368, HPA036636, HPA044572, HPA056798"	Supported	Supported	Enhanced	"Golgi apparatus"	"Secreted to blood"			"Golgi apparatus"		"CAB016733: , CAB034368: AB_2298657, HPA036636: , HPA044572: , HPA056798: "			"unprognostic (2.00e-1)"	"prognostic unfavourable (5.78e-4)"	"unprognostic (4.15e-1)"					"unprognostic (3.76e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.52e-1)"		1.6	50.5	27.2	5.5	63.6	2.8	1.0	0.1	55.9	1.0	1.8	2.8	1.4	4.7	1.1	1.1	2.5	1.0	1.4	1.0	11.9	20.6	1.1	1.0	1.1	1.0	2.6	18.3	1.0	4.0	1.0	0.5	1.0	1.9	131.2	1.7	0.0	1.0	14.7	1.0	1.0	5.0	1.4	1.4	1.0	1.7	1.3	13.9	0.0	1.1	0.0	1.0	3.9	4.5	0.5	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	3.4	0.0	0.1	0.0	0.0	0.1	121.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	27.2	63.6	0.1	31.2	11.9	20.6	2.6	18.3	1.9	13.9
NRTN	NTN	ENSG00000171119	Neurturin	Q99748	19	5823802-5828324	"Disease related genes, Predicted secreted proteins"		"Growth factor"	"Disease mutation, Hirschsprung disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 15.3;pancreas: 12.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.1;K-562: 6.9;REH: 18.2;SH-SY5Y: 9.8;U-266/70: 10.4"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 1.9;T-reg: 1.7"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065260			Approved	"Golgi apparatus"	"Secreted to blood"			"Golgi apparatus"		"HPA065260: "	"unprognostic (4.85e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.96e-2)"	"prognostic favourable (3.86e-4)"	"unprognostic (1.60e-2)"	"prognostic favourable (7.23e-4)"	"unprognostic (8.21e-3)"	"unprognostic (5.60e-3)"	"prognostic favourable (9.92e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.78e-3)"	"unprognostic (3.39e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.32e-2)"	0.0	3.6	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.4	4.9			1.5	0.3	0.6	2.1	0.4	0.5	15.3	0.0	0.0	1.8	7.6	0.0	0.0	0.0		0.0	12.3	0.6	0.3	0.0		1.3	0.0		6.8	1.2	0.0	3.0	1.5	0.9	0.0	0.0	5.0	0.3			0.0		0.0	1.8	1.3	0.7	1.9	0.0	0.1	0.0	1.7	0.3	0.5	0.7	0.8	2.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.8	0.0	0.1	2.9	0.0	0.0	7.1	5.1	0.0	0.0	2.3	0.9	0.1	1.9	0.1	0.7	0.0	0.0	0.0	6.9	0.0	0.0	1.4	0.6	0.7	2.4	1.8	18.2	2.4	4.2	0.3	0.0	0.5	9.8	0.1	0.9	1.0	0.3	0.6	0.0	0.0	1.5	0.0	0.0	10.4	2.2	0.5	0.0	1.2	0.7	0.0	0.1	0.0	0.2	0.0	0.4	0.0	0.7	0.1	0.4	0.7	0.3	0.3	0.0	0.0	0.0	1.9	1.7	0.3										
NT5DC3	"FLJ11266, TU12B1-TY"	ENSG00000111696	"5'-nucleotidase domain containing 3"	Q86UY8	12	103770453-103841197	"Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 52.0"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 21.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA041634			Approved	Mitochondria,Cytosol	"Secreted - unknown location"			"Mitochondria, Cytosol"		"HPA041634: AB_10795597"	"unprognostic (2.61e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.72e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavourable (4.31e-4)"	"unprognostic (1.57e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.45e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.95e-1)"	"prognostic unfavourable (5.72e-6)"	"unprognostic (8.60e-3)"	"unprognostic (7.42e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavourable (8.11e-4)"	4.2	5.4	14.8	3.2	10.5	23.9	5.4	2.7	16.2	12.2	52.0	2.9	9.4	2.0	17.9	8.4	8.9	3.5	2.6	2.2	13.3	5.7	2.2	4.0	2.8	2.3	2.8	11.7	3.8	3.5	1.8	4.2	4.5	10.4	9.8	12.5	3.7	3.9	9.1	7.0	2.8	4.2	32.9	2.1	1.9	6.6	3.5	2.7	0.0	2.9	0.9	2.4	22.4	5.2	4.1	4.9	2.4	1.6	1.5	3.3	0.8	3.2	5.9	3.4	3.9	4.9	3.8	6.4	5.4	3.2	3.8	2.5	4.0	0.9	5.5	1.1	6.4	3.8	4.8	10.7	5.6	4.1	3.9	6.9	2.2	4.7	2.7	3.6	1.8	3.4	2.4	5.0	21.6	2.2	10.8	2.8	8.6	2.9	3.2	5.9	4.2	6.4	4.4	6.0	2.1	6.1	2.2	4.6	1.9	4.6	5.1	6.4	2.9	3.5	2.9	3.8	4.6	5.2	10.8	2.5	3.1	4.1	3.6	5.6	5.5	0.8	1.5	0.1	1.7	1.6	3.3	3.5	2.4	1.4	3.8	4.1	2.1	1.8	2.4	1.5	1.0	4.9	0.6	0.8	14.8	10.5	2.7	16.2	13.3	5.7	2.8	11.7	10.4	2.7
NTF4	"GLC1O, NT-4/5, NTF5"	ENSG00000225950	"Neurotrophin 4"	P34130	19	49061066-49065054	"Cancer-related genes, Disease related genes, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"	"Cancer-related genes, Glaucoma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skin 1: 24.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 8.1;HaCaT: 18.3;HBEC3-KT: 6.8;hTCEpi: 30.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA049376			Approved	"Golgi apparatus"	"Secreted in other tissues"			"Golgi apparatus"		"HPA049376: "	"unprognostic (4.15e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.27e-4)"	"unprognostic (1.76e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.02e-2)"		"unprognostic (1.60e-1)"	"unprognostic (2.73e-2)"	"unprognostic (4.87e-3)"	"unprognostic (3.90e-4)"	"unprognostic (2.97e-1)"	"unprognostic (1.40e-3)"	"unprognostic (3.71e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.46e-3)"	0.3	0.0	0.3	0.3	0.3	0.0	3.6	0.3	1.0	2.8	0.3	0.3	5.7	0.0	0.3	8.0	7.1	1.7	0.3	0.3	0.3	0.0	0.3	0.3	3.3	0.3	0.3	0.3	0.3	0.3	0.0	2.3	3.0	0.3	11.9	0.0	0.3	5.7	6.1	11.9	24.3	0.3	1.4	0.3	0.3	0.0	1.3	0.3	1.4	0.9	2.3	2.2	6.2	5.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.1	1.3	0.0	0.0	5.5	0.0	0.0	0.0	0.0	2.0	8.1	0.0	2.1	0.0	18.3	0.0	6.8	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	30.3	0.0	0.9	0.0	0.0	0.1	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	5.1	0.0	0.0	0.4	0.1	0.0	4.8	0.0	0.1	1.1	2.2	0.1	5.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	1.0	0.3	0.0	0.3	0.3	0.3	0.3
NTN3	NTN2L	ENSG00000162068	"Netrin 3"	O00634	16	2471499-2474145	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.3"	"Cell line enhanced"	"Detected in some"		"REH: 8.0;SCLC-21H: 10.3;SH-SY5Y: 5.7"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050817	Uncertain				"Secreted in brain"					"HPA050817: "	"unprognostic (2.60e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.17e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.23e-2)"	"unprognostic (9.62e-3)"	"unprognostic (2.11e-1)"	"unprognostic (4.55e-2)"	"unprognostic (6.95e-2)"	"unprognostic (5.58e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.26e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.39e-2)"	"unprognostic (6.61e-2)"	1.2	0.7	5.8	0.5	6.0	0.8	0.5	1.4	3.8	1.8	0.6	1.6	0.0	0.3	1.9	0.5	0.4	0.8	0.6	0.8	6.3	2.4	0.6	1.5	0.5	0.7	1.8	3.0	0.3	2.1	0.3	1.3	0.5	4.7	0.6	0.3	1.3	1.0	0.9	1.0	0.3	0.9	0.3	2.3	1.1	0.5	3.1	3.3	2.5	0.8	0.0	0.4	0.4	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.9	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.6	0.2	0.5	0.1	0.0	0.3	0.1	0.0	0.0	1.2	1.2	0.1	2.3	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	1.2	0.3	0.1	8.0	0.1	0.2	0.0	0.0	10.3	5.7	0.0	0.0	0.1	0.1	0.0	0.0	0.3	1.5	0.1	0.1	0.5	0.4	0.7	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	6.0	1.4	3.8	6.3	2.4	1.8	3.0	4.7	3.3
NTS		ENSG00000133636	Neurotensin	P30990	12	85874295-85882992	"Predicted secreted proteins"		Vasoactive		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 115.3"	"Cell line enriched"	"Detected in some"	5	"HEL: 32.5"	"Cancer enhanced"	"Detected in many"		"lung cancer: 155.1"	"Group enriched"	"Detected in many"	4	"hippocampal formation: 10.3;hypothalamus: 22.1;midbrain: 6.3;pons and medulla: 25.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 81.8"	HPA026664	Enhanced				"Secreted to digestive system"	120000	120000			"HPA026664: "	"unprognostic (3.63e-1)"	"prognostic favourable (9.94e-5)"	"unprognostic (8.18e-2)"	"prognostic unfavourable (5.10e-4)"	"unprognostic (1.99e-2)"	"unprognostic (3.04e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.53e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.30e-6)"	"unprognostic (2.94e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.48e-2)"	2.9	0.6	3.9	1.4	3.2	0.1	2.5	0.3	0.4	0.5	5.2	2.5	0.0	2.8	0.2	1.6	2.5	0.5	0.8	0.8	10.3	22.1	0.9	0.7	2.0	15.1	6.3	0.1	0.7	0.4	0.1	15.0	0.3	25.0	0.4	0.7	0.0	1.6	0.5	0.1	0.1	115.3	0.5	2.7	0.2	18.8	0.3	0.4	0.1	0.9	0.8	1.2	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.7	32.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.2	2.7	0.0	1.1	0.0	0.0	0.0	3.6	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	3.2	0.3	0.4	10.3	22.1	6.3	0.1	25.0	0.4
NUCB1	"Calnuc, NUC"	ENSG00000104805	"Nucleobindin 1"	Q02818	19	48900050-48923372	"Plasma proteins, Predicted secreted proteins"		"DNA-binding, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008176	Supported		Supported	"Golgi apparatus,Microtubules"	"Secreted to blood"	15000000	15000000	"Golgi apparatus"	Microtubules	"HPA008176: AB_1845923"	"unprognostic (2.13e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.36e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.95e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.51e-2)"	"unprognostic (8.14e-3)"	"unprognostic (2.34e-3)"	"unprognostic (9.89e-2)"	"unprognostic (5.04e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.90e-3)"	"unprognostic (3.41e-1)"	49.5	32.2	18.1	30.5	20.2	19.3	50.1	17.9	36.0	31.0	42.5	24.8	32.5	51.6	36.7	46.8	33.1	30.7	47.2	58.8	16.8	20.3	56.7	144.7	42.6	48.4	20.5	25.2	40.0	37.4	42.7	21.3	46.9	29.1	36.6	15.3	31.0	37.8	29.7	46.7	26.0	51.8	36.7	20.7	32.4	33.4	19.0	15.9	17.1	48.0	29.0	23.2	36.4	58.2	19.1	42.3	39.2	47.7	24.4	40.2	40.1	10.1	32.9	15.8	34.0	57.4	44.4	18.2	39.3	34.7	19.1	26.9	16.5	36.8	9.8	29.9	47.8	24.1	9.0	19.2	8.1	35.7	16.4	25.5	23.4	21.3	27.8	15.4	33.9	52.2	8.5	18.2	12.1	29.3	31.0	52.3	18.6	12.1	7.4	9.6	7.8	17.1	13.9	23.7	20.6	14.1	24.2	11.3	23.4	45.9	28.4	15.6	14.5	20.3	44.1	32.4	22.1	20.0	18.5	39.5	90.7	6.7	24.9	9.7	37.9	31.6	39.6	37.6	40.2	47.7	30.4	19.1	27.3	30.5	29.9	15.5	22.9	22.7	39.2	24.4	40.7	42.3	27.0	40.1	18.1	20.2	17.9	36.0	16.8	20.3	20.5	25.2	29.1	15.9
NXPH2	NPH2	ENSG00000144227	"Neurexophilin 2"	O95156	2	138670772-138780348	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	15	"brain: 23.0;kidney: 8.0;ovary: 19.3"	"Cell line enhanced"	"Detected in some"		"AF22: 6.2;SCLC-21H: 2.4;SiHa: 6.0;U-2 OS: 9.9;U-251 MG: 3.2"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in many"	4	"pons and medulla: 23.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA034759	Approved				"Secreted in brain"					"HPA034759: AB_10669732"	"unprognostic (5.83e-2)"				"unprognostic (8.83e-2)"			"unprognostic (1.41e-1)"		"unprognostic (2.72e-1)"	"unprognostic (1.80e-1)"							0.4	0.5	3.1	0.6	3.7	0.2	0.4	0.8	6.0	0.6	0.3	0.0	0.0	0.2	1.1	0.5	0.2	0.6	0.2	0.2	1.9	1.5	8.0	0.3	0.3	0.2	2.4	2.0	19.3	0.2	0.4	0.4	0.4	23.0	0.3	0.3	0.5	0.2	1.1	0.2	0.2	0.4	0.3	0.7	0.2	0.2	0.4	0.8	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	2.4	1.6	6.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	3.7	0.8	5.6	1.9	1.5	2.4	2.0	23.0	0.8
NXPH3	NPH3	ENSG00000182575	"Neurexophilin 3"	O95157	17	49575858-49583827	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"BEWO: 17.7;BJ: 5.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"cerebellum: 61.3"						"Secreted in brain"						"unprognostic (2.39e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.01e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.03e-2)"	"unprognostic (6.33e-2)"	"unprognostic (4.62e-4)"	"unprognostic (2.59e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.05e-3)"	4.5	2.4	3.2	2.9	7.4	0.3	3.9	23.5	16.4	18.9	8.9	3.4	0.0	1.2	11.3	3.8	4.5	8.0	4.0	5.0	4.7	3.4	0.8	0.4	5.1	1.3	2.7	7.7	9.2	1.6	0.7	7.2	4.1	5.1	11.2	1.6	6.8	6.0	12.3	2.6	2.1	1.7	11.0	1.7	1.2	3.6	3.5	3.2	0.0	1.4	3.9	1.2	15.9	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	17.7	5.6	0.6	0.4	0.2	0.8	0.0	0.0	0.3	0.1	0.1	0.6	0.2	0.1	0.0	0.4	0.0	0.1	0.5	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.6	0.1	0.2	0.1	0.5	0.0	0.0	2.0	0.0	0.0	0.4	0.3	0.1	0.0	1.8	0.1	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	7.4	23.5	11.4	4.7	3.4	2.7	7.7	5.1	3.2
NXPH4	NPH4	ENSG00000182379	"Neurexophilin 4"	O95158	12	57216795-57226449	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.1;skin 1: 17.7"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 34.4;RH-30: 28.2;RPMI-8226: 18.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.9"	"Lineage enriched"	"Detected in single"	19	"B-cells: 1.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted in brain"						"unprognostic (1.08e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.70e-3)"	"prognostic unfavourable (6.21e-4)"	"prognostic unfavourable (5.42e-4)"	"unprognostic (1.16e-1)"	"prognostic unfavourable (2.57e-4)"	"unprognostic (3.07e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.92e-3)"	"unprognostic (6.77e-2)"	"prognostic unfavourable (7.68e-6)"	"unprognostic (7.83e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.03e-3)"	2.8	1.4	2.6	0.8	3.8	0.9	1.9	18.1	9.4	1.9	0.4	0.0	0.0	0.3	0.3	0.7	2.5	0.4	0.4	4.6	1.6	3.7	0.7	1.1	0.4	1.1	2.6	6.2	0.3	1.6	0.7	0.7	4.8	10.9	8.2	0.3	2.7	3.2	0.4	0.6	17.7	0.4	0.5	3.4	0.8	0.4	1.3	0.0	0.0	1.0	0.7	1.7	0.5	2.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.6	0.1	34.4	4.0	1.0	3.2	2.2	5.1	0.9	1.2	2.2	0.4	8.5	3.5	2.2	7.2	4.6	1.0	0.3	1.4	9.2	0.0	0.3	0.1	3.4	0.3	1.1	0.9	1.8	0.9	1.4	0.0	0.3	9.0	0.7	8.0	0.0	0.0	0.3	6.0	0.4	28.2	18.5	0.0	1.4	5.6	0.3	4.9	10.1	9.8	10.0	0.2	0.0	2.5	8.2	1.0	2.5	4.9	0.9	3.0	1.6	4.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.8	18.1	5.7	1.6	3.7	2.6	6.2	10.9	0.0
OBP2A	"hOBPIIa, LCN13, OBP"	ENSG00000122136	"Odorant binding protein 2A"	Q9NY56	9	135546139-135549969	"Predicted secreted proteins"	"Olfaction, Sensory transduction, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"fallopian tube: 23.7;testis: 13.3"	"Group enriched"	"Detected in some"	11	"U-266/70: 2.7;U-266/84: 10.3"	"Cancer enriched"	"Detected in some"	6	"ovarian cancer: 18.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA055955	Uncertain				"Secreted in other tissues"					"HPA055955: "	"unprognostic (2.30e-1)"	"unprognostic (3.68e-1)"	"unprognostic (4.63e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.20e-1)"		"unprognostic (2.75e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.23e-2)"	"unprognostic (8.27e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.83e-11)"	"unprognostic (5.17e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.84e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.8	0.1	23.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.1	0.0	1.2	0.4	0.1	0.4	0.0	0.1	0.1	0.1	0.1	2.9	0.1	0.1	0.1	0.2	0.0	13.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
OBP2B	"hOBPIIb, LCN14"	ENSG00000171102	"Odorant binding protein 2B"	Q9NPH6	9	133205277-133209250	"Predicted secreted proteins"	"Olfaction, Sensory transduction, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 3.6;skin 1: 3.0;testis: 12.1"	"Cell line enhanced"	"Detected in single"		"U-266/84: 2.3"	"Group enriched"	"Detected in many"	8	"breast cancer: 7.8;endometrial cancer: 16.2;ovarian cancer: 4.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"						"unprognostic (1.40e-1)"		"unprognostic (5.70e-2)"	"unprognostic (9.45e-3)"	"unprognostic (6.65e-2)"					"unprognostic (1.04e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.03e-2)"	"unprognostic (6.82e-6)"	"unprognostic (2.00e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.53e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0			0.0	1.2	2.5	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.1	0.1		0.0	0.0		0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.1	0.0	12.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OC90	PLA2L	ENSG00000253117	"Otoconin 90"	Q02509	8	132024220-132059380	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 1.5;lymphoid tissue: 1.1;placenta: 1.3;retina: 2.9"	"Cell line enriched"	"Detected in single"	46	"SK-MEL-30: 4.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"														"unprognostic (1.92e-1)"						"unprognostic (2.93e-1)"			0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.4	0.2	0.7	1.5	0.0	0.0	0.0
ODAPH	"AI2A4, C4orf26, FLJ23657"	ENSG00000174792	"Odontogenesis associated phosphoprotein"	Q17RF5	4	75556048-75565885	"Disease related genes, Predicted secreted proteins"			"Amelogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"blood: 10.4;placenta: 34.3"	"Cell line enriched"	"Detected in some"	5	"HDLM-2: 30.4"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.1"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	20	"basophil: 10.4"	"Lineage enriched"	"Detected in single"	24	"granulocytes: 10.4"														"Secreted in other tissues"						"unprognostic (1.13e-1)"	"unprognostic (4.45e-3)"	"unprognostic (3.78e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.12e-2)"		"unprognostic (1.75e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.87e-2)"	"unprognostic (5.30e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.17e-7)"	"unprognostic (8.31e-2)"	"unprognostic (2.70e-2)"	"unprognostic (8.40e-4)"	"unprognostic (6.53e-3)"	0.3	0.1	1.5	0.4	1.9	0.6	0.2	1.2	0.9	0.3	0.2	0.2	0.2	0.1	0.3	0.4	0.4	0.1	0.3	0.2	1.9	1.5	0.3	0.4	0.3	0.5	2.4	0.2	0.4	0.2	0.0	1.3	34.3	0.7	0.2	0.5	0.2	0.2	0.3	1.6	0.9	0.3	0.2	2.7	0.4	0.3	0.8	0.4	0.2	0.2	0.2	0.7	0.2	0.2	0.4	0.1	10.4	0.2	0.2	0.3	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.2	30.4	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	1.4	0.0	0.1	0.1	0.0	0.0	1.4	0.1	0.4	5.5	0.0	0.1	0.3	0.1	0.0	10.4	0.2	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.5	0.2	0.1	0.1	0.1	0.1	1.5	1.9	1.2	0.9	1.9	1.5	2.4	0.2	0.7	0.4
OIT3	"FLJ39116, LZP"	ENSG00000138315	"Oncoprotein induced transcript 3"	Q8WWZ8	10	72893581-72933033	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 49.1"	"Group enriched"	"Detected in some"	6	"CACO-2: 5.6;Hep G2: 5.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	150000000	150000000				"unprognostic (2.42e-2)"	"unprognostic (6.76e-2)"	"unprognostic (7.98e-4)"	"unprognostic (9.26e-2)"	"unprognostic (9.47e-4)"	"unprognostic (3.05e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.50e-3)"	"unprognostic (1.41e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.19e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.1	0.1	2.2	0.1	0.1	0.3	0.0	0.1	2.0	0.1	0.0	0.6	49.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.0	2.5	0.1	0.1	6.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.3	0.0	0.2	0.3	0.3	0.0	0.1	0.0	0.0	0.0	5.6	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.4	0.3	5.9	0.2	0.2	0.1	0.4	0.2	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.3	0.1
OLFM4	"GC1, GW112, OlfD"	ENSG00000102837	"Olfactomedin 4"	Q6UX06	13	53028759-53052057	"Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 280.2;pancreas: 105.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.4;BJ hTERT+: 15.2;HaCaT: 21.3;RPMI-8226: 4.7"	"Group enriched"	"Detected in many"	14	"colorectal cancer: 711.4;pancreatic cancer: 594.7;stomach cancer: 724.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.4"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA077718	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol"	"Secreted in other tissues"			"Nucleoplasm, Plasma membrane"	"Cytokinetic bridge, Cytosol"	"HPA077718: "	"prognostic favourable (8.77e-4)"	"unprognostic (4.84e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.33e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.37e-2)"	"unprognostic (4.84e-3)"	0.3	0.0	0.3	18.1	0.3	11.4	2.5	0.3	0.5	50.3	132.5	0.4	0.2	121.4	0.8	3.3	0.5	0.9	6.0	1.1	0.3	0.1	7.5	0.3	1.6	0.4	0.3	0.2	0.7	105.8	0.0	0.2	0.9	0.3	16.2	58.9	0.2	2.9	0.2	0.3	0.1	280.2	5.6	0.2	2.2	2.4	1.4	0.3	1.8	0.3	0.4	0.3	18.4	40.9	0.0	0.0	1.4	0.6	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	4.4	1.9	15.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	21.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.7	4.7	0.1	0.0	0.9	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.5	0.7	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.6	0.0	0.0	0.9	0.3	0.3	0.3	0.5	0.3	0.1	0.3	0.2	0.3	0.3
OLFML1	UNQ564	ENSG00000183801	"Olfactomedin like 1"	Q6UWY5	11	7485388-7511377	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"BEWO: 23.9;U-2197: 15.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA039735	Uncertain				"Secreted - unknown location"	270000	270000			"HPA039735: AB_10673148"	"unprognostic (3.05e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.80e-2)"	"unprognostic (5.32e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavourable (4.28e-8)"	"unprognostic (3.13e-3)"	"unprognostic (2.00e-2)"	"unprognostic (3.34e-2)"	"unprognostic (8.72e-3)"	16.8	3.0	0.8	6.2	1.3	0.0	9.4	1.8	2.1	32.2	6.4	2.5	7.6	2.0	28.0	19.9	17.1	10.5	15.3	11.8	1.7	0.8	4.2	5.1	12.4	5.3	1.6	1.8	32.1	2.8	0.6	2.6	3.1	4.5	27.9	4.8	14.6	5.1	11.8	5.4	5.4	6.9	12.9	1.2	8.3	4.5	8.0	0.6	0.7	6.8	14.3	5.4	12.9	15.4	2.7	0.6	0.9	3.0	0.2	0.5	0.1	0.0	0.0	0.3	0.0	1.5	1.5	23.9	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.2	0.0	0.1	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	15.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.9	0.3	0.9	0.3	1.7	0.3	0.0	0.2	2.7	0.5	0.5	0.9	0.2	3.0	0.6	0.1	0.1	0.8	1.3	1.8	2.1	1.7	0.8	1.6	1.8	4.5	0.6
OMD	"osteoadherin, SLRR2C"	ENSG00000127083	Osteomodulin	Q99983	9	92414245-92424461	"Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	14	"ASC diff: 12.3;ASC TERT1: 11.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069948			Approved	"Nucleoli fibrillar center,Endoplasmic reticulum"	"Secreted in other tissues"	14000000	14000000	"Endoplasmic reticulum"	"Nucleoli fibrillar center"	"HPA069948: "	"unprognostic (1.18e-1)"	"unprognostic (2.33e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.26e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.87e-2)"	"unprognostic (4.31e-3)"	"unprognostic (6.42e-2)"	"unprognostic (4.53e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.02e-3)"	"unprognostic (5.81e-3)"	"unprognostic (6.35e-2)"	"unprognostic (2.84e-3)"	"unprognostic (2.08e-3)"	14.0	7.9	2.2	1.2	4.3	0.0	14.6	3.7	3.4	20.3	8.3	1.0	8.0	0.8	8.2	19.3	14.0	8.7	8.9	20.2	2.8	1.7	2.9	0.8	12.2	0.8	7.0	5.4	15.3	1.8	1.5	4.2	11.5	6.0	13.6	2.2	14.2	2.3	4.2	2.8	3.5	3.7	13.9	19.3	0.7	5.0	12.8	1.3	0.2	9.2	14.5	3.2	22.1	7.6	0.3	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	12.3	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.3	0.0	0.2	0.0	0.3	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	2.2	4.3	3.7	3.4	2.8	1.7	7.0	5.4	6.0	1.3
OPRPN	"BPLP, PRL1, PROL1"	ENSG00000171199	"Opiorphin prepropeptide"	Q99935	4	70397882-70410194	"Predicted secreted proteins"		"Protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	27	"breast: 19.1;salivary gland: 59.7"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"breast cancer: 7.4;liver cancer: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA065711	Approved				"Secreted in other tissues"	36000	36000			"HPA065711: "	"unprognostic (3.11e-3)"						"unprognostic (2.22e-2)"											0.0	0.0	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.4	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OPTC		ENSG00000188770	Opticin	Q9UBM4	1	203494143-203508864	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	92	"retina: 245.8"	"Cell line enhanced"	"Detected in some"		"BJ: 1.0;HeLa: 1.5;NTERA-2: 2.5;RT4: 1.6;SCLC-21H: 1.2;U-2 OS: 1.0"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA034951, HPA034952"	Enhanced				"Secreted in other tissues"					"HPA034951: AB_10669852, HPA034952: AB_2674379"				"unprognostic (3.29e-1)"	"unprognostic (1.56e-1)"					"unprognostic (7.69e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.70e-3)"		"unprognostic (8.24e-2)"	"unprognostic (3.65e-2)"			0.3	0.0	0.2	0.1	0.2	0.0	0.2	0.4	1.0	0.4	1.3	0.1	0.1	0.4	1.3	2.2	0.8	0.8	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	1.1	0.3	0.0	0.1	0.4	0.1	0.7	0.3	245.8	0.1	0.6	0.1	1.1	0.2	1.1	0.1	0.1	0.1	2.6	0.1	0.1	0.2	0.1	0.1	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.2	1.0	0.3	0.0	0.0	0.0	0.1	0.4	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.7	0.0	0.1	0.0	0.0	1.6	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.1	0.1	0.2	0.2	0.1	0.1	0.1
ORM1		ENSG00000229314	"Orosomucoid 1"	P02763	9	114323056-114326475	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Acute phase, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"liver: 834.6"	"Cell line enriched"	"Detected in some"	11	"Hep G2: 157.9"	"Cancer enriched"	"Detected in many"	16	"liver cancer: 2506.9"					"Cell type enriched"	"Detected in some"	45	"neutrophil: 53.4"	"Lineage enriched"	"Detected in many"	45	"granulocytes: 53.4"									"CAB006265, HPA046438, HPA047725, HPA057726"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	120000000000	120000000000	Vesicles	"Golgi apparatus"	"CAB006265: AB_425575, HPA046438: , HPA047725: , HPA057726: "	"unprognostic (3.85e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.26e-1)"		"unprognostic (1.16e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavourable (2.35e-4)"	"unprognostic (2.10e-1)"	"unprognostic (4.38e-2)"	"unprognostic (9.32e-3)"	"unprognostic (4.51e-2)"	0.1	0.0	0.0	0.2	0.0	6.7	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	834.6	0.3	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.6	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.0			0.0		0.0	0.0	0.0	0.0	0.0	53.4	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	157.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.0	13.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.6	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.4	0.0	0.2	0.0	0.0	0.3										
ORM2	"AGP-B, AGP-B', AGP2"	ENSG00000228278	"Orosomucoid 2"	P19652	9	114329869-114333252	"Plasma proteins, Predicted secreted proteins"	"Acute phase, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"liver: 404.1"	"Cell line enriched"	"Detected in single"	237	"Hep G2: 133.4"	"Cancer enriched"	"Detected in many"	34	"liver cancer: 873.1"					"Cell type enriched"	"Detected in single"	35	"neutrophil: 13.2"	"Lineage enriched"	"Detected in single"	35	"granulocytes: 13.2"									"HPA046438, HPA047725, HPA057726"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	61000000000	61000000000	Vesicles	"Golgi apparatus"	"HPA046438: , HPA047725: , HPA057726: "	"unprognostic (6.77e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.61e-2)"	"unprognostic (5.66e-2)"	"unprognostic (9.70e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-2)"	"unprognostic (5.76e-2)"	"prognostic unfavourable (1.23e-9)"	"unprognostic (3.23e-1)"	"unprognostic (6.80e-2)"	"unprognostic (7.62e-2)"	"unprognostic (9.15e-4)"	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	404.1	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0		1.2	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	13.2	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	133.4	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.1	0.0	0.0	0.1										
OSTN		ENSG00000188729	Osteocrin	P61366	3	191199241-191265615	"Predicted secreted proteins"	Differentiation	"Developmental protein, Hormone"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 7.8;brain: 7.9;prostate: 8.0"	"Cell line enriched"	"Detected in some"	24	"U-2197: 29.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"memory B-cell: 7.8"	"Lineage enriched"	"Detected in single"	10	"B-cells: 7.8"	"Region enriched"	"Detected in single"	4	"cerebellum: 1.2"	"Low region specificity"	"Detected in all"			"CAB024997, CAB025649, HPA030878"	Uncertain				"Secreted in other tissues"					"CAB024997: , CAB025649: , HPA030878: "					"unprognostic (2.35e-2)"		"unprognostic (9.12e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.52e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.45e-1)"			0.9	0.4	1.9	1.6	2.1	0.0	0.6	0.2	7.9	7.1	0.4	0.0	0.0	0.0	0.2	4.4	0.1	1.9	1.9	1.5	1.8	1.9	0.5	1.6	1.0	1.3	1.5	2.4	0.5	0.1	0.0	0.3	1.1	0.4	8.0	0.1	0.0	0.4	0.2	2.3	3.4	0.3	2.3	1.1	0.5	0.6	1.1	0.0	0.0	0.6	0.7	0.0	3.7	1.0	7.8	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.5	0.0	1.2	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	1.9	2.1	0.2	7.9	1.8	1.9	1.5	2.4	0.4	0.0
OTOL1	"C1QTNF15, C1QTNF16"	ENSG00000182447	"Otolin 1"	A6NHN0	3	161496808-161503942	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	8	"brain: 3.7"	"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.1"	HPA041030	Uncertain				"Secreted in other tissues"					"HPA041030: AB_10795000"																		0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.1	0.0	0.0	0.1		0.0	0.0	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4			0.0		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OTOR	"FDP, MIAL, MIAL1"	ENSG00000125879	Otoraplin	Q9NRC9	20	16748358-16770062	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 1.3;stomach 1: 1.2"	"Cell line enriched"	"Detected in some"	5	"SK-BR-3: 16.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA024335	Uncertain				"Secreted in other tissues"					"HPA024335: AB_1854838"	"unprognostic (8.50e-3)"				"unprognostic (9.56e-2)"						"unprognostic (2.34e-1)"				"unprognostic (1.81e-1)"	"unprognostic (1.72e-1)"		0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0			0.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3		0.3	0.0	0.0	0.1	0.0		0.0	0.0		0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0			0.3		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	16.6	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OTOS	OTOSP	ENSG00000178602	Otospiralin	Q8NHW6	2	240139026-240144562	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"pituitary gland: 39.1;thyroid gland: 41.0"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.0;hTEC/SVTERT24-B: 1.8;U-138 MG: 2.2"	"Group enriched"	"Detected in some"	13	"glioma: 6.5;thyroid cancer: 28.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"hippocampal formation: 1.8"	"Low region specificity"	"Detected in all"								"Secreted in other tissues"						"unprognostic (8.52e-2)"			"unprognostic (1.73e-1)"	"unprognostic (9.01e-3)"					"unprognostic (1.35e-1)"					"unprognostic (2.72e-1)"	"unprognostic (3.27e-3)"		0.3	0.3	4.5	0.3	4.6	0.3	0.4	0.3	3.8	0.5	0.3	0.7	0.0	0.3	0.4	0.7	0.3	0.4	0.3	0.3	2.4	1.1	0.3	0.3	0.3	0.3	0.6	2.0	0.3	0.3	0.3	39.1	0.3	5.5	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.8	0.3	0.3	0.4	0.8	0.0	41.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.3	0.0	0.0	0.0	0.5	0.0	0.0	2.2	0.7	0.0	0.5	0.0	0.1	0.0	0.4	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	4.6	0.3	3.8	2.4	1.1	0.6	2.0	5.5	0.8
OVCH2	OVTN	ENSG00000183378	"Ovochymase 2 (gene/pseudogene)"		11	7689438-7706421	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	23	"epididymis: 60.7"	"Cell line enriched"	"Detected in some"	7	"REH: 21.9"	"Low cancer specificity"	"Detected in single"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 0.2"						"Secreted in male reproductive system"						"unprognostic (1.59e-2)"	"unprognostic (3.74e-1)"		"unprognostic (8.03e-2)"		"unprognostic (9.77e-2)"		"unprognostic (1.85e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.06e-1)"	"unprognostic (9.27e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.22e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	60.7	0.0	0.0	0.0	0.0	0.0		1.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.6	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.0	3.1	0.0	0.2	0.0	0.0	0.0	0.4	0.6	0.6	0.1	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	21.9	0.0	0.1	0.2	2.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0										
OXT	"OT, OT-NPI, OXT-NPI"	ENSG00000101405	"Oxytocin/neurophysin I prepropeptide"	P01178	20	3071620-3072517	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 232.0"	"Group enriched"	"Detected in some"	4	"CACO-2: 5.1;HL-60: 1.3;HMC-1: 3.7;PC-3: 2.6"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 12.1"	"Region enriched"	"Detected in some"	59	"hypothalamus: 232.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in some"	5	"hypothalamus: 210.0"	"Group enriched"	"Detected in some"	878	"basal ganglia: 840.1;hypothalamus: 2453.1"	HPA071892	Supported	Supported			"Secreted to blood"					"HPA071892: "	"unprognostic (7.45e-3)"	"unprognostic (1.99e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.82e-2)"	"unprognostic (8.22e-2)"	"unprognostic (8.36e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.05e-2)"	"unprognostic (6.65e-2)"	"unprognostic (6.18e-1)"	"unprognostic (3.81e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.10e-1)"	5.0	0.2	0.0	0.1	3.9	0.2	0.2	0.0	0.3	0.1	0.0	0.4	0.0	2.6	0.0	3.8	0.0	0.0	0.0	0.0	0.1	232.0	1.6	24.0	0.2	0.2	0.0	0.0	0.2	0.0	0.0	1.8	0.6	0.2	0.2	0.0	0.0	0.4	0.2	0.2	0.2	2.4	0.0	0.0	0.2	0.2	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.7	1.5	6.3	0.4	0.4	3.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	6.3	0.8	0.4	1.0	3.7	1.7	1.1	0.9	3.6	3.2	3.6	1.1	0.4	0.0	1.5	2.4	0.9	0.0	3.9	0.0	0.3	0.1	232.0	0.0	0.0	0.2	0.0
PAPPA	"ASBABP2, DIPLA1, IGFBP-4ase, PAPA, PAPP-A, PAPPA1"	ENSG00000182752	"Pappalysin 1"	Q13219	9	116153804-116402322	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	86	"placenta: 484.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 19.0;ASC TERT1: 14.5;HSkMC: 52.2;U-138 MG: 13.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"midbrain: 10.4;olfactory region: 4.1;pons and medulla: 8.3;thalamus: 4.8"	"HPA001667, CAB016724"	Enhanced				"Secreted in female reproductive system"	41000	41000			"CAB016724: , HPA001667: AB_1854960"	"unprognostic (3.25e-1)"	"unprognostic (6.18e-6)"	"unprognostic (2.47e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.42e-3)"	"unprognostic (5.44e-2)"	"unprognostic (3.87e-2)"	"unprognostic (6.87e-3)"	"unprognostic (8.25e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.37e-3)"	"unprognostic (2.48e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.02e-3)"	4.8	2.3	0.5	1.0	0.5	0.0	0.8	0.4	0.6	3.6	2.4	0.6	1.0	0.1	3.5	1.0	3.6	2.0	1.1	3.7	0.4	0.0	4.3	0.5	2.4	0.7	0.4	0.4	1.4	0.7	5.6	0.7	484.6	0.7	1.4	0.9	0.9	0.5	1.2	0.5	1.1	0.9	2.4	0.6	0.6	1.0	0.8	0.5	0.4	1.3	1.0	1.0	2.3	3.4	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	5.4	8.3	0.0	19.0	14.5	0.0	4.4	7.8	1.2	2.1	0.0	0.0	0.0	0.0	3.1	0.6	0.0	0.0	5.9	0.0	0.0	0.9	4.5	0.0	9.2	0.0	0.0	52.2	0.0	6.1	0.7	0.0	0.2	0.0	1.4	0.0	0.0	0.0	2.4	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	10.5	13.6	0.7	0.3	0.5	0.0	0.0	0.0	9.7	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.4	0.6	0.4	0.0	0.4	0.4	0.7	0.5
PATE1	PATE	ENSG00000171053	"Prostate and testis expressed 1"	Q8WXA2	11	125746293-125749867	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	28	"ductus deferens: 426.3;epididymis: 222.7;seminal vesicle: 185.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.8;NB-4: 6.4;RPMI-8226: 1.6;SH-SY5Y: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA076587	Approved				"Secreted in male reproductive system"					"HPA076587: "																		0.2	0.2	0.2	0.0	0.2	0.0	0.2	0.3	0.2	0.3	0.2	0.0	426.3	0.0	0.2	222.7	0.2	0.2	0.0	0.2	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.2	0.0	0.0	10.0	0.0	0.0	0.2	185.4	0.2	0.2	0.2	0.0	0.2	0.2	0.2	1.4	0.0	0.0	0.2	0.0	0.0	0.9	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	6.4	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.0	0.0	0.0
PATE2	"C11orf38, LVLF3112, PATE-M, UNQ3112"	ENSG00000196844	"Prostate and testis expressed 2"	Q6UY27	11	125776113-125778819	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"ductus deferens: 56.1;epididymis: 112.4;seminal vesicle: 44.9"	"Cell line enhanced"	"Detected in some"		"NB-4: 4.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"								"Secreted in male reproductive system"						"unprognostic (3.28e-1)"				"unprognostic (7.26e-2)"	"unprognostic (2.95e-1)"		"unprognostic (1.18e-2)"	"unprognostic (2.63e-1)"	"unprognostic (6.84e-3)"		"unprognostic (1.55e-2)"		"unprognostic (5.08e-1)"	"unprognostic (2.55e-1)"			0.1	0.1	0.4	0.0	1.0	0.1	0.1	0.7	0.6	0.1	0.2	0.0	56.1	0.0	0.1	112.4	0.0	0.1	0.0	0.2	0.5	0.9	0.1	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	1.0	0.0	0.0	1.2	0.0	0.0	0.0	44.9	0.1	0.0	0.0	0.0	0.4	0.0	0.1	4.2	0.0	0.0	0.1	0.0	0.0	0.9	0.1	0.5	0.2	1.6	0.6	0.2	1.0	0.0	0.9	0.0	0.2	0.7	0.4	0.0	1.7	0.5	0.2	0.6	0.3	0.4	0.8	0.2	0.6	0.5	0.4	0.1	0.3	0.8	0.7	0.3	0.7	1.1	0.0	0.0	0.7	1.4	0.0	0.1	0.7	0.5	0.0	0.6	1.7	0.1	1.6	0.5	4.4	1.6	1.6	1.2	0.1	1.9	0.7	0.7	0.4	0.5	2.6	1.6	0.3	1.4	2.0	2.7	0.8	0.6	0.9	0.6	0.9	0.5	0.8	1.5	0.7	1.5	0.7	0.6	0.6	0.3	0.6	0.2	0.3	0.2	0.1	0.2	0.5	1.0	0.3	1.6	0.2	0.3	0.2	0.3	0.0	0.4	1.0	0.7	0.6	0.5	0.9	1.1	0.0	0.0	0.0
PATE3	"HEL-127, PATE-DJ"	ENSG00000236027	"Prostate and testis expressed 3"	B3GLJ2	11	125788111-125791600	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"epididymis: 86.5"	"Cell line enhanced"	"Detected in some"		"NB-4: 2.7;RPMI-8226: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted in male reproductive system"																							0.1	0.1	0.2	0.0	0.3	0.0	0.1	0.3	0.2	0.1	0.1	0.0	8.7	0.0	0.1	86.5	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.1	3.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	2.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	2.7	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.2	0.1	0.1	0.1	0.0	0.0	0.0
PATE4	"FLJ41047, PATE-B"	ENSG00000237353	"Prostate and testis expressed 4"	P0C8F1	11	125833316-125840069	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	25	"ductus deferens: 194.5;seminal vesicle: 232.9"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA045632	Approved				"Secreted in male reproductive system"					"HPA045632: AB_10960489"	"unprognostic (4.90e-1)"									"unprognostic (2.93e-2)"		"unprognostic (1.03e-1)"		"unprognostic (1.91e-1)"				0.1	0.1	0.2	0.0	0.2	0.1	0.1	0.4	0.2	0.2	0.1	0.0	194.5	0.0	0.1	7.3	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.0	0.0	8.4	0.0	0.0	0.1	232.9	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.9	0.0	0.0	0.1	0.0	0.0	2.1	0.2	1.6	1.5	1.2	0.6	0.6	0.9	0.1	0.5	0.5	0.8	1.4	0.4	0.5	0.4	0.3	0.2	0.0	0.3	0.6	0.9	1.6	0.5	0.0	0.9	0.1	0.1	0.4	0.3	0.3	0.6	1.5	0.8	0.1	0.5	3.1	0.7	0.3	0.2	0.6	0.1	0.9	2.6	0.2	0.7	0.2	0.9	1.6	0.8	0.6	0.6	0.6	0.5	1.8	0.4	0.3	0.5	0.1	0.3	0.9	0.1	1.7	1.3	1.5	2.5	0.8	1.4	0.7	0.8	1.1	0.2	1.3	0.6	0.6	0.3	0.9	0.5	0.6	1.4	0.7	0.4	0.3	1.6	0.9	0.8	1.2	0.6	0.4	1.5	0.2	0.1	0.2	0.2	0.4	0.2	0.1	0.2	0.1	0.0	0.0	0.0
PCOLCE	"PCPE, PCPE1"	ENSG00000106333	"Procollagen C-endopeptidase enhancer"	Q15113	7	100602177-100608175	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 83.4;BJ hTERT+: 62.1;HSkMC: 95.6;SH-SY5Y: 66.7;U-2197: 117.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB017623, HPA042927"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to extracellular matrix"	1300000000	1300000000	"Golgi apparatus, Vesicles"		"CAB017623: AB_2251882, HPA042927: "	"unprognostic (4.14e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.93e-2)"	"prognostic unfavourable (9.76e-4)"	"unprognostic (2.16e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.13e-2)"	"prognostic unfavourable (1.68e-5)"	"unprognostic (1.04e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.43e-2)"	29.5	16.7	0.6	18.1	1.3	0.0	29.3	1.0	2.0	90.4	11.2	1.6	22.8	2.0	42.1	89.9	23.1	29.6	34.3	47.3	0.7	0.7	14.6	73.0	24.5	51.1	3.7	1.9	38.8	7.9	1.2	11.4	23.8	2.9	49.4	4.5	54.6	16.0	19.8	10.0	16.0	7.4	26.1	6.9	10.5	9.1	20.8	0.5	2.4	17.8	20.1	18.4	28.2	34.0	0.8	1.0	1.6	1.0	1.1	1.1	0.1	0.0	0.0	0.1	0.2	29.5	83.4	0.2	34.2	62.1	15.5	13.6	1.2	0.0	0.0	0.0	36.1	0.0	0.0	0.0	1.3	0.2	0.2	0.0	0.5	1.7	8.2	0.0	0.2	95.6	0.0	8.1	0.0	0.0	0.7	0.1	0.0	0.1	0.0	0.2	6.8	0.3	0.0	0.1	0.0	0.0	0.0	0.1	66.7	0.0	0.1	0.1	0.1	0.0	0.2	38.5	10.7	117.7	0.0	0.0	0.0	0.0	13.4	0.0	6.4	0.0	0.3	1.6	0.5	1.0	1.1	0.8	0.9	0.6	1.0	0.2	0.6	0.3	0.4	1.1	0.8	0.0	0.4	0.1	0.6	1.3	1.0	2.0	0.7	0.7	3.7	1.9	2.9	0.5
PCOLCE2	PCPE2	ENSG00000163710	"Procollagen C-endopeptidase enhancer 2"	Q9UKZ9	3	142815922-142889203	"Predicted secreted proteins"		Heparin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 55.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 25.4;RPMI-8226: 13.2;U-2197: 28.4;U-266/70: 28.2;U-266/84: 13.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	7	"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA013203	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"			"Nucleoplasm, Cytosol"		"HPA013203: AB_1855084"	"unprognostic (1.31e-1)"	"unprognostic (3.75e-2)"	"unprognostic (5.71e-6)"	"unprognostic (8.36e-6)"	"unprognostic (3.03e-2)"	"unprognostic (1.06e-3)"	"unprognostic (2.78e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavourable (1.96e-5)"	"unprognostic (1.85e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.74e-4)"	"prognostic unfavourable (1.08e-4)"	35.2	1.2	1.0	2.0	0.5	5.5	29.0	0.3	0.7	12.4	3.6	0.5	9.1	0.0	3.9	6.0	16.8	2.1	3.8	55.6	1.4	1.2	7.3	7.9	6.9	1.6	0.6	0.7	2.5	0.6	0.1	13.8	20.1	0.4	14.2	2.1	2.5	2.7	3.9	6.3	2.7	1.5	41.6	0.8	1.2	2.0	1.9	0.3	0.0	3.5	6.2	0.9	28.2	30.6	0.0	0.0	1.4	0.2	0.0	0.0	0.3	0.5	4.2	1.4	0.0	25.4	7.0	0.0	0.3	0.1	1.1	1.5	0.2	0.5	0.0	1.2	1.9	0.0	5.0	0.0	1.4	0.0	8.4	0.8	2.8	0.0	0.0	0.5	0.0	2.8	0.0	2.6	0.6	0.0	0.2	0.0	0.5	0.7	1.5	0.4	2.1	8.8	0.0	3.2	13.2	1.2	0.0	2.7	1.7	6.6	0.0	2.4	0.0	1.7	0.0	2.2	5.1	28.4	2.1	28.2	13.0	0.0	6.3	0.7	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	1.0	0.5	0.3	0.7	1.4	1.2	0.6	0.7	0.4	0.3
PCSK1N	"BigLEN, PEN, proSAAS, SAAS, SCG8, SgVIII"	ENSG00000102109	"Proprotein convertase subtilisin/kexin type 1 inhibitor"	Q9UHG2	X	48831094-48835633	"Predicted secreted proteins"		Neuropeptide		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 74.9;kidney: 72.9;pituitary gland: 127.7"	"Cell line enhanced"	"Detected in some"		"HEK 293: 19.6;PC-3: 49.6;SCLC-21H: 19.7;SH-SY5Y: 18.2;SiHa: 17.2;U-266/84: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"MAIT T-cell: 3.0;memory CD4 T-cell: 6.5;memory CD8 T-cell: 6.3;naive CD4 T-cell: 2.7;naive CD8 T-cell: 8.2;T-reg: 2.1"	"Lineage enriched"	"Detected in single"	77	"T-cells: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003925, HPA064734"	Enhanced	Supported	Approved	Vesicles	"Secreted to blood"	5300000	5300000	Vesicles		"HPA003925: AB_1079582, HPA064734: AB_2685339"	"unprognostic (2.44e-3)"	"unprognostic (5.86e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavourable (1.15e-4)"	"unprognostic (3.36e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.49e-2)"	"unprognostic (3.34e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.50e-3)"	"unprognostic (2.79e-3)"	"prognostic favourable (1.36e-4)"	"unprognostic (3.34e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.14e-1)"	4.1	27.5	49.1	2.6	72.7	2.1	2.2	15.6	70.3	3.2	9.8	10.8	1.5	12.4	4.4	10.9	2.1	2.3	2.8	2.7	38.5	74.9	72.9	2.1	2.6	2.2	33.5	29.0	2.2	20.0	12.4	127.7	2.3	32.9	4.6	2.7	6.6	2.8	3.1	2.2	2.8	8.5	2.7	18.3	2.4	26.0	3.8	9.8	0.0	2.2	0.0	2.1	2.1	0.5	0.1	0.0	0.0	0.0	0.0	8.2	0.8	0.0	1.8	0.0	5.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	3.5	0.0	0.2	0.0	0.3	0.0	0.0	19.6	0.0	0.0	2.9	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	2.7	49.6	0.0	0.0	0.1	0.4	0.0	19.7	18.2	17.2	0.0	1.4	0.0	0.0	0.0	0.0	7.6	0.0	1.6	4.5	22.9	0.0	0.1	0.0	0.5	0.0	0.0	0.0	1.1	0.0	3.0	0.0	6.5	6.3	0.0	0.1	2.7	8.2	0.0	0.0	0.0	0.0	2.1	0.8	49.1	72.7	15.6	70.3	38.5	74.9	33.5	29.0	32.9	9.8
PCSK9	"FH3, HCHOLA3, NARC-1"	ENSG00000169174	"Proprotein convertase subtilisin/kexin type 9"	Q8NBP7	1	55039548-55064852	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Apoptosis, Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Hydrolase, Protease, Serine protease"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 47.1;lung: 14.6"	"Cell line enhanced"	"Detected in some"		"A-431: 28.4;HaCaT: 38.1;HeLa: 33.2;RPTEC TERT1: 18.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"cerebellum: 6.9;pons and medulla: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"								"Secreted to blood"	300000000	300000000				"unprognostic (1.28e-3)"	"unprognostic (6.93e-2)"	"unprognostic (4.02e-1)"	"unprognostic (2.19e-2)"	"unprognostic (7.30e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.14e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.09e-3)"	"unprognostic (3.70e-2)"	"unprognostic (2.45e-4)"	"unprognostic (1.49e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavourable (2.40e-4)"	0.2	0.1	0.0	6.1	0.5	0.4	0.0	6.9	0.2	0.6	4.4	0.0	0.0	3.9	0.2	0.7	5.2	0.4	2.6	0.0	0.0	0.0	0.1	47.1	14.6	0.0	0.1	0.0	0.1	11.0	0.0	0.0	0.0	2.6	0.0	1.9	0.1	0.3	0.3	0.0	0.8	5.1	0.8	0.1	0.2	1.0	0.4	0.0	0.0	0.0	6.1	0.9	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.4	6.3	0.9	0.0	2.1	1.4	0.0	0.0	0.0	0.0	0.0	13.2	4.5	0.0	5.2	2.5	38.1	1.1	11.6	0.0	0.0	0.0	0.0	33.2	9.2	0.7	0.0	0.0	2.2	8.6	8.4	6.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	5.4	0.6	0.0	0.0	0.3	18.8	0.0	0.5	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.9	0.2	0.0	0.0	0.1	0.0	2.6	0.0
PDGFC	"fallotein, SCDGF"	ENSG00000145431	"Platelet derived growth factor C"	Q9NRA1	4	156760454-156971394	"Predicted secreted proteins, RAS pathway related proteins"		"Developmental protein, Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 18.4;fHDF/TERT166: 28.1;U-138 MG: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 2.1;intermediate monocyte: 1.0;non-classical monocyte: 1.4"	"Lineage enriched"	"Detected in single"	11	"monocytes: 2.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA009134	Approved		Supported	"Plasma membrane,Cytosol"	"Secreted to blood"			"Plasma membrane, Cytosol"		"HPA009134: AB_10601981"	"unprognostic (3.12e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.79e-2)"	"unprognostic (3.67e-2)"	"unprognostic (3.97e-1)"	"unprognostic (3.41e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.14e-1)"	"prognostic favourable (1.35e-5)"	"prognostic unfavourable (3.05e-4)"	"unprognostic (1.25e-1)"	"unprognostic (1.19e-2)"	"prognostic unfavourable (3.17e-4)"	11.5	9.1	3.2	6.5	3.4	0.7	7.9	1.3	3.5	21.8	6.1	1.9	8.4	2.2	21.3	9.4	6.1	9.0	12.7	3.6	2.4	2.0	9.7	10.3	6.9	4.3	2.2	3.8	10.4	9.8	28.0	2.2	4.9	1.9	17.7	2.4	5.5	26.6	9.3	6.5	4.1	5.4	11.9	2.0	4.1	5.6	4.3	1.7	2.2	10.4	4.4	1.5	8.3	4.7	0.0	0.2	0.0	2.1	0.0	0.0	0.7	1.0	1.6	18.4	12.1	3.4	6.7	0.4	9.6	10.2	5.8	7.8	1.0	4.3	0.0	1.7	28.1	1.1	5.1	6.3	8.0	0.0	2.3	11.2	1.7	1.0	9.0	1.7	0.1	6.9	3.2	14.7	10.6	2.8	0.0	0.0	14.3	0.0	0.0	0.0	0.2	0.7	0.0	3.8	0.0	11.0	0.4	0.0	0.0	0.0	0.0	0.1	1.4	0.5	12.4	20.0	0.2	5.0	7.8	0.0	0.0	0.0	7.6	0.0	0.7	0.0	2.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.7	3.2	3.4	1.3	3.5	2.4	2.0	2.2	3.8	1.9	1.7
PDGFRL	PRLTS	ENSG00000104213	"Platelet derived growth factor receptor like"	Q15198	8	17576433-17644071	"Disease related genes, Predicted secreted proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 14.3"	"Group enriched"	"Detected in some"	5	"AN3-CA: 48.4;BJ hTERT+: 39.2;HSkMC: 21.4"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.4;neutrophil: 1.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA052801			Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"	"Secreted - unknown location"			"Nucleoli, Golgi apparatus"	Nucleoplasm	"HPA052801: "	"unprognostic (1.25e-1)"	"unprognostic (1.73e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.59e-2)"	"unprognostic (7.39e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.54e-2)"	"unprognostic (3.86e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.72e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.58e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.47e-3)"	"unprognostic (6.00e-3)"	7.7	0.4	0.5	0.1	0.9	0.0	14.3	0.6	0.5	8.0	1.3			0.0	3.6	2.0	0.3	5.8	2.6	1.2	0.3	0.4	0.4	0.3	0.7	0.0	0.4		11.6	1.6	2.3	2.0	1.5		0.9	0.0		1.4	1.1	3.3	1.8	0.6	6.3	0.5	0.2	1.0	0.9			8.3		0.0	0.9	2.0	0.0	0.9	1.4	1.4	0.0	0.0	0.1	0.0	4.4	0.2	48.4	1.5	0.6	3.1	0.9	39.2	1.8	7.8	0.2	0.0	0.0	0.2	0.6	0.0	2.6	0.2	0.9	0.0	2.9	0.0	1.4	1.0	3.7	0.0	0.0	21.4	0.0	2.2	0.0	3.2	0.0	0.6	0.2	3.1	0.0	0.1	2.4	0.6	0.0	0.0	0.1	0.2	2.8	0.1	0.3	0.3	0.3	0.8	0.1	0.0	0.5	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1										
PDYN	"ADCA, PENKB, SCA23"	ENSG00000101327	Prodynorphin	P01213	20	1978757-1994285	"Disease related genes, Potential drug targets, Predicted secreted proteins, Transporters"		"Endorphin, Neuropeptide, Neurotransmitter, Opioid peptide"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"brain: 55.9"	"Cell line enhanced"	"Detected in some"		"AF22: 1.5;NTERA-2: 2.8;THP-1: 2.6"	"Group enriched"	"Detected in some"	29	"glioma: 2.6;ovarian cancer: 1.6"	"Region enriched"	"Detected in many"	4	"basal ganglia: 55.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basal ganglia: 150.7;hypothalamus: 70.9"	"Region enhanced"	"Detected in many"		"basal ganglia: 131.1"	"HPA053342, CAB079777"	Enhanced	Supported			"Secreted in brain"					"CAB079777: , HPA053342: "					"unprognostic (7.00e-2)"				"unprognostic (1.07e-1)"	"unprognostic (1.40e-1)"					"unprognostic (3.73e-2)"			0.4	0.4	13.2	0.4	55.9	0.4	0.4	0.0	40.3	0.4	0.4	1.2	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	5.0	3.9	0.4	0.4	0.4	0.4	0.7	3.7	0.4	0.4	0.4	0.0	0.4	0.2	0.4	0.4	0.0	0.4	0.4	0.4	0.6	0.4	0.4	2.2	0.4	0.4	3.2	1.1	0.0	0.5	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	55.9	0.0	3.8	5.0	3.9	0.7	3.7	0.2	1.1
PENK		ENSG00000181195	Proenkephalin	P01210	8	56436674-56446734	"Plasma proteins, Predicted secreted proteins, Transporters"		"Endorphin, Neuropeptide, Opioid peptide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 124.3;brain: 171.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 16.2;ASC TERT1: 9.7;BJ: 9.0;THP-1: 8.4"	"Cancer enhanced"	"Detected in many"		"lung cancer: 4.5"	"Region enriched"	"Detected in many"	12	"basal ganglia: 171.5"	"Cell type enhanced"	"Detected in some"		"naive B-cell: 3.1"	"Group enriched"	"Detected in many"	19	"B-cells: 3.1;dendritic cells: 1.2;monocytes: 1.2"	"Region enriched"	"Detected in all"	7	"basal ganglia: 3244.3"	"Region enriched"	"Detected in many"	7	"basal ganglia: 1049.6"	"HPA013138, CAB016390"	Enhanced				"Secreted in other tissues"	35000	35000			"CAB016390: AB_2161515, HPA013138: AB_1855191"	"unprognostic (6.89e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.56e-2)"	"unprognostic (3.58e-3)"		"unprognostic (1.31e-2)"	"unprognostic (3.60e-1)"	"unprognostic (6.34e-2)"	"unprognostic (5.73e-2)"	"unprognostic (3.47e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.11e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.98e-3)"	2.5	124.3	2.8	1.7	171.5	0.3	0.9	3.9	7.8	14.3	2.2	0.9	0.1	0.6	3.0	0.9	0.9	2.6	4.0	9.1	1.2	9.1	0.3	0.2	1.0	0.3	2.5	0.4	8.2	0.6	0.2	1.5	1.1	8.4	11.7	0.9	2.2	0.9	8.1	1.1	0.5	0.9	1.7	7.0	0.3	1.1	29.9	14.7	0.0	0.6	0.3	0.3	0.5	0.6	3.1	1.2	0.0	1.2	0.0	0.0	0.5	0.0	0.0	0.1	0.0	16.2	9.7	0.0	9.0	2.9	1.6	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.2	3.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.5	2.8	171.5	3.9	7.8	1.2	9.1	2.5	0.4	8.4	14.7
PF4	"CXCL4, SCYB4"	ENSG00000163737	"Platelet factor 4"	P02776	4	73981077-73982124	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	Chemotaxis	"Cytokine, Heparin-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"blood: 50.5;bone marrow: 46.8;heart muscle: 46.0;lymphoid tissue: 42.6"	"Cell line enriched"	"Detected in some"	10	"HEL: 29.7"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 4.4"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	9	"basophil: 18.3;neutrophil: 16.5"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 18.3"									"CAB026008, HPA052485"	Enhanced				"Secreted to blood"					"CAB026008: , HPA052485: "		"unprognostic (4.14e-4)"	"unprognostic (1.00e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.96e-4)"	"unprognostic (7.58e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.84e-2)"	"unprognostic (3.03e-2)"	"unprognostic (9.54e-5)"	"unprognostic (2.55e-1)"	"unprognostic (8.77e-2)"	"unprognostic (9.69e-2)"	"unprognostic (4.81e-2)"	0.7	0.4	0.2	0.7	0.9	46.8	0.8	0.2	0.3	0.3	1.1	0.0	0.0	0.1	0.2	0.4	0.2	0.5	0.8	46.0	0.8	0.3	0.5	1.7	9.1	3.3	2.6	0.3	3.0	0.4	0.1	0.4	4.8	1.9	0.2	0.9	1.0	0.4	0.2	1.0	0.2	0.3	0.2	0.9	42.6	0.9	0.6	0.0	0.0	1.8	0.9	0.1	1.0	3.0	0.3	1.9	18.3	1.4	0.0	0.3	50.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	29.7	0.0	0.0	1.5	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	1.4	0.4	0.3	0.3	0.3	0.0	0.0	0.0	0.5	0.3	0.2	0.1	16.5	0.0	1.1	1.9	0.2	50.5	0.2	0.9	0.2	0.3	0.8	0.3	2.6	0.3	1.9	0.0
PF4V1	"CXCL4L1, CXCL4V1, SCYB4V1"	ENSG00000109272	"Platelet factor 4 variant 1"	P10720	4	73853189-73854155	"Plasma proteins, Predicted secreted proteins"		"Cytokine, Heparin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 12.6;lymphoid tissue: 27.8"	"Cell line enhanced"	"Detected in some"		"BJ: 2.7;CAPAN-2: 3.5;EFO-21: 5.5;HHSteC: 2.2;HSkMC: 3.4;HUVEC TERT2: 1.8;RPTEC TERT1: 3.3;U-2197: 1.9"	"Cancer enhanced"	"Detected in some"		"renal cancer: 3.4"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	28	"basophil: 9.1;neutrophil: 11.2"	"Lineage enriched"	"Detected in single"	30	"granulocytes: 11.2"									HPA052485	Supported				"Secreted to blood"	1400000000	1400000000			"HPA052485: "		"unprognostic (4.95e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.16e-3)"	"unprognostic (9.88e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.68e-3)"		"unprognostic (2.66e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.39e-2)"			"unprognostic (2.11e-1)"	0.3	0.2	0.1	0.9	0.4	2.8	0.6	0.2	0.5	0.8	0.7	0.0	0.7	4.8	0.1	1.1	0.6	0.5	0.5	8.7	0.4	0.6	2.0	1.9	2.6	0.9	0.4	0.3	7.4	0.4	0.1	0.4	2.0	1.2	1.0	0.7	0.2	1.5	4.0	0.1	0.2	3.2	0.0	0.6	27.8	0.2	0.3	0.0	0.1	0.2	1.1	0.2	5.0	1.0	0.1	0.3	11.2	0.2	0.0	0.2	12.6	0.0	0.0	0.0	0.0	0.7	0.6	0.3	2.7	0.4	0.0	0.0	0.0	3.5	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.2	0.0	0.0	3.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	11.2	0.0	0.1	0.3	0.0	12.6	0.1	0.4	0.2	0.5	0.4	0.6	0.4	0.3	1.2	0.0
PGF	"D12S1900, PGFL, PIGF, PLGF, PlGF-2, SHGC-10760"	ENSG00000119630	"Placental growth factor"	P49763	14	74941834-74955784	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"placenta: 177.3"	"Group enriched"	"Detected in some"	6	"BEWO: 91.3;HUVEC TERT2: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA041624			Approved	Nucleoplasm,Mitochondria,Cytosol	"Secreted to blood"			Nucleoplasm	"Mitochondria, Cytosol"	"HPA041624: AB_10794522"	"unprognostic (1.67e-2)"	"unprognostic (4.62e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.34e-3)"	"unprognostic (8.67e-3)"	"unprognostic (2.41e-1)"	"prognostic unfavourable (1.40e-4)"	"unprognostic (7.26e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.51e-3)"	"prognostic unfavourable (1.33e-6)"	"unprognostic (2.52e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.14e-1)"	4.3	2.7	1.9	4.4	2.4	0.0	4.3	1.6	3.5	13.1	2.3	2.3	4.0	1.3	2.9	6.3	3.9	9.2	3.4	5.1	2.4	4.1	3.1	2.6	3.6	4.9	2.9	2.0	3.8	1.9	5.4	2.0	177.3	4.6	7.5	1.1	3.5	3.8	6.7	3.3	6.0	4.3	4.6	1.7	1.2	1.7	3.3	2.0	1.4	24.2	4.4	2.9	5.1	5.9	0.7	0.7	1.1	1.0	0.0	2.4	0.2	0.3	0.3	0.3	0.2	0.4	0.0	91.3	0.8	0.8	0.4	0.5	2.1	0.1	0.0	2.0	0.6	0.1	0.4	4.1	0.3	0.0	0.5	0.0	0.0	2.2	0.3	0.0	2.4	1.0	1.0	1.6	0.4	43.0	0.0	0.0	12.1	0.1	0.0	0.1	0.4	0.7	0.0	11.3	0.0	0.1	0.2	6.9	3.7	0.0	0.1	1.6	0.0	0.1	8.7	0.0	2.3	0.0	3.6	0.0	0.0	0.1	1.4	0.1	0.1	0.0	0.2	1.1	2.4	1.0	0.0	0.7	0.3	0.7	0.3	0.3	0.6	1.0	0.0	0.0	0.8	0.7	0.5	0.2	1.9	2.4	1.6	2.2	2.4	4.1	2.9	2.0	4.6	2.0
PGLYRP1	"PGLYRP, PGRP, PGRP-S, PGRPS, TAG7, TNFSF3L"	ENSG00000008438	"Peptidoglycan recognition protein 1"	O75594	19	46019153-46023065	"Plasma proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 73.7;bone marrow: 130.1"	"Cell line enhanced"	"Detected in some"		"A549: 7.1;HEK 293: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	190	"eosinophil: 63.0;neutrophil: 73.7"	"Lineage enriched"	"Detected in single"	205	"granulocytes: 73.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA045702	Enhanced				"Secreted to blood"	47000000	47000000			"HPA045702: AB_10960204"	"unprognostic (2.87e-2)"	"unprognostic (4.26e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.93e-3)"	"unprognostic (2.20e-1)"	"unprognostic (6.46e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.61e-2)"	"unprognostic (8.51e-3)"	"unprognostic (7.18e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.37e-3)"	0.7	0.1	0.2	0.5	0.4	130.1	0.2	0.4	0.2	0.1	0.3	0.3	0.0	0.2	0.1	0.1	0.2	0.4	0.1	10.9	0.2	0.2	0.2	1.5	10.9	1.0	0.2	0.0	0.7	0.2	0.1	1.4	4.1	0.1	0.1	0.1	0.5	0.7	0.1	1.3	0.3	0.2	0.1	0.1	26.9	0.2	0.9	0.0	7.5	1.3	0.0	0.5	0.1	5.5	0.0	0.0	73.7	0.3	0.0	0.0	0.4	0.6	7.1	1.1	0.7	0.0	0.0	1.9	0.6	0.0	0.0	0.0	1.1	0.6	1.9	0.2	0.0	2.6	0.0	0.0	0.0	1.8	4.0	0.8	3.4	0.2	0.0	0.4	2.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.5	0.4	2.2	0.4	2.7	1.5	0.2	0.1	0.0	2.6	0.8	0.1	0.5	0.1	0.0	0.3	0.1	0.0	0.1	0.3	0.7	1.1	1.5	1.3	0.8	1.1	1.6	0.1	0.0	0.0	63.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.7	0.0	0.3	0.0	0.0	0.4	0.2	0.4	0.4	0.2	0.2	0.2	0.2	0.0	0.1	0.0
PGLYRP3	"PGLYRPIalpha, PGRP-Ialpha, PGRPIA"	ENSG00000159527	"Peptidoglycan recognition protein 3"	Q96LB9	1	153297862-153310718	"Predicted secreted proteins"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"esophagus: 21.3;skin 1: 39.1;vagina: 10.9"	"Group enriched"	"Detected in some"	15	"HaCaT: 8.6;HDLM-2: 3.5;hTCEpi: 3.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 16.5"					"Cell type enriched"	"Detected in single"	11	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA030369	Uncertain				"Secreted in other tissues"					"HPA030369: AB_10603984"		"unprognostic (6.34e-2)"	"unprognostic (1.60e-1)"			"unprognostic (7.09e-2)"		"unprognostic (2.24e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.88e-3)"			"unprognostic (1.28e-1)"	"unprognostic (1.82e-1)"		"unprognostic (2.25e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	6.8	0.0			0.0	0.0	0.0	21.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		2.9	0.0	0.0	39.1	0.0	0.0	0.0	0.0	0.0	0.0			0.0		3.8	0.0	10.9	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	3.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0										
PGLYRP4	"PGLYRPIbeta, PGRP-Ibeta, PGRPIB, SBBI67"	ENSG00000163218	"Peptidoglycan recognition protein 4"	Q96LB8	1	153330120-153348840	"Predicted secreted proteins"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 8.1;skin 1: 19.5;tongue: 13.7;vagina: 8.5"	"Cell line enhanced"	"Detected in some"		"HaCaT: 8.0;HDLM-2: 5.2;hTCEpi: 1.7;Karpas-707: 4.3"	"Group enriched"	"Detected in some"	9	"cervical cancer: 2.7;head and neck cancer: 7.8;lung cancer: 1.9;melanoma: 1.6;urothelial cancer: 2.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	8	"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB025879			Supported	"Vesicles,Plasma membrane"	"Secreted in other tissues"			"Vesicles, Plasma membrane"		"CAB025879: "	"unprognostic (2.76e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.34e-2)"		"unprognostic (3.61e-3)"		"unprognostic (1.46e-1)"	"unprognostic (3.13e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.07e-2)"		"unprognostic (2.15e-1)"	"unprognostic (1.81e-1)"		"unprognostic (1.88e-1)"	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	8.1	0.0	0.0	0.0	0.1	2.0	0.0	7.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.2	0.2	0.0	1.5	0.0	0.1	19.5	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	13.7	6.5	0.0	8.5	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	5.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.9	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PI15	P25TI	ENSG00000137558	"Peptidase inhibitor 15"	O43692	8	74824537-74855029	"Predicted secreted proteins"		"Developmental protein, Protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"AF22: 15.7;SH-SY5Y: 15.6;SK-MEL-30: 20.7;U-266/70: 5.4"	"Group enriched"	"Detected in many"	7	"breast cancer: 11.1;melanoma: 8.6;prostate cancer: 18.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA006593, HPA030057"	Uncertain		Approved	Vesicles,Cytosol	"Secreted in other tissues"			Vesicles	Cytosol	"HPA006593: AB_1078568, HPA030057: AB_10602143"	"unprognostic (2.77e-1)"	"unprognostic (1.57e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.88e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.33e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.85e-2)"	"unprognostic (8.63e-14)"	"unprognostic (2.54e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.05e-2)"	4.2	1.4	3.7	33.4	6.5	0.2	23.4	0.5	2.2	17.3	8.8	0.0	6.5	0.3	26.5	33.8	1.8	18.5	1.2	18.8	1.3	0.9	2.5	0.4	2.3	4.6	3.5	0.0	28.7	0.5	0.2	0.7	0.4	5.9	21.4	3.3	0.0	1.9	5.2	0.6	0.5	8.3	30.7	6.0	15.2	1.0	2.6	1.7	0.1	0.8	0.9	0.3	7.8	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	15.6	0.0	0.0	20.7	0.3	0.4	0.0	0.0	0.3	0.0	0.1	5.4	2.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	6.5	0.5	2.2	1.3	0.9	3.5	0.0	5.9	1.7
PI3	"cementoin, ELAFIN, ESI, SKALP, WAP3, WFDC14"	ENSG00000124102	"Peptidase inhibitor 3"	P19957	20	45174876-45176544	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 157.1;esophagus: 200.8;lymphoid tissue: 173.5;tongue: 468.6"	"Group enriched"	"Detected in some"	6	"EFO-21: 27.0;HaCaT: 32.8;PC-3: 55.7"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 2666.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	1121	"neutrophil: 157.1"	"Lineage enriched"	"Detected in single"	1571	"granulocytes: 157.1"									"CAB009449, HPA017737"	Enhanced		Approved	"Plasma membrane"	"Secreted to blood"	2100000	2100000	"Plasma membrane"		"CAB009449: AB_2252354, HPA017737: AB_1848107"	"prognostic favourable (6.94e-4)"	"unprognostic (3.61e-2)"	"unprognostic (1.00e-1)"	"unprognostic (8.30e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.20e-3)"	"unprognostic (5.53e-3)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (3.84e-6)"	"prognostic unfavourable (6.89e-4)"	"unprognostic (8.54e-3)"	"prognostic unfavourable (1.94e-8)"	"unprognostic (1.23e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.91e-3)"	0.4	0.0	0.2	8.8	0.2	0.0	0.7	0.2	0.2	85.3	9.3	0.2	0.4	0.1	7.7	0.2	200.8	0.3	4.8	0.6	0.2	0.0	0.3	0.6	3.1	0.8	0.2	0.2	0.3	0.4	0.0	0.2	0.6	0.3	1.0	3.7	0.3	35.6	0.4	0.2	6.4	3.2	0.6	0.2	1.4	0.7	5.1	0.2	23.4	0.2	468.6	173.5	1.6	118.7	0.0	0.0	157.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.9	0.6	0.4	27.0	0.0	32.8	0.0	6.7	0.0	0.3	0.0	0.1	2.0	0.2	0.0	0.2	0.0	0.0	6.4	5.3	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	55.7	0.0	0.3	0.0	6.4	0.1	0.0	0.0	4.6	0.6	0.0	0.0	0.0	0.2	0.3	3.2	0.0	0.2	0.1	0.4	0.1	4.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	157.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.3	0.2
PIP	"GCDFP-15, GCDFP15, GPIP4"	ENSG00000159763	"Prolactin induced protein"	P12273	7	143132077-143139746	"Plasma proteins, Predicted secreted proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"salivary gland: 1246.7;seminal vesicle: 651.3"	"Cell line enriched"	"Detected in single"	330	"T-47d: 123.4"	"Cancer enriched"	"Detected in many"	70	"breast cancer: 672.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"memory B-cell: 1.5;naive B-cell: 2.6"	"Lineage enriched"	"Detected in single"	17	"B-cells: 2.6"									"CAB002661, HPA009177"	Enhanced				"Secreted in other tissues"	89000000	89000000			"CAB002661: , HPA009177: AB_1845459"	"unprognostic (2.80e-1)"	"unprognostic (2.15e-1)"		"unprognostic (1.08e-3)"		"unprognostic (3.01e-2)"		"unprognostic (5.93e-2)"		"unprognostic (2.25e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.05e-1)"	"prognostic favourable (5.96e-5)"	"unprognostic (3.14e-1)"		"unprognostic (3.49e-2)"	"unprognostic (5.55e-1)"	0.4	0.1	0.1	0.0	0.2	0.0	144.4	0.2	0.1	0.2	0.1	0.0	219.3	0.0	0.1	0.0	0.2	0.2	0.0	0.2	0.2	0.1	0.1	0.2	0.6	0.0	0.2	0.0	0.1	0.7	0.0	0.1	0.0	0.0	2.9	0.0	0.0	1246.7	651.3	0.2	7.7	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	49.3	1.1	1.8	0.1	2.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	123.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.2	0.1	0.2	0.0	0.0	0.0
PKDCC	"SgK493, Vlk"	ENSG00000162878	"Protein kinase domain containing, cytoplasmic"	Q504Y2	2	42048020-42058528	"Enzymes, Predicted secreted proteins"	"Differentiation, Osteogenesis, Protein transport, Transport"	"Developmental protein, Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 30.5;ASC diff: 24.2;CACO-2: 36.1;HHSteC: 20.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026427, HPA026442, HPA026526"	Approved				"Secreted to blood"	10000	10000			"HPA026427: AB_10600773, HPA026442: AB_10601237, HPA026526: AB_10602416"	"unprognostic (6.77e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.04e-2)"	"unprognostic (3.59e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.18e-2)"	"unprognostic (5.79e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.20e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.14e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.73e-3)"	"unprognostic (2.58e-3)"	21.4	5.7	1.9	8.4	1.8	0.8	18.9	0.3	4.7	20.8	13.7	1.7	6.3	9.3	17.6	16.0	9.2	10.0	29.6	17.0	2.3	0.7	4.7	3.5	8.0	3.7	3.7	0.3	43.6	3.3	0.9	3.2	3.2	2.6	13.0	5.2	17.0	38.6	5.6	40.2	1.7	7.7	26.2	2.3	4.6	4.8	14.1	2.3	4.2	3.1	13.1	2.1	22.8	23.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.9	5.4	30.5	24.2	0.3	1.9	0.1	0.0	0.4	0.6	36.1	0.0	0.0	0.1	0.6	0.0	0.5	0.0	0.0	2.9	1.2	0.0	1.3	9.5	20.8	0.0	0.4	2.1	0.1	0.0	0.0	0.2	0.4	0.0	0.1	0.1	0.0	0.1	8.9	0.6	0.0	10.5	0.0	0.0	0.0	1.1	1.9	0.5	0.0	0.0	0.0	0.2	0.0	0.2	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.8	0.3	4.7	2.3	0.7	3.7	0.3	2.6	2.3
PLA2G10	GXPLA2	ENSG00000069764	"Phospholipase A2 group X"	O15496	16	14672545-14694669	"Enzymes, Predicted secreted proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 9.4;stomach 1: 13.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;CAPAN-2: 4.5;SK-BR-3: 2.8;U-266/84: 2.3"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"neutrophil: 2.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041893	Uncertain				"Secreted in other tissues"					"HPA041893: AB_10794495"	"unprognostic (8.44e-3)"	"unprognostic (2.37e-1)"	"unprognostic (6.72e-2)"	"prognostic favourable (5.74e-5)"	"unprognostic (1.62e-2)"	"unprognostic (3.16e-2)"	"unprognostic (5.48e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.30e-2)"	"unprognostic (9.97e-3)"	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.3	9.4			2.4	0.0	0.0	0.0	1.1	0.9	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0		0.0	4.2	0.0	0.0	0.0		0.2	7.2		0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	13.0	2.1			0.0		0.0	2.8	0.0	0.9	0.5	2.0	0.5	0.1	0.4	0.1	0.1	1.0	0.1	0.2	0.0	0.1	2.7	0.2	0.0	0.0	0.0	0.7	4.5	0.4	0.5	0.0	2.2	0.0	0.0	0.0	0.2	0.1	0.4	0.4	0.0	0.1	0.8	0.9	0.0	0.1	0.0	0.1	0.0	0.2	0.7	0.0	2.1	0.4	0.3	0.4	0.1	0.8	0.3	0.2	0.0	0.3	0.6	0.5	1.1	2.8	0.4	0.5	0.4	0.9	0.0	0.3	0.1	0.0	0.8	2.3	0.7	0.7	0.1	0.1	0.1	0.5	0.5	0.3	0.4	0.3	0.1	0.2	0.4	0.5	0.9	0.3	0.3	2.0	0.1	0.3	0.3	0.1	0.1										
PLA2G12A	PLA2G12	ENSG00000123739	"Phospholipase A2 group XIIA"	Q9BZM1	4	109709989-109730077	"Enzymes, Predicted secreted proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035908, HPA035909"	Approved				"Secreted to blood"					"HPA035908: , HPA035909: AB_10672074"	"unprognostic (8.40e-2)"	"unprognostic (3.87e-1)"	"unprognostic (3.81e-3)"	"unprognostic (3.09e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.42e-2)"	"prognostic favourable (2.54e-9)"	"unprognostic (3.10e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.16e-3)"	"unprognostic (3.64e-2)"	9.8	9.9	13.1	4.4	16.2	5.6	12.9	14.5	14.3	9.6	12.2	13.4	7.3	11.9	8.9	8.2	12.6	9.2	9.2	21.0	13.0	11.4	15.3	20.6	7.8	4.9	16.8	11.7	11.9	38.8	22.8	19.0	10.4	12.7	16.4	12.0	10.7	12.1	8.3	21.1	9.8	16.3	8.1	20.3	5.5	10.0	5.7	12.4	4.9	19.0	9.2	6.2	7.5	7.7	4.9	8.7	3.6	4.6	4.9	10.2	13.8	9.6	3.6	2.8	4.2	9.0	9.1	5.6	9.0	7.1	5.0	5.3	8.9	17.1	14.0	6.8	6.5	5.4	8.7	11.6	7.8	5.2	13.5	4.9	10.5	5.4	9.0	10.7	3.5	9.2	13.5	5.1	12.7	5.1	27.2	6.5	8.6	17.1	8.7	4.8	5.0	14.1	5.3	8.5	11.0	9.4	14.4	18.3	6.0	7.9	20.8	6.7	12.5	2.3	6.0	7.4	6.1	7.6	6.1	11.0	19.8	10.3	8.3	6.3	9.1	3.6	4.6	2.7	7.2	2.9	6.6	4.2	9.0	6.9	8.7	4.9	10.2	9.2	2.2	4.9	4.4	7.6	8.7	13.8	13.1	16.2	14.5	14.3	13.0	11.4	16.8	11.7	12.7	12.4
PLA2G12B	PLA2G13	ENSG00000138308	"Phospholipase A2 group XIIB"	Q9BX93	10	72935170-72954778	"Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 47.8;liver: 42.8"	"Group enriched"	"Detected in some"	9	"CACO-2: 11.8;Hep G2: 19.6"	"Cancer enriched"	"Detected in many"	8	"liver cancer: 35.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA057745, HPA059562"	Approved				"Secreted to blood"					"HPA057745: , HPA059562: "			"unprognostic (1.11e-2)"				"unprognostic (2.66e-2)"	"unprognostic (2.02e-3)"			"unprognostic (3.41e-1)"		"unprognostic (1.68e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.14e-2)"		0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	25.6	0.0	0.0	15.4	0.1	0.3	0.1	0.1	0.0	3.5	0.1	0.1	8.0	42.8	0.9	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.7	0.1	0.1	0.0	0.1	0.1	47.8	0.0	0.1	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	11.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	19.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
PLA2G2A	"PLA2B, PLA2L"	ENSG00000188257	"Phospholipase A2 group IIA"	P14555	1	19975431-19980416	"Enzymes, FDA approved drug targets, Predicted secreted proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 377.9"	"Group enriched"	"Detected in some"	14	"Hep G2: 34.2;RT4: 31.4"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 875.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA015236	Enhanced				"Secreted to blood"	290000	290000			"HPA015236: AB_10601047"	"unprognostic (2.33e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.85e-3)"	"unprognostic (8.71e-2)"	"unprognostic (9.27e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.80e-1)"	"prognostic favourable (1.49e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.77e-15)"	"unprognostic (2.72e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.51e-1)"	25.2	1.0	0.0	13.1	0.0	0.6	14.0	0.0	0.6	1.4	63.9	0.0	0.1	35.0	0.7	22.7	31.5	11.7	2.4	105.4	0.0	0.0	1.6	377.9	3.0	6.5	0.0	0.0	35.6	2.4	0.6	0.5	15.5	0.0	27.1	68.2	6.1	9.5	1.0	30.6	5.0	99.0	39.7	0.0	0.6	4.0	9.8	0.0	0.0	16.0	8.9	19.3	39.0	72.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	31.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PLA2G2C		ENSG00000187980	"Phospholipase A2 group IIC"	Q5R387	1	20161253-20177424	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"esophagus: 4.2;intestine: 4.7"	"Group enriched"	"Detected in some"	5	"HL-60: 4.4;NB-4: 1.4;SK-BR-3: 1.2;U-698: 4.9;U-937: 4.7"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted - unknown location"						"unprognostic (3.02e-3)"	"unprognostic (2.75e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.00e-4)"	"unprognostic (9.44e-3)"	"unprognostic (6.55e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.22e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.65e-2)"	"unprognostic (8.16e-2)"	0.1	0.1	0.3	0.0	0.3	1.0	0.1	0.2	0.2	0.1	4.7			0.4	0.9	0.3	4.2	0.2	0.0	0.1	0.3	0.4	0.2	0.2	0.1	0.3	0.4		0.3	0.0	0.4	0.1	0.0		1.0	0.7		0.2	0.7	0.5	1.2	0.8	0.0	0.2	0.1	1.1	0.9			0.1		0.0	0.9	0.1	0.7	2.4	2.3	1.4	1.3	1.4	0.5	0.2	0.0	0.4	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.2	0.1	0.3	0.3	0.0	4.4	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.1	0.7	1.4	0.4	0.1	0.2	0.2	0.4	0.1	0.3	0.2	0.1	0.4	1.2	0.1	0.3	0.1	0.2	0.6	0.2	0.2	0.2	0.2	0.1	4.9	0.4	4.7	0.1	2.3	1.4	0.5	0.7	0.5	1.4	0.6	0.7	0.9	2.4	0.7	0.6	0.5	2.3	1.3	0.4	0.8	0.3	0.5										
PLA2G2D	sPLA2S	ENSG00000117215	"Phospholipase A2 group IID"	Q9UNK4	1	20111939-20119566	"Enzymes, Predicted secreted proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 39.9"	"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 13.4"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 25.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"memory B-cell: 6.6;naive B-cell: 5.6;plasmacytoid DC: 3.4"	"Group enriched"	"Detected in many"	5	"B-cells: 6.6;dendritic cells: 3.4"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"								"Secreted - unknown location"						"prognostic favourable (4.35e-4)"	"prognostic favourable (8.15e-5)"	"unprognostic (3.88e-3)"	"prognostic favourable (9.74e-4)"	"unprognostic (1.78e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.82e-5)"	"unprognostic (7.51e-4)"	"unprognostic (2.50e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.64e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.60e-1)"	0.4	0.3	0.3	38.8	0.3	0.0	0.4	0.3	0.3	0.3	0.9	0.0	0.0	0.3	0.3	0.2	0.4	0.5	0.4	0.3	0.3	0.3	0.4	0.4	1.0	39.9	0.3	0.0	0.3	0.3	0.0	0.3	0.2	0.0	0.4	1.2	0.1	5.0	0.3	0.3	0.3	7.7	0.0	0.3	18.1	0.6	0.3	0.0	6.6	0.7	0.5	33.0	2.5	0.3	6.6	3.4	1.0	0.2	0.3	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	13.4	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.3	0.1	0.0	0.3	0.1	2.1	0.1	0.2	0.1	0.1	0.0	1.0	0.2	0.2	0.1	0.1	0.1	6.6	0.1	0.1	0.1	5.6	0.1	0.1	0.4	0.3	0.1	3.4	0.0	0.2	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0
PLA2G2E		ENSG00000188784	"Phospholipase A2 group IIE"	Q9NZK7	1	19920009-19923617	"Enzymes, Predicted secreted proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	10	"lymphoid tissue: 7.7;skin 1: 3.2"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.2;CAPAN-2: 1.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064085	Uncertain				"Secreted - unknown location"					"HPA064085: "														"unprognostic (9.56e-2)"		"unprognostic (3.71e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	3.2	0.5	0.0	0.0	0.0	0.0	0.2			0.0		7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PLA2G3	GIII-SPLA2	ENSG00000100078	"Phospholipase A2 group III"	Q9NZ20	22	31134809-31140607	"Enzymes, Predicted secreted proteins, RAS pathway related proteins"	"Cilium biogenesis/degradation, Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 13.1;skin 1: 14.1;tongue: 17.4"	"Group enriched"	"Detected in some"	5	"AF22: 13.9;AN3-CA: 14.0;NTERA-2: 7.1;SCLC-21H: 10.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA021016	Uncertain				"Secreted to blood"					"HPA021016: AB_1855443"	"unprognostic (1.80e-1)"	"unprognostic (4.63e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.49e-2)"	"unprognostic (9.72e-2)"	"prognostic favourable (4.47e-4)"		"unprognostic (1.74e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.25e-2)"	"unprognostic (9.55e-3)"	"unprognostic (4.41e-1)"		"unprognostic (3.67e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.49e-3)"	"unprognostic (3.72e-2)"	0.1	0.0	0.1	0.1	0.2	0.0	2.0	0.4	0.9	5.3	0.1	0.1	1.9	0.5	0.3	0.1	13.1	0.0	0.1	0.1	0.6	0.0	0.3	0.1	4.2	0.1	0.1	0.4	0.1	0.1	1.7	0.1	0.1	3.1	0.4	0.0	0.8	1.8	0.5	0.3	14.1	0.1	0.1	0.1	0.1	0.9	0.3	0.1	0.4	0.8	17.4	3.5	0.1	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	14.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.9	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.9	0.6	0.0	0.1	0.4	3.1	0.1
PLA2G5		ENSG00000127472	"Phospholipase A2 group V"	P39877	1	20028179-20091190	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 48.3;retina: 58.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.4;HaCaT: 1.0;hTEC/SVTERT24-B: 1.5;U-138 MG: 3.1;U-2197: 6.6"	"Group enriched"	"Detected in many"	5	"glioma: 13.0;prostate cancer: 3.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	23	"plasmacytoid DC: 2.3"	"Lineage enriched"	"Detected in single"	23	"dendritic cells: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA053361	Approved				"Secreted - unknown location"					"HPA053361: "	"unprognostic (2.78e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.68e-3)"	"unprognostic (6.16e-2)"	"unprognostic (2.01e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.70e-3)"	"unprognostic (6.00e-5)"	"unprognostic (2.87e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.97e-3)"	2.6	0.5	2.8	2.0	6.7	0.2	1.9	1.9	5.2	0.3	10.5	2.1	2.5	1.2	0.5	2.1	5.7	1.9	3.0	48.3	2.6	2.4	0.2	1.8	3.2	1.0	6.1	2.0	17.3	1.2	0.2	0.1	8.3	6.8	6.9	3.2	58.3	1.0	10.3	0.4	0.4	1.0	19.3	1.0	0.8	2.3	3.3	1.3	0.0	0.7	0.0	1.7	7.3	2.2	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	3.1	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	2.8	6.7	1.9	5.2	2.6	2.4	6.1	2.0	6.8	1.3
PLA2G7	"LDL-PLA2, PAFAH"	ENSG00000146070	"Phospholipase A2 group VII"	Q13093	6	46704201-46735693	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Asthma, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 57.0;lymphoid tissue: 32.9"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.8;PC-3: 7.7;RT4: 3.5;U-2 OS: 3.7"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 37.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 24.2"	"Group enriched"	"Detected in many"	56	"dendritic cells: 7.9;monocytes: 24.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	170000000	170000000				"unprognostic (3.63e-3)"	"unprognostic (2.82e-3)"	"unprognostic (8.69e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.26e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.06e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.47e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.08e-2)"	57.0	2.1	2.8	14.0	5.8	1.1	2.9	2.0	2.7	1.5	4.4	2.0	0.4	2.3	2.9	1.6	0.8	1.4	3.6	2.0	2.1	1.7	1.0	4.3	19.0	22.2	3.2	1.8	4.0	0.9	0.1	3.1	15.8	2.3	8.5	6.6	2.8	2.5	1.6	0.9	2.3	3.7	1.5	7.1	32.9	1.4	0.7	2.0	6.4	13.1	0.6	6.0	7.2	0.8	0.1	7.9	0.2	24.2	0.0	0.2	6.1	0.0	0.5	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	1.5	0.0	0.1	0.0	0.2	1.9	0.0	1.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.3	3.8	7.7	0.0	0.0	0.1	0.0	3.5	0.1	0.5	0.0	0.0	0.0	1.0	1.0	0.0	0.0	3.7	0.1	0.8	0.1	0.0	0.0	0.0	0.2	1.3	0.0	24.2	0.1	0.0	5.0	0.2	0.1	0.0	0.0	7.9	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	6.1	2.8	5.8	2.0	2.7	2.1	1.7	3.2	1.8	2.3	2.0
PLAC1	"CT92, OOSP2L"	ENSG00000170965	"Placenta specific 1"	Q9HBJ0	X	134565838-134764322	"Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"placenta: 90.4"	"Cell line enhanced"	"Detected in some"		"HEK 293: 18.3;hTCEpi: 14.4;hTERT-HME1: 5.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA063425	Enhanced				"Secreted in female reproductive system"					"HPA063425: "	"unprognostic (2.93e-1)"	"unprognostic (2.50e-3)"	"unprognostic (2.89e-4)"	"unprognostic (1.35e-7)"	"unprognostic (3.83e-3)"	"unprognostic (2.07e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.33e-16)"	"unprognostic (7.64e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.91e-2)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.1	90.4	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.5	0.0	0.0	0.1	0.0	0.1	3.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.8	0.0	1.1	0.0	0.2	1.0	0.3	0.3	0.9	0.0	0.2	0.1	1.7	0.3	0.4	18.3	0.0	0.1	0.2	2.2	0.0	0.0	0.8	14.4	0.1	5.8	2.1	0.1	1.6	0.1	0.9	0.0	0.2	0.0	2.4	0.0	0.3	3.2	0.0	0.0	2.8	0.0	0.0	3.4	0.6	0.1	0.0	0.0	0.4	0.7	0.2	0.0	0.4	0.0	0.3	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PLAT		ENSG00000104368	"Plasminogen activator, tissue type"	P00750	8	42175233-42207724	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Plasminogen activation"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 132.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 85.8;HMC-1: 55.1;LHCN-M2: 55.6;U-2197: 58.0;WM-115: 115.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.1;T-reg: 2.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 1.6;T-cells: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003412, CAB009335"	Supported		Approved	"Actin filaments"	"Secreted to blood"	12000	12000	"Actin filaments"		"CAB009335: AB_2237146, HPA003412: AB_1858205"	"prognostic favourable (7.57e-4)"	"unprognostic (2.23e-1)"	"unprognostic (4.08e-1)"	"unprognostic (3.39e-1)"	"unprognostic (4.88e-3)"	"unprognostic (9.39e-2)"	"unprognostic (4.65e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.98e-3)"	"unprognostic (2.46e-1)"	"prognostic unfavourable (4.95e-4)"	"unprognostic (8.72e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.63e-2)"	"unprognostic (6.09e-2)"	19.3	14.9	5.2	12.9	6.8	0.4	13.3	2.2	6.2	24.5	17.1	9.1	19.0	11.2	35.5	28.1	18.1	19.1	18.5	7.3	6.0	5.9	67.6	2.8	15.9	1.9	8.2	3.6	18.4	5.8	132.2	5.1	15.5	9.4	27.4	12.2	39.4	6.1	12.7	5.8	2.0	31.7	23.0	7.0	1.0	14.6	12.2	3.8	0.6	11.2	14.7	7.4	47.9	13.7	0.3	0.1	1.6	0.0	0.0	2.3	0.3	0.5	0.2	4.2	1.0	7.7	10.5	0.1	18.0	32.0	7.7	6.6	0.2	85.8	0.0	0.6	2.3	1.4	0.0	4.0	15.9	7.8	1.4	0.1	0.1	0.1	37.9	0.0	55.1	10.5	0.0	18.8	0.7	14.4	0.5	0.1	55.6	0.0	0.0	0.0	5.6	7.6	0.0	15.6	0.0	2.5	0.0	0.0	0.9	0.0	0.1	24.5	0.1	0.0	27.5	1.5	5.7	58.0	1.8	0.0	0.1	0.0	1.2	0.0	115.3	1.6	0.0	0.0	0.3	0.0	1.0	0.3	2.1	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	2.3	0.3	5.2	6.8	2.2	6.2	6.0	5.9	8.2	3.6	9.4	3.8
PLG		ENSG00000122194	Plasminogen	P00747	6	160702238-160753315	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis, Tissue remodeling"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 269.9"	"Cell line enhanced"	"Detected in some"		"HL-60: 3.5;RH-30: 3.9;U-698: 2.0;U-937: 1.6"	"Cancer enriched"	"Detected in some"	84	"liver cancer: 180.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB000668, CAB016678, HPA021602, HPA048823"	Supported				"Secreted to blood"	41000000000	41000000000			"CAB000668: , CAB016678: AB_1621208, HPA021602: AB_1855453, HPA048823: "		"unprognostic (1.70e-1)"		"unprognostic (2.16e-3)"	"unprognostic (2.44e-1)"		"unprognostic (8.54e-3)"	"unprognostic (1.41e-1)"		"unprognostic (1.76e-3)"	"unprognostic (6.28e-2)"	"unprognostic (7.25e-2)"	"prognostic favourable (4.22e-4)"	"unprognostic (3.97e-3)"	"unprognostic (5.21e-2)"		"unprognostic (2.33e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	269.9	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.5	0.0	3.5	0.6	0.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.3	0.2	0.8	0.0	0.4	3.9	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	1.0	0.0	2.0	0.0	1.6	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PLGLB1	"PLGL, PRP-B"	ENSG00000183281	"Plasminogen-like B1"	Q02325	2	87002559-87021852	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in many"	5	"liver: 66.8"	"Low cell line specificity"	"Detected in many"			"Cancer enriched"	"Detected in single"	7	"liver cancer: 0.7"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"																"Secreted to blood"						"unprognostic (7.25e-2)"	"unprognostic (7.25e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.39e-5)"	"unprognostic (7.04e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.53e-4)"	"unprognostic (1.60e-1)"	"unprognostic (4.56e-4)"	"unprognostic (9.90e-3)"	"unprognostic (2.96e-5)"	"unprognostic (1.02e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.32e-2)"	"unprognostic (3.98e-5)"	0.3	1.3	2.0	0.7	3.4	1.7	0.7	14.3	2.1	0.4	0.5			0.7	1.3	2.1	0.3	0.8	1.0	0.6	1.9	2.1	1.0	66.8	0.6	1.5	1.4		1.5	0.4	0.7	1.6	0.3		1.0	0.3		1.1	0.5	1.9	3.4	0.8	0.2	1.1	1.3	0.7	0.8			1.1		0.5	0.7	0.5	2.7	1.6	5.1	0.8	0.9	2.7	0.4	3.0	4.3	4.8	2.6	4.6	5.4	5.1	3.4	2.5	2.1	2.8	3.3	7.7	7.7	3.5	1.2	2.6	1.3	0.6	2.1	9.2	3.6	6.6	6.4	3.5	3.1	4.1	1.6	5.6	4.6	5.6	5.7	0.9	3.2	6.6	2.6	4.4	13.4	11.4	6.9	2.7	2.2	2.1	4.5	4.7	3.1	3.8	4.2	2.9	2.6	3.0	1.3	7.1	5.5	3.9	2.5	2.2	2.1	7.0	5.4	3.4	2.1	5.5	2.6	5.1	0.4	0.9	1.9	0.2	1.2	2.7	2.0	1.4	0.2	2.2	2.7	1.6	1.9	0.9	0.8	1.6	2.6	0.4										
PLGLB2	PLGP1	ENSG00000125551	"Plasminogen-like B2"	Q02325	2	87748087-87758793	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in some"	28	"liver: 105.2"	"Cell line enhanced"	"Detected in many"		"AF22: 4.5;RPTEC TERT1: 4.5;U-266/84: 5.1"	"Cancer enriched"	"Detected in single"	25	"liver cancer: 1.2"					"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.7;T-reg: 3.7"	"Lineage enriched"	"Detected in single"	16	"T-cells: 3.7"														"Secreted to blood"						"unprognostic (1.10e-2)"	"unprognostic (8.78e-2)"			"unprognostic (3.42e-2)"	"unprognostic (7.03e-4)"	"unprognostic (1.68e-2)"	"unprognostic (3.77e-1)"		"unprognostic (1.82e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.94e-1)"	"unprognostic (5.04e-4)"	"unprognostic (6.39e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.22e-2)"	"unprognostic (7.11e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	105.2	0.0	0.1	0.1		0.1	0.1	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	3.7	0.2	0.0	1.4	4.5	1.4	0.0	1.4	0.0	3.8	2.3	0.6	2.6	0.0	1.4	2.8	2.7	0.6	1.0	0.5	0.0	0.8	0.0	1.2	1.0	3.3	0.0	0.3	0.6	0.5	0.0	0.0	0.3	0.4	0.5	0.3	0.0	0.9	0.0	2.6	0.0	0.0	0.0	2.5	0.0	0.0	4.5	0.3	0.0	3.3	0.9	1.1	0.1	0.2	1.8	0.0	0.0	2.0	0.9	1.4	2.9	5.1	0.4	1.6	0.0	1.2	0.0	0.2	0.0	0.1	0.0	0.1	0.0	2.7	0.8	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	3.7	0.2										
PM20D1	"Cps1, FLJ32569"	ENSG00000162877	"Peptidase M20 domain containing 1"	Q6GTS8	1	205828022-205850132	"Enzymes, Predicted secreted proteins"		"Hydrolase, Lyase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"pancreas: 103.5"	"Cell line enriched"	"Detected in single"	9	"Karpas-707: 6.4"	"Cancer enriched"	"Detected in some"	32	"urothelial cancer: 30.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.5"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.5"	"Low region specificity"	"Detected in all"												"Secreted to digestive system"	3000000	3000000				"unprognostic (1.16e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.07e-2)"	"unprognostic (4.83e-1)"	"unprognostic (4.08e-3)"	"unprognostic (1.17e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.50e-2)"	"unprognostic (5.81e-2)"	"unprognostic (4.57e-2)"	"unprognostic (7.79e-3)"	"unprognostic (9.77e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.68e-2)"	0.5	0.0	0.0	0.5	0.2	0.0	0.6	0.1	0.4	0.0	0.2	0.6	0.4	0.0	0.2	0.3	0.0	0.1	0.0	0.3	0.3	0.0	3.2	0.1	0.2	0.5	0.2	0.0	0.3	103.5	0.0	0.0	0.1	0.4	0.8	0.0	0.3	0.2	0.4	0.0	14.3	0.1	0.1	0.1	0.4	1.2	0.2	0.1	0.1	0.1	0.1	0.4	1.5	0.3	0.3	0.0	0.8	0.2	0.0	4.5	1.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.7	0.0	1.3	0.3	0.9	2.4	0.0	0.2	0.3	0.9	0.0	0.0	0.2	0.0	4.5	1.0	0.0	0.2	0.1	0.4	0.3	0.0	0.2	0.0	0.4	0.1
PMCH	MCH	ENSG00000183395	"Pro-melanin concentrating hormone"	P20382	12	102196459-102197845	"Predicted secreted proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, Hormone, Neuropeptide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"brain: 124.8"	"Cell line enriched"	"Detected in some"	8	"HDLM-2: 30.6"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.8"	"Region enriched"	"Detected in some"	27	"hypothalamus: 124.8"	"Cell type enriched"	"Detected in some"	8	"T-reg: 11.3"	"Lineage enriched"	"Detected in single"	81	"T-cells: 11.3"	"Group enriched"	"Detected in some"	131	"hypothalamus: 737.6;thalamus: 373.6"	"Region enriched"	"Detected in single"	30	"hypothalamus: 98.6"	"HPA046055, HPA061884"	Enhanced	Supported			"Secreted to blood"					"HPA046055: AB_2679517, HPA061884: AB_2684632"	"unprognostic (3.23e-3)"	"unprognostic (8.04e-2)"	"unprognostic (3.96e-4)"	"unprognostic (2.09e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.73e-2)"		"unprognostic (4.31e-3)"	"unprognostic (1.43e-2)"	"unprognostic (3.18e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.16e-6)"	"unprognostic (1.17e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.10e-2)"	"unprognostic (3.53e-2)"	0.1	0.0	0.3	2.1	2.0	2.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	1.1	1.0	0.0	0.2	0.6	0.8	124.8	0.1	0.1	0.2	6.4	0.4	0.1	0.1	0.1	0.0	1.4	0.2	4.5	0.2	0.0	0.1	0.2	0.1	0.1	0.9	0.1	0.1	0.9	1.1	2.0	0.2	0.7	1.0	0.1	0.1	1.7	0.2	0.1	0.0	0.0	0.0	0.0	0.1	11.3	0.0	0.3	0.1	0.3	0.3	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.2	0.0	0.0	0.0	30.6	0.1	0.5	0.6	0.3	0.0	1.0	0.4	0.0	0.0	0.0	0.0	3.7	0.7	0.1	0.0	0.0	0.6	1.0	0.5	1.2	0.3	0.6	1.2	0.0	0.2	0.3	0.4	0.4	0.6	0.1	0.2	0.1	0.4	0.4	0.4	0.1	0.5	0.1	0.5	0.4	0.4	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.3	0.0	0.3	2.0	0.1	0.1	0.8	124.8	0.4	0.1	4.5	0.7
PNLIP	PL	ENSG00000175535	"Pancreatic lipase"	P16233	10	116545931-116567855	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1895	"pancreas: 3207.8"	"Cell line enhanced"	"Detected in some"		"EFO-21: 3.0;HDLM-2: 2.7;U-2 OS: 4.5;U-251 MG: 1.0;U-266/84: 1.5"	"Cancer enriched"	"Detected in some"	4854	"pancreatic cancer: 2731.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"cerebral cortex: 0.4"	"HPA062430, HPA062494"	Enhanced				"Secreted to digestive system"	13000000	13000000			"HPA062430: AB_2684761, HPA062494: AB_2684782"											"unprognostic (2.05e-2)"	"unprognostic (4.46e-2)"						0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	1.6	3207.8	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	1.0	0.0	1.5	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
PNLIPRP1	PLRP1	ENSG00000187021	"Pancreatic lipase related protein 1"	P54315	10	116590385-116609175	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	2629	"pancreas: 516.5"	"Group enriched"	"Detected in some"	7	"EFO-21: 1.1;U-2 OS: 1.7;U-266/84: 4.3"	"Cancer enriched"	"Detected in single"	475	"pancreatic cancer: 32.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to digestive system"	210000	210000						"unprognostic (1.21e-1)"	"unprognostic (4.08e-3)"						"unprognostic (1.40e-1)"	"unprognostic (1.80e-1)"		"unprognostic (2.76e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.49e-1)"		0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	516.5	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.2	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
PNLIPRP3		ENSG00000203837	"Pancreatic lipase related protein 3"	Q17RR3	10	116427867-116477957	"Enzymes, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 8.5;breast: 15.9;esophagus: 12.0;skin 1: 15.5"	"Cell line enriched"	"Detected in some"	18	"hTCEpi: 84.8"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"HPA046202, HPA052009"	Uncertain				"Secreted - unknown location"					"HPA046202: AB_10959739, HPA052009: "					"unprognostic (2.62e-4)"	"unprognostic (1.60e-1)"			"unprognostic (6.97e-2)"									8.5	0.1	0.0	0.0	0.2	0.0	15.9	0.0	0.0	1.6	0.2	0.0	0.0	0.1	0.0	0.4	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	15.5	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.3	0.0	8.1	1.9	0.7	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	84.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
POMC	"ACTH, CLIP, LPH, MSH, NPP, POC"	ENSG00000115138	Proopiomelanocortin	P01189	2	25160853-25168903	"Cancer-related genes, Disease related genes, Predicted secreted proteins"		"Endorphin, Hormone"	"Cancer-related genes, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	36	"pituitary gland: 811.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.6;HMC-1: 4.1;THP-1: 5.4"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 18.5"	"Region enriched"	"Detected in single"	5	"hypothalamus: 1.8"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"hypothalamus: 77.9"	"CAB002762, HPA046135, HPA063644"	Enhanced				"Secreted to blood"					"CAB002762: , HPA046135: AB_2679552, HPA063644: AB_2685071"	"unprognostic (8.02e-2)"	"unprognostic (1.47e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.96e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.30e-2)"	"unprognostic (8.74e-3)"	"unprognostic (1.38e-1)"	"prognostic favourable (5.70e-4)"	"unprognostic (8.02e-2)"	"unprognostic (4.29e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.84e-2)"	1.0	3.2	0.3	0.8	0.3	0.5	0.3	0.3	0.7	0.3	0.3	0.3	0.3	0.1	0.3	0.5	0.3	0.0	0.3	0.3	0.3	1.8	0.5	0.3	0.3	0.6	0.3	0.3	0.3	22.2	0.0	811.1	0.9	0.3	0.3	0.0	0.3	0.4	0.3	3.6	0.9	0.3	0.3	0.3	1.3	0.4	2.9	0.3	0.3	0.3	0.4	0.3	0.3	0.3	13.7	22.2	6.6	10.1	12.6	10.5	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.1	0.0	4.1	1.1	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	9.9	6.6	9.8	10.1	7.7	12.8	7.5	9.3	12.5	13.7	9.9	10.5	3.1	12.6	5.9	22.2	7.9	7.6	0.3	0.3	0.3	0.3	0.3	1.8	0.3	0.3	0.3	0.3
PON1	"ESA, PON"	ENSG00000005421	"Paraoxonase 1"	P27169	7	95297676-95324707	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"		Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"liver: 144.1"	"Cell line enhanced"	"Detected in some"		"A549: 1.4;RH-30: 1.0"	"Cancer enriched"	"Detected in some"	78	"liver cancer: 97.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA001610	Approved				"Secreted to blood"	24000000000	24000000000			"HPA001610: AB_1079656"	"unprognostic (2.02e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.70e-1)"		"prognostic favourable (7.24e-7)"	"unprognostic (2.24e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.76e-3)"	"unprognostic (3.97e-2)"	"unprognostic (6.74e-9)"	"unprognostic (1.09e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.54e-3)"	0.0	1.7	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	144.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	0.0	1.0	0.1	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.6	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.4	0.2	0.0	1.0	0.0	0.0	0.3	0.6	0.1	0.0	0.3	0.0	0.4	0.0	0.5	0.0	0.1	0.0	0.2	0.9	0.3	0.0	0.0	0.2	0.2	0.6	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.0	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0
PON3		ENSG00000105852	"Paraoxonase 3"	Q15166	7	95359944-95396368	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 148.0"	"Cell line enhanced"	"Detected in some"		"A549: 19.8;CACO-2: 6.4;CAPAN-2: 4.8;Hep G2: 21.9;T-47d: 12.3"	"Group enriched"	"Detected in many"	9	"liver cancer: 30.8;lung cancer: 7.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"NK-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"NK-cells: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA014848, CAB025250"	Enhanced				"Secreted to blood"	350000000	350000000			"CAB025250: , HPA014848: AB_1855540"	"unprognostic (2.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.28e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.44e-3)"	"unprognostic (6.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.44e-3)"	"unprognostic (9.14e-2)"	"unprognostic (7.18e-3)"	"unprognostic (8.30e-9)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.29e-2)"	"unprognostic (5.12e-2)"	0.4	0.7	0.3	0.1	0.6	0.0	6.9	0.2	0.5	0.9	1.0	0.3	2.3	1.5	0.2	1.2	0.2	0.4	0.7	0.4	0.7	0.3	0.7	148.0	4.0	0.0	0.4	0.2	2.4	7.1	0.0	15.5	0.2	0.5	0.2	0.4	0.8	21.4	5.5	0.1	1.8	1.7	0.1	0.3	0.2	0.5	3.6	0.4	0.4	1.5	0.0	1.1	0.5	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	2.1	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	4.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.9	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	12.3	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.6	0.2	0.5	0.7	0.3	0.4	0.2	0.5	0.4
POSTN	"OSF-2, periostin, PN"	ENSG00000133110	Periostin	Q15063	13	37562583-37598844	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"hTEC/SVTERT24-B: 77.4;U-138 MG: 98.9;U-2197: 67.3"	"Cancer enhanced"	"Detected in all"		"breast cancer: 231.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA012306	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to extracellular matrix"	740000000	740000000	"Golgi apparatus"	Nucleoplasm	"HPA012306: AB_1854827"	"unprognostic (7.73e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.19e-3)"	"prognostic unfavourable (2.93e-4)"	"unprognostic (3.05e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (5.93e-2)"	"prognostic unfavourable (1.83e-7)"	"prognostic unfavourable (4.86e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.32e-3)"	60.9	2.0	5.3	12.7	4.0	0.0	26.9	0.5	2.7	17.6	14.1	0.6	11.7	0.6	29.0	20.0	16.5	20.3	14.5	34.1	6.2	0.5	47.5	3.0	28.4	19.5	0.5	1.1	21.0	3.1	8.2	1.7	17.3	2.5	12.4	19.7	0.8	10.8	10.2	14.2	46.1	9.6	14.5	1.7	0.7	37.3	21.5	0.1	3.1	8.0	5.5	1.7	23.5	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.2	13.7	8.3	0.0	3.5	0.0	0.8	0.1	0.0	0.2	0.0	0.0	2.8	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	14.6	0.0	77.4	0.3	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	98.9	0.0	67.3	0.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	4.0	0.5	2.7	6.2	0.5	0.5	1.1	2.5	0.1
PPBP	"b-TG1, Beta-TG, CTAP3, CTAPIII, CXCL7, LA-PF4, LDGF, MDGF, NAP-2, NAP-2-L1, PBP, SCYB7, TGB, TGB1, THBGB1"	ENSG00000163736	"Pro-platelet basic protein"	P02775	4	73987038-73988197	"Plasma proteins, Predicted secreted proteins"	Chemotaxis	"Antibiotic, Antimicrobial, Cytokine, Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 206.7;bone marrow: 67.0;lymphoid tissue: 60.0"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 4.0;HEL: 11.7;RPTEC TERT1: 2.7"	"Cancer enriched"	"Detected in many"	7	"colorectal cancer: 86.8"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	9	"basophil: 30.0;neutrophil: 18.4"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 30.0"					"Low region specificity"	"Detected in all"			"HPA008354, CAB017624"	Supported				"Secreted to blood"	3500000000	3500000000			"CAB017624: AB_1127132, HPA008354: AB_1847353"	"unprognostic (2.13e-1)"	"prognostic unfavourable (6.17e-4)"	"unprognostic (7.69e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.37e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.79e-1)"	"unprognostic (6.98e-3)"	"unprognostic (2.58e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.15e-3)"	"unprognostic (2.59e-2)"	1.4	0.6	0.4	0.6	1.7	67.0	0.6	0.2	0.4	0.5	0.2	0.1	0.0	0.1	0.3	0.5	0.5	0.8	0.9	35.7	0.3	0.3	0.5	1.9	13.3	0.1	1.6	0.0	6.0	0.4	0.1	0.5	8.7	1.3	0.6	0.2	0.4	0.5	0.1	1.0	0.3	0.2	0.2	1.3	60.0	0.3	0.5	0.0	0.0	2.2	0.9	0.1	1.7	11.0	0.3	2.6	30.0	1.8	0.2	0.5	206.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	4.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	30.0	1.8	1.1	0.2	0.6	0.3	0.1	0.1	0.0	1.0	0.3	0.5	0.1	18.4	0.2	0.5	2.6	0.2	206.7	0.4	1.7	0.2	0.4	0.3	0.3	1.6	0.0	1.3	0.0
PPIB	"CYPB, OI9"	ENSG00000166794	"Peptidylprolyl isomerase B"	P23284	15	64155812-64163205	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Isomerase, Rotamase"	"Disease mutation, Dwarfism, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011487, HPA012720"	Enhanced		Supported	"Nucleoplasm,Endoplasmic reticulum"	"Secreted to blood"	120000000	120000000	"Endoplasmic reticulum"	Nucleoplasm	"CAB011487: AB_443295, HPA012720: AB_1847399"	"unprognostic (3.00e-3)"	"unprognostic (5.65e-3)"	"unprognostic (2.81e-1)"	"prognostic favourable (1.56e-5)"	"unprognostic (1.65e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.19e-2)"	"unprognostic (8.80e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.79e-2)"	"prognostic unfavourable (2.02e-11)"	"unprognostic (7.05e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.90e-2)"	56.9	64.3	23.9	49.3	26.9	54.9	48.1	15.1	32.1	75.3	44.1	35.4	102.8	42.0	64.2	106.9	48.0	54.8	58.1	44.5	23.8	27.3	89.5	285.9	57.2	63.8	29.7	19.6	67.5	193.7	26.7	71.8	120.2	27.5	51.0	47.7	36.2	123.3	95.4	19.5	33.1	57.5	54.3	30.7	78.0	47.7	27.2	29.5	53.7	154.3	45.7	69.1	49.2	51.7	63.5	191.6	41.0	51.1	44.9	71.6	87.1	39.3	49.5	44.7	101.6	156.7	91.0	39.3	94.0	123.5	74.4	88.5	71.2	73.1	37.6	76.4	145.5	64.2	81.7	63.1	38.4	23.8	30.8	53.0	54.7	93.1	164.3	52.9	48.0	83.8	68.1	43.4	105.8	89.8	37.0	131.0	56.4	62.8	16.1	81.1	39.0	31.8	30.9	47.5	191.8	77.2	61.4	25.3	39.9	43.0	74.0	68.4	44.2	161.8	55.2	74.4	61.7	41.6	63.4	71.2	68.9	39.5	69.5	85.2	74.2	41.0	51.1	33.9	71.6	39.2	71.5	63.5	50.5	58.1	67.4	38.0	33.0	44.2	25.5	44.9	25.2	191.6	40.1	87.1	23.9	26.9	15.1	32.1	23.8	27.3	29.7	19.6	27.5	29.5
PRADC1	"C2orf7, hPAP21, MGC13004, PAP21"	ENSG00000135617	"Protease associated domain containing 1"	Q9BSG0	2	73228006-73233238	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 59.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051066	Approved				"Secreted to blood"					"HPA051066: "	"unprognostic (2.94e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.23e-2)"	"unprognostic (3.93e-2)"	"unprognostic (8.54e-2)"	"unprognostic (9.08e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.09e-3)"	"unprognostic (9.99e-3)"	"unprognostic (3.56e-2)"	"unprognostic (2.96e-1)"	"unprognostic (4.89e-1)"	"unprognostic (1.93e-1)"	"unprognostic (9.23e-2)"	10.3	12.0	11.6	5.6	13.9	4.2	22.5	9.3	13.3	6.2	12.3	6.7	6.6	13.6	4.5	9.5	9.1	4.1	6.4	37.3	10.6	7.7	11.8	23.3	6.4	14.4	10.6	7.3	3.9	39.7	4.8	8.3	4.7	10.9	6.6	12.0	6.9	25.6	8.7	59.4	6.7	16.2	13.1	9.6	8.5	8.7	9.6	7.0	4.1	7.8	22.2	5.8	7.5	5.7	6.2	25.6	11.6	33.8	13.3	10.5	15.0	8.7	7.4	7.5	14.3	23.4	9.2	9.9	14.6	6.9	15.1	8.8	20.8	9.3	9.7	8.5	17.1	8.3	11.8	10.2	10.8	14.6	10.6	14.6	10.6	15.5	7.3	7.6	14.6	11.9	6.3	13.6	7.2	14.0	12.7	21.3	17.3	18.6	21.3	14.6	2.2	30.0	12.3	29.1	30.5	8.4	8.6	15.5	5.1	7.0	19.5	6.9	10.3	7.0	7.3	17.6	7.0	15.0	13.2	22.3	16.8	8.8	11.2	16.9	7.2	4.1	12.3	11.6	9.1	28.9	7.4	6.1	8.9	8.5	12.7	6.2	8.4	7.4	1.6	13.3	33.8	25.6	10.5	15.0	11.6	13.9	9.3	13.3	10.6	7.7	10.6	7.3	10.9	7.0
PRAP1	UPA	ENSG00000165828	"Proline rich acidic protein 1"	Q96NZ9	10	133347146-133352683	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 196.7;liver: 112.7"	"Cell line enriched"	"Detected in some"	4	"Hep G2: 44.3"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 72.9;liver cancer: 348.8"	"Region enriched"	"Detected in single"	4	"pons and medulla: 1.1"	"Cell type enhanced"	"Detected in some"		"basophil: 2.9;NK-cell: 3.6"	"Group enriched"	"Detected in many"	4	"granulocytes: 2.9;NK-cells: 3.6"									"HPA038713, HPA052451"	Supported				"Secreted to digestive system"	330000000	330000000			"HPA038713: AB_10673117, HPA052451: "	"unprognostic (1.63e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.90e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.30e-1)"	"unprognostic (4.35e-3)"	"unprognostic (4.91e-2)"	"unprognostic (8.23e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.22e-3)"	0.1	0.1	0.1	1.0	0.1	0.0	0.1	0.1	0.2	0.1	145.3	0.2	0.4	111.1	0.1	2.4	0.1	0.2	3.4	0.1	0.1	0.1	24.4	112.7	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.2	0.1	1.1	0.1	3.1	3.6	0.2	0.1	0.1	0.1	196.7	0.1	0.1	0.2	0.1	2.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.8	0.7	2.9	0.2	3.6	0.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	4.1	0.0	0.0	0.0	0.0	10.4	0.1	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	44.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.6	0.1	0.0	0.2	0.3	0.4	0.0	0.0	0.3	1.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.2	0.2	0.3	0.0	0.0	0.0	2.9	0.2	0.2	0.1	0.0	0.0	0.5	0.1	0.0	0.2	0.8	0.4	0.4	1.8	3.6	0.1	0.7	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	1.1	0.1
PRB1	"PM, PMF, PMS, PRB1L, PRB1M"	ENSG00000251655	"Proline rich protein BstNI subfamily 1"		12	11351823-11395566	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	80	"salivary gland: 605.6"	"Cell line enriched"	"Detected in single"	5	"U-2 OS: 1.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to digestive system"																							0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	605.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0
PRB2	"cP7, PRPPRB1, Ps"	ENSG00000121335	"Proline rich protein BstNI subfamily 2"	P02812	12	11391540-11501041	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	94	"salivary gland: 544.2"	"Cell line enriched"	"Detected in single"	5	"U-2 OS: 2.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 5.8"	"Cell type enriched"	"Detected in single"	23	"myeloid DC: 2.2"	"Lineage enriched"	"Detected in single"	23	"dendritic cells: 2.2"														"Secreted to digestive system"										"unprognostic (1.36e-1)"	"unprognostic (1.01e-2)"		"unprognostic (2.61e-1)"	"unprognostic (2.07e-2)"	"unprognostic (9.21e-2)"	"unprognostic (5.51e-3)"			"unprognostic (1.97e-4)"	"unprognostic (1.51e-1)"			0.1	0.0	1.3	0.1	5.8	0.0	0.1	0.1	2.9	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	2.3	0.7	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	544.2	0.1	0.1	1.7	0.1	0.1	0.1	0.1	0.0	0.8	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	5.8	0.1	2.9	2.3	0.7	0.1	0.1	0.1	0.1
PRB3	PRG	ENSG00000197870	"Proline rich protein BstNI subfamily 3"	Q04118	12	11265924-11269805	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	208	"salivary gland: 2125.3"	"Cell line enriched"	"Detected in some"	5	"NTERA-2: 6.9"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.4"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.4"														"Secreted to digestive system"						"unprognostic (4.12e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.51e-1)"		"unprognostic (7.46e-3)"		"unprognostic (4.12e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.94e-2)"	"unprognostic (8.27e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.06e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	2125.3	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	1.3	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.9	0.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.3	0.5	0.0	0.0	1.4	0.6	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRB4		ENSG00000230657	"Proline rich protein BstNI subfamily 4"		12	11307083-11310435	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	273	"salivary gland: 3472.8"	"Cell line enriched"	"Detected in single"	31	"CACO-2: 7.6"	"Group enriched"	"Detected in some"	10	"lung cancer: 2.0;melanoma: 0.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to digestive system"															"unprognostic (1.05e-1)"				"unprognostic (8.25e-2)"				0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	12.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3472.8	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.1	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
PRELP	"prolargin, SLRR2A"	ENSG00000188783	"Proline and arginine rich end leucine rich repeat protein"	P51888	1	203475828-203491352	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 183.7"	"Group enriched"	"Detected in some"	9	"ASC diff: 18.5;BJ: 7.5;fHDF/TERT166: 11.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	280000	280000				"unprognostic (1.98e-1)"	"unprognostic (7.74e-2)"	"prognostic unfavourable (9.70e-5)"	"unprognostic (2.83e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (5.62e-6)"	"unprognostic (2.81e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavourable (1.02e-4)"	46.7	16.0	6.3	7.7	5.8	1.1	52.3	3.6	5.0	57.4	35.7	3.7	16.8	5.0	45.3	17.8	46.2	29.5	27.4	58.6	7.0	1.8	8.1	7.3	49.9	5.2	6.4	9.5	62.3	6.6	1.8	7.3	8.3	8.6	48.3	6.6	64.6	10.4	52.5	24.5	16.4	17.0	61.8	7.7	22.6	13.5	23.4	3.3	0.0	25.1	16.1	11.5	98.7	183.7	1.0	1.0	4.0	1.2	1.1	0.8	0.6	0.2	0.2	0.5	0.2	18.5	0.5	0.5	7.5	1.0	0.2	0.2	0.0	0.2	1.1	0.7	11.4	0.7	0.2	0.3	0.3	0.1	0.2	0.4	0.4	0.2	0.0	0.3	0.2	0.0	0.1	0.1	0.2	0.1	0.2	0.5	1.3	0.1	0.2	0.5	0.5	0.1	0.4	0.2	0.5	0.0	0.3	1.1	0.3	0.2	0.2	0.8	0.3	0.2	0.6	0.5	0.3	0.3	0.1	0.3	0.4	1.2	0.1	0.2	0.5	4.0	1.2	1.7	0.7	1.0	0.8	0.6	0.7	0.5	0.4	1.0	0.7	0.6	2.7	1.1	1.1	1.0	0.6	0.6	6.3	5.8	3.6	5.0	7.0	1.8	6.4	9.5	8.6	3.3
PRG3	"MBP2, MBPH"	ENSG00000156575	"Proteoglycan 3, pro eosinophil major basic protein 2"	Q9Y2Y8	11	57376769-57381150	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"bone marrow: 31.6;lymphoid tissue: 8.7"	"Cell line enriched"	"Detected in some"	48	"HMC-1: 66.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA064183	Enhanced				"Secreted in other tissues"	240000	240000			"HPA064183: "																		0.1	0.0	0.0	0.0	0.0	31.6	0.1	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	66.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0
PRG4	"bG174L6.2, CACP, FLJ32635, HAPO, JCAP, MSF, SZP"	ENSG00000116690	"Proteoglycan 4"	Q92954	1	186296279-186314562	"Disease related genes, Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 20.9;liver: 76.0"	"Cell line enriched"	"Detected in some"	7	"ASC diff: 79.8"	"Cancer enriched"	"Detected in many"	10	"liver cancer: 28.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"T-reg: 4.0"	"Lineage enriched"	"Detected in single"	33	"T-cells: 4.0"	"Low region specificity"	"Detected in many"							HPA028523	Uncertain				"Secreted to extracellular matrix"	4300000000	4300000000			"HPA028523: AB_10669642"	"unprognostic (8.67e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.87e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.91e-13)"	"unprognostic (1.40e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.60e-3)"	"unprognostic (7.05e-3)"	20.9	0.7	0.1	1.0	0.1	0.2	5.1	0.2	0.3	0.2	2.8	0.4	0.1	0.1	0.2	1.7	0.9	6.8	0.3	11.0	0.1	0.3	0.2	76.0	7.2	0.3	0.3	0.1	0.7	1.1	0.1	0.3	0.1	0.3	0.3	0.2	2.6	1.0	0.2	13.8	1.6	0.2	0.7	0.1	0.3	0.2	1.1	0.1	0.2	0.7	1.9	0.3	0.7	0.1	0.1	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.0	0.0	79.8	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.3	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.6	0.2	0.0	0.0	0.0	0.0	4.0	0.1	0.1	0.1	0.2	0.3	0.1	0.3	0.3	0.1	0.3	0.1
PRH2	Pr	ENSG00000134551	"Proline rich protein HaeIII subfamily 2"	P02810	12	10929236-10932341	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	128	"salivary gland: 2507.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.6;hTERT-HME1: 1.2;PC-3: 1.1"	"Cancer enriched"	"Detected in some"	11	"head and neck cancer: 11.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to digestive system"						"unprognostic (1.01e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.65e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.52e-2)"	"unprognostic (3.83e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.01e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.63e-5)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.26e-1)"	"unprognostic (3.43e-2)"	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.6	0.0	0.0	0.1	0.1	0.1	0.0	0.2	3.8	0.0	0.1	0.0	0.1	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2507.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.0	0.0	4.6	2.9	0.0	0.0	0.4	0.3	0.1	0.2	0.5	0.9	0.2	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.6	0.7	0.4	0.1	0.0	0.3	0.3	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	1.2	0.0	0.5	0.2	0.0	0.0	0.3	0.3	0.8	1.1	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.8	0.0	0.2	0.0	0.2	0.2	0.0	0.2	0.2	0.0	0.1	0.1	0.7	0.2	0.9	0.4	0.3	0.7	0.1	0.2	0.3	0.5	0.1	0.5	0.1	0.3	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0
PRL		ENSG00000172179	Prolactin	P01236	6	22287244-22297501	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	Lactation	Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	81	"pituitary gland: 1739.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 17.6;SCLC-21H: 6.6;U-937: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 1.2;non-classical monocyte: 1.0"	"Group enriched"	"Detected in many"	12	"monocytes: 1.0;T-cells: 1.2"					"Not detected"	"Not detected"			"CAB023353, HPA042416, HPA062017"	Enhanced				"Secreted to blood"	3300000	3300000			"CAB023353: AB_617369, HPA042416: AB_2677987, HPA062017: AB_2684660"	"unprognostic (1.66e-1)"	"unprognostic (4.08e-3)"	"unprognostic (5.89e-3)"	"unprognostic (4.83e-3)"	"unprognostic (2.87e-1)"			"unprognostic (1.11e-4)"	"unprognostic (4.54e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.79e-2)"			"unprognostic (4.29e-5)"	"unprognostic (2.20e-1)"			0.2	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1739.5	21.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.6	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	1.2	0.6	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.3	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.2	0.0	0.0	1.0	0.0	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0
PRLH	PRH	ENSG00000071677	"Prolactin releasing hormone"	P81277	2	237566574-237567175	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 8.1;heart muscle: 4.5"	"Cell line enhanced"	"Detected in some"		"A549: 5.9;MCF7: 4.3;RPMI-8226: 3.6;SK-BR-3: 1.8;T-47d: 2.0;U-87 MG: 2.4"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	58	"hypothalamus: 13.4;pons and medulla: 22.5"	"Region enriched"	"Detected in single"	13	"pons and medulla: 5.1"	HPA014976	Approved				"Secreted - unknown location"					"HPA014976: "	"unprognostic (8.28e-4)"			"unprognostic (3.22e-2)"						"unprognostic (5.42e-2)"								0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	1.8	0.0	4.5	0.0	0.6	0.0	0.0	0.5	0.0	0.0		0.0	0.0	0.0	0.5	0.0		0.1	0.0		1.1	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.3	1.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	1.8	0.3	2.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PROK1	"EGVEGF, PK1, PRK1"	ENSG00000143125	"Prokineticin 1"	P58294	1	110451200-110457354	"Predicted secreted proteins"	Angiogenesis	"Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"ovary: 107.6;testis: 52.8"	"Cell line enriched"	"Detected in some"	11	"ASC diff: 23.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.7"	"Region enriched"	"Detected in single"	9	"basal ganglia: 4.9"	"Group enriched"	"Detected in some"	8	"MAIT T-cell: 1.5;NK-cell: 1.0"	"Group enriched"	"Detected in many"	8	"NK-cells: 1.0;T-cells: 1.5"	"Region enriched"	"Detected in single"	11	"pons and medulla: 1.4"	"Low region specificity"	"Detected in many"								"Secreted to blood"						"unprognostic (2.66e-1)"	"unprognostic (2.71e-2)"		"unprognostic (1.30e-1)"	"unprognostic (1.42e-1)"		"unprognostic (1.37e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.86e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.74e-2)"	"unprognostic (7.39e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.38e-1)"	0.8	2.8	0.1	0.1	4.9	0.0	1.2	0.1	0.3	3.4	0.2	0.2	0.5	0.0	0.3	1.5	0.3	1.0	0.1	1.4	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	107.6	0.1	0.0	0.1	18.0	0.5	3.6	0.0	0.1	0.1	4.0	0.2	0.4	0.1	0.1	0.4	0.3	0.0	52.8	0.1	0.1	0.2	0.2	0.1	1.5	6.8	0.1	0.0	0.0	0.1	1.0	1.5	0.0	0.0	0.0	0.0	0.1	23.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	4.9	0.1	0.2	0.1	0.0	0.1	0.1	0.5	0.1
PROK2	"BV8, KAL4, MIT1, PK2"	ENSG00000163421	"Prokineticin 2"	Q9HC23	3	71771656-71785206	"Disease related genes, Predicted secreted proteins"	"Biological rhythms"	Neuropeptide	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 82.6;bone marrow: 42.8"	"Cell line enhanced"	"Detected in some"		"HL-60: 8.8;NB-4: 7.6;NTERA-2: 5.4;U-266/70: 12.1;U-266/84: 19.7;U-937: 8.1"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.1"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	49	"neutrophil: 82.6"	"Lineage enriched"	"Detected in many"	49	"granulocytes: 82.6"	"Group enriched"	"Detected in some"	6	"basal ganglia: 2.7;hypothalamus: 1.3;olfactory region: 4.3"	"Region enhanced"	"Detected in many"		"olfactory region: 11.4"	HPA041408	Approved				"Secreted to blood"					"HPA041408: AB_10964057"	"unprognostic (5.24e-2)"	"unprognostic (3.13e-3)"	"unprognostic (3.51e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.97e-2)"	"unprognostic (9.52e-2)"	"unprognostic (4.29e-2)"	"unprognostic (9.91e-3)"	"unprognostic (6.89e-2)"	"unprognostic (5.73e-1)"	"unprognostic (1.59e-4)"	"unprognostic (2.02e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.16e-2)"	5.7	0.2	0.8	12.6	0.9	42.8	0.3	0.5	2.1	0.3	0.4	0.6	0.0	0.2	0.2	0.1	0.5	2.7	0.9	9.0	0.8	0.8	0.5	2.0	10.7	21.9	3.7	0.0	0.7	0.7	0.0	0.5	2.2	0.8	0.8	0.1	0.9	0.2	0.0	0.6	0.2	0.7	1.0	1.3	20.8	0.6	22.1	1.1	0.4	1.4	0.1	0.3	2.0	4.3	0.0	0.1	82.6	1.6	0.0	1.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.8	0.2	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.2	7.6	5.4	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	19.7	0.0	0.0	8.1	0.0	0.0	1.6	0.6	0.7	0.1	0.0	0.0	0.6	0.6	0.1	0.0	0.2	1.1	82.6	0.0	0.0	0.0	0.3	0.5	0.8	0.9	0.5	2.1	0.8	0.8	3.7	0.0	0.8	1.1
PROZ	PZ	ENSG00000126231	"Protein Z, vitamin K dependent plasma glycoprotein"	P22891	13	113158654-113172383	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Serine protease homolog"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 45.0"	"Cell line enhanced"	"Detected in some"		"HaCaT: 4.8;Hep G2: 7.6"	"Cancer enriched"	"Detected in single"	27	"liver cancer: 12.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 2.7;T-reg: 1.5"	"Group enriched"	"Detected in many"	12	"monocytes: 2.7;T-cells: 1.5"	"Not detected"	"Not detected"							HPA052006	Supported				"Secreted to blood"	510000000	510000000			"HPA052006: AB_2681691"	"unprognostic (5.03e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.39e-1)"	"prognostic favourable (3.46e-4)"	"unprognostic (4.10e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.50e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.87e-1)"	"unprognostic (9.83e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.51e-4)"	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.0	9.3	45.0	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.0	2.7	0.0	1.5	0.2	0.9	1.4	0.7	1.0	0.0	0.0	0.6	1.5	0.0	0.0	0.0	3.0	1.8	0.8	0.0	0.0	4.8	0.0	0.0	0.0	0.8	2.4	1.0	2.8	7.6	0.1	0.8	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	1.0	0.6	0.8	1.8	0.4	1.3	0.2	0.3	0.0	1.1	2.9	0.2	0.0	0.3	1.3	0.0	1.0	0.7	0.8	0.1	0.8	0.3	1.6	0.9	0.8	1.6	0.9	0.7	0.0	0.0	0.0	0.3	2.7	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.1	1.5	0.2	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1
PRR27	C4orf40	ENSG00000187533	"Proline rich 27"	Q6MZM9	4	70133616-70176799	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	268	"salivary gland: 669.3"	"Cell line enhanced"	"Detected in single"		"HeLa: 1.2"	"Cancer enriched"	"Detected in single"	10	"breast cancer: 0.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.4"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.4"									"HPA036150, HPA036151"	Enhanced				"Secreted to digestive system"					"HPA036150: AB_10673001, HPA036151: AB_2674971"														"unprognostic (9.52e-2)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	669.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.5	0.2	2.4	0.3	0.5	0.2	0.0	0.3	0.2	0.1	0.3	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.3	0.0	0.3	0.0	0.0	0.0	0.7	0.2	0.2	1.2	0.1	0.0	0.0	0.4	0.1	0.0	0.5	0.0	0.0	0.2	0.5	0.0	0.7	0.1	0.4	0.5	0.1	0.2	0.1	0.5	0.0	0.0	0.1	0.0	0.3	0.2	0.2	0.4	0.0	0.3	0.2	0.2	0.2	0.2	0.4	0.1	0.3	0.1	0.0	0.4	1.5	0.3	0.2	0.2	0.2	0.0	0.3	0.1	0.2	0.0	0.5	0.2	0.2	2.4	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRR4	"LPRP, PROL4"	ENSG00000111215	"Proline rich 4 (lacrimal)"	Q16378	12	10845849-10849475	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"salivary gland: 1184.0"	"Cell line enhanced"	"Detected in some"		"HAP1: 1.5;HBEC3-KT: 1.3;Hep G2: 1.6;NB-4: 2.7;U-2 OS: 2.8;WM-115: 2.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042133	Supported				"Secreted to digestive system"	25000000	25000000			"HPA042133: AB_10793979"	"unprognostic (1.34e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.01e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.57e-6)"	"unprognostic (2.81e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.15e-2)"	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1184.0	1.1	0.0	4.2	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	20.0	38.4	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.4	1.5	1.3	0.0	0.1	0.0	0.8	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	2.7	0.6	0.0	0.1	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRSS12	"BSSP-3, MRT1"	ENSG00000164099	"Serine protease 12"	P56730	4	118280038-118353003	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 27.5;testis: 31.3"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 20.4;SH-SY5Y: 64.8;THP-1: 29.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"amygdala: 11.6;basal ganglia: 8.7;cerebral cortex: 26.5;hippocampal formation: 15.3;olfactory region: 11.0"	"Low region specificity"	"Detected in all"			HPA035054	Uncertain		Approved	"Nucleoplasm,Actin filaments"	"Secreted - unknown location"			"Actin filaments"	Nucleoplasm	"HPA035054: AB_10603990"	"unprognostic (4.30e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.41e-2)"	"prognostic favourable (2.66e-4)"	"prognostic favourable (1.03e-4)"	"unprognostic (4.21e-1)"	"unprognostic (3.48e-2)"	"unprognostic (7.83e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.09e-1)"	0.9	0.5	2.1	4.1	1.4	0.0	1.9	0.5	2.8	16.5	6.0	2.0	1.3	2.2	3.0	2.7	3.6	9.8	27.5	0.3	2.2	0.9	1.1	0.8	8.0	0.0	0.7	2.4	1.9	9.8	0.0	0.9	20.4	4.1	2.0	5.8	20.0	3.1	3.2	0.3	5.9	8.6	1.0	0.5	0.3	8.1	31.3	0.2	0.3	0.6	7.7	7.7	3.1	16.2	0.3	0.4	0.0	0.1	0.0	0.7	0.0	1.4	0.0	0.5	0.0	0.0	4.1	0.0	13.5	12.2	2.9	4.8	0.0	5.5	0.0	0.0	20.4	0.2	9.1	2.7	3.8	0.0	2.1	0.0	1.1	0.0	0.4	0.0	0.0	1.2	5.2	1.0	3.0	0.0	0.0	0.0	2.3	0.0	0.1	2.7	0.6	0.8	0.0	11.5	0.0	0.0	2.0	1.5	64.8	0.0	0.0	0.8	0.0	29.0	0.0	5.8	0.8	3.6	2.6	0.3	0.0	0.0	0.3	0.9	3.3	0.0	0.1	0.0	0.0	0.1	0.7	0.3	0.0	0.0	0.4	0.3	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	2.1	1.4	0.5	2.8	2.2	0.9	0.7	2.4	4.1	0.2
PRSS2	TRY2	ENSG00000275896	"Serine protease 2"	P07478	7	142760398-142774564	"Enzymes, Plasma proteins, Predicted secreted proteins"	Digestion	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	708	"pancreas: 6267.9"	"Cell line enriched"	"Detected in some"	5	"RPMI-8226: 37.2"	"Cancer enriched"	"Detected in many"	72	"pancreatic cancer: 3463.4"					"Group enriched"	"Detected in some"	6	"basophil: 5.6;T-reg: 5.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 5.6;T-cells: 5.1"									"HPA062452, HPA063471"	Supported		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to digestive system"	27000000000	27000000000	Vesicles	"Endoplasmic reticulum"	"HPA062452: , HPA063471: "	"prognostic favourable (2.32e-4)"	"unprognostic (3.80e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.30e-3)"		"unprognostic (1.99e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.36e-1)"		"unprognostic (4.62e-3)"	"unprognostic (1.48e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.58e-2)"	"unprognostic (3.50e-1)"	"unprognostic (5.36e-3)"	"unprognostic (1.18e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.1	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.6	6267.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	5.6	0.0	0.7	5.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.4	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	37.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.5	2.1	0.0	1.6	0.2	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	5.1	0.3										
PRSS22	"BSSP-4, hBSSP-4, SP001LA"	ENSG00000005001	"Serine protease 22"	Q9GZN4	16	2852727-2858170	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.4;lymphoid tissue: 40.1;tongue: 36.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.6;MCF7: 12.4;RT4: 5.8;SK-BR-3: 13.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	16	"cerebellum: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 2.6"	"Low region specificity"	"Detected in all"			HPA049161	Approved		Approved	Nucleoplasm	"Secreted in other tissues"			Nucleoplasm		"HPA049161: "	"unprognostic (1.45e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.50e-2)"	"unprognostic (4.48e-1)"	"unprognostic (2.29e-4)"	"unprognostic (2.58e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.06e-1)"	"unprognostic (7.52e-2)"	"unprognostic (3.74e-3)"	"unprognostic (4.12e-1)"	"unprognostic (2.32e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.75e-1)"	0.4	0.7	0.0	0.4	0.0	0.6	1.3	1.5	0.4	9.9	1.0	0.0	8.6	1.5	3.0	0.6	40.4	3.0	6.8	0.4	0.0	0.0	2.4	0.7	3.0	0.4	0.0	0.0	0.4	7.5	0.4	1.1	4.3	0.0	5.1	0.6	0.0	13.4	10.6	2.3	1.3	0.4	0.7	0.0	0.4	3.5	0.4	0.0	0.0	1.5	36.5	40.1	5.2	9.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	13.1	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRSS27	"CAPH2, MPN"	ENSG00000172382	"Serine protease 27"	Q9BQR3	16	2712418-2720551	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 94.1;lymphoid tissue: 97.2;tongue: 64.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.4;SK-BR-3: 21.8;T-47d: 12.8;U-266/70: 4.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 5.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.4;myeloid DC: 1.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.7;T-cells: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB024920, HPA028848"	Approved		Approved	Vesicles	"Secreted to digestive system"			Vesicles		"CAB024920: , HPA028848: "	"unprognostic (2.10e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.46e-3)"	"unprognostic (5.35e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.12e-1)"	"unprognostic (4.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.79e-2)"	"unprognostic (4.40e-3)"	"unprognostic (4.03e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.28e-2)"	0.2	0.3	0.1	0.2	0.5	0.2	0.4	0.7	0.4	15.3	0.2	0.1	0.1	0.1	1.2	0.1	94.1	0.3	0.2	0.2	0.1	0.4	0.2	0.2	0.2	0.2	0.1	0.1	0.2	0.1	0.5	0.1	0.2	0.1	0.2	0.1	0.1	10.0	0.3	0.2	1.2	0.1	0.2	0.1	0.2	0.1	0.5	0.1	0.3	0.2	64.5	97.2	0.5	24.0	0.1	1.7	0.2	0.0	0.2	1.4	1.2	0.0	0.2	0.5	1.8	0.3	0.6	5.4	0.0	0.2	0.2	0.1	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.5	0.1	0.1	0.0	0.9	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	1.6	0.0	0.9	1.3	0.0	0.8	0.2	0.1	0.1	0.3	0.6	2.6	0.0	21.8	0.5	12.8	1.5	0.0	0.3	0.0	0.0	0.0	4.5	3.1	0.4	0.0	0.1	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.4	0.0	1.7	0.0	0.3	0.7	0.2	0.2	0.0	0.0	0.0	1.2	0.1	0.5	0.7	0.1	0.1	0.4	0.1	0.1	0.1	0.1
PRSS33	EOS	ENSG00000103355	"Serine protease 33"	Q8NF86	16	2783953-2787948	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"blood: 132.7"	"Group enriched"	"Detected in some"	9	"HMC-1: 5.1;SK-MEL-30: 10.4;U-2 OS: 3.8"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 8.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	78	"eosinophil: 132.7"	"Lineage enriched"	"Detected in single"	422	"granulocytes: 132.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"						"unprognostic (4.78e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.99e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.86e-2)"		"unprognostic (1.16e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.42e-2)"			"unprognostic (2.28e-1)"	"unprognostic (1.91e-1)"		"unprognostic (2.70e-2)"	0.0	0.0	0.3	1.1	0.3	0.1	0.1	0.2	0.4	0.2	0.2	0.2	0.0	0.8	0.1	0.0	0.1	10.2	3.6	0.0	0.1	0.1	0.3	0.0	0.2	1.1	0.1	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.2	22.5	1.9	0.0	0.0	0.0	1.8	0.8	0.0	0.7	1.1	0.9	0.2	0.2	0.2	1.0	0.2	1.0	0.0	0.0	0.0	132.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.0	10.4	0.0	0.0	0.0	0.0	3.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	132.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.4	0.1	0.1	0.1	0.0	0.0	0.2
PRSS35	"C6orf158, dJ223E3.1, MGC46520"	ENSG00000146250	"Serine protease 35"	Q8N3Z0	6	83512538-83525704	"Enzymes, Predicted secreted proteins"		"Serine protease homolog"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 17.1;ovary: 16.3"	"Group enriched"	"Detected in some"	4	"CACO-2: 42.1;RPTEC TERT1: 12.4"	"Cancer enhanced"	"Detected in some"		"testis cancer: 4.7"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	9	"MAIT T-cell: 17.1"	"Lineage enriched"	"Detected in single"	172	"T-cells: 17.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 4.2;cerebellum: 7.0;cerebral cortex: 7.5;hippocampal formation: 6.8;olfactory region: 5.7"	"HPA038787, HPA038788"	Uncertain				"Secreted in female reproductive system"					"HPA038787: AB_10675951, HPA038788: AB_2676208"	"unprognostic (6.17e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.70e-4)"	"unprognostic (6.08e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.33e-2)"	"unprognostic (7.01e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.88e-6)"	"unprognostic (7.15e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.54e-4)"	2.0	3.8	7.7	1.3	11.3	0.0	0.6	0.2	9.3	4.8	0.4	2.5	0.3	0.5	2.2	2.1	0.6	2.2	6.2	5.6	4.8	1.1	4.9	0.7	2.0	3.0	1.1	5.4	16.3	0.6	0.9	1.5	5.2	2.7	2.7	0.6	11.1	0.4	0.7	0.4	0.5	0.4	2.2	1.4	1.1	0.6	4.6	1.3	0.0	0.7	0.4	0.2	2.0	0.9	0.0	0.0	0.0	0.0	0.0	17.1	0.1	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.1	5.1	0.5	1.0	42.1	0.0	0.0	0.0	0.2	0.0	6.3	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	4.1	0.0	0.0	0.0	12.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	17.1	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.7	11.3	0.2	7.1	4.8	1.1	1.1	5.4	2.7	1.3
PRSS36	FLJ90661	ENSG00000178226	"Serine protease 36"	Q5K4E3	16	31138925-31150094	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 2.2;HeLa: 6.3;HMC-1: 2.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"eosinophil: 4.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA036079	Uncertain				"Secreted - unknown location"					"HPA036079: AB_10602290"	"unprognostic (3.74e-2)"	"prognostic favourable (2.97e-7)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.26e-3)"	"unprognostic (1.31e-5)"	"unprognostic (4.18e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.65e-2)"	"unprognostic (8.03e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.39e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.13e-1)"	3.0	2.0	0.4	1.0	1.2	1.1	6.2	0.4	1.8	1.6	1.8	0.4	0.4	3.2	0.4	1.8	1.2	0.5	0.4	2.1	0.4	0.5	0.5	0.7	2.3	0.4	0.4	0.4	1.7	0.4	0.4	6.5	2.5	0.4	1.0	0.9	0.4	3.5	0.4	1.3	3.4	2.1	1.2	0.4	0.4	1.0	0.7	0.4	0.4	0.6	0.4	1.0	2.0	0.4	0.0	2.1	4.3	0.8	0.2	0.4	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.2	0.3	0.3	0.2	0.1	0.4	1.4	0.0	0.8	0.3	1.3	0.1	0.2	0.0	0.2	0.6	2.2	6.3	1.1	0.1	0.3	2.8	0.2	0.1	0.2	0.2	0.2	0.1	0.0	0.2	0.5	0.0	0.3	0.4	0.1	0.5	0.1	0.0	0.0	0.2	0.3	0.0	0.6	0.7	0.0	0.1	1.2	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.8	4.3	0.2	0.1	0.1	0.0	0.0	0.0	2.1	0.0	0.1	0.4	2.6	0.2	0.0	0.6	0.1	0.1	0.4	1.2	0.4	1.8	0.4	0.5	0.4	0.4	0.4	0.4
PRSS37		ENSG00000165076	"Serine protease 37"	A4D1T9	7	141836286-141841487	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"	Fertilization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	127	"testis: 39.1"	"Cell line enhanced"	"Detected in some"		"HL-60: 2.3;U-937: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA020541	Enhanced				"Secreted in male reproductive system"					"HPA020541: AB_1853004"	"unprognostic (4.70e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.69e-1)"		"unprognostic (2.41e-1)"			"unprognostic (3.21e-2)"		"unprognostic (1.30e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.30e-7)"	"unprognostic (1.42e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.72e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	39.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	2.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.2	0.0	0.0	0.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRSS38	MPN2	ENSG00000185888	"Serine protease 38"	A1L453	1	227815693-227846470	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"blood: 2.2;testis: 8.4"	"Cell line enriched"	"Detected in single"	20	"U-266/84: 5.1"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	18	"gdT-cell: 1.4;NK-cell: 2.2"	"Group enriched"	"Detected in many"	18	"NK-cells: 2.2;T-cells: 1.4"	"Not detected"	"Not detected"							"HPA028003, HPA055809"	Enhanced				"Secreted in male reproductive system"					"HPA028003: AB_1853572, HPA055809: AB_2682931"										"unprognostic (9.54e-3)"					"unprognostic (3.61e-3)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	8.4			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0										
PRSS42	TESSP2	ENSG00000178055	"Serine protease 42"	Q7Z5A4	3	46829542-46834095	"Enzymes, Predicted secreted proteins"	"Differentiation, Spermatogenesis"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"heart muscle: 12.9;skeletal muscle: 19.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.3;Daudi: 3.9;Karpas-707: 2.4;NTERA-2: 3.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046925	Uncertain				"Secreted - unknown location"					"HPA046925: AB_10961401"	"unprognostic (6.53e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.57e-3)"	"unprognostic (9.14e-2)"	"unprognostic (3.26e-1)"		"unprognostic (2.37e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.54e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.98e-2)"	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.2			0.0	0.2	3.4	0.0	0.2	0.0	12.9	0.0	0.0	1.3	0.5	0.2	0.0	0.0		0.2	0.2	1.6	0.0	0.1		0.4	0.0		0.3	0.2	19.2	0.0	0.0	0.0	0.0	0.4	0.0	0.7			0.8		0.0	0.0	0.6	0.4	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.8	0.2	1.6	0.0	0.0	0.0	0.7	0.2	2.3	3.9	0.4	0.0	0.0	0.0	0.2	1.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	2.4	0.0	0.0	0.0	0.4	3.6	0.0	1.2	0.0	0.0	0.1	0.0	0.6	0.5	0.5	0.0	0.3	0.0	0.5	0.0	1.0	0.7	0.0	0.0	0.0	0.3	0.9	0.1	0.0	0.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PRSS53	POL3S	ENSG00000151006	"Serine protease 53"	Q2L4Q9	16	31083425-31089628	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"liver: 10.9"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 9.8"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA034955, HPA034956"	Uncertain				"Secreted - unknown location"					"HPA034955: , HPA034956: AB_10696365"	"unprognostic (3.13e-1)"	"unprognostic (4.15e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.63e-4)"	"unprognostic (2.53e-12)"	"unprognostic (1.02e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	0.3	0.0	0.0	0.5	0.3	0.0	0.1	2.9	0.4	0.2	0.3			1.4	1.0	0.0	0.1	0.3	0.6	0.2	0.1	0.3	0.6	10.9	0.5	0.9	0.1		0.3	2.2	0.0	0.8	0.2		1.2	0.0		0.0	0.8	0.0	3.9	0.5	0.4	0.2	1.0	1.3	0.0			0.3		0.0	0.5	0.3	0.3	0.0	0.0	0.0	0.0	0.4	0.8	0.3	0.0	0.3	0.0	0.0	0.0	1.0	0.5	1.1	1.0	0.0	0.2	0.0	0.3	0.7	0.0	1.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.5	0.0	0.0	0.0	0.1	0.3	0.1	1.3	0.3	1.6	0.8	1.9	1.6	0.0	0.0	0.0	0.0	9.8	0.8	0.9	0.0	1.0	0.7	0.1	0.7	1.0	0.7	2.5	0.2	1.4	0.1	0.3	2.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8										
PRSS57	"PRSSL1, UNQ782"	ENSG00000185198	"Serine protease 57"	Q6UWY2	19	685546-695498	"Enzymes, Predicted secreted proteins"		"Heparin-binding, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"bone marrow: 61.8"	"Group enriched"	"Detected in some"	13	"NB-4: 85.1;THP-1: 42.6"	"Cancer enriched"	"Detected in single"	10	"pancreatic cancer: 2.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 8.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"								"Secreted to blood"						"unprognostic (2.89e-1)"	"unprognostic (1.43e-1)"		"unprognostic (2.10e-1)"		"unprognostic (3.99e-4)"	"unprognostic (3.07e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.50e-2)"	"unprognostic (4.04e-2)"	"unprognostic (7.70e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.46e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.56e-2)"		0.3	0.2	0.0	0.0	0.0	61.8	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.6	0.0	3.9	0.0	0.1	0.2	0.8	4.0	0.1	0.1	0.0	0.9	0.0	0.0	0.1	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	5.1	0.0	0.2	0.0	9.3	0.3	0.0	0.9	0.0	0.2	0.0	2.2	8.7	1.6	3.1	4.5	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	1.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	85.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	8.7	1.6	0.0	0.6	0.3	0.0	0.0	0.0	4.5	2.2	0.0	0.0	0.8	1.0	3.1	0.0	0.1	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0
PRSS58	TRYX3	ENSG00000258223	"Serine protease 58"	Q8IYP2	7	142252143-142258058	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	85	"testis: 27.2"	"Cell line enriched"	"Detected in single"	22	"RH-30: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted in male reproductive system"																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	27.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PSAPL1		ENSG00000178597	"Prosaposin like 1 (gene/pseudogene)"	Q6NUJ1	4	7430294-7434973	"Predicted secreted proteins"	"Lipid metabolism, Sphingolipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"skin 1: 42.2;stomach 1: 23.9;testis: 19.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 14.0;HaCaT: 3.8;hTCEpi: 4.8;RPMI-8226: 20.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038013, HPA038482"	Approved		Enhanced	Cytosol	"Secreted - unknown location"			Cytosol		"HPA038013: AB_10673652, HPA038482: "		"unprognostic (2.64e-2)"				"unprognostic (2.40e-1)"		"unprognostic (9.33e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.90e-3)"	"unprognostic (2.52e-1)"		"unprognostic (2.08e-2)"	"unprognostic (2.75e-1)"		"unprognostic (2.63e-3)"	0.1	0.0	0.1	0.1	0.1	0.0	3.2	0.1	0.1	0.1	0.5	0.1	0.1	0.0	0.1	1.4	0.6	0.0	1.7	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	42.2	0.1	0.1	0.1	0.1	23.9	19.9	0.1	2.5	0.1	0.1	2.1	0.1	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
PSG3		ENSG00000221826	"Pregnancy specific beta-1-glycoprotein 3"	Q16557	19	42721638-42740569	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	146	"placenta: 495.8"	"Cell line enriched"	"Detected in single"	6	"U-2197: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046327	Supported				"Secreted in female reproductive system"					"HPA046327: "																		0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	495.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.7	0.5	0.2	0.0	0.0	0.0	0.5	0.7	0.1	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PSG5	"FL-NCA-3, PSG"	ENSG00000204941	"Pregnancy specific beta-1-glycoprotein 5"	Q15238	19	43166256-43186536	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	73	"placenta: 171.3"	"Group enriched"	"Detected in some"	8	"BJ: 51.2;fHDF/TERT166: 176.3"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA046327	Supported				"Secreted in female reproductive system"					"HPA046327: "	"unprognostic (1.59e-1)"	"unprognostic (3.38e-2)"				"unprognostic (4.69e-2)"		"unprognostic (1.62e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.75e-2)"		"unprognostic (1.12e-2)"	"unprognostic (2.62e-2)"		"unprognostic (1.03e-1)"	"unprognostic (7.92e-2)"	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.1	171.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.2	0.0	0.4	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.5	2.0	0.5	0.6	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	51.2	14.7	0.8	7.1	0.0	0.0	0.0	0.0	176.3	1.9	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.5	0.4	0.7	0.4	0.5	0.6	0.5	0.5	0.2	1.0	0.7	0.5	2.0	0.6	0.4	0.5	0.4	0.0	0.0	0.1	0.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0
PSORS1C2	"C6orf17, SPR1"	ENSG00000204538	"Psoriasis susceptibility 1 candidate 2"	Q9UIG4	6	31137536-31139350	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 13.8;skin 1: 58.0;tongue: 35.9"	"Cell line enhanced"	"Detected in some"		"A-431: 1.1;HaCaT: 1.6;SiHa: 1.5"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 20.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA061228	Enhanced				"Secreted in other tissues"					"HPA061228: "	"unprognostic (8.86e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.67e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.67e-1)"		"unprognostic (1.75e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.40e-5)"	"unprognostic (2.09e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.66e-1)"	0.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	58.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	13.8	0.0	35.9	0.7	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.6	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PSPN	PSP	ENSG00000125650	Persephin	O60542	19	6375148-6379058	"Predicted secreted proteins"		"Growth factor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB025366	Uncertain				"Secreted in other tissues"					"CAB025366: "	"unprognostic (3.21e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.67e-1)"	"unprognostic (2.05e-2)"	"unprognostic (5.80e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.69e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.54e-6)"	"unprognostic (5.39e-3)"	"unprognostic (1.01e-3)"	"unprognostic (4.25e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.60e-1)"	1.0	1.7	2.5	1.1	2.7	1.6	1.1	6.4	3.4	1.8	1.4			1.1	1.6	3.5	1.3	2.5	1.3	1.1	2.3	2.1	2.5	2.2	1.1	1.2	1.5		2.8	1.6	2.7	2.4	1.1		1.8	1.5		1.8	1.6	1.3	1.7	1.8	1.4	0.8	1.9	1.5	1.5			2.5		1.5	1.1	1.0	2.6	2.8	4.6	2.6	1.8	3.0	1.6	1.6	3.8	2.2	5.5	5.1	3.4	1.2	1.9	1.9	2.2	2.3	3.8	1.4	2.0	3.1	2.4	2.4	3.7	1.4	2.4	3.0	3.0	2.0	2.3	2.9	3.7	1.6	2.9	4.0	4.3	1.7	2.8	1.4	2.4	2.6	2.4	2.9	3.7	3.3	2.2	4.3	3.2	2.7	1.3	3.6	2.2	3.0	4.7	3.2	3.0	2.5	3.4	1.9	1.8	2.7	2.6	4.7	1.2	4.4	7.0	1.1	5.0	3.3	2.6	4.6	2.1	1.8	2.1	1.6	3.0	2.0	1.5	2.6	1.2	2.6	2.3	2.3	3.6	1.8	2.6	2.8	1.7	1.6										
PTH	PTH1	ENSG00000152266	"Parathyroid hormone"	P01270	11	13492055-13496181	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"parathyroid gland: 963.9"	"Cell line enhanced"	"Detected in single"		"U-2197: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB000072, CAB023409, CAB026363, HPA048540"	Enhanced				"Secreted to blood"					"CAB000072: , CAB023409: AB_619175, CAB026363: , HPA048540: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	963.9	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	129.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PTH2	TIP39	ENSG00000142538	"Parathyroid hormone 2"	Q96A98	19	49422414-49423441	"Predicted secreted proteins"		Neuropeptide		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	28	"blood: 2.4;brain: 4.1;testis: 1.7"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.3;REH: 3.7;SCLC-21H: 3.2;U-266/84: 1.1;U-937: 1.0"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	18	"naive B-cell: 2.4"	"Lineage enriched"	"Detected in single"	18	"B-cells: 2.4"	"Region enriched"	"Detected in single"	10	"olfactory region: 3.5"	"Region enriched"	"Detected in many"	4	"cerebellum: 36.9"						"Secreted in brain"																				"unprognostic (3.41e-1)"			0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.3	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.7		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7			0.0		0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	3.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.5	1.1	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PTHLH	"HHM, PLP, PTHR, PTHRP"	ENSG00000087494	"Parathyroid hormone like hormone"	P12272	12	27958084-27972705	"Cancer-related genes, Disease related genes, Predicted secreted proteins"		Hormone	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 45.6"	"Group enriched"	"Detected in some"	4	"HaCaT: 63.2;HBEC3-KT: 78.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 64.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"T-reg: 3.0"	"Lineage enriched"	"Detected in single"	30	"T-cells: 3.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035982	Approved	Approved	Supported	"Nucleoplasm,Golgi apparatus,Cytosol"	"Secreted in other tissues"			"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA035982: AB_10794631"	"unprognostic (1.67e-1)"	"unprognostic (5.26e-3)"	"unprognostic (1.31e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavourable (3.37e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.16e-2)"	"unprognostic (4.09e-3)"	"unprognostic (3.84e-1)"	"prognostic unfavourable (1.82e-9)"	"unprognostic (2.01e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.23e-3)"	"unprognostic (7.87e-3)"	2.9	1.0	6.5	3.5	5.3	0.0	20.2	1.4	8.7	11.0	2.3	1.4	2.1	2.4	11.2	2.0	17.0	1.2	45.6	4.0	4.3	3.5	0.4	0.2	1.3	1.1	1.4	4.3	2.6	1.7	0.7	2.3	3.6	3.1	5.5	1.8	2.4	5.3	2.6	0.7	1.5	1.6	13.4	0.8	3.6	1.9	1.3	1.0	0.1	1.4	15.8	3.4	8.0	12.3	0.0	0.0	0.0	0.0	0.0	3.0	0.1	0.3	2.1	0.0	0.0	0.6	0.6	0.0	0.0	0.2	0.1	0.2	0.0	1.7	0.0	0.1	0.5	63.2	0.2	78.1	0.0	1.5	0.3	0.1	0.4	0.0	0.1	0.0	0.1	0.0	4.3	2.0	7.7	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.6	0.0	0.3	0.1	7.6	0.0	0.0	0.0	3.5	0.0	0.4	0.1	0.0	1.2	0.3	1.9	1.1	16.6	1.0	0.0	2.5	1.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.1	6.5	5.3	1.4	6.2	4.3	3.5	1.4	4.3	3.1	1.0
PTN	"HBGF8, HBNF, NEGF1"	ENSG00000105894	Pleiotrophin	P21246	7	137227341-137343865	"Cancer-related genes, Predicted secreted proteins"		"Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 160.7"	"Cell line enriched"	"Detected in some"	12	"AF22: 186.3"	"Cancer enriched"	"Detected in all"	11	"glioma: 514.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017685, HPA073913"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted to blood"	1800000	1800000	"Endoplasmic reticulum"		"CAB017685: AB_1128556, HPA073913: "	"unprognostic (1.51e-2)"	"unprognostic (7.87e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.81e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.22e-2)"	"prognostic favourable (1.35e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-2)"	7.8	6.6	55.5	2.0	43.3	0.9	27.7	38.6	58.5	30.7	7.2	26.9	9.9	2.5	25.2	18.7	25.0	7.2	18.2	29.4	42.3	29.7	12.7	3.4	6.5	2.6	31.6	27.0	7.2	3.4	160.7	52.5	11.8	31.4	38.5	7.7	19.0	12.0	18.1	1.5	3.6	4.0	17.7	23.4	12.4	5.4	16.8	23.3	1.3	5.1	8.7	5.3	7.7	18.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	186.3	2.2	0.0	0.1	15.2	4.8	14.3	2.7	3.7	0.0	0.0	0.0	0.0	6.3	0.1	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	1.8	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	14.4	0.1	0.0	0.3	0.0	0.0	0.0	0.8	12.7	0.0	0.0	0.0	0.0	0.0	0.0	4.1	3.6	0.1	10.3	0.0	0.0	0.0	13.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.5	43.3	38.6	42.0	42.3	29.7	31.6	27.0	31.4	23.3
PTX3	"TNFAIP5, TSG-14"	ENSG00000163661	"Pentraxin 3"	P26022	3	157436789-157443628	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 61.7;skeletal muscle: 67.7;urinary bladder: 77.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 84.6;ASC TERT1: 122.6;BJ hTERT+: 80.5;HHSteC: 157.4;HSkMC: 163.9;hTEC/SVTERT24-B: 86.6;TIME: 116.7;U-2197: 108.8"	"Cancer enhanced"	"Detected in many"		"glioma: 22.5"	"Group enriched"	"Detected in some"	6	"hippocampal formation: 1.1;pons and medulla: 3.6"	"Cell type enhanced"	"Detected in some"		"eosinophil: 3.2"	"Group enriched"	"Detected in many"	20	"dendritic cells: 1.3;granulocytes: 3.2;monocytes: 1.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA069320	Approved		Approved	"Plasma membrane"	"Secreted to blood"	310000	310000	"Plasma membrane"		"HPA069320: "	"unprognostic (1.93e-2)"	"unprognostic (4.96e-3)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (8.35e-9)"	"unprognostic (5.79e-3)"	"prognostic unfavourable (6.36e-4)"	"unprognostic (6.03e-3)"	"prognostic unfavourable (8.75e-6)"	"unprognostic (2.45e-1)"	"unprognostic (6.69e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.76e-9)"	"unprognostic (6.03e-3)"	"unprognostic (5.98e-2)"	"unprognostic (2.15e-4)"	"unprognostic (1.92e-3)"	61.7	3.4	0.3	16.7	0.2	31.6	35.3	0.2	0.7	0.8	13.2	0.3	0.6	0.5	0.5	0.8	2.0	6.5	3.5	14.7	1.1	0.0	3.0	0.6	22.5	7.0	0.3	0.1	6.8	18.0	0.3	1.0	4.9	3.6	2.5	1.2	5.2	1.8	0.4	67.7	6.0	1.9	6.4	0.9	9.6	4.9	0.9	0.2	0.3	2.7	0.4	0.4	77.0	2.5	0.0	1.3	3.2	1.2	0.0	0.0	0.1	0.0	0.0	51.0	0.0	84.6	122.6	0.0	8.8	80.5	3.8	4.1	0.0	0.5	0.0	31.4	10.3	0.0	0.0	0.0	7.5	0.0	0.0	0.1	0.0	0.0	157.4	0.1	0.0	163.9	0.0	86.6	29.5	17.8	0.0	0.0	25.4	0.0	0.0	0.1	0.7	0.3	0.0	0.0	0.0	0.3	3.5	0.4	0.0	0.5	0.0	0.0	0.0	0.1	116.7	17.3	0.8	108.8	1.5	0.0	0.0	0.0	3.6	0.4	4.9	0.0	1.2	3.2	0.0	1.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.3	0.2	0.2	0.2	1.1	0.0	0.3	0.1	3.6	0.2
PYY	PYY1	ENSG00000131096	"Peptide YY"	P10082	17	43952738-44004469	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"intestine: 40.0"	"Cell line enhanced"	"Detected in many"		"HMC-1: 7.8"	"Group enriched"	"Detected in many"	8	"endometrial cancer: 7.9;ovarian cancer: 15.2;testis cancer: 18.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	22	"pons and medulla: 1.4"	"Low region specificity"	"Detected in many"			"HPA010973, CAB016734"	Enhanced				"Secreted to blood"					"CAB016734: AB_876471, HPA010973: AB_1855194"	"unprognostic (8.17e-3)"	"unprognostic (5.41e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.81e-3)"	"unprognostic (2.48e-4)"	"unprognostic (5.26e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.69e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.20e-1)"	0.1	0.8	0.1	2.0	0.2	0.0	0.2	0.1	0.1	0.1	40.0	0.1	0.1	1.2	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.5	0.1	20.6	0.1	0.1	0.3	0.1	0.0	24.8	0.1	0.1	0.1	0.1	1.0	0.1	4.2	0.2	0.1	0.1	0.1	0.1	0.9	0.1	0.0	0.1	0.0	0.4	0.0	0.2	0.5	0.7	1.2	1.0	1.7	0.2	1.2	0.3	1.4	0.8	1.2	0.9	0.7	1.6	1.4	0.7	1.1	0.4	0.9	3.1	0.6	1.8	0.5	0.2	1.2	0.5	7.8	2.2	0.4	1.3	0.6	0.3	0.4	1.3	1.2	1.6	0.5	1.0	1.5	0.7	0.3	0.3	0.2	2.1	0.1	1.3	0.3	0.7	0.0	2.0	1.2	0.1	1.3	1.5	1.4	0.3	1.1	0.1	1.2	0.2	1.8	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.5	0.1
PZP	CPAMD6	ENSG00000126838	"PZP, alpha-2-macroglobulin like"	P20742	12	9148840-9208370	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"liver: 56.9"	"Group enriched"	"Detected in some"	8	"HeLa: 9.7;SiHa: 5.0"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.0"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 3.5;MAIT T-cell: 3.5"	"Lineage enriched"	"Detected in single"	12	"T-cells: 3.5"									"HPA041403, HPA041471"	Supported				"Secreted to blood"	13000000000	13000000000			"HPA041403: AB_10804003, HPA041471: AB_10795636"	"unprognostic (8.48e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.54e-4)"	"unprognostic (4.79e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.04e-4)"	"unprognostic (4.57e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.71e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.08e-5)"	"unprognostic (5.49e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.81e-3)"	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.8	0.1	0.0	0.7	0.0	0.0	0.9	0.6	0.0	56.9	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.1	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	3.5	0.0	0.7	0.9	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.2	1.4	0.0	0.0	0.9	0.6	0.0	0.0	1.4	0.6
QRFP	"26RFa, P518"	ENSG00000188710	"Pyroglutamylated RFamide peptide"	P83859	9	130892702-130896812	"Predicted secreted proteins"		Neuropeptide		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 7.4"	"Low cancer specificity"	"Detected in some"							"Group enriched"	"Detected in some"	10	"classical monocyte: 1.8;intermediate monocyte: 3.3;non-classical monocyte: 1.5"	"Lineage enriched"	"Detected in single"	15	"monocytes: 3.3"	"Region enriched"	"Detected in single"	18	"hypothalamus: 1.0"	"Low region specificity"	"Detected in all"			HPA043377	Uncertain				"Secreted in other tissues"					"HPA043377: AB_10959754"	"unprognostic (1.79e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.28e-3)"	"unprognostic (4.14e-3)"	"unprognostic (7.78e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.67e-3)"	"unprognostic (5.11e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.43e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.04e-3)"	0.9	0.3	0.0	0.9	0.1	0.6	0.3	0.0	0.4	1.4	3.7			0.7	1.1	0.0	4.2	0.8	1.1	0.5	0.1	0.2	0.4	0.0	0.5	0.4	0.0		1.0	4.9	0.0	1.8	0.4		3.2	0.2		0.3	0.0	0.4	0.7	1.3	0.0	0.2	0.2	1.7	1.8			1.1		0.0	3.0	1.0	0.0	0.0	0.0	3.3	0.0	0.2	0.5	1.2	0.6	0.5	3.3	0.0	0.0	1.7	1.3	0.0	0.0	0.0	2.1	0.8	0.5	0.5	0.0	0.5	0.0	0.0	0.0	0.2	0.4	0.1	1.7	1.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	4.3	0.5	2.9	2.8	0.4	3.0	1.9	1.3	0.0	1.1	1.1	1.4	1.1	0.4	1.3	1.8	1.0	0.4	7.4	1.9	2.9	3.5	0.3	1.2	1.5	1.3	0.8	3.7	0.0	1.8	0.0	0.0	3.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.5										
R3HDML	dJ881L22.3	ENSG00000101074	"R3H domain containing like"	Q9H3Y0	20	44336986-44351235	"Predicted secreted proteins"		"Protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 2.4;intestine: 5.9"	"Cell line enhanced"	"Detected in some"		"AF22: 1.9;CACO-2: 3.9;U-2 OS: 2.9"	"Cancer enhanced"	"Detected in single"		"colorectal cancer: 1.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA070264	Enhanced				"Secreted - unknown location"					"HPA070264: "	"unprognostic (1.89e-1)"		"unprognostic (2.23e-1)"				"unprognostic (9.86e-2)"	"unprognostic (9.12e-2)"	"unprognostic (6.06e-3)"		"unprognostic (2.64e-1)"			"unprognostic (6.32e-2)"	"unprognostic (4.95e-3)"			0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.1	0.0	1.5			5.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.4	0.5	0.2	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.8	1.4			0.1		0.0	0.0	0.0	0.3	0.5	0.9	0.0	0.2	0.2	0.0	0.0	0.3	1.9	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	3.9	0.9	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.5	0.2	1.3	0.9	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.4	0.2	0.0	0.4	0.2	0.0	0.0	0.4	2.9	0.0	0.3	0.1	0.2	0.2	0.0	0.0	0.6	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.2	0.2	0.0	0.5	0.0	0.0										
RARRES2	"HP10433, TIG2"	ENSG00000106538	"Retinoic acid receptor responder 2"	Q99969	7	150338317-150341674	"Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Differentiation, Inflammatory response"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 145.8;liver: 184.8;pancreas: 145.4"	"Group enriched"	"Detected in some"	6	"AF22: 27.1;Hep G2: 39.3;HHSteC: 35.5;NTERA-2: 82.8"	"Cancer enhanced"	"Detected in all"		"liver cancer: 420.2"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"plasmacytoid DC: 8.2"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	550000000	550000000				"unprognostic (1.96e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.81e-2)"	"prognostic unfavourable (7.70e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.29e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavourable (6.83e-4)"	"unprognostic (2.94e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.17e-2)"	46.5	145.8	4.6	20.5	5.0	0.0	28.0	2.6	4.4	51.2	31.0	10.7	10.9	5.0	23.8	21.0	18.3	21.9	30.5	12.9	5.3	3.6	21.9	184.8	33.2	10.7	7.6	3.0	40.2	145.4	66.7	6.3	5.6	12.0	35.5	8.0	23.5	6.1	12.2	7.4	3.2	10.3	27.5	7.7	11.0	10.9	11.1	5.4	1.0	7.8	5.2	10.5	26.3	39.7	0.1	8.2	0.0	0.0	0.8	0.3	0.0	0.0	0.0	27.1	0.0	0.0	0.0	0.3	2.1	5.1	0.8	3.5	0.2	1.6	0.2	3.1	0.5	0.1	0.0	0.0	0.0	0.4	0.1	0.1	4.4	39.3	35.5	0.4	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.4	0.5	82.8	0.0	0.0	3.6	0.0	0.6	0.2	0.1	0.2	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.8	0.0	8.2	0.0	0.0	4.6	5.0	2.6	4.4	5.3	3.6	7.6	3.0	12.0	5.4
RBP3	"D10S64, D10S65, D10S66, RP66"	ENSG00000265203	"Retinol binding protein 3"	P10745	10	47348371-47357875	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"	Transport		"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	45	"retina: 135.2"	"Group enriched"	"Detected in some"	8	"HaCaT: 2.6;HDLM-2: 2.4;SH-SY5Y: 2.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041301, HPA044239"	Enhanced				"Secreted in other tissues"					"HPA041301: , HPA044239: "	"unprognostic (3.48e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.36e-2)"		"unprognostic (4.02e-2)"	"unprognostic (1.40e-1)"		"unprognostic (1.58e-2)"		"unprognostic (5.09e-2)"	"unprognostic (5.14e-3)"			"unprognostic (7.44e-2)"	"unprognostic (1.23e-1)"		"unprognostic (4.68e-3)"	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	135.2	0.0	0.0	0.0	0.5	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	2.6	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
REG1A	"PSP, PSPS, PSPS1, PTP, REG"	ENSG00000115386	"Regenerating family member 1 alpha"	P05451	2	79120362-79123419	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"pancreas: 1772.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.8;EFO-21: 11.7;HDLM-2: 9.3;NB-4: 6.7;RPMI-8226: 18.9;SH-SY5Y: 8.1;U-2 OS: 18.9;U-251 MG: 6.3;U-266/84: 6.3"	"Group enriched"	"Detected in many"	10	"colorectal cancer: 313.8;pancreatic cancer: 1268.4;stomach cancer: 521.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB025138, HPA045549, HPA045579"	Enhanced				"Secreted to digestive system"	61000000	61000000			"CAB025138: , HPA045549: , HPA045579: "			"unprognostic (1.89e-1)"	"unprognostic (2.91e-2)"	"unprognostic (3.39e-1)"		"unprognostic (1.45e-1)"	"unprognostic (2.10e-1)"		"unprognostic (1.63e-1)"	"unprognostic (5.52e-2)"		"unprognostic (3.54e-3)"	"unprognostic (5.53e-2)"	"unprognostic (5.54e-2)"			0.3	0.1	0.3	2.8	0.4	0.0	0.3	0.3	0.3	0.3	37.9	0.3	0.3	129.0	0.3	0.3	0.3	0.1	1.3	0.3	0.3	0.0	14.6	0.3	0.3	0.3	0.3	0.3	0.3	1772.6	0.0	0.3	0.3	0.3	0.3	4.5	0.3	0.3	0.4	0.3	0.1	74.7	2.5	0.3	0.3	15.9	0.5	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.3	0.0	0.0	0.0	18.9	0.0	0.0	0.9	8.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	18.9	1.3	6.3	0.0	6.3	2.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3
REG3A	"HIP, PAP, PAP1, PBCGF, REG-III, REG3"	ENSG00000172016	"Regenerating family member 3 alpha"	Q06141	2	79157003-79159753	"Plasma proteins, Predicted secreted proteins, Transporters"	"Acute phase, Inflammatory response"	Antimicrobial		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	62	"intestine: 354.2;pancreas: 502.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 12.2;EFO-21: 11.5;HDLM-2: 10.6;NB-4: 11.9;RPMI-8226: 15.3;SH-SY5Y: 10.0;U-2 OS: 19.0;U-266/84: 10.0"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 710.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA047894, HPA048334, HPA060705"	Supported		Approved	Cytosol	"Secreted to digestive system"	22000000	22000000	Cytosol		"HPA047894: , HPA048334: , HPA060705: "			"unprognostic (2.43e-2)"				"unprognostic (2.12e-1)"				"unprognostic (3.62e-2)"			"unprognostic (1.42e-1)"				0.2	0.4	0.2	0.4	0.2	0.0	0.2	0.2	0.2	0.2	73.1	0.2	0.2	276.3	0.2	0.2	0.2	0.0	1.1	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	502.4	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	354.2	0.2	0.2	0.2	6.9	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.1	0.0	0.0	0.0	15.3	0.0	0.0	1.2	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	3.7	7.1	0.0	10.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
REG3G	"LPPM429, PAP1B, UNQ429"	ENSG00000143954	"Regenerating family member 3 gamma"	Q6UW15	2	79025686-79028505	"Predicted secreted proteins"	"Acute phase, Inflammatory response"	Antimicrobial		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"pancreas: 262.6"	"Cell line enhanced"	"Detected in some"		"NB-4: 2.0;SK-MEL-30: 3.1;U-2 OS: 1.6;U-266/84: 1.3"	"Cancer enriched"	"Detected in many"	13	"pancreatic cancer: 71.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA047894, HPA048334, HPA060705"	Uncertain		Approved	Cytosol	"Secreted to digestive system"			Cytosol		"HPA047894: , HPA048334: , HPA060705: "									"unprognostic (3.29e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.29e-1)"		"unprognostic (8.82e-2)"	"unprognostic (7.20e-3)"	"unprognostic (5.64e-2)"			0.1	3.9	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.8	0.6	0.1	61.1	0.1	0.0	0.1	0.1	0.1	0.0	7.1	0.1	0.1	0.1	0.1	0.1	0.1	262.6	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.0	2.8	0.3	0.1	0.1	0.0	19.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.9	0.0	0.0	3.1	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.0	1.3	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1
REG4	"GISP, REG-IV, RELP"	ENSG00000134193	"Regenerating family member 4"	Q9BYZ8	1	119794018-119811660	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 55.1;intestine: 121.9"	"Group enriched"	"Detected in some"	22	"PC-3: 44.2;RT4: 12.2"	"Group enriched"	"Detected in many"	21	"colorectal cancer: 180.6;pancreatic cancer: 215.1;stomach cancer: 162.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	6	"naive CD8 T-cell: 18.1"	"Lineage enriched"	"Detected in single"	115	"T-cells: 18.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB025867, HPA046555"	Enhanced				"Secreted to digestive system"	400000	400000			"CAB025867: , HPA046555: "	"unprognostic (3.22e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.86e-3)"	"unprognostic (2.57e-1)"	"unprognostic (6.52e-2)"	"unprognostic (6.20e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.64e-2)"		"unprognostic (7.10e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.99e-1)"	"unprognostic (5.12e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.10e-1)"		"unprognostic (1.32e-3)"	0.2	0.1	0.2	4.2	0.2	0.0	0.2	0.2	0.2	0.2	55.5	0.3	0.2	36.3	0.2	0.2	1.2	0.1	55.1	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	23.8	0.0	0.2	0.2	0.2	0.6	43.1	0.2	0.6	0.2	0.2	0.1	121.9	0.8	0.2	0.2	2.2	0.7	0.2	0.2	0.2	0.2	0.3	0.3	0.2	0.0	0.0	0.1	0.0	0.0	18.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	44.2	0.0	0.0	0.3	0.0	12.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.8	18.1	0.1	0.0	0.0	0.0	0.0	2.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
RETN	"ADSF, FIZZ3, RETN1"	ENSG00000104918	Resistin	Q9HD89	19	7669044-7670454	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		Hormone	"Diabetes mellitus, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 45.5;bone marrow: 79.5;lymphoid tissue: 27.6"	"Group enriched"	"Detected in some"	11	"NB-4: 100.1;U-937: 46.8"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 4.8"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 45.5;myeloid DC: 30.3"	"Group enriched"	"Detected in many"	11	"dendritic cells: 30.3;monocytes: 45.5"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"								"Secreted to blood"	350000	350000				"unprognostic (5.61e-2)"	"unprognostic (6.20e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.19e-4)"	"unprognostic (1.53e-4)"	"unprognostic (7.34e-2)"	"unprognostic (3.35e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.02e-1)"	"unprognostic (7.16e-5)"	"unprognostic (4.23e-2)"	"unprognostic (2.26e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.20e-1)"	1.3	0.4	0.0	1.9	0.6	79.5	0.6	0.4	0.9	0.1	0.2	0.1	0.7	2.3	0.3	0.1	0.2	1.3	0.2	21.9	0.0	0.0	0.9	1.6	17.3	7.5	1.3	0.0	0.8	1.6	0.1	0.4	1.1	0.2	0.2	0.1	0.7	0.7	0.1	0.6	0.2	0.3	1.5	0.4	27.6	0.4	0.4	0.5	2.7	0.8	0.0	0.4	0.2	2.3	0.0	30.3	3.4	45.5	0.0	2.4	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	100.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	46.8	0.0	0.0	45.5	0.0	0.1	21.7	0.3	0.0	0.5	0.4	30.3	0.0	1.1	2.4	3.4	0.0	11.1	1.2	0.0	14.0	0.0	0.6	0.4	0.9	0.0	0.0	1.3	0.0	0.2	0.5
RETNLB	"FIZZ2, HXCP2, RELMb"	ENSG00000163515	"Resistin like beta"	Q9BQ08	3	108743424-108757384	"Predicted secreted proteins"		Hormone		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	10	"intestine: 71.9"	"Cell line enhanced"	"Detected in single"		"RPMI-8226: 1.6"	"Cancer enriched"	"Detected in some"	10	"colorectal cancer: 16.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA049152	Approved				"Secreted to blood"					"HPA049152: "			"prognostic favourable (6.86e-5)"			"unprognostic (1.19e-3)"		"unprognostic (3.37e-2)"		"unprognostic (4.69e-2)"				"unprognostic (2.67e-2)"	"unprognostic (5.78e-2)"		"unprognostic (4.26e-1)"	0.1	0.0	0.1	7.0	0.1	0.0	0.1	0.1	0.1	0.1	20.6	0.1	0.1	4.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	71.9	0.1	0.1	0.1	0.1	0.0	24.1	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
RLN1	H1	ENSG00000107018	"Relaxin 1"	P04808	9	5334969-5339873	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	12	"prostate: 25.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.1;HEL: 4.7;SK-BR-3: 1.0"	"Cancer enriched"	"Detected in some"	106	"prostate cancer: 67.0"	"Region enhanced"	"Detected in single"		"hippocampal formation: 2.1"	"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.6"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.6"														"Secreted to blood"						"unprognostic (7.12e-6)"	"unprognostic (2.32e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.04e-1)"		"unprognostic (4.32e-2)"	"unprognostic (3.44e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.08e-4)"	"unprognostic (8.15e-2)"	"unprognostic (2.89e-4)"	"unprognostic (8.82e-3)"	"unprognostic (3.23e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.53e-2)"	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.1	0.9	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	2.1	0.0	0.0	0.0	0.0	0.0
RLN3	"H3, RXN3, ZINS4"	ENSG00000171136	"Relaxin 3"	Q8WXF3	19	14028148-14031042	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 2.7;parathyroid gland: 5.6;testis: 5.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.0;K-562: 4.0;SCLC-21H: 1.5;THP-1: 2.2;U-266/70: 1.0;U-698: 1.2"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	11	"midbrain: 14.0;pons and medulla: 28.5"	"Region enriched"	"Detected in some"	9	"pons and medulla: 34.0"						"Secreted to blood"													"unprognostic (1.96e-2)"		"unprognostic (2.54e-2)"					"unprognostic (3.94e-1)"			0.3	0.1	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0			0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.9	1.3		0.1	0.0	5.6	0.2	0.0		0.7	0.0		0.8	0.0	0.1	0.0	0.3	0.0	0.0	1.0	0.1	5.0			0.0		0.4	0.2	0.0	2.7	1.8	0.0	1.3	0.0	2.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.2	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	1.1	0.0	0.9	0.9	1.8	2.7	2.0	1.2	0.0	0.0	0.3	0.0	0.2	0.5										
RNASE11	"C14orf6, RAJ1"	ENSG00000173464	"Ribonuclease A family member 11 (inactive)"	Q8TAA1	14	20583559-20609884	"Predicted secreted proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	18	"epididymis: 106.3;testis: 33.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.3;NB-4: 2.7;RPMI-8226: 1.4;SH-SY5Y: 1.3;U-937: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA003724	Uncertain				"Secreted in male reproductive system"					"HPA003724: AB_1079817"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	106.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RNASE12	RAI1	ENSG00000258436	"Ribonuclease A family member 12 (inactive)"	Q5GAN4	14	20590193-20590823	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	43	"epididymis: 143.2"	"Group enriched"	"Detected in some"	5	"NB-4: 3.6;SH-SY5Y: 1.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044175, HPA059465"	Enhanced				"Secreted in male reproductive system"					"HPA044175: AB_10960390, HPA059465: AB_2732638"																		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0			0.0	0.0	143.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.6	0.0		0.3	0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
RNASE13	RAL1	ENSG00000206150	"Ribonuclease A family member 13 (inactive)"	Q5GAN3	14	21032820-21034785	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	33	"epididymis: 95.8"	"Cell line enhanced"	"Detected in single"		"NB-4: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted in male reproductive system"						"unprognostic (2.54e-1)"				"unprognostic (2.52e-1)"		"unprognostic (2.86e-1)"			"unprognostic (8.40e-2)"	"unprognostic (1.93e-1)"		"unprognostic (7.15e-2)"	"unprognostic (1.63e-3)"		"unprognostic (5.20e-4)"	"unprognostic (1.47e-2)"	0.5	0.2	0.2	0.2	0.2	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.4	95.8	0.2	0.2	0.2	0.2	0.2	0.0	0.2	2.8	0.5	0.2	0.2	0.2	0.2	0.9	0.0	0.2	0.2	0.2	0.2	0.0	0.2	1.3	0.2	0.5	0.5	0.2	0.2	0.2	1.9	0.0	1.8	0.2	0.2	0.7	0.2	0.2	0.2	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
RNASE2	"EDN, RAF3, RNS2"	ENSG00000169385	"Ribonuclease A family member 2"	P10153	14	20955452-20956436	"Enzymes, Plasma proteins, Predicted secreted proteins"	Chemotaxis	"Endonuclease, Hydrolase, Lyase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"blood: 137.2;bone marrow: 236.7"	"Group enriched"	"Detected in some"	318	"HL-60: 53.6;NB-4: 53.6;THP-1: 143.6;U-937: 130.2"	"Cancer enriched"	"Detected in many"	7	"glioma: 14.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basophil: 37.8;eosinophil: 137.2"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 137.2"									HPA044983	Enhanced				"Secreted to blood"	300000000	300000000			"HPA044983: AB_10963689"	"unprognostic (6.66e-2)"	"unprognostic (3.00e-1)"	"unprognostic (6.85e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.73e-2)"	"unprognostic (9.26e-2)"	"unprognostic (4.94e-3)"	"unprognostic (6.77e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.45e-1)"	"prognostic unfavourable (3.28e-13)"	"unprognostic (2.27e-2)"	"unprognostic (7.14e-3)"	"unprognostic (5.33e-2)"	"unprognostic (1.50e-1)"	2.7	3.2	4.8	2.0	9.3	236.7	0.5	0.9	3.7	0.9	0.6	1.4	0.1	0.5	0.7	0.5	0.5	3.2	0.9	3.7	3.9	1.8	1.2	1.3	6.6	7.2	4.7	0.1	0.5	2.5	0.5	0.6	0.8	4.9	0.5	0.6	0.1	0.7	0.5	0.9	0.9	0.6	2.1	10.5	19.4	0.9	0.6	3.7	0.1	0.5	0.1	0.6	1.4	0.3	0.0	20.0	137.2	11.5	0.0	0.0	3.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	53.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	143.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	130.2	0.0	37.8	11.5	137.2	0.0	2.0	0.0	0.0	0.0	0.0	20.0	0.0	0.0	0.0	1.0	0.0	0.2	0.2	0.0	3.3	4.8	9.3	0.9	3.7	3.9	1.8	4.7	0.1	4.9	3.7
RNASE3	"ECP, RAF1, RNS3"	ENSG00000169397	"Ribonuclease A family member 3"	P12724	14	20891399-20892348	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"blood: 60.9;bone marrow: 154.1"	"Cell line enhanced"	"Detected in some"		"HL-60: 36.2;NB-4: 12.3;THP-1: 15.6;U-937: 74.0"	"Cancer enriched"	"Detected in single"	8	"glioma: 2.0"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	21	"eosinophil: 60.9"	"Lineage enriched"	"Detected in many"	21	"granulocytes: 60.9"									HPA056183	Enhanced				"Secreted to blood"					"HPA056183: "	"unprognostic (2.54e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.37e-2)"	"unprognostic (8.21e-2)"		"unprognostic (6.45e-2)"	"unprognostic (9.20e-3)"	"unprognostic (1.20e-1)"	"unprognostic (9.21e-2)"		"unprognostic (8.62e-7)"	"unprognostic (6.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.37e-1)"	0.2	0.4	1.0	0.2	3.6	154.1	0.1	1.0	3.1	0.1	0.1	0.8	0.0	0.1	0.1	0.2	0.1	0.3	0.2	0.2	0.8	0.9	0.1	0.5	3.2	0.2	4.4	0.0	0.2	0.1	0.1	0.3	0.6	1.5	0.1	0.1	0.0	0.3	0.1	0.1	0.4	0.1	0.3	2.9	11.8	0.1	1.7	1.9	1.0	0.1	0.0	0.1	0.2	0.0	0.0	2.8	60.9	1.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.0	0.0	1.8	1.8	60.9	0.0	0.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.9	0.0	0.1	0.3	0.0	0.7	1.0	3.6	1.0	3.1	0.8	0.9	4.4	0.0	1.5	1.9
RNASE4	RAB1	ENSG00000258818	"Ribonuclease A family member 4"	P34096	14	20684100-20701215	"Plasma proteins, Predicted secreted proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"liver: 366.2"	"Group enriched"	"Detected in many"	4	"ASC diff: 30.8;ASC TERT1: 34.9;Hep G2: 43.4;HSkMC: 20.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 17.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"												"Secreted to blood"	27000000	27000000				"unprognostic (1.07e-1)"	"unprognostic (3.46e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.18e-4)"	"unprognostic (1.20e-1)"	"unprognostic (7.05e-2)"	"prognostic favourable (9.62e-5)"	"unprognostic (1.43e-1)"	"unprognostic (2.22e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.16e-2)"	"unprognostic (4.27e-2)"	29.6	1.7	1.5	5.7	1.8	0.2	28.7	1.0	1.2	25.2	16.3	2.5	12.3	4.9	19.2	18.4	14.7	15.7	23.4	10.3	2.3	1.0	18.9	366.2	12.8	5.2	3.0	1.4	30.8	16.3	3.8	3.0	4.4	2.7	30.4	15.0	10.5	35.0	14.2	7.1	10.6	13.6	17.4	3.8	3.2	19.2	13.2	1.9	0.3	8.4	10.5	7.3	25.1	26.3	4.0	9.7	0.5	17.0	0.4	2.5	5.0	0.8	4.1	0.8	0.0	30.8	34.9	0.2	3.3	7.6	0.5	1.4	1.0	1.1	0.0	0.8	7.7	0.8	0.4	0.8	0.6	5.3	0.4	0.0	0.9	43.4	3.4	0.4	0.1	20.8	1.9	0.5	3.5	4.0	0.0	3.7	2.2	0.5	0.2	0.0	0.1	3.3	0.1	0.6	1.1	0.7	0.7	0.0	0.1	1.2	0.6	0.8	0.9	0.1	4.1	0.9	0.5	1.2	0.1	0.7	0.9	0.1	1.4	0.3	0.8	0.1	17.0	0.0	0.6	0.9	0.8	4.0	1.1	0.4	9.7	2.2	0.2	0.4	0.5	0.4	0.1	2.3	2.5	5.0	1.5	1.8	1.0	1.2	2.3	1.0	3.0	1.4	2.7	1.9
RNASE6	"RAD1, RNaseK6, RNS6"	ENSG00000169413	"Ribonuclease A family member k6"	Q93091	14	20781051-20782467	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 117.6"	"Cell line enriched"	"Detected in some"	7	"RPMI-8226: 33.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 117.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							HPA000698	Approved				"Secreted to blood"	2300000	2300000			"HPA000698: AB_2181340"	"unprognostic (5.04e-2)"	"unprognostic (5.21e-3)"	"unprognostic (3.59e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.31e-2)"	"unprognostic (7.91e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.85e-3)"	"unprognostic (9.62e-2)"	"unprognostic (5.60e-3)"	"unprognostic (3.46e-2)"	"unprognostic (5.54e-2)"	25.0	10.8	7.8	19.3	10.3	7.3	11.9	1.8	7.7	10.7	9.1	7.9	4.6	5.7	5.5	25.9	4.7	7.2	14.6	11.2	7.0	6.5	10.6	8.2	16.4	51.0	10.9	3.3	4.3	4.9	1.3	4.1	13.9	9.8	6.0	10.8	6.9	9.5	5.6	2.7	4.9	23.4	7.2	24.0	49.3	5.8	5.7	10.3	12.8	4.2	3.3	25.5	14.7	4.5	42.2	117.6	33.8	52.0	3.6	1.4	26.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.1	1.2	0.0	0.0	0.0	0.0	0.8	0.3	0.1	0.0	0.0	1.0	2.2	0.0	0.0	0.1	0.0	33.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	33.8	52.0	1.1	0.5	12.2	1.2	28.9	1.4	0.6	49.4	42.2	0.6	0.1	19.0	3.6	0.1	117.6	0.1	26.8	7.8	10.3	1.8	7.7	7.0	6.5	10.9	3.3	9.8	10.3
RNASE7	RAE1	ENSG00000165799	"Ribonuclease A family member 7"	Q9H1E1	14	21042226-21044234	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 38.3;lymphoid tissue: 41.0;tongue: 21.4"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 15.0;hTCEpi: 6.5;hTERT-HME1: 32.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 17.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA005690, CAB062560, CAB068225"	Enhanced				"Secreted in other tissues"					"CAB062560: , CAB068225: , HPA005690: AB_1079819"	"unprognostic (1.13e-2)"	"unprognostic (3.21e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.27e-2)"	"unprognostic (7.80e-2)"	"unprognostic (8.73e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.23e-2)"	"unprognostic (3.24e-1)"	"unprognostic (3.42e-1)"	0.1	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.3	38.3	0.0	4.0	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.2	0.0	0.5	0.2	0.0	3.5	0.2	0.2	14.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.3	0.1	21.4	41.0	0.6	7.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	15.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	32.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
RNASE8	RAE2	ENSG00000173431	"Ribonuclease A family member 8"	Q8TDE3	14	21057822-21058455	"Predicted secreted proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	146	"salivary gland: 38.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to digestive system"																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		38.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
RNASE9	"h461, RAK1"	ENSG00000188655	"Ribonuclease A family member 9 (inactive)"	P60153	14	20556093-20560931	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	63	"epididymis: 56.1"	"Cell line enhanced"	"Detected in some"		"HEL: 1.6;NB-4: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in male reproductive system"																							0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	56.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
RNLS	"C10orf59, FLJ11218, renalase"	ENSG00000184719	"Renalase, FAD dependent amine oxidase"	Q5VYX0	10	88273864-88584530	"Enzymes, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 13.0;fHDF/TERT166: 12.7;HSkMC: 15.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted to blood"						"unprognostic (3.27e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.75e-2)"	"unprognostic (7.74e-3)"	"unprognostic (1.37e-2)"	"unprognostic (9.80e-2)"	"unprognostic (1.71e-1)"	7.1	20.6	3.9	4.9	6.6	2.1	10.2	16.7	10.5	8.9	8.2	5.4	7.5	6.3	8.4	9.4	7.7	6.4	7.2	13.4	3.9	6.4	25.1	13.6	4.0	10.4	4.9	5.7	8.9	10.5	10.9	17.3	2.5	7.5	8.5	9.1	15.1	8.2	5.3	10.0	5.1	7.0	5.6	5.3	7.1	8.7	5.8	3.9	2.1	10.9	6.8	5.0	6.0	6.4	5.3	6.1	2.6	7.0	4.7	5.0	3.4	13.0	6.0	0.2	0.1	2.1	2.9	0.0	3.6	0.4	2.9	2.4	0.8	5.3	0.0	7.3	12.7	1.8	0.0	0.8	2.9	2.8	0.1	2.1	3.9	0.1	9.6	0.0	0.3	15.3	1.5	8.2	0.0	4.4	0.9	7.1	0.1	5.5	0.0	3.7	0.0	0.0	1.7	0.0	0.0	0.0	1.2	3.3	0.0	0.2	3.1	9.7	1.8	7.9	1.0	2.2	3.4	5.5	2.9	4.9	5.9	0.1	0.1	7.4	0.0	0.0	4.0	2.6	5.0	7.0	3.6	5.3	3.8	3.5	6.1	4.5	3.9	3.1	0.2	4.7	4.6	5.6	1.7	3.4	3.9	6.6	16.7	10.5	3.9	6.4	4.9	5.7	7.5	3.9
RS1	"RS, XLRS1"	ENSG00000102104	"Retinoschisin 1"	O15537	X	18639910-18672109	"Disease related genes, Predicted secreted proteins"	"Cell adhesion, Sensory transduction, Vision"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"retina: 54.9"	"Cell line enhanced"	"Detected in single"		"HeLa: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA059546	Enhanced				"Secreted in other tissues"					"HPA059546: "	"unprognostic (8.31e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.80e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.14e-1)"	"unprognostic (7.03e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.04e-4)"	0.1	0.0	1.0	0.1	2.3	0.0	0.1	0.6	3.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	1.0	0.4	0.4	0.1	5.1	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	54.9	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.5	0.1	0.2	0.1	0.1	0.5	0.1	0.5	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.1	0.0	0.5	0.2	0.1	0.1	0.1	0.0	1.0	2.3	0.6	2.4	1.0	0.4	0.1	0.1	0.1	0.1
RSPO3	"FLJ14440, THSD2"	ENSG00000146374	"R-spondin 3"	Q9BXY4	6	127118604-127197765	"Cancer-related genes, Predicted secreted proteins"	"Sensory transduction, Wnt signaling pathway"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"A549: 23.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"cerebellum: 5.7;hippocampal formation: 20.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"hippocampal formation: 32.5"	HPA029957	Uncertain				"Secreted to blood"					"HPA029957: AB_10602087"	"unprognostic (4.77e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.99e-1)"	"unprognostic (9.71e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.07e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.64e-2)"	"unprognostic (7.89e-3)"	18.5	10.5	2.8	12.1	0.8	0.0	40.7	5.7	2.3	12.9	8.5	0.0	23.8	1.2	50.3	32.5	23.7	14.9	7.6	4.2	20.5	1.7	3.3	4.2	3.8	10.2	0.8	2.4	13.2	1.5	0.0	2.6	24.1	0.8	10.2	4.7	8.6	3.9	15.3	19.7	2.2	6.7	34.1	0.6	1.4	10.8	12.4	0.0	0.2	2.9	2.1	0.9	9.3	39.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.4	0.0	0.0	1.3	0.0	0.0	0.0	4.0	0.2	0.5	0.0	0.0	0.0	0.5	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	2.6	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.2	0.0	0.0	0.0	0.0	0.0	5.2	2.0	0.7	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.8	5.7	2.2	20.5	1.7	0.8	2.4	0.8	0.0
RSPO4	"C20orf182, dJ824F16.3"	ENSG00000101282	"R-spondin 4"	Q2I0M5	20	958452-1002264	"Disease related genes, Predicted secreted proteins"	"Sensory transduction, Wnt signaling pathway"	Heparin-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 17.5;lung: 12.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.3;EFO-21: 3.2;fHDF/TERT166: 3.4;NTERA-2: 8.9;SK-BR-3: 6.1;U-2 OS: 10.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"basal ganglia: 0.5"	HPA048887	Uncertain				"Secreted in other tissues"					"HPA048887: "	"unprognostic (2.36e-1)"	"unprognostic (3.60e-3)"	"unprognostic (2.88e-2)"	"prognostic unfavourable (2.98e-6)"	"unprognostic (8.93e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.02e-2)"	"unprognostic (5.26e-3)"	"unprognostic (2.96e-1)"	"unprognostic (5.68e-9)"	"unprognostic (6.65e-3)"	"unprognostic (4.41e-2)"	"unprognostic (6.18e-3)"	"unprognostic (2.22e-2)"	1.0	0.8	2.0	1.7	6.2	0.2	1.7	0.5	2.4	2.0	0.3	1.6	0.0	0.7	0.3	4.2	2.3	3.1	1.5	1.1	2.8	9.0	0.3	0.5	12.0	0.4	4.5	0.8	0.4	0.4	0.4	1.7	0.9	17.5	0.6	0.3	3.7	0.3	0.9	0.2	3.1	0.4	1.8	2.0	0.3	0.5	3.4	1.4	0.0	5.4	0.6	1.3	0.4	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	1.6	0.0	0.1	0.0	0.0	0.0	1.1	3.2	3.4	0.1	0.0	0.2	0.5	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	6.1	0.0	0.1	0.1	0.0	0.0	10.5	0.0	0.0	2.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	6.2	0.5	1.6	2.8	9.0	4.5	0.8	17.5	1.4
SAA1	"PIG4, SAA, TP53I4"	ENSG00000173432	"Serum amyloid A1"	P0DJI8	11	18266174-18269977	"Disease related genes, Predicted secreted proteins"	"Acute phase"	Heparin-binding	Amyloidosis	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"adipose tissue: 216.6;liver: 849.2"	"Cell line enriched"	"Detected in some"	5	"HBEC3-KT: 160.1"	"Cancer enriched"	"Detected in many"	16	"liver cancer: 1249.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"gdT-cell: 1.1;intermediate monocyte: 2.6;memory B-cell: 2.1"	"Group enriched"	"Detected in many"	6	"B-cells: 2.1;monocytes: 2.6;T-cells: 1.1"														"Secreted to blood"	22000000000	22000000000				"unprognostic (2.86e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.63e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavourable (4.57e-12)"	"unprognostic (5.15e-2)"	"unprognostic (9.78e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.64e-1)"	216.6	4.3	0.8	17.4	0.8	0.0	31.9	0.8	0.8	28.5	3.2	0.8	0.8	0.0	0.8	1.1	1.0	1.0	2.9	1.0	0.8	0.0	1.1	849.2	1.7	2.4	0.8	0.8	0.8	4.7	0.0	1.0	0.9	0.8	1.1	0.3	0.8	50.3	1.0	11.5	1.2	1.2	1.5	0.8	0.8	0.6	0.8	0.8	1.0	1.0	1.1	1.1	1.1	1.3	2.1	0.3	0.0	2.6	0.0	1.1	0.0	10.8	0.0	0.0	0.0	7.9	0.0	4.3	0.3	0.2	0.0	0.0	0.0	3.8	0.0	8.8	0.0	10.3	0.0	160.1	0.0	0.1	0.0	0.1	0.0	0.0	34.9	0.2	0.0	14.2	19.0	0.0	18.5	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	6.4	0.2	0.0	0.0	0.9	1.2	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	1.1	2.6	0.0	2.1	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.8	0.8	0.8	0.0	0.8	0.8	0.8	0.8
SAA2		ENSG00000134339	"Serum amyloid A2"	P0DJI9	11	18239223-18248643	"Disease related genes, Predicted secreted proteins"	"Acute phase"		Amyloidosis	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 752.1"	"Cell line enhanced"	"Detected in some"		"A-431: 15.3;EFO-21: 11.8;HaCaT: 14.4;HBEC3-KT: 31.3;HSkMC: 10.2"	"Cancer enriched"	"Detected in many"	22	"liver cancer: 150.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"																"Secreted to blood"	11000000000	11000000000				"unprognostic (1.73e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.63e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.40e-3)"	"unprognostic (7.12e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.78e-2)"	"unprognostic (6.13e-2)"	"prognostic unfavourable (1.30e-8)"	"unprognostic (1.53e-1)"	"unprognostic (9.72e-2)"	"unprognostic (7.62e-3)"	"unprognostic (1.28e-1)"	68.6	1.7	0.7	16.3	0.7	0.0	9.8	0.7	0.7	33.1	0.7	0.7	0.7	0.0	0.7	0.7	0.7	0.3	1.2	0.7	0.7	0.0	0.7	752.1	0.8	0.7	0.7	0.7	0.7	0.7	0.0	0.7	0.7	0.7	0.8	0.0	0.7	46.0	0.7	5.2	0.3	0.7	0.7	0.7	0.7	0.2	0.7	0.7	1.1	0.7	0.7	0.7	1.1	0.7	2.0	1.0	3.1	1.2	0.6	0.9	0.4	15.3	0.0	0.1	0.1	0.6	0.0	2.1	0.0	0.5	0.0	0.2	0.0	6.9	0.1	11.8	0.1	14.4	0.0	31.3	0.0	0.6	0.0	0.5	0.2	0.0	4.5	0.4	0.1	10.2	4.3	0.0	5.1	0.1	0.0	0.7	0.8	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	7.0	0.7	0.1	0.0	1.1	4.8	0.0	0.2	0.3	0.1	0.1	0.6	0.3	0.6	0.2	0.4	1.0	0.0	0.6	0.2	3.0	1.2	1.0	0.6	0.6	0.9	0.8	0.6	0.4	0.3	2.0	0.4	0.6	3.1	0.6	1.0	1.0	0.9	0.4	0.7	0.7	0.7	0.7	0.7	0.0	0.7	0.7	0.7	0.7
SAA4	"C-SAA, CSAA"	ENSG00000148965	"Serum amyloid A4, constitutive"	P35542	11	18231349-18236893	"Plasma proteins, Predicted secreted proteins"	"Acute phase"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	132	"liver: 263.3"	"Cell line enriched"	"Detected in some"	18	"Hep G2: 22.1"	"Cancer enriched"	"Detected in many"	141	"liver cancer: 118.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	20	"memory B-cell: 1.9"	"Lineage enriched"	"Detected in single"	20	"B-cells: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB026061, HPA060139"	Supported				"Secreted to blood"	72000000000	72000000000			"CAB026061: , HPA060139: "	"unprognostic (4.70e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.83e-1)"	"unprognostic (4.15e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.63e-3)"	"unprognostic (5.94e-2)"		"unprognostic (2.40e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.35e-2)"	"unprognostic (2.54e-8)"	"unprognostic (2.49e-1)"			"unprognostic (6.46e-2)"	0.7	0.0	0.1	0.1	0.1	0.0	0.6	0.1	0.1	1.6	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	263.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	1.2	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.2	0.0	22.1	0.2	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SBSPON	"C8orf84, RPESP"	ENSG00000164764	"Somatomedin B and thrombospondin type 1 domain containing"	Q8IVN8	8	73064540-73124088	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 66.7;urinary bladder: 47.9"	"Group enriched"	"Detected in some"	8	"BJ: 9.8;RPTEC TERT1: 17.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA029595	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	19000	19000	Vesicles		"HPA029595: AB_10600763"	"prognostic favourable (7.18e-4)"	"unprognostic (5.08e-3)"	"unprognostic (3.24e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.78e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (8.82e-4)"	"unprognostic (6.14e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.25e-2)"	6.7	3.0	0.6	1.7	0.7	0.3	6.7	2.6	0.7	6.5	4.2	2.9	16.5	0.8	4.9	18.1	9.6	8.2	3.0	3.5	1.1	0.8	14.4	0.6	5.0	2.4	2.5	0.9	9.0	1.2	0.0	1.7	9.3	5.4	19.4	1.1	4.3	4.3	25.4	1.1	1.8	2.6	66.7	15.7	1.1	9.9	5.6	0.7	0.1	3.2	2.5	0.9	47.9	7.6	0.9	1.2	1.1	0.4	1.5	0.8	0.3	0.3	0.2	0.5	0.5	0.0	0.0	1.4	9.8	0.0	0.0	0.0	0.1	0.2	0.4	0.5	0.1	0.2	0.0	0.0	0.0	0.3	0.4	0.3	0.4	0.4	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.4	0.3	1.0	0.2	0.2	0.2	0.0	17.8	0.1	0.6	0.5	1.0	0.4	0.1	0.2	0.1	0.5	0.2	1.7	0.2	0.2	0.0	0.0	0.1	0.2	0.2	0.2	0.7	0.4	0.4	0.6	0.0	0.1	0.4	0.6	0.7	0.1	0.9	0.4	0.8	1.1	1.5	0.4	1.2	0.2	0.3	0.6	0.7	2.6	0.7	1.1	0.8	2.5	0.9	5.4	0.7
SCG2	"CHGC, SgII, SN"	ENSG00000171951	"Secretogranin II"	P13521	2	223596940-223602503	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 133.0;brain: 94.1;pituitary gland: 76.5"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 26.2;HSkMC: 22.4;SCLC-21H: 22.8;SH-SY5Y: 9.9;WM-115: 16.7"	"Group enriched"	"Detected in many"	8	"glioma: 70.0;pancreatic cancer: 52.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011893, HPA075062"	Enhanced	Supported	Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	54000	54000	"Golgi apparatus"	Vesicles	"HPA011893: AB_1856656, HPA075062: AB_2732277"	"unprognostic (2.93e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.23e-3)"	"unprognostic (6.82e-4)"	"unprognostic (2.51e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.77e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.69e-2)"	"prognostic favourable (5.58e-4)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (7.01e-10)"	"unprognostic (2.47e-3)"	"unprognostic (4.02e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.90e-3)"	3.5	133.0	13.3	11.0	94.1	0.9	0.9	5.6	55.9	1.4	5.4	5.8	0.0	17.3	2.1	0.9	1.0	0.8	2.2	1.4	10.5	79.4	1.0	0.8	1.9	0.9	21.7	11.0	1.3	10.7	1.1	76.5	1.1	57.7	2.1	5.5	1.5	0.9	1.3	0.8	1.0	8.0	5.2	10.3	0.8	8.0	0.9	5.0	0.0	3.1	0.0	0.8	1.1	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.4	4.9	4.1	1.1	26.2	0.1	0.2	0.9	1.9	4.9	0.2	0.4	0.0	0.4	0.3	0.1	0.1	0.0	2.5	0.0	0.2	0.0	0.3	0.0	0.3	0.3	2.2	22.4	0.1	2.7	0.9	0.0	0.1	0.2	2.4	0.1	0.0	0.1	3.5	0.0	0.0	0.1	0.0	0.3	0.0	22.8	9.9	0.0	0.2	1.1	0.0	0.0	0.0	2.6	1.0	0.1	1.7	0.0	0.0	0.1	0.7	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	13.3	94.1	5.6	23.0	10.5	79.4	21.7	11.0	57.7	5.0
SCG5	"7B2, SGNE1, SgV"	ENSG00000166922	"Secretogranin V"	P05408	15	32641676-32697098	"Predicted secreted proteins"	Transport	"Chaperone, Neuropeptide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 71.1;pancreas: 63.5;parathyroid gland: 60.1;pituitary gland: 74.6"	"Cell line enhanced"	"Detected in some"		"HHSteC: 14.7;HSkMC: 18.2;NTERA-2: 8.2;SCLC-21H: 16.8;SH-SY5Y: 19.5;U-87 MG: 25.5"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 82.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 2.8;naive CD4 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	28	"T-cells: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013136, HPA074618"	Enhanced				"Secreted to blood"	22000	22000			"HPA013136: AB_1856657, HPA074618: AB_2732262"	"unprognostic (1.71e-1)"	"unprognostic (9.87e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.59e-3)"	"prognostic unfavourable (9.64e-4)"	"unprognostic (2.69e-1)"	"unprognostic (1.27e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.62e-3)"	"unprognostic (3.92e-1)"	"prognostic unfavourable (4.51e-9)"	"unprognostic (3.57e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.08e-3)"	"unprognostic (8.88e-2)"	1.2	30.7	24.0	2.2	47.2	0.9	2.5	36.4	71.1	1.0	4.4	13.0	0.0	9.0	3.4	21.8	1.0	2.4	3.4	1.0	30.5	36.9	1.2	2.2	2.5	1.3	25.2	23.1	2.0	63.5	60.1	74.6	0.9	30.5	3.2	5.5	15.4	0.7	1.2	0.7	1.3	3.3	3.9	24.1	1.0	21.0	3.0	9.5	0.0	1.8	0.0	0.9	2.5	0.5	0.0	0.0	0.0	0.0	0.0	2.8	0.2	0.2	0.1	0.0	0.1	0.3	2.5	0.0	2.2	0.2	0.2	0.2	0.0	0.0	0.2	1.0	0.2	0.6	0.3	0.1	0.6	0.3	0.1	0.3	0.0	0.0	14.7	0.1	0.4	18.2	0.1	0.4	0.2	0.3	0.1	0.3	0.4	0.0	0.1	0.1	8.2	0.4	0.0	0.2	0.3	0.2	0.0	16.8	19.5	0.1	0.0	0.1	0.0	0.2	0.0	2.8	1.9	0.1	0.2	0.3	1.1	0.2	25.5	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.3	0.2	24.0	47.2	36.4	50.8	30.5	36.9	25.2	23.1	30.5	9.5
SCGB1C1	RYD5	ENSG00000188076	"Secretoglobin family 1C member 1"	Q8TD33	11	193080-194573	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 7.0;pancreas: 5.9;salivary gland: 7.7"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.1;RPMI-8226: 1.8;SK-BR-3: 2.1;U-266/70: 1.9"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"basophil: 5.0;neutrophil: 2.4"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 5.0"														"Secreted - unknown location"															"unprognostic (5.09e-3)"								0.1	0.7	0.1	0.1	0.1	2.5	0.4	0.3	0.1	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.4	0.0	0.3	0.1	0.1	0.0	1.8	0.1	0.3	0.1	0.1	0.1	0.1	5.9	0.0	0.1	0.1	0.1	0.1	0.0	0.1	7.7	0.1	0.1	0.0	0.1	0.1	0.1	0.7	0.1	0.6	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.2	5.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.9	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.2	0.0	7.0	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SCGB1C2		ENSG00000268320	"Secretoglobin family 1C member 2"	P0DMR2	17	137526-139067	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	6	"blood: 4.5;pancreas: 3.6"	"Group enriched"	"Detected in some"	18	"PC-3: 1.4;U-266/70: 2.1"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.5"					"Group enriched"	"Detected in some"	18	"basophil: 2.2;neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 2.2"														"Secreted - unknown location"															"unprognostic (4.65e-2)"								0.0	0.0		0.7		0.6	0.1		0.0	0.0	0.0			0.0	0.0	0.0	0.4	0.0	0.0	0.6			0.0	0.0	0.1	0.0			0.0	3.6	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.1	0.0		0.0	0.0	0.7			0.0		0.0	0.0		0.0	0.0	2.2	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	4.5										
SCGB1D1	"LIPA, LPHA, MGC71958"	ENSG00000168515	"Secretoglobin family 1D member 1"	O95968	11	62190216-62193539	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 5.4;fallopian tube: 3.2;lymphoid tissue: 2.0"	"Cell line enriched"	"Detected in single"	24	"SCLC-21H: 11.6"	"Group enriched"	"Detected in some"	40	"endometrial cancer: 23.3;ovarian cancer: 16.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"									"unprognostic (6.95e-3)"						"unprognostic (9.01e-2)"								0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	5.4	0.1	0.1	0.1	0.0	1.1	0.1	1.4	3.2	0.1	0.1	0.1	0.8	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.7	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.3	0.1	2.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.1	0.1
SCGB1D2	"LIPB, LPHB"	ENSG00000124935	"Secretoglobin family 1D member 2"	O95969	11	62242210-62244808	"Cancer-related genes, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 101.5;cervix, uterine: 315.2"	"Cell line enriched"	"Detected in some"	6	"SCLC-21H: 14.4"	"Group enriched"	"Detected in many"	6	"breast cancer: 625.1;endometrial cancer: 226.0"	"Region enriched"	"Detected in some"	6	"pons and medulla: 7.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA035318	Approved				"Secreted in other tissues"					"HPA035318: AB_10610421"	"unprognostic (8.76e-2)"	"unprognostic (2.14e-1)"		"prognostic favourable (3.46e-6)"	"unprognostic (2.39e-2)"				"unprognostic (5.89e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.99e-1)"	"unprognostic (6.43e-2)"	"prognostic favourable (8.03e-6)"		"unprognostic (1.55e-1)"	"unprognostic (1.15e-2)"		1.8	0.4	0.8	0.2	0.6	0.0	101.5	0.9	0.5	315.2	0.2	0.9	6.2	0.0	18.4	43.8	0.8	8.5	0.4	1.0	1.2	0.4	1.1	0.2	0.2	0.2	1.0	0.5	1.1	2.9	0.0	1.0	0.6	7.3	1.1	0.0	1.2	9.5	0.5	2.4	59.6	0.2	0.2	0.4	0.2	0.0	1.6	0.5	0.2	0.3	2.1	1.2	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	14.4	0.2	0.0	2.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.9	0.5	1.2	0.4	1.0	0.5	7.3	0.5
SCGB1D4	IIS	ENSG00000197745	"Secretoglobin family 1D member 4"	Q6XE38	11	62296277-62299064	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"cervix, uterine: 27.5;ductus deferens: 9.9;endometrium 1: 9.5;epididymis: 27.9;fallopian tube: 36.8"	"Group enriched"	"Detected in some"	20	"HL-60: 3.1;Karpas-707: 1.0;RPMI-8226: 1.8"	"Cancer enriched"	"Detected in some"	57	"endometrial cancer: 100.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in female reproductive system"									"unprognostic (2.26e-3)"						"unprognostic (3.20e-1)"								0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	27.5	0.1	0.1	9.9	0.0	9.5	27.9	0.1	36.8	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	5.3	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.5	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.9	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SCGB2A1	"LPHC, MGB2, MGC71973, UGB3"	ENSG00000124939	"Secretoglobin family 2A member 1"	O75556	11	62208668-62213939	"Cancer-related genes, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"cervix, uterine: 191.8;epididymis: 135.9"	"Cell line enriched"	"Detected in some"	4	"EFO-21: 13.7"	"Group enriched"	"Detected in many"	10	"endometrial cancer: 971.9;ovarian cancer: 208.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA034584	Enhanced		Approved	Vesicles	"Secreted in other tissues"			Vesicles		"HPA034584: AB_10602221"	"unprognostic (7.73e-2)"	"unprognostic (3.77e-1)"	"prognostic favourable (1.22e-4)"	"prognostic favourable (1.54e-8)"		"unprognostic (2.98e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.39e-1)"		"unprognostic (1.95e-1)"	"unprognostic (2.69e-1)"	"unprognostic (6.87e-3)"	"prognostic favourable (6.36e-4)"	"unprognostic (5.67e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-3)"	"unprognostic (3.35e-1)"	0.2	0.0	0.2	0.5	0.2	0.0	6.8	0.2	0.3	191.8	1.0	0.3	20.8	0.0	40.8	135.9	1.0	28.7	2.5	0.4	0.2	0.3	1.2	0.4	0.9	0.2	0.2	0.3	5.6	2.2	0.0	1.5	0.7	0.5	1.2	1.3	0.2	18.8	1.4	0.2	2.3	0.3	0.2	0.2	0.2	4.3	4.5	0.2	0.3	0.8	1.1	3.1	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.1	0.0	1.0	0.2	0.0	2.5	0.6	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.2	0.3	0.2	0.3	0.5	0.2
SCGB2A2	"MGB1, MGC71974, UGB2"	ENSG00000110484	"Secretoglobin family 2A member 2"	Q13296	11	62270155-62273156	"Cancer-related genes, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"breast: 300.8"	"Cell line enriched"	"Detected in single"	118	"SK-BR-3: 19.8"	"Cancer enriched"	"Detected in many"	23	"breast cancer: 823.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											CAB026270	Enhanced				"Secreted in female reproductive system"					"CAB026270: AB_912980"	"unprognostic (2.38e-1)"	"unprognostic (7.28e-2)"		"prognostic favourable (9.57e-8)"						"unprognostic (4.17e-1)"				"unprognostic (3.75e-1)"				2.9	0.0	0.2	0.2	0.2	0.0	300.8	0.2	0.2	34.4	0.2	0.2	0.2	0.0	0.6	0.2	7.2	0.0	0.2	0.5	0.2	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	13.9	0.2	0.2	75.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.4	0.2	0.6	5.9	0.2	0.9	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
SCGB2B2	"SCGB4A2, SCGBL"	ENSG00000205209	"Secretoglobin family 2B member 2"	Q4G0G5	19	34593329-34675699	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	7	"epididymis: 4.1;pancreas: 12.7;skin 1: 5.9;testis: 15.9"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 4.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"											HPA046806	Uncertain				"Secreted - unknown location"					"HPA046806: AB_10962373"	"unprognostic (9.99e-2)"	"unprognostic (3.62e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.38e-5)"	"unprognostic (4.80e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.75e-3)"	"unprognostic (3.67e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.52e-1)"	0.6	0.7	0.7	0.6	0.6	0.0	1.2	0.6	0.9	0.6	0.6	0.6	0.6	0.7	0.6	4.1	1.3	0.7	0.6	0.6	0.7	0.7	0.6	0.7	0.7	0.6	0.6	0.6	0.6	12.7	0.3	0.6	0.6	1.0	0.6	0.2	0.6	0.6	0.6	1.1	5.9	0.6	0.6	0.9	0.6	0.4	15.9	0.6	0.6	1.0	0.6	0.6	1.0	0.6	0.6	0.3	1.4	0.3	0.3	0.8	0.1	0.7	1.3	1.2	0.7	0.8	0.4	1.4	0.8	0.8	0.3	0.4	4.0	0.6	0.5	0.6	0.1	0.7	1.3	1.2	0.3	1.5	0.6	0.7	2.1	1.0	0.4	0.3	0.9	0.5	1.3	0.1	0.7	0.0	0.2	4.3	0.3	1.3	0.6	1.9	0.5	0.7	1.0	1.0	0.5	0.8	1.5	1.2	1.1	0.8	0.7	0.6	1.3	0.5	0.8	1.5	1.0	1.0	0.3	3.8	1.8	1.3	0.5	0.2	2.3	1.4	0.3	0.1	0.8	0.0	0.4	0.3	0.5	0.3	0.3	0.6	0.8	0.5	0.3	0.3	0.1	0.1	0.3	0.1	0.7	0.6	0.6	0.9	0.7	0.7	0.6	0.6	1.0	0.6
SCGB3A1	"HIN-1, HIN1, LU105, PnSP-2, UGRP2"	ENSG00000161055	"Secretoglobin family 3A member 1"	Q96QR1	5	180590103-180591540	"Plasma proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"cervix, uterine: 56.1;gallbladder: 113.1;lung: 176.2;salivary gland: 196.6"	"Cell line enhanced"	"Detected in some"		"NB-4: 6.2;T-47d: 2.3;U-2197: 2.1"	"Group enriched"	"Detected in many"	7	"endometrial cancer: 114.2;lung cancer: 288.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 25.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to blood"	8000000	8000000				"unprognostic (7.70e-3)"	"unprognostic (4.90e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.36e-2)"	"unprognostic (7.87e-3)"	"unprognostic (2.00e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.55e-2)"	"unprognostic (7.19e-2)"	"unprognostic (8.74e-3)"	"unprognostic (5.43e-2)"	"unprognostic (4.62e-1)"	"unprognostic (4.50e-1)"	"unprognostic (1.50e-2)"	0.2	0.1	0.1	0.1	0.3	0.1	23.5	0.1	0.2	56.1	0.1	0.1	0.1	0.1	2.3	1.6	12.1	5.7	113.1	0.3	0.1	0.6	0.1	0.5	176.2	0.1	0.1	0.1	1.5	2.9	0.0	1.6	0.1	0.2	4.5	0.0	0.3	196.6	0.6	0.2	0.4	0.1	0.1	0.1	1.6	9.6	0.3	0.1	0.2	0.2	8.4	19.9	3.9	0.1	0.7	5.3	10.3	25.1	0.0	7.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	6.2	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	2.3	0.3	0.0	0.0	0.4	2.1	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	10.3	1.5	8.2	7.2	0.7	1.9	2.5	5.3	0.0	3.3	2.6	0.0	0.0	25.1	0.1	2.2	1.2	0.1	0.3	0.1	0.2	0.1	0.6	0.1	0.1	0.2	0.1
SCRG1	SCRG-1	ENSG00000164106	"Stimulator of chondrogenesis 1"	O75711	4	173384701-173406380	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.4"	"Group enriched"	"Detected in some"	13	"HSkMC: 6.6;WM-115: 19.3"	"Cancer enriched"	"Detected in many"	6	"glioma: 35.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012882	Approved				"Secreted in brain"					"HPA012882: AB_1856635"	"unprognostic (1.09e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.60e-5)"	"unprognostic (2.58e-1)"	"unprognostic (3.22e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.14e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.95e-10)"	"unprognostic (4.86e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.34e-3)"	"unprognostic (8.74e-4)"	5.8	3.1	19.2	2.6	18.6	2.2	2.3	6.0	30.6	2.1	2.9	15.9	4.0	2.5	2.5	7.7	2.3	2.1	5.1	3.6	19.9	12.0	1.5	1.4	1.5	1.5	24.9	12.9	1.6	1.8	1.2	1.1	1.6	20.5	6.4	2.7	0.0	3.4	11.6	1.9	2.0	2.0	15.6	33.4	2.4	2.8	16.3	22.5	0.0	1.5	0.3	1.3	4.1	1.0	1.4	1.3	4.4	1.8	1.6	1.0	0.4	0.1	0.0	0.9	0.2	0.4	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.1	0.7	0.1	0.2	6.6	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.2	0.1	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.2	0.1	0.1	0.1	0.1	0.2	0.2	0.2	0.3	0.1	0.0	0.1	0.1	0.1	19.3	3.9	1.8	1.2	0.8	1.2	0.6	0.8	0.6	0.7	0.7	1.4	0.8	1.0	4.4	1.6	1.3	1.3	0.5	0.4	19.2	18.6	6.0	16.7	19.9	12.0	24.9	12.9	20.5	22.5
SCT		ENSG00000070031	Secretin	P09683	11	626431-627143	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"blood: 39.8;intestine: 52.3"	"Cell line enhanced"	"Detected in some"		"A549: 2.3;HSkMC: 5.4;U-266/70: 2.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	152	"plasmacytoid DC: 39.8"	"Lineage enriched"	"Detected in single"	152	"dendritic cells: 39.8"					"Low region specificity"	"Detected in many"			HPA050961	Enhanced				"Secreted to blood"					"HPA050961: "	"unprognostic (5.28e-2)"	"unprognostic (6.18e-2)"	"prognostic unfavourable (3.70e-4)"	"unprognostic (2.72e-1)"	"unprognostic (7.91e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.43e-3)"	"unprognostic (4.19e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.01e-2)"	"unprognostic (8.37e-2)"	"unprognostic (5.45e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.13e-1)"	0.2	0.1	0.2	0.4	0.3	0.5	0.2	0.5	0.4	0.2	52.3	0.3	0.2	30.4	0.3	0.5	0.2	0.1	0.2	2.3	0.3	0.4	0.4	0.4	3.1	1.1	0.3	0.2	0.3	0.2	0.0	2.6	0.5	0.4	1.0	0.1	3.6	1.4	0.2	11.5	0.1	10.5	0.2	0.5	3.9	0.7	3.5	0.2	0.2	0.6	1.6	0.7	0.4	0.2	0.0	39.8	0.0	0.0	0.2	0.0	0.1	0.4	2.3	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.9	0.6	0.5	0.2	0.0	0.7	0.0	0.0	0.0	0.3	0.7	0.0	0.5	0.0	0.7	0.0	0.2	5.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.9	0.2	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.7	0.6	0.2	0.0	0.0	0.6	1.0	0.0	0.4	2.9	1.0	0.2	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	39.8	0.0	0.1	0.2	0.3	0.5	0.4	0.3	0.4	0.3	0.2	0.4	0.2
SCUBE3	"CEGF3, FLJ34743"	ENSG00000146197	"Signal peptide, CUB domain and EGF like domain containing 3"	Q8IX30	6	35214419-35253079	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 38.0"	"Cell line enhanced"	"Detected in some"		"AF22: 10.4;ASC diff: 31.7;ASC TERT1: 42.6;HSkMC: 19.8;hTEC/SVTERT24-B: 12.1;U-138 MG: 11.8;WM-115: 10.0"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 9.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040606	Uncertain		Approved	"Plasma membrane"	"Secreted to blood"	110000	110000	"Plasma membrane"		"HPA040606: AB_10795383"	"unprognostic (1.45e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.83e-8)"	"unprognostic (1.54e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavourable (1.38e-4)"	"unprognostic (3.06e-3)"	1.6	2.6	0.5	1.1	0.4	0.2	0.3	0.3	0.7	1.6	3.3	0.0	2.8	0.2	1.3	7.0	1.5	0.7	0.7	6.4	0.3	0.5	2.3	0.2	1.3	0.2	0.4	0.6	0.9	0.2	0.3	1.6	0.9	0.6	7.0	1.1	6.8	1.1	5.3	0.8	0.7	0.8	13.8	0.6	0.3	1.2	1.7	0.0	0.0	38.0	0.3	0.3	11.4	2.5	1.1	1.6	2.5	0.7	1.1	1.1	0.1	0.0	0.0	10.4	0.1	31.7	42.6	0.1	2.6	1.3	0.0	0.0	0.2	0.0	0.0	0.3	6.1	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	19.8	0.0	12.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.2	0.7	0.2	0.0	0.6	11.8	0.5	0.0	0.1	0.0	0.0	0.0	1.8	0.0	10.0	1.4	0.7	1.3	1.1	0.5	0.3	0.8	0.7	0.3	0.1	1.1	0.8	0.8	2.5	1.1	0.5	1.6	0.8	0.1	0.5	0.4	0.3	0.7	0.3	0.5	0.4	0.6	0.6	0.0
SEMA3C	"SEMAE, SemE"	ENSG00000075223	"Semaphorin 3C"	Q99985	7	80742538-80922359	"Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RT4: 46.6;T-47d: 52.8;U-2197: 68.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"basophil: 25.8"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 25.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA042418			Approved	"Golgi apparatus,Plasma membrane,Cytosol"	"Secreted in other tissues"			"Golgi apparatus, Cytosol"	"Plasma membrane"	"HPA042418: AB_10797389"	"unprognostic (1.93e-2)"	"unprognostic (2.54e-3)"	"unprognostic (4.94e-1)"	"unprognostic (9.86e-2)"	"unprognostic (6.74e-2)"	"prognostic unfavourable (5.72e-5)"	"unprognostic (9.28e-3)"	"unprognostic (1.91e-3)"	"unprognostic (1.39e-2)"	"unprognostic (9.01e-2)"	"prognostic unfavourable (4.08e-5)"	"unprognostic (2.07e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.92e-2)"	27.1	4.1	3.7	11.9	5.6	0.2	25.1	1.2	6.8	37.0	31.7	7.6	21.6	4.3	26.9	25.1	20.0	7.1	16.4	12.4	5.2	6.1	5.8	1.1	12.3	0.3	13.1	3.0	23.5	1.5	0.0	4.1	5.9	25.5	29.6	14.1	27.4	13.6	19.7	7.3	9.7	10.6	48.8	8.5	8.9	13.3	11.6	6.0	0.2	2.5	15.2	1.5	35.5	14.5	0.0	2.0	25.8	3.2	0.0	0.0	0.8	1.2	15.0	31.3	0.1	7.0	17.1	0.0	10.2	11.8	5.2	6.6	2.4	28.4	0.0	0.4	3.4	6.1	0.1	9.2	8.5	0.0	3.1	1.9	13.5	0.1	8.5	0.1	0.0	7.4	6.1	12.7	12.6	0.1	0.1	0.0	8.7	21.8	0.0	0.0	0.2	2.4	0.0	15.1	0.2	27.1	46.6	0.1	16.1	28.6	7.4	1.7	52.8	0.0	24.5	28.4	13.0	68.4	17.9	0.2	0.0	0.0	10.7	0.0	28.1	25.8	3.2	0.5	0.0	1.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.5	0.0	1.0	1.8	0.0	0.8	3.7	5.6	1.2	6.8	5.2	6.1	13.1	3.0	25.5	6.0
SEMA3G	"FLJ00014, sem2"	ENSG00000010319	"Semaphorin 3G"	Q9NS98	3	52433053-52445085	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 46.2;breast: 89.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 23.4;Hep G2: 6.2;HUVEC TERT2: 6.6;THP-1: 5.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	14	"T-reg: 4.5"	"Lineage enriched"	"Detected in single"	18	"T-cells: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001761	Uncertain				"Secreted to blood"	4400000	4400000			"HPA001761: AB_1079902"	"unprognostic (2.10e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.79e-4)"	"unprognostic (5.20e-3)"	"unprognostic (9.14e-2)"	"unprognostic (5.54e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.14e-1)"	"prognostic favourable (8.86e-5)"	"unprognostic (5.63e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.14e-1)"	46.2	1.6	3.1	2.4	5.0	0.2	89.1	11.5	5.3	3.5	5.4	2.8	1.5	2.1	3.3	3.0	3.5	3.2	4.5	8.0	3.8	3.3	8.8	0.7	30.4	1.2	5.5	2.5	2.0	2.2	1.1	1.1	19.3	3.1	2.9	2.8	6.8	13.6	2.1	8.0	5.2	6.7	3.2	3.6	7.2	2.7	2.0	1.1	0.4	3.5	4.7	1.4	3.7	5.3	0.2	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.1	0.1	0.2	23.4	0.2	2.6	0.0	0.0	0.0	0.0	0.7	0.4	3.0	1.3	0.0	0.0	0.1	0.0	0.0	0.2	1.2	3.4	0.2	6.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	6.6	0.0	0.3	0.0	0.2	0.2	4.0	1.2	0.1	0.0	0.0	3.7	0.0	0.2	0.6	0.6	0.0	0.3	0.4	2.0	5.8	2.5	0.0	2.5	0.0	0.0	0.4	1.7	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	3.1	5.0	11.5	5.3	3.8	3.3	5.5	2.5	3.1	1.1
SEMG1	"CT103, SEMG"	ENSG00000124233	"Semenogelin I"	P04279	20	45206997-45209772	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	26	"ductus deferens: 2077.7;seminal vesicle: 1931.9"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.3;NB-4: 1.7;NTERA-2: 3.3;THP-1: 7.7"	"Cancer enriched"	"Detected in some"	14	"prostate cancer: 20.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	192	"eosinophil: 19.2"	"Lineage enriched"	"Detected in single"	192	"granulocytes: 19.2"									"HPA042476, HPA064892"	Enhanced				"Secreted in male reproductive system"	1700000	1700000			"HPA042476: AB_10794799, HPA064892: AB_2732724"			"unprognostic (3.71e-1)"								"unprognostic (2.92e-2)"	"unprognostic (1.44e-1)"		"unprognostic (3.32e-1)"			"unprognostic (1.11e-2)"	0.2	0.2	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.2	0.0	2077.7	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.2	0.2	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	76.5	0.0	0.0	0.2	1931.9	0.2	0.2	0.2	0.0	0.1	0.2	0.2	0.2	0.0	0.0	0.1	0.0	0.0	19.5	0.1	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
SEMG2	SGII	ENSG00000124157	"Semenogelin II"	Q02383	20	45221300-45224458	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	24	"ductus deferens: 1137.0;seminal vesicle: 1095.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	25	"prostate cancer: 9.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA042767, HPA042835"	Enhanced				"Secreted in male reproductive system"	920000	920000			"HPA042767: AB_10959312, HPA042835: AB_10964060"												"unprognostic (1.39e-1)"		"unprognostic (2.17e-1)"				0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	1137.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	46.2	0.0	0.0	0.1	1095.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	8.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
SERPINA11		ENSG00000186910	"Serpin family A member 11"	Q86U17	14	94442464-94452790	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	140	"liver: 189.6"	"Cell line enriched"	"Detected in some"	8	"Hep G2: 19.1"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 94.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	460000000	460000000				"unprognostic (2.50e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.00e-2)"	"prognostic favourable (6.30e-4)"		"unprognostic (7.44e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.44e-1)"		"unprognostic (5.14e-2)"	"unprognostic (1.53e-1)"		"unprognostic (1.64e-1)"				0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	189.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SERPINA12	"OL-64, Vaspin"	ENSG00000165953	"Serpin family A member 12"	Q8IW75	14	94487274-94517844	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"skin 1: 81.9"	"Cell line enriched"	"Detected in some"	6	"Hep G2: 6.9"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.8;melanoma: 2.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	13	"cerebellum: 0.2"						"Secreted in other tissues"	570000	570000				"unprognostic (1.82e-3)"				"unprognostic (6.44e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.00e-2)"		"unprognostic (5.98e-2)"	"unprognostic (2.97e-2)"	"unprognostic (7.64e-3)"				"unprognostic (6.67e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.2	0.0			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.3	81.9	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SERPINA4	"KAL, kallistatin, KLST, KST, PI4"	ENSG00000100665	"Serpin family A member 4"	P29622	14	94561091-94569913	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 24.8;liver: 118.6;pancreas: 36.2"	"Cell line enriched"	"Detected in some"	4	"Hep G2: 22.4"	"Group enriched"	"Detected in many"	8	"liver cancer: 94.8;pancreatic cancer: 21.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA003607	Approved				"Secreted to blood"	22000000000	22000000000			"HPA003607: AB_1079914"	"unprognostic (1.65e-3)"		"unprognostic (4.13e-2)"	"prognostic favourable (2.95e-4)"			"unprognostic (2.09e-3)"	"unprognostic (1.99e-3)"		"unprognostic (2.82e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.24e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.45e-2)"			0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.1	0.1	3.2	0.3	0.1	7.9	0.1	0.1	24.8	0.1	0.0	0.0	1.4	118.6	0.0	0.0	0.0	0.0	0.1	36.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	8.2	0.0	0.1	0.1	0.0	0.0	0.1	4.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
SERPINA5	"PAI3, PCI, PLANH3, PROCI"	ENSG00000188488	"Serpin family A member 5"	P05154	14	94561442-94593120	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Fertilization, Lipid transport, Transport"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 100.4;ductus deferens: 126.6;liver: 112.4;seminal vesicle: 106.7;testis: 146.5"	"Cell line enriched"	"Detected in some"	14	"Hep G2: 74.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 121.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056919			Approved	Mitochondria	"Secreted to blood"	2300000000	2300000000	Mitochondria		"HPA056919: "	"unprognostic (5.94e-3)"	"unprognostic (2.64e-4)"	"unprognostic (1.13e-1)"	"prognostic favourable (7.72e-4)"	"unprognostic (3.34e-3)"	"unprognostic (6.10e-3)"	"unprognostic (3.94e-2)"	"unprognostic (1.39e-3)"	"unprognostic (5.36e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.87e-2)"	"unprognostic (8.39e-3)"	"unprognostic (3.38e-3)"	"unprognostic (9.92e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.23e-1)"	1.1	100.4	0.4	1.8	1.8	0.0	7.7	0.2	0.5	4.0	1.0	1.6	126.6	0.6	4.8	5.0	0.5	3.6	34.3	5.6	0.6	0.4	33.6	112.4	0.3	1.9	3.1	0.3	6.4	33.8	0.0	0.8	0.2	1.9	1.9	0.0	0.9	10.9	106.7	6.6	0.7	0.7	0.4	1.5	36.1	2.0	146.5	0.6	0.1	0.9	1.5	0.6	1.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	3.9	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.3	0.1	0.1	0.0	0.5	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	1.2	0.0	0.1	5.1	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.8	0.2	0.5	0.6	0.4	3.1	0.3	1.9	0.6
SERPINA6	CBG	ENSG00000170099	"Serpin family A member 6"	P08185	14	94304248-94323394	"Disease related genes, Plasma proteins, Predicted secreted proteins"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"liver: 223.9"	"Cell line enriched"	"Detected in some"	11	"T-47d: 116.8"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 244.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA017864	Approved				"Secreted to blood"	59000000000	59000000000			"HPA017864: AB_1856721"	"unprognostic (2.82e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-3)"	"prognostic favourable (6.96e-5)"		"unprognostic (2.93e-3)"	"unprognostic (9.98e-3)"	"unprognostic (4.43e-2)"		"unprognostic (3.11e-1)"	"unprognostic (4.80e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.47e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.43e-1)"		"unprognostic (2.14e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.1	1.0	0.0	2.3	10.3	0.1	0.0	0.0	5.2	223.9	0.1	0.0	0.0	0.0	0.8	9.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	116.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SERPINA7	TBG	ENSG00000123561	"Serpin family A member 7"	P05543	X	106032442-106038738	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	414	"liver: 101.8"	"Cell line enriched"	"Detected in single"	474	"Hep G2: 47.3"	"Cancer enriched"	"Detected in single"	203	"liver cancer: 82.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA002803	Approved				"Secreted to blood"	49000000000	49000000000			"HPA002803: AB_1079915"			"unprognostic (6.22e-2)"				"unprognostic (1.63e-3)"				"unprognostic (3.34e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.15e-3)"		"unprognostic (2.95e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	101.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SERPINC1	"AT3, ATIII, MGC22579"	ENSG00000117601	"Serpin family C member 1"	P01008	1	173903804-173917378	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Disease mutation, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	203	"liver: 450.5"	"Cell line enriched"	"Detected in some"	35	"Hep G2: 41.6"	"Cancer enriched"	"Detected in some"	871	"liver cancer: 1504.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"eosinophil: 2.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA001816, CAB016790, HPA024007"	Supported				"Secreted to blood"	210000000000	210000000000			"CAB016790: , HPA001816: AB_1079926, HPA024007: AB_1856732"	"unprognostic (1.28e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.83e-2)"	"unprognostic (5.98e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.93e-2)"	"prognostic favourable (3.40e-5)"	"unprognostic (1.75e-2)"	"unprognostic (8.67e-2)"	"unprognostic (3.48e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.28e-3)"	"unprognostic (5.80e-2)"	"unprognostic (6.35e-2)"	"unprognostic (8.21e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	450.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	41.6	0.0	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.1	0.5	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
SERPIND1	"D22S673, HC-II, HC2, HCF2, HLS2"	ENSG00000099937	"Serpin family D member 1"	P05546	22	20773879-20787720	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Chemotaxis, Hemostasis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Disease mutation, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	47	"liver: 170.8"	"Cell line enriched"	"Detected in some"	10	"Hep G2: 62.7"	"Cancer enriched"	"Detected in many"	80	"liver cancer: 334.4"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008639, HPA055767"	Supported		Approved	Vesicles	"Secreted to blood"	94000000000	94000000000	Vesicles		"CAB008639: AB_1618010, HPA055767: "	"unprognostic (1.68e-1)"	"unprognostic (8.27e-2)"	"unprognostic (4.40e-2)"	"prognostic favourable (4.09e-4)"	"unprognostic (5.42e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.94e-9)"	"unprognostic (2.01e-1)"	"unprognostic (4.66e-2)"	"unprognostic (8.36e-3)"	"unprognostic (1.46e-1)"	0.0	0.0	0.0	0.0	2.3	0.0	0.2	0.6	0.9	0.3	0.0	1.4	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	170.8	0.3	0.0	0.0	0.7	0.3	0.0	3.6	0.1	0.2	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.1	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.1	1.9	2.7	0.7	0.4	1.3	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	62.7	0.0	0.2	0.1	0.0	0.0	0.5	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	4.3	0.0	0.4	0.0	1.0	0.2	1.7	0.4	0.5	0.6	0.1	1.9	0.9	0.7	0.7	1.3	0.2	2.7	0.7	0.1	0.0	2.3	0.6	0.9	0.0	0.0	0.0	0.7	2.6	0.5
SERPINE1	"PAI, PAI1, PLANH1"	ENSG00000106366	"Serpin family E member 1"	P05121	7	101127089-101139266	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 253.6"	"Cell line enhanced"	"Detected in many"		"BJ: 140.2;HUVEC TERT2: 162.7;LHCN-M2: 157.1;TIME: 402.3;U-138 MG: 191.5;U-251 MG: 168.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	20	"NK-cell: 10.8"	"Lineage enriched"	"Detected in single"	20	"NK-cells: 10.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA050039, CAB068501"	Uncertain		Approved	Cytosol	"Secreted to blood"	14000000	14000000	Cytosol		"CAB068501: AB_1642775, HPA050039: "	"unprognostic (5.02e-2)"	"prognostic unfavourable (5.01e-4)"	"prognostic unfavourable (2.82e-4)"	"unprognostic (2.10e-2)"	"unprognostic (9.04e-3)"	"prognostic unfavourable (2.84e-5)"	"unprognostic (6.80e-3)"	"prognostic unfavourable (4.41e-6)"	"unprognostic (2.33e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.88e-3)"	"unprognostic (1.58e-1)"	"prognostic unfavourable (5.88e-8)"	"prognostic unfavourable (3.27e-6)"	"unprognostic (1.05e-1)"	"unprognostic (4.33e-2)"	"prognostic unfavourable (5.51e-4)"	45.5	14.0	1.1	16.7	1.8	0.1	11.4	0.5	1.5	13.3	7.0	3.4	3.3	1.2	6.6	14.4	6.8	9.3	69.6	29.2	1.5	0.6	7.8	65.3	56.3	3.3	4.1	1.8	19.7	24.7	1.4	2.6	253.6	5.9	7.6	0.9	2.3	2.4	6.2	12.4	4.1	2.3	13.5	4.1	5.8	6.6	8.6	2.2	0.6	11.3	3.7	2.8	71.7	18.1	0.2	0.4	0.5	0.2	10.8	0.3	1.0	3.0	2.5	0.0	0.2	32.1	64.0	3.6	140.2	26.5	70.7	61.8	0.3	0.2	0.1	33.6	44.6	0.7	0.0	10.8	73.1	0.1	0.0	0.0	0.2	2.4	64.6	0.0	0.1	25.0	4.3	108.5	57.1	162.7	0.2	0.1	157.1	0.0	0.0	0.0	0.7	1.6	0.0	0.2	0.1	0.2	1.2	0.0	0.0	11.5	3.1	0.3	0.1	0.3	402.3	191.5	8.4	65.2	168.3	0.0	0.1	0.1	47.8	0.0	1.8	0.5	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.3	0.3	0.2	0.0	0.1	0.2	10.8	0.0	0.4	0.0	1.0	1.1	1.8	0.5	1.5	1.5	0.6	4.1	1.8	5.9	2.2
SERPINE2	"GDN, nexin, PI7, PN1, PNI"	ENSG00000135919	"Serpin family E member 2"	P07093	2	223975112-224039319	"Plasma proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Heparin-binding, Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"placenta: 257.0"	"Cell line enhanced"	"Detected in many"		"BJ: 82.0;fHDF/TERT166: 350.3;SK-MEL-30: 156.2;WM-115: 120.4"	"Cancer enriched"	"Detected in all"	9	"melanoma: 271.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"naive CD4 T-cell: 10.5;naive CD8 T-cell: 5.3;NK-cell: 16.5"	"Group enriched"	"Detected in many"	13	"NK-cells: 16.5;T-cells: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in female reproductive system"	490000	490000				"unprognostic (1.73e-1)"	"unprognostic (7.08e-3)"	"unprognostic (8.49e-2)"	"unprognostic (7.78e-3)"	"unprognostic (2.57e-3)"	"unprognostic (5.57e-2)"	"unprognostic (1.49e-2)"	"unprognostic (7.43e-3)"	"unprognostic (4.41e-1)"	"unprognostic (7.12e-2)"	"unprognostic (7.56e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.18e-2)"	"prognostic unfavourable (6.48e-5)"	8.0	5.8	34.7	18.0	30.6	2.2	4.8	14.9	35.2	8.6	6.1	13.0	0.1	7.4	5.1	4.4	9.7	6.0	11.9	24.5	21.9	25.3	10.6	3.3	3.2	7.7	33.0	14.4	38.4	2.9	1.3	2.0	257.0	25.2	6.6	6.2	4.9	3.1	2.8	3.2	3.5	6.0	28.1	23.0	7.8	2.7	14.2	11.9	1.6	6.2	3.2	10.8	18.3	6.9	1.0	0.1	0.3	0.0	16.5	10.5	2.2	0.1	4.4	1.6	1.7	67.4	25.4	0.2	82.0	47.0	6.6	6.4	0.2	0.3	0.0	1.8	350.3	0.2	0.1	5.6	5.7	0.0	1.4	0.8	2.9	1.2	3.3	0.6	0.0	7.3	3.8	19.0	28.6	0.5	0.0	0.0	22.8	0.2	0.1	0.2	3.1	4.9	0.5	1.4	3.3	61.5	5.1	2.3	0.4	15.6	0.0	156.2	0.0	0.3	57.8	39.3	5.4	11.9	3.8	0.3	0.6	0.0	25.1	0.6	120.4	0.0	0.0	0.0	0.6	0.0	0.3	0.7	0.4	0.5	0.0	1.0	10.5	5.3	0.3	16.5	0.0	0.1	0.5	2.2	34.7	30.6	14.9	29.8	21.9	25.3	33.0	14.4	25.2	11.9
SERPINE3		ENSG00000253309	"Serpin family E member 3"	A8MV23	13	51335773-51364735	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"retina: 49.3"	"Cell line enhanced"	"Detected in some"		"HeLa: 2.7;TIME: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA051904, HPA055804"	Uncertain				"Secreted in other tissues"					"HPA051904: , HPA055804: "	"unprognostic (1.60e-1)"	"unprognostic (6.17e-2)"	"unprognostic (9.66e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.52e-2)"	"unprognostic (8.54e-3)"	"unprognostic (2.67e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.94e-6)"	"unprognostic (1.29e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.31e-2)"	2.6	0.9	0.6	1.2	0.8	0.2	0.6	1.9	1.7	0.6	0.8	0.6	0.6	0.8	1.1	2.0	1.1	0.9	1.4	1.9	0.7	0.5	0.8	1.2	0.6	1.4	0.6	0.6	1.0	5.7	0.1	0.6	0.6	1.2	0.6	0.1	49.3	0.9	0.6	0.6	4.0	3.2	0.6	1.1	0.8	0.8	1.0	0.6	0.6	1.1	0.6	0.6	0.9	0.9	1.6	0.0	0.1	0.9	0.0	0.8	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.1	0.2	0.8	0.3	0.0	0.7	0.0	0.0	0.0	0.9	0.1	0.9	2.7	0.2	0.0	1.9	0.9	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.4	0.3	0.8	2.3	0.0	0.3	0.0	0.0	1.3	1.1	0.3	2.1	0.1	0.2	1.0	2.1	2.9	0.7	1.9	0.2	1.3	0.4	0.7	0.2	1.5	0.2	1.4	0.0	0.2	0.0	0.3	0.9	0.0	0.0	0.8	0.1	0.0	1.6	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.8	1.9	0.6	0.7	0.5	0.6	0.6	1.2	0.6
SERPINF2	"A2AP, AAP, ALPHA-2-PI, API, PLI"	ENSG00000167711	"Serpin family F member 2"	P08697	17	1742836-1755268	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Acute phase"	"Protease inhibitor, Serine protease inhibitor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	21	"liver: 417.7"	"Cell line enriched"	"Detected in some"	32	"Hep G2: 55.8"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 450.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	4	"plasmacytoid DC: 19.8"	"Lineage enriched"	"Detected in single"	27	"dendritic cells: 19.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA001885, CAB024863"	Approved				"Secreted to blood"	110000000000	110000000000			"CAB024863: , HPA001885: AB_1079922"	"unprognostic (2.17e-3)"	"unprognostic (2.56e-3)"	"unprognostic (2.48e-1)"	"unprognostic (7.57e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.45e-2)"	"prognostic favourable (2.26e-5)"	"unprognostic (1.44e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.88e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.09e-3)"	"unprognostic (7.05e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.68e-3)"	"unprognostic (2.93e-1)"	0.9	0.0	0.2	0.6	0.2	0.0	1.8	0.2	0.2	0.6	0.3	0.2	6.6	0.0	0.7	17.2	0.2	2.1	0.2	0.3	0.2	0.0	10.2	417.7	1.3	3.4	0.2	0.2	0.7	0.8	0.0	0.2	0.2	0.8	2.1	0.0	1.8	0.5	9.0	0.2	0.4	1.0	0.2	0.2	0.6	0.2	1.7	0.2	0.2	0.7	0.2	0.5	0.6	0.4	0.2	19.8	0.5	0.7	0.4	0.0	0.4	0.3	1.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.3	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.2	55.8	0.4	0.1	0.0	0.5	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.2	0.0	0.2	0.0	0.0	4.6	0.1	0.0	0.0	0.0	0.4	0.0	19.8	0.0	0.4	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.8	0.2
SERPINI2	"MEPI, PANCPIN, PI14, TSA2004"	ENSG00000114204	"Serpin family I member 2"	O75830	3	167441789-167479004	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	73	"pancreas: 184.7"	"Cell line enriched"	"Detected in some"	6	"THP-1: 13.8"	"Cancer enriched"	"Detected in some"	6	"pancreatic cancer: 7.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 2.5"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to digestive system"						"unprognostic (1.88e-2)"	"unprognostic (2.23e-3)"		"unprognostic (1.14e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.17e-2)"		"unprognostic (1.29e-2)"		"unprognostic (1.11e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.76e-5)"	"unprognostic (5.35e-2)"	"unprognostic (4.16e-2)"			0.1	0.0	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	184.7	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	2.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	13.8	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	2.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
SFRP2	"FRP-2, SARP1, SDF-5"	ENSG00000145423	"Secreted frizzled related protein 2"	Q96HF1	4	153780592-153789120	"Predicted secreted proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"urinary bladder: 102.5"	"Group enriched"	"Detected in some"	12	"AF22: 52.3;ASC diff: 19.9;HSkMC: 32.8;NTERA-2: 72.5"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 370.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA002652			Approved	"Intermediate filaments"	"Secreted in other tissues"			"Intermediate filaments"		"HPA002652: AB_1079937"	"unprognostic (2.63e-1)"	"unprognostic (2.47e-1)"	"unprognostic (7.21e-3)"	"unprognostic (1.80e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.80e-3)"	"unprognostic (5.71e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.47e-3)"	"unprognostic (1.44e-2)"	"unprognostic (5.29e-2)"	"prognostic unfavourable (8.56e-6)"	"unprognostic (9.29e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavourable (4.39e-4)"	42.9	4.0	3.4	17.6	1.7	0.2	70.0	1.3	8.0	10.9	20.6	11.3	18.2	4.4	6.4	64.4	51.5	18.5	74.9	42.2	8.5	1.2	1.9	0.2	21.3	2.6	2.8	5.6	7.9	22.5	1.6	23.2	0.3	4.6	33.4	10.8	8.4	23.9	19.5	2.5	26.1	13.7	72.3	5.4	0.3	11.4	13.2	5.0	0.3	29.1	29.4	6.8	102.5	37.4	0.0	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.0	52.3	0.0	19.9	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.4	1.7	1.3	5.7	8.5	1.2	2.8	5.6	4.6	5.0
SFRP5	SARP3	ENSG00000120057	"Secreted frizzled related protein 5"	Q5T4F7	10	97766751-97771952	"Predicted secreted proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"gallbladder: 34.9;heart muscle: 27.1;intestine: 17.8;pancreas: 70.4;retina: 67.6"	"Cell line enhanced"	"Detected in some"		"A549: 3.3;CACO-2: 15.9;RPMI-8226: 5.7;SCLC-21H: 2.6"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 30.4"	"Group enriched"	"Detected in some"	5	"hypothalamus: 1.8;midbrain: 4.5;pons and medulla: 5.6"	"Cell type enriched"	"Detected in some"	5	"naive CD8 T-cell: 7.4"	"Lineage enriched"	"Detected in many"	5	"T-cells: 7.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"								"Secreted in other tissues"						"unprognostic (2.63e-4)"	"unprognostic (3.03e-3)"	"unprognostic (6.74e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.51e-9)"	"unprognostic (1.67e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.62e-1)"	0.9	5.1	0.0	1.3	0.8	0.4	0.6	0.5	0.4	1.8	10.9	1.1	9.1	14.7	1.1	2.8	4.3	0.6	34.9	27.1	0.7	1.8	0.2	3.2	1.9	0.4	4.5	0.1	0.3	70.4	0.2	0.1	0.2	5.6	1.9	0.5	67.6	9.2	2.4	0.4	0.9	17.8	1.0	1.9	0.3	3.4	0.4	0.3	0.0	0.2	1.6	0.3	1.3	1.4	0.0	1.5	0.0	0.0	0.0	7.4	0.5	0.0	3.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.7	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.1	5.7	0.0	0.0	2.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	7.4	0.0	0.0	0.0	1.5	0.0	0.5	0.0	0.8	0.5	0.3	0.7	1.8	4.5	0.1	5.6	0.3
SFTPA1	"COLEC4, SFTP1, SP-A, SP-A1"	ENSG00000122852	"Surfactant protein A1"	Q8IWL2	10	79610939-79615455	"Disease related genes, Predicted secreted proteins"	"Gaseous exchange"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	66	"lung: 411.8"	"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 30.0"	"Cancer enriched"	"Detected in some"	25	"lung cancer: 706.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	63	"plasmacytoid DC: 6.2"	"Lineage enriched"	"Detected in single"	63	"dendritic cells: 6.2"									"CAB016793, HPA042638, HPA045752, HPA049368"	Supported				"Secreted in other tissues"					"CAB016793: , HPA042638: , HPA045752: , HPA049368: "						"unprognostic (5.83e-4)"		"unprognostic (1.17e-1)"			"unprognostic (3.38e-2)"	"unprognostic (4.24e-1)"		"unprognostic (3.47e-2)"		"unprognostic (9.09e-2)"		0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	411.8	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.7	0.1	0.0	0.0	0.0	30.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SFTPA2	"COLEC5, SP-A2"	ENSG00000185303	"Surfactant protein A2"	Q8IWL1	10	79555852-79560402	"Disease related genes, Predicted secreted proteins"	"Gaseous exchange"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	225	"lung: 501.0"	"Group enriched"	"Detected in some"	21	"BEWO: 6.3;NB-4: 6.6;RPMI-8226: 21.2;U-2197: 12.8"	"Cancer enriched"	"Detected in many"	21	"lung cancer: 863.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"plasmacytoid DC: 2.2"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 2.2"									"CAB002439, HPA042638, HPA045752, HPA049368"	Enhanced				"Secreted in other tissues"					"CAB002439: AB_564143, HPA042638: , HPA045752: , HPA049368: "	"unprognostic (2.51e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.99e-2)"	"unprognostic (4.38e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.05e-1)"		"unprognostic (5.78e-2)"	"unprognostic (5.08e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.68e-3)"	"unprognostic (3.10e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.20e-1)"		"unprognostic (1.33e-1)"	"unprognostic (4.69e-3)"	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.1	501.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.2	0.0	0.1	0.4	0.3	0.1	0.0	0.2	0.1	0.1	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.0	2.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.6	0.4	0.0	0.2	0.0	21.2	0.0	0.3	0.2	0.2	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.2	12.8	0.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SFTPD	"COLEC7, SFTP4, SP-D"	ENSG00000133661	"Surfactant protein D"	P35247	10	79937740-79982614	"Predicted secreted proteins"	"Gaseous exchange, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"lung: 127.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.2;HaCaT: 2.4;HMC-1: 2.7;hTCEpi: 7.5;MCF7: 3.4;U-2197: 2.6"	"Cancer enriched"	"Detected in many"	16	"lung cancer: 106.4"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	11	"intermediate monocyte: 6.4;non-classical monocyte: 21.6"	"Lineage enriched"	"Detected in many"	17	"monocytes: 21.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004578, HPA044582, HPA056768"	Enhanced				"Secreted in other tissues"	5500000	5500000			"CAB004578: AB_628276, HPA044582: AB_2679004, HPA056768: AB_2683232"	"unprognostic (3.81e-5)"	"unprognostic (7.00e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.66e-3)"	"unprognostic (6.83e-2)"	"unprognostic (3.85e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.29e-2)"	"unprognostic (2.57e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.86e-2)"	0.3	0.3	0.6	0.3	1.1	3.9	0.3	0.3	0.6	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.5	0.5	0.3	0.3	127.0	0.3	0.3	0.3	0.3	0.9	0.3	0.7	0.3	0.3	0.3	0.0	0.3	0.4	0.3	0.3	1.6	0.3	0.3	0.3	0.3	0.1	0.3	0.3	0.4	1.2	0.4	0.3	0.3	0.3	0.0	1.2	0.4	21.6	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.2	1.8	0.0	0.2	0.7	2.4	0.3	0.1	0.0	0.3	0.3	0.6	0.0	0.0	0.0	0.2	2.7	0.0	7.5	0.0	0.0	0.0	0.0	0.4	0.0	3.4	0.1	1.8	0.8	0.6	0.0	0.1	0.0	0.0	0.0	0.7	0.8	0.1	0.5	0.0	1.0	0.7	1.4	0.0	0.2	2.6	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.0	6.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	21.6	0.0	0.0	0.5	0.6	1.1	0.3	0.6	0.5	0.5	0.3	0.3	0.3	0.3
SLIT1	"MEGF4, SLIL1, Slit-1, slit1, SLIT3"	ENSG00000187122	"Slit guidance ligand 1"	O75093	10	96998038-97185920	"Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 44.3"	"Cell line enriched"	"Detected in some"	15	"MOLT-4: 41.2"	"Group enriched"	"Detected in many"	10	"glioma: 9.2;prostate cancer: 2.2;thyroid cancer: 10.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.6;plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA006879			Approved	"Plasma membrane"	"Secreted in brain"			"Plasma membrane"		"HPA006879: AB_1078197"	"unprognostic (2.72e-1)"	"unprognostic (2.25e-2)"	"unprognostic (5.67e-3)"	"unprognostic (1.43e-5)"	"unprognostic (8.40e-2)"	"unprognostic (2.60e-3)"	"unprognostic (4.57e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.53e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.08e-5)"	"unprognostic (1.66e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.39e-3)"	1.2	0.8	13.4	0.9	16.1	0.9	0.8	0.4	44.3	0.8	0.9	0.5	0.0	0.9	0.8	0.7	0.8	1.0	0.8	0.8	13.9	10.5	0.8	0.7	1.0	0.9	4.6	13.2	0.8	1.4	0.8	8.0	0.8	2.2	1.1	0.8	0.3	0.8	0.7	0.9	0.8	0.9	0.8	1.4	0.9	1.1	2.0	0.3	3.3	3.6	0.0	0.9	0.8	0.0	0.0	1.6	0.4	0.7	0.0	0.0	0.2	0.0	0.0	2.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	41.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.6	1.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.4	0.0	0.4	1.6	0.0	0.2	13.4	16.1	0.4	24.8	13.9	10.5	4.6	13.2	2.2	0.3
SLPI	"ALK1, ALP, BLPI, HUSI, HUSI-I, WAP4, WFDC4"	ENSG00000124107	"Secretory leukocyte peptidase inhibitor"	P03973	20	45252239-45254564	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial, Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"cervix, uterine: 934.9;ductus deferens: 268.3;salivary gland: 480.2;seminal vesicle: 548.7"	"Cell line enhanced"	"Detected in some"		"EFO-21: 155.4;hTCEpi: 182.5;SiHa: 54.7;THP-1: 46.2"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in single"	11	"pons and medulla: 4.7"	"Cell type enriched"	"Detected in single"	90	"neutrophil: 68.8"	"Lineage enriched"	"Detected in single"	90	"granulocytes: 68.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002303, HPA027774"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	2600000	2600000	"Golgi apparatus"		"CAB002303: AB_564008, HPA027774: AB_10602405"	"unprognostic (2.31e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.16e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.83e-3)"	"unprognostic (4.01e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavourable (6.91e-5)"	"unprognostic (1.53e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.81e-2)"	"unprognostic (8.31e-2)"	9.2	0.4	0.0	2.4	0.0	10.0	10.0	0.1	0.2	934.9	3.4	0.1	268.3	0.2	11.9	5.5	51.3	23.3	19.6	3.5	0.0	0.0	17.3	20.1	81.5	1.3	0.3	0.4	5.5	5.4	0.1	25.9	1.4	4.7	13.4	3.6	2.0	480.2	548.7	41.3	9.6	0.7	3.9	0.9	0.7	5.2	7.1	0.0	2.3	2.0	86.2	53.0	17.7	24.0	0.0	0.1	68.8	0.7	0.0	0.0	1.1	0.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	28.1	0.0	155.4	0.0	11.6	0.0	5.6	0.0	0.7	0.0	0.0	20.8	0.0	30.0	0.0	0.0	0.8	182.5	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	10.6	0.0	0.0	0.0	31.6	1.2	0.0	0.0	54.7	11.7	0.1	0.2	46.2	0.0	0.0	0.7	0.1	0.0	0.1	0.7	0.4	0.0	2.8	0.0	0.5	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	68.8	0.0	0.7	0.0	0.0	1.1	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.4	4.7	0.0
SLURP1	"ANUP, ARS, ArsB, LY6LS, MDM"	ENSG00000126233	"Secreted LY6/PLAUR domain containing 1"	P55000	8	142740944-142742411	"Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"		Cytokine	"Disease mutation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 137.6;lymphoid tissue: 93.7;skin 1: 91.2;tongue: 107.5"	"Group enriched"	"Detected in some"	4	"HaCaT: 3.3;hTCEpi: 2.2;MCF7: 3.8;RT4: 2.6;T-47d: 6.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 66.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA050967	Approved				"Secreted in other tissues"	5400000	5400000			"HPA050967: "	"unprognostic (1.22e-2)"	"unprognostic (5.08e-2)"		"unprognostic (1.16e-2)"		"unprognostic (1.42e-2)"		"unprognostic (1.84e-1)"	"unprognostic (7.32e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.33e-4)"	"unprognostic (1.58e-1)"		"unprognostic (2.98e-1)"			"unprognostic (1.43e-1)"	0.1	0.1	0.1	0.1	0.1	0.1	2.5	0.1	0.1	17.3	0.1	0.1	0.1	0.1	1.1	0.1	137.6	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	7.7	0.1	0.4	91.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	107.5	93.7	0.1	19.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.8	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	3.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SLURP2		ENSG00000283992	"Secreted LY6/PLAUR domain containing 2"	P0DP57	8	142764338-142769844	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"esophagus: 112.1;lymphoid tissue: 60.7;tongue: 105.8"	"Cell line enriched"	"Detected in some"	4	"HaCaT: 24.1"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"																							0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.8	0.0	112.1	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	24.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	105.8	60.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.1	5.4	0.0	24.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SMIM31	LINC01207	ENSG00000248771	"Small integral membrane protein 31"		4	164754064-164803795	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"			"Tissue enriched"	"Detected in some"	4	"intestine: 42.7"	"Cell line enhanced"	"Detected in some"		"A549: 3.2;RPTEC TERT1: 4.4"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 8.8"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted - unknown location"						"unprognostic (2.84e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.87e-4)"			"unprognostic (2.95e-2)"	"unprognostic (1.78e-1)"			"unprognostic (4.17e-2)"	"unprognostic (4.82e-1)"		"unprognostic (9.47e-2)"			"unprognostic (5.63e-3)"	0.0	0.0	0.1	4.0	0.0	0.2	0.6	0.0	0.0	3.1	25.4	0.0	0.0	13.7	0.7	0.2	0.1	0.0	6.9	0.0	0.0		0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	9.8	9.8	0.0	2.1	0.0	0.0	0.0	42.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	1.1	1.4	3.1	0.5	1.3	0.5	0.0	0.4	3.2	0.2	0.8	0.2	0.4	0.8	0.3	0.1	0.3	0.3	1.2	0.4	0.6	0.3	0.2	0.7	0.1	0.4	0.1	0.3	0.4	0.0	0.4	0.2	0.4	0.6	0.9	0.3	0.3	0.2	0.2	0.0	0.5	1.4	0.0	0.6	0.3	1.4	0.4	0.1	0.6	0.2	1.4	4.4	0.6	0.5	0.2	0.4	0.5	0.6	0.4	0.7	0.4	0.4	0.2	0.8	0.5	1.7	0.4	0.7	0.7	0.7	1.2	3.1	0.5	0.6	0.4	0.3	0.4	0.4	0.4	0.4	0.2	1.1	0.5	0.5	2.8	1.3	0.4	1.4	0.3	0.0										
SMOC1		ENSG00000198732	"SPARC related modular calcium binding 1"	Q9H4F8	14	69854131-70032366	"Disease related genes, Predicted secreted proteins"	Differentiation	"Developmental protein"	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 62.2;liver: 48.0"	"Cell line enhanced"	"Detected in some"		"AF22: 19.4;HeLa: 53.3;HSkMC: 15.6;SiHa: 31.4;SK-BR-3: 13.8;U-266/70: 19.9;U-87 MG: 19.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	12	"plasmacytoid DC: 4.9"	"Lineage enriched"	"Detected in single"	50	"dendritic cells: 4.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004153, CAB034427"	Approved		Approved	"Plasma membrane"	"Secreted to extracellular matrix"	27000	27000	"Plasma membrane"		"CAB034427: AB_2193382, HPA004153: AB_1080035"	"unprognostic (3.31e-1)"	"unprognostic (2.17e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.89e-2)"	"unprognostic (4.04e-1)"	"unprognostic (6.75e-3)"	"unprognostic (2.09e-3)"	"unprognostic (4.76e-2)"	"unprognostic (2.80e-2)"	"unprognostic (5.10e-2)"	"unprognostic (5.63e-2)"	"unprognostic (4.09e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.87e-1)"	7.4	10.7	23.0	1.4	10.8	1.1	2.9	5.2	62.2	8.6	2.2	32.0	19.4	3.0	2.2	10.3	1.3	7.1	1.5	4.7	22.6	16.2	2.1	48.0	1.4	1.8	23.8	8.5	1.8	26.4	1.1	2.4	9.0	21.7	42.9	2.0	14.7	3.6	35.8	8.7	1.2	2.3	1.9	15.0	19.5	3.5	24.7	16.9	0.0	2.9	0.6	1.5	1.7	3.6	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	1.4	19.4	0.0	3.9	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	7.5	0.0	53.3	7.8	0.0	0.0	0.0	15.6	4.5	0.6	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.7	0.1	31.4	13.8	0.0	0.0	0.0	0.1	0.1	1.4	0.0	0.0	19.9	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	23.0	10.8	5.2	11.2	22.6	16.2	23.8	8.5	21.7	16.9
SMPDL3B	ASML3B	ENSG00000130768	"Sphingomyelin phosphodiesterase acid like 3B"	Q92485	1	27934993-27959157	"Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.0;pancreas: 48.0;salivary gland: 25.5;thyroid gland: 24.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 22.6;CAPAN-2: 17.4;NTERA-2: 13.5;RPMI-8226: 14.0;SK-BR-3: 22.6;T-47d: 16.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 5.6"	"Group enriched"	"Detected in some"	7	"eosinophil: 6.3;myeloid DC: 2.7;neutrophil: 3.8"	"Group enriched"	"Detected in many"	8	"dendritic cells: 2.7;granulocytes: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030561			Approved	"Golgi apparatus,Cytosol"	"Secreted to blood"	330000	330000	"Golgi apparatus, Cytosol"		"HPA030561: AB_10604095"	"unprognostic (1.22e-2)"	"unprognostic (4.45e-1)"	"unprognostic (4.58e-3)"	"unprognostic (3.83e-2)"	"unprognostic (3.35e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.95e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.40e-2)"	"unprognostic (3.09e-3)"	1.3	0.2	1.1	2.7	1.4	0.6	2.7	5.6	1.2	1.3	14.0	0.5	0.5	12.5	1.1	8.6	1.1	3.5	3.6	0.5	0.8	0.5	5.8	0.8	7.3	2.0	0.3	0.9	1.3	48.0	5.0	1.5	1.0	1.0	2.3	12.6	1.3	25.5	0.5	0.3	0.9	25.0	0.8	0.8	1.6	9.1	1.0	0.3	0.7	24.4	1.4	3.5	1.4	0.5	0.5	2.7	6.3	0.3	0.5	0.2	0.2	2.5	1.2	0.0	0.1	0.0	0.0	22.6	0.0	0.5	0.3	1.7	5.7	17.4	0.8	4.1	0.0	2.8	1.8	1.5	0.2	0.0	11.6	3.7	0.2	1.4	0.0	1.2	0.0	0.1	1.4	3.4	0.2	0.4	0.5	0.2	0.0	9.2	0.0	0.3	13.5	2.1	0.2	0.1	14.0	12.2	4.5	11.7	0.2	0.0	22.6	0.6	16.3	0.7	0.0	0.0	3.9	0.0	0.0	0.1	5.9	0.3	0.3	0.0	0.0	0.4	0.3	6.3	0.0	0.3	0.0	0.5	0.1	0.0	2.7	0.5	0.2	0.0	3.8	0.5	0.0	0.1	0.0	0.2	1.1	1.4	5.6	1.2	0.8	0.5	0.3	0.9	1.0	0.3
SMR3A	"PBI, PRL5, PROL5"	ENSG00000109208	"Submaxillary gland androgen regulated protein 3A"	Q99954	4	70360761-70367158	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	52	"salivary gland: 186.9"	"Cell line enriched"	"Detected in single"	13	"EFO-21: 1.3"	"Cancer enhanced"	"Detected in some"		"breast cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA044567	Enhanced				"Secreted to digestive system"					"HPA044567: AB_10796114"																"unprognostic (2.06e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	186.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SMR3B	"P-B, PRL3, PROL3"	ENSG00000171201	"Submaxillary gland androgen regulated protein 3B"	P02814	4	70370093-70390244	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	2372	"salivary gland: 6520.0"	"Cell line enriched"	"Detected in single"	35	"EFO-21: 9.6"	"Cancer enriched"	"Detected in some"	22	"breast cancer: 32.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to digestive system"	4500000	4500000																			"unprognostic (3.72e-1)"		0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.2	0.0	0.2	0.1	0.0	0.1	0.0	0.0	6520.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SOD3	EC-SOD	ENSG00000109610	"Superoxide dismutase 3"	P08294	4	24789912-24800842	"Enzymes, Plasma proteins, Predicted secreted proteins"		"Antioxidant, Heparin-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 19.4;BJ: 10.8;PC-3: 15.6;RPTEC TERT1: 65.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042110	Supported				"Secreted to blood"	830000000	830000000			"HPA042110: "	"unprognostic (7.67e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.80e-2)"	"unprognostic (3.32e-2)"	"unprognostic (9.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.80e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.45e-2)"	90.0	9.9	3.7	13.8	5.0	0.8	31.9	1.6	8.3	46.4	24.7	14.7	8.0	10.4	34.4	21.1	52.1	39.5	55.1	61.9	6.4	1.9	40.4	3.9	40.1	6.7	3.4	6.2	36.1	41.0	1.6	4.6	30.4	24.3	40.0	8.1	45.0	13.7	15.5	16.1	19.9	13.7	53.6	5.4	8.4	25.4	25.9	2.1	4.4	68.0	25.2	17.7	61.1	52.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.4	5.1	0.5	10.8	4.7	0.6	0.4	0.1	0.0	0.0	3.4	2.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.9	0.0	4.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	2.3	15.6	0.0	0.0	0.1	65.8	0.2	0.0	0.0	0.0	0.3	0.0	9.8	0.0	0.0	2.5	0.3	0.4	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	5.0	1.6	8.3	6.4	1.9	3.4	6.2	24.3	2.1
SOST	"DAND6, VBCH"	ENSG00000167941	Sclerostin	Q9BQB4	17	43753731-43758788	"Disease related genes, Predicted secreted proteins"	"Wnt signaling pathway"	Heparin-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 17.1;retina: 7.2"	"Cell line enriched"	"Detected in single"	42	"HaCaT: 10.7"	"Group enriched"	"Detected in some"	8	"head and neck cancer: 1.2;lung cancer: 6.2;urothelial cancer: 2.5"	"Group enriched"	"Detected in some"	6	"basal ganglia: 1.0;cerebral cortex: 3.1"	"Cell type enhanced"	"Detected in single"		"eosinophil: 2.3"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 2.3"	"Group enriched"	"Detected in some"	11	"basal ganglia: 1.7;cerebellum: 1.1"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.1"	CAB025660	Approved				"Secreted to extracellular matrix"					"CAB025660: "	"unprognostic (1.26e-1)"	"unprognostic (4.06e-2)"		"unprognostic (6.57e-2)"	"unprognostic (2.55e-3)"	"unprognostic (3.37e-1)"		"unprognostic (4.67e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.38e-2)"		"unprognostic (1.20e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.56e-1)"		"unprognostic (7.90e-2)"	0.3	0.1	0.1	1.4	1.0	0.1	0.1	0.1	3.1	0.2	0.1	0.0	1.1	0.1	0.1	0.1	0.1	0.1	0.1	2.9	0.1	0.1	17.1	0.1	2.4	0.1	0.1	0.3	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	7.2	1.1	0.4	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.3	0.5	0.1	0.1	0.2	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.1	3.1	0.1	0.1	0.1	0.3	0.2	0.0
SOSTDC1	"DAND7, DKFZp564D206, USAG1"	ENSG00000171243	"Sclerostin domain containing 1"	Q6X4U4	7	16461481-16530580	"Predicted secreted proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 51.1;retina: 74.8;stomach 1: 32.3"	"Cell line enhanced"	"Detected in some"		"AF22: 7.3;EFO-21: 10.9;HEL: 4.1;NTERA-2: 4.2;RPTEC TERT1: 20.3"	"Cancer enhanced"	"Detected in many"		"renal cancer: 25.9"	"Region enriched"	"Detected in many"	9	"pons and medulla: 51.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 9.4;hippocampal formation: 20.4;pons and medulla: 15.8;thalamus: 12.8"	"Low region specificity"	"Detected in some"								"Secreted to extracellular matrix"						"unprognostic (2.08e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.17e-3)"	"unprognostic (5.59e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.41e-2)"	"prognostic favourable (8.69e-4)"	"unprognostic (2.59e-1)"	"unprognostic (2.62e-1)"	"prognostic favourable (3.22e-5)"	"unprognostic (7.01e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.50e-2)"	"prognostic unfavourable (8.72e-4)"	0.4	0.4	2.0	1.4	1.9	0.0	9.5	0.5	5.8	2.6	5.9	7.0	0.2	6.1	2.5	2.4	2.7	2.7	0.4	3.7	3.5	1.6	12.8	0.2	22.0	0.1	0.7	5.3	0.6	1.1	0.0	2.9	0.0	51.1	1.1	8.4	74.8	12.5	6.4	0.3	13.7	4.8	0.5	1.0	0.2	32.3	1.9	0.0	0.0	4.7	3.1	4.9	1.0	3.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	10.9	0.0	0.2	0.4	0.0	0.0	0.1	2.2	4.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	20.3	0.0	0.0	0.3	0.1	0.0	0.0	0.8	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.0	1.9	0.5	5.8	3.5	1.6	0.7	5.3	51.1	0.0
SPACA5	"dJ54B20.3, LYC5, LYZL5, PNPK6288, SLLP2, UNQ6288"	ENSG00000171489	"Sperm acrosome associated 5"	Q96QH8	X	48004336-48009729	"Enzymes, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 15.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.3;NB-4: 3.9;RPMI-8226: 1.1;T-47d: 1.1;U-266/70: 1.2;U-266/84: 2.0"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"T-reg: 1.9"	"Low lineage specificity"	"Detected in single"											"HPA044747, HPA047149"	Supported				"Secreted in male reproductive system"					"HPA044747: , HPA047149: "																		0.0	0.0	0.3	0.0	0.3	0.1	0.0	0.2	0.4	0.0	0.0			0.0	0.2	0.8	0.0	0.3	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.5	0.4		0.3	1.4	0.0	0.0	0.0		0.2	0.0		0.0	0.0	0.0	0.8	0.1	0.0	0.2	0.0	0.0	15.1			1.3		0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.9	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.9	0.9	0.0	0.4	0.0	1.1	0.0	0.0	0.5	0.0	0.0	0.4	0.0	1.1	0.0	0.0	0.4	0.0	0.7	0.0	1.2	2.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.8	1.9	0.3										
SPACA5B	LYZL5B	ENSG00000171478	"Sperm acrosome associated 5B"	Q96QH8	X	48130657-48132613	"Enzymes, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 18.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	19	"T-reg: 1.9"	"Lineage enriched"	"Detected in single"	19	"T-cells: 1.9"									"HPA044747, HPA047149"	Supported				"Secreted in male reproductive system"					"HPA044747: , HPA047149: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0										
SPINK1	"PCTT, PSTI, Spink3, TATI"	ENSG00000164266	"Serine peptidase inhibitor, Kazal type 1"	P00995	5	147824568-147831786	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	68	"pancreas: 1767.1"	"Group enriched"	"Detected in some"	8	"CACO-2: 43.1;RT4: 118.4"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 513.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB026366, HPA027498"	Enhanced				"Secreted to digestive system"	7900000	7900000			"CAB026366: , HPA027498: AB_10603115"	"unprognostic (1.05e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.96e-3)"	"unprognostic (3.55e-1)"	"unprognostic (6.12e-3)"	"unprognostic (1.79e-4)"	"unprognostic (8.34e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.82e-2)"	"unprognostic (8.13e-2)"	"prognostic unfavourable (5.44e-7)"	"unprognostic (7.98e-2)"	"unprognostic (2.07e-1)"		"prognostic favourable (2.15e-5)"	0.3	0.0	0.3	1.6	0.3	0.0	0.3	0.3	0.3	0.3	6.0	0.3	0.3	6.3	0.3	0.3	0.3	0.0	1.5	0.3	0.3	0.0	2.0	13.3	0.4	0.3	0.3	0.3	0.3	1767.1	0.0	0.3	0.3	0.3	1.4	6.4	0.3	0.3	0.3	0.3	0.0	6.9	1.0	0.3	0.3	25.8	0.4	0.3	0.3	0.3	0.3	0.3	13.1	2.2	0.7	0.5	1.9	0.5	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	43.1	0.0	0.0	0.8	0.0	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.0	10.7	0.0	0.0	0.5	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	118.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.4	0.3	0.5	0.2	2.1	0.0	0.0	1.9	0.4	0.2	0.4	0.5	0.2	0.4	0.4	0.3	0.1	0.7	0.5	0.6	1.8	0.3	0.4	0.5	0.1	0.1	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3
SPINK14	SPINK5L2	ENSG00000196800	"Serine peptidase inhibitor, Kazal type 14 (putative)"	Q6IE38	5	148169733-148175398	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"breast: 2.7;intestine: 3.6;liver: 3.5"	"Cell line enriched"	"Detected in single"	6	"SK-BR-3: 2.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted - unknown location"						"unprognostic (4.98e-2)"		"unprognostic (3.44e-1)"				"unprognostic (1.94e-2)"	"unprognostic (2.96e-2)"				"unprognostic (5.69e-1)"		"unprognostic (1.48e-3)"				0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	1.5	1.4			0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.5	0.5	0.0	0.0		0.0	0.1	0.0	0.0	0.5		0.3	3.6		1.6	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.6	0.1			0.2		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SPINK2	HUSI-II	ENSG00000128040	"Serine peptidase inhibitor, Kazal type 2"	P20155	4	56809860-56821742	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"epididymis: 376.2"	"Cell line enriched"	"Detected in some"	4	"U-266/70: 43.8"	"Group enriched"	"Detected in some"	5	"lung cancer: 1.3;testis cancer: 4.6;thyroid cancer: 2.4"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in many"	6	"NK-cell: 43.3"	"Lineage enriched"	"Detected in many"	6	"NK-cells: 43.3"									"CAB020824, HPA026813"	Enhanced				"Secreted to blood"					"CAB020824: , HPA026813: AB_1857446"	"unprognostic (5.56e-3)"	"unprognostic (3.60e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.60e-1)"		"prognostic favourable (2.82e-4)"	"unprognostic (9.83e-2)"	"unprognostic (6.62e-2)"	"unprognostic (9.40e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.10e-3)"	"unprognostic (3.18e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.87e-2)"	0.2	0.1	0.2	0.5	0.2	0.7	0.3	0.1	0.3	0.4	0.4	0.0	85.2	0.0	0.2	376.2	0.1	0.2	0.0	2.2	0.3	0.3	0.2	0.1	0.1	0.2	0.2	0.0	0.2	0.1	0.0	1.4	0.0	1.1	1.1	0.1	0.0	0.6	49.9	0.5	0.2	0.5	0.0	0.2	0.6	0.2	85.5	0.0	0.3	0.2	0.0	0.2	1.3	1.3	3.9	0.4	1.3	0.0	43.3	7.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	8.4	0.2	0.0	0.0	0.0	2.0	0.0	2.8	0.1	1.5	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	43.8	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.2	0.0	0.2	2.3	1.7	1.8	0.4	3.9	3.9	7.3	0.3	43.3	0.0	0.2	0.1	2.0	0.2	0.2	0.1	0.3	0.3	0.3	0.2	0.0	1.1	0.0
SPINK5	"DKFZp686K19184, FLJ21544, FLJ97536, FLJ97596, FLJ99794, LEKTI, LETKI, NETS, NS, VAKTI"	ENSG00000133710	"Serine peptidase inhibitor, Kazal type 5"	Q9NQ38	5	148025683-148137289	"Disease related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Hypotrichosis, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 101.6;esophagus: 313.0;tongue: 97.4"	"Cell line enhanced"	"Detected in some"		"HaCaT: 12.1;HeLa: 17.9;Karpas-707: 15.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 45.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA009067, HPA011351, CAB015347"	Enhanced		Enhanced	Vesicles	"Secreted in other tissues"	28000000	28000000	Vesicles		"CAB015347: AB_2196138, HPA009067: AB_1080084, HPA011351: AB_1857447"	"unprognostic (9.66e-3)"	"unprognostic (1.42e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.45e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.92e-3)"	"unprognostic (4.56e-1)"	"unprognostic (2.44e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.59e-1)"	0.1	0.0	0.2	0.1	0.1	0.0	2.8	0.1	0.2	101.6	0.7	0.2	0.1	0.0	3.2	0.2	313.0	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.3	0.1	0.2	1.7	0.2	18.1	0.1	0.2	48.6	0.1	0.1	0.1	0.1	0.7	0.2	0.1	3.6	0.3	97.4	65.3	0.3	64.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.2	1.5	0.0	12.1	0.0	1.0	0.0	0.0	0.0	0.0	17.9	0.0	0.0	0.2	0.0	0.0	3.4	0.0	0.0	0.2	0.7	15.8	0.0	1.7	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	4.6	2.4	0.0	0.5	0.0	0.0	3.8	0.0	0.0	0.0	0.1	0.0	0.0	4.1	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1
SPINK6	"BUSI2, MGC21394, UNQ844"	ENSG00000178172	"Serine peptidase inhibitor, Kazal type 6"	Q6UWN8	5	148202794-148215137	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.6;cervix, uterine: 7.2;tongue: 7.1;vagina: 8.6"	"Group enriched"	"Detected in some"	84	"HeLa: 239.2;SiHa: 114.9"	"Group enriched"	"Detected in many"	6	"cervical cancer: 21.4;head and neck cancer: 21.0"	"Region enriched"	"Detected in single"	78	"cerebellum: 10.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA011039	Uncertain				"Secreted - unknown location"					"HPA011039: "		"unprognostic (2.92e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.65e-1)"	"unprognostic (4.87e-2)"	"prognostic favourable (7.16e-4)"		"unprognostic (2.49e-2)"	"unprognostic (4.04e-1)"		"unprognostic (1.80e-2)"	"unprognostic (2.09e-2)"		"unprognostic (2.22e-2)"		"unprognostic (1.29e-2)"	"unprognostic (7.29e-2)"	1.9	1.1	0.1	0.1	0.1	0.0	0.9	10.6	0.1	7.2	1.6	0.1	0.1	0.0	0.1	3.7	5.9	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.6	0.1	0.1	0.8	0.1	5.0	0.2	0.1	0.5	0.1	0.9	0.1	0.1	0.0	0.2	0.1	1.6	0.1	7.1	0.1	0.4	8.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	239.2	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	114.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.1	10.6	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SPINK8		ENSG00000229453	"Serine peptidase inhibitor, Kazal type 8 (putative)"	P0C7L1	3	48306842-48328341	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"breast: 33.5"	"Cell line enriched"	"Detected in single"	62	"SK-BR-3: 40.2"	"Group enriched"	"Detected in some"	10	"breast cancer: 8.6;glioma: 9.6;prostate cancer: 2.4"					"Group enriched"	"Detected in some"	10	"eosinophil: 3.3;neutrophil: 4.5"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 4.5"	"Region enriched"	"Detected in some"	9	"hippocampal formation: 80.7"					HPA053151	Uncertain				"Secreted to blood"					"HPA053151: "	"prognostic unfavourable (8.47e-4)"			"unprognostic (1.98e-1)"	"unprognostic (1.75e-2)"					"unprognostic (1.99e-1)"		"unprognostic (1.15e-1)"					"unprognostic (1.20e-1)"	0.0	0.0	1.4	0.0	1.0	7.3	33.5	0.3	0.6	0.0	0.0			0.0	0.0	1.8	4.1	0.0	0.0	0.0	2.2	1.7	0.0	0.0	0.0	0.0	1.5		0.0	0.2	0.0	0.2	0.0		0.4	0.0		1.8	0.1	0.0	0.2	0.0	0.0	2.3	1.2	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	4.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	40.2	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.4	0.0	0.0	0.0										
SPINT3	HKIB9	ENSG00000101446	"Serine peptidase inhibitor, Kunitz type 3"	P49223	20	45512461-45515624	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"epididymis: 113.9"	"Group enriched"	"Detected in some"	14	"Karpas-707: 1.4;NTERA-2: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA026852	Enhanced				"Secreted in male reproductive system"					"HPA026852: "																		0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	23.8	0.0	0.0	113.9	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	16.7	0.0	4.8	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPINT4	"C20orf137, dJ601O1.1"	ENSG00000149651	"Serine peptidase inhibitor, Kunitz type 4"	Q6UDR6	20	45722351-45725830	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	12	"epididymis: 134.6"	"Group enriched"	"Detected in some"	5	"NB-4: 4.5;U-87 MG: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046703	Enhanced				"Secreted in male reproductive system"					"HPA046703: "														"unprognostic (3.61e-1)"				0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	11.5	0.0	0.1	134.6	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.1	0.1	2.1	0.0	0.0	0.1	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
SPOCK2	"KIAA0275, testican-2"	ENSG00000107742	"SPARC/osteonectin, cwcv and kazal like domains proteoglycan 2"	Q92563	10	72059035-72089032	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 47.1;brain: 70.7;lung: 52.1"	"Group enriched"	"Detected in some"	7	"Hep G2: 24.8;SCLC-21H: 35.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 27.5;MAIT T-cell: 47.1;memory CD4 T-cell: 27.7;memory CD8 T-cell: 21.9;naive CD4 T-cell: 21.5;naive CD8 T-cell: 21.2;T-reg: 37.5"	"Lineage enriched"	"Detected in many"	8	"T-cells: 47.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044605	Enhanced				"Secreted to blood"	42000	42000			"HPA044605: AB_10965991"	"prognostic favourable (4.05e-4)"	"unprognostic (3.11e-3)"	"unprognostic (2.92e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.77e-2)"	"prognostic favourable (1.95e-5)"	"unprognostic (4.18e-2)"	"unprognostic (9.04e-2)"	"prognostic favourable (4.72e-4)"	"prognostic unfavourable (7.19e-4)"	"unprognostic (4.53e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.46e-3)"	"unprognostic (5.59e-2)"	"unprognostic (5.49e-2)"	"unprognostic (3.19e-3)"	"unprognostic (2.24e-2)"	4.2	29.8	31.9	24.9	47.8	27.9	2.0	70.7	63.2	2.5	4.2	9.8	0.0	6.2	2.5	2.7	2.8	4.7	9.9	4.7	27.5	49.5	18.8	2.5	52.1	36.4	36.0	32.1	3.7	1.5	1.7	12.8	2.9	47.9	3.0	4.1	5.4	2.8	4.5	3.6	1.9	9.3	3.4	22.3	16.9	8.3	13.6	9.2	43.4	3.3	0.6	27.0	8.0	1.4	5.6	0.7	2.9	0.2	2.8	47.1	10.3	0.1	0.2	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	4.3	0.1	0.7	0.0	0.4	0.0	0.0	0.0	0.2	0.4	0.1	0.6	24.8	0.8	0.2	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	35.3	2.1	0.0	0.7	0.2	0.0	0.9	0.1	0.0	0.1	0.1	0.0	0.4	0.8	3.7	0.1	0.0	0.1	0.0	0.1	0.0	27.5	0.2	47.1	5.6	27.7	21.9	0.0	4.5	21.5	21.2	2.9	2.8	0.0	0.7	37.5	10.3	31.9	47.8	70.7	42.0	27.5	49.5	36.0	32.1	47.9	9.2
SPON1	"f-spondin, KIAA0762"	ENSG00000262655	"Spondin 1"	Q9HCB6	11	13962689-14267884	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 40.2"	"Group enriched"	"Detected in some"	35	"EFO-21: 41.0;RPTEC TERT1: 115.2"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 199.1"					"Cell type enriched"	"Detected in some"	5	"MAIT T-cell: 7.3"	"Lineage enriched"	"Detected in single"	74	"T-cells: 7.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038584, HPA077546"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Actin filaments,Microtubule ends,Cytokinetic bridge"	"Secreted to blood"	27000000	27000000	"Nucleoli, Microtubule ends"	"Nucleoplasm, Actin filaments, Cytokinetic bridge"	"HPA038584: AB_10697394, HPA077546: "	"unprognostic (1.66e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.36e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.82e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.93e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.07e-1)"	"prognostic favourable (3.12e-4)"	"unprognostic (7.22e-3)"	"unprognostic (7.89e-2)"	"unprognostic (4.65e-2)"	"prognostic unfavourable (1.88e-4)"	16.8	5.1	8.3	5.2	12.5	0.0	3.3	4.8	10.7	15.7	9.7	7.6	0.0	9.6	12.0	4.6	5.3	20.3	40.2	4.9	7.2		5.4	0.1	8.1	0.7	5.1	8.8	12.0	0.8	0.0	2.0	12.3	7.5	7.2	15.0	8.5	0.9	2.5	0.0	1.6	12.4	15.7	3.2	1.8	3.9	0.8	5.7	0.0	0.8	0.6	0.0	15.6	9.9	0.0	0.0	0.0	0.0	0.0	7.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	41.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	115.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	7.3	0.0	1.3	0.7	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.3										
SPP1	"BNSP, BSPI, ETA-1, OPN"	ENSG00000118785	"Secreted phosphoprotein 1"	P10451	4	87975650-87983426	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Biomineralization, Cell adhesion"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 303.9;kidney: 700.7;placenta: 331.0"	"Cell line enhanced"	"Detected in some"		"EFO-21: 213.7;Hep G2: 105.2;RPTEC TERT1: 466.7"	"Cancer enhanced"	"Detected in all"		"glioma: 1690.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"neutrophil: 19.2"	"Lineage enriched"	"Detected in single"	192	"granulocytes: 19.2"	"Region enhanced"	"Detected in all"		"pons and medulla: 331.4"	"Low region specificity"	"Detected in all"			"CAB002212, HPA027540, HPA027541"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted to blood"	54000000	54000000	"Golgi apparatus"		"CAB002212: AB_564074, HPA027540: AB_10600222, HPA027541: AB_10601446"	"unprognostic (4.74e-2)"	"prognostic unfavourable (9.52e-4)"	"unprognostic (1.13e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.31e-2)"	"unprognostic (6.96e-3)"	"prognostic unfavourable (2.84e-6)"	"unprognostic (2.46e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavourable (5.89e-4)"	"unprognostic (4.31e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.63e-2)"	20.7	4.1	25.5	8.3	42.7	1.1	8.7	4.3	61.0	4.7	2.7	27.3	0.0	2.1	17.3	2.3	1.5	4.2	303.9	2.6	37.2	26.4	700.7	3.9	3.2	2.0	97.0	9.1	3.1	23.6	1.3	1.5	331.0	52.3	2.4	1.9	3.9	7.3	3.9	2.5	1.1	2.1	5.6	147.9	2.1	2.0	2.4	58.9	0.0	1.7	0.0	1.6	5.3	0.3	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	6.1	0.8	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	213.7	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	105.2	0.0	0.2	0.2	0.0	0.0	1.5	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.9	9.9	0.0	0.1	0.0	50.1	466.7	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.2	0.0	0.5	1.1	0.0	1.1	0.0	0.3	0.4	19.5	0.0	19.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	25.5	42.7	4.3	28.8	37.2	26.4	97.0	9.1	52.3	58.9
SPX	"C12orf39, MGC10946, NPQ, spexin"	ENSG00000134548	"Spexin hormone"	Q9BT56	12	21526307-21537377	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 34.3;brain: 14.4;breast: 23.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 14.7;HBEC3-KT: 7.5;hTERT-HME1: 10.2;U-2 OS: 4.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 13.5"	"Region enriched"	"Detected in some"	9	"pons and medulla: 14.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"cerebral cortex: 65.0;hippocampal formation: 70.8;olfactory region: 47.5;pons and medulla: 40.3"						"Secreted to blood"						"unprognostic (2.78e-2)"	"unprognostic (9.34e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.11e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.95e-1)"	"prognostic favourable (1.31e-6)"	"unprognostic (2.37e-3)"	"unprognostic (9.78e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.01e-2)"	34.3	0.0	0.2	0.0	0.3	0.0	23.1	0.1	1.4	0.0	2.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.4	1.5	0.4	0.7	7.1	0.7	0.2	0.5	1.5	0.0	0.0	7.8	0.0	0.0	12.7	14.4	0.0	0.0	0.0	6.4	0.0	1.3	0.1	0.0	0.0	0.4	0.3	0.0	0.0	0.2	1.3	2.7	0.4	0.0	0.1	0.0	0.1	0.6	0.5	0.0	0.0	0.2	1.5	0.0	0.5	0.3	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.8	14.7	0.0	0.6	0.2	0.0	0.0	0.0	7.5	0.8	0.0	0.0	2.8	0.0	0.0	0.7	0.0	0.0	3.1	0.4	0.1	10.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.7	0.0	0.5	0.1	0.4	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	4.8	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.6	0.0	1.5	0.2	0.3	0.1	0.3	0.4	0.7	1.5	0.0	14.4	0.2
SRPX	ETX1	ENSG00000101955	"Sushi repeat containing protein, X-linked"	P78539	X	38149336-38220924	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 82.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 278.5;ASC TERT1: 62.2;HSkMC: 93.6;HUVEC TERT2: 57.7"	"Group enriched"	"Detected in all"	6	"glioma: 64.2;melanoma: 70.1;pancreatic cancer: 14.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	56	"plasmacytoid DC: 10.5"	"Lineage enriched"	"Detected in single"	56	"dendritic cells: 10.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"	310000	310000				"unprognostic (2.35e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.08e-3)"	"prognostic unfavourable (1.18e-4)"	"unprognostic (6.48e-2)"	"unprognostic (3.83e-3)"	"unprognostic (3.50e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.00e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.22e-2)"	"prognostic unfavourable (7.80e-13)"	"unprognostic (6.94e-3)"	"unprognostic (3.90e-2)"	"unprognostic (2.71e-2)"	"prognostic unfavourable (3.36e-4)"	56.2	11.9	2.2	8.5	5.0	0.0	82.4	6.6	4.8	14.1	23.1	7.7	10.1	3.1	17.7	35.5	15.1	37.1	23.3	28.9	5.3	2.9	4.1	6.6	14.2	27.7	9.6	1.9	11.6	7.8	1.4	1.5	34.1	13.4	22.1	10.2	4.7	9.5	6.6	9.9	8.7	14.4	27.8	18.9	0.6	13.3	14.9	7.3	0.9	17.8	5.3	5.1	29.6	54.6	0.0	10.5	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.8	0.0	278.5	62.2	0.0	2.5	4.8	0.8	1.4	0.0	0.2	0.0	0.0	5.2	0.1	0.1	2.2	0.7	0.0	0.9	0.0	0.0	0.0	12.5	0.2	0.0	93.6	0.1	8.3	4.2	57.7	0.0	0.0	9.3	0.1	0.0	0.0	0.7	1.8	0.0	3.1	0.4	0.0	0.1	0.1	0.1	0.1	0.0	11.6	0.0	0.0	24.8	6.0	3.1	7.8	7.2	0.0	0.0	0.0	17.5	0.2	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.5	0.0	0.1	2.2	5.0	6.6	3.2	5.3	2.9	9.6	1.9	13.4	7.3
SSC4D	"S4D-SRCRB, SRCRB-S4D, SRCRB4D"	ENSG00000146700	"Scavenger receptor cysteine rich family member with 4 domains"	Q8WTU2	7	76389334-76409695	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"salivary gland: 9.3;seminal vesicle: 9.5;thyroid gland: 8.6"	"Group enriched"	"Detected in some"	13	"EFO-21: 6.0;Hep G2: 8.1;U-2 OS: 23.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.6"	"Lineage enriched"	"Detected in single"	5	"monocytes: 1.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA062611	Uncertain				"Secreted - unknown location"					"HPA062611: "	"unprognostic (3.39e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.20e-2)"	"prognostic unfavourable (2.83e-6)"	"prognostic unfavourable (7.08e-4)"	"unprognostic (3.52e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.49e-2)"	"unprognostic (8.49e-3)"	"unprognostic (3.18e-1)"	"unprognostic (3.72e-2)"	"prognostic unfavourable (4.71e-4)"	"unprognostic (2.59e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.73e-2)"	1.1	0.5	0.1	0.1	0.1	0.0	0.4	0.0	0.2	1.0	0.2	0.3	3.0	0.2	0.3	0.8	0.0	0.4	0.1	0.0	0.2	0.2	7.7	0.7	0.2	0.1	0.2	0.8	2.3	4.4	7.8	7.2	0.7	0.4	0.1	0.0	0.8	9.3	9.5	0.4	0.0	0.0	0.2	0.7	0.3	0.1	0.3	0.0	0.0	8.6	0.0	0.2	0.0	0.0	0.3	0.1	0.0	1.6	0.0	0.2	0.1	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.2	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.1	0.0	0.4	0.0	0.0	0.8	0.2	0.0	0.7	0.1	0.0	0.0	0.1	0.9	0.4	0.0	0.0	0.1	0.0	0.0	0.0	23.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.6	0.1	0.3	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.2	0.2	0.2	0.8	0.4	0.0
SSPO	"FLJ36112, KIAA0543, SCO-spondin"	ENSG00000197558	SCO-spondin		7	149776042-149833979	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"brain: 1.7;salivary gland: 1.7"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.2;RPMI-8226: 2.7;T-47d: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in some"	13	"midbrain: 44.5"						"Secreted in brain"						"unprognostic (1.11e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.95e-4)"	"unprognostic (5.81e-3)"	"unprognostic (3.50e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.41e-3)"	"unprognostic (9.17e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.59e-5)"	"unprognostic (1.04e-1)"	"unprognostic (2.65e-10)"	"unprognostic (1.19e-1)"	"unprognostic (2.94e-1)"	"unprognostic (8.15e-3)"	"unprognostic (2.46e-2)"	0.6	0.0		0.3		0.2	0.1		1.7	0.0	0.0			0.0	0.0	0.0	0.0	0.3	0.1	0.0			0.2	0.0	0.0	0.0			0.1	0.3	0.0		0.0		0.2	0.0		1.7	0.1	0.1	0.3	0.0	0.0		0.4	0.2	0.2			0.2		0.0	0.0		0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.7	1.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.5	0.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.2	0.2	0.0	0.0	2.7	0.1	0.0	0.4	0.5	0.0	0.1	0.0	1.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.8	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SST	SMST	ENSG00000157005	Somatostatin	P61278	3	187668906-187670399	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 102.8;intestine: 105.2;pancreas: 105.6;stomach 1: 90.4"	"Cell line enhanced"	"Detected in some"		"EFO-21: 15.2;U-2 OS: 28.3;U-251 MG: 4.7;U-698: 5.9"	"Group enriched"	"Detected in many"	7	"ovarian cancer: 249.9;pancreatic cancer: 1039.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000075, HPA019472, CAB034105"	Enhanced	Supported			"Secreted to blood"					"CAB000075: AB_2688022, CAB034105: AB_2271061, HPA019472: AB_1857360"		"unprognostic (2.44e-1)"	"unprognostic (2.05e-1)"	"prognostic unfavourable (1.93e-5)"	"unprognostic (5.12e-3)"	"unprognostic (1.54e-2)"			"unprognostic (4.69e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.07e-3)"	"unprognostic (8.47e-2)"	"unprognostic (4.19e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.45e-1)"	2.0	13.0	28.6	1.9	53.8	1.7	0.7	0.1	47.9	0.7	45.1	1.8	21.9	105.2	0.9	0.7	1.1	0.7	1.0	0.9	17.5	102.8	2.5	0.7	0.7	1.0	6.2	15.4	0.8	105.6	0.7	1.5	0.7	16.1	1.5	7.4	0.4	0.7	7.5	0.7	3.1	36.1	1.4	18.4	0.7	90.4	0.7	8.6	0.0	0.9	0.0	0.7	4.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	28.3	0.3	4.7	0.0	1.6	5.9	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.6	53.8	0.1	47.9	17.5	102.8	6.2	15.4	16.1	8.6
STATH	STR	ENSG00000126549	Statherin	P02808	4	69995930-70002570	"Plasma proteins, Predicted secreted proteins, Transporters"	Biomineralization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	162	"salivary gland: 5940.6"	"Cell line enhanced"	"Detected in single"		"HHSteC: 1.5"	"Group enriched"	"Detected in some"	14	"head and neck cancer: 3.5;lung cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA044569	Enhanced				"Secreted to digestive system"					"HPA044569: AB_10966146"						"unprognostic (2.00e-2)"												0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.5	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.3	1.5	0.0	0.1	0.1	0.0	0.5	0.0	0.0	5940.6	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.1	36.5	5.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.0	0.0	0.0
TAC1	"NKNA, NPK, TAC2"	ENSG00000006128	"Tachykinin precursor 1"	P20366	7	97731908-97740472	"Predicted secreted proteins"		"Neuropeptide, Neurotransmitter"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 61.3;lymphoid tissue: 62.9"	"Cell line enriched"	"Detected in some"	19	"U-266/70: 22.0"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 61.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 557.4"	"Region enriched"	"Detected in many"	9	"basal ganglia: 312.7"	HPA014429	Enhanced				"Secreted to blood"					"HPA014429: AB_1857722"	"unprognostic (9.24e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.92e-1)"					"unprognostic (2.08e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.70e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.86e-2)"	1.8	6.5	4.1	7.7	61.3	0.3	1.7	0.3	39.8	0.7	3.7	0.1	0.0	6.0	0.9	1.6	0.3	0.7	4.9	0.5	9.3	21.5	1.6	0.6	0.3	0.3	8.0	4.5	0.3	0.7	0.3	0.3	0.3	24.5	1.0	2.9	0.3	4.5	2.0	0.4	1.2	7.6	5.3	6.7	62.9	0.9	0.6	9.4	0.0	1.6	0.0	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	61.3	0.3	9.2	9.3	21.5	8.0	4.5	24.5	9.4
TAC3	"NKB, NKNB, ZNEUROK1"	ENSG00000166863	"Tachykinin 3"	Q9UHF0	12	57010000-57028883	"Disease related genes, Predicted secreted proteins"		Neuropeptide	"Disease mutation, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"placenta: 133.5"	"Cell line enriched"	"Detected in some"	5	"K-562: 17.2"	"Cancer enriched"	"Detected in many"	7	"urothelial cancer: 40.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA045919	Supported	Supported	Approved	Vesicles	"Secreted in female reproductive system"			Vesicles		"HPA045919: AB_10960533"	"unprognostic (4.53e-2)"	"unprognostic (1.97e-2)"	"unprognostic (8.41e-2)"	"unprognostic (3.00e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.99e-2)"	"unprognostic (8.41e-2)"		"unprognostic (1.34e-1)"	"unprognostic (2.03e-1)"	"unprognostic (5.28e-2)"	"unprognostic (4.71e-14)"	"unprognostic (1.58e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.39e-1)"	0.5	0.6	3.9	1.5	20.0	0.8	0.5	0.0	11.0	0.5	1.2	0.1	0.0	1.5	0.6	0.5	0.5	0.5	0.6	0.5	4.4	9.5	0.5	0.5	0.5	0.5	0.8	2.1	0.5	0.7	0.5	0.0	133.5	1.5	0.5	1.0	0.3	0.5	0.5	0.5	0.7	3.2	2.0	9.4	0.5	8.1	0.8	0.2	0.0	0.5	0.0	0.6	2.2	0.5	0.0	0.1	0.0	0.1	0.0	0.7	0.0	0.0	0.1	0.0	0.5	0.0	0.0	1.6	0.0	1.3	0.4	0.0	3.4	0.0	1.0	0.0	0.1	0.0	0.2	0.0	0.4	0.0	0.0	1.5	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.3	0.0	0.0	17.2	0.4	0.0	0.0	0.0	0.2	2.3	0.0	0.0	0.0	0.0	0.0	1.7	2.9	0.8	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	3.9	20.0	0.0	11.0	4.4	9.5	0.8	2.1	1.5	0.2
TAC4	"HK-1, PPT-C, Pptc"	ENSG00000176358	"Tachykinin 4"	Q86UU9	17	49838309-49848017	"Predicted secreted proteins"		"Hypotensive agent"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"liver: 4.7;pituitary gland: 10.4"	"Cell line enhanced"	"Detected in some"		"A549: 4.4;BEWO: 10.5;CACO-2: 6.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"								"Secreted to blood"						"unprognostic (4.49e-2)"	"unprognostic (8.14e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.24e-2)"	"unprognostic (8.15e-2)"	"unprognostic (5.61e-2)"	"unprognostic (6.05e-3)"	"unprognostic (3.19e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.52e-2)"	"unprognostic (4.69e-3)"	"unprognostic (8.19e-5)"	"unprognostic (8.69e-2)"	"unprognostic (2.23e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.92e-1)"	0.4	0.6	0.4	0.5	0.4	1.2	0.4	0.4	0.4	0.5	0.4	0.4	0.4	0.3	0.4	0.4	1.4	0.2	0.4	2.2	0.4	0.1	0.4	4.7	0.5	0.7	0.4	0.4	0.4	0.4	0.0	10.4	0.4	0.4	0.4	0.0	0.4	1.0	0.4	0.4	4.0	0.4	0.4	0.4	1.3	0.7	0.5	0.4	0.4	1.1	0.4	0.4	0.9	0.4	0.1	0.7	0.0	0.0	0.0	0.2	0.0	0.0	4.4	0.1	0.7	0.0	0.0	10.5	0.0	0.0	0.0	0.0	6.0	0.4	0.0	1.9	0.0	0.2	0.0	0.0	0.0	0.1	0.7	1.2	0.2	0.7	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.9	0.4	0.5	0.0	0.4	0.0	0.4	0.3	0.0	0.1	0.1	1.2	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.6	0.5	0.0	0.8	0.4	0.2	0.2	0.3	0.9	0.4	0.0	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.1	0.4	0.4	0.4	0.4
TCN1	"TC1, TCI"	ENSG00000134827	"Transcobalamin 1"	P20061	11	59852800-59866575	"Plasma proteins, Predicted secreted proteins"	"Cobalt transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 152.9;salivary gland: 172.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.1;HaCaT: 6.8;PC-3: 9.1;SiHa: 9.5;THP-1: 3.5"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 124.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	95	"basophil: 152.9"	"Lineage enriched"	"Detected in single"	1202	"granulocytes: 152.9"					"Low region specificity"	"Detected in all"								"Secreted to blood"	3300000	3300000				"prognostic favourable (1.90e-4)"	"unprognostic (1.17e-1)"	"unprognostic (5.89e-2)"	"unprognostic (3.61e-3)"	"unprognostic (2.49e-2)"	"unprognostic (5.28e-3)"	"unprognostic (4.52e-3)"	"unprognostic (3.11e-3)"	"unprognostic (1.13e-1)"	"unprognostic (7.56e-2)"	"unprognostic (9.07e-3)"	"unprognostic (3.88e-1)"	"prognostic unfavourable (1.56e-8)"	"unprognostic (2.50e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.76e-2)"	0.2	0.1	0.1	0.1	0.1	27.6	2.1	0.1	0.2	5.5	0.2	0.1	0.0	1.3	1.5	0.0	4.6	0.2	26.7	1.1	0.1	0.1	0.7	0.4	1.8	0.0	0.2	0.0	0.2	3.8	0.1	0.4	0.2	0.1	0.4	0.0	0.1	172.4	0.3	0.2	0.3	0.2	0.1	0.2	1.0	12.7	0.2	0.0	0.3	0.2	28.4	10.0	3.8	1.9	0.0	0.0	152.9	0.1	0.0	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	3.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	1.7	1.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	2.0	0.0	9.1	0.0	0.2	0.0	1.8	0.0	0.0	0.0	9.5	0.0	2.3	0.0	3.5	0.1	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.2	152.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.1	0.0
TEPP		ENSG00000159648	"Testis, prostate and placenta expressed"	Q6URK8	16	57976435-57988116	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 46.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.9;HMC-1: 2.0;RPMI-8226: 2.4;TIME: 2.1"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 3.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"naive CD8 T-cell: 4.5"	"Lineage enriched"	"Detected in single"	6	"T-cells: 4.5"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA062092	Enhanced				"Secreted in male reproductive system"					"HPA062092: "	"unprognostic (4.86e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.12e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.79e-2)"	"unprognostic (8.04e-2)"	"unprognostic (3.67e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.97e-3)"	"unprognostic (2.59e-1)"	0.1	0.7	0.1	0.1	0.1	0.0	0.1	0.1	0.4	0.3	0.1	0.4	0.1	0.0	0.1	0.5	0.3	0.6	0.1	0.3	0.1	0.2	0.1	0.1	0.8	0.1	0.1	0.3	0.7	0.1	0.0	0.1	0.1	0.4	0.3	0.0	0.1	0.2	1.2	0.1	0.1	0.1	0.1	0.3	0.1	0.0	46.3	0.2	0.1	2.6	0.1	0.2	1.6	0.5	0.7	0.2	0.3	0.0	0.2	4.5	1.3	0.0	0.0	0.6	0.0	0.0	0.0	2.9	0.0	0.4	0.5	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.8	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.5	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.6	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	0.0	2.5	0.1	3.0	2.0	0.0	0.7	2.9	4.5	0.0	0.2	0.0	0.2	1.4	1.3	0.1	0.1	0.1	0.4	0.1	0.2	0.1	0.3	0.4	0.2
TFF1	"BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2"	ENSG00000160182	"Trefoil factor 1"	P04155	21	42362282-42366594	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	34	"gallbladder: 247.7;stomach 1: 375.3"	"Cell line enriched"	"Detected in some"	58	"MCF7: 484.6"	"Group enriched"	"Detected in many"	10	"breast cancer: 402.1;colorectal cancer: 268.3;pancreatic cancer: 805.7;stomach cancer: 744.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"CAB002170, HPA003425"	Enhanced				"Secreted to digestive system"	990000	990000			"CAB002170: AB_563985, HPA003425: AB_1848260"	"prognostic favourable (5.00e-4)"	"unprognostic (8.81e-3)"	"unprognostic (9.82e-2)"	"prognostic favourable (5.67e-4)"		"unprognostic (2.42e-1)"	"unprognostic (1.72e-3)"	"unprognostic (8.14e-2)"		"unprognostic (2.45e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.62e-2)"		"unprognostic (1.01e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.72e-3)"	"unprognostic (1.07e-1)"	0.1	0.0	0.1	1.0	0.2	0.0	3.5	0.1	0.1	0.5	4.9	1.4	0.1	1.4	0.1	0.1	1.1	0.1	247.7	0.1	0.1	0.0	0.1	0.3	0.5	0.1	0.1	0.1	0.1	0.9	0.0	0.1	0.1	0.1	1.9	4.7	0.1	5.0	0.2	0.1	0.0	5.6	0.1	0.1	0.1	375.3	0.1	0.1	0.1	0.2	1.1	9.2	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	484.6	0.1	0.0	0.2	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
TFF2	SML1	ENSG00000160181	"Trefoil factor 2"	Q03403	21	42346357-42351128	"Cancer-related genes, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"gallbladder: 361.8;stomach 1: 332.4"	"Group enriched"	"Detected in some"	15	"CAPAN-2: 14.8;PC-3: 53.3"	"Group enriched"	"Detected in many"	11	"pancreatic cancer: 320.9;stomach cancer: 244.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025834, HPA036705"	Enhanced				"Secreted to digestive system"	670000	670000			"CAB025834: , HPA036705: "	"unprognostic (3.95e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.30e-1)"			"prognostic unfavourable (1.99e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.89e-2)"	"unprognostic (5.55e-2)"		"unprognostic (1.27e-9)"	"unprognostic (1.99e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.26e-3)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.5	0.1	62.9	0.1	0.1	0.5	0.0	361.8	0.2	0.1	0.0	0.1	0.5	0.1	0.1	0.1	0.1	0.1	3.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	332.4	0.1	0.1	0.1	0.3	0.1	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.8	0.0	0.7	53.3	0.2	0.0	2.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
TFPI	"EPI, LACI, TFI, TFPI1"	ENSG00000003436	"Tissue factor pathway inhibitor"	P10646	2	187464230-187565760	"Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Protease inhibitor, Serine protease inhibitor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 98.2;placenta: 192.3"	"Cell line enhanced"	"Detected in many"		"HHSteC: 55.2;HUVEC TERT2: 103.8;LHCN-M2: 63.6;TIME: 62.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.5;plasmacytoid DC: 5.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA005575, CAB020842"	Supported		Approved	"Intermediate filaments,Cytosol"	"Secreted to blood"	95000000	95000000	Cytosol	"Intermediate filaments"	"CAB020842: , HPA005575: AB_1080290"	"unprognostic (8.75e-2)"	"prognostic unfavourable (2.02e-4)"	"unprognostic (7.95e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.05e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.86e-3)"	"unprognostic (9.22e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.39e-3)"	"unprognostic (4.05e-2)"	"unprognostic (4.49e-2)"	"unprognostic (5.81e-2)"	52.8	5.0	1.3	5.2	2.2	1.6	18.5	1.9	2.4	22.8	32.1	0.3	7.2	12.8	13.3	14.8	25.9	12.5	15.0	14.0	1.2	1.1	35.6	98.2	89.7	40.2	2.4	1.0	17.3	7.7	0.9	4.9	192.3	2.3	18.2	6.9	3.8	6.0	3.8	15.8	6.6	37.0	13.6	5.4	16.5	7.7	13.7	1.6	3.4	22.6	10.4	4.0	30.0	14.7	1.5	5.1	5.5	0.6	1.0	0.6	4.9	5.0	3.5	4.1	0.1	32.1	38.5	0.0	9.1	21.7	5.9	9.2	3.2	27.0	0.0	3.6	7.1	0.3	1.2	0.4	15.5	0.2	1.0	1.6	10.9	27.4	55.2	0.1	0.0	17.6	0.7	32.1	8.6	103.8	4.0	0.1	63.6	4.7	0.6	0.1	2.5	8.8	0.0	5.7	0.0	10.1	0.2	0.0	0.0	7.4	0.2	0.4	0.1	0.0	62.1	4.3	4.0	8.5	1.7	0.0	0.1	0.0	34.6	0.0	4.9	5.5	0.6	0.5	0.5	0.3	0.2	0.9	0.4	0.2	0.5	1.5	0.5	0.6	2.6	1.0	0.3	5.1	0.2	4.9	1.3	2.2	1.9	2.4	1.2	1.1	2.4	1.0	2.3	1.6
TGFB2		ENSG00000092969	"Transforming growth factor beta 2"	P61812	1	218346235-218444619	"Cancer-related genes, Disease related genes, Predicted secreted proteins"		"Growth factor, Mitogen"	"Aortic aneurysm, Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 20.9;EFO-21: 25.9;HHSteC: 21.5;U-2 OS: 25.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.3;naive B-cell: 2.6"	"Lineage enriched"	"Detected in single"	5	"B-cells: 2.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted to blood"						"unprognostic (7.24e-2)"	"unprognostic (7.23e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.86e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.64e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.90e-2)"	"unprognostic (6.04e-2)"	2.9	2.6	13.4	3.2	11.4	0.8	7.0	5.2	13.7	12.3	5.2	10.0	7.0	1.6	10.8	7.5	3.6	6.9	3.9	9.5	13.3	6.7	2.9	1.6	12.4	1.6	5.9	9.9	8.1	3.5	4.3	6.3	20.1	10.2	27.8	2.1	11.6	16.9	18.7	6.9	3.8	1.8	8.5	19.0	4.4	2.8	2.1	8.2	0.0	4.8	2.8	1.9	5.2	7.4	2.6	0.5	0.0	0.0	0.0	0.1	0.0	1.7	8.6	0.8	6.8	2.0	1.0	0.0	1.2	0.1	13.8	9.9	2.3	20.9	0.0	25.9	0.0	4.5	0.5	1.1	14.4	0.0	0.1	0.0	0.7	0.0	21.5	0.0	0.0	0.9	2.4	1.9	7.3	3.7	0.0	0.0	13.1	0.1	0.0	0.0	0.7	0.7	0.0	3.9	0.0	4.4	0.0	0.1	0.0	14.3	1.7	0.2	1.3	0.5	16.1	9.8	25.7	8.1	13.2	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.5	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	11.4	5.2	13.7	13.3	6.7	5.9	9.9	10.2	8.2
TGFB3	"ARVD, ARVD1"	ENSG00000119699	"Transforming growth factor beta 3"	P10600	14	75958099-75982991	"Cancer-related genes, Disease related genes, Predicted secreted proteins"		"Growth factor, Mitogen"	"Cancer-related genes, Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"SK-BR-3: 49.2;T-47d: 34.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.8"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA063582			Approved	Vesicles	"Secreted to blood"			Vesicles		"HPA063582: "	"unprognostic (7.84e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.32e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.79e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.51e-2)"	"unprognostic (5.63e-2)"	"unprognostic (4.10e-1)"	"prognostic unfavourable (4.01e-7)"	"unprognostic (6.38e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.22e-2)"	"unprognostic (3.27e-3)"	6.9	4.7	10.6	8.4	14.0	0.4	7.8	3.2	8.6	29.2	4.1	6.7	13.1	2.3	10.4	21.4	4.4	4.9	21.5	17.9	11.9	6.6	4.8	12.2	8.6	4.2	16.8	7.0	3.1	11.1	6.8	4.6	31.0	8.4	25.8	3.2	10.0	5.0	12.0	13.3	1.5	2.9	20.7	13.0	2.2	4.5	3.8	8.8	4.2	4.4	5.7	8.2	11.6	6.4	0.4	0.1	0.0	0.0	0.0	1.8	0.2	0.3	0.1	0.4	5.4	0.9	1.3	0.1	0.2	0.4	0.2	0.2	0.3	1.3	0.0	0.4	1.0	0.3	1.1	0.1	0.1	0.3	0.5	0.0	1.1	0.6	1.3	0.2	0.3	4.5	0.1	0.4	0.1	1.3	0.5	2.4	0.3	2.4	0.2	0.2	0.1	1.8	1.1	1.6	0.2	0.5	0.2	8.9	2.1	1.6	49.2	0.3	34.5	0.0	0.3	0.8	1.8	0.8	2.2	0.2	0.2	0.1	1.3	0.3	1.3	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.1	0.6	0.0	0.4	1.8	0.5	0.0	0.0	0.0	0.1	0.3	0.2	10.6	14.0	3.2	8.6	11.9	6.6	16.8	7.0	8.4	8.8
THBS1	"THBS, THBS-1, TSP, TSP-1, TSP1"	ENSG00000137801	"Thrombospondin 1"	P07996	15	39581079-39599466	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion, Unfolded protein response"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 162.1;HUVEC TERT2: 157.6;LHCN-M2: 117.7;TIME: 229.8"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basal ganglia: 3.4;pons and medulla: 8.1"	"Cell type enhanced"	"Detected in some"		"eosinophil: 14.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"CAB033678, HPA059756"	Approved		Approved	"Plasma membrane"	"Secreted to extracellular matrix"	1600000000	1600000000	"Plasma membrane"		"CAB033678: AB_793044, HPA059756: "	"unprognostic (1.72e-2)"	"unprognostic (9.55e-3)"	"unprognostic (7.49e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.03e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.07e-1)"	"unprognostic (6.40e-2)"	"unprognostic (9.16e-2)"	"prognostic unfavourable (8.47e-5)"	"prognostic unfavourable (8.50e-4)"	"unprognostic (1.00e-1)"	"unprognostic (9.25e-3)"	"unprognostic (1.48e-3)"	79.6	15.2	0.9	81.4	3.4	19.3	41.0	0.7	1.3	25.7	42.7	2.5	6.6	5.0	72.8	30.5	22.7	40.8	57.7	49.0	1.0	1.0	23.4	27.2	118.4	38.8	1.1	0.8	60.9	14.0	1.3	7.7	38.1	8.1	31.9	18.3	8.4	38.0	13.2	22.6	9.2	23.0	63.5	4.5	58.0	46.5	27.5	0.2	0.6	14.0	21.4	18.4	111.8	78.9	0.0	0.5	14.1	7.4	7.5	2.6	8.6	11.5	3.9	3.1	1.1	13.1	15.4	0.0	67.0	54.8	18.4	12.1	11.4	8.7	0.0	25.3	162.1	41.2	0.1	32.7	9.3	3.0	0.0	2.9	2.3	2.9	2.9	0.0	0.8	34.5	2.4	15.3	34.5	157.6	0.0	0.1	117.7	0.8	0.0	0.2	0.5	1.4	0.0	8.1	0.0	27.6	29.4	0.0	0.0	19.0	1.0	1.1	11.7	0.2	229.8	64.5	15.3	75.9	76.9	0.1	0.1	0.1	2.1	0.0	68.9	0.2	7.4	14.1	0.8	0.8	2.6	0.0	0.4	0.5	0.5	0.0	0.1	0.1	1.4	7.5	0.1	0.3	0.0	8.6	0.9	3.4	0.7	1.0	1.0	1.0	1.1	0.8	8.1	0.2
THBS2	TSP2	ENSG00000186340	"Thrombospondin 2"	P35442	6	169215780-169254044	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 84.6;urinary bladder: 67.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 81.9;ASC TERT1: 56.2;BJ hTERT+ SV40 Large T+ RasG12V: 27.2;HSkMC: 30.3;hTEC/SVTERT24-B: 29.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB017716, HPA044304"	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	22000000	22000000	"Plasma membrane"	"Nuclear speckles, Cytosol"	"CAB017716: , HPA044304: "	"unprognostic (2.85e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.87e-2)"	"unprognostic (8.90e-2)"	"unprognostic (3.64e-2)"	"unprognostic (8.73e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.39e-1)"	"unprognostic (4.71e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.56e-1)"	"prognostic unfavourable (3.77e-6)"	"unprognostic (2.19e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.48e-3)"	43.5	4.0	4.3	10.1	7.8	0.4	84.6	1.1	9.0	24.3	17.0	6.3	3.3	1.9	26.1	16.1	9.8	14.8	43.0	21.9	5.5	3.6	4.6	5.9	8.4	3.8	8.1	1.4	26.2	5.9	1.5	4.4	2.0	14.8	10.5	3.4	0.7	3.9	2.8	14.6	22.7	3.8	22.0	16.0	2.8	2.6	12.5	5.2	0.0	13.2	10.6	4.8	67.4	29.4	0.4	0.7	0.2	0.8	0.1	0.3	0.0	0.0	0.0	0.5	0.3	81.9	56.2	0.0	15.6	21.4	21.6	27.2	0.1	0.0	0.0	0.0	18.6	0.0	0.6	0.8	12.4	0.0	0.0	0.0	0.0	0.0	22.9	0.0	0.0	30.3	0.0	29.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.8	3.3	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	9.9	0.1	22.0	1.8	0.0	0.3	0.0	6.1	0.1	0.5	0.0	0.8	0.2	0.2	0.5	0.0	0.4	0.1	0.0	0.2	0.3	0.1	0.3	0.0	0.1	0.5	0.7	0.2	0.0	4.3	7.8	1.1	3.1	5.5	3.6	8.1	1.4	14.8	5.2
THPO	"MGDF, MPLLG, TPO"	ENSG00000090534	Thrombopoietin	P40225	3	184371935-184381968	"Cancer-related genes, Disease related genes, Predicted secreted proteins"		"Cytokine, Hormone"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	6	"liver: 55.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.8;Hep G2: 17.4;K-562: 3.1;RPMI-8226: 4.6"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 8.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted to blood"						"unprognostic (5.57e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.21e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.40e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (2.48e-6)"	"unprognostic (1.40e-3)"	"unprognostic (4.13e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.25e-2)"	1.7	1.3	2.3	0.5	0.7	0.0	1.4	4.3	3.3	1.5	0.7	0.4	0.4	0.1	2.6	1.7	0.4	0.9	0.4	1.7	1.5	0.0	8.6	55.5	0.4	0.4	0.4	0.4	1.5	2.7	0.0	1.3	0.6	0.4	0.7	0.3	0.5	0.9	0.7	6.0	0.1	0.4	2.1	0.7	0.9	0.2	2.4	0.4	0.4	0.7	0.7	0.5	0.4	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	2.5	0.0	0.0	0.1	0.0	6.8	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	17.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	3.1	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.3	0.8	4.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.1	0.0	0.0	0.1	1.9	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.7	4.3	3.3	1.5	0.0	0.4	0.4	0.4	0.4
TIMP3	SFD	ENSG00000100234	"TIMP metallopeptidase inhibitor 3"	P35625	22	32801701-32863043	"Cancer-related genes, Disease related genes, Predicted secreted proteins"	"Sensory transduction, Vision"	"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 392.5;retina: 247.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 55.9;BJ: 125.0;BJ hTERT+: 55.2;fHDF/TERT166: 113.6;WM-115: 95.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"NK-cell: 2.2"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"						"unprognostic (4.98e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.60e-1)"	"unprognostic (8.53e-4)"	"unprognostic (1.67e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.22e-2)"	"unprognostic (8.42e-2)"	"prognostic unfavourable (1.90e-5)"	"unprognostic (3.92e-1)"	"unprognostic (1.95e-1)"	"prognostic favourable (1.50e-4)"	"unprognostic (2.66e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.55e-3)"	"unprognostic (3.11e-2)"	130.4	44.6	8.7	15.8	10.1	0.1	103.3	5.1	12.1	68.3	25.4	13.5	27.8	4.5	65.1	47.4	40.2	51.9	39.9	75.0	10.2	8.5	54.0	14.1	115.4	31.3	11.4	8.7	25.3	11.8	15.6	21.6	392.5	19.1	44.2	12.6	247.1	24.3	55.0	22.7	22.9	16.2	58.3	7.2	35.1	22.9	43.2	7.1	1.2	48.9	29.4	10.1	37.5	38.3	0.4	0.0	0.0	0.0	2.2	0.0	0.0	2.0	0.0	1.8	0.2	55.9	31.5	0.1	125.0	55.2	10.2	12.2	2.1	0.0	0.0	3.0	113.6	1.9	0.3	5.1	14.8	0.0	1.5	15.4	2.6	5.4	22.0	0.0	6.5	5.2	13.1	18.1	1.0	0.0	0.0	0.1	4.7	0.1	0.0	0.5	0.2	0.0	0.0	0.3	0.0	0.2	10.2	1.3	1.8	2.5	0.0	32.8	0.0	0.1	0.0	0.8	2.8	26.6	2.0	0.0	0.0	0.0	25.5	0.0	95.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	8.7	10.1	5.1	12.1	10.2	8.5	11.4	8.7	19.1	7.1
TIMP4		ENSG00000157150	"TIMP metallopeptidase inhibitor 4"	Q99727	3	12153051-12159351	"Plasma proteins, Predicted secreted proteins"		"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 72.2;breast: 97.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 53.4;ASC TERT1: 13.3;HSkMC: 23.2;NTERA-2: 13.3;U-87 MG: 13.6"	"Cancer enriched"	"Detected in many"	13	"glioma: 66.4"	"Region enriched"	"Detected in all"	5	"cerebellum: 17.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in all"		"cerebellum: 118.9"	"Region enriched"	"Detected in all"	6	"cerebellum: 100.1"						"Secreted to extracellular matrix"						"unprognostic (2.99e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.97e-4)"	"unprognostic (9.33e-3)"	"unprognostic (4.26e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.78e-1)"	"unprognostic (6.81e-2)"	"unprognostic (4.99e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.66e-5)"	"unprognostic (2.86e-1)"	72.2	4.3	1.9	2.2	1.6	0.7	97.5	17.8	11.2	2.6	11.7	2.4	0.7	1.1	1.9	0.9	3.2	1.6	2.9	10.9	1.7	1.5	1.9	0.8	2.6	6.0	3.1	1.5	1.2	1.5	1.2	3.2	4.6	3.8	2.9	2.4	2.4	3.1	1.6	7.7	1.7	2.4	2.4	2.9	0.8	2.3	1.8	1.2	0.1	6.1	3.8	0.6	3.7	9.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	5.9	0.2	0.0	53.4	13.3	6.6	0.2	2.1	0.2	0.3	0.1	0.0	0.0	0.5	0.2	0.2	0.0	0.1	0.1	0.2	0.0	0.0	3.4	0.2	8.3	0.0	0.0	23.2	0.5	1.4	0.0	0.0	0.1	4.3	0.0	0.1	0.0	0.0	13.3	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	13.6	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.6	17.8	1.3	1.7	1.5	3.1	1.5	3.8	1.2
TLL2		ENSG00000095587	"Tolloid like 2"	Q9Y6L7	10	96364606-96513918	"Enzymes, Predicted secreted proteins"	Differentiation	"Developmental protein, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 7.4"	"Cell line enriched"	"Detected in some"	11	"RPTEC TERT1: 21.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"						"unprognostic (1.28e-2)"	"unprognostic (7.54e-4)"	"unprognostic (1.50e-1)"	"unprognostic (3.31e-3)"	"unprognostic (2.67e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.31e-2)"	"unprognostic (3.52e-4)"	"unprognostic (7.08e-2)"	"unprognostic (2.50e-1)"	"unprognostic (6.71e-2)"	"unprognostic (3.37e-2)"	"unprognostic (4.98e-4)"	"unprognostic (2.90e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.95e-4)"	"unprognostic (2.30e-1)"	0.7	1.1	3.2	1.4	4.9	1.6	0.7	0.7	5.8	0.8	1.1	5.7	2.5	1.7	1.2	1.1	0.9	0.7	2.6	7.4	3.3	3.8	0.7	0.6	0.5	1.8	3.4	2.1	1.4	1.5	0.4	2.8	1.1	4.6	1.1	1.1	0.0	3.9	2.7	4.1	1.0	2.1	0.9	6.1	0.9	2.1	1.1	5.7	0.0	1.5	4.0	0.7	0.8	0.5	0.9	0.3	0.6	0.2	0.3	0.2	0.0	0.2	0.1	0.4	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.3	1.1	0.1	0.1	0.2	0.1	0.0	1.9	0.4	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	1.2	0.1	0.1	0.4	0.0	21.2	0.1	0.8	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.9	0.2	0.1	0.0	0.9	0.2	0.2	0.6	0.3	0.2	0.3	0.1	0.0	3.2	4.9	0.7	4.0	3.3	3.8	3.4	2.1	4.6	5.7
TMEM155	FLJ30834	ENSG00000164112	"Transmembrane protein 155"	Q4W5P6	4	121758933-121765427	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	4	"brain: 25.6"	"Group enriched"	"Detected in some"	5	"fHDF/TERT166: 7.2;HAP1: 3.3;LHCN-M2: 10.2;MOLT-4: 6.2"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in many"		"cerebral cortex: 25.6"	"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 2.3;T-reg: 1.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.3"									HPA077585	Approved				"Secreted in brain"					"HPA077585: "	"unprognostic (9.67e-3)"	"unprognostic (3.25e-3)"	"unprognostic (3.13e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.73e-3)"	"unprognostic (3.63e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.40e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.82e-7)"	"unprognostic (1.06e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.04e-1)"	0.6	0.3	5.9	0.5	8.3	0.3	0.3	0.3	25.6	0.4	1.3	0.0	0.0	0.4	0.3	0.3	0.5	0.3	0.4	0.4	7.9	1.6	0.3	0.3	0.6	4.0	0.9	8.9	0.3	0.3	0.2	0.2	6.1	0.7	0.5	0.7	0.9	0.5	0.6	0.3	0.3	0.6	0.9	0.3	0.8	0.5	0.7	0.0	0.0	0.3	0.0	0.6	0.5	0.3	0.0	0.0	0.7	0.0	0.0	2.3	0.3	0.0	0.0	0.1	0.0	1.4	0.2	1.0	0.7	0.2	0.3	0.5	0.0	0.0	0.0	0.0	7.2	0.0	3.3	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.8	0.0	0.2	0.0	0.3	0.0	0.0	10.2	0.0	6.2	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.1	0.3	5.9	8.3	0.3	25.6	7.9	1.6	0.9	8.9	0.7	0.0
TNFAIP6	"TSG-6, TSG6"	ENSG00000123610	"TNF alpha induced protein 6"	P98066	2	151357592-151380048	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 50.9"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 30.4;HHSteC: 18.9;hTEC/SVTERT24-B: 25.1;SH-SY5Y: 9.9;U-2197: 20.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 27.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	22	"neutrophil: 50.9"	"Lineage enriched"	"Detected in many"	22	"granulocytes: 50.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB032719, HPA050884"	Approved				"Secreted to blood"	15000	15000			"CAB032719: AB_2204650, HPA050884: "	"unprognostic (1.31e-1)"	"prognostic unfavourable (8.18e-5)"	"unprognostic (8.66e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.15e-3)"	"unprognostic (3.26e-3)"	"unprognostic (3.75e-4)"	"unprognostic (4.49e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.90e-1)"	"unprognostic (5.87e-3)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (5.59e-4)"	"unprognostic (1.06e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.46e-2)"	"prognostic unfavourable (9.16e-5)"	14.0	0.6	4.8	23.7	5.6	5.8	10.3	0.3	3.8	9.4	6.8	0.4	0.2	0.7	2.0	4.0	8.2	2.4	17.9	17.3	6.3	1.9	0.8	1.1	17.3	2.2	9.9	1.2	1.4	1.1	0.7	0.6	1.8	5.6	4.3	2.6	2.2	2.8	1.0	4.7	3.2	2.5	7.8	4.3	3.9	3.8	9.7	5.8	0.7	1.9	6.6	0.5	13.5	2.8	0.0	0.0	50.9	2.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.7	7.3	0.0	1.1	30.4	1.1	5.7	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	18.9	0.0	0.0	9.1	0.0	25.1	1.7	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.1	7.0	0.0	0.5	0.0	0.0	0.0	0.0	9.9	0.2	0.0	0.0	0.0	0.0	0.0	1.0	2.1	20.2	0.3	0.0	0.0	0.0	2.2	0.3	1.5	0.0	2.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.9	0.0	0.5	0.0	0.0	0.6	4.8	5.6	0.3	3.8	6.3	1.9	9.9	1.2	5.6	5.8
TNFRSF11B	"OCIF, OPG, TR1"	ENSG00000164761	"TNF receptor superfamily member 11b"	O00300	8	118923557-118952200	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	Apoptosis	Receptor	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 18.6;thyroid gland: 52.8"	"Group enriched"	"Detected in some"	4	"BJ: 49.7;BJ hTERT+: 184.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	66	"plasmacytoid DC: 6.5"	"Lineage enriched"	"Detected in single"	66	"dendritic cells: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB034939	Approved				"Secreted in other tissues"					"CAB034939: "	"unprognostic (1.39e-2)"	"prognostic unfavourable (6.22e-4)"	"unprognostic (5.27e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.10e-3)"	"unprognostic (1.21e-3)"	"unprognostic (5.50e-2)"	"unprognostic (9.94e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.43e-1)"	"prognostic favourable (6.79e-4)"	"unprognostic (1.32e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.61e-3)"	"prognostic unfavourable (3.88e-4)"	3.0	3.0	2.2	2.8	2.8	0.2	4.4	2.9	5.2	1.2	1.5	0.7	0.5	0.9	5.5	4.1	1.0	1.7	3.2	7.3	2.8	1.4	18.6	7.6	8.1	5.3	1.7	0.8	0.5	2.8	0.3	1.9	4.0	12.0	1.1	2.0	1.8	1.4	0.8	0.6	0.7	1.4	1.5	7.9	1.5	0.8	0.3	2.7	0.9	52.8	0.8	1.7	1.7	1.1	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	2.6	0.5	0.0	49.7	184.9	2.4	0.6	0.5	0.1	0.0	13.4	27.5	0.5	0.0	0.0	1.2	0.0	0.0	0.0	2.3	0.0	0.3	0.0	0.0	0.2	0.0	2.4	0.0	0.0	0.0	0.0	6.9	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	1.5	0.8	0.9	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	2.2	2.8	2.9	5.2	2.8	1.4	1.7	0.8	12.0	2.7
TNFRSF6B	"DcR3, M68, TR6"	ENSG00000243509	"TNF receptor superfamily member 6b"	O95407	20	63696651-63698684	"Predicted secreted proteins"	Apoptosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 39.4;lymphoid tissue: 56.3"	"Group enriched"	"Detected in some"	4	"HBEC3-KT: 11.4;RPTEC TERT1: 45.0;TIME: 27.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	18	"plasmacytoid DC: 17.4"	"Lineage enriched"	"Detected in single"	18	"dendritic cells: 17.4"					"Low region specificity"	"Detected in many"			HPA047154	Approved				"Secreted to blood"					"HPA047154: "																		11.8	2.0	10.0	39.2	17.6	2.5	7.0	5.4	8.1	4.5	6.0	2.1	0.0	2.0	3.0	2.0	6.6	2.5	3.6	2.0	11.6	6.6	4.4	2.5	39.4	9.8	5.9	0.0	3.6	2.2	2.0	4.2	2.1	23.6	2.7	2.3	0.0	2.9	2.0	10.0	4.8	3.8	4.6	13.0	56.3	10.0	2.1	5.3	2.7	6.5	3.3	12.1	11.6	2.3	0.0	17.4	0.0	0.9	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	3.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	45.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	27.8	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.9	17.4	0.0	0.1	10.0	17.6	5.4	8.1	11.6	6.6	5.9	0.0	23.6	5.3
TNFSF12	"APO3L, DR3LG, TWEAK"	ENSG00000239697	"TNF superfamily member 12"	O43508	17	7548891-7557890	"Predicted secreted proteins"	"Angiogenesis, Apoptosis, Differentiation"	"Cytokine, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 11.6;BJ hTERT+: 11.0;HDLM-2: 9.7;HSkMC: 10.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035984, HPA052967"	Uncertain		Approved	Vesicles	"Secreted to blood"	150000	150000	Vesicles		"HPA035984: , HPA052967: "	"unprognostic (2.96e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.71e-2)"	"prognostic favourable (5.70e-5)"	"unprognostic (5.31e-2)"	"unprognostic (7.91e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.09e-2)"	"unprognostic (6.20e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.29e-2)"	"unprognostic (4.11e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.38e-1)"	32.9	16.7	23.0	14.0	16.9	2.9	20.4	15.7	21.8	22.1	27.4	9.5	18.0	9.5	17.6	18.6	24.5	19.8	30.1	23.3	16.3	13.3	15.0	8.8	23.8	16.8	14.8	13.9	31.3	20.6	9.0	8.4	13.4	7.8	27.8	6.2	19.7	26.7	32.7	12.8	8.2	11.3	24.2	9.1	21.6	18.0	7.4	8.5	2.6	11.3	9.6	11.0	26.0	37.7	2.6	2.4	10.5	5.7	2.4	6.9	0.8	0.0	0.0	0.5	0.0	9.0	11.6	2.5	3.9	11.0	4.4	2.7	0.0	1.3	0.0	3.4	9.5	0.9	0.4	0.4	0.4	9.7	1.7	0.6	0.2	0.8	8.8	0.0	0.0	10.1	1.1	1.5	0.1	7.1	0.1	0.0	3.8	0.0	0.0	0.3	0.4	4.9	0.1	0.0	0.1	7.0	0.0	0.0	4.7	1.3	0.0	3.8	0.7	0.4	6.9	6.0	0.5	0.0	2.1	0.0	0.0	0.0	1.1	0.0	5.3	4.0	3.1	10.5	5.2	5.7	6.9	2.6	3.8	2.8	1.8	2.5	4.4	4.1	2.2	2.4	1.4	2.4	4.1	0.8	23.0	16.9	15.7	21.8	16.3	13.3	14.8	13.9	7.8	8.5
TNN		ENSG00000120332	"Tenascin N"	Q9UQP3	1	175067858-175148066	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 15.2;gallbladder: 14.2"	"Cell line enhanced"	"Detected in some"		"AF22: 7.5;NB-4: 4.6;THP-1: 14.0;U-266/70: 3.6;U-937: 2.6"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB010907, HPA026726, HPA026764"	Uncertain				"Secreted to extracellular matrix"	11000000	11000000			"CAB010907: AB_477565, HPA026726: AB_10601771, HPA026764: AB_10601859"	"unprognostic (1.16e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.55e-1)"	"unprognostic (5.25e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.69e-1)"	"unprognostic (5.07e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.76e-2)"	"unprognostic (9.38e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.02e-2)"	15.2	0.2	0.1	1.5	0.2	0.0	7.9	0.4	0.8	0.3	0.8	0.1	0.1	1.0	0.1	0.5	0.3	0.0	14.2	0.6	0.1	0.0	0.4	1.8	1.8	0.1	0.1	0.9	0.1	0.3	1.8	3.7	0.1	0.6	0.1	0.1	4.8	6.4	0.1	0.1	5.3	1.0	0.8	0.7	0.6	0.5	0.1	0.3	0.3	2.6	7.5	0.3	0.1	0.2	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	3.6	0.5	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.7	0.1	0.0	0.1	0.9	0.6	0.3
TOR2A	"FLJ14771, TORP1"	ENSG00000160404	"Torsin family 2 member A"	"Q5JU69, Q8N2E6"	9	127731524-127735317	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071229	Approved				"Secreted to blood"					"HPA071229: "	"unprognostic (1.67e-1)"	"unprognostic (9.19e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.27e-3)"	"unprognostic (3.04e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.43e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.05e-2)"	"unprognostic (6.98e-2)"	"prognostic favourable (7.51e-4)"	"unprognostic (1.72e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.82e-2)"	7.3	10.1	6.2	11.8	6.2	33.3	10.9	11.3	9.1	7.2	13.5	6.1	8.2	16.4	6.3	10.1	9.9	7.9	11.8	5.8	5.8	5.6	10.2	16.2	12.8	22.8	4.9	7.3	7.9	18.3	3.2	8.3	15.0	5.1	7.1	8.4	6.1	9.7	10.2	2.8	8.3	20.9	4.5	4.0	18.9	12.6	16.9	5.6	18.6	8.0	6.8	10.9	7.2	6.3	6.2	26.3	34.5	28.8	10.0	13.1	13.4	4.0	6.1	5.3	6.6	2.6	2.6	7.1	3.1	3.4	4.4	3.5	4.2	6.8	7.4	4.2	2.3	12.7	1.6	3.4	1.2	11.8	6.1	2.8	5.4	5.0	4.3	5.8	15.2	4.1	6.5	4.1	2.2	6.2	8.5	20.3	2.5	22.6	7.4	18.3	4.8	5.7	12.8	2.5	16.0	4.5	3.7	11.5	4.7	2.6	9.0	2.6	20.1	11.3	3.8	2.8	3.4	5.0	3.2	13.1	11.3	3.0	3.5	9.5	2.7	8.8	25.3	34.5	13.1	28.8	10.2	4.8	7.6	12.6	26.3	6.2	5.8	10.2	17.1	10.0	26.6	6.1	11.6	13.4	6.2	6.2	11.3	9.1	5.8	5.6	4.9	7.3	5.1	5.6
TPSB2		ENSG00000197253	"Tryptase beta 2 (gene/pseudogene)"	P20231	16	1227272-1230184	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 16.2"	"Cell line enriched"	"Detected in some"	8	"HMC-1: 81.3"	"Low cancer specificity"	"Detected in many"							"Cell type enriched"	"Detected in single"	84	"basophil: 8.4"	"Lineage enriched"	"Detected in single"	84	"granulocytes: 8.4"									"HPA049153, HPA049554"	Supported				"Secreted to blood"	7500000	7500000			"HPA049153: , HPA049554: "	"unprognostic (9.05e-2)"	"unprognostic (8.46e-3)"	"unprognostic (2.42e-3)"	"unprognostic (2.27e-2)"	"unprognostic (4.97e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.55e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.95e-1)"	"unprognostic (8.30e-3)"	"unprognostic (1.91e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.17e-2)"	1.8	0.0	0.9	1.9	0.9	0.0	4.1	0.9	0.9	8.8	5.3	0.9	0.9	4.9	2.9	0.9	7.7	0.1	16.2	0.9	0.9		0.9	0.9	12.3	2.4	0.9	0.9	0.9	1.3	0.0	0.9	0.9	0.9	2.7	2.3	0.9	6.2	1.2	0.9	3.4	9.7	4.4	0.9	0.9	13.6	0.9	0.9	0.9	0.9	0.9	0.9	4.2	0.9	0.0	0.0	8.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.1	81.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1										
TRH		ENSG00000170893	"Thyrotropin releasing hormone"	P20396	3	129974305-129977938	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 33.9;cervix, uterine: 23.6;endometrium 1: 17.5"	"Cell line enhanced"	"Detected in some"		"REH: 3.1;T-47d: 2.9"	"Cancer enhanced"	"Detected in some"		"breast cancer: 13.3;endometrial cancer: 10.2"	"Group enriched"	"Detected in many"	14	"hypothalamus: 33.9;pons and medulla: 33.8"	"Group enriched"	"Detected in some"	11	"intermediate monocyte: 1.1;non-classical monocyte: 1.0"	"Lineage enriched"	"Detected in single"	12	"monocytes: 1.1"	"Group enriched"	"Detected in many"	5	"hypothalamus: 204.6;olfactory region: 182.2"	"Low region specificity"	"Detected in many"			HPA035596	Enhanced				"Secreted in other tissues"					"HPA035596: "	"unprognostic (1.22e-1)"	"unprognostic (8.94e-2)"		"unprognostic (5.82e-3)"	"unprognostic (5.24e-2)"	"unprognostic (2.82e-1)"		"unprognostic (1.11e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.44e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.82e-2)"	0.3	0.1	0.4	0.2	2.4	2.8	0.9	0.3	1.7	23.6	0.1	0.1	0.6	0.2	17.5	0.1	0.1	2.3	0.1	0.5	2.0	33.9	0.1	0.1	0.6	0.1	0.4	0.8	3.2	0.1	0.1	0.1	0.3	33.8	0.1	0.1	6.3	1.0	0.2	0.2	0.5	0.1	0.4	3.6	0.1	0.1	0.8	0.0	0.8	0.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	3.1	0.0	0.0	0.0	0.0	0.5	0.1	0.3	0.0	0.0	2.9	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.4	2.4	0.3	1.7	2.0	33.9	0.4	0.8	33.8	0.0
TSHB		ENSG00000134200	"Thyroid stimulating hormone beta"	P01222	1	115029824-115034309	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	77	"pituitary gland: 192.4"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.0;SH-SY5Y: 1.0;U-937: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"NK-cell: 2.0"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB022202, HPA042681"	Enhanced				"Secreted to blood"					"CAB022202: , HPA042681: "											"unprognostic (2.14e-4)"	"unprognostic (1.37e-1)"		"unprognostic (1.73e-1)"				0.1	0.0	0.1	0.9	0.1	2.4	0.1	0.1	0.9	0.1	0.1	0.1	0.1	0.0	1.4	0.1	1.4	0.0	1.8	0.1	0.1	0.0	0.3	0.1	1.4	0.1	0.1	0.1	0.1	1.6	0.0	192.4	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	1.0	0.6	0.1	0.1	0.1	0.4	1.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.0	0.2	0.1	2.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1
TSKU	"E2IG4, LRRC54, TSK"	ENSG00000182704	"Tsukushi, small leucine rich proteoglycan"	Q8WUA8	11	76782251-76798154	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 86.8"	"Cell line enhanced"	"Detected in many"		"A549: 42.5;ASC diff: 72.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA008164	Approved		Approved	"Nucleoplasm,Nuclear bodies"	"Secreted - unknown location"	2100000	2100000	Nucleoplasm	"Nuclear bodies"	"HPA008164: AB_1853327"	"unprognostic (1.07e-2)"	"unprognostic (2.29e-3)"	"unprognostic (6.15e-2)"	"prognostic favourable (3.66e-4)"	"unprognostic (7.05e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.17e-3)"	"unprognostic (4.81e-2)"	"unprognostic (4.62e-2)"	"prognostic unfavourable (2.87e-4)"	"prognostic favourable (1.66e-4)"	"prognostic unfavourable (2.80e-8)"	"unprognostic (1.47e-1)"	"unprognostic (4.93e-2)"	"unprognostic (6.71e-2)"	"unprognostic (3.88e-2)"	33.1	2.8	1.0	3.6	1.4	0.6	26.9	1.5	2.0	38.8	16.1	1.8	6.4	11.5	13.2	25.5	17.8	15.3	8.6	9.3	1.2	0.3	31.8	86.8	5.1	3.7	1.7	1.3	27.8	12.2	2.6	4.3	43.0	3.4	15.7	4.5	48.5	9.3	10.8	7.0	15.0	21.4	13.0	0.8	3.0	8.7	9.0	0.8	1.5	12.2	16.0	12.4	18.2	27.9	1.8	0.7	2.1	0.4	0.7	1.3	0.2	0.8	42.5	4.7	4.6	72.7	9.3	8.7	1.4	8.0	3.1	3.0	5.5	11.7	0.1	8.3	5.3	17.0	2.7	10.4	1.0	8.7	1.4	2.0	11.0	15.2	13.7	0.7	3.2	9.5	11.5	5.6	4.6	3.9	4.6	0.3	2.9	19.6	0.1	1.5	6.2	1.8	1.4	4.5	6.7	7.4	7.4	4.3	7.1	8.1	6.4	3.8	8.5	0.6	1.2	8.9	7.1	21.7	3.4	0.3	0.1	0.3	4.2	2.2	1.6	1.8	0.4	0.5	0.9	0.2	0.4	1.8	0.8	0.7	0.4	1.8	0.9	1.3	2.1	0.7	0.4	0.7	0.8	0.2	1.0	1.4	1.5	2.0	1.2	0.3	1.7	1.3	3.4	0.8
TTC9B	FLJ30373	ENSG00000174521	"Tetratricopeptide repeat domain 9B"	Q8N6N2	19	40216058-40218399	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"brain: 47.9"	"Cell line enriched"	"Detected in some"	19	"SCLC-21H: 24.5"	"Cancer enriched"	"Detected in single"	15	"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042496	Approved				"Secreted in brain"					"HPA042496: AB_10795506"	"unprognostic (2.31e-1)"	"unprognostic (1.39e-4)"	"unprognostic (5.09e-2)"	"unprognostic (5.24e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.54e-2)"	"unprognostic (3.69e-1)"	"unprognostic (8.75e-6)"	"unprognostic (1.39e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.24e-2)"	1.0	1.8	45.5	1.4	10.3	1.0	1.0	24.6	47.9	1.0	1.2	1.2	0.0	1.1	1.0	1.0	1.0	1.0	1.0	1.0	22.3	14.0	1.0	1.0	1.0	1.0	7.5	9.9	1.0	1.0	1.0	0.0	1.0	7.1	1.0	1.0	0.3	1.0	1.0	1.0	1.0	1.2	1.1	2.5	1.0	1.1	1.1	1.0	0.0	1.0	0.0	1.0	1.0	0.0	0.1	0.5	0.0	1.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	24.5	1.3	0.1	0.0	0.9	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.3	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.5	0.3	0.0	45.5	10.3	24.6	31.3	22.3	14.0	7.5	9.9	7.1	1.0
TTR	"CTS, CTS1, HsT2651, PALB"	ENSG00000118271	Transthyretin	P02766	18	31591726-31599021	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	Transport	"Hormone, Thyroid hormone"	"Amyloidosis, Cancer-related genes, Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"brain: 1008.0;liver: 680.8;retina: 332.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 30.7;EFO-21: 10.8;Hep G2: 47.1;U-2 OS: 14.2"	"Group enriched"	"Detected in many"	28	"liver cancer: 928.2;pancreatic cancer: 666.0"	"Region enriched"	"Detected in many"	9	"pons and medulla: 1008.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 1513.1;hippocampal formation: 5269.0;pons and medulla: 5831.5;thalamus: 3501.9"	"Region enhanced"	"Detected in many"		"pons and medulla: 1006.9"	"CAB002517, HPA002550, CAB062567, CAB073406"	Supported		Approved	"Golgi apparatus"	"Secreted to blood"	180000000000	180000000000	"Golgi apparatus"		"CAB002517: AB_563965, CAB062567: , CAB073406: , HPA002550: AB_1080419"	"unprognostic (6.79e-3)"		"unprognostic (3.38e-2)"	"unprognostic (4.10e-1)"	"unprognostic (1.74e-1)"		"unprognostic (1.84e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.74e-2)"		"unprognostic (9.66e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.35e-3)"	"unprognostic (5.26e-1)"		"unprognostic (3.52e-2)"	0.5	0.4	3.6	0.4	3.0	0.6	0.4	5.8	60.8	0.4	0.6	361.3	0.0	0.9	0.4	0.4	0.4	0.4	3.3	0.4	115.6	4.4	1.0	680.8	0.4	0.4	7.1	0.0	0.4	62.3	1.6	0.5	0.4	1008.0	0.4	0.5	332.4	0.4	0.4	0.4	1.0	0.6	0.4	4.9	0.5	2.0	0.4	0.6	0.0	0.4	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	30.7	0.0	0.6	10.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.1	0.0	47.1	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.3	0.0	14.2	0.0	1.0	0.0	0.6	4.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	3.0	5.8	60.8	115.6	4.4	7.1	0.0	1008.0	0.6
TWSG1	TSG	ENSG00000128791	"Twisted gastrulation BMP signaling modulator 1"	Q9GZX9	18	9334767-9402420	"Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014898	Uncertain		Supported	Centrosome,Cytosol	"Secreted - unknown location"	6600000	6600000	"Centrosome, Cytosol"		"HPA014898: AB_1858467"	"unprognostic (2.55e-1)"	"unprognostic (3.17e-2)"	"unprognostic (7.31e-2)"	"unprognostic (8.95e-3)"	"unprognostic (2.92e-3)"	"unprognostic (1.83e-1)"	"unprognostic (8.29e-2)"	"unprognostic (5.88e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.36e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.32e-2)"	13.0	8.9	8.3	6.9	8.5	2.9	17.3	5.0	6.2	21.9	17.4	9.3	56.2	4.7	33.0	21.5	19.0	14.4	16.4	9.2	8.4	7.1	19.8	4.8	12.6	6.6	11.0	6.1	20.4	4.4	12.7	11.4	10.7	9.1	26.5	10.2	10.6	9.4	34.8	6.1	7.6	8.6	36.0	12.3	9.4	12.0	13.0	8.1	4.3	20.5	8.7	6.8	26.0	17.9	3.3	7.8	7.5	4.1	4.1	7.5	3.1	14.8	5.4	15.6	7.7	30.8	27.9	7.2	28.4	35.4	15.6	22.5	5.7	19.6	2.1	14.4	37.5	5.2	15.2	11.2	28.9	5.8	4.3	3.8	4.6	2.8	27.4	2.7	8.0	28.2	9.2	13.1	6.3	24.2	5.8	3.9	40.0	4.5	3.0	3.4	5.1	4.4	5.3	16.0	1.3	17.7	19.9	2.0	5.4	22.3	6.2	6.0	7.0	6.5	20.0	28.7	14.4	26.9	17.7	5.8	5.1	4.0	17.6	3.9	10.1	7.5	4.1	5.8	6.7	2.2	4.4	3.3	3.2	6.8	7.8	2.8	3.8	7.5	2.0	4.1	0.7	7.8	1.4	3.1	8.3	8.5	5.0	6.2	8.4	7.1	11.0	6.1	9.1	8.1
UCMA	C10orf49	ENSG00000165623	"Upper zone of growth plate and cartilage matrix associated"	Q8WVF2	10	13221767-13234334	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 6.2;heart muscle: 3.2;ovary: 5.4;pituitary gland: 2.4"	"Cell line enhanced"	"Detected in single"		"THP-1: 3.5"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.7"	"Group enriched"	"Detected in some"	6	"amygdala: 6.2;basal ganglia: 3.7;cerebral cortex: 6.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA046718	Uncertain				"Secreted to extracellular matrix"					"HPA046718: "															"unprognostic (4.25e-1)"			0.0	0.0	6.2	0.2	3.7	0.0	0.0	0.2	6.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.3	3.2	0.7	0.2	0.0	0.1	0.5	0.0	0.1	0.9	5.4	0.0	0.0	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	3.7	0.2	6.1	0.7	0.2	0.1	0.9	0.0	0.0
UCN	"UI, UROC"	ENSG00000163794	Urocortin	P55089	2	27307400-27308445	"Predicted secreted proteins"	Hearing	Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 8.5"	"Cell line enhanced"	"Detected in many"		"U-266/70: 19.7"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in single"		"NK-cell: 2.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			CAB010911	Approved		Approved	"Endoplasmic reticulum"	"Secreted to blood"			"Endoplasmic reticulum"		"CAB010911: AB_261834"	"unprognostic (7.35e-2)"	"unprognostic (2.77e-1)"	"prognostic unfavourable (8.10e-4)"	"unprognostic (1.42e-2)"	"unprognostic (5.08e-2)"	"unprognostic (7.72e-2)"	"unprognostic (5.69e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.75e-2)"	"prognostic unfavourable (1.84e-7)"	"unprognostic (4.84e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.11e-1)"	1.1	2.8	4.6	1.3	5.5	2.4	1.0	3.1	4.5	0.9	0.7			0.8	1.9	1.4	0.6	1.9	2.0	4.2	4.7	3.8	0.7	3.2	1.6	1.6	3.1		2.3	1.8	0.0	2.2	2.4		1.2	0.0		1.3	0.9	8.5	0.8	1.2	1.0	2.8	3.0	0.5	1.5			1.5		0.4	0.5	0.4	0.0	0.0	0.0	0.7	2.9	0.9	0.2	1.2	2.6	0.4	0.7	1.2	1.1	5.2	0.4	1.0	0.4	0.4	0.2	2.1	1.0	0.6	0.4	0.4	0.5	0.3	0.0	3.3	4.4	2.4	1.6	2.1	3.1	0.2	2.6	1.5	2.0	0.2	2.4	0.0	2.3	1.9	0.1	1.9	1.2	7.0	4.4	2.8	3.4	2.3	1.5	0.1	0.5	0.8	2.3	1.1	0.1	5.7	1.1	3.2	0.2	0.8	4.9	1.5	1.9	19.7	2.1	0.7	3.8	5.6	1.4	0.0	0.7	0.0	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	2.9	0.4	0.0	0.6	0.2										
UCN2	"SRP, UCN-II, UCNI, URP"	ENSG00000145040	"Urocortin 2"	Q96RP3	3	48561727-48563773	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"skin 1: 18.6;vagina: 6.3"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 15.3;hTEC/SVTERT24-B: 12.1;SiHa: 10.5;U-251 MG: 11.2;WM-115: 31.0"	"Cancer enhanced"	"Detected in many"		"melanoma: 18.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA066841	Uncertain				"Secreted to blood"					"HPA066841: "	"unprognostic (7.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.92e-3)"	"unprognostic (2.02e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.93e-3)"	"unprognostic (2.52e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.34e-14)"	"unprognostic (4.39e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.88e-2)"	1.7	0.0	0.3	0.5	0.9	0.1	0.6	0.3	0.3	2.0	0.3	0.3	0.3	0.1	1.8	1.1	3.7	0.1	0.6	0.3	0.3	0.5	0.9	0.3	0.3	0.3	1.6	0.3	0.3	0.3	0.0	0.3	0.3	0.9	3.3	0.1	0.3	1.6	0.7	0.3	18.6	0.3	0.4	0.3	0.5	0.1	1.1	0.3	0.3	0.3	0.3	0.3	0.3	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.0	1.0	0.6	1.4	5.3	6.7	3.3	2.5	0.0	0.0	0.0	0.2	1.2	1.0	0.0	6.4	1.8	4.9	0.1	0.1	8.7	0.7	1.1	0.0	0.3	0.7	15.3	12.1	2.4	0.0	0.0	0.1	0.5	0.0	0.0	0.9	0.4	0.1	0.1	0.1	0.0	1.0	0.0	0.0	0.0	10.5	0.0	7.9	0.1	0.2	0.0	1.5	1.0	0.1	11.2	0.0	0.1	0.0	5.0	0.0	31.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.3	0.3	0.3	0.5	1.6	0.3	0.9	0.3
UCN3	"SPC, UCNIII"	ENSG00000178473	"Urocortin 3"	Q969E3	10	5365009-5374692	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 14.9;pancreas: 10.6;pituitary gland: 5.6;stomach 1: 4.6"	"Cell line enriched"	"Detected in single"	8	"SCLC-21H: 5.4"	"Group enriched"	"Detected in many"	5	"lung cancer: 5.1;pancreatic cancer: 15.4;stomach cancer: 3.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"hypothalamus: 5.9"	"Region enriched"	"Detected in single"	7	"hypothalamus: 4.7"	HPA038281	Uncertain				"Secreted to blood"					"HPA038281: AB_10672408"			"unprognostic (2.00e-2)"	"unprognostic (2.31e-1)"				"unprognostic (1.60e-1)"		"unprognostic (2.10e-1)"	"unprognostic (3.18e-3)"	"unprognostic (8.42e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.91e-2)"				0.1	0.9	0.1	0.1	0.4	0.0	0.1	0.4	0.4	0.1	14.4	0.1	0.1	11.6	0.1	0.1	0.1	1.2	1.2	0.1	0.1	1.7	0.8	0.1	1.3	0.1	0.1	0.5	0.1	10.6	0.0	5.6	0.1	1.6	0.2	3.1	0.3	0.1	0.1	0.1	0.0	14.9	0.1	0.5	0.1	4.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.0	5.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.4	0.4	0.1	1.7	0.1	0.5	1.6	0.1
UTS2B	"U2B, URP, UTS2D"	ENSG00000188958	"Urotensin 2B"	Q765I0	3	191267168-191330536	"Predicted secreted proteins"		Hormone		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in many"		"brain: 19.0"	"Cell line enhanced"	"Detected in many"		"PC-3: 7.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	7	"amygdala: 19.0"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 6.2;naive B-cell: 3.0"	"Lineage enriched"	"Detected in many"	5	"B-cells: 6.2"									HPA026992	Uncertain				"Secreted - unknown location"					"HPA026992: AB_1858703"	"unprognostic (1.73e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.77e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.58e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.10e-2)"	1.1	1.5	19.0	0.7	0.8	0.2	1.6	0.5	2.5	0.6	0.6	0.8	0.5	7.7	1.5	0.5	0.6	1.0	3.0	0.9	1.5	1.2	0.5	4.8	0.6	0.9	0.8	0.5	1.7	4.1	0.0	0.5	0.5	1.0	0.5	0.1	0.5	0.5	0.5	0.5	1.3	4.2	0.5	1.1	1.1	1.9	2.9	0.5	0.5	0.5	0.5	0.8	0.9	0.7	6.2	1.2	0.1	0.1	0.0	0.1	0.1	0.9	2.1	2.9	1.4	0.8	3.8	0.9	2.2	1.2	0.8	0.4	1.5	1.1	1.4	1.1	1.0	1.2	0.9	0.0	3.6	1.4	1.0	1.3	2.9	6.2	0.7	1.6	0.9	1.5	0.4	0.5	0.6	0.8	0.9	1.5	1.1	1.3	0.4	1.2	1.7	7.3	1.8	3.4	0.5	0.4	3.6	1.6	1.1	1.4	1.6	0.8	1.2	1.0	3.0	1.7	0.9	2.8	0.9	2.4	1.3	1.4	2.0	1.1	1.1	0.0	0.0	0.1	0.1	0.0	0.0	6.2	0.1	0.0	0.0	3.0	0.1	0.1	0.1	0.0	0.1	1.2	0.1	0.1	19.0	0.8	0.5	2.5	1.5	1.2	0.8	0.5	1.0	0.5
VEGFC	VRP	ENSG00000150630	"Vascular endothelial growth factor C"	P49767	4	176683538-176792727	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins, Transporters"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 20.1"	"Cell line enhanced"	"Detected in many"		"BJ: 41.2;HBF TERT88: 33.5;hTEC/SVTERT24-B: 33.7;LHCN-M2: 37.2"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in single"	12	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to blood"	50000	50000				"unprognostic (4.18e-1)"	"unprognostic (4.07e-2)"	"unprognostic (4.84e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.57e-1)"	"prognostic unfavourable (7.88e-5)"	"unprognostic (4.53e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavourable (1.17e-4)"	"unprognostic (1.89e-3)"	"unprognostic (4.41e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.22e-1)"	8.9	2.0	0.5	1.9	2.0	0.0	20.1	1.5	1.9	4.8	4.5	0.7	2.9	0.8	6.2	1.5	5.5	5.1	7.7	5.9	0.8		1.5	1.7	16.0	3.5	0.0	0.1	3.9	0.5	0.6	0.0	11.6	1.6	4.8	1.6	3.4	4.3	2.7	6.2	0.2	1.6	3.8	1.7	2.6	0.4	2.4	0.4	0.3	17.7	3.4	2.3	6.8	9.2	0.0	0.0	1.2	0.0	0.0	0.0	0.1	1.5	0.8	0.5	0.0	7.5	7.5	0.0	41.2	24.9	23.0	18.3	0.0	0.2	0.0	0.0	23.2	1.2	0.3	15.5	33.5	0.0	0.8	0.0	1.1	0.0	4.1	0.0	0.0	8.0	0.7	33.7	23.5	14.1	0.0	0.0	37.2	0.6	0.0	0.0	0.3	13.5	0.0	2.4	0.0	0.0	0.9	0.0	0.0	0.6	0.9	0.0	0.2	0.0	6.8	24.4	2.6	6.0	11.6	0.0	0.0	0.0	10.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1										
VEGFD	"FIGF, VEGF-D"	ENSG00000165197	"Vascular endothelial growth factor D"	O43915	X	15345591-15384376	"Cancer-related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 39.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 7.1;ASC TERT1: 5.9;EFO-21: 2.6;HSkMC: 5.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA027342	Uncertain				"Secreted to blood"	340000	340000			"HPA027342: AB_1848597"	"unprognostic (5.90e-2)"	"unprognostic (9.79e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.07e-1)"	"unprognostic (6.06e-3)"	"unprognostic (5.57e-2)"	"unprognostic (2.24e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.59e-5)"	"unprognostic (3.08e-2)"	"unprognostic (2.03e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.75e-2)"	9.5	7.4	0.6	1.8	1.0	0.1	19.5	1.1	0.7	10.5	7.6	0.2	4.1	1.1	10.1	12.9	15.4	2.7	3.5	27.8	0.6	1.1	1.0	1.3	39.0	0.7	0.8	0.2	7.3	2.6	0.2	4.4	0.2	0.8	22.2	1.9	0.2	1.5	1.8	12.0	0.5	4.3	9.8	0.6	2.3	3.4	14.9	0.1	0.0	2.0	17.5	1.2	12.3	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.1	1.8	7.1	5.9	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.3	2.6	0.0	0.5	0.5	0.0	0.0	0.0	0.1	0.0	1.5	0.6	0.4	0.0	0.8	5.9	0.7	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.5	0.5	0.4	0.3	0.1	0.6	0.0	0.7	0.3	0.0	0.1	0.3	0.3	0.4	1.1	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	1.1	0.7	0.6	1.1	0.8	0.2	0.8	0.1
VGF	"SCG7, SgVII"	ENSG00000128564	"VGF nerve growth factor inducible"	O15240	7	101162509-101165593	"Plasma proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial, Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 59.4;pituitary gland: 30.4"	"Cell line enhanced"	"Detected in some"		"SH-SY5Y: 35.9;SK-MEL-30: 96.8;U-2 OS: 17.6;WM-115: 29.0"	"Cancer enriched"	"Detected in many"	6	"melanoma: 236.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA055177, HPA072505"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"	2800000	2800000	"Golgi apparatus, Vesicles"		"HPA055177: AB_2682728, HPA072505: AB_2686528"	"unprognostic (3.04e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.19e-3)"	"prognostic unfavourable (4.25e-4)"	"prognostic unfavourable (3.31e-4)"	"unprognostic (1.51e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.25e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.84e-3)"	"unprognostic (3.70e-3)"	"unprognostic (9.82e-3)"	"unprognostic (3.79e-1)"	"unprognostic (7.23e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.21e-1)"	3.8	3.1	10.9	2.3	25.2	1.3	1.1	1.3	59.4	1.1	1.5	1.3	0.0	1.3	2.2	1.1	1.1	1.1	1.2	1.2	12.2	51.0	1.4	1.1	1.1	1.1	3.9	22.8	1.1	6.2	1.1	30.4	1.2	41.2	1.2	1.2	0.5	1.1	1.1	1.1	1.4	1.3	1.5	6.6	1.2	3.6	1.4	0.5	0.0	1.2	0.0	1.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	1.9	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.6	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.0	0.0	0.1	0.0	0.7	0.4	0.0	4.6	0.0	0.4	3.6	0.4	0.1	0.0	0.0	0.0	0.0	2.9	35.9	0.0	0.1	96.8	0.0	0.0	0.0	0.0	17.6	0.0	0.4	0.0	0.1	0.9	2.8	0.0	29.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	25.2	1.3	59.4	12.2	51.0	3.9	22.8	41.2	0.5
VMO1		ENSG00000182853	"Vitelline membrane outer layer 1 homolog"	Q7Z5L0	17	4785285-4786433	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 37.9"	"Cell line enhanced"	"Detected in many"		"A549: 6.0;MCF7: 7.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	9	"non-classical monocyte: 37.9"	"Lineage enriched"	"Detected in many"	9	"monocytes: 37.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA023038	Uncertain				"Secreted to blood"	1200000	1200000			"HPA023038: AB_10964632"	"unprognostic (1.30e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.65e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.77e-2)"	"unprognostic (5.58e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.41e-2)"	"unprognostic (4.23e-1)"	"prognostic unfavourable (1.34e-6)"	"unprognostic (1.10e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.69e-1)"	3.8	1.3	1.6	5.9	1.4	1.5	1.9	1.2	2.8	2.6	1.4	1.7	0.4	4.4	1.1	1.9	1.1	0.5	2.8	7.1	1.8	2.1	2.1	9.2	7.4	4.9	1.9	1.4	1.1	2.3	21.2	19.9	1.9	3.6	1.7	0.5	13.1	2.9	1.4	8.8	1.3	4.6	1.0	3.3	21.1	0.8	0.9	1.9	1.4	0.7	2.8	1.2	3.5	1.8	0.0	4.4	0.0	37.9	0.1	0.0	1.1	0.5	6.0	0.6	3.6	0.8	1.5	0.7	1.1	2.1	0.3	0.7	1.9	2.3	0.2	0.1	0.3	1.0	0.0	0.9	0.4	4.3	0.9	0.2	1.1	1.5	1.2	0.0	2.8	1.0	0.9	0.2	0.9	0.0	0.6	0.9	1.2	7.7	0.0	1.7	1.5	2.3	1.3	2.7	0.6	0.0	1.4	0.5	0.9	0.4	0.5	0.6	2.2	0.2	0.6	2.6	0.2	0.7	0.4	0.1	0.5	0.1	1.0	1.3	1.7	0.0	0.1	0.0	0.0	3.1	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.1	37.9	0.0	0.0	1.1	1.6	1.4	1.2	2.8	1.8	2.1	1.9	1.4	3.6	1.9
VSTM2A	"MGC33530, VSTM2"	ENSG00000170419	"V-set and transmembrane domain containing 2A"	Q8TAG5	7	54542325-54571080	"Plasma proteins, Predicted secreted proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 13.7;brain: 51.7;prostate: 13.7"	"Group enriched"	"Detected in some"	6	"Karpas-707: 3.3;SCLC-21H: 10.2;SH-SY5Y: 7.1"	"Cancer enhanced"	"Detected in some"		"breast cancer: 4.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"						"unprognostic (1.15e-1)"		"unprognostic (1.02e-1)"		"unprognostic (1.89e-1)"						"unprognostic (1.14e-2)"	"unprognostic (4.66e-1)"	"prognostic favourable (5.34e-4)"	"unprognostic (4.34e-2)"	"unprognostic (6.79e-2)"		"unprognostic (7.15e-2)"	0.7	13.7	18.4	0.7	22.7	0.7	1.1	0.5	51.7	0.7	6.0	1.4	0.0	2.4	0.7	0.7	0.7	0.7	0.9	0.7	9.4	15.5	0.8	0.7	0.8	0.7	4.4	13.6	0.7	1.8	0.7	0.4	0.7	6.7	13.7	5.8	1.1	0.7	0.7	0.8	0.7	1.1	0.8	3.2	0.7	7.2	1.2	3.0	0.0	0.7	0.0	0.7	0.9	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	10.2	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	18.4	22.7	0.5	51.7	9.4	15.5	4.4	13.6	6.7	3.0
VSTM2L	"C20orf102, dJ1118M15.2"	ENSG00000132821	"V-set and transmembrane domain containing 2 like"	Q96N03	20	37903104-37945350	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 26.3;HDLM-2: 36.0;hTCEpi: 9.3;SK-BR-3: 32.2"	"Group enriched"	"Detected in all"	5	"lung cancer: 23.6;pancreatic cancer: 34.4;prostate cancer: 72.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043832	Uncertain				"Secreted - unknown location"					"HPA043832: AB_10968449"	"unprognostic (1.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.33e-2)"	"prognostic unfavourable (1.63e-5)"	"unprognostic (4.96e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.34e-3)"	"unprognostic (9.86e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.85e-3)"	"unprognostic (1.29e-3)"	"unprognostic (1.68e-1)"	"unprognostic (9.66e-2)"	"prognostic unfavourable (8.14e-4)"	1.6	7.5	29.3	1.6	22.7	0.8	1.4	7.0	44.8	14.0	1.8	1.8	21.4	2.0	1.6	11.5	1.6	17.5	18.9	25.6	34.9	23.5	1.1	2.5	4.5	1.2	10.7	17.6	0.9	3.5	0.9	6.9	1.6	9.7	6.0	1.3	3.6	3.8	19.8	1.0	1.0	1.4	1.7	6.2	18.6	8.9	2.5	1.5	0.0	1.3	0.0	1.8	1.2	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.1	0.1	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.1	26.3	0.0	0.1	0.2	0.0	0.0	1.2	0.0	36.0	0.6	0.0	0.0	0.0	1.4	0.0	0.9	1.3	9.3	0.0	0.2	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.1	0.0	0.0	1.0	8.7	1.0	32.2	0.3	0.1	0.0	1.6	0.0	0.2	0.0	0.5	0.1	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.3	22.7	7.0	44.8	34.9	23.5	10.7	17.6	9.7	1.5
VTN	VN	ENSG00000109072	Vitronectin	P04004	17	28367276-28373091	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	42	"liver: 321.7"	"Cell line enriched"	"Detected in some"	11	"CACO-2: 164.9"	"Cancer enriched"	"Detected in many"	85	"liver cancer: 2216.6"					"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016695, CAB016765, HPA060933"	Supported		Supported	"Endoplasmic reticulum,Vesicles"	"Secreted to blood"	32000000000	32000000000	"Endoplasmic reticulum, Vesicles"		"CAB016695: AB_1624536, CAB016765: , HPA060933: "	"unprognostic (1.19e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.29e-2)"	"unprognostic (6.13e-2)"	"unprognostic (9.74e-2)"	"unprognostic (8.42e-2)"	"prognostic favourable (3.74e-4)"	"unprognostic (6.20e-2)"	"unprognostic (3.97e-1)"	"unprognostic (8.95e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavourable (4.10e-11)"	"unprognostic (8.82e-3)"	"unprognostic (2.27e-1)"	"unprognostic (4.86e-3)"	"unprognostic (7.09e-2)"	0.2	7.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	3.6	2.2	0.0	0.0	0.0	321.7	0.0	0.0	0.0		0.0	0.6	0.0	0.0	2.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4			0.0		0.0	0.0	0.0	0.3	0.2	0.6	0.2	0.7	2.1	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.7	0.2	0.1	0.1	0.0	164.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	8.5	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	15.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	1.0	0.0	0.9	0.0	0.9	0.9	0.1	0.3	0.6	2.1	0.6	0.7	0.0	0.2	0.0	0.1										
VWA7	"C6orf27, G7c, NG37"	ENSG00000204396	"Von Willebrand factor A domain containing 7"	Q9Y334	6	31765590-31777294	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 19.6;pituitary gland: 20.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.1;HeLa: 3.3;Karpas-707: 3.0;RPTEC TERT1: 2.2;U-266/70: 4.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"cerebellum: 7.8;pons and medulla: 4.1"	"Low region specificity"	"Detected in many"			"HPA046954, HPA054262"	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted - unknown location"			"Plasma membrane, Cytosol"		"HPA046954: , HPA054262: "	"unprognostic (9.13e-2)"	"unprognostic (8.60e-4)"	"unprognostic (9.99e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.85e-3)"	"unprognostic (4.96e-3)"	"unprognostic (6.38e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.68e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.25e-2)"	"prognostic favourable (4.35e-8)"	"unprognostic (3.75e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.48e-2)"	"unprognostic (7.66e-2)"	1.1	1.6	3.1	1.4	9.5	1.1	1.2	5.6	10.5	1.1	1.9	0.0	3.9	2.6	4.6	3.0	1.1	19.6	2.0	3.9	1.6	5.5	5.6	1.5	2.5	1.2	1.7	5.4	1.4	2.5	5.1	20.5	1.0	9.7	1.3	1.7	0.8	1.7	2.0	5.3	1.7	3.3	2.3	2.3	1.3	5.8	1.3	2.3	0.0	1.8	0.6	1.3	1.3	0.8	0.2	0.0	1.2	0.0	0.0	0.4	0.0	0.4	1.1	0.4	0.4	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.1	2.1	0.5	0.7	0.3	0.9	0.7	0.2	0.0	0.0	0.0	0.1	3.3	0.5	0.1	0.0	0.9	0.1	0.9	0.1	0.0	0.0	0.2	3.0	0.0	0.2	0.0	0.5	0.0	0.1	0.3	0.0	2.0	2.2	0.0	0.3	0.1	0.4	0.1	0.0	0.1	0.1	0.0	0.3	0.8	0.0	0.1	4.4	1.2	0.1	0.0	0.6	0.1	1.2	0.0	0.0	0.3	0.0	0.0	0.2	0.2	0.2	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.4	0.0	3.1	9.5	5.6	10.5	1.6	5.5	1.7	5.4	9.7	2.3
VWC2	"PSST739, UNQ739"	ENSG00000188730	"Von Willebrand factor C domain containing 2"	Q2TAL6	7	49773661-49921950	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 17.0;heart muscle: 12.8;ovary: 12.5"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.4;U-266/70: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA055243	Approved				"Secreted to extracellular matrix"					"HPA055243: "	"unprognostic (3.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.90e-4)"	"unprognostic (8.97e-2)"	"unprognostic (8.77e-2)"	"unprognostic (1.56e-3)"		"unprognostic (3.41e-2)"		"unprognostic (4.11e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.69e-4)"	"unprognostic (1.60e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.94e-1)"	"unprognostic (9.70e-3)"	0.5	0.3	3.6	0.4	3.9	0.4	0.5	17.0	6.9	0.6	0.5	1.4	0.0	0.5	1.9	0.4	0.5	0.8	0.5	12.8	1.7	2.8	0.4	0.3	0.6	0.4	2.1	1.8	12.5	0.3	0.3	0.2	0.3	3.8	0.4	0.5	0.6	0.4	0.5	0.4	1.2	0.7	1.5	0.8	0.6	0.4	0.5	0.8	0.0	0.4	0.0	0.3	0.4	0.2	0.1	0.0	0.9	0.4	1.0	0.1	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.4	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.2	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.9	1.0	0.2	0.0	0.0	0.0	3.6	3.9	17.0	6.9	1.7	2.8	2.1	1.8	3.8	0.8
VWC2L		ENSG00000174453	"Von Willebrand factor C domain containing protein 2 like"	B2RUY7	2	214411065-214578959	"Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"brain: 8.9;pituitary gland: 2.3"	"Cell line enhanced"	"Detected in single"		"AF22: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA044815, HPA059414"	Uncertain				"Secreted - unknown location"					"HPA044815: AB_10962359, HPA059414: "	"unprognostic (8.77e-2)"				"unprognostic (2.83e-3)"			"unprognostic (2.05e-2)"		"unprognostic (8.49e-2)"	"unprognostic (1.51e-3)"	"unprognostic (4.36e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.05e-1)"		"unprognostic (3.89e-1)"		0.3	0.3	1.9	0.3	3.2	0.3	0.3	0.2	8.9	0.3	0.3	0.0	0.0	0.3	0.3	0.5	0.3	0.4	0.3	0.3	2.4	6.6	0.3	0.3	0.5	0.3	3.9	2.9	0.3	0.3	0.3	2.3	0.3	6.6	0.4	0.3	0.1	0.3	0.4	0.5	0.4	0.3	0.3	1.0	0.3	0.4	0.5	0.0	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	3.2	0.2	8.5	2.4	6.6	3.9	2.9	6.6	0.0
VWF	F8VWF	ENSG00000110799	"Von Willebrand factor"	P04275	12	5948874-6124770	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Cell adhesion, Hemostasis"		"Cancer-related genes, Disease mutation, FDA approved drug targets, von Willebrand disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 91.7"	"Cell line enriched"	"Detected in some"	57	"HUVEC TERT2: 111.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB001694, HPA001815, HPA002082, CAB072874, CAB072875"	Supported				"Secreted to blood"	6400000000	6400000000			"CAB001694: , CAB072874: , CAB072875: , HPA001815: AB_1080574, HPA002082: AB_1080575"	"unprognostic (3.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.91e-3)"	"unprognostic (7.09e-2)"	"unprognostic (4.63e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.92e-2)"	"unprognostic (4.69e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavourable (2.31e-4)"	"unprognostic (1.55e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.73e-3)"	91.7	3.1	6.1	9.7	8.1	0.8	41.5	3.7	8.6	19.7	13.9	7.3	6.8	6.6	21.5	16.7	14.4	15.1	15.3	38.7	7.4	5.0	4.6	1.5	41.2	9.9	9.4	7.1	13.6	5.8	17.7	2.6	36.4	10.2	18.7	5.1	26.3	7.2	10.5	28.9	8.1	11.8	22.1	7.4	19.0	9.6	12.7	5.9	1.8	18.6	13.2	6.5	18.9	35.0	0.0	0.0	1.3	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	111.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.8	6.1	8.1	3.7	8.6	7.4	5.0	9.4	7.1	10.2	5.9
WFDC1	PS20	ENSG00000103175	"WAP four-disulfide core domain 1"	Q9HC57	16	84294646-84329851	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 64.5"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 18.7;BJ: 12.8;HEL: 10.7;HeLa: 17.1;THP-1: 6.2;U-937: 6.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031411	Uncertain				"Secreted to extracellular matrix"					"HPA031411: AB_10600921"	"unprognostic (6.53e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.61e-2)"	"unprognostic (8.66e-4)"	"unprognostic (1.41e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.47e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.78e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.74e-2)"	"unprognostic (3.04e-1)"	3.9	12.0	6.3	4.2	5.5	0.9	1.9	7.0	5.9	15.8	28.8	2.2	12.0	3.9	11.4	8.3	10.6	3.4	64.5	2.8	5.5	5.0	8.7	1.9	16.0	2.5	3.7	4.3	3.3	0.6	0.3	2.2	40.7	1.9	29.9	7.5	43.8	4.2	50.6	1.2	1.1	6.6	47.5	1.7	1.9	8.9	9.4	0.7	0.0	2.0	4.6	2.2	30.3	5.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.8	18.7	0.0	0.1	0.1	12.8	1.5	0.0	0.0	0.0	0.0	0.0	3.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	10.7	17.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.2	0.2	0.0	0.0	1.4	0.0	0.0	3.5	0.1	0.0	0.3	2.0	0.1	6.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.3	5.5	7.0	5.9	5.5	5.0	3.7	4.3	1.9	0.7
WFDC10A	"C20orf146, dJ688G8.3, WAP10"	ENSG00000180305	"WAP four-disulfide core domain 10A"	Q9H1F0	20	45629526-45631196	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	25	"epididymis: 62.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.1;CACO-2: 2.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebral cortex: 1.6"	"Cell type enriched"	"Detected in single"	7	"naive CD4 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	8	"T-cells: 1.2"					"Not detected"	"Not detected"								"Secreted in male reproductive system"								"unprognostic (1.76e-1)"											"unprognostic (2.95e-1)"				0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	2.5	0.0	0.1	62.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.0	1.2	0.9	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.1	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.0
WFDC11	WAP11	ENSG00000180083	"WAP four-disulfide core domain 11"	Q8NEX6	20	45648563-45670270	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"epididymis: 46.2"	"Group enriched"	"Detected in some"	5	"HeLa: 12.7;RPMI-8226: 7.7"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"basophil: 4.7"	"Low lineage specificity"	"Detected in many"																"Secreted in male reproductive system"																							0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0			0.0	0.1	46.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	8.6			0.0		0.0	0.4	0.0	0.8	0.7	4.7	0.4	1.3	0.8	0.1	0.2	1.1	0.0	0.2	0.6	0.8	1.2	1.1	0.1	0.0	0.0	0.7	0.3	0.6	0.4	0.0	0.6	0.0	0.2	0.0	0.0	0.8	1.1	12.7	0.8	0.0	0.6	0.8	0.3	0.0	0.0	0.2	0.0	0.6	0.2	0.0	0.2	0.5	1.1	1.1	0.6	0.2	0.5	7.7	0.0	0.4	0.1	0.0	0.0	0.4	0.0	0.1	1.1	0.0	0.2	0.7	0.3	0.1	0.5	0.5	0.0	0.1	2.1	0.3	4.7	0.4	0.2	0.4	0.2	0.4	0.3	0.3	0.3	0.1	0.8	0.4	0.8	1.2	1.3	0.2	0.7	0.0	0.1										
WFDC12	"C20orf122, dJ211D12.4, WAP2"	ENSG00000168703	"WAP four-disulfide core domain 12"	Q8WWY7	20	45123425-45124465	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 26.9;skin 1: 30.5"	"Low cell line specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"head and neck cancer: 18.9;melanoma: 14.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"																"Secreted - unknown location"	20000	20000					"unprognostic (3.52e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.18e-2)"		"unprognostic (5.42e-2)"		"unprognostic (2.25e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.40e-3)"	"unprognostic (1.72e-2)"	"unprognostic (8.70e-3)"	"prognostic unfavourable (5.65e-4)"	"unprognostic (4.49e-2)"		"unprognostic (3.91e-1)"	"unprognostic (5.50e-3)"	0.1	0.0	0.1	0.1	0.1	0.5	1.9	0.1	0.1	1.5	0.1	0.1	26.9	0.2	0.1	1.2	6.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	3.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	1.3	0.0	0.1	1.8	4.1	0.2	30.5	0.1	0.1	0.1	0.1	0.0	1.0	0.1	2.2	0.1	6.4	0.9	0.1	10.0	0.8	0.3	0.9	0.4	0.0	1.1	0.0	0.8	0.6	0.3	0.5	3.4	0.4	1.3	0.3	1.7	0.2	1.6	0.6	0.4	0.8	0.3	0.4	0.6	0.3	0.9	2.3	1.5	0.0	0.0	1.1	1.2	1.3	0.0	1.3	0.0	0.3	1.4	0.9	1.0	0.9	1.2	1.1	0.4	0.4	1.3	1.6	0.4	0.3	1.9	0.4	2.1	0.5	0.0	0.2	0.0	1.0	0.0	0.6	2.5	0.0	0.2	0.4	1.2	1.2	1.3	1.3	1.3	0.9	3.2	0.6	0.1	0.4	0.9	0.1	0.4	1.1	0.3	0.1	0.2	0.1	0.8	0.4	0.3	0.3	0.0	0.3	0.3	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
WFDC13	"C20orf138, dJ601O1.3, WAP13"	ENSG00000168634	"WAP four-disulfide core domain 13"	Q8IUB5	20	45702016-45708817	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	11	"epididymis: 92.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.9;RT4: 3.3;U-87 MG: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"naive CD4 T-cell: 3.1"	"Lineage enriched"	"Detected in single"	7	"T-cells: 3.1"														"Secreted in male reproductive system"						"unprognostic (2.53e-1)"		"unprognostic (1.30e-2)"					"unprognostic (7.84e-3)"		"unprognostic (7.96e-3)"	"unprognostic (2.04e-1)"		"unprognostic (1.02e-11)"	"unprognostic (1.17e-1)"		"unprognostic (1.44e-2)"	"unprognostic (2.22e-2)"	0.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.2	0.0	8.3	0.0	0.1	92.8	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.1	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	3.3	0.3	0.0	0.0	0.0	0.4	0.0	3.1	1.3	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.4	1.9	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.2	0.0	3.3	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.3	0.0	0.6	0.1	0.1	0.1	0.0	0.0	0.0
WFDC5	"dJ211D12.5, WAP1"	ENSG00000175121	"WAP four-disulfide core domain 5"	Q8TCV5	20	45109452-45115172	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"skin 1: 99.0"	"Group enriched"	"Detected in some"	4	"HBEC3-KT: 2.4;Karpas-707: 3.7;RT4: 3.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 17.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"												"Secreted in other tissues"							"unprognostic (1.32e-1)"				"unprognostic (3.22e-2)"		"unprognostic (3.05e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.28e-4)"	"unprognostic (6.59e-2)"	"unprognostic (2.23e-2)"	"prognostic unfavourable (2.32e-5)"	"unprognostic (4.12e-2)"		"unprognostic (2.17e-1)"	"unprognostic (5.96e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.4	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.4	0.7	0.2	99.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	1.8	0.0	22.6	11.4	0.2	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.6	0.0	2.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.1	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
WFDC6	"C20orf171, dJ461P17.11, WAP6"	ENSG00000243543	"WAP four-disulfide core domain 6"	Q9BQY6	20	45534196-45539495	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"epididymis: 79.9;testis: 25.5"	"Cell line enriched"	"Detected in some"	4	"U-87 MG: 7.6"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in male reproductive system"						"unprognostic (3.68e-3)"			"unprognostic (2.21e-3)"				"unprognostic (1.26e-2)"		"unprognostic (8.74e-2)"					"unprognostic (2.91e-2)"			0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.1	0.1	0.1	7.6	0.0	0.2	79.9	0.1	2.8	0.1	0.1	0.1	0.0	0.1	0.1	0.8	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.4	0.1	0.3	0.1	0.1	0.1	0.1	0.0	25.5	0.1	0.1	0.3	0.1	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
WFDC8	"C20orf170, dJ461P17.1, WAP8"	ENSG00000158901	"WAP four-disulfide core domain 8"	Q8IUA0	20	45551153-45579326	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"epididymis: 103.1"	"Cell line enriched"	"Detected in some"	6	"U-87 MG: 7.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			"HPA042710, HPA071119"	Enhanced				"Secreted in male reproductive system"					"HPA042710: AB_2732501, HPA071119: AB_2732172"				"unprognostic (5.63e-3)"						"unprognostic (1.09e-2)"				"unprognostic (2.34e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.07e-2)"		0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.0	0.0	5.6	0.0	1.0	103.1	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.7	0.0	0.0	0.1	0.1	1.0	0.6	1.0	0.9	0.7	0.4	0.9	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.1	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	7.7	0.0	0.1	0.6	0.9	0.2	0.3	0.3	0.2	0.2	0.2	0.1	0.1	1.0	0.4	0.4	1.0	0.7	0.4	0.6	0.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
WFIKKN1	"C16orf12, RJD2, WFDC20A, WFIKKN"	ENSG00000127578	"WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1"	Q96NZ8	16	629239-634116	"Predicted secreted proteins"		"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.8;lymphoid tissue: 5.1"	"Cell line enhanced"	"Detected in some"		"EFO-21: 9.7;Hep G2: 2.1;NTERA-2: 2.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"						"unprognostic (3.12e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.28e-2)"	"unprognostic (3.36e-2)"	"unprognostic (4.45e-2)"	"unprognostic (8.53e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.78e-3)"	"unprognostic (1.19e-1)"	"unprognostic (5.56e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.50e-3)"	"unprognostic (4.70e-5)"	0.7	0.2	1.3	0.3	2.4	0.4	0.3	5.8	1.9	0.7	1.4	0.3	0.3	0.2	1.3	0.3	0.3	0.2	0.3	0.3	1.0	0.2	1.3	0.6	1.3	0.3	0.4	2.3	0.5	1.2	0.2	1.5	0.5	0.3	0.6	0.2	0.3	0.5	0.3	1.0	0.7	0.4	0.3	0.3	1.6	1.2	1.0	0.3	5.1	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.6	0.7	0.0	0.0	0.4	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.6	2.9	0.5	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.3	0.0	0.1	0.0	0.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	1.3	2.4	5.8	1.9	1.0	0.2	0.4	2.3	0.3	0.3
WISP1	"CCN4, WISP-1, WISP1-OT1, WISP1-UT1"	ENSG00000104415	"WNT1 inducible signaling pathway protein 1"	O95388	8	133191039-133231690	"Cancer-related genes, Predicted secreted proteins"	"Cell adhesion, Wnt signaling pathway"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HHSteC: 7.9;HSkMC: 44.5;hTEC/SVTERT24-B: 25.4;U-2197: 24.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"olfactory region: 11.9"	"Not detected"	"Not detected"			"HPA007121, CAB012205"	Uncertain		Approved	Cytosol	"Secreted to extracellular matrix"			Cytosol		"CAB012205: , HPA007121: AB_1858844"	"unprognostic (7.77e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.20e-1)"	"unprognostic (7.72e-2)"	"unprognostic (6.63e-2)"	"unprognostic (8.61e-3)"	"unprognostic (3.26e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.41e-3)"	"unprognostic (3.01e-2)"	"unprognostic (2.67e-1)"	"prognostic unfavourable (1.91e-5)"	"unprognostic (7.52e-3)"	"unprognostic (2.55e-3)"	"unprognostic (6.03e-2)"	"unprognostic (5.67e-3)"	4.2	11.0	0.6	7.7	1.6	0.0	2.3	0.6	2.9	14.7	3.9	1.0	0.0	1.2	18.5	6.4	2.2	6.5	8.5	4.0	0.7	0.3	18.0	2.9	8.9	13.4	0.8	0.4	13.0	1.0	0.2	2.7	3.5	1.2	3.4	0.9	4.5	1.3	4.2	2.0	1.6	3.9	14.4	6.2	14.6	3.8	3.7	0.4	0.3	1.3	2.7	4.2	14.4	4.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.0	1.7	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	44.5	0.0	25.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.9	0.3	24.3	0.0	0.0	0.0	0.0	4.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.6	1.6	0.6	2.9	0.7	0.3	0.8	0.4	1.2	0.4
WISP2	"CCN5, CT58, CTGF-L"	ENSG00000064205	"WNT1 inducible signaling pathway protein 2"	O76076	20	44714844-44728509	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 109.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 9.8;ASC TERT1: 26.3;HeLa: 14.7;HSkMC: 10.6;U-2197: 83.9"	"Cancer enhanced"	"Detected in many"		"melanoma: 8.8"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB019273	Approved				"Secreted to extracellular matrix"	400000	400000			"CAB019273: "	"unprognostic (1.87e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.53e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.95e-3)"	"unprognostic (1.76e-10)"	"unprognostic (1.55e-3)"	"unprognostic (7.21e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.28e-1)"	57.0	6.5	0.2	2.0	2.2	0.4	32.7	0.1	0.5	109.7	4.7	0.6	8.6	0.6	7.0	12.4	47.1	5.5	8.4	29.7	0.3	0.0	0.5	0.9	25.6	0.9	0.1	1.4	48.4	1.8	0.7	0.0	0.9	0.2	20.1	0.9	0.5	4.3	8.9	18.0	30.6	1.4	22.0	0.2	0.5	1.4	37.7	0.4	0.0	2.5	3.7	0.6	18.2	18.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	9.8	26.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.0	0.0	0.0	0.0	83.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	2.2	0.1	0.5	0.3	0.0	0.1	1.4	0.2	0.4
WNT1	INT1	ENSG00000125084	"Wnt family member 1"	P04628	12	48978453-48981676	"Cancer-related genes, Disease related genes, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes, Disease mutation, Osteogenesis imperfecta, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 7.7;brain: 6.5;placenta: 17.5"	"Cell line enhanced"	"Detected in single"		"CACO-2: 2.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"basal ganglia: 6.5;cerebral cortex: 1.8"	"Group enriched"	"Detected in some"	8	"gdT-cell: 5.3;MAIT T-cell: 7.7;memory CD4 T-cell: 3.0;memory CD8 T-cell: 4.8;naive CD8 T-cell: 3.2"	"Lineage enriched"	"Detected in single"	24	"T-cells: 7.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"cerebral cortex: 1.3;hippocampal formation: 1.5;midbrain: 3.5;olfactory region: 2.1"						"Secreted to extracellular matrix"						"unprognostic (2.02e-2)"	"unprognostic (5.80e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.65e-3)"	"unprognostic (5.29e-3)"	"unprognostic (5.68e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.08e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.35e-3)"	"unprognostic (2.76e-2)"	0.3	0.1	0.4	1.5	6.5	2.3	0.3	0.3	2.9	0.3	0.3	0.3	0.3	1.5	0.3	0.3	0.5	0.1	0.7	0.3	0.6	0.5	0.3	0.3	0.7	2.9	0.3	0.3	0.3	0.3	0.0	0.3	17.5	0.3	0.3	0.0	0.3	1.2	0.3	0.3	0.0	1.8	0.3	0.3	1.9	1.2	1.4	0.3	0.3	0.3	0.3	0.3	0.6	0.3	0.3	0.0	0.0	0.0	0.0	7.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.7	0.2	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	7.7	0.3	3.0	4.8	0.0	0.0	0.5	3.2	0.0	0.0	0.0	0.0	0.4	0.8	0.4	6.5	0.3	1.8	0.6	0.5	0.3	0.3	0.3	0.3
WNT10B	"SHFM6, WNT-12"	ENSG00000169884	"Wnt family member 10B"	O00744	12	48965340-48971763	"Disease related genes, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.4"	"Cell line enhanced"	"Detected in many"		"K-562: 8.0;T-47d: 9.5;U-266/84: 8.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.6"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA055048, HPA062539"	Enhanced		Approved	"Golgi apparatus"	"Secreted to extracellular matrix"			"Golgi apparatus"		"HPA055048: , HPA062539: "	"unprognostic (1.13e-1)"	"unprognostic (2.14e-2)"	"unprognostic (5.73e-4)"	"unprognostic (2.27e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.33e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.99e-3)"	"unprognostic (3.05e-2)"	"unprognostic (5.39e-6)"	"unprognostic (4.29e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.50e-1)"	"unprognostic (1.25e-1)"	2.3	0.6	10.9	2.6	23.4	2.1	1.8	0.0	14.3	0.5	1.7	0.5	3.0	2.8	0.4	3.2	1.5	0.6	1.1	1.2	7.3	4.9	0.2	0.3	1.3	3.0	3.0	7.2	1.2	0.0	0.1	1.1	7.0	4.1	1.0	1.6	0.7	1.7	1.4	1.6	5.0	3.3	2.0	0.8	2.9	2.0	1.7	0.3	0.2	0.5	1.2	2.9	1.8	1.6	0.0	0.0	0.0	0.0	0.0	1.6	0.2	2.1	1.3	0.0	2.0	0.0	0.0	5.3	1.5	2.8	0.6	0.2	4.1	4.6	0.0	0.4	0.3	2.5	5.5	0.4	0.2	1.2	7.2	2.4	1.7	0.1	0.0	0.8	3.4	0.0	0.4	0.1	2.5	0.0	8.0	0.3	0.8	2.7	0.1	2.8	0.0	2.9	0.0	0.7	2.5	0.0	0.5	0.1	0.0	0.3	0.2	0.7	9.5	3.1	0.0	3.0	5.9	0.4	0.7	3.0	8.5	0.0	1.2	6.1	0.2	0.0	0.0	0.0	1.6	0.0	0.9	0.0	0.0	0.5	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.2	10.9	23.4	0.0	13.9	7.3	4.9	3.0	7.2	4.1	0.3
WNT2	"INT1L1, IRP"	ENSG00000105989	"Wnt family member 2"	P09544	7	117276631-117323289	"Cancer-related genes, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 10.4;lung: 10.9;placenta: 40.9"	"Cell line enriched"	"Detected in some"	5	"U-2197: 21.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 12.6"	"Low region specificity"	"Detected in all"			HPA020920			Approved	Vesicles	"Secreted to extracellular matrix"			Vesicles		"HPA020920: AB_1858850"	"unprognostic (1.90e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.88e-2)"	"unprognostic (4.11e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.43e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.10e-1)"	1.8	0.0	0.2	0.1	1.1	0.0	1.4	0.3	2.3	3.0	0.2	0.4	0.4	0.0	10.4	2.7	0.4	1.0	0.2	0.7	0.9	0.9	0.3	0.8	10.9	0.0	0.1	0.5	0.8	0.1	0.0	0.2	40.9	0.5	7.6	0.0	0.9	0.1	0.5	0.0	1.1	0.2	1.2	0.2	1.5	0.1	0.7	0.0	0.0	0.2	0.0	0.1	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	1.4	2.1	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.3	2.3	0.9	0.9	0.1	0.5	0.5	0.0
WNT3	"INT4, MGC131950, MGC138321, MGC138323"	ENSG00000108379	"Wnt family member 3"	P56703	17	46762506-46833154	"Disease related genes, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 7.8;skin 1: 17.2"	"Cell line enhanced"	"Detected in many"		"AF22: 10.1;U-698: 11.1"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 13.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA066281			Approved	Vesicles	"Secreted to extracellular matrix"			Vesicles		"HPA066281: "	"unprognostic (1.84e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.35e-1)"	"unprognostic (6.41e-4)"	"unprognostic (4.73e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.97e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.10e-8)"	"unprognostic (1.77e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.38e-1)"	0.5	0.6	1.0	0.6	3.9	0.4	0.4	1.4	4.7	0.2	0.2	3.8	0.1	4.7	0.3	0.4	0.6	0.4	0.4	0.6	1.4	2.9	0.6	7.8	0.3	2.9	2.1	3.5	0.6	0.3	6.0	0.9	0.7	4.1	0.8	0.6	0.1	1.2	0.3	0.5	17.2	1.4	0.5	1.6	0.5	0.4	2.4	2.3	0.1	0.6	1.4	0.5	0.2	0.3	1.0	1.4	0.2	0.3	0.0	1.2	0.1	2.5	0.0	10.1	0.0	0.0	0.0	0.9	0.8	0.6	1.8	0.0	2.6	2.0	1.9	1.1	0.4	1.2	0.4	0.0	2.2	0.0	0.2	0.0	0.5	2.2	0.0	0.0	0.3	0.0	1.4	0.3	0.6	0.5	1.6	0.0	0.3	0.4	0.0	1.6	0.1	1.1	1.0	1.9	0.1	0.1	0.0	0.2	0.7	1.4	0.0	0.5	0.0	2.4	0.0	3.1	1.3	0.5	0.7	0.3	0.2	11.1	0.5	0.0	1.0	0.2	0.1	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.4	0.1	0.3	0.0	0.0	0.3	1.4	1.2	0.1	1.0	3.9	1.4	4.7	1.4	2.9	2.1	3.5	4.1	2.3
WNT3A		ENSG00000154342	"Wnt family member 3A"	P56704	1	228007051-228061260	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"lung: 7.4;placenta: 19.9"	"Group enriched"	"Detected in some"	9	"HEK 293: 2.7;U-2 OS: 9.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA066281			Approved	Vesicles	"Secreted to extracellular matrix"			Vesicles		"HPA066281: "	"unprognostic (9.84e-3)"	"prognostic favourable (6.11e-5)"	"unprognostic (2.40e-1)"	"unprognostic (3.37e-1)"		"unprognostic (7.82e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.22e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.80e-3)"	"unprognostic (1.99e-1)"	"unprognostic (7.26e-2)"	"unprognostic (5.43e-3)"	"unprognostic (1.54e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.6	0.1	0.1	0.1	0.0	0.1	0.1	2.0	0.2	0.1	0.1	0.1	0.0	0.2	0.1	7.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	19.9	0.1	2.4	0.0	0.1	1.7	0.1	0.1	3.0	0.1	0.1	0.6	0.1	0.0	1.0	0.1	0.1	0.1	0.1	0.1	0.1	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1
WNT5A	hWNT5A	ENSG00000114251	"Wnt family member 5A"	P41221	3	55465715-55490539	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Wnt signaling pathway"	"Developmental protein"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 26.8"	"Cell line enhanced"	"Detected in many"		"BJ: 42.1;BJ hTERT+: 58.0;HeLa: 44.3;SiHa: 65.7;U-87 MG: 47.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"						"unprognostic (2.34e-3)"	"unprognostic (1.35e-1)"	"prognostic favourable (2.94e-5)"	"unprognostic (1.37e-1)"	"unprognostic (3.45e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.89e-2)"	"unprognostic (9.58e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.81e-3)"	"unprognostic (9.70e-3)"	"unprognostic (2.40e-1)"	"unprognostic (5.42e-3)"	"unprognostic (3.63e-2)"	2.1	0.8	3.4	3.8	2.0	0.0	3.4	2.5	3.8	6.1	2.3	1.6	6.8	2.2	19.6	2.8	15.8	4.8	5.0	2.3	2.6	2.0	2.7	1.6	3.6	4.6	2.3	1.3	8.2	5.3	0.1	1.9	25.6	2.0	5.0	2.1	1.0	26.8	18.2	1.1	2.3	2.5	4.2	4.8	2.5	2.2	1.6	2.5	1.9	2.7	13.1	6.8	21.0	10.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	3.0	7.2	0.0	42.1	58.0	8.6	15.2	0.2	0.0	1.2	0.1	23.9	0.0	1.8	0.0	9.0	0.0	1.1	1.1	44.3	0.0	6.7	0.0	0.0	4.7	1.1	26.0	1.4	0.0	0.0	20.6	20.8	0.0	0.0	0.0	2.1	2.5	0.0	2.6	0.1	1.1	1.4	0.0	0.2	65.7	8.0	0.0	0.0	0.0	0.0	14.6	2.6	13.2	3.3	4.9	0.0	0.4	47.2	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	2.0	2.5	3.8	2.6	2.0	2.3	1.3	2.0	2.5
WNT5B		ENSG00000111186	"Wnt family member 5B"	Q9H1J7	12	1529891-1647243	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 51.3;BJ hTERT+: 32.2;BJ hTERT+ SV40 Large T+: 37.6;BJ hTERT+ SV40 Large T+ RasG12V: 31.3;fHDF/TERT166: 35.8;HBF TERT88: 33.1;hTEC/SVTERT24-B: 32.8;U-138 MG: 32.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"classical monocyte: 4.6;eosinophil: 3.5;intermediate monocyte: 2.1;myeloid DC: 2.1"	"Group enriched"	"Detected in many"	13	"dendritic cells: 2.1;granulocytes: 3.5;monocytes: 4.6"	"Low region specificity"	"Detected in many"							HPA061991			Approved	Vesicles	"Secreted to extracellular matrix"			Vesicles		"HPA061991: "	"unprognostic (7.44e-2)"	"unprognostic (5.59e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.02e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.49e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.71e-2)"	4.1	1.7	1.6	6.5	3.4	0.1	4.1	1.0	1.7	8.0	14.1	1.3	19.4	3.0	6.3	6.2	11.9	4.8	3.6	2.9	1.4	3.0	2.7	3.3	2.7	4.0	1.8	0.5	5.3	0.7	13.6	7.1	2.7	2.3	23.4	4.4	5.8	14.2	16.5	0.7	3.4	5.2	17.8	1.4	4.3	4.0	1.7	1.0	2.9	1.2	5.1	5.0	23.3	14.3	0.0	2.1	3.5	4.6	0.0	0.2	1.3	0.0	0.0	0.3	0.0	8.0	14.3	0.0	51.3	32.2	37.6	31.3	1.9	0.2	0.6	0.0	35.8	0.7	0.7	0.0	33.1	11.9	1.7	2.7	0.0	0.0	1.9	0.0	0.0	11.9	0.7	32.8	9.4	0.0	2.0	11.7	8.8	0.0	0.0	0.0	1.3	0.1	0.0	0.5	0.8	0.4	0.0	0.2	0.7	1.0	0.1	0.0	0.0	0.2	0.0	32.6	1.3	12.8	26.1	3.1	0.4	0.1	3.1	0.0	0.3	0.0	4.6	3.5	0.0	2.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	1.3	1.6	3.4	1.0	1.7	1.4	3.0	1.8	0.5	2.3	1.0
WNT6		ENSG00000115596	"Wnt family member 6"	Q9Y6F9	2	218859821-218874233	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.4"	"Cell line enriched"	"Detected in some"	7	"BEWO: 27.5"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 8.7"	"Group enriched"	"Detected in many"	7	"basal ganglia: 23.4;thalamus: 7.4"	"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.1;NK-cell: 1.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA070759	Approved				"Secreted to extracellular matrix"					"HPA070759: "	"unprognostic (1.86e-2)"	"unprognostic (6.03e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.32e-2)"	"unprognostic (7.34e-2)"	"unprognostic (8.08e-3)"	"unprognostic (4.73e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.24e-3)"	"unprognostic (5.26e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.07e-1)"	2.5	3.5	0.8	1.4	23.4	0.6	15.0	0.9	2.1	4.0	5.7	0.2	1.1	1.3	2.3	2.0	3.1	2.3	2.1	4.8	0.9	0.3	1.6	0.7	0.7	1.3	2.1	0.1	2.9	1.7	0.6	1.7	9.8	1.4	4.0	0.9	4.3	1.9	2.1	2.4	2.3	2.3	2.0	2.4	6.4	2.3	3.7	7.4	0.0	0.7	0.8	1.2	1.5	11.1	0.7	1.1	0.0	0.6	1.5	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	27.5	0.0	0.0	0.0	0.0	2.6	0.4	0.0	3.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.0	2.7	0.1	0.0	0.0	4.0	1.3	0.0	0.0	0.1	3.6	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.7	0.0	0.0	0.0	1.5	0.0	0.7	0.0	0.0	0.8	23.4	0.9	0.9	0.9	0.3	2.1	0.1	1.4	7.4
WNT8A	WNT8D	ENSG00000061492	"Wnt family member 8A"	Q9H1J5	5	138083892-138092365	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 2.5;testis: 3.2"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.1;Hep G2: 2.5"	"Cancer enriched"	"Detected in single"	12	"testis cancer: 0.5"	"Region enhanced"	"Detected in single"		"basal ganglia: 2.5"	"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.1"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA038539	Uncertain				"Secreted to extracellular matrix"					"HPA038539: AB_10669646"					"unprognostic (1.11e-5)"					"unprognostic (4.11e-2)"					"unprognostic (4.11e-2)"	"unprognostic (5.32e-2)"		0.1	0.0	0.2	0.1	2.5	0.1	0.4	0.7	0.8	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.6	0.1	0.1	0.3	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	3.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.2	2.5	0.7	0.8	0.3	0.3	0.1	0.1	0.1	0.1
WNT8B		ENSG00000075290	"Wnt family member 8B"	Q93098	10	100463041-100483744	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 3.3;parathyroid gland: 3.8"	"Cell line enhanced"	"Detected in some"		"AF22: 6.5;MOLT-4: 2.2;RPMI-8226: 2.6;SCLC-21H: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA036570	Uncertain				"Secreted to extracellular matrix"					"HPA036570: AB_10670113"	"unprognostic (6.92e-2)"	"unprognostic (1.57e-1)"	"unprognostic (7.13e-2)"	"unprognostic (6.67e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.64e-1)"	"unprognostic (9.16e-4)"	"unprognostic (1.95e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.42e-3)"	"unprognostic (5.02e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.24e-2)"	0.2	3.3	0.2	0.2	0.5	0.0	0.3	0.3	0.3	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.4	2.3	0.2	0.2	0.2	0.2	0.2	0.3	1.6	3.8	0.5	0.2	0.2	0.7	0.0	0.2	2.1	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.1	2.6	0.2	2.2	0.2	0.2	0.2	1.6	0.2	0.0	0.3	0.7	0.0	0.0	1.3	0.3	0.0	0.0	6.5	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.1	0.0	1.0	0.2	0.0	0.0	0.6	1.3	0.0	0.0	0.2	0.0	1.8	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	1.8	2.2	0.0	0.0	0.4	0.7	0.0	2.6	0.0	1.9	3.0	0.8	0.0	0.0	0.1	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.3	0.7	0.0	0.0	0.3	0.0	0.3	0.2	0.5	0.3	0.2	0.2	0.4	0.2	0.2	0.2	0.2
WNT9A	WNT14	ENSG00000143816	"Wnt family member 9A"	O14904	1	227918656-227947898	"Plasma proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 12.9;PC-3: 8.7;RH-30: 13.3;SCLC-21H: 12.1;SiHa: 11.7;U-2197: 8.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to extracellular matrix"						"unprognostic (2.27e-2)"	"unprognostic (3.24e-1)"	"unprognostic (3.77e-3)"	"unprognostic (4.57e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.23e-1)"	"prognostic unfavourable (1.06e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.72e-2)"	"unprognostic (8.71e-2)"	"unprognostic (5.04e-2)"	"unprognostic (9.93e-2)"	2.4	1.4	1.0	13.1	0.5	0.2	2.6	1.4	1.0	4.0	14.1	2.6	2.2	1.9	6.3	4.7	9.5	5.4	15.3	14.6	0.7	0.9	0.8	0.4	9.2	2.1	0.8	0.1	8.9	7.5	0.8	4.3	4.3	3.1	4.7	1.6	4.9	4.9	4.2	20.2	1.0	6.8	8.3	0.6	1.2	5.7	1.8	1.0	0.6	1.8	10.6	4.0	7.1	3.0	0.4	0.0	0.0	0.0	0.0	0.9	0.0	0.7	2.6	0.3	0.1	0.3	0.6	6.6	0.9	0.7	0.1	0.0	0.0	7.0	0.0	3.8	1.1	12.9	0.3	0.6	0.0	1.2	0.5	0.0	4.3	0.2	0.3	0.0	0.4	0.1	3.2	0.1	0.1	0.8	0.0	0.0	1.4	1.7	0.0	0.0	0.8	8.7	0.2	13.3	1.3	3.7	0.8	12.1	0.0	11.7	5.3	0.0	6.7	1.4	0.5	1.7	1.1	8.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	0.5	1.4	0.7	0.7	0.9	0.8	0.1	3.1	1.0
XCL1	"ATAC, LPTN, LTN, SCM-1, SCM-1a, SCYC1"	ENSG00000143184	"X-C motif chemokine ligand 1"	P47992	1	168576473-168582077	"Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	6	"blood: 33.8;lymphoid tissue: 29.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.6;CACO-2: 4.8;Hep G2: 6.1;SCLC-21H: 5.8;U-266/70: 8.3;U-266/84: 3.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	10	"NK-cell: 33.8"	"Lineage enriched"	"Detected in many"	10	"NK-cells: 33.8"									HPA057725	Approved				"Secreted to blood"					"HPA057725: "	"unprognostic (5.38e-3)"	"unprognostic (5.72e-2)"	"unprognostic (8.23e-3)"	"unprognostic (4.19e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.96e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.34e-2)"	"unprognostic (4.61e-1)"	"unprognostic (8.85e-2)"	"unprognostic (5.34e-10)"	"unprognostic (1.96e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.15e-2)"	1.7	0.4	0.6	8.8	0.6	5.0	1.3	0.7	0.5	1.5	1.1	0.2	0.0	1.4	4.8	2.8	1.4	1.8	1.6	2.6	0.6	0.9	1.8	3.9	4.1	10.7	0.8	0.0	1.0	2.4	0.0	0.7	3.7	0.3	1.6	1.5	1.6	3.7	0.6	0.4	0.6	2.6	1.0	1.1	10.6	1.7	0.5	0.1	29.6	1.3	2.2	5.9	2.9	1.3	0.0	0.0	0.8	0.0	33.8	3.3	0.7	1.6	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	6.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	2.1	5.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	8.3	3.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	3.2	0.0	0.1	0.0	0.5	3.3	0.0	0.0	0.1	2.5	0.1	33.8	0.0	0.0	0.0	0.7	0.6	0.6	0.7	0.5	0.6	0.9	0.8	0.0	0.3	0.1
XCL2	"SCM-1b, SCYC2"	ENSG00000143185	"X-C motif chemokine ligand 2"	Q9UBD3	1	168540765-168543997	"Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 73.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.3;CACO-2: 7.0;HSkMC: 1.3;RT4: 3.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	8	"NK-cell: 73.4"	"Lineage enriched"	"Detected in many"	8	"NK-cells: 73.4"									HPA057725	Approved				"Secreted to blood"					"HPA057725: "	"unprognostic (9.88e-3)"	"unprognostic (7.89e-3)"	"unprognostic (4.77e-2)"	"unprognostic (9.32e-3)"	"unprognostic (8.21e-2)"	"unprognostic (6.79e-4)"	"unprognostic (9.33e-2)"	"prognostic favourable (3.17e-4)"	"unprognostic (1.58e-3)"	"unprognostic (6.26e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.12e-1)"	"prognostic unfavourable (8.36e-9)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.06e-1)"	1.9	0.6	0.5	10.0	0.5	11.8	3.0	0.4	0.4	1.2	1.4	0.2	0.9	2.6	5.4	2.8	0.9	1.4	4.7	2.0	0.5	0.5	1.2	4.6	6.7	4.4	0.6	0.4	0.6	1.9	0.0	0.7	7.0	0.3	2.2	1.1	2.4	4.8	0.9	0.4	0.6	3.9	1.0	1.1	19.3	2.3	0.4	0.0	10.6	1.3	1.4	3.9	2.3	1.2	0.0	0.0	0.3	0.0	73.4	9.5	2.9	0.4	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	1.0	0.0	7.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	3.0	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.2	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	9.5	0.0	0.5	0.0	0.7	9.4	0.0	0.0	0.4	7.6	0.3	73.4	0.0	0.0	0.0	2.9	0.5	0.5	0.4	0.4	0.5	0.5	0.6	0.4	0.3	0.0
XYLT1	"PXYLT1, XT-I"	ENSG00000103489	"Xylosyltransferase 1"	Q86Y38	16	17101769-17470881	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"		"Glycosyltransferase, Transferase"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 18.8;U-2197: 19.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007478, HPA007966"	Approved		Approved	"Endoplasmic reticulum,Plasma membrane"	"Secreted to blood"	30000	30000	"Plasma membrane"	"Endoplasmic reticulum"	"HPA007478: AB_1080616, HPA007966: AB_1080618"	"unprognostic (1.82e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.83e-1)"	"unprognostic (9.12e-2)"	"unprognostic (8.13e-2)"	"unprognostic (9.40e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.66e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.95e-1)"	"unprognostic (6.05e-2)"	5.7	5.9	6.3	21.6	3.1	5.9	7.0	3.8	6.7	8.0	7.4	1.4	0.9	3.9	7.4	3.0	4.9	3.2	4.4	3.8	6.3	4.2	1.9	0.9	2.9	7.5	4.3	2.2	5.5	2.6	0.2	1.8	5.4	2.6	4.4	4.9	3.4	2.6	4.3	1.3	4.1	4.7	5.1	3.9	6.3	3.2	3.0	2.1	4.6	2.7	6.7	6.6	4.7	4.2	1.2	0.8	1.2	3.6	0.9	0.7	0.5	0.0	0.1	2.6	0.0	18.8	11.7	3.2	8.4	4.3	0.9	0.4	0.1	0.2	2.0	0.0	10.1	0.2	0.0	1.7	1.5	4.0	0.2	2.5	0.0	0.0	0.2	3.6	3.4	4.3	0.2	5.4	0.8	0.0	0.3	7.9	0.9	0.3	0.0	3.9	2.8	0.0	1.2	0.0	0.4	0.0	3.8	0.7	5.1	0.6	2.6	0.5	0.6	2.3	0.0	8.8	1.0	19.3	0.0	8.8	0.5	3.8	9.8	4.1	7.4	0.6	0.6	1.2	0.6	2.5	0.7	1.2	0.5	0.3	0.8	1.2	0.5	0.4	0.3	0.9	3.6	0.2	0.7	0.5	6.3	3.1	3.8	5.3	6.3	4.2	4.3	2.2	2.6	2.1
ZG16	"hZG16, JCLN, JCLN1, ZG16A"	ENSG00000174992	"Zymogen granule protein 16"	O60844	16	29778240-29782973	"Predicted secreted proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 84.6"	"Cell line enhanced"	"Detected in some"		"MCF7: 1.8;SK-BR-3: 6.9"	"Cancer enriched"	"Detected in some"	6	"colorectal cancer: 21.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA052066, HPA052512"	Enhanced				"Secreted to digestive system"	250000	250000			"HPA052066: AB_2681716, HPA052512: AB_2681857"	"unprognostic (1.64e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.60e-3)"	"unprognostic (8.20e-2)"		"unprognostic (3.50e-2)"	"unprognostic (1.93e-2)"	"unprognostic (5.14e-2)"		"unprognostic (1.65e-1)"	"unprognostic (7.77e-2)"	"unprognostic (3.27e-1)"		"unprognostic (2.56e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.42e-1)"	0.2	0.0	0.2	13.3	0.2	0.0	0.2	0.2	0.2	0.2	67.8	0.2	0.2	9.9	0.2	0.2	0.2	0.1	0.4	0.2	0.2	0.0	0.2	3.6	0.2	0.2	0.2	0.2	0.2	8.9	0.0	0.2	0.2	0.2	0.2	84.6	0.2	0.2	0.2	0.2	0.0	51.6	2.3	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.7	0.2	0.4	0.7	1.1	1.0	0.1	0.7	0.2	0.1	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.2	0.1	0.1	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	1.2	0.1	0.1	0.0	0.1	0.7	0.0	0.3	0.2	0.4	0.0	6.9	0.0	0.4	0.0	0.1	0.0	0.0	0.7	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.4	0.7	0.1	0.5	0.3	0.6	0.3	0.6	0.5	0.0	0.7	0.9	1.0	0.4	1.1	0.3	0.2	0.5	0.1	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
ZPBP2	"MGC41930, ZPBPL"	ENSG00000186075	"Zona pellucida binding protein 2"	Q6X784	17	39868164-39877896	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	32	"testis: 85.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.8;U-698: 10.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.6"	"Group enriched"	"Detected in many"	8	"B-cells: 2.6;T-cells: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA027997, HPA053070"	Enhanced				"Secreted in male reproductive system"					"HPA027997: AB_1859488, HPA053070: AB_2682033"		"unprognostic (2.14e-2)"						"unprognostic (3.38e-1)"				"unprognostic (1.62e-1)"		"unprognostic (2.87e-1)"	"unprognostic (5.39e-1)"		"unprognostic (2.54e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	85.7	0.0	0.0	0.1	0.0	0.3	0.0	0.0	2.6	0.1	0.1	0.2	0.0	1.0	0.2	0.1	0.1	1.0	0.4	0.3	0.5	0.1	0.3	0.2	0.2	0.5	0.4	0.1	2.8	0.2	0.4	0.1	0.5	0.2	0.5	0.6	1.3	0.4	0.4	0.0	0.3	0.4	0.2	0.2	0.7	0.1	0.2	0.3	0.3	0.8	0.0	0.1	0.1	0.6	0.9	0.7	0.4	0.9	2.1	0.3	0.3	1.0	0.3	0.1	0.6	0.3	0.2	0.0	0.4	0.3	0.3	0.6	0.1	1.0	0.2	10.2	0.3	0.4	0.5	0.0	0.0	0.1	0.4	0.0	0.1	0.8	0.4	1.0	0.0	2.6	1.0	0.5	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
